The table below lists the options of the executed module.
Option | Value |
---|---|
analyze.sites | yes |
region.types | tiling1kb, tiling200bp, genes, promoters, cpgislands, ensembleRegBuildBPall |
differential.permutations | 0 |
differential.comparison.columns | disease_type, disease_type_detailed, sample_source, tumor_location, tumor_size, relapse, metastases_at_diagnosis, comp.column, Tissue_vs_MSC |
differential.comparison.columns.all.pairwise | default |
columns.pairing | default |
differential.site.test.method | limma |
covariate.adjustment.columns | default |
differential.adjustment.sva | yes |
differential.adjustment.celltype | yes |
differential.enrichment.go | yes |
differential.enrichment.lola | yes |
differential.enrichment.lola.dbs | ${LOLACore} |
Differential methylation analysis was conducted on site and region level according to the sample groups specified in the analysis.
The following comparisons were made:
In the following anlyses, p-values on the site level were computed using the limma
method. I.e. hierarchical linear models from the limma package were employed and fitted using an empirical Bayes approach on derived M-values.
Differential methylation on the site level was computed based on a variety of metrics. Of particular interest for the following plots and analyses are the following quantities for each site: a) the difference in mean methylation levels of the two groups being compared, b) the quotient in mean methylation and c) a statistical test (limma or t-test depending on the settings) assessing whether the methylation values in the two groups originate from distinct distributions. Additionally each site was assigned a rank based on each of these three criteria. A combined rank is computed as the maximum (i.e. worst) rank among the three ranks. The smaller the combined rank for a site, the more evidence for differential methylation it exhibits. This section includes scatterplots of the site group means as well as volcano plots of each pairwise comparison colored according to the combined ranks or p-values of a given site.
The following rank cutfoffs have been automatically selected for the analysis of differentially methylated sites:
Rank Cutoff | |
Ewing vs. Healthy (based on disease_type) | 91956 |
Ewing_Cell_Line vs. non.Ewing_Cell_Line (based on disease_type_detailed) | 71879 |
Ewing_Tumor vs. non.Ewing_Tumor (based on disease_type_detailed) | 75419 |
MSC_Ewing vs. non.MSC_Ewing (based on disease_type_detailed) | 73210 |
MSC_normal vs. non.MSC_normal (based on disease_type_detailed) | 91956 |
Graz vs. non.Graz (based on sample_source) | 331571 |
Münster vs. non.Münster (based on sample_source) | 273050 |
Paris vs. non.Paris (based on sample_source) | 222226 |
Vienna vs. non.Vienna (based on sample_source) | 201492 |
abdomen vs. non.abdomen (based on tumor_location) | 283168 |
head_and_neck vs. non.head_and_neck (based on tumor_location) | 335505 |
lower_extremity vs. non.lower_extremity (based on tumor_location) | 231115 |
pelvis vs. non.pelvis (based on tumor_location) | 244007 |
spine vs. non.spine (based on tumor_location) | 255517 |
thorax vs. non.thorax (based on tumor_location) | 228900 |
upper_extremity vs. non.upper_extremity (based on tumor_location) | 249541 |
greater_than_200mL vs. less_than_200mL (based on tumor_size) | 409269 |
no_relapse vs. relapse (based on relapse) | 156026 |
metastases vs. no_metastases (based on metastases_at_diagnosis) | 164839 |
Ewing_Cell_Line vs. Ewing_Tumor (based on comp.column) | 59565 |
Ewing_Tumor vs. MSC (based on Tissue_vs_MSC) | 123532 |
comparison | |
differential methylation measure |
Scatterplot for differential methylation (sites). If the selected criterion is not rankGradient
:
The transparency corresponds to point density. If the number of points exceeds 2e+06 then the number of points for density estimation is reduced to that number by random sampling.The1% of the points in the sparsest populated plot regions are drawn explicitly (up to a maximum of 10000 points).Additionally, the colored points represent differentially methylated sites (according to the selected criterion).
If the selected criterion is rankGradient
: median combined ranks accross hexagonal bins are shown
as a gradient according to the color legend.
comparison | |
difference metric | |
significance metric |
Volcano plot for differential methylation quantified by various metrics. Color scale according to combined ranking.
A tabular overview of measures for differential methylation on the site level for the individual comparisons are provided in this section. Below, a brief explanation of the different columns can be found:
The tables for the individual comparisons can be found here:
Differentially variable sites were computed with diffVar
. For more information about the method, have a look at the missMethyl Bioconductor package.[1] This section contains plots and tables describing the results of this test and further analyses of the sites that were selected as differentially variable. Please note that missing methylation values have been imputed with none.
The following rank cutoffs have been automatically selected for the analysis of differentially variable sites:
Rank Cutoff | |
Ewing vs. Healthy (based on disease_type) | 37696 |
Ewing_Cell_Line vs. non.Ewing_Cell_Line (based on disease_type_detailed) | 41266 |
Ewing_Tumor vs. non.Ewing_Tumor (based on disease_type_detailed) | 49972 |
MSC_Ewing vs. non.MSC_Ewing (based on disease_type_detailed) | 95107 |
MSC_normal vs. non.MSC_normal (based on disease_type_detailed) | 37696 |
Graz vs. non.Graz (based on sample_source) | 165164 |
Münster vs. non.Münster (based on sample_source) | 117306 |
Paris vs. non.Paris (based on sample_source) | 91799 |
Vienna vs. non.Vienna (based on sample_source) | 76835 |
abdomen vs. non.abdomen (based on tumor_location) | 40305 |
head_and_neck vs. non.head_and_neck (based on tumor_location) | 84587 |
lower_extremity vs. non.lower_extremity (based on tumor_location) | 86053 |
pelvis vs. non.pelvis (based on tumor_location) | 76683 |
spine vs. non.spine (based on tumor_location) | 97190 |
thorax vs. non.thorax (based on tumor_location) | 81168 |
upper_extremity vs. non.upper_extremity (based on tumor_location) | 42071 |
greater_than_200mL vs. less_than_200mL (based on tumor_size) | 80857 |
no_relapse vs. relapse (based on relapse) | 85233 |
metastases vs. no_metastases (based on metastases_at_diagnosis) | 54706 |
Ewing_Cell_Line vs. Ewing_Tumor (based on comp.column) | 59148 |
Ewing_Tumor vs. MSC (based on Tissue_vs_MSC) | 70237 |
comparison | |
differential variability measure |
Scatterplot for differential variable sites. The transparency corresponds to point density. If the number of points exceeds 2e+06 then the number of points for density estimation is reduced to that number by random sampling. The1% of the points in the sparsest populated plot regions are drawn explicitly (up to a maximum of 10000 points). Additionally, the colored points represent differentially variable sites (according to the selected criterion).
Differential methylation on the region level was computed based on a variety of metrics. Of particular interest for the following plots and analyses are the following quantities for each region: the mean difference in means across all sites in a region of the two groups being compared and the mean of quotients in mean methylation as well as a combined p-value calculated from all site p-values in the region [2]. Additionally each region was assigned a rank based on each of these three criteria. A combined rank is computed as the maximum (i.e. worst) value among the three ranks. The smaller the combined rank for a region, the more evidence for differential methylation it exhibits. Regions were defined based on the region types specified in the analysis. This section includes scatterplots of the region group means as well as volcano plots of each pairwise comparison colored according to the combined rank of a given region.
The following rank cutfoffs have been automatically selected for the analysis of differentially methylated regions:
tiling1kb | tiling200bp | genes | promoters | cpgislands | ensembleRegBuildBPall | |
Ewing vs. Healthy (based on disease_type) | 14628 | 27135 | 1516 | 1506 | 1660 | 8924 |
Ewing_Cell_Line vs. non.Ewing_Cell_Line (based on disease_type_detailed) | 13654 | 21984 | 3468 | 3783 | 2805 | 7581 |
Ewing_Tumor vs. non.Ewing_Tumor (based on disease_type_detailed) | 20230 | 38124 | 1896 | 2628 | 3129 | 7167 |
MSC_Ewing vs. non.MSC_Ewing (based on disease_type_detailed) | 16058 | 35395 | 1446 | 1776 | 843 | 8438 |
MSC_normal vs. non.MSC_normal (based on disease_type_detailed) | 14628 | 27135 | 1516 | 1506 | 1660 | 8924 |
Graz vs. non.Graz (based on sample_source) | 48701 | 95930 | 1194 | 2150 | 559 | 13033 |
Münster vs. non.Münster (based on sample_source) | 5985 | 21828 | 116 | 397 | 456 | 1516 |
Paris vs. non.Paris (based on sample_source) | 3906 | 21131 | 32 | 135 | 250 | 167 |
Vienna vs. non.Vienna (based on sample_source) | 322 | 2800 | 63 | 51 | 134 | 176 |
abdomen vs. non.abdomen (based on tumor_location) | 14835 | 40170 | 395 | 625 | 555 | 3839 |
head_and_neck vs. non.head_and_neck (based on tumor_location) | 19429 | 48273 | 653 | 1197 | 362 | 4327 |
lower_extremity vs. non.lower_extremity (based on tumor_location) | 248 | 3527 | 46 | 83 | 73 | 96 |
pelvis vs. non.pelvis (based on tumor_location) | 560 | 4485 | 34 | 85 | 80 | 207 |
spine vs. non.spine (based on tumor_location) | 9122 | 23494 | 220 | 313 | 85 | 1679 |
thorax vs. non.thorax (based on tumor_location) | 184 | 3006 | 21 | 24 | 51 | 145 |
upper_extremity vs. non.upper_extremity (based on tumor_location) | 3686 | 12265 | 161 | 182 | 181 | 766 |
greater_than_200mL vs. less_than_200mL (based on tumor_size) | 1624 | 12738 | 156 | 188 | 123 | 431 |
no_relapse vs. relapse (based on relapse) | 540 | 3372 | 63 | 129 | 84 | 252 |
metastases vs. no_metastases (based on metastases_at_diagnosis) | 4104 | 27127 | 130 | 118 | 129 | 329 |
Ewing_Cell_Line vs. Ewing_Tumor (based on comp.column) | 5226 | 12430 | 3188 | 3212 | 3108 | 3330 |
Ewing_Tumor vs. MSC (based on Tissue_vs_MSC) | 32569 | 63613 | 1615 | 964 | 2025 | 8194 |
comparison | |
regions | |
differential methylation measure |
Scatterplot for differential methylation (regions). If the selected criterion is not rankGradient
:
The transparency corresponds to point density. The 1% of the points in the sparsest populated plot regions are drawn explicitly.
Additionally, the colored points represent differentially methylated regions (according to the selected criterion).
If the selected criterion is rankGradient
: median combined ranks accross hexagonal bins are shown
as a gradient according to the color legend.
comparison | |
regions | |
difference metric | |
significance metric |
Volcano plot for differential methylation quantified by various metrics. Color scale according to combined ranking.
A tabular overview of measures for differential methylation on the region level for the individual comparisons are provided in this section.
The tables for the individual comparisons can be found here:
tiling1kb | tiling200bp | genes | promoters | cpgislands | ensembleRegBuildBPall | |
Ewing vs. Healthy (based on disease_type) | csv | csv | csv | csv | csv | csv |
Ewing_Cell_Line vs. non.Ewing_Cell_Line (based on disease_type_detailed) | csv | csv | csv | csv | csv | csv |
Ewing_Tumor vs. non.Ewing_Tumor (based on disease_type_detailed) | csv | csv | csv | csv | csv | csv |
MSC_Ewing vs. non.MSC_Ewing (based on disease_type_detailed) | csv | csv | csv | csv | csv | csv |
MSC_normal vs. non.MSC_normal (based on disease_type_detailed) | csv | csv | csv | csv | csv | csv |
Graz vs. non.Graz (based on sample_source) | csv | csv | csv | csv | csv | csv |
Münster vs. non.Münster (based on sample_source) | csv | csv | csv | csv | csv | csv |
Paris vs. non.Paris (based on sample_source) | csv | csv | csv | csv | csv | csv |
Vienna vs. non.Vienna (based on sample_source) | csv | csv | csv | csv | csv | csv |
abdomen vs. non.abdomen (based on tumor_location) | csv | csv | csv | csv | csv | csv |
head_and_neck vs. non.head_and_neck (based on tumor_location) | csv | csv | csv | csv | csv | csv |
lower_extremity vs. non.lower_extremity (based on tumor_location) | csv | csv | csv | csv | csv | csv |
pelvis vs. non.pelvis (based on tumor_location) | csv | csv | csv | csv | csv | csv |
spine vs. non.spine (based on tumor_location) | csv | csv | csv | csv | csv | csv |
thorax vs. non.thorax (based on tumor_location) | csv | csv | csv | csv | csv | csv |
upper_extremity vs. non.upper_extremity (based on tumor_location) | csv | csv | csv | csv | csv | csv |
greater_than_200mL vs. less_than_200mL (based on tumor_size) | csv | csv | csv | csv | csv | csv |
no_relapse vs. relapse (based on relapse) | csv | csv | csv | csv | csv | csv |
metastases vs. no_metastases (based on metastases_at_diagnosis) | csv | csv | csv | csv | csv | csv |
Ewing_Cell_Line vs. Ewing_Tumor (based on comp.column) | csv | csv | csv | csv | csv | csv |
Ewing_Tumor vs. MSC (based on Tissue_vs_MSC) | csv | csv | csv | csv | csv | csv |
Differential variability on the region level was computed similar to differential methylation, but the mean of variances, the log-ratio of the quotient of variances as well as the p-values from the differentiality test were employed. Ranking was performed in line with the ranking of differential methylation.
The following rank cutoffs have been automatically selected for the analysis of differentially variable regions:
tiling1kb | tiling200bp | genes | promoters | cpgislands | ensembleRegBuildBPall | |
Ewing vs. Healthy (based on disease_type) | 13373 | 11502 | 1548 | 1322 | 476 | 6485 |
Ewing_Cell_Line vs. non.Ewing_Cell_Line (based on disease_type_detailed) | 8047 | 13189 | 830 | 1281 | 1595 | 2035 |
Ewing_Tumor vs. non.Ewing_Tumor (based on disease_type_detailed) | 10763 | 19445 | 952 | 1195 | 1018 | 3128 |
MSC_Ewing vs. non.MSC_Ewing (based on disease_type_detailed) | 18272 | 27660 | 1170 | 2833 | 2352 | 7037 |
MSC_normal vs. non.MSC_normal (based on disease_type_detailed) | 13373 | 11324 | 1548 | 1459 | 604 | 6473 |
Graz vs. non.Graz (based on sample_source) | 24441 | 61810 | 3474 | 2552 | 3353 | 6790 |
Münster vs. non.Münster (based on sample_source) | 14623 | 27321 | 2242 | 2351 | 1887 | 3630 |
Paris vs. non.Paris (based on sample_source) | 8541 | 20263 | 1075 | 2483 | 1152 | 3415 |
Vienna vs. non.Vienna (based on sample_source) | 6278 | 18665 | 1568 | 1771 | 1084 | 6349 |
abdomen vs. non.abdomen (based on tumor_location) | 15556 | 10277 | 2213 | 2911 | 3246 | 6112 |
head_and_neck vs. non.head_and_neck (based on tumor_location) | 24311 | 32741 | 1970 | 3794 | 2479 | 4857 |
lower_extremity vs. non.lower_extremity (based on tumor_location) | 14380 | 16144 | 89 | 1203 | 229 | 2556 |
pelvis vs. non.pelvis (based on tumor_location) | 11406 | 27821 | 132 | 1224 | 329 | 3363 |
spine vs. non.spine (based on tumor_location) | 19903 | 39972 | 797 | 1485 | 967 | 4524 |
thorax vs. non.thorax (based on tumor_location) | 8378 | 27482 | 284 | 2880 | 2428 | 1928 |
upper_extremity vs. non.upper_extremity (based on tumor_location) | 9879 | 21115 | 2229 | 1964 | 1775 | 5223 |
greater_than_200mL vs. less_than_200mL (based on tumor_size) | 18493 | 24864 | 132 | 664 | 427 | 3631 |
no_relapse vs. relapse (based on relapse) | 11832 | 20200 | 96 | 1558 | 367 | 5716 |
metastases vs. no_metastases (based on metastases_at_diagnosis) | 11641 | 20847 | 215 | 1638 | 949 | 3524 |
Ewing_Cell_Line vs. Ewing_Tumor (based on comp.column) | 8323 | 14858 | 766 | 1444 | 869 | 2949 |
Ewing_Tumor vs. MSC (based on Tissue_vs_MSC) | 12233 | 26203 | 1214 | 2763 | 1412 | 4450 |
comparison | |
regions | |
differential variability measure |
Scatterplot for differential variable regions. The transparency corresponds to point density. The 1% of the points in the sparsest populated plot regions are drawn explicitly. Additionally, the colored points represent differentially methylated regions (according to the selected criterion).
comparison | |
regions | |
difference metric | |
significance metric |
Volcano plot for differential variability quantified by various metrics. Color scale according to combined ranking.
comparison | |
regions | |
rankCutoff |
Scatterplot comparing differentially methylated (DMRs) and variable regions (DVRs), as well as regions that are both differentially methylated and variable. The dotted lines corrspond to the respective rank cutoffs used to call a region differentially methylated/variable.
GO Enrichment Analysis was conducted. The wordclouds and tables below contains significant GO terms as determined by a hypergeometric test.
comparison | |
Hypermethylation/hypomethylation | |
ontology | |
regions | |
differential methylation measure |
Wordclouds for GO enrichment terms.
comparison | |
Hypermethylation/hypomethylation | |
ontology | |
regions | |
differential methylation measure |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1903706 | 4e-04 | 9.6333 | 0.6451 | 5 | 409 | regulation of hemopoiesis |
GO:0060216 | 4e-04 | 81.1551 | 0.03 | 2 | 19 | definitive hemopoiesis |
GO:0048534 | 0.0012 | 6.0289 | 1.2649 | 6 | 802 | hematopoietic or lymphoid organ development |
GO:0071345 | 0.0013 | 6.0209 | 1.2665 | 6 | 803 | cellular response to cytokine stimulus |
GO:0010734 | 0.0016 | Inf | 0.0016 | 1 | 1 | negative regulation of protein glutathionylation |
GO:1902867 | 0.0016 | Inf | 0.0016 | 1 | 1 | negative regulation of retina development in camera-type eye |
GO:1902870 | 0.0016 | Inf | 0.0016 | 1 | 1 | negative regulation of amacrine cell differentiation |
GO:0030099 | 0.0021 | 8.457 | 0.5599 | 4 | 355 | myeloid cell differentiation |
GO:0045596 | 0.0022 | 6.4116 | 0.9526 | 5 | 604 | negative regulation of cell differentiation |
GO:0050902 | 0.0032 | 660.5217 | 0.0032 | 1 | 2 | leukocyte adhesive activation |
GO:0071461 | 0.0032 | 660.5217 | 0.0032 | 1 | 2 | cellular response to redox state |
GO:1901003 | 0.0032 | 660.5217 | 0.0032 | 1 | 2 | negative regulation of fermentation |
GO:0051239 | 0.0042 | 3.4436 | 4.1322 | 10 | 2620 | regulation of multicellular organismal process |
GO:0071560 | 0.0043 | 10.2919 | 0.3328 | 3 | 211 | cellular response to transforming growth factor beta stimulus |
GO:0070315 | 0.0047 | 330.2391 | 0.0047 | 1 | 3 | G1 to G0 transition involved in cell differentiation |
GO:1990791 | 0.0047 | 330.2391 | 0.0047 | 1 | 3 | dorsal root ganglion development |
GO:0045652 | 0.0048 | 21.4901 | 0.1041 | 2 | 66 | regulation of megakaryocyte differentiation |
GO:0007275 | 0.0049 | 3.1352 | 7.4191 | 14 | 4704 | multicellular organism development |
GO:0050793 | 0.0052 | 3.4841 | 3.5345 | 9 | 2241 | regulation of developmental process |
GO:0001501 | 0.0057 | 6.3771 | 0.735 | 4 | 466 | skeletal system development |
GO:0050768 | 0.0057 | 9.2529 | 0.3691 | 3 | 234 | negative regulation of neurogenesis |
GO:1903273 | 0.0063 | 220.1449 | 0.0063 | 1 | 4 | regulation of sodium ion export |
GO:1903278 | 0.0063 | 220.1449 | 0.0063 | 1 | 4 | positive regulation of sodium ion export across plasma membrane |
GO:0048869 | 0.0075 | 2.9835 | 6.0343 | 12 | 3826 | cellular developmental process |
GO:0061056 | 0.0079 | 165.0978 | 0.0079 | 1 | 5 | sclerotome development |
GO:0090259 | 0.0079 | 165.0978 | 0.0079 | 1 | 5 | regulation of retinal ganglion cell axon guidance |
GO:0060842 | 0.0094 | 132.0696 | 0.0095 | 1 | 6 | arterial endothelial cell differentiation |
GO:0061074 | 0.0094 | 132.0696 | 0.0095 | 1 | 6 | regulation of neural retina development |
GO:0045664 | 0.0097 | 5.4375 | 0.8564 | 4 | 543 | regulation of neuron differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 104.0247 | 0.0712 | 5 | 57 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 48.5425 | 0.1448 | 5 | 116 | detection of chemical stimulus |
GO:0050906 | 0 | 43.4159 | 0.1611 | 5 | 129 | detection of stimulus involved in sensory perception |
GO:0007606 | 0 | 42.3819 | 0.1648 | 5 | 132 | sensory perception of chemical stimulus |
GO:0050877 | 5e-04 | 7.7234 | 1.0775 | 6 | 863 | nervous system process |
GO:0002041 | 0.0012 | Inf | 0.0012 | 1 | 1 | intussusceptive angiogenesis |
GO:0140076 | 0.0012 | Inf | 0.0012 | 1 | 1 | negative regulation of lipoprotein transport |
GO:0007186 | 0.0031 | 6.1511 | 1.0476 | 5 | 839 | G-protein coupled receptor signaling pathway |
GO:0002803 | 0.0037 | 422.1111 | 0.0037 | 1 | 3 | positive regulation of antibacterial peptide production |
GO:0002249 | 0.005 | 281.3889 | 0.005 | 1 | 4 | lymphocyte anergy |
GO:0002667 | 0.005 | 281.3889 | 0.005 | 1 | 4 | regulation of T cell anergy |
GO:0002760 | 0.005 | 281.3889 | 0.005 | 1 | 4 | positive regulation of antimicrobial humoral response |
GO:0002784 | 0.005 | 281.3889 | 0.005 | 1 | 4 | regulation of antimicrobial peptide production |
GO:0010961 | 0.005 | 281.3889 | 0.005 | 1 | 4 | cellular magnesium ion homeostasis |
GO:0031133 | 0.005 | 281.3889 | 0.005 | 1 | 4 | regulation of axon diameter |
GO:0060591 | 0.0062 | 211.0278 | 0.0062 | 1 | 5 | chondroblast differentiation |
GO:0030198 | 0.0068 | 8.8589 | 0.3971 | 3 | 318 | extracellular matrix organization |
GO:0010811 | 0.0071 | 17.7624 | 0.1274 | 2 | 102 | positive regulation of cell-substrate adhesion |
GO:0003278 | 0.0075 | 168.8111 | 0.0075 | 1 | 6 | apoptotic process involved in heart morphogenesis |
GO:0060842 | 0.0075 | 168.8111 | 0.0075 | 1 | 6 | arterial endothelial cell differentiation |
GO:0090370 | 0.0075 | 168.8111 | 0.0075 | 1 | 6 | negative regulation of cholesterol efflux |
GO:0052548 | 0.0081 | 8.3188 | 0.422 | 3 | 338 | regulation of endopeptidase activity |
GO:0060710 | 0.0087 | 140.6667 | 0.0087 | 1 | 7 | chorio-allantoic fusion |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0010469 | 4e-04 | 15.2402 | 0.384 | 4 | 487 | regulation of receptor activity |
GO:2000872 | 8e-04 | Inf | 8e-04 | 1 | 1 | positive regulation of progesterone secretion |
GO:0042221 | 0.0022 | 6.2658 | 2.9075 | 8 | 3687 | response to chemical |
GO:0008628 | 0.0032 | 460.6667 | 0.0032 | 1 | 4 | hormone-mediated apoptotic signaling pathway |
GO:0007195 | 0.0047 | 276.3636 | 0.0047 | 1 | 6 | adenylate cyclase-inhibiting dopamine receptor signaling pathway |
GO:0030223 | 0.0047 | 276.3636 | 0.0047 | 1 | 6 | neutrophil differentiation |
GO:0060842 | 0.0047 | 276.3636 | 0.0047 | 1 | 6 | arterial endothelial cell differentiation |
GO:0061074 | 0.0047 | 276.3636 | 0.0047 | 1 | 6 | regulation of neural retina development |
GO:0031017 | 0.0063 | 197.3766 | 0.0063 | 1 | 8 | exocrine pancreas development |
GO:0035881 | 0.0063 | 197.3766 | 0.0063 | 1 | 8 | amacrine cell differentiation |
GO:0042117 | 0.0063 | 197.3766 | 0.0063 | 1 | 8 | monocyte activation |
GO:2000252 | 0.0063 | 197.3766 | 0.0063 | 1 | 8 | negative regulation of feeding behavior |
GO:0060158 | 0.0071 | 172.6932 | 0.0071 | 1 | 9 | phospholipase C-activating dopamine receptor signaling pathway |
GO:0097305 | 0.0075 | 18.0096 | 0.1333 | 2 | 169 | response to alcohol |
GO:0001553 | 0.0079 | 153.4949 | 0.0079 | 1 | 10 | luteinization |
GO:0051481 | 0.0079 | 153.4949 | 0.0079 | 1 | 10 | negative regulation of cytosolic calcium ion concentration |
GO:0051967 | 0.0079 | 153.4949 | 0.0079 | 1 | 10 | negative regulation of synaptic transmission, glutamatergic |
GO:1905941 | 0.0079 | 153.4949 | 0.0079 | 1 | 10 | positive regulation of gonad development |
GO:2001214 | 0.0079 | 153.4949 | 0.0079 | 1 | 10 | positive regulation of vasculogenesis |
GO:0002573 | 0.0079 | 17.5836 | 0.1364 | 2 | 173 | myeloid leukocyte differentiation |
GO:0048149 | 0.0086 | 138.1364 | 0.0087 | 1 | 11 | behavioral response to ethanol |
GO:0007268 | 0.0089 | 8.6213 | 0.4487 | 3 | 569 | chemical synaptic transmission |
GO:0099537 | 0.009 | 8.5898 | 0.4503 | 3 | 571 | trans-synaptic signaling |
GO:0071280 | 0.0094 | 125.5702 | 0.0095 | 1 | 12 | cellular response to copper ion |
GO:1901386 | 0.0094 | 125.5702 | 0.0095 | 1 | 12 | negative regulation of voltage-gated calcium channel activity |
GO:2000194 | 0.0094 | 125.5702 | 0.0095 | 1 | 12 | regulation of female gonad development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0035066 | 3e-04 | 97.2949 | 0.0256 | 2 | 26 | positive regulation of histone acetylation |
GO:0031960 | 4e-04 | 26.3269 | 0.1439 | 3 | 146 | response to corticosteroid |
GO:0003203 | 4e-04 | 86.4672 | 0.0286 | 2 | 29 | endocardial cushion morphogenesis |
GO:1901985 | 4e-04 | 80.4934 | 0.0306 | 2 | 31 | positive regulation of protein acetylation |
GO:0031099 | 5e-04 | 22.9238 | 0.1646 | 3 | 167 | regeneration |
GO:0031103 | 7e-04 | 63.0561 | 0.0384 | 2 | 39 | axon regeneration |
GO:0002152 | 0.001 | Inf | 0.001 | 1 | 1 | bile acid conjugation |
GO:2000756 | 0.0012 | 46.6215 | 0.0513 | 2 | 52 | regulation of peptidyl-lysine acetylation |
GO:0071385 | 0.0012 | 45.7044 | 0.0522 | 2 | 53 | cellular response to glucocorticoid stimulus |
GO:0050911 | 0.0014 | 42.3692 | 0.0562 | 2 | 57 | detection of chemical stimulus involved in sensory perception of smell |
GO:0060411 | 0.0018 | 36.9695 | 0.0641 | 2 | 65 | cardiac septum morphogenesis |
GO:0032024 | 0.0019 | 36.3894 | 0.0651 | 2 | 66 | positive regulation of insulin secretion |
GO:0036304 | 0.002 | 1085.7857 | 0.002 | 1 | 2 | umbilical cord morphogenesis |
GO:0046452 | 0.002 | 1085.7857 | 0.002 | 1 | 2 | dihydrofolate metabolic process |
GO:0071657 | 0.002 | 1085.7857 | 0.002 | 1 | 2 | positive regulation of granulocyte colony-stimulating factor production |
GO:2000820 | 0.002 | 1085.7857 | 0.002 | 1 | 2 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation |
GO:1901214 | 0.0021 | 14.2006 | 0.2622 | 3 | 266 | regulation of neuron death |
GO:0003208 | 0.0022 | 33.7414 | 0.07 | 2 | 71 | cardiac ventricle morphogenesis |
GO:1905269 | 0.0029 | 29.0808 | 0.0808 | 2 | 82 | positive regulation of chromatin organization |
GO:0003095 | 0.003 | 542.8571 | 0.003 | 1 | 3 | pressure natriuresis |
GO:0021524 | 0.003 | 542.8571 | 0.003 | 1 | 3 | visceral motor neuron differentiation |
GO:0048936 | 0.003 | 542.8571 | 0.003 | 1 | 3 | peripheral nervous system neuron axonogenesis |
GO:0060913 | 0.003 | 542.8571 | 0.003 | 1 | 3 | cardiac cell fate determination |
GO:0042221 | 0.0039 | 5.1754 | 3.0742 | 8 | 3571 | response to chemical |
GO:0031427 | 0.0039 | 361.881 | 0.0039 | 1 | 4 | response to methotrexate |
GO:0032730 | 0.0039 | 361.881 | 0.0039 | 1 | 4 | positive regulation of interleukin-1 alpha production |
GO:0036101 | 0.0039 | 361.881 | 0.0039 | 1 | 4 | leukotriene B4 catabolic process |
GO:0042360 | 0.0039 | 361.881 | 0.0039 | 1 | 4 | vitamin E metabolic process |
GO:1901256 | 0.0039 | 361.881 | 0.0039 | 1 | 4 | regulation of macrophage colony-stimulating factor production |
GO:0051101 | 0.0048 | 22.3343 | 0.1045 | 2 | 106 | regulation of DNA binding |
GO:0048880 | 0.0049 | 271.3929 | 0.0049 | 1 | 5 | sensory system development |
GO:0090074 | 0.0049 | 271.3929 | 0.0049 | 1 | 5 | negative regulation of protein homodimerization activity |
GO:1901523 | 0.0049 | 271.3929 | 0.0049 | 1 | 5 | icosanoid catabolic process |
GO:0046887 | 0.0054 | 20.9161 | 0.1114 | 2 | 113 | positive regulation of hormone secretion |
GO:0045471 | 0.0056 | 20.5432 | 0.1134 | 2 | 115 | response to ethanol |
GO:0009593 | 0.0057 | 20.3617 | 0.1143 | 2 | 116 | detection of chemical stimulus |
GO:0006545 | 0.0059 | 217.1 | 0.0059 | 1 | 6 | glycine biosynthetic process |
GO:0019530 | 0.0059 | 217.1 | 0.0059 | 1 | 6 | taurine metabolic process |
GO:0030223 | 0.0059 | 217.1 | 0.0059 | 1 | 6 | neutrophil differentiation |
GO:0060842 | 0.0059 | 217.1 | 0.0059 | 1 | 6 | arterial endothelial cell differentiation |
GO:0006766 | 0.006 | 19.8356 | 0.1173 | 2 | 119 | vitamin metabolic process |
GO:0031056 | 0.0062 | 19.4997 | 0.1193 | 2 | 121 | regulation of histone modification |
GO:0003190 | 0.0069 | 180.9048 | 0.0069 | 1 | 7 | atrioventricular valve formation |
GO:0006729 | 0.0069 | 180.9048 | 0.0069 | 1 | 7 | tetrahydrobiopterin biosynthetic process |
GO:0046654 | 0.0069 | 180.9048 | 0.0069 | 1 | 7 | tetrahydrofolate biosynthetic process |
GO:0001837 | 0.007 | 18.2617 | 0.1272 | 2 | 129 | epithelial to mesenchymal transition |
GO:0050906 | 0.007 | 18.2617 | 0.1272 | 2 | 129 | detection of stimulus involved in sensory perception |
GO:0007606 | 0.0073 | 17.8367 | 0.1301 | 2 | 132 | sensory perception of chemical stimulus |
GO:0018393 | 0.0075 | 17.5641 | 0.1321 | 2 | 134 | internal peptidyl-lysine acetylation |
GO:0007186 | 0.0077 | 6.2567 | 0.827 | 4 | 839 | G-protein coupled receptor signaling pathway |
GO:0051100 | 0.0077 | 17.2997 | 0.1341 | 2 | 136 | negative regulation of binding |
GO:0033993 | 0.0078 | 6.233 | 0.83 | 4 | 842 | response to lipid |
GO:2000113 | 0.0079 | 5.122 | 1.3376 | 5 | 1357 | negative regulation of cellular macromolecule biosynthetic process |
GO:0035912 | 0.0079 | 155.051 | 0.0079 | 1 | 8 | dorsal aorta morphogenesis |
GO:0006544 | 0.0083 | 146.0481 | 0.0083 | 1 | 9 | glycine metabolic process |
GO:0003139 | 0.0088 | 135.6607 | 0.0089 | 1 | 9 | secondary heart field specification |
GO:0003266 | 0.0088 | 135.6607 | 0.0089 | 1 | 9 | regulation of secondary heart field cardioblast proliferation |
GO:0061314 | 0.0088 | 135.6607 | 0.0089 | 1 | 9 | Notch signaling involved in heart development |
GO:0051222 | 0.0089 | 8.2713 | 0.4426 | 3 | 449 | positive regulation of protein transport |
GO:0003205 | 0.0097 | 15.3347 | 0.1508 | 2 | 153 | cardiac chamber development |
GO:0003263 | 0.0098 | 120.5794 | 0.0099 | 1 | 10 | cardioblast proliferation |
GO:2000121 | 0.0098 | 120.5794 | 0.0099 | 1 | 10 | regulation of removal of superoxide radicals |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0010665 | 0.0014 | 41.7631 | 0.0552 | 2 | 35 | regulation of cardiac muscle cell apoptotic process |
GO:0003327 | 0.0016 | Inf | 0.0016 | 1 | 1 | type B pancreatic cell fate commitment |
GO:0031989 | 0.0016 | Inf | 0.0016 | 1 | 1 | bombesin receptor signaling pathway |
GO:0060450 | 0.0016 | Inf | 0.0016 | 1 | 1 | positive regulation of hindgut contraction |
GO:0060580 | 0.0016 | Inf | 0.0016 | 1 | 1 | ventral spinal cord interneuron fate determination |
GO:0051094 | 0.0016 | 5.0093 | 1.8311 | 7 | 1161 | positive regulation of developmental process |
GO:0010658 | 0.0018 | 36.256 | 0.0631 | 2 | 40 | striated muscle cell apoptotic process |
GO:0032570 | 0.0023 | 32.0296 | 0.071 | 2 | 45 | response to progesterone |
GO:0000320 | 0.0032 | 660.5217 | 0.0032 | 1 | 2 | re-entry into mitotic cell cycle |
GO:0003326 | 0.0032 | 660.5217 | 0.0032 | 1 | 2 | pancreatic A cell fate commitment |
GO:0003329 | 0.0032 | 660.5217 | 0.0032 | 1 | 2 | pancreatic PP cell fate commitment |
GO:0014718 | 0.0032 | 660.5217 | 0.0032 | 1 | 2 | positive regulation of satellite cell activation involved in skeletal muscle regeneration |
GO:0048627 | 0.0032 | 660.5217 | 0.0032 | 1 | 2 | myoblast development |
GO:0051965 | 0.0034 | 25.9691 | 0.0867 | 2 | 55 | positive regulation of synapse assembly |
GO:0010660 | 0.0035 | 25.4865 | 0.0883 | 2 | 56 | regulation of muscle cell apoptotic process |
GO:0002125 | 0.0047 | 330.2391 | 0.0047 | 1 | 3 | maternal aggressive behavior |
GO:0003245 | 0.0047 | 330.2391 | 0.0047 | 1 | 3 | cardiac muscle tissue growth involved in heart morphogenesis |
GO:0007525 | 0.0047 | 330.2391 | 0.0047 | 1 | 3 | somatic muscle development |
GO:0021530 | 0.0047 | 330.2391 | 0.0047 | 1 | 3 | spinal cord oligodendrocyte cell fate specification |
GO:0045925 | 0.0047 | 330.2391 | 0.0047 | 1 | 3 | positive regulation of female receptivity |
GO:0061737 | 0.0047 | 330.2391 | 0.0047 | 1 | 3 | leukotriene signaling pathway |
GO:0060415 | 0.0062 | 18.8294 | 0.1183 | 2 | 75 | muscle tissue morphogenesis |
GO:0010701 | 0.0063 | 220.1449 | 0.0063 | 1 | 4 | positive regulation of norepinephrine secretion |
GO:0035811 | 0.0063 | 220.1449 | 0.0063 | 1 | 4 | negative regulation of urine volume |
GO:0060406 | 0.0063 | 220.1449 | 0.0063 | 1 | 4 | positive regulation of penile erection |
GO:0070318 | 0.0063 | 220.1449 | 0.0063 | 1 | 4 | positive regulation of G0 to G1 transition |
GO:1905205 | 0.0063 | 220.1449 | 0.0063 | 1 | 4 | positive regulation of connective tissue replacement |
GO:0021779 | 0.0079 | 165.0978 | 0.0079 | 1 | 5 | oligodendrocyte cell fate commitment |
GO:0021780 | 0.0079 | 165.0978 | 0.0079 | 1 | 5 | glial cell fate specification |
GO:0060455 | 0.0079 | 165.0978 | 0.0079 | 1 | 5 | negative regulation of gastric acid secretion |
GO:0009744 | 0.0094 | 132.0696 | 0.0095 | 1 | 6 | response to sucrose |
GO:0014719 | 0.0094 | 132.0696 | 0.0095 | 1 | 6 | skeletal muscle satellite cell activation |
GO:0042713 | 0.0094 | 132.0696 | 0.0095 | 1 | 6 | sperm ejaculation |
GO:0060179 | 0.0094 | 132.0696 | 0.0095 | 1 | 6 | male mating behavior |
GO:0070141 | 0.0094 | 132.0696 | 0.0095 | 1 | 6 | response to UV-A |
GO:1904684 | 0.0094 | 132.0696 | 0.0095 | 1 | 6 | negative regulation of metalloendopeptidase activity |
GO:0007200 | 0.0097 | 14.7605 | 0.1498 | 2 | 95 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0051412 | 3e-04 | 96.3746 | 0.0257 | 2 | 17 | response to corticosterone |
GO:0019098 | 9e-04 | 51.585 | 0.0453 | 2 | 30 | reproductive behavior |
GO:0007618 | 0.0013 | 43.7547 | 0.0529 | 2 | 35 | mating |
GO:0071444 | 0.0015 | Inf | 0.0015 | 1 | 1 | cellular response to pheromone |
GO:0035176 | 0.0021 | 33.557 | 0.068 | 2 | 45 | social behavior |
GO:0045851 | 0.0024 | 31.3623 | 0.0726 | 2 | 48 | pH reduction |
GO:0050801 | 0.0029 | 6.031 | 1.0187 | 5 | 674 | ion homeostasis |
GO:0055082 | 0.003 | 6.0028 | 1.0233 | 5 | 677 | cellular chemical homeostasis |
GO:0042322 | 0.003 | 690.5909 | 0.003 | 1 | 2 | negative regulation of circadian sleep/wake cycle, REM sleep |
GO:0060468 | 0.003 | 690.5909 | 0.003 | 1 | 2 | prevention of polyspermy |
GO:2000854 | 0.003 | 690.5909 | 0.003 | 1 | 2 | positive regulation of corticosterone secretion |
GO:0075733 | 0.0033 | 26.2147 | 0.0862 | 2 | 57 | intracellular transport of virus |
GO:0009988 | 0.004 | 23.6269 | 0.0952 | 2 | 63 | cell-cell recognition |
GO:1904063 | 0.004 | 23.6269 | 0.0952 | 2 | 63 | negative regulation of cation transmembrane transport |
GO:0006811 | 0.0044 | 4.1628 | 2.1947 | 7 | 1452 | ion transport |
GO:0002125 | 0.0045 | 345.2727 | 0.0045 | 1 | 3 | maternal aggressive behavior |
GO:0031394 | 0.0045 | 345.2727 | 0.0045 | 1 | 3 | positive regulation of prostaglandin biosynthetic process |
GO:0033685 | 0.0045 | 345.2727 | 0.0045 | 1 | 3 | negative regulation of luteinizing hormone secretion |
GO:0042631 | 0.0045 | 345.2727 | 0.0045 | 1 | 3 | cellular response to water deprivation |
GO:0046968 | 0.0045 | 345.2727 | 0.0045 | 1 | 3 | peptide antigen transport |
GO:0070093 | 0.0045 | 345.2727 | 0.0045 | 1 | 3 | negative regulation of glucagon secretion |
GO:0071314 | 0.0045 | 345.2727 | 0.0045 | 1 | 3 | cellular response to cocaine |
GO:0051952 | 0.005 | 21.1849 | 0.1058 | 2 | 70 | regulation of amine transport |
GO:0042310 | 0.0051 | 20.8765 | 0.1073 | 2 | 71 | vasoconstriction |
GO:0044766 | 0.0051 | 20.8765 | 0.1073 | 2 | 71 | multi-organism transport |
GO:0050886 | 0.0055 | 20.0026 | 0.1118 | 2 | 74 | endocrine process |
GO:0001992 | 0.006 | 230.1667 | 0.006 | 1 | 4 | regulation of systemic arterial blood pressure by vasopressin |
GO:0007621 | 0.006 | 230.1667 | 0.006 | 1 | 4 | negative regulation of female receptivity |
GO:0008628 | 0.006 | 230.1667 | 0.006 | 1 | 4 | hormone-mediated apoptotic signaling pathway |
GO:0010841 | 0.006 | 230.1667 | 0.006 | 1 | 4 | positive regulation of circadian sleep/wake cycle, wakefulness |
GO:0010961 | 0.006 | 230.1667 | 0.006 | 1 | 4 | cellular magnesium ion homeostasis |
GO:0031133 | 0.006 | 230.1667 | 0.006 | 1 | 4 | regulation of axon diameter |
GO:0032811 | 0.006 | 230.1667 | 0.006 | 1 | 4 | negative regulation of epinephrine secretion |
GO:0032849 | 0.006 | 230.1667 | 0.006 | 1 | 4 | positive regulation of cellular pH reduction |
GO:0043315 | 0.006 | 230.1667 | 0.006 | 1 | 4 | positive regulation of neutrophil degranulation |
GO:0051461 | 0.006 | 230.1667 | 0.006 | 1 | 4 | positive regulation of corticotropin secretion |
GO:0051464 | 0.006 | 230.1667 | 0.006 | 1 | 4 | positive regulation of cortisol secretion |
GO:1901842 | 0.006 | 230.1667 | 0.006 | 1 | 4 | negative regulation of high voltage-gated calcium channel activity |
GO:1902527 | 0.006 | 230.1667 | 0.006 | 1 | 4 | positive regulation of protein monoubiquitination |
GO:0034763 | 0.0064 | 18.4567 | 0.1209 | 2 | 80 | negative regulation of transmembrane transport |
GO:0051970 | 0.0075 | 172.6136 | 0.0076 | 1 | 5 | negative regulation of transmission of nerve impulse |
GO:1902255 | 0.0075 | 172.6136 | 0.0076 | 1 | 5 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator |
GO:1903232 | 0.0075 | 172.6136 | 0.0076 | 1 | 5 | melanosome assembly |
GO:2000987 | 0.0075 | 172.6136 | 0.0076 | 1 | 5 | positive regulation of behavioral fear response |
GO:2001279 | 0.0075 | 172.6136 | 0.0076 | 1 | 5 | regulation of unsaturated fatty acid biosynthetic process |
GO:0051453 | 0.0076 | 16.9289 | 0.1315 | 2 | 87 | regulation of intracellular pH |
GO:0030003 | 0.0082 | 5.7462 | 0.8177 | 4 | 541 | cellular cation homeostasis |
GO:0014062 | 0.009 | 138.0818 | 0.0091 | 1 | 6 | regulation of serotonin secretion |
GO:0042713 | 0.009 | 138.0818 | 0.0091 | 1 | 6 | sperm ejaculation |
GO:0048241 | 0.009 | 138.0818 | 0.0091 | 1 | 6 | epinephrine transport |
GO:0060179 | 0.009 | 138.0818 | 0.0091 | 1 | 6 | male mating behavior |
GO:0014902 | 0.0097 | 14.8228 | 0.1496 | 2 | 99 | myotube differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0061760 | 0 | 1519.4 | 0.0043 | 2 | 3 | antifungal innate immune response |
GO:0009620 | 0 | 66.4868 | 0.0564 | 3 | 39 | response to fungus |
GO:0070098 | 1e-04 | 44.2719 | 0.0824 | 3 | 57 | chemokine-mediated signaling pathway |
GO:0050829 | 1e-04 | 39.8289 | 0.0911 | 3 | 63 | defense response to Gram-negative bacterium |
GO:0030593 | 1e-04 | 36.753 | 0.0983 | 3 | 68 | neutrophil chemotaxis |
GO:0050830 | 2e-04 | 33.1645 | 0.1084 | 3 | 75 | defense response to Gram-positive bacterium |
GO:0098542 | 2e-04 | 11.6235 | 0.5494 | 5 | 380 | defense response to other organism |
GO:0097530 | 4e-04 | 24.8339 | 0.1431 | 3 | 99 | granulocyte migration |
GO:0071346 | 6e-04 | 21.2636 | 0.1663 | 3 | 115 | cellular response to interferon-gamma |
GO:0007186 | 0.001 | 6.4655 | 1.213 | 6 | 839 | G-protein coupled receptor signaling pathway |
GO:0061844 | 0.0013 | 43.3143 | 0.0535 | 2 | 37 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0048247 | 0.0014 | 40.9676 | 0.0564 | 2 | 39 | lymphocyte chemotaxis |
GO:0031640 | 0.0017 | 37.8875 | 0.0607 | 2 | 42 | killing of cells of other organism |
GO:0002548 | 0.0018 | 36.0786 | 0.0636 | 2 | 44 | monocyte chemotaxis |
GO:0045087 | 0.0023 | 6.5574 | 0.9728 | 5 | 740 | innate immune response |
GO:0043207 | 0.0029 | 6.0541 | 1.025 | 5 | 709 | response to external biotic stimulus |
GO:0009617 | 0.0036 | 7.3658 | 0.6491 | 4 | 449 | response to bacterium |
GO:0060326 | 0.0039 | 10.6983 | 0.3238 | 3 | 224 | cell chemotaxis |
GO:0045918 | 0.0043 | 361.7381 | 0.0043 | 1 | 3 | negative regulation of cytolysis |
GO:0010469 | 0.0048 | 6.7688 | 0.7041 | 4 | 487 | regulation of receptor activity |
GO:0002690 | 0.0048 | 21.6071 | 0.1041 | 2 | 72 | positive regulation of leukocyte chemotaxis |
GO:0071347 | 0.0052 | 20.7151 | 0.1084 | 2 | 75 | cellular response to interleukin-1 |
GO:0002376 | 0.0053 | 3.558 | 3.5912 | 9 | 2484 | immune system process |
GO:0002249 | 0.0058 | 241.1429 | 0.0058 | 1 | 4 | lymphocyte anergy |
GO:0002667 | 0.0058 | 241.1429 | 0.0058 | 1 | 4 | regulation of T cell anergy |
GO:0019732 | 0.0058 | 241.1429 | 0.0058 | 1 | 4 | antifungal humoral response |
GO:0016525 | 0.0065 | 18.4305 | 0.1214 | 2 | 84 | negative regulation of angiogenesis |
GO:0045347 | 0.0072 | 180.8452 | 0.0072 | 1 | 5 | negative regulation of MHC class II biosynthetic process |
GO:1901343 | 0.0077 | 16.7833 | 0.133 | 2 | 92 | negative regulation of vasculature development |
GO:0007195 | 0.0086 | 144.6667 | 0.0087 | 1 | 6 | adenylate cyclase-inhibiting dopamine receptor signaling pathway |
GO:0043950 | 0.0086 | 144.6667 | 0.0087 | 1 | 6 | positive regulation of cAMP-mediated signaling |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048704 | 0 | 65.4749 | 0.1572 | 7 | 92 | embryonic skeletal system morphogenesis |
GO:0043009 | 0 | 20.2066 | 0.9278 | 11 | 543 | chordate embryonic development |
GO:0048568 | 0 | 19.6774 | 0.6954 | 9 | 407 | embryonic organ development |
GO:0048598 | 0 | 16.482 | 0.9654 | 10 | 565 | embryonic morphogenesis |
GO:0007389 | 0 | 16.5193 | 0.6937 | 8 | 406 | pattern specification process |
GO:0009888 | 0 | 11.9817 | 1.4933 | 10 | 1033 | tissue development |
GO:0009952 | 0 | 23.941 | 0.3315 | 6 | 194 | anterior/posterior pattern specification |
GO:0021545 | 0 | 64.0507 | 0.0803 | 4 | 47 | cranial nerve development |
GO:0072358 | 0 | 10.6967 | 1.0491 | 8 | 614 | cardiovascular system development |
GO:0030878 | 0 | 94.2236 | 0.041 | 3 | 24 | thyroid gland development |
GO:0001525 | 0 | 14.9283 | 0.5329 | 6 | 336 | angiogenesis |
GO:0021615 | 0 | 632.875 | 0.0068 | 2 | 4 | glossopharyngeal nerve morphogenesis |
GO:0009887 | 0 | 8.1179 | 1.4029 | 8 | 886 | animal organ morphogenesis |
GO:0048869 | 1e-04 | 4.7794 | 6.5372 | 16 | 3826 | cellular developmental process |
GO:0060837 | 1e-04 | 180.7619 | 0.0154 | 2 | 9 | blood vessel endothelial cell differentiation |
GO:0007275 | 2e-04 | 6.3759 | 5.2234 | 13 | 4298 | multicellular organism development |
GO:0051216 | 2e-04 | 16.3571 | 0.2922 | 4 | 171 | cartilage development |
GO:0001568 | 2e-04 | 8.5775 | 0.9058 | 6 | 574 | blood vessel development |
GO:0030855 | 2e-04 | 10.9703 | 0.5748 | 5 | 374 | epithelial cell differentiation |
GO:0045944 | 2e-04 | 6.0725 | 1.7838 | 8 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
GO:2001212 | 3e-04 | 105.4097 | 0.0239 | 2 | 14 | regulation of vasculogenesis |
GO:0001501 | 8e-04 | 11.2509 | 0.4313 | 4 | 295 | skeletal system development |
GO:0003158 | 8e-04 | 18.3876 | 0.1879 | 3 | 110 | endothelium development |
GO:0003203 | 0.0011 | 46.8025 | 0.0495 | 2 | 29 | endocardial cushion morphogenesis |
GO:1903508 | 0.0013 | 4.6167 | 2.293 | 8 | 1342 | positive regulation of nucleic acid-templated transcription |
GO:0031328 | 0.0013 | 4.2605 | 2.8841 | 9 | 1688 | positive regulation of cellular biosynthetic process |
GO:2000113 | 0.0014 | 4.5604 | 2.3186 | 8 | 1357 | negative regulation of cellular macromolecule biosynthetic process |
GO:0048665 | 0.0014 | 40.7527 | 0.0564 | 2 | 33 | neuron fate specification |
GO:0031424 | 0.0016 | 14.6564 | 0.2341 | 3 | 137 | keratinization |
GO:0006355 | 0.0017 | 3.5184 | 5.7666 | 13 | 3375 | regulation of transcription, DNA-templated |
GO:0003327 | 0.0017 | Inf | 0.0017 | 1 | 1 | type B pancreatic cell fate commitment |
GO:0060580 | 0.0017 | Inf | 0.0017 | 1 | 1 | ventral spinal cord interneuron fate determination |
GO:0071444 | 0.0017 | Inf | 0.0017 | 1 | 1 | cellular response to pheromone |
GO:0110023 | 0.0017 | Inf | 0.0017 | 1 | 1 | negative regulation of cardiac muscle myoblast proliferation |
GO:1903769 | 0.0017 | Inf | 0.0017 | 1 | 1 | negative regulation of cell proliferation in bone marrow |
GO:1905322 | 0.0017 | Inf | 0.0017 | 1 | 1 | positive regulation of mesenchymal stem cell migration |
GO:2001141 | 0.0018 | 3.4838 | 5.811 | 13 | 3401 | regulation of RNA biosynthetic process |
GO:0051254 | 0.0018 | 4.3678 | 2.4109 | 8 | 1411 | positive regulation of RNA metabolic process |
GO:0031960 | 0.0019 | 13.7258 | 0.2495 | 3 | 146 | response to corticosteroid |
GO:0021983 | 0.0021 | 33.2303 | 0.0683 | 2 | 40 | pituitary gland development |
GO:1903507 | 0.0021 | 4.6873 | 1.9034 | 7 | 1114 | negative regulation of nucleic acid-templated transcription |
GO:0019219 | 0.0021 | 3.3568 | 6.7183 | 14 | 3932 | regulation of nucleobase-containing compound metabolic process |
GO:0003205 | 0.0022 | 13.0791 | 0.2614 | 3 | 153 | cardiac chamber development |
GO:0021517 | 0.0024 | 30.7927 | 0.0735 | 2 | 43 | ventral spinal cord development |
GO:0034654 | 0.0025 | 3.2942 | 6.8122 | 14 | 3987 | nucleobase-containing compound biosynthetic process |
GO:0060711 | 0.0027 | 29.3566 | 0.0769 | 2 | 45 | labyrinthine layer development |
GO:0009890 | 0.0028 | 4.0446 | 2.5834 | 8 | 1512 | negative regulation of biosynthetic process |
GO:0051253 | 0.003 | 4.3745 | 2.0281 | 7 | 1187 | negative regulation of RNA metabolic process |
GO:0048729 | 0.0031 | 5.851 | 1.0235 | 5 | 599 | tissue morphogenesis |
GO:0031102 | 0.0031 | 26.8511 | 0.0837 | 2 | 49 | neuron projection regeneration |
GO:0042692 | 0.0032 | 7.448 | 0.6254 | 4 | 366 | muscle cell differentiation |
GO:0051173 | 0.0033 | 3.3728 | 4.6543 | 11 | 2724 | positive regulation of nitrogen compound metabolic process |
GO:0021515 | 0.0034 | 25.7517 | 0.0871 | 2 | 51 | cell differentiation in spinal cord |
GO:0003326 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | pancreatic A cell fate commitment |
GO:0003329 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | pancreatic PP cell fate commitment |
GO:0036304 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | umbilical cord morphogenesis |
GO:0060764 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | cell-cell signaling involved in mammary gland development |
GO:0071657 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | positive regulation of granulocyte colony-stimulating factor production |
GO:2000820 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation |
GO:0010557 | 0.0035 | 3.9058 | 2.6654 | 8 | 1560 | positive regulation of macromolecule biosynthetic process |
GO:0002066 | 0.0035 | 25.235 | 0.0888 | 2 | 52 | columnar/cuboidal epithelial cell development |
GO:0071385 | 0.0037 | 24.7386 | 0.0906 | 2 | 53 | cellular response to glucocorticoid stimulus |
GO:0007420 | 0.0041 | 5.4489 | 1.0952 | 5 | 641 | brain development |
GO:0050911 | 0.0042 | 22.9333 | 0.0974 | 2 | 57 | detection of chemical stimulus involved in sensory perception of smell |
GO:0048645 | 0.0045 | 22.1257 | 0.1008 | 2 | 59 | animal organ formation |
GO:0010159 | 0.0051 | 303.78 | 0.0051 | 1 | 3 | specification of animal organ position |
GO:0014707 | 0.0051 | 303.78 | 0.0051 | 1 | 3 | branchiomeric skeletal muscle development |
GO:0021524 | 0.0051 | 303.78 | 0.0051 | 1 | 3 | visceral motor neuron differentiation |
GO:0021530 | 0.0051 | 303.78 | 0.0051 | 1 | 3 | spinal cord oligodendrocyte cell fate specification |
GO:0048936 | 0.0051 | 303.78 | 0.0051 | 1 | 3 | peripheral nervous system neuron axonogenesis |
GO:0060435 | 0.0051 | 303.78 | 0.0051 | 1 | 3 | bronchiole development |
GO:0060913 | 0.0051 | 303.78 | 0.0051 | 1 | 3 | cardiac cell fate determination |
GO:0003281 | 0.0051 | 20.6694 | 0.1076 | 2 | 63 | ventricular septum development |
GO:0060411 | 0.0055 | 20.0106 | 0.1111 | 2 | 65 | cardiac septum morphogenesis |
GO:0010629 | 0.0058 | 3.5553 | 2.8978 | 8 | 1696 | negative regulation of gene expression |
GO:0010628 | 0.0059 | 3.5388 | 2.9098 | 8 | 1703 | positive regulation of gene expression |
GO:1901342 | 0.0064 | 8.8548 | 0.3852 | 3 | 244 | regulation of vasculature development |
GO:0003208 | 0.0065 | 18.2633 | 0.1213 | 2 | 71 | cardiac ventricle morphogenesis |
GO:0000122 | 0.0068 | 4.8337 | 1.2356 | 5 | 752 | negative regulation of transcription from RNA polymerase II promoter |
GO:0032730 | 0.0068 | 202.5067 | 0.0068 | 1 | 4 | positive regulation of interleukin-1 alpha production |
GO:0060480 | 0.0068 | 202.5067 | 0.0068 | 1 | 4 | lung goblet cell differentiation |
GO:0060535 | 0.0068 | 202.5067 | 0.0068 | 1 | 4 | trachea cartilage morphogenesis |
GO:0060574 | 0.0068 | 202.5067 | 0.0068 | 1 | 4 | intestinal epithelial cell maturation |
GO:1901256 | 0.0068 | 202.5067 | 0.0068 | 1 | 4 | regulation of macrophage colony-stimulating factor production |
GO:0060485 | 0.0069 | 8.5601 | 0.3947 | 3 | 231 | mesenchyme development |
GO:0031016 | 0.0072 | 17.258 | 0.1281 | 2 | 75 | pancreas development |
GO:0048513 | 0.008 | 5.3274 | 1.3685 | 5 | 1433 | animal organ development |
GO:0060255 | 0.0085 | 2.7731 | 9.5238 | 16 | 5574 | regulation of macromolecule metabolic process |
GO:0007406 | 0.0085 | 151.87 | 0.0085 | 1 | 5 | negative regulation of neuroblast proliferation |
GO:0021779 | 0.0085 | 151.87 | 0.0085 | 1 | 5 | oligodendrocyte cell fate commitment |
GO:0021780 | 0.0085 | 151.87 | 0.0085 | 1 | 5 | glial cell fate specification |
GO:0048625 | 0.0085 | 151.87 | 0.0085 | 1 | 5 | myoblast fate commitment |
GO:0048880 | 0.0085 | 151.87 | 0.0085 | 1 | 5 | sensory system development |
GO:0090074 | 0.0085 | 151.87 | 0.0085 | 1 | 5 | negative regulation of protein homodimerization activity |
GO:0031623 | 0.0088 | 15.5453 | 0.1418 | 2 | 83 | receptor internalization |
GO:0009913 | 0.0088 | 7.8271 | 0.4306 | 3 | 252 | epidermal cell differentiation |
GO:0051961 | 0.0089 | 7.7953 | 0.4323 | 3 | 253 | negative regulation of nervous system development |
GO:0016525 | 0.009 | 15.3547 | 0.1435 | 2 | 84 | negative regulation of angiogenesis |
GO:0001843 | 0.0092 | 15.1687 | 0.1452 | 2 | 85 | neural tube closure |
GO:0048522 | 0.0098 | 2.7106 | 7.834 | 14 | 4585 | positive regulation of cellular process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0002152 | 0.0018 | Inf | 0.0018 | 1 | 1 | bile acid conjugation |
GO:0021763 | 0.0018 | Inf | 0.0018 | 1 | 1 | subthalamic nucleus development |
GO:0042404 | 0.0018 | Inf | 0.0018 | 1 | 1 | thyroid hormone catabolic process |
GO:0060127 | 0.0018 | Inf | 0.0018 | 1 | 1 | prolactin secreting cell differentiation |
GO:0060578 | 0.0018 | Inf | 0.0018 | 1 | 1 | superior vena cava morphogenesis |
GO:0048536 | 0.002 | 34.2873 | 0.0662 | 2 | 36 | spleen development |
GO:0002503 | 0.0037 | 562.5185 | 0.0037 | 1 | 2 | peptide antigen assembly with MHC class II protein complex |
GO:0007506 | 0.0037 | 562.5185 | 0.0037 | 1 | 2 | gonadal mesoderm development |
GO:0060460 | 0.0037 | 562.5185 | 0.0037 | 1 | 2 | left lung morphogenesis |
GO:0060577 | 0.0037 | 562.5185 | 0.0037 | 1 | 2 | pulmonary vein morphogenesis |
GO:2000355 | 0.0037 | 562.5185 | 0.0037 | 1 | 2 | negative regulation of ovarian follicle development |
GO:2001190 | 0.0037 | 562.5185 | 0.0037 | 1 | 2 | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
GO:0055013 | 0.0054 | 20.0676 | 0.1104 | 2 | 60 | cardiac muscle cell development |
GO:0000454 | 0.0055 | 281.2407 | 0.0055 | 1 | 3 | snoRNA guided rRNA pseudouridine synthesis |
GO:0001546 | 0.0055 | 281.2407 | 0.0055 | 1 | 3 | preantral ovarian follicle growth |
GO:0003245 | 0.0055 | 281.2407 | 0.0055 | 1 | 3 | cardiac muscle tissue growth involved in heart morphogenesis |
GO:0003350 | 0.0055 | 281.2407 | 0.0055 | 1 | 3 | pulmonary myocardium development |
GO:0035993 | 0.0055 | 281.2407 | 0.0055 | 1 | 3 | deltoid tuberosity development |
GO:0061031 | 0.0055 | 281.2407 | 0.0055 | 1 | 3 | endodermal digestive tract morphogenesis |
GO:0009653 | 0.0068 | 3.0521 | 4.3223 | 10 | 2349 | anatomical structure morphogenesis |
GO:0001880 | 0.0073 | 187.4815 | 0.0074 | 1 | 4 | Mullerian duct regression |
GO:0002396 | 0.0073 | 187.4815 | 0.0074 | 1 | 4 | MHC protein complex assembly |
GO:0019732 | 0.0073 | 187.4815 | 0.0074 | 1 | 4 | antifungal humoral response |
GO:0021855 | 0.0073 | 187.4815 | 0.0074 | 1 | 4 | hypothalamus cell migration |
GO:0060126 | 0.0073 | 187.4815 | 0.0074 | 1 | 4 | somatotropin secreting cell differentiation |
GO:0061325 | 0.0073 | 187.4815 | 0.0074 | 1 | 4 | cell proliferation involved in outflow tract morphogenesis |
GO:1905205 | 0.0073 | 187.4815 | 0.0074 | 1 | 4 | positive regulation of connective tissue replacement |
GO:0060415 | 0.0083 | 15.9283 | 0.138 | 2 | 75 | muscle tissue morphogenesis |
GO:0002074 | 0.0092 | 140.6019 | 0.0092 | 1 | 5 | extraocular skeletal muscle development |
GO:0048731 | 0.0095 | 2.639 | 7.7061 | 14 | 4188 | system development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0060706 | 8e-04 | 55.1564 | 0.0426 | 2 | 27 | cell differentiation involved in embryonic placenta development |
GO:0018149 | 9e-04 | 51.064 | 0.0457 | 2 | 29 | peptide cross-linking |
GO:0043616 | 0.0015 | 40.5321 | 0.0568 | 2 | 36 | keratinocyte proliferation |
GO:0003144 | 0.0016 | Inf | 0.0016 | 1 | 1 | embryonic heart tube formation |
GO:0008544 | 0.0021 | 8.5316 | 0.5552 | 4 | 352 | epidermis development |
GO:0030855 | 0.0026 | 6.1751 | 0.9873 | 5 | 626 | epithelial cell differentiation |
GO:0048588 | 0.0026 | 12.3309 | 0.2792 | 3 | 177 | developmental cell growth |
GO:0003218 | 0.0032 | 660.5217 | 0.0032 | 1 | 2 | cardiac left ventricle formation |
GO:0003290 | 0.0032 | 660.5217 | 0.0032 | 1 | 2 | atrial septum secundum morphogenesis |
GO:0038195 | 0.0032 | 660.5217 | 0.0032 | 1 | 2 | urokinase plasminogen activator signaling pathway |
GO:0060354 | 0.0032 | 660.5217 | 0.0032 | 1 | 2 | negative regulation of cell adhesion molecule production |
GO:0061044 | 0.0032 | 660.5217 | 0.0032 | 1 | 2 | negative regulation of vascular wound healing |
GO:0001947 | 0.0036 | 25.0215 | 0.0899 | 2 | 57 | heart looping |
GO:0030216 | 0.0039 | 10.6553 | 0.3217 | 3 | 204 | keratinocyte differentiation |
GO:0060411 | 0.0047 | 21.8326 | 0.1025 | 2 | 65 | cardiac septum morphogenesis |
GO:0035054 | 0.0047 | 330.2391 | 0.0047 | 1 | 3 | embryonic heart tube anterior/posterior pattern specification |
GO:0045590 | 0.0047 | 330.2391 | 0.0047 | 1 | 3 | negative regulation of regulatory T cell differentiation |
GO:0003208 | 0.0055 | 19.9262 | 0.112 | 2 | 71 | cardiac ventricle morphogenesis |
GO:0035050 | 0.0057 | 19.6403 | 0.1136 | 2 | 72 | embryonic heart tube development |
GO:0003219 | 0.0063 | 220.1449 | 0.0063 | 1 | 4 | cardiac right ventricle formation |
GO:0090298 | 0.0063 | 220.1449 | 0.0063 | 1 | 4 | negative regulation of mitochondrial DNA replication |
GO:0097476 | 0.0063 | 220.1449 | 0.0063 | 1 | 4 | spinal cord motor neuron migration |
GO:1903026 | 0.0063 | 220.1449 | 0.0063 | 1 | 4 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding |
GO:1905205 | 0.0063 | 220.1449 | 0.0063 | 1 | 4 | positive regulation of connective tissue replacement |
GO:0003300 | 0.0063 | 18.5737 | 0.1199 | 2 | 76 | cardiac muscle hypertrophy |
GO:1903035 | 0.0063 | 18.5737 | 0.1199 | 2 | 76 | negative regulation of response to wounding |
GO:0014896 | 0.0068 | 17.8465 | 0.1246 | 2 | 79 | muscle hypertrophy |
GO:0003289 | 0.0079 | 165.0978 | 0.0079 | 1 | 5 | atrial septum primum morphogenesis |
GO:0016098 | 0.0079 | 165.0978 | 0.0079 | 1 | 5 | monoterpenoid metabolic process |
GO:0051891 | 0.0079 | 165.0978 | 0.0079 | 1 | 5 | positive regulation of cardioblast differentiation |
GO:1902565 | 0.0079 | 165.0978 | 0.0079 | 1 | 5 | positive regulation of neutrophil activation |
GO:1903244 | 0.0079 | 165.0978 | 0.0079 | 1 | 5 | positive regulation of cardiac muscle hypertrophy in response to stress |
GO:1904995 | 0.0079 | 165.0978 | 0.0079 | 1 | 5 | negative regulation of leukocyte adhesion to vascular endothelial cell |
GO:0003008 | 0.0079 | 3.6691 | 2.4289 | 7 | 1540 | system process |
GO:0048562 | 0.0091 | 7.7784 | 0.4369 | 3 | 277 | embryonic organ morphogenesis |
GO:0048675 | 0.0092 | 15.2556 | 0.1451 | 2 | 92 | axon extension |
GO:0031642 | 0.0094 | 132.0696 | 0.0095 | 1 | 6 | negative regulation of myelination |
GO:0070268 | 0.0095 | 14.9219 | 0.1483 | 2 | 94 | cornification |
GO:0050905 | 0.0097 | 14.7605 | 0.1498 | 2 | 95 | neuromuscular process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048704 | 1e-04 | 39.1841 | 0.0967 | 3 | 92 | embryonic skeletal system morphogenesis |
GO:0030878 | 3e-04 | 98.5649 | 0.0252 | 2 | 24 | thyroid gland development |
GO:0035176 | 0.001 | 50.3588 | 0.0473 | 2 | 45 | social behavior |
GO:0009952 | 0.001 | 18.1353 | 0.204 | 3 | 194 | anterior/posterior pattern specification |
GO:0021754 | 0.0011 | Inf | 0.0011 | 1 | 1 | facial nucleus development |
GO:0071444 | 0.0011 | Inf | 0.0011 | 1 | 1 | cellular response to pheromone |
GO:0007417 | 0.0014 | 7.7224 | 0.8937 | 5 | 850 | central nervous system development |
GO:0021546 | 0.002 | 1085.5 | 0.002 | 1 | 2 | rhombomere development |
GO:0021570 | 0.0021 | 1013.3333 | 0.0021 | 1 | 2 | rhombomere 4 development |
GO:0042495 | 0.0021 | 1013.3333 | 0.0021 | 1 | 2 | detection of triacyl bacterial lipopeptide |
GO:0042496 | 0.0021 | 1013.3333 | 0.0021 | 1 | 2 | detection of diacyl bacterial lipopeptide |
GO:0060764 | 0.0021 | 1013.3333 | 0.0021 | 1 | 2 | cell-cell signaling involved in mammary gland development |
GO:0021675 | 0.0025 | 31.3292 | 0.0747 | 2 | 71 | nerve development |
GO:0050830 | 0.0028 | 29.6047 | 0.0789 | 2 | 75 | defense response to Gram-positive bacterium |
GO:0002125 | 0.0032 | 506.6333 | 0.0032 | 1 | 3 | maternal aggressive behavior |
GO:0014005 | 0.0032 | 506.6333 | 0.0032 | 1 | 3 | microglia development |
GO:0021571 | 0.0032 | 506.6333 | 0.0032 | 1 | 3 | rhombomere 5 development |
GO:0031394 | 0.0032 | 506.6333 | 0.0032 | 1 | 3 | positive regulation of prostaglandin biosynthetic process |
GO:0032289 | 0.0032 | 506.6333 | 0.0032 | 1 | 3 | central nervous system myelin formation |
GO:0038123 | 0.0032 | 506.6333 | 0.0032 | 1 | 3 | toll-like receptor TLR1:TLR2 signaling pathway |
GO:0042631 | 0.0032 | 506.6333 | 0.0032 | 1 | 3 | cellular response to water deprivation |
GO:0060435 | 0.0032 | 506.6333 | 0.0032 | 1 | 3 | bronchiole development |
GO:0071727 | 0.0032 | 506.6333 | 0.0032 | 1 | 3 | cellular response to triacyl bacterial lipopeptide |
GO:0045944 | 0.0035 | 6.1956 | 1.0977 | 5 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
GO:0001992 | 0.0042 | 337.7333 | 0.0042 | 1 | 4 | regulation of systemic arterial blood pressure by vasopressin |
GO:0007621 | 0.0042 | 337.7333 | 0.0042 | 1 | 4 | negative regulation of female receptivity |
GO:0019732 | 0.0042 | 337.7333 | 0.0042 | 1 | 4 | antifungal humoral response |
GO:0021615 | 0.0042 | 337.7333 | 0.0042 | 1 | 4 | glossopharyngeal nerve morphogenesis |
GO:0032741 | 0.0042 | 337.7333 | 0.0042 | 1 | 4 | positive regulation of interleukin-18 production |
GO:0032849 | 0.0042 | 337.7333 | 0.0042 | 1 | 4 | positive regulation of cellular pH reduction |
GO:0038124 | 0.0042 | 337.7333 | 0.0042 | 1 | 4 | toll-like receptor TLR6:TLR2 signaling pathway |
GO:0042494 | 0.0042 | 337.7333 | 0.0042 | 1 | 4 | detection of bacterial lipoprotein |
GO:0060480 | 0.0042 | 337.7333 | 0.0042 | 1 | 4 | lung goblet cell differentiation |
GO:0060535 | 0.0042 | 337.7333 | 0.0042 | 1 | 4 | trachea cartilage morphogenesis |
GO:0060574 | 0.0042 | 337.7333 | 0.0042 | 1 | 4 | intestinal epithelial cell maturation |
GO:0071726 | 0.0042 | 337.7333 | 0.0042 | 1 | 4 | cellular response to diacyl bacterial lipopeptide |
GO:0006690 | 0.0049 | 21.7922 | 0.1062 | 2 | 101 | icosanoid metabolic process |
GO:0045110 | 0.0052 | 253.2833 | 0.0053 | 1 | 5 | intermediate filament bundle assembly |
GO:0051970 | 0.0052 | 253.2833 | 0.0053 | 1 | 5 | negative regulation of transmission of nerve impulse |
GO:2001279 | 0.0052 | 253.2833 | 0.0053 | 1 | 5 | regulation of unsaturated fatty acid biosynthetic process |
GO:0031328 | 0.0055 | 4.8225 | 1.7749 | 6 | 1688 | positive regulation of cellular biosynthetic process |
GO:0010628 | 0.0058 | 4.7745 | 1.7906 | 6 | 1703 | positive regulation of gene expression |
GO:0042713 | 0.0063 | 202.6133 | 0.0063 | 1 | 6 | sperm ejaculation |
GO:0051964 | 0.0063 | 202.6133 | 0.0063 | 1 | 6 | negative regulation of synapse assembly |
GO:0060482 | 0.0063 | 202.6133 | 0.0063 | 1 | 6 | lobar bronchus development |
GO:0070339 | 0.0063 | 202.6133 | 0.0063 | 1 | 6 | response to bacterial lipopeptide |
GO:0071220 | 0.0063 | 202.6133 | 0.0063 | 1 | 6 | cellular response to bacterial lipoprotein |
GO:0021612 | 0.0073 | 168.8333 | 0.0074 | 1 | 7 | facial nerve structural organization |
GO:0006887 | 0.0078 | 6.1545 | 0.8254 | 4 | 785 | exocytosis |
GO:0007389 | 0.0082 | 8.4738 | 0.4269 | 3 | 406 | pattern specification process |
GO:0048568 | 0.0082 | 8.4522 | 0.4279 | 3 | 407 | embryonic organ development |
GO:0045647 | 0.0084 | 144.7048 | 0.0084 | 1 | 8 | negative regulation of erythrocyte differentiation |
GO:0060638 | 0.0084 | 144.7048 | 0.0084 | 1 | 8 | mesenchymal-epithelial cell signaling |
GO:0071223 | 0.0084 | 144.7048 | 0.0084 | 1 | 8 | cellular response to lipoteichoic acid |
GO:0032502 | 0.0088 | 3.842 | 5.8314 | 11 | 5546 | developmental process |
GO:0010870 | 0.0094 | 126.6083 | 0.0095 | 1 | 9 | positive regulation of receptor biosynthetic process |
GO:0014049 | 0.0094 | 126.6083 | 0.0095 | 1 | 9 | positive regulation of glutamate secretion |
GO:0021561 | 0.0094 | 126.6083 | 0.0095 | 1 | 9 | facial nerve development |
GO:0043084 | 0.0094 | 126.6083 | 0.0095 | 1 | 9 | penile erection |
GO:0060180 | 0.0094 | 126.6083 | 0.0095 | 1 | 9 | female mating behavior |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0061760 | 0 | 1519.4 | 0.0043 | 2 | 3 | antifungal innate immune response |
GO:0009620 | 0.0014 | 40.9676 | 0.0564 | 2 | 39 | response to fungus |
GO:0006952 | 0.0021 | 4.8529 | 1.9373 | 7 | 1340 | defense response |
GO:0060468 | 0.0029 | 723.5238 | 0.0029 | 1 | 2 | prevention of polyspermy |
GO:0050911 | 0.003 | 27.5273 | 0.0824 | 2 | 57 | detection of chemical stimulus involved in sensory perception of smell |
GO:0070098 | 0.003 | 27.5273 | 0.0824 | 2 | 57 | chemokine-mediated signaling pathway |
GO:0050829 | 0.0037 | 24.8098 | 0.0911 | 2 | 63 | defense response to Gram-negative bacterium |
GO:0050830 | 0.0052 | 20.7151 | 0.1084 | 2 | 75 | defense response to Gram-positive bacterium |
GO:0071611 | 0.0058 | 241.1429 | 0.0058 | 1 | 4 | granulocyte colony-stimulating factor production |
GO:0007186 | 0.006 | 5.0645 | 1.213 | 5 | 839 | G-protein coupled receptor signaling pathway |
GO:0051606 | 0.0073 | 8.5349 | 0.4034 | 3 | 279 | detection of stimulus |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 192.8055 | 0.0674 | 7 | 57 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 88.0984 | 0.1372 | 7 | 116 | detection of chemical stimulus |
GO:0050906 | 0 | 78.6431 | 0.1526 | 7 | 129 | detection of stimulus involved in sensory perception |
GO:0007606 | 0 | 76.7404 | 0.1561 | 7 | 132 | sensory perception of chemical stimulus |
GO:0007186 | 0 | 13.832 | 0.9924 | 8 | 839 | G-protein coupled receptor signaling pathway |
GO:0050877 | 0 | 10.6628 | 1.0208 | 7 | 863 | nervous system process |
GO:0070227 | 0.0024 | 31.5396 | 0.0733 | 2 | 62 | lymphocyte apoptotic process |
GO:0035990 | 0.0035 | 446.9706 | 0.0035 | 1 | 3 | tendon cell differentiation |
GO:0035993 | 0.0035 | 446.9706 | 0.0035 | 1 | 3 | deltoid tuberosity development |
GO:0036112 | 0.0035 | 446.9706 | 0.0035 | 1 | 3 | medium-chain fatty-acyl-CoA metabolic process |
GO:0002249 | 0.0047 | 297.9608 | 0.0047 | 1 | 4 | lymphocyte anergy |
GO:0002667 | 0.0047 | 297.9608 | 0.0047 | 1 | 4 | regulation of T cell anergy |
GO:0035989 | 0.0059 | 223.4559 | 0.0059 | 1 | 5 | tendon development |
GO:0061056 | 0.0059 | 223.4559 | 0.0059 | 1 | 5 | sclerotome development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1903706 | 4e-04 | 9.6333 | 0.6451 | 5 | 409 | regulation of hemopoiesis |
GO:0060216 | 4e-04 | 81.1551 | 0.03 | 2 | 19 | definitive hemopoiesis |
GO:0048534 | 0.0012 | 6.0289 | 1.2649 | 6 | 802 | hematopoietic or lymphoid organ development |
GO:0071345 | 0.0013 | 6.0209 | 1.2665 | 6 | 803 | cellular response to cytokine stimulus |
GO:0010734 | 0.0016 | Inf | 0.0016 | 1 | 1 | negative regulation of protein glutathionylation |
GO:1902867 | 0.0016 | Inf | 0.0016 | 1 | 1 | negative regulation of retina development in camera-type eye |
GO:1902870 | 0.0016 | Inf | 0.0016 | 1 | 1 | negative regulation of amacrine cell differentiation |
GO:0030099 | 0.0021 | 8.457 | 0.5599 | 4 | 355 | myeloid cell differentiation |
GO:0045596 | 0.0022 | 6.4116 | 0.9526 | 5 | 604 | negative regulation of cell differentiation |
GO:0050902 | 0.0032 | 660.5217 | 0.0032 | 1 | 2 | leukocyte adhesive activation |
GO:0071461 | 0.0032 | 660.5217 | 0.0032 | 1 | 2 | cellular response to redox state |
GO:1901003 | 0.0032 | 660.5217 | 0.0032 | 1 | 2 | negative regulation of fermentation |
GO:0051239 | 0.0042 | 3.4436 | 4.1322 | 10 | 2620 | regulation of multicellular organismal process |
GO:0071560 | 0.0043 | 10.2919 | 0.3328 | 3 | 211 | cellular response to transforming growth factor beta stimulus |
GO:0070315 | 0.0047 | 330.2391 | 0.0047 | 1 | 3 | G1 to G0 transition involved in cell differentiation |
GO:1990791 | 0.0047 | 330.2391 | 0.0047 | 1 | 3 | dorsal root ganglion development |
GO:0045652 | 0.0048 | 21.4901 | 0.1041 | 2 | 66 | regulation of megakaryocyte differentiation |
GO:0007275 | 0.0049 | 3.1352 | 7.4191 | 14 | 4704 | multicellular organism development |
GO:0050793 | 0.0052 | 3.4841 | 3.5345 | 9 | 2241 | regulation of developmental process |
GO:0001501 | 0.0057 | 6.3771 | 0.735 | 4 | 466 | skeletal system development |
GO:0050768 | 0.0057 | 9.2529 | 0.3691 | 3 | 234 | negative regulation of neurogenesis |
GO:1903273 | 0.0063 | 220.1449 | 0.0063 | 1 | 4 | regulation of sodium ion export |
GO:1903278 | 0.0063 | 220.1449 | 0.0063 | 1 | 4 | positive regulation of sodium ion export across plasma membrane |
GO:0048869 | 0.0075 | 2.9835 | 6.0343 | 12 | 3826 | cellular developmental process |
GO:0061056 | 0.0079 | 165.0978 | 0.0079 | 1 | 5 | sclerotome development |
GO:0090259 | 0.0079 | 165.0978 | 0.0079 | 1 | 5 | regulation of retinal ganglion cell axon guidance |
GO:0060842 | 0.0094 | 132.0696 | 0.0095 | 1 | 6 | arterial endothelial cell differentiation |
GO:0061074 | 0.0094 | 132.0696 | 0.0095 | 1 | 6 | regulation of neural retina development |
GO:0045664 | 0.0097 | 5.4375 | 0.8564 | 4 | 543 | regulation of neuron differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032570 | 5e-04 | 78.3618 | 0.0325 | 2 | 45 | response to progesterone |
GO:0002152 | 7e-04 | Inf | 7e-04 | 1 | 1 | bile acid conjugation |
GO:0042495 | 0.0014 | 1520.5 | 0.0014 | 1 | 2 | detection of triacyl bacterial lipopeptide |
GO:0042496 | 0.0014 | 1520.5 | 0.0014 | 1 | 2 | detection of diacyl bacterial lipopeptide |
GO:0014005 | 0.0022 | 760.2 | 0.0022 | 1 | 3 | microglia development |
GO:0032289 | 0.0022 | 760.2 | 0.0022 | 1 | 3 | central nervous system myelin formation |
GO:0038123 | 0.0022 | 760.2 | 0.0022 | 1 | 3 | toll-like receptor TLR1:TLR2 signaling pathway |
GO:0071727 | 0.0022 | 760.2 | 0.0022 | 1 | 3 | cellular response to triacyl bacterial lipopeptide |
GO:0032741 | 0.0029 | 506.7667 | 0.0029 | 1 | 4 | positive regulation of interleukin-18 production |
GO:0038124 | 0.0029 | 506.7667 | 0.0029 | 1 | 4 | toll-like receptor TLR6:TLR2 signaling pathway |
GO:0042494 | 0.0029 | 506.7667 | 0.0029 | 1 | 4 | detection of bacterial lipoprotein |
GO:0071726 | 0.0029 | 506.7667 | 0.0029 | 1 | 4 | cellular response to diacyl bacterial lipopeptide |
GO:0009593 | 0.003 | 29.4191 | 0.0839 | 2 | 116 | detection of chemical stimulus |
GO:0019530 | 0.0043 | 304.02 | 0.0043 | 1 | 6 | taurine metabolic process |
GO:0051964 | 0.0043 | 304.02 | 0.0043 | 1 | 6 | negative regulation of synapse assembly |
GO:0070339 | 0.0043 | 304.02 | 0.0043 | 1 | 6 | response to bacterial lipopeptide |
GO:0071220 | 0.0043 | 304.02 | 0.0043 | 1 | 6 | cellular response to bacterial lipoprotein |
GO:0071223 | 0.0058 | 217.1286 | 0.0058 | 1 | 8 | cellular response to lipoteichoic acid |
GO:0031284 | 0.0079 | 151.96 | 0.008 | 1 | 11 | positive regulation of guanylate cyclase activity |
GO:0051770 | 0.0079 | 151.96 | 0.008 | 1 | 11 | positive regulation of nitric-oxide synthase biosynthetic process |
GO:0007252 | 0.0086 | 138.1364 | 0.0087 | 1 | 12 | I-kappaB phosphorylation |
GO:0098543 | 0.0086 | 138.1364 | 0.0087 | 1 | 12 | detection of other organism |
GO:0034134 | 0.0094 | 126.6167 | 0.0094 | 1 | 13 | toll-like receptor 2 signaling pathway |
GO:0006909 | 0.0097 | 15.9458 | 0.1525 | 2 | 211 | phagocytosis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001764 | 9e-04 | 18.2976 | 0.1923 | 3 | 133 | neuron migration |
GO:0031989 | 0.0014 | Inf | 0.0014 | 1 | 1 | bombesin receptor signaling pathway |
GO:0035847 | 0.0014 | Inf | 0.0014 | 1 | 1 | uterine epithelium development |
GO:0035849 | 0.0014 | Inf | 0.0014 | 1 | 1 | nephric duct elongation |
GO:0035852 | 0.0014 | Inf | 0.0014 | 1 | 1 | horizontal cell localization |
GO:0045407 | 0.0014 | Inf | 0.0014 | 1 | 1 | positive regulation of interleukin-5 biosynthetic process |
GO:0005978 | 0.0017 | 36.961 | 0.0622 | 2 | 43 | glycogen biosynthetic process |
GO:0021517 | 0.0017 | 36.961 | 0.0622 | 2 | 43 | ventral spinal cord development |
GO:0021515 | 0.0024 | 30.9102 | 0.0737 | 2 | 51 | cell differentiation in spinal cord |
GO:0060067 | 0.0029 | 723.5238 | 0.0029 | 1 | 2 | cervix development |
GO:2000744 | 0.0029 | 723.5238 | 0.0029 | 1 | 2 | positive regulation of anterior head development |
GO:0033692 | 0.0029 | 28.0389 | 0.081 | 2 | 56 | cellular polysaccharide biosynthetic process |
GO:0002088 | 0.0038 | 24.4081 | 0.0925 | 2 | 64 | lens development in camera-type eye |
GO:0007525 | 0.0043 | 361.7381 | 0.0043 | 1 | 3 | somatic muscle development |
GO:0038113 | 0.0043 | 361.7381 | 0.0043 | 1 | 3 | interleukin-9-mediated signaling pathway |
GO:0038123 | 0.0043 | 361.7381 | 0.0043 | 1 | 3 | toll-like receptor TLR1:TLR2 signaling pathway |
GO:0060066 | 0.0043 | 361.7381 | 0.0043 | 1 | 3 | oviduct development |
GO:0061205 | 0.0043 | 361.7381 | 0.0043 | 1 | 3 | paramesonephric duct development |
GO:0071104 | 0.0043 | 361.7381 | 0.0043 | 1 | 3 | response to interleukin-9 |
GO:0071727 | 0.0043 | 361.7381 | 0.0043 | 1 | 3 | cellular response to triacyl bacterial lipopeptide |
GO:0097477 | 0.0043 | 361.7381 | 0.0043 | 1 | 3 | lateral motor column neuron migration |
GO:2000768 | 0.0043 | 361.7381 | 0.0043 | 1 | 3 | positive regulation of nephron tubule epithelial cell differentiation |
GO:0006073 | 0.0045 | 22.2456 | 0.1012 | 2 | 70 | cellular glucan metabolic process |
GO:0001705 | 0.0058 | 241.1429 | 0.0058 | 1 | 4 | ectoderm formation |
GO:0038124 | 0.0058 | 241.1429 | 0.0058 | 1 | 4 | toll-like receptor TLR6:TLR2 signaling pathway |
GO:0071726 | 0.0058 | 241.1429 | 0.0058 | 1 | 4 | cellular response to diacyl bacterial lipopeptide |
GO:0072278 | 0.0058 | 241.1429 | 0.0058 | 1 | 4 | metanephric comma-shaped body morphogenesis |
GO:0006112 | 0.0062 | 18.8938 | 0.1186 | 2 | 82 | energy reserve metabolic process |
GO:0009953 | 0.0077 | 16.7833 | 0.133 | 2 | 92 | dorsal/ventral pattern formation |
GO:0005976 | 0.0082 | 16.2387 | 0.1373 | 2 | 95 | polysaccharide metabolic process |
GO:0055114 | 0.0083 | 4.6661 | 1.3099 | 5 | 906 | oxidation-reduction process |
GO:0021937 | 0.0086 | 144.6667 | 0.0087 | 1 | 6 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation |
GO:0034128 | 0.0086 | 144.6667 | 0.0087 | 1 | 6 | negative regulation of MyD88-independent toll-like receptor signaling pathway |
GO:0035502 | 0.0086 | 144.6667 | 0.0087 | 1 | 6 | metanephric part of ureteric bud development |
GO:0070339 | 0.0086 | 144.6667 | 0.0087 | 1 | 6 | response to bacterial lipopeptide |
GO:0071220 | 0.0086 | 144.6667 | 0.0087 | 1 | 6 | cellular response to bacterial lipoprotein |
GO:0072284 | 0.0086 | 144.6667 | 0.0087 | 1 | 6 | metanephric S-shaped body morphogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0060429 | 2e-04 | 11.0442 | 0.9406 | 6 | 1101 | epithelium development |
GO:0001837 | 2e-04 | 35.9 | 0.1102 | 3 | 129 | epithelial to mesenchymal transition |
GO:0031424 | 2e-04 | 33.7388 | 0.117 | 3 | 137 | keratinization |
GO:0003203 | 3e-04 | 102.202 | 0.0248 | 2 | 29 | endocardial cushion morphogenesis |
GO:0030154 | 7e-04 | 7.1044 | 3.1319 | 9 | 3666 | cell differentiation |
GO:0032812 | 9e-04 | Inf | 9e-04 | 1 | 1 | positive regulation of epinephrine secretion |
GO:0060485 | 9e-04 | 19.7053 | 0.1973 | 3 | 231 | mesenchyme development |
GO:0071385 | 9e-04 | 54.0214 | 0.0453 | 2 | 53 | cellular response to glucocorticoid stimulus |
GO:0009913 | 0.0011 | 18.0181 | 0.2153 | 3 | 252 | epidermal cell differentiation |
GO:0060411 | 0.0014 | 43.697 | 0.0555 | 2 | 65 | cardiac septum morphogenesis |
GO:0003208 | 0.0016 | 39.8814 | 0.0607 | 2 | 71 | cardiac ventricle morphogenesis |
GO:0036304 | 0.0017 | 1266.9167 | 0.0017 | 1 | 2 | umbilical cord morphogenesis |
GO:0060468 | 0.0017 | 1266.9167 | 0.0017 | 1 | 2 | prevention of polyspermy |
GO:0071657 | 0.0017 | 1266.9167 | 0.0017 | 1 | 2 | positive regulation of granulocyte colony-stimulating factor production |
GO:2000820 | 0.0017 | 1266.9167 | 0.0017 | 1 | 2 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation |
GO:0043588 | 0.0021 | 14.4612 | 0.2665 | 3 | 312 | skin development |
GO:0021524 | 0.0026 | 633.4167 | 0.0026 | 1 | 3 | visceral motor neuron differentiation |
GO:0048936 | 0.0026 | 633.4167 | 0.0026 | 1 | 3 | peripheral nervous system neuron axonogenesis |
GO:0060913 | 0.0026 | 633.4167 | 0.0026 | 1 | 3 | cardiac cell fate determination |
GO:0070093 | 0.0026 | 633.4167 | 0.0026 | 1 | 3 | negative regulation of glucagon secretion |
GO:0032730 | 0.0034 | 422.25 | 0.0034 | 1 | 4 | positive regulation of interleukin-1 alpha production |
GO:0070253 | 0.0034 | 422.25 | 0.0034 | 1 | 4 | somatostatin secretion |
GO:1901256 | 0.0034 | 422.25 | 0.0034 | 1 | 4 | regulation of macrophage colony-stimulating factor production |
GO:0051101 | 0.0036 | 26.3986 | 0.0906 | 2 | 106 | regulation of DNA binding |
GO:0045471 | 0.0042 | 24.2816 | 0.0982 | 2 | 115 | response to ethanol |
GO:0048880 | 0.0043 | 316.6667 | 0.0043 | 1 | 5 | sensory system development |
GO:0090074 | 0.0043 | 316.6667 | 0.0043 | 1 | 5 | negative regulation of protein homodimerization activity |
GO:0030223 | 0.0051 | 253.3167 | 0.0051 | 1 | 6 | neutrophil differentiation |
GO:0048241 | 0.0051 | 253.3167 | 0.0051 | 1 | 6 | epinephrine transport |
GO:0060842 | 0.0051 | 253.3167 | 0.0051 | 1 | 6 | arterial endothelial cell differentiation |
GO:0051100 | 0.0058 | 20.4478 | 0.1162 | 2 | 136 | negative regulation of binding |
GO:0003190 | 0.006 | 211.0833 | 0.006 | 1 | 7 | atrioventricular valve formation |
GO:0051971 | 0.006 | 211.0833 | 0.006 | 1 | 7 | positive regulation of transmission of nerve impulse |
GO:0031960 | 0.0067 | 19.0152 | 0.1247 | 2 | 146 | response to corticosteroid |
GO:0008343 | 0.0068 | 180.9167 | 0.0068 | 1 | 8 | adult feeding behavior |
GO:0035912 | 0.0068 | 180.9167 | 0.0068 | 1 | 8 | dorsal aorta morphogenesis |
GO:0003205 | 0.0073 | 18.1252 | 0.1307 | 2 | 153 | cardiac chamber development |
GO:0003139 | 0.0077 | 158.2917 | 0.0077 | 1 | 9 | secondary heart field specification |
GO:0003266 | 0.0077 | 158.2917 | 0.0077 | 1 | 9 | regulation of secondary heart field cardioblast proliferation |
GO:0061314 | 0.0077 | 158.2917 | 0.0077 | 1 | 9 | Notch signaling involved in heart development |
GO:0050731 | 0.0078 | 17.4256 | 0.1358 | 2 | 159 | positive regulation of peptidyl-tyrosine phosphorylation |
GO:0051099 | 0.0079 | 17.3142 | 0.1367 | 2 | 160 | positive regulation of binding |
GO:0050796 | 0.0081 | 17.0955 | 0.1384 | 2 | 162 | regulation of insulin secretion |
GO:0045937 | 0.0084 | 6.2994 | 0.8594 | 4 | 1006 | positive regulation of phosphate metabolic process |
GO:0003263 | 0.0085 | 140.6944 | 0.0085 | 1 | 10 | cardioblast proliferation |
GO:0071396 | 0.0092 | 8.388 | 0.4511 | 3 | 528 | cellular response to lipid |
GO:0002573 | 0.0092 | 15.9841 | 0.1478 | 2 | 173 | myeloid leukocyte differentiation |
GO:0045935 | 0.0093 | 5.1236 | 1.4164 | 5 | 1658 | positive regulation of nucleobase-containing compound metabolic process |
GO:0021559 | 0.0094 | 126.6167 | 0.0094 | 1 | 11 | trigeminal nerve development |
GO:0060379 | 0.0094 | 126.6167 | 0.0094 | 1 | 11 | cardiac muscle cell myoblast differentiation |
GO:0045944 | 0.0095 | 6.053 | 0.8919 | 4 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
GO:1901215 | 0.0098 | 15.5248 | 0.1521 | 2 | 178 | negative regulation of neuron death |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0002264 | 7e-04 | Inf | 7e-04 | 1 | 1 | endothelial cell activation involved in immune response |
GO:0007495 | 7e-04 | Inf | 7e-04 | 1 | 1 | visceral mesoderm-endoderm interaction involved in midgut development |
GO:0060764 | 0.0013 | 1689.5556 | 0.0013 | 1 | 2 | cell-cell signaling involved in mammary gland development |
GO:0060435 | 0.002 | 844.7222 | 0.002 | 1 | 3 | bronchiole development |
GO:0061146 | 0.002 | 844.7222 | 0.002 | 1 | 3 | Peyer's patch morphogenesis |
GO:0060480 | 0.0026 | 563.1111 | 0.0026 | 1 | 4 | lung goblet cell differentiation |
GO:0060535 | 0.0026 | 563.1111 | 0.0026 | 1 | 4 | trachea cartilage morphogenesis |
GO:0060574 | 0.0026 | 563.1111 | 0.0026 | 1 | 4 | intestinal epithelial cell maturation |
GO:0048565 | 0.003 | 30.164 | 0.0835 | 2 | 127 | digestive tract development |
GO:1900020 | 0.0033 | 422.3056 | 0.0033 | 1 | 5 | positive regulation of protein kinase C activity |
GO:0048537 | 0.0039 | 337.8222 | 0.0039 | 1 | 6 | mucosal-associated lymphoid tissue development |
GO:0060482 | 0.0039 | 337.8222 | 0.0039 | 1 | 6 | lobar bronchus development |
GO:0048251 | 0.0046 | 281.5 | 0.0046 | 1 | 7 | elastic fiber assembly |
GO:0045647 | 0.0052 | 241.2698 | 0.0053 | 1 | 8 | negative regulation of erythrocyte differentiation |
GO:0060638 | 0.0052 | 241.2698 | 0.0053 | 1 | 8 | mesenchymal-epithelial cell signaling |
GO:0071493 | 0.0052 | 241.2698 | 0.0053 | 1 | 8 | cellular response to UV-B |
GO:0010870 | 0.0059 | 211.0972 | 0.0059 | 1 | 9 | positive regulation of receptor biosynthetic process |
GO:0010739 | 0.0066 | 187.6296 | 0.0066 | 1 | 10 | positive regulation of protein kinase A signaling |
GO:0060484 | 0.0066 | 187.6296 | 0.0066 | 1 | 10 | lung-associated mesenchyme development |
GO:0060033 | 0.0072 | 168.8556 | 0.0072 | 1 | 11 | anatomical structure regression |
GO:2000353 | 0.0079 | 153.4949 | 0.0079 | 1 | 12 | positive regulation of endothelial cell apoptotic process |
GO:0009650 | 0.0085 | 140.6944 | 0.0085 | 1 | 13 | UV protection |
GO:1902259 | 0.0092 | 129.8632 | 0.0092 | 1 | 14 | regulation of delayed rectifier potassium channel activity |
GO:0048534 | 0.0095 | 9.0851 | 0.471 | 3 | 796 | hematopoietic or lymphoid organ development |
GO:0002070 | 0.0098 | 120.5794 | 0.0099 | 1 | 15 | epithelial cell maturation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0009952 | 0 | 23.941 | 0.3315 | 6 | 194 | anterior/posterior pattern specification |
GO:0048704 | 0 | 68.6591 | 0.0759 | 4 | 48 | embryonic skeletal system morphogenesis |
GO:0021675 | 0 | 41.0421 | 0.1213 | 4 | 71 | nerve development |
GO:0021615 | 0 | 632.875 | 0.0068 | 2 | 4 | glossopharyngeal nerve morphogenesis |
GO:0043009 | 0 | 10.0732 | 0.9278 | 7 | 543 | chordate embryonic development |
GO:0045944 | 0 | 7.2409 | 1.7838 | 9 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
GO:0007389 | 1e-04 | 11.0932 | 0.6937 | 6 | 406 | pattern specification process |
GO:0048568 | 1e-04 | 11.0648 | 0.6954 | 6 | 407 | embryonic organ development |
GO:0048598 | 2e-04 | 8.3111 | 0.9235 | 6 | 562 | embryonic morphogenesis |
GO:1903508 | 2e-04 | 5.5038 | 2.293 | 9 | 1342 | positive regulation of nucleic acid-templated transcription |
GO:0048589 | 2e-04 | 8.2024 | 0.9261 | 6 | 542 | developmental growth |
GO:0009889 | 3e-04 | 4.288 | 7.0805 | 16 | 4144 | regulation of biosynthetic process |
GO:0051254 | 4e-04 | 5.2069 | 2.4109 | 9 | 1411 | positive regulation of RNA metabolic process |
GO:0009887 | 4e-04 | 7.6915 | 1.0301 | 6 | 701 | animal organ morphogenesis |
GO:0021602 | 6e-04 | 65.6623 | 0.0363 | 2 | 23 | cranial nerve morphogenesis |
GO:0010557 | 8e-04 | 4.6558 | 2.6654 | 9 | 1560 | positive regulation of macromolecule biosynthetic process |
GO:0030878 | 8e-04 | 57.4583 | 0.041 | 2 | 24 | thyroid gland development |
GO:0048646 | 9e-04 | 5.4736 | 1.6488 | 7 | 965 | anatomical structure formation involved in morphogenesis |
GO:0001501 | 0.001 | 10.658 | 0.451 | 4 | 295 | skeletal system development |
GO:0040018 | 0.0013 | 43.569 | 0.053 | 2 | 31 | positive regulation of multicellular organism growth |
GO:0031328 | 0.0013 | 4.2605 | 2.8841 | 9 | 1688 | positive regulation of cellular biosynthetic process |
GO:0043010 | 0.0014 | 9.5094 | 0.4938 | 4 | 289 | camera-type eye development |
GO:0010628 | 0.0014 | 4.2181 | 2.9098 | 9 | 1703 | positive regulation of gene expression |
GO:0009888 | 0.0016 | 4.1627 | 2.9439 | 9 | 1723 | tissue development |
GO:0006355 | 0.0017 | 3.5184 | 5.7666 | 13 | 3375 | regulation of transcription, DNA-templated |
GO:0007634 | 0.0017 | Inf | 0.0017 | 1 | 1 | optokinetic behavior |
GO:0021754 | 0.0017 | Inf | 0.0017 | 1 | 1 | facial nucleus development |
GO:0036321 | 0.0017 | Inf | 0.0017 | 1 | 1 | ghrelin secretion |
GO:0042404 | 0.0017 | Inf | 0.0017 | 1 | 1 | thyroid hormone catabolic process |
GO:2001141 | 0.0018 | 3.4838 | 5.811 | 13 | 3401 | regulation of RNA biosynthetic process |
GO:0019219 | 0.0021 | 3.3568 | 6.7183 | 14 | 3932 | regulation of nucleobase-containing compound metabolic process |
GO:0034654 | 0.0025 | 3.2942 | 6.8122 | 14 | 3987 | nucleobase-containing compound biosynthetic process |
GO:0048701 | 0.0025 | 30.0575 | 0.0752 | 2 | 44 | embryonic cranial skeleton morphogenesis |
GO:0060173 | 0.0029 | 11.7344 | 0.2905 | 3 | 170 | limb development |
GO:0051216 | 0.003 | 11.6638 | 0.2922 | 3 | 171 | cartilage development |
GO:0060324 | 0.0031 | 26.8511 | 0.0837 | 2 | 49 | face development |
GO:0021546 | 0.0033 | 632.7917 | 0.0033 | 1 | 2 | rhombomere development |
GO:0006711 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | estrogen catabolic process |
GO:0021560 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | abducens nerve development |
GO:0021570 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | rhombomere 4 development |
GO:0021599 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | abducens nerve formation |
GO:0030824 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | negative regulation of cGMP metabolic process |
GO:0031283 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | negative regulation of guanylate cyclase activity |
GO:0043134 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | regulation of hindgut contraction |
GO:0060876 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | semicircular canal formation |
GO:0090327 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | negative regulation of locomotion involved in locomotory behavior |
GO:0120054 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | intestinal motility |
GO:0120058 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | positive regulation of small intestinal transit |
GO:1904008 | 0.0034 | 607.6 | 0.0034 | 1 | 2 | response to monosodium glutamate |
GO:1901360 | 0.0044 | 3.0712 | 9.9134 | 17 | 5802 | organic cyclic compound metabolic process |
GO:0050795 | 0.0048 | 21.3729 | 0.1042 | 2 | 61 | regulation of behavior |
GO:0010159 | 0.0051 | 303.78 | 0.0051 | 1 | 3 | specification of animal organ position |
GO:0021571 | 0.0051 | 303.78 | 0.0051 | 1 | 3 | rhombomere 5 development |
GO:0060672 | 0.0051 | 303.78 | 0.0051 | 1 | 3 | epithelial cell morphogenesis involved in placental branching |
GO:1904000 | 0.0051 | 303.78 | 0.0051 | 1 | 3 | positive regulation of eating behavior |
GO:1904349 | 0.0051 | 303.78 | 0.0051 | 1 | 3 | positive regulation of small intestine smooth muscle contraction |
GO:1905333 | 0.0051 | 303.78 | 0.0051 | 1 | 3 | regulation of gastric motility |
GO:1901576 | 0.0052 | 3.0035 | 10.0501 | 17 | 5882 | organic substance biosynthetic process |
GO:0009653 | 0.0061 | 6.8032 | 0.7807 | 4 | 760 | anatomical structure morphogenesis |
GO:0032100 | 0.0068 | 202.5067 | 0.0068 | 1 | 4 | positive regulation of appetite |
GO:1905564 | 0.0068 | 202.5067 | 0.0068 | 1 | 4 | positive regulation of vascular endothelial cell proliferation |
GO:0051289 | 0.0068 | 17.7465 | 0.1247 | 2 | 73 | protein homotetramerization |
GO:0007423 | 0.0073 | 8.4756 | 0.404 | 3 | 263 | sensory organ development |
GO:0090596 | 0.008 | 8.1255 | 0.4152 | 3 | 243 | sensory organ morphogenesis |
GO:0045409 | 0.0085 | 151.87 | 0.0085 | 1 | 5 | negative regulation of interleukin-6 biosynthetic process |
GO:1904304 | 0.0085 | 151.87 | 0.0085 | 1 | 5 | regulation of gastro-intestinal system smooth muscle contraction |
GO:2000110 | 0.0085 | 151.87 | 0.0085 | 1 | 5 | negative regulation of macrophage apoptotic process |
GO:0006725 | 0.0089 | 2.7535 | 9.5665 | 16 | 5599 | cellular aromatic compound metabolic process |
GO:0001942 | 0.009 | 15.3547 | 0.1435 | 2 | 84 | hair follicle development |
GO:0022404 | 0.0094 | 14.9871 | 0.1469 | 2 | 86 | molting cycle process |
GO:0048522 | 0.0098 | 2.7106 | 7.834 | 14 | 4585 | positive regulation of cellular process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050877 | 1e-04 | 8.3762 | 1.191 | 7 | 863 | nervous system process |
GO:0048704 | 3e-04 | 28.2903 | 0.127 | 3 | 92 | embryonic skeletal system morphogenesis |
GO:0032501 | 4e-04 | 7.0547 | 6.7766 | 14 | 5904 | multicellular organismal process |
GO:0030878 | 5e-04 | 72.6029 | 0.0331 | 2 | 24 | thyroid gland development |
GO:0003016 | 6e-04 | 66.5439 | 0.0359 | 2 | 26 | respiratory system process |
GO:0050906 | 7e-04 | 19.9339 | 0.178 | 3 | 129 | detection of stimulus involved in sensory perception |
GO:0051216 | 0.0016 | 14.9087 | 0.236 | 3 | 171 | cartilage development |
GO:0007389 | 0.0021 | 8.6591 | 0.5603 | 4 | 406 | pattern specification process |
GO:0009952 | 0.0023 | 13.0934 | 0.2677 | 3 | 194 | anterior/posterior pattern specification |
GO:0050976 | 0.0028 | 759.75 | 0.0028 | 1 | 2 | detection of mechanical stimulus involved in sensory perception of touch |
GO:0060163 | 0.0028 | 759.75 | 0.0028 | 1 | 2 | subpallium neuron fate commitment |
GO:0060764 | 0.0028 | 759.75 | 0.0028 | 1 | 2 | cell-cell signaling involved in mammary gland development |
GO:0050911 | 0.0028 | 28.978 | 0.0787 | 2 | 57 | detection of chemical stimulus involved in sensory perception of smell |
GO:0010159 | 0.0041 | 379.85 | 0.0041 | 1 | 3 | specification of animal organ position |
GO:0014707 | 0.0041 | 379.85 | 0.0041 | 1 | 3 | branchiomeric skeletal muscle development |
GO:0046010 | 0.0041 | 379.85 | 0.0041 | 1 | 3 | positive regulation of circadian sleep/wake cycle, non-REM sleep |
GO:0060435 | 0.0041 | 379.85 | 0.0041 | 1 | 3 | bronchiole development |
GO:0021615 | 0.0055 | 253.2167 | 0.0055 | 1 | 4 | glossopharyngeal nerve morphogenesis |
GO:0060480 | 0.0055 | 253.2167 | 0.0055 | 1 | 4 | lung goblet cell differentiation |
GO:0060535 | 0.0055 | 253.2167 | 0.0055 | 1 | 4 | trachea cartilage morphogenesis |
GO:0060574 | 0.0055 | 253.2167 | 0.0055 | 1 | 4 | intestinal epithelial cell maturation |
GO:0048598 | 0.0068 | 6.1382 | 0.7797 | 4 | 565 | embryonic morphogenesis |
GO:0048625 | 0.0069 | 189.9 | 0.0069 | 1 | 5 | myoblast fate commitment |
GO:0019233 | 0.0069 | 17.8675 | 0.1256 | 2 | 91 | sensory perception of pain |
GO:0048856 | 0.0079 | 3.1792 | 7.1113 | 13 | 5153 | anatomical structure development |
GO:0023041 | 0.0083 | 151.91 | 0.0083 | 1 | 6 | neuronal signal transduction |
GO:0033603 | 0.0083 | 151.91 | 0.0083 | 1 | 6 | positive regulation of dopamine secretion |
GO:0060482 | 0.0083 | 151.91 | 0.0083 | 1 | 6 | lobar bronchus development |
GO:0071286 | 0.0083 | 151.91 | 0.0083 | 1 | 6 | cellular response to magnesium ion |
GO:0010038 | 0.0083 | 8.1645 | 0.4237 | 3 | 307 | response to metal ion |
GO:0021798 | 0.0096 | 126.5833 | 0.0097 | 1 | 7 | forebrain dorsal/ventral pattern formation |
GO:0060017 | 0.0096 | 126.5833 | 0.0097 | 1 | 7 | parathyroid gland development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050877 | 8e-04 | 9.2884 | 0.794 | 5 | 863 | nervous system process |
GO:0002264 | 9e-04 | Inf | 9e-04 | 1 | 1 | endothelial cell activation involved in immune response |
GO:0009913 | 0.0014 | 16.379 | 0.2318 | 3 | 252 | epidermal cell differentiation |
GO:0003335 | 0.0018 | 1169.3846 | 0.0018 | 1 | 2 | corneocyte development |
GO:0060468 | 0.0018 | 1169.3846 | 0.0018 | 1 | 2 | prevention of polyspermy |
GO:0043588 | 0.0026 | 13.1456 | 0.287 | 3 | 312 | skin development |
GO:2000503 | 0.0028 | 584.6538 | 0.0028 | 1 | 3 | positive regulation of natural killer cell chemotaxis |
GO:0019233 | 0.0031 | 28.3034 | 0.0837 | 2 | 91 | sensory perception of pain |
GO:0043308 | 0.0037 | 389.7436 | 0.0037 | 1 | 4 | eosinophil degranulation |
GO:0043307 | 0.0046 | 292.2885 | 0.0046 | 1 | 5 | eosinophil activation |
GO:0043615 | 0.0046 | 292.2885 | 0.0046 | 1 | 5 | astrocyte cell migration |
GO:1900020 | 0.0046 | 292.2885 | 0.0046 | 1 | 5 | positive regulation of protein kinase C activity |
GO:0010536 | 0.0055 | 233.8154 | 0.0055 | 1 | 6 | positive regulation of activation of Janus kinase activity |
GO:0008037 | 0.0064 | 19.1756 | 0.1224 | 2 | 133 | cell recognition |
GO:0031424 | 0.0068 | 18.6025 | 0.126 | 2 | 137 | keratinization |
GO:0048245 | 0.0073 | 166.989 | 0.0074 | 1 | 8 | eosinophil chemotaxis |
GO:0043901 | 0.0078 | 17.308 | 0.1352 | 2 | 147 | negative regulation of multi-organism process |
GO:0010739 | 0.0092 | 129.8632 | 0.0092 | 1 | 10 | positive regulation of protein kinase A signaling |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 104.0247 | 0.0712 | 5 | 57 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 48.5425 | 0.1448 | 5 | 116 | detection of chemical stimulus |
GO:0050906 | 0 | 43.4159 | 0.1611 | 5 | 129 | detection of stimulus involved in sensory perception |
GO:0007606 | 0 | 42.3819 | 0.1648 | 5 | 132 | sensory perception of chemical stimulus |
GO:0007186 | 0 | 12.5737 | 1.0476 | 8 | 839 | G-protein coupled receptor signaling pathway |
GO:0003095 | 0 | 1787.8824 | 0.0037 | 2 | 3 | pressure natriuresis |
GO:0036101 | 0 | 893.8824 | 0.005 | 2 | 4 | leukotriene B4 catabolic process |
GO:1901523 | 0 | 595.8824 | 0.0062 | 2 | 5 | icosanoid catabolic process |
GO:0019373 | 3e-04 | 93.9876 | 0.0262 | 2 | 21 | epoxygenase P450 pathway |
GO:0003071 | 4e-04 | 85.0252 | 0.0287 | 2 | 23 | renal system process involved in regulation of systemic arterial blood pressure |
GO:0006691 | 6e-04 | 63.7395 | 0.0375 | 2 | 30 | leukotriene metabolic process |
GO:0055080 | 7e-04 | 8.7195 | 0.7529 | 5 | 603 | cation homeostasis |
GO:0098771 | 8e-04 | 8.5119 | 0.7704 | 5 | 617 | inorganic ion homeostasis |
GO:0003091 | 8e-04 | 55.7574 | 0.0425 | 2 | 34 | renal water homeostasis |
GO:0048247 | 0.0011 | 48.2067 | 0.0487 | 2 | 39 | lymphocyte chemotaxis |
GO:0055078 | 0.0011 | 46.935 | 0.0499 | 2 | 40 | sodium ion homeostasis |
GO:0002548 | 0.0014 | 42.4538 | 0.0549 | 2 | 44 | monocyte chemotaxis |
GO:0070098 | 0.0023 | 32.3914 | 0.0712 | 2 | 57 | chemokine-mediated signaling pathway |
GO:0030104 | 0.0028 | 28.7211 | 0.0799 | 2 | 64 | water homeostasis |
GO:0030593 | 0.0032 | 26.9733 | 0.0849 | 2 | 68 | neutrophil chemotaxis |
GO:0050877 | 0.0035 | 5.969 | 1.0775 | 5 | 863 | nervous system process |
GO:0071347 | 0.0039 | 24.3755 | 0.0936 | 2 | 75 | cellular response to interleukin-1 |
GO:0002249 | 0.005 | 281.3889 | 0.005 | 1 | 4 | lymphocyte anergy |
GO:0002667 | 0.005 | 281.3889 | 0.005 | 1 | 4 | regulation of T cell anergy |
GO:0007198 | 0.005 | 281.3889 | 0.005 | 1 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
GO:0042360 | 0.005 | 281.3889 | 0.005 | 1 | 4 | vitamin E metabolic process |
GO:0001676 | 0.0057 | 19.9722 | 0.1136 | 2 | 91 | long-chain fatty acid metabolic process |
GO:0033559 | 0.006 | 19.3171 | 0.1174 | 2 | 94 | unsaturated fatty acid metabolic process |
GO:0002933 | 0.0062 | 211.0278 | 0.0062 | 1 | 5 | lipid hydroxylation |
GO:0009062 | 0.0063 | 18.9036 | 0.1199 | 2 | 96 | fatty acid catabolic process |
GO:0097530 | 0.0067 | 18.3153 | 0.1236 | 2 | 99 | granulocyte migration |
GO:0007195 | 0.0075 | 168.8111 | 0.0075 | 1 | 6 | adenylate cyclase-inhibiting dopamine receptor signaling pathway |
GO:0071346 | 0.0089 | 15.7054 | 0.1436 | 2 | 115 | cellular response to interferon-gamma |
GO:0006874 | 0.0097 | 7.7502 | 0.452 | 3 | 362 | cellular calcium ion homeostasis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 247.3469 | 0.0674 | 8 | 57 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 111.7852 | 0.1372 | 8 | 116 | detection of chemical stimulus |
GO:0050906 | 0 | 99.6893 | 0.1526 | 8 | 129 | detection of stimulus involved in sensory perception |
GO:0007606 | 0 | 97.2581 | 0.1561 | 8 | 132 | sensory perception of chemical stimulus |
GO:0007186 | 0 | 17.312 | 0.9924 | 9 | 839 | G-protein coupled receptor signaling pathway |
GO:0050877 | 0 | 16.7974 | 1.0208 | 9 | 863 | nervous system process |
GO:0070227 | 0.0024 | 31.5396 | 0.0733 | 2 | 62 | lymphocyte apoptotic process |
GO:0036112 | 0.0035 | 446.9706 | 0.0035 | 1 | 3 | medium-chain fatty-acyl-CoA metabolic process |
GO:0002249 | 0.0047 | 297.9608 | 0.0047 | 1 | 4 | lymphocyte anergy |
GO:0002667 | 0.0047 | 297.9608 | 0.0047 | 1 | 4 | regulation of T cell anergy |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001077 | 8e-04 | 11.0035 | 0.4313 | 4 | 263 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
GO:0000978 | 0.0023 | 8.2375 | 0.5706 | 4 | 348 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
GO:0001159 | 0.0027 | 7.863 | 0.5969 | 4 | 364 | core promoter proximal region DNA binding |
GO:0004174 | 0.0033 | 634.1667 | 0.0033 | 1 | 2 | electron-transferring-flavoprotein dehydrogenase activity |
GO:0061629 | 0.0033 | 634.1667 | 0.0033 | 1 | 2 | RNA polymerase II sequence-specific DNA binding transcription factor binding |
GO:0004028 | 0.0082 | 158.5104 | 0.0082 | 1 | 5 | 3-chloroallyl aldehyde dehydrogenase activity |
GO:0004111 | 0.0098 | 126.8 | 0.0098 | 1 | 6 | creatine kinase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001530 | 0.0021 | 33.6608 | 0.0677 | 2 | 24 | lipopolysaccharide binding |
GO:0031855 | 0.0028 | Inf | 0.0028 | 1 | 1 | oxytocin receptor binding |
GO:0005185 | 0.0056 | 361.9524 | 0.0056 | 1 | 2 | neurohypophyseal hormone activity |
GO:0004740 | 0.0084 | 180.9643 | 0.0085 | 1 | 3 | pyruvate dehydrogenase (acetyl-transferring) kinase activity |
GO:0070891 | 0.0084 | 180.9643 | 0.0085 | 1 | 3 | lipoteichoic acid binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 104.2239 | 0.071 | 5 | 57 | olfactory receptor activity |
GO:0004930 | 1e-04 | 12.7155 | 0.5247 | 5 | 421 | G-protein coupled receptor activity |
GO:0099600 | 0.0031 | 6.1169 | 1.0531 | 5 | 845 | transmembrane receptor activity |
GO:0004867 | 0.0037 | 25.1135 | 0.091 | 2 | 73 | serine-type endopeptidase inhibitor activity |
GO:0038023 | 0.0042 | 5.6853 | 1.1278 | 5 | 905 | signaling receptor activity |
GO:0004222 | 0.0074 | 17.2747 | 0.1309 | 2 | 105 | metalloendopeptidase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008260 | 0.0018 | 1171.6154 | 0.0018 | 1 | 2 | 3-oxoacid CoA-transferase activity |
GO:0031708 | 0.0018 | 1171.6154 | 0.0018 | 1 | 2 | endothelin B receptor binding |
GO:0001588 | 0.0037 | 390.4872 | 0.0037 | 1 | 4 | dopamine neurotransmitter receptor activity, coupled via Gs |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1903231 | 8e-04 | 56.2815 | 0.042 | 2 | 32 | mRNA binding involved in posttranscriptional gene silencing |
GO:0031249 | 0.0013 | Inf | 0.0013 | 1 | 1 | denatured protein binding |
GO:0005546 | 0.0026 | 30.0992 | 0.0761 | 2 | 58 | phosphatidylinositol-4,5-bisphosphate binding |
GO:0005153 | 0.0026 | 801.3158 | 0.0026 | 1 | 2 | interleukin-8 receptor binding |
GO:0031708 | 0.0026 | 801.3158 | 0.0026 | 1 | 2 | endothelin B receptor binding |
GO:0001664 | 0.003 | 11.8726 | 0.2965 | 3 | 226 | G-protein coupled receptor binding |
GO:0005094 | 0.0039 | 400.6316 | 0.0039 | 1 | 3 | Rho GDP-dissociation inhibitor activity |
GO:0001588 | 0.0052 | 267.0702 | 0.0052 | 1 | 4 | dopamine neurotransmitter receptor activity, coupled via Gs |
GO:0005047 | 0.0065 | 200.2895 | 0.0066 | 1 | 5 | signal recognition particle binding |
GO:0042826 | 0.0075 | 17.1519 | 0.1312 | 2 | 100 | histone deacetylase binding |
GO:0055131 | 0.0078 | 160.2211 | 0.0079 | 1 | 6 | C3HC4-type RING finger domain binding |
GO:0008312 | 0.0091 | 133.5088 | 0.0092 | 1 | 7 | 7S RNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0030545 | 1e-04 | 24.9832 | 0.2624 | 4 | 400 | receptor regulator activity |
GO:0005130 | 7e-04 | Inf | 7e-04 | 1 | 1 | granulocyte colony-stimulating factor receptor binding |
GO:0005179 | 0.002 | 37.4629 | 0.0676 | 2 | 103 | hormone activity |
GO:0001591 | 0.0026 | 564.1852 | 0.0026 | 1 | 4 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
GO:0005125 | 0.0052 | 22.5584 | 0.1108 | 2 | 169 | cytokine activity |
GO:0035240 | 0.0052 | 241.7302 | 0.0052 | 1 | 8 | dopamine binding |
GO:0005102 | 0.0084 | 6.8517 | 0.8888 | 4 | 1355 | receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001228 | 1e-04 | 10.3966 | 0.7254 | 6 | 395 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
GO:0003700 | 9e-04 | 4.834 | 2.1506 | 8 | 1171 | DNA binding transcription factor activity |
GO:0004506 | 0.0018 | Inf | 0.0018 | 1 | 1 | squalene monooxygenase activity |
GO:0031700 | 0.0018 | Inf | 0.0018 | 1 | 1 | adrenomedullin receptor binding |
GO:0001567 | 0.0037 | 563.5926 | 0.0037 | 1 | 2 | cholesterol 25-hydroxylase activity |
GO:0035939 | 0.0055 | 281.7778 | 0.0055 | 1 | 3 | microsatellite binding |
GO:0070891 | 0.0055 | 281.7778 | 0.0055 | 1 | 3 | lipoteichoic acid binding |
GO:0001847 | 0.0073 | 187.8395 | 0.0073 | 1 | 4 | opsonin receptor activity |
GO:1990837 | 0.0083 | 4.529 | 1.2893 | 5 | 702 | sequence-specific double-stranded DNA binding |
GO:0046982 | 0.0087 | 5.5202 | 0.8264 | 4 | 450 | protein heterodimerization activity |
GO:0016019 | 0.0092 | 140.8704 | 0.0092 | 1 | 5 | peptidoglycan receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005130 | 0.001 | Inf | 0.001 | 1 | 1 | granulocyte colony-stimulating factor receptor binding |
GO:0018169 | 0.001 | Inf | 0.001 | 1 | 1 | ribosomal S6-glutamic acid ligase activity |
GO:0033560 | 0.001 | Inf | 0.001 | 1 | 1 | folate reductase activity |
GO:0047963 | 0.001 | Inf | 0.001 | 1 | 1 | glycine N-choloyltransferase activity |
GO:0052817 | 0.001 | Inf | 0.001 | 1 | 1 | very long chain acyl-CoA hydrolase activity |
GO:0004984 | 0.0014 | 42.4503 | 0.0561 | 2 | 57 | olfactory receptor activity |
GO:0004146 | 0.002 | 1087.8571 | 0.002 | 1 | 2 | dihydrofolate reductase activity |
GO:0051870 | 0.002 | 1087.8571 | 0.002 | 1 | 2 | methotrexate binding |
GO:0052815 | 0.002 | 1087.8571 | 0.002 | 1 | 2 | medium-chain acyl-CoA hydrolase activity |
GO:0035939 | 0.0029 | 543.8929 | 0.003 | 1 | 3 | microsatellite binding |
GO:0051431 | 0.0029 | 543.8929 | 0.003 | 1 | 3 | corticotropin-releasing hormone receptor 2 binding |
GO:0018685 | 0.0039 | 362.5714 | 0.0039 | 1 | 4 | alkane 1-monooxygenase activity |
GO:0050051 | 0.0039 | 362.5714 | 0.0039 | 1 | 4 | leukotriene-B4 20-monooxygenase activity |
GO:0019788 | 0.0059 | 217.5143 | 0.0059 | 1 | 6 | NEDD8 transferase activity |
GO:0004930 | 0.0074 | 8.8594 | 0.4142 | 3 | 421 | G-protein coupled receptor activity |
GO:0099600 | 0.0078 | 6.222 | 0.8314 | 4 | 845 | transmembrane receptor activity |
GO:0019957 | 0.0078 | 155.3469 | 0.0079 | 1 | 8 | C-C chemokine binding |
GO:0102991 | 0.0078 | 155.3469 | 0.0079 | 1 | 8 | myristoyl-CoA hydrolase activity |
GO:0005542 | 0.0088 | 135.9196 | 0.0089 | 1 | 9 | folic acid binding |
GO:1990825 | 0.0088 | 135.9196 | 0.0089 | 1 | 9 | sequence-specific mRNA binding |
GO:0051427 | 0.0099 | 15.1614 | 0.1525 | 2 | 155 | hormone receptor binding |
GO:0038023 | 0.0099 | 5.7835 | 0.8904 | 4 | 905 | signaling receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005212 | 3e-04 | 95.05 | 0.026 | 2 | 18 | structural constituent of eye lens |
GO:0004946 | 0.0014 | Inf | 0.0014 | 1 | 1 | bombesin receptor activity |
GO:0031855 | 0.0014 | Inf | 0.0014 | 1 | 1 | oxytocin receptor binding |
GO:0004930 | 0.0028 | 7.8908 | 0.6075 | 4 | 421 | G-protein coupled receptor activity |
GO:0001632 | 0.0029 | 724.9048 | 0.0029 | 1 | 2 | leukotriene B4 receptor activity |
GO:0005185 | 0.0029 | 724.9048 | 0.0029 | 1 | 2 | neurohypophyseal hormone activity |
GO:0047025 | 0.0029 | 724.9048 | 0.0029 | 1 | 2 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity |
GO:0070404 | 0.0043 | 362.4286 | 0.0043 | 1 | 3 | NADH binding |
GO:0001588 | 0.0058 | 241.6032 | 0.0058 | 1 | 4 | dopamine neurotransmitter receptor activity, coupled via Gs |
GO:0047035 | 0.0086 | 144.9429 | 0.0087 | 1 | 6 | testosterone dehydrogenase (NAD+) activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003924 | 7e-04 | 11.6459 | 0.4109 | 4 | 261 | GTPase activity |
GO:0017045 | 0.0016 | Inf | 0.0016 | 1 | 1 | corticotropin-releasing hormone activity |
GO:0003854 | 0.0031 | 661.7826 | 0.0031 | 1 | 2 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity |
GO:0031894 | 0.0031 | 661.7826 | 0.0031 | 1 | 2 | V1A vasopressin receptor binding |
GO:0036461 | 0.0031 | 661.7826 | 0.0031 | 1 | 2 | BLOC-2 complex binding |
GO:1990932 | 0.0031 | 661.7826 | 0.0031 | 1 | 2 | 5.8S rRNA binding |
GO:0048306 | 0.0034 | 26.0189 | 0.0866 | 2 | 55 | calcium-dependent protein binding |
GO:0004024 | 0.0047 | 330.8696 | 0.0047 | 1 | 3 | alcohol dehydrogenase activity, zinc-dependent |
GO:0030369 | 0.0047 | 330.8696 | 0.0047 | 1 | 3 | ICAM-3 receptor activity |
GO:0035651 | 0.0047 | 330.8696 | 0.0047 | 1 | 3 | AP-3 adaptor complex binding |
GO:0051431 | 0.0047 | 330.8696 | 0.0047 | 1 | 3 | corticotropin-releasing hormone receptor 2 binding |
GO:0000213 | 0.0063 | 220.5652 | 0.0063 | 1 | 4 | tRNA-intron endonuclease activity |
GO:0032190 | 0.0063 | 220.5652 | 0.0063 | 1 | 4 | acrosin binding |
GO:0035650 | 0.0063 | 220.5652 | 0.0063 | 1 | 4 | AP-1 adaptor complex binding |
GO:0051430 | 0.0063 | 220.5652 | 0.0063 | 1 | 4 | corticotropin-releasing hormone receptor 1 binding |
GO:0005000 | 0.0094 | 132.3217 | 0.0094 | 1 | 6 | vasopressin receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031727 | 0 | Inf | 0.0024 | 2 | 2 | CCR2 chemokine receptor binding |
GO:0005126 | 0 | 27.3733 | 0.255 | 5 | 216 | cytokine receptor binding |
GO:0001664 | 0 | 26.1173 | 0.2668 | 5 | 226 | G-protein coupled receptor binding |
GO:0008009 | 0 | 112.6 | 0.0354 | 3 | 30 | chemokine activity |
GO:0048020 | 2e-04 | 108.6286 | 0.0231 | 2 | 22 | CCR chemokine receptor binding |
GO:0001530 | 4e-04 | 86.3977 | 0.0283 | 2 | 24 | lipopolysaccharide binding |
GO:0008201 | 6e-04 | 20.95 | 0.1736 | 3 | 147 | heparin binding |
GO:0048018 | 8e-04 | 11.4101 | 0.4439 | 4 | 376 | receptor ligand activity |
GO:0008502 | 0.0024 | 895.7059 | 0.0024 | 1 | 2 | melatonin receptor activity |
GO:0048248 | 0.0024 | 895.7059 | 0.0024 | 1 | 2 | CXCR3 chemokine receptor binding |
GO:0001591 | 0.0047 | 298.5294 | 0.0047 | 1 | 4 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
GO:0005502 | 0.0047 | 298.5294 | 0.0047 | 1 | 4 | 11-cis retinal binding |
GO:0035240 | 0.0094 | 127.9076 | 0.0094 | 1 | 8 | dopamine binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 76.3472 | 0.071 | 4 | 57 | olfactory receptor activity |
GO:0034899 | 0.0012 | Inf | 0.0012 | 1 | 1 | trimethylamine monooxygenase activity |
GO:0050661 | 0.0013 | 43.5753 | 0.0536 | 2 | 43 | NADP binding |
GO:0004930 | 0.0016 | 9.4708 | 0.5247 | 4 | 421 | G-protein coupled receptor activity |
GO:0004096 | 0.0037 | 422.9167 | 0.0037 | 1 | 3 | catalase activity |
GO:0035939 | 0.0037 | 422.9167 | 0.0037 | 1 | 3 | microsatellite binding |
GO:0003839 | 0.005 | 281.9259 | 0.005 | 1 | 4 | gamma-glutamylcyclotransferase activity |
GO:0004499 | 0.005 | 281.9259 | 0.005 | 1 | 4 | N,N-dimethylaniline monooxygenase activity |
GO:0004046 | 0.0062 | 211.4306 | 0.0062 | 1 | 5 | aminoacylase activity |
GO:0004872 | 0.0099 | 4.5777 | 1.3796 | 5 | 1107 | receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0033798 | 0.002 | Inf | 0.002 | 1 | 1 | thyroxine 5-deiodinase activity |
GO:0047963 | 0.002 | Inf | 0.002 | 1 | 1 | glycine N-choloyltransferase activity |
GO:0052817 | 0.002 | Inf | 0.002 | 1 | 1 | very long chain acyl-CoA hydrolase activity |
GO:0004522 | 0.0039 | 524.6552 | 0.0039 | 1 | 2 | ribonuclease A activity |
GO:0052815 | 0.0039 | 524.6552 | 0.0039 | 1 | 2 | medium-chain acyl-CoA hydrolase activity |
GO:0004800 | 0.0059 | 262.3103 | 0.0059 | 1 | 3 | thyroxine 5'-deiodinase activity |
GO:0034513 | 0.0078 | 174.8621 | 0.0079 | 1 | 4 | box H/ACA snoRNA binding |
GO:0015057 | 0.0098 | 131.1379 | 0.0098 | 1 | 5 | thrombin-activated receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001567 | 0.0033 | 634.1667 | 0.0033 | 1 | 2 | cholesterol 25-hydroxylase activity |
GO:0008502 | 0.0033 | 634.1667 | 0.0033 | 1 | 2 | melatonin receptor activity |
GO:0030549 | 0.0033 | 634.1667 | 0.0033 | 1 | 2 | acetylcholine receptor activator activity |
GO:0043565 | 0.0045 | 4.574 | 1.6217 | 6 | 989 | sequence-specific DNA binding |
GO:0034875 | 0.0049 | 317.0625 | 0.0049 | 1 | 3 | caffeine oxidase activity |
GO:0046848 | 0.0049 | 317.0625 | 0.0049 | 1 | 3 | hydroxyapatite binding |
GO:0000981 | 0.0059 | 5.0131 | 1.1938 | 5 | 728 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
GO:0030197 | 0.0065 | 211.3611 | 0.0066 | 1 | 4 | extracellular matrix constituent, lubricant activity |
GO:0030345 | 0.0065 | 211.3611 | 0.0066 | 1 | 4 | structural constituent of tooth enamel |
GO:0051525 | 0.0065 | 211.3611 | 0.0066 | 1 | 4 | NFAT protein binding |
GO:0001077 | 0.0088 | 7.8467 | 0.4313 | 3 | 263 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
GO:0140110 | 0.0088 | 3.5599 | 2.4695 | 7 | 1506 | transcription regulator activity |
GO:0046983 | 0.0092 | 3.8895 | 1.8841 | 6 | 1149 | protein dimerization activity |
GO:0004497 | 0.0093 | 15.1264 | 0.1459 | 2 | 89 | monooxygenase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031727 | 0 | Inf | 0.0018 | 2 | 2 | CCR2 chemokine receptor binding |
GO:0042379 | 0 | 112.0025 | 0.0367 | 3 | 40 | chemokine receptor binding |
GO:0001530 | 2e-04 | 115.2273 | 0.022 | 2 | 24 | lipopolysaccharide binding |
GO:0060089 | 3e-04 | 9.2273 | 1.0569 | 6 | 1151 | molecular transducer activity |
GO:0004506 | 9e-04 | Inf | 9e-04 | 1 | 1 | squalene monooxygenase activity |
GO:0038023 | 9e-04 | 8.8469 | 0.831 | 5 | 905 | signaling receptor activity |
GO:0004984 | 0.0012 | 45.9909 | 0.0523 | 2 | 57 | olfactory receptor activity |
GO:0001791 | 0.0018 | 1171.6154 | 0.0018 | 1 | 2 | IgM binding |
GO:0004867 | 0.002 | 35.5892 | 0.067 | 2 | 73 | serine-type endopeptidase inhibitor activity |
GO:0031014 | 0.0028 | 585.7692 | 0.0028 | 1 | 3 | troponin T binding |
GO:0005502 | 0.0037 | 390.4872 | 0.0037 | 1 | 4 | 11-cis retinal binding |
GO:0032190 | 0.0037 | 390.4872 | 0.0037 | 1 | 4 | acrosin binding |
GO:0004930 | 0.0046 | 10.8667 | 0.3515 | 3 | 412 | G-protein coupled receptor activity |
GO:0099600 | 0.006 | 6.8447 | 0.7759 | 4 | 845 | transmembrane receptor activity |
GO:0030414 | 0.007 | 18.3637 | 0.1276 | 2 | 139 | peptidase inhibitor activity |
GO:0061135 | 0.007 | 18.3637 | 0.1276 | 2 | 139 | endopeptidase regulator activity |
GO:0019957 | 0.0073 | 167.3077 | 0.0073 | 1 | 8 | C-C chemokine binding |
GO:0008201 | 0.0078 | 17.3414 | 0.135 | 2 | 147 | heparin binding |
GO:0008020 | 0.0082 | 146.3846 | 0.0083 | 1 | 9 | G-protein coupled photoreceptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0.0014 | 5.5405 | 1.2397 | 6 | 450 | protein heterodimerization activity |
GO:1903231 | 0.0035 | 25.29 | 0.0882 | 2 | 32 | mRNA binding involved in posttranscriptional gene silencing |
GO:0043565 | 0.005 | 3.4114 | 2.7245 | 8 | 989 | sequence-specific DNA binding |
GO:0031492 | 0.0051 | 20.4959 | 0.1074 | 2 | 39 | nucleosomal DNA binding |
GO:0001078 | 0.0055 | 9.132 | 0.3581 | 3 | 130 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding |
GO:1990430 | 0.0082 | 185.3902 | 0.0083 | 1 | 3 | extracellular matrix protein binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005523 | 8e-04 | 58.8721 | 0.0413 | 2 | 14 | tropomyosin binding |
GO:0001530 | 0.0023 | 32.0909 | 0.0708 | 2 | 24 | lipopolysaccharide binding |
GO:0017024 | 0.003 | Inf | 0.003 | 1 | 1 | myosin I binding |
GO:0031855 | 0.003 | Inf | 0.003 | 1 | 1 | oxytocin receptor binding |
GO:0002020 | 0.0052 | 9.2888 | 0.3512 | 3 | 119 | protease binding |
GO:0005185 | 0.0059 | 345.4545 | 0.0059 | 1 | 2 | neurohypophyseal hormone activity |
GO:0032090 | 0.0059 | 345.4545 | 0.0059 | 1 | 2 | Pyrin domain binding |
GO:0004740 | 0.0088 | 172.7159 | 0.0089 | 1 | 3 | pyruvate dehydrogenase (acetyl-transferring) kinase activity |
GO:0070891 | 0.0088 | 172.7159 | 0.0089 | 1 | 3 | lipoteichoic acid binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001077 | 0.0047 | 10.1579 | 0.345 | 3 | 263 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
GO:0000977 | 0.0064 | 6.2792 | 0.77 | 4 | 587 | RNA polymerase II regulatory region sequence-specific DNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1903231 | 8e-04 | 56.2815 | 0.042 | 2 | 32 | mRNA binding involved in posttranscriptional gene silencing |
GO:0031249 | 0.0013 | Inf | 0.0013 | 1 | 1 | denatured protein binding |
GO:0005546 | 0.0026 | 30.0992 | 0.0761 | 2 | 58 | phosphatidylinositol-4,5-bisphosphate binding |
GO:0005153 | 0.0026 | 801.3158 | 0.0026 | 1 | 2 | interleukin-8 receptor binding |
GO:0031708 | 0.0026 | 801.3158 | 0.0026 | 1 | 2 | endothelin B receptor binding |
GO:0001664 | 0.003 | 11.8726 | 0.2965 | 3 | 226 | G-protein coupled receptor binding |
GO:0005094 | 0.0039 | 400.6316 | 0.0039 | 1 | 3 | Rho GDP-dissociation inhibitor activity |
GO:0001588 | 0.0052 | 267.0702 | 0.0052 | 1 | 4 | dopamine neurotransmitter receptor activity, coupled via Gs |
GO:0005047 | 0.0065 | 200.2895 | 0.0066 | 1 | 5 | signal recognition particle binding |
GO:0042826 | 0.0075 | 17.1519 | 0.1312 | 2 | 100 | histone deacetylase binding |
GO:0055131 | 0.0078 | 160.2211 | 0.0079 | 1 | 6 | C3HC4-type RING finger domain binding |
GO:0008312 | 0.0091 | 133.5088 | 0.0092 | 1 | 7 | 7S RNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 212.506 | 0.0636 | 7 | 57 | olfactory receptor activity |
GO:0004930 | 0 | 25.0495 | 0.4694 | 7 | 421 | G-protein coupled receptor activity |
GO:0099600 | 0 | 15.2842 | 0.9422 | 8 | 845 | transmembrane receptor activity |
GO:0038023 | 0 | 14.2024 | 1.0091 | 8 | 905 | signaling receptor activity |
GO:0060089 | 0 | 10.9544 | 1.2834 | 8 | 1151 | molecular transducer activity |
GO:0004867 | 0.0029 | 28.4657 | 0.0814 | 2 | 73 | serine-type endopeptidase inhibitor activity |
GO:0042608 | 0.0067 | 190.3 | 0.0067 | 1 | 6 | T cell receptor binding |
GO:0004321 | 0.0078 | 158.5729 | 0.0078 | 1 | 7 | fatty-acyl-CoA synthase activity |
GO:0003996 | 0.0089 | 135.9107 | 0.0089 | 1 | 8 | acyl-CoA ligase activity |
GO:0047760 | 0.0089 | 135.9107 | 0.0089 | 1 | 8 | butyrate-CoA ligase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004953 | 3e-04 | 101.38 | 0.0248 | 2 | 14 | icosanoid receptor activity |
GO:0060089 | 0.0032 | 4.3062 | 2.0384 | 7 | 1151 | molecular transducer activity |
GO:0001632 | 0.0035 | 585.3077 | 0.0035 | 1 | 2 | leukotriene B4 receptor activity |
GO:0031708 | 0.0035 | 585.3077 | 0.0035 | 1 | 2 | endothelin B receptor binding |
GO:0038023 | 0.0043 | 4.5511 | 1.6027 | 6 | 905 | signaling receptor activity |
GO:0001588 | 0.0071 | 195.0769 | 0.0071 | 1 | 4 | dopamine neurotransmitter receptor activity, coupled via Gs |
GO:0050833 | 0.0071 | 195.0769 | 0.0071 | 1 | 4 | pyruvate transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003854 | 0.0021 | 1015.2667 | 0.0021 | 1 | 2 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001077 | 8e-04 | 11.0035 | 0.4313 | 4 | 263 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
GO:0000978 | 0.0023 | 8.2375 | 0.5706 | 4 | 348 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
GO:0001159 | 0.0027 | 7.863 | 0.5969 | 4 | 364 | core promoter proximal region DNA binding |
GO:0004174 | 0.0033 | 634.1667 | 0.0033 | 1 | 2 | electron-transferring-flavoprotein dehydrogenase activity |
GO:0061629 | 0.0033 | 634.1667 | 0.0033 | 1 | 2 | RNA polymerase II sequence-specific DNA binding transcription factor binding |
GO:0004028 | 0.0082 | 158.5104 | 0.0082 | 1 | 5 | 3-chloroallyl aldehyde dehydrogenase activity |
GO:0004111 | 0.0098 | 126.8 | 0.0098 | 1 | 6 | creatine kinase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005549 | 0 | 281.9074 | 0.0101 | 2 | 11 | odorant binding |
GO:0042056 | 3e-04 | 97.4744 | 0.0257 | 2 | 28 | chemoattractant activity |
GO:0004984 | 0.0012 | 45.9909 | 0.0523 | 2 | 57 | olfactory receptor activity |
GO:0004035 | 0.0037 | 390.4872 | 0.0037 | 1 | 4 | alkaline phosphatase activity |
GO:0043199 | 0.0037 | 390.4872 | 0.0037 | 1 | 4 | sulfate binding |
GO:0004465 | 0.0073 | 167.3077 | 0.0073 | 1 | 8 | lipoprotein lipase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042497 | 7e-04 | Inf | 7e-04 | 1 | 1 | triacyl lipopeptide binding |
GO:0047963 | 7e-04 | Inf | 7e-04 | 1 | 1 | glycine N-choloyltransferase activity |
GO:0052817 | 7e-04 | Inf | 7e-04 | 1 | 1 | very long chain acyl-CoA hydrolase activity |
GO:0052815 | 0.0013 | 1692.7778 | 0.0013 | 1 | 2 | medium-chain acyl-CoA hydrolase activity |
GO:0038023 | 0.0019 | 10.6067 | 0.5936 | 4 | 905 | signaling receptor activity |
GO:0001875 | 0.0026 | 564.1852 | 0.0026 | 1 | 4 | lipopolysaccharide receptor activity |
GO:0008048 | 0.0033 | 423.1111 | 0.0033 | 1 | 5 | calcium sensitive guanylate cyclase activator activity |
GO:0042608 | 0.0039 | 338.4667 | 0.0039 | 1 | 6 | T cell receptor binding |
GO:0010853 | 0.0046 | 282.037 | 0.0046 | 1 | 7 | cyclase activator activity |
GO:0060089 | 0.0047 | 8.1889 | 0.755 | 4 | 1151 | molecular transducer activity |
GO:0005125 | 0.0052 | 22.5584 | 0.1108 | 2 | 169 | cytokine activity |
GO:0030249 | 0.0052 | 241.7302 | 0.0052 | 1 | 8 | guanylate cyclase regulator activity |
GO:0035325 | 0.0052 | 241.7302 | 0.0052 | 1 | 8 | Toll-like receptor binding |
GO:0102991 | 0.0052 | 241.7302 | 0.0052 | 1 | 8 | myristoyl-CoA hydrolase activity |
GO:0015643 | 0.0065 | 187.9877 | 0.0066 | 1 | 10 | toxic substance binding |
GO:0042834 | 0.0065 | 187.9877 | 0.0066 | 1 | 10 | peptidoglycan binding |
GO:0045295 | 0.0065 | 187.9877 | 0.0066 | 1 | 10 | gamma-catenin binding |
GO:0005509 | 0.007 | 9.8869 | 0.4172 | 3 | 636 | calcium ion binding |
GO:0016290 | 0.0072 | 169.1778 | 0.0072 | 1 | 11 | palmitoyl-CoA hydrolase activity |
GO:0005149 | 0.0078 | 153.7879 | 0.0079 | 1 | 12 | interleukin-1 receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004506 | 0.0015 | Inf | 0.0015 | 1 | 1 | squalene monooxygenase activity |
GO:0004946 | 0.0015 | Inf | 0.0015 | 1 | 1 | bombesin receptor activity |
GO:0005140 | 0.0015 | Inf | 0.0015 | 1 | 1 | interleukin-9 receptor binding |
GO:0047025 | 0.003 | 691.9091 | 0.003 | 1 | 2 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity |
GO:0070404 | 0.0045 | 345.9318 | 0.0045 | 1 | 3 | NADH binding |
GO:0070891 | 0.0045 | 345.9318 | 0.0045 | 1 | 3 | lipoteichoic acid binding |
GO:0001847 | 0.006 | 230.6061 | 0.006 | 1 | 4 | opsonin receptor activity |
GO:0016019 | 0.0075 | 172.9432 | 0.0075 | 1 | 5 | peptidoglycan receptor activity |
GO:0047035 | 0.009 | 138.3455 | 0.0091 | 1 | 6 | testosterone dehydrogenase (NAD+) activity |
GO:0071723 | 0.009 | 138.3455 | 0.0091 | 1 | 6 | lipopeptide binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005130 | 7e-04 | Inf | 7e-04 | 1 | 1 | granulocyte colony-stimulating factor receptor binding |
GO:0008502 | 0.0013 | 1692.7778 | 0.0013 | 1 | 2 | melatonin receptor activity |
GO:0035939 | 0.002 | 846.3333 | 0.002 | 1 | 3 | microsatellite binding |
GO:0032190 | 0.0026 | 564.1852 | 0.0026 | 1 | 4 | acrosin binding |
GO:1990254 | 0.0026 | 564.1852 | 0.0026 | 1 | 4 | keratin filament binding |
GO:0008134 | 0.0036 | 12.6833 | 0.3286 | 3 | 501 | transcription factor binding |
GO:1990837 | 0.0091 | 8.9129 | 0.4604 | 3 | 702 | sequence-specific double-stranded DNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032393 | 0.005 | 253.8167 | 0.0051 | 1 | 7 | MHC class I receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1903231 | 0 | 135.6964 | 0.042 | 4 | 32 | mRNA binding involved in posttranscriptional gene silencing |
GO:0001604 | 0.0013 | Inf | 0.0013 | 1 | 1 | urotensin II receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0043565 | 0 | 10.0625 | 1.4271 | 9 | 989 | sequence-specific DNA binding |
GO:0003700 | 9e-04 | 5.6369 | 1.6898 | 7 | 1171 | DNA binding transcription factor activity |
GO:0015361 | 0.0014 | Inf | 0.0014 | 1 | 1 | low-affinity sodium:dicarboxylate symporter activity |
GO:0004984 | 0.003 | 27.58 | 0.0823 | 2 | 57 | olfactory receptor activity |
GO:0001601 | 0.0043 | 362.4286 | 0.0043 | 1 | 3 | peptide YY receptor activity |
GO:0046848 | 0.0043 | 362.4286 | 0.0043 | 1 | 3 | hydroxyapatite binding |
GO:0004784 | 0.0058 | 241.6032 | 0.0058 | 1 | 4 | superoxide dismutase activity |
GO:0030197 | 0.0058 | 241.6032 | 0.0058 | 1 | 4 | extracellular matrix constituent, lubricant activity |
GO:0030345 | 0.0058 | 241.6032 | 0.0058 | 1 | 4 | structural constituent of tooth enamel |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0070888 | 0.0012 | 45.6842 | 0.051 | 2 | 37 | E-box binding |
GO:0033798 | 0.0014 | Inf | 0.0014 | 1 | 1 | thyroxine 5-deiodinase activity |
GO:0001228 | 0.0019 | 8.9267 | 0.5441 | 4 | 395 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
GO:0004984 | 0.0028 | 29.0335 | 0.0785 | 2 | 57 | olfactory receptor activity |
GO:0004800 | 0.0041 | 380.575 | 0.0041 | 1 | 3 | thyroxine 5'-deiodinase activity |
GO:0001591 | 0.0055 | 253.7 | 0.0055 | 1 | 4 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
GO:0000977 | 0.0077 | 5.9094 | 0.8085 | 4 | 587 | RNA polymerase II regulatory region sequence-specific DNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0015361 | 9e-04 | Inf | 9e-04 | 1 | 1 | low-affinity sodium:dicarboxylate symporter activity |
GO:0005148 | 0.0017 | 1269.3333 | 0.0017 | 1 | 2 | prolactin receptor binding |
GO:0031726 | 0.0026 | 634.625 | 0.0026 | 1 | 3 | CCR1 chemokine receptor binding |
GO:0004698 | 0.0034 | 423.0556 | 0.0034 | 1 | 4 | calcium-dependent protein kinase C activity |
GO:0032190 | 0.0034 | 423.0556 | 0.0034 | 1 | 4 | acrosin binding |
GO:0005131 | 0.0043 | 317.2708 | 0.0043 | 1 | 5 | growth hormone receptor binding |
GO:0031730 | 0.0043 | 317.2708 | 0.0043 | 1 | 5 | CCR5 chemokine receptor binding |
GO:0016004 | 0.0085 | 140.963 | 0.0085 | 1 | 10 | phospholipase activator activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1903231 | 0.0026 | 29.7647 | 0.0756 | 2 | 32 | mRNA binding involved in posttranscriptional gene silencing |
GO:0016779 | 0.0032 | 11.2429 | 0.2952 | 3 | 125 | nucleotidyltransferase activity |
GO:0001632 | 0.0047 | 434.5429 | 0.0047 | 1 | 2 | leukotriene B4 receptor activity |
GO:0070891 | 0.0071 | 217.2571 | 0.0071 | 1 | 3 | lipoteichoic acid binding |
GO:0001847 | 0.0094 | 144.8286 | 0.0094 | 1 | 4 | opsonin receptor activity |
GO:0010385 | 0.0094 | 144.8286 | 0.0094 | 1 | 4 | double-stranded methylated DNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 112.2485 | 0.0673 | 5 | 57 | olfactory receptor activity |
GO:0004930 | 0 | 17.847 | 0.497 | 6 | 421 | G-protein coupled receptor activity |
GO:0018685 | 0 | 951.625 | 0.0047 | 2 | 4 | alkane 1-monooxygenase activity |
GO:0050051 | 0 | 951.625 | 0.0047 | 2 | 4 | leukotriene-B4 20-monooxygenase activity |
GO:0099600 | 0 | 10.9275 | 0.9976 | 7 | 845 | transmembrane receptor activity |
GO:0004497 | 1e-04 | 35.214 | 0.1051 | 3 | 89 | monooxygenase activity |
GO:0008392 | 2e-04 | 126.775 | 0.0201 | 2 | 17 | arachidonic acid epoxygenase activity |
GO:0060089 | 2e-04 | 7.8344 | 1.3589 | 7 | 1151 | molecular transducer activity |
GO:0020037 | 4e-04 | 25.8308 | 0.1417 | 3 | 120 | heme binding |
GO:0048020 | 4e-04 | 86.3977 | 0.0283 | 2 | 24 | CCR chemokine receptor binding |
GO:0008009 | 6e-04 | 67.8571 | 0.0354 | 2 | 30 | chemokine activity |
GO:0016705 | 7e-04 | 20.8041 | 0.1747 | 3 | 148 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
GO:0005506 | 7e-04 | 20.6603 | 0.1759 | 3 | 149 | iron ion binding |
GO:0019825 | 0.0011 | 48.6827 | 0.0484 | 2 | 41 | oxygen binding |
GO:0102116 | 0.0012 | Inf | 0.0012 | 1 | 1 | laurate hydroxylase activity |
GO:0103002 | 0.0012 | Inf | 0.0012 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
GO:0038023 | 0.0013 | 7.9049 | 0.8744 | 5 | 829 | signaling receptor activity |
GO:0030594 | 0.0036 | 25.598 | 0.0897 | 2 | 76 | neurotransmitter receptor activity |
GO:0001591 | 0.0047 | 298.5294 | 0.0047 | 1 | 4 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
GO:0035240 | 0.0094 | 127.9076 | 0.0094 | 1 | 8 | dopamine binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 275.3741 | 0.0636 | 8 | 57 | olfactory receptor activity |
GO:0004930 | 0 | 31.8881 | 0.4694 | 8 | 421 | G-protein coupled receptor activity |
GO:0099600 | 0 | 19.3686 | 0.9422 | 9 | 845 | transmembrane receptor activity |
GO:0038023 | 0 | 17.9962 | 1.0091 | 9 | 905 | signaling receptor activity |
GO:0060089 | 0 | 13.8773 | 1.2834 | 9 | 1151 | molecular transducer activity |
GO:0004867 | 0.0029 | 28.4657 | 0.0814 | 2 | 73 | serine-type endopeptidase inhibitor activity |
GO:0042608 | 0.0067 | 190.3 | 0.0067 | 1 | 6 | T cell receptor binding |
GO:0004321 | 0.0078 | 158.5729 | 0.0078 | 1 | 7 | fatty-acyl-CoA synthase activity |
GO:0003996 | 0.0089 | 135.9107 | 0.0089 | 1 | 8 | acyl-CoA ligase activity |
GO:0047760 | 0.0089 | 135.9107 | 0.0089 | 1 | 8 | butyrate-CoA ligase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031249 | 0.001 | Inf | 0.001 | 1 | 1 | denatured protein binding |
GO:0031708 | 0.002 | 1087.8571 | 0.002 | 1 | 2 | endothelin B receptor binding |
GO:0001588 | 0.0039 | 362.5714 | 0.0039 | 1 | 4 | dopamine neurotransmitter receptor activity, coupled via Gs |
GO:0042826 | 0.0042 | 23.7567 | 0.0984 | 2 | 100 | histone deacetylase binding |
GO:0055131 | 0.0059 | 217.5143 | 0.0059 | 1 | 6 | C3HC4-type RING finger domain binding |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001955 | 5e-04 | 84.9355 | 0.0339 | 2 | 7 | blood vessel maturation |
GO:0030199 | 7e-04 | 19.5782 | 0.1741 | 3 | 36 | collagen fibril organization |
GO:0061042 | 0.0015 | 42.4516 | 0.058 | 2 | 12 | vascular wound healing |
GO:0030574 | 0.0016 | 14.3443 | 0.2321 | 3 | 48 | collagen catabolic process |
GO:0006954 | 0.0017 | 3.9922 | 2.2391 | 8 | 463 | inflammatory response |
GO:0006590 | 0.0017 | 38.5894 | 0.0629 | 2 | 13 | thyroid hormone generation |
GO:0045600 | 0.002 | 13.1693 | 0.2515 | 3 | 52 | positive regulation of fat cell differentiation |
GO:0048771 | 0.0025 | 7.7032 | 0.5658 | 4 | 117 | tissue remodeling |
GO:0008217 | 0.0032 | 7.1301 | 0.6093 | 4 | 126 | regulation of blood pressure |
GO:0018958 | 0.0047 | 9.6181 | 0.3385 | 3 | 70 | phenol-containing compound metabolic process |
GO:0098869 | 0.0047 | 9.6181 | 0.3385 | 3 | 70 | cellular oxidant detoxification |
GO:0006599 | 0.0048 | Inf | 0.0048 | 1 | 1 | phosphagen metabolic process |
GO:0009115 | 0.0048 | Inf | 0.0048 | 1 | 1 | xanthine catabolic process |
GO:0019732 | 0.0048 | Inf | 0.0048 | 1 | 1 | antifungal humoral response |
GO:0019805 | 0.0048 | Inf | 0.0048 | 1 | 1 | quinolinate biosynthetic process |
GO:0033477 | 0.0048 | Inf | 0.0048 | 1 | 1 | S-methylmethionine metabolic process |
GO:0042128 | 0.0048 | Inf | 0.0048 | 1 | 1 | nitrate assimilation |
GO:0046314 | 0.0048 | Inf | 0.0048 | 1 | 1 | phosphocreatine biosynthetic process |
GO:0061760 | 0.0048 | Inf | 0.0048 | 1 | 1 | antifungal innate immune response |
GO:2000494 | 0.0048 | Inf | 0.0048 | 1 | 1 | positive regulation of interleukin-18-mediated signaling pathway |
GO:0072359 | 0.0051 | 2.8749 | 3.9027 | 10 | 807 | circulatory system development |
GO:0001578 | 0.0059 | 8.8235 | 0.3675 | 3 | 76 | microtubule bundle formation |
GO:0098754 | 0.0059 | 8.8235 | 0.3675 | 3 | 76 | detoxification |
GO:0051216 | 0.0065 | 5.7867 | 0.7447 | 4 | 154 | cartilage development |
GO:0097237 | 0.0068 | 8.3626 | 0.3869 | 3 | 80 | cellular response to toxic substance |
GO:0048646 | 0.0072 | 2.7252 | 4.101 | 10 | 848 | anatomical structure formation involved in morphogenesis |
GO:0070286 | 0.0075 | 16.9613 | 0.1306 | 2 | 27 | axonemal dynein complex assembly |
GO:0044259 | 0.0091 | 7.4823 | 0.4304 | 3 | 89 | multicellular organismal macromolecule metabolic process |
GO:0043537 | 0.0092 | 15.1406 | 0.1451 | 2 | 30 | negative regulation of blood vessel endothelial cell migration |
GO:0003050 | 0.0096 | 209.0317 | 0.0097 | 1 | 2 | regulation of systemic arterial blood pressure by atrial natriuretic peptide |
GO:0007525 | 0.0096 | 209.0317 | 0.0097 | 1 | 2 | somatic muscle development |
GO:0035669 | 0.0096 | 209.0317 | 0.0097 | 1 | 2 | TRAM-dependent toll-like receptor 4 signaling pathway |
GO:0042418 | 0.0096 | 209.0317 | 0.0097 | 1 | 2 | epinephrine biosynthetic process |
GO:0060354 | 0.0096 | 209.0317 | 0.0097 | 1 | 2 | negative regulation of cell adhesion molecule production |
GO:2000669 | 0.0096 | 209.0317 | 0.0097 | 1 | 2 | negative regulation of dendritic cell apoptotic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0043112 | 2e-04 | 16.4724 | 0.2871 | 4 | 131 | receptor metabolic process |
GO:0022603 | 3e-04 | 5.6988 | 1.8135 | 8 | 800 | regulation of anatomical structure morphogenesis |
GO:0048589 | 4e-04 | 9.3586 | 0.6492 | 5 | 314 | developmental growth |
GO:0002009 | 4e-04 | 7.2353 | 1.0133 | 6 | 447 | morphogenesis of an epithelium |
GO:0001763 | 4e-04 | 12.9519 | 0.3604 | 4 | 159 | morphogenesis of a branching structure |
GO:0001759 | 5e-04 | 72.478 | 0.034 | 2 | 15 | organ induction |
GO:0035295 | 8e-04 | 6.3919 | 1.1402 | 6 | 503 | tube development |
GO:0048704 | 9e-04 | 17.7805 | 0.1927 | 3 | 85 | embryonic skeletal system morphogenesis |
GO:0009888 | 0.0011 | 3.9851 | 3.3595 | 10 | 1482 | tissue development |
GO:0030878 | 0.0012 | 44.8401 | 0.0521 | 2 | 23 | thyroid gland development |
GO:0001838 | 0.0021 | 13.1061 | 0.2584 | 3 | 114 | embryonic epithelial tube formation |
GO:0007495 | 0.0023 | Inf | 0.0023 | 1 | 1 | visceral mesoderm-endoderm interaction involved in midgut development |
GO:0038129 | 0.0023 | Inf | 0.0023 | 1 | 1 | ERBB3 signaling pathway |
GO:0110023 | 0.0023 | Inf | 0.0023 | 1 | 1 | negative regulation of cardiac muscle myoblast proliferation |
GO:1903769 | 0.0023 | Inf | 0.0023 | 1 | 1 | negative regulation of cell proliferation in bone marrow |
GO:1905243 | 0.0023 | Inf | 0.0023 | 1 | 1 | cellular response to 3,3',5-triiodo-L-thyronine |
GO:1905322 | 0.0023 | Inf | 0.0023 | 1 | 1 | positive regulation of mesenchymal stem cell migration |
GO:0051241 | 0.0023 | 4.4969 | 1.9133 | 7 | 844 | negative regulation of multicellular organismal process |
GO:0048754 | 0.0029 | 11.7204 | 0.2879 | 3 | 127 | branching morphogenesis of an epithelial tube |
GO:0007507 | 0.003 | 5.8155 | 1.0065 | 5 | 444 | heart development |
GO:0035148 | 0.0034 | 11.0882 | 0.3038 | 3 | 134 | tube formation |
GO:0090102 | 0.0035 | 25.4189 | 0.0884 | 2 | 39 | cochlea development |
GO:0051093 | 0.0045 | 4.4523 | 1.605 | 6 | 708 | negative regulation of developmental process |
GO:0006624 | 0.0045 | 455.2759 | 0.0045 | 1 | 2 | vacuolar protein processing |
GO:0017186 | 0.0045 | 455.2759 | 0.0045 | 1 | 2 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase |
GO:0021842 | 0.0045 | 455.2759 | 0.0045 | 1 | 2 | chemorepulsion involved in interneuron migration from the subpallium to the cortex |
GO:0060480 | 0.0045 | 455.2759 | 0.0045 | 1 | 2 | lung goblet cell differentiation |
GO:0060764 | 0.0045 | 455.2759 | 0.0045 | 1 | 2 | cell-cell signaling involved in mammary gland development |
GO:2000729 | 0.0045 | 455.2759 | 0.0045 | 1 | 2 | positive regulation of mesenchymal cell proliferation involved in ureter development |
GO:0043009 | 0.005 | 5.1242 | 1.1357 | 5 | 501 | chordate embryonic development |
GO:0050877 | 0.0051 | 4.3411 | 1.6435 | 6 | 725 | nervous system process |
GO:2000026 | 0.0053 | 3.3042 | 3.457 | 9 | 1525 | regulation of multicellular organismal development |
GO:0001568 | 0.0053 | 5.0397 | 1.1538 | 5 | 509 | blood vessel development |
GO:0048598 | 0.0053 | 5.0397 | 1.1538 | 5 | 509 | embryonic morphogenesis |
GO:0030166 | 0.0057 | 19.5774 | 0.1133 | 2 | 50 | proteoglycan biosynthetic process |
GO:0048645 | 0.0057 | 19.5774 | 0.1133 | 2 | 50 | animal organ formation |
GO:0030855 | 0.0059 | 4.9079 | 1.1833 | 5 | 522 | epithelial cell differentiation |
GO:1901185 | 0.0061 | 18.7914 | 0.1179 | 2 | 52 | negative regulation of ERBB signaling pathway |
GO:0072358 | 0.0065 | 4.7826 | 1.2128 | 5 | 535 | cardiovascular system development |
GO:0060675 | 0.0066 | 18.0659 | 0.1224 | 2 | 54 | ureteric bud morphogenesis |
GO:0008582 | 0.0068 | 227.6207 | 0.0068 | 1 | 3 | regulation of synaptic growth at neuromuscular junction |
GO:0045213 | 0.0068 | 227.6207 | 0.0068 | 1 | 3 | neurotransmitter receptor metabolic process |
GO:0060435 | 0.0068 | 227.6207 | 0.0068 | 1 | 3 | bronchiole development |
GO:0061146 | 0.0068 | 227.6207 | 0.0068 | 1 | 3 | Peyer's patch morphogenesis |
GO:0061551 | 0.0068 | 227.6207 | 0.0068 | 1 | 3 | trigeminal ganglion development |
GO:0072095 | 0.0068 | 227.6207 | 0.0068 | 1 | 3 | regulation of branch elongation involved in ureteric bud branching |
GO:0072193 | 0.0068 | 227.6207 | 0.0068 | 1 | 3 | ureter smooth muscle cell differentiation |
GO:0072513 | 0.0068 | 227.6207 | 0.0068 | 1 | 3 | positive regulation of secondary heart field cardioblast proliferation |
GO:0090191 | 0.0068 | 227.6207 | 0.0068 | 1 | 3 | negative regulation of branching involved in ureteric bud morphogenesis |
GO:0097647 | 0.0068 | 227.6207 | 0.0068 | 1 | 3 | amylin receptor signaling pathway |
GO:2000821 | 0.0068 | 227.6207 | 0.0068 | 1 | 3 | regulation of grooming behavior |
GO:0060560 | 0.007 | 8.4685 | 0.3944 | 3 | 174 | developmental growth involved in morphogenesis |
GO:0001570 | 0.0084 | 15.914 | 0.1383 | 2 | 61 | vasculogenesis |
GO:0072078 | 0.0086 | 15.6476 | 0.1405 | 2 | 62 | nephron tubule morphogenesis |
GO:0001525 | 0.0088 | 5.4889 | 0.8251 | 4 | 364 | angiogenesis |
GO:0030910 | 0.009 | 151.7356 | 0.0091 | 1 | 4 | olfactory placode formation |
GO:0060482 | 0.009 | 151.7356 | 0.0091 | 1 | 4 | lobar bronchus development |
GO:0060535 | 0.009 | 151.7356 | 0.0091 | 1 | 4 | trachea cartilage morphogenesis |
GO:0060574 | 0.009 | 151.7356 | 0.0091 | 1 | 4 | intestinal epithelial cell maturation |
GO:0060638 | 0.009 | 151.7356 | 0.0091 | 1 | 4 | mesenchymal-epithelial cell signaling |
GO:0061055 | 0.009 | 151.7356 | 0.0091 | 1 | 4 | myotome development |
GO:0061197 | 0.009 | 151.7356 | 0.0091 | 1 | 4 | fungiform papilla morphogenesis |
GO:0071698 | 0.009 | 151.7356 | 0.0091 | 1 | 4 | olfactory placode development |
GO:0072107 | 0.009 | 151.7356 | 0.0091 | 1 | 4 | positive regulation of ureteric bud formation |
GO:0098706 | 0.009 | 151.7356 | 0.0091 | 1 | 4 | ferric iron import across plasma membrane |
GO:0048663 | 0.0092 | 15.1406 | 0.1451 | 2 | 64 | neuron fate commitment |
GO:0072028 | 0.0092 | 15.1406 | 0.1451 | 2 | 64 | nephron morphogenesis |
GO:0048568 | 0.0094 | 5.3813 | 0.841 | 4 | 371 | embryonic organ development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007416 | 3e-04 | 13.6688 | 0.3355 | 4 | 120 | synapse assembly |
GO:0007156 | 4e-04 | 13.0989 | 0.3495 | 4 | 125 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0033197 | 4e-04 | 83.7333 | 0.0308 | 2 | 11 | response to vitamin E |
GO:0016339 | 0.0019 | 35.8531 | 0.0643 | 2 | 23 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
GO:0009645 | 0.0028 | Inf | 0.0028 | 1 | 1 | response to low light intensity stimulus |
GO:0046690 | 0.0028 | Inf | 0.0028 | 1 | 1 | response to tellurium ion |
GO:0097254 | 0.0028 | Inf | 0.0028 | 1 | 1 | renal tubular secretion |
GO:0000023 | 0.0056 | 366.5556 | 0.0056 | 1 | 2 | maltose metabolic process |
GO:0007506 | 0.0056 | 366.5556 | 0.0056 | 1 | 2 | gonadal mesoderm development |
GO:0010159 | 0.0056 | 366.5556 | 0.0056 | 1 | 2 | specification of animal organ position |
GO:0031022 | 0.0056 | 366.5556 | 0.0056 | 1 | 2 | nuclear migration along microfilament |
GO:0098609 | 0.0068 | 3.9801 | 1.7278 | 6 | 618 | cell-cell adhesion |
GO:0003221 | 0.0084 | 183.2639 | 0.0084 | 1 | 3 | right ventricular cardiac muscle tissue morphogenesis |
GO:0015742 | 0.0084 | 183.2639 | 0.0084 | 1 | 3 | alpha-ketoglutarate transport |
GO:0015747 | 0.0084 | 183.2639 | 0.0084 | 1 | 3 | urate transport |
GO:0021615 | 0.0084 | 183.2639 | 0.0084 | 1 | 3 | glossopharyngeal nerve morphogenesis |
GO:0021817 | 0.0084 | 183.2639 | 0.0084 | 1 | 3 | nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration |
GO:0031427 | 0.0084 | 183.2639 | 0.0084 | 1 | 3 | response to methotrexate |
GO:0090292 | 0.0084 | 183.2639 | 0.0084 | 1 | 3 | nuclear matrix anchoring at nuclear membrane |
GO:0097116 | 0.0084 | 183.2639 | 0.0084 | 1 | 3 | gephyrin clustering involved in postsynaptic density assembly |
GO:0099560 | 0.0084 | 183.2639 | 0.0084 | 1 | 3 | synaptic membrane adhesion |
GO:2000821 | 0.0084 | 183.2639 | 0.0084 | 1 | 3 | regulation of grooming behavior |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048247 | 0 | 84.5321 | 0.046 | 3 | 29 | lymphocyte chemotaxis |
GO:0016045 | 1e-04 | 231.7018 | 0.0127 | 2 | 8 | detection of bacterium |
GO:0050900 | 1e-04 | 14.0245 | 0.4649 | 5 | 293 | leukocyte migration |
GO:0098581 | 1e-04 | 154.4327 | 0.0175 | 2 | 11 | detection of external biotic stimulus |
GO:0045087 | 2e-04 | 8.8886 | 0.9124 | 6 | 575 | innate immune response |
GO:0031424 | 6e-04 | 21.008 | 0.1698 | 3 | 107 | keratinization |
GO:0061844 | 9e-04 | 51.4074 | 0.046 | 2 | 29 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0031640 | 0.001 | 49.5677 | 0.0476 | 2 | 30 | killing of cells of other organism |
GO:0048006 | 0.0016 | Inf | 0.0016 | 1 | 1 | antigen processing and presentation, endogenous lipid antigen via MHC class Ib |
GO:0060326 | 0.0027 | 12.3456 | 0.284 | 3 | 179 | cell chemotaxis |
GO:0030593 | 0.0029 | 28.2793 | 0.0809 | 2 | 51 | neutrophil chemotaxis |
GO:0050830 | 0.003 | 27.7116 | 0.0825 | 2 | 52 | defense response to Gram-positive bacterium |
GO:0001775 | 0.0032 | 5.0883 | 1.5376 | 6 | 969 | cell activation |
GO:0006740 | 0.0032 | 660.6 | 0.0032 | 1 | 2 | NADPH regeneration |
GO:0044657 | 0.0032 | 660.6 | 0.0032 | 1 | 2 | pore formation in membrane of other organism during symbiotic interaction |
GO:0051714 | 0.0032 | 660.6 | 0.0032 | 1 | 2 | positive regulation of cytolysis in other organism |
GO:0052043 | 0.0032 | 660.6 | 0.0032 | 1 | 2 | modification by symbiont of host cellular component |
GO:0052185 | 0.0032 | 660.6 | 0.0032 | 1 | 2 | modification of structure of other organism involved in symbiotic interaction |
GO:0052332 | 0.0032 | 660.6 | 0.0032 | 1 | 2 | modification by organism of membrane in other organism involved in symbiotic interaction |
GO:0060468 | 0.0032 | 660.6 | 0.0032 | 1 | 2 | prevention of polyspermy |
GO:0009913 | 0.0036 | 11.1265 | 0.3142 | 3 | 198 | epidermal cell differentiation |
GO:0044419 | 0.0047 | 5.4303 | 1.1489 | 5 | 724 | interspecies interaction between organisms |
GO:0051673 | 0.0048 | 330.275 | 0.0048 | 1 | 3 | membrane disruption in other organism |
GO:0009253 | 0.0063 | 220.1667 | 0.0063 | 1 | 4 | peptidoglycan catabolic process |
GO:0048007 | 0.0063 | 220.1667 | 0.0063 | 1 | 4 | antigen processing and presentation, exogenous lipid antigen via MHC class Ib |
GO:0097530 | 0.0065 | 18.4393 | 0.1222 | 2 | 77 | granulocyte migration |
GO:0043588 | 0.0074 | 8.5375 | 0.4062 | 3 | 256 | skin development |
GO:0071346 | 0.0086 | 15.8814 | 0.1412 | 2 | 89 | cellular response to interferon-gamma |
GO:0002475 | 0.0095 | 132.08 | 0.0095 | 1 | 6 | antigen processing and presentation via MHC class Ib |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001955 | 5e-04 | 82.2687 | 0.0349 | 2 | 7 | blood vessel maturation |
GO:0030199 | 8e-04 | 18.9538 | 0.1795 | 3 | 36 | collagen fibril organization |
GO:0061042 | 0.0016 | 41.1187 | 0.0598 | 2 | 12 | vascular wound healing |
GO:0030574 | 0.0017 | 13.8868 | 0.2394 | 3 | 48 | collagen catabolic process |
GO:0046394 | 0.0018 | 5.1047 | 1.2917 | 6 | 259 | carboxylic acid biosynthetic process |
GO:0006590 | 0.0018 | 37.3778 | 0.0648 | 2 | 13 | thyroid hormone generation |
GO:0045600 | 0.0022 | 12.7493 | 0.2593 | 3 | 52 | positive regulation of fat cell differentiation |
GO:0048771 | 0.0027 | 7.4536 | 0.5835 | 4 | 117 | tissue remodeling |
GO:0008217 | 0.0036 | 6.899 | 0.6284 | 4 | 126 | regulation of blood pressure |
GO:0006599 | 0.005 | Inf | 0.005 | 1 | 1 | phosphagen metabolic process |
GO:0009115 | 0.005 | Inf | 0.005 | 1 | 1 | xanthine catabolic process |
GO:0019732 | 0.005 | Inf | 0.005 | 1 | 1 | antifungal humoral response |
GO:0019805 | 0.005 | Inf | 0.005 | 1 | 1 | quinolinate biosynthetic process |
GO:0033477 | 0.005 | Inf | 0.005 | 1 | 1 | S-methylmethionine metabolic process |
GO:0042128 | 0.005 | Inf | 0.005 | 1 | 1 | nitrate assimilation |
GO:0046314 | 0.005 | Inf | 0.005 | 1 | 1 | phosphocreatine biosynthetic process |
GO:0061760 | 0.005 | Inf | 0.005 | 1 | 1 | antifungal innate immune response |
GO:2000494 | 0.005 | Inf | 0.005 | 1 | 1 | positive regulation of interleukin-18-mediated signaling pathway |
GO:0018958 | 0.0051 | 9.3113 | 0.3491 | 3 | 70 | phenol-containing compound metabolic process |
GO:0098869 | 0.0051 | 9.3113 | 0.3491 | 3 | 70 | cellular oxidant detoxification |
GO:0022900 | 0.0052 | 6.1822 | 0.6982 | 4 | 140 | electron transport chain |
GO:0098754 | 0.0064 | 8.5421 | 0.379 | 3 | 76 | detoxification |
GO:0002700 | 0.0072 | 8.203 | 0.394 | 3 | 79 | regulation of production of molecular mediator of immune response |
GO:0051216 | 0.0073 | 5.5991 | 0.768 | 4 | 154 | cartilage development |
GO:0097237 | 0.0074 | 8.0959 | 0.399 | 3 | 80 | cellular response to toxic substance |
GO:0070286 | 0.0079 | 16.4288 | 0.1347 | 2 | 27 | axonemal dynein complex assembly |
GO:0006954 | 0.0081 | 3.3075 | 2.3091 | 7 | 463 | inflammatory response |
GO:0043537 | 0.0097 | 14.6652 | 0.1496 | 2 | 30 | negative regulation of blood vessel endothelial cell migration |
GO:0044259 | 0.0099 | 7.2436 | 0.4439 | 3 | 89 | multicellular organismal macromolecule metabolic process |
GO:0003050 | 0.0099 | 202.5692 | 0.01 | 1 | 2 | regulation of systemic arterial blood pressure by atrial natriuretic peptide |
GO:0035669 | 0.0099 | 202.5692 | 0.01 | 1 | 2 | TRAM-dependent toll-like receptor 4 signaling pathway |
GO:0042418 | 0.0099 | 202.5692 | 0.01 | 1 | 2 | epinephrine biosynthetic process |
GO:0060354 | 0.0099 | 202.5692 | 0.01 | 1 | 2 | negative regulation of cell adhesion molecule production |
GO:2000669 | 0.0099 | 202.5692 | 0.01 | 1 | 2 | negative regulation of dendritic cell apoptotic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0019265 | 8e-04 | Inf | 8e-04 | 1 | 1 | glycine biosynthetic process, by transamination of glyoxylate |
GO:0019481 | 8e-04 | Inf | 8e-04 | 1 | 1 | L-alanine catabolic process, by transamination |
GO:0042361 | 8e-04 | Inf | 8e-04 | 1 | 1 | menaquinone catabolic process |
GO:0042377 | 8e-04 | Inf | 8e-04 | 1 | 1 | vitamin K catabolic process |
GO:0009436 | 0.0017 | 1322.2 | 0.0017 | 1 | 2 | glyoxylate catabolic process |
GO:0038060 | 0.0017 | 1322.2 | 0.0017 | 1 | 2 | nitric oxide-cGMP-mediated signaling pathway |
GO:0042376 | 0.0017 | 1322.2 | 0.0017 | 1 | 2 | phylloquinone catabolic process |
GO:0002249 | 0.0025 | 661.05 | 0.0025 | 1 | 3 | lymphocyte anergy |
GO:0002667 | 0.0025 | 661.05 | 0.0025 | 1 | 3 | regulation of T cell anergy |
GO:0021759 | 0.0025 | 661.05 | 0.0025 | 1 | 3 | globus pallidus development |
GO:0042851 | 0.0025 | 661.05 | 0.0025 | 1 | 3 | L-alanine metabolic process |
GO:0006524 | 0.0033 | 440.6667 | 0.0033 | 1 | 4 | alanine catabolic process |
GO:0009078 | 0.0033 | 440.6667 | 0.0033 | 1 | 4 | pyruvate family amino acid metabolic process |
GO:0042182 | 0.005 | 264.36 | 0.005 | 1 | 6 | ketone catabolic process |
GO:0002517 | 0.0058 | 220.2833 | 0.0058 | 1 | 7 | T cell tolerance induction |
GO:0071241 | 0.0066 | 19.6321 | 0.1247 | 2 | 150 | cellular response to inorganic substance |
GO:0009109 | 0.0066 | 188.8 | 0.0066 | 1 | 8 | coenzyme catabolic process |
GO:0009111 | 0.0066 | 188.8 | 0.0066 | 1 | 8 | vitamin catabolic process |
GO:0090026 | 0.0075 | 165.1875 | 0.0075 | 1 | 9 | positive regulation of monocyte chemotaxis |
GO:0009642 | 0.0083 | 146.8222 | 0.0083 | 1 | 10 | response to light intensity |
GO:0002643 | 0.0099 | 120.1091 | 0.01 | 1 | 12 | regulation of tolerance induction |
GO:1903818 | 0.0099 | 120.1091 | 0.01 | 1 | 12 | positive regulation of voltage-gated potassium channel activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1900131 | 0.001 | Inf | 0.001 | 1 | 1 | negative regulation of lipid binding |
GO:0031338 | 0.0016 | 39.8818 | 0.0609 | 2 | 62 | regulation of vesicle fusion |
GO:1901475 | 0.002 | 1101.6667 | 0.002 | 1 | 2 | pyruvate transmembrane transport |
GO:0090630 | 0.0028 | 30.2463 | 0.0796 | 2 | 81 | activation of GTPase activity |
GO:0002351 | 0.0029 | 550.7917 | 0.0029 | 1 | 3 | serotonin production involved in inflammatory response |
GO:0002554 | 0.0029 | 550.7917 | 0.0029 | 1 | 3 | serotonin secretion by platelet |
GO:0006003 | 0.0029 | 550.7917 | 0.0029 | 1 | 3 | fructose 2,6-bisphosphate metabolic process |
GO:0002778 | 0.0039 | 367.1667 | 0.0039 | 1 | 4 | antibacterial peptide production |
GO:0035873 | 0.0039 | 367.1667 | 0.0039 | 1 | 4 | lactate transmembrane transport |
GO:0098528 | 0.0049 | 275.3542 | 0.0049 | 1 | 5 | skeletal muscle fiber differentiation |
GO:0045046 | 0.0059 | 220.2667 | 0.0059 | 1 | 6 | protein import into peroxisome membrane |
GO:0001820 | 0.0078 | 157.3095 | 0.0079 | 1 | 8 | serotonin secretion |
GO:0003056 | 0.0078 | 157.3095 | 0.0079 | 1 | 8 | regulation of vascular smooth muscle contraction |
GO:0016559 | 0.0078 | 157.3095 | 0.0079 | 1 | 8 | peroxisome fission |
GO:0033234 | 0.0078 | 157.3095 | 0.0079 | 1 | 8 | negative regulation of protein sumoylation |
GO:0090174 | 0.0081 | 17.1118 | 0.1385 | 2 | 141 | organelle membrane fusion |
GO:0072321 | 0.0088 | 137.6354 | 0.0088 | 1 | 9 | chaperone-mediated protein transport |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007339 | 7e-04 | 59.6787 | 0.0402 | 2 | 28 | binding of sperm to zona pellucida |
GO:0009988 | 0.0019 | 35.2166 | 0.066 | 2 | 46 | cell-cell recognition |
GO:0009644 | 0.0029 | 734.1111 | 0.0029 | 1 | 2 | response to high light intensity |
GO:0010845 | 0.0029 | 734.1111 | 0.0029 | 1 | 2 | positive regulation of reciprocal meiotic recombination |
GO:0060468 | 0.0029 | 734.1111 | 0.0029 | 1 | 2 | prevention of polyspermy |
GO:0006311 | 0.0043 | 367.0278 | 0.0043 | 1 | 3 | meiotic gene conversion |
GO:0043605 | 0.0043 | 367.0278 | 0.0043 | 1 | 3 | cellular amide catabolic process |
GO:0043588 | 0.0055 | 9.6062 | 0.3675 | 3 | 256 | skin development |
GO:2000275 | 0.0057 | 244.6667 | 0.0057 | 1 | 4 | regulation of oxidative phosphorylation uncoupler activity |
GO:0031642 | 0.0072 | 183.4861 | 0.0072 | 1 | 5 | negative regulation of myelination |
GO:0007338 | 0.0082 | 16.4218 | 0.1378 | 2 | 96 | single fertilization |
GO:2000241 | 0.0096 | 15.1246 | 0.1493 | 2 | 104 | regulation of reproductive process |
GO:0044236 | 0.0098 | 14.9766 | 0.1507 | 2 | 105 | multicellular organism metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048704 | 0 | 45.3176 | 0.1798 | 6 | 85 | embryonic skeletal system morphogenesis |
GO:0048568 | 0 | 11.7601 | 0.7849 | 7 | 371 | embryonic organ development |
GO:0001501 | 0 | 10.6169 | 0.8653 | 7 | 409 | skeletal system development |
GO:0009952 | 0 | 16.4737 | 0.3745 | 5 | 177 | anterior/posterior pattern specification |
GO:0048598 | 1e-04 | 8.4356 | 1.0769 | 7 | 509 | embryonic morphogenesis |
GO:0007389 | 1e-04 | 9.7877 | 0.7701 | 6 | 364 | pattern specification process |
GO:0009887 | 2e-04 | 6.1295 | 1.7286 | 8 | 817 | animal organ morphogenesis |
GO:0043009 | 5e-04 | 7.0033 | 1.06 | 6 | 501 | chordate embryonic development |
GO:0045446 | 6e-04 | 20.1969 | 0.1714 | 3 | 81 | endothelial cell differentiation |
GO:0002215 | 0.0021 | Inf | 0.0021 | 1 | 1 | defense response to nematode |
GO:0003336 | 0.0021 | Inf | 0.0021 | 1 | 1 | corneocyte desquamation |
GO:0019265 | 0.0021 | Inf | 0.0021 | 1 | 1 | glycine biosynthetic process, by transamination of glyoxylate |
GO:0019481 | 0.0021 | Inf | 0.0021 | 1 | 1 | L-alanine catabolic process, by transamination |
GO:0021754 | 0.0021 | Inf | 0.0021 | 1 | 1 | facial nucleus development |
GO:0043538 | 0.0021 | Inf | 0.0021 | 1 | 1 | regulation of actin phosphorylation |
GO:0097254 | 0.0021 | Inf | 0.0021 | 1 | 1 | renal tubular secretion |
GO:0110023 | 0.0021 | Inf | 0.0021 | 1 | 1 | negative regulation of cardiac muscle myoblast proliferation |
GO:1903769 | 0.0021 | Inf | 0.0021 | 1 | 1 | negative regulation of cell proliferation in bone marrow |
GO:1905322 | 0.0021 | Inf | 0.0021 | 1 | 1 | positive regulation of mesenchymal stem cell migration |
GO:1905716 | 0.0021 | Inf | 0.0021 | 1 | 1 | negative regulation of cornification |
GO:0021545 | 0.003 | 27.3784 | 0.0825 | 2 | 39 | cranial nerve development |
GO:0021546 | 0.0041 | 507.8077 | 0.0041 | 1 | 2 | rhombomere development |
GO:0009436 | 0.0042 | 489.0741 | 0.0042 | 1 | 2 | glyoxylate catabolic process |
GO:0021570 | 0.0042 | 489.0741 | 0.0042 | 1 | 2 | rhombomere 4 development |
GO:0021571 | 0.0042 | 489.0741 | 0.0042 | 1 | 2 | rhombomere 5 development |
GO:0015742 | 0.0063 | 244.5185 | 0.0063 | 1 | 3 | alpha-ketoglutarate transport |
GO:0015747 | 0.0063 | 244.5185 | 0.0063 | 1 | 3 | urate transport |
GO:0021615 | 0.0063 | 244.5185 | 0.0063 | 1 | 3 | glossopharyngeal nerve morphogenesis |
GO:0030047 | 0.0063 | 244.5185 | 0.0063 | 1 | 3 | actin modification |
GO:0031427 | 0.0063 | 244.5185 | 0.0063 | 1 | 3 | response to methotrexate |
GO:0032714 | 0.0063 | 244.5185 | 0.0063 | 1 | 3 | negative regulation of interleukin-5 production |
GO:0042851 | 0.0063 | 244.5185 | 0.0063 | 1 | 3 | L-alanine metabolic process |
GO:0006524 | 0.0084 | 163 | 0.0085 | 1 | 4 | alanine catabolic process |
GO:0009078 | 0.0084 | 163 | 0.0085 | 1 | 4 | pyruvate family amino acid metabolic process |
GO:0021612 | 0.0084 | 163 | 0.0085 | 1 | 4 | facial nerve structural organization |
GO:0042989 | 0.0084 | 163 | 0.0085 | 1 | 4 | sequestering of actin monomers |
GO:0072593 | 0.0089 | 7.7642 | 0.4316 | 3 | 204 | reactive oxygen species metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045671 | 5e-04 | 72.4835 | 0.0339 | 2 | 16 | negative regulation of osteoclast differentiation |
GO:0042930 | 0.0021 | Inf | 0.0021 | 1 | 1 | enterobactin transport |
GO:0009566 | 0.0023 | 12.7639 | 0.2666 | 3 | 126 | fertilization |
GO:0006749 | 0.0032 | 26.6559 | 0.0846 | 2 | 40 | glutathione metabolic process |
GO:0050915 | 0.0042 | 489.0741 | 0.0042 | 1 | 2 | sensory perception of sour taste |
GO:0060468 | 0.0042 | 489.0741 | 0.0042 | 1 | 2 | prevention of polyspermy |
GO:0002249 | 0.0063 | 244.5185 | 0.0063 | 1 | 3 | lymphocyte anergy |
GO:0002667 | 0.0063 | 244.5185 | 0.0063 | 1 | 3 | regulation of T cell anergy |
GO:0015688 | 0.0063 | 244.5185 | 0.0063 | 1 | 3 | iron chelate transport |
GO:0050968 | 0.0063 | 244.5185 | 0.0063 | 1 | 3 | detection of chemical stimulus involved in sensory perception of pain |
GO:1902106 | 0.0073 | 17.1408 | 0.1291 | 2 | 61 | negative regulation of leukocyte differentiation |
GO:0032414 | 0.0075 | 16.8538 | 0.1312 | 2 | 62 | positive regulation of ion transmembrane transporter activity |
GO:0043255 | 0.0083 | 16.0476 | 0.1375 | 2 | 65 | regulation of carbohydrate biosynthetic process |
GO:0032962 | 0.0084 | 163 | 0.0085 | 1 | 4 | positive regulation of inositol trisphosphate biosynthetic process |
GO:0045638 | 0.0095 | 14.862 | 0.1481 | 2 | 70 | negative regulation of myeloid cell differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0014059 | 5e-04 | 69.8042 | 0.0348 | 2 | 23 | regulation of dopamine secretion |
GO:0006953 | 7e-04 | 58.6178 | 0.0408 | 2 | 27 | acute-phase response |
GO:0048247 | 9e-04 | 54.2675 | 0.0438 | 2 | 29 | lymphocyte chemotaxis |
GO:0006874 | 9e-04 | 11.1414 | 0.4443 | 4 | 294 | cellular calcium ion homeostasis |
GO:0006022 | 0.001 | 17.4893 | 0.204 | 3 | 135 | aminoglycan metabolic process |
GO:0015872 | 0.0011 | 47.2509 | 0.0499 | 2 | 33 | dopamine transport |
GO:0072507 | 0.0013 | 9.946 | 0.4957 | 4 | 328 | divalent inorganic cation homeostasis |
GO:0050432 | 0.0017 | 37.5356 | 0.062 | 2 | 41 | catecholamine secretion |
GO:0032501 | 0.0021 | 4.3506 | 8.1729 | 15 | 5408 | multicellular organismal process |
GO:0030593 | 0.0026 | 29.8526 | 0.0771 | 2 | 51 | neutrophil chemotaxis |
GO:0051714 | 0.003 | 695.4211 | 0.003 | 1 | 2 | positive regulation of cytolysis in other organism |
GO:0007204 | 0.0032 | 11.7209 | 0.3007 | 3 | 199 | positive regulation of cytosolic calcium ion concentration |
GO:0055065 | 0.0034 | 7.5782 | 0.6438 | 4 | 426 | metal ion homeostasis |
GO:0015844 | 0.0034 | 26.1071 | 0.0877 | 2 | 58 | monoamine transport |
GO:0000271 | 0.0038 | 24.774 | 0.0922 | 2 | 61 | polysaccharide biosynthetic process |
GO:0030003 | 0.0039 | 7.2922 | 0.668 | 4 | 442 | cellular cation homeostasis |
GO:0070887 | 0.004 | 3.8581 | 3.5076 | 9 | 2321 | cellular response to chemical stimulus |
GO:0051952 | 0.0041 | 23.5699 | 0.0967 | 2 | 64 | regulation of amine transport |
GO:0034637 | 0.0043 | 23.194 | 0.0982 | 2 | 65 | cellular carbohydrate biosynthetic process |
GO:0002249 | 0.0045 | 347.6842 | 0.0045 | 1 | 3 | lymphocyte anergy |
GO:0002667 | 0.0045 | 347.6842 | 0.0045 | 1 | 3 | regulation of T cell anergy |
GO:0045226 | 0.0045 | 347.6842 | 0.0045 | 1 | 3 | extracellular polysaccharide biosynthetic process |
GO:0097006 | 0.0051 | 21.1675 | 0.1073 | 2 | 71 | regulation of plasma lipoprotein particle levels |
GO:0031279 | 0.0053 | 20.5681 | 0.1103 | 2 | 73 | regulation of cyclase activity |
GO:0051339 | 0.0056 | 20.0015 | 0.1133 | 2 | 75 | regulation of lyase activity |
GO:0097530 | 0.0059 | 19.4652 | 0.1164 | 2 | 77 | granulocyte migration |
GO:0009253 | 0.006 | 231.7719 | 0.006 | 1 | 4 | peptidoglycan catabolic process |
GO:0019800 | 0.006 | 231.7719 | 0.006 | 1 | 4 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan |
GO:0098967 | 0.006 | 231.7719 | 0.006 | 1 | 4 | exocytic insertion of neurotransmitter receptor to postsynaptic membrane |
GO:0044264 | 0.0062 | 18.9567 | 0.1194 | 2 | 79 | cellular polysaccharide metabolic process |
GO:0006828 | 0.0075 | 173.8158 | 0.0076 | 1 | 5 | manganese ion transport |
GO:0045937 | 0.0076 | 4.8486 | 1.2921 | 5 | 855 | positive regulation of phosphate metabolic process |
GO:0050801 | 0.0084 | 5.8004 | 0.8312 | 4 | 550 | ion homeostasis |
GO:1903510 | 0.0085 | 16.0232 | 0.1405 | 2 | 93 | mucopolysaccharide metabolic process |
GO:0055082 | 0.0088 | 5.7238 | 0.8418 | 4 | 557 | cellular chemical homeostasis |
GO:0001666 | 0.0089 | 7.977 | 0.4368 | 3 | 289 | response to hypoxia |
GO:0007195 | 0.009 | 139.0421 | 0.0091 | 1 | 6 | adenylate cyclase-inhibiting dopamine receptor signaling pathway |
GO:0035865 | 0.009 | 139.0421 | 0.0091 | 1 | 6 | cellular response to potassium ion |
GO:0045785 | 0.0092 | 7.8923 | 0.4413 | 3 | 292 | positive regulation of cell adhesion |
GO:0050921 | 0.0096 | 15.0252 | 0.1496 | 2 | 99 | positive regulation of chemotaxis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0038060 | 0.0014 | 1653 | 0.0014 | 1 | 2 | nitric oxide-cGMP-mediated signaling pathway |
GO:0002249 | 0.002 | 826.4375 | 0.002 | 1 | 3 | lymphocyte anergy |
GO:0002667 | 0.002 | 826.4375 | 0.002 | 1 | 3 | regulation of T cell anergy |
GO:0021759 | 0.002 | 826.4375 | 0.002 | 1 | 3 | globus pallidus development |
GO:0045950 | 0.0027 | 550.9167 | 0.0027 | 1 | 4 | negative regulation of mitotic recombination |
GO:0002517 | 0.0048 | 275.3958 | 0.0048 | 1 | 7 | T cell tolerance induction |
GO:0090026 | 0.0061 | 206.5156 | 0.0061 | 1 | 9 | positive regulation of monocyte chemotaxis |
GO:0009642 | 0.0068 | 183.5556 | 0.0068 | 1 | 10 | response to light intensity |
GO:0002643 | 0.0081 | 150.1591 | 0.0082 | 1 | 12 | regulation of tolerance induction |
GO:1903818 | 0.0081 | 150.1591 | 0.0082 | 1 | 12 | positive regulation of voltage-gated potassium channel activity |
GO:0002724 | 0.0095 | 127.0385 | 0.0095 | 1 | 14 | regulation of T cell cytokine production |
GO:0071732 | 0.0095 | 127.0385 | 0.0095 | 1 | 14 | cellular response to nitric oxide |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0016501 | 0.002 | Inf | 0.002 | 1 | 1 | prostacyclin receptor activity |
GO:0017020 | 0.002 | Inf | 0.002 | 1 | 1 | myosin phosphatase regulator activity |
GO:0033791 | 0.002 | Inf | 0.002 | 1 | 1 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity |
GO:0038182 | 0.002 | Inf | 0.002 | 1 | 1 | G-protein coupled bile acid receptor activity |
GO:0004174 | 0.0041 | 510 | 0.0041 | 1 | 2 | electron-transferring-flavoprotein dehydrogenase activity |
GO:0015333 | 0.0061 | 254.9808 | 0.0061 | 1 | 3 | peptide:proton symporter activity |
GO:0016402 | 0.0061 | 254.9808 | 0.0061 | 1 | 3 | pristanoyl-CoA oxidase activity |
GO:0050660 | 0.0068 | 17.901 | 0.1239 | 2 | 61 | flavin adenine dinucleotide binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0043546 | 2e-04 | 157.4643 | 0.0218 | 2 | 5 | molybdopterin cofactor binding |
GO:0005201 | 0.0013 | 15.2994 | 0.2182 | 3 | 50 | extracellular matrix structural constituent |
GO:0048037 | 0.0029 | 5.5789 | 0.9821 | 5 | 225 | cofactor binding |
GO:0000334 | 0.0044 | Inf | 0.0044 | 1 | 1 | 3-hydroxyanthranilate 3,4-dioxygenase activity |
GO:0004031 | 0.0044 | Inf | 0.0044 | 1 | 1 | aldehyde oxidase activity |
GO:0004603 | 0.0044 | Inf | 0.0044 | 1 | 1 | phenylethanolamine N-methyltransferase activity |
GO:0008482 | 0.0044 | Inf | 0.0044 | 1 | 1 | sulfite oxidase activity |
GO:0061627 | 0.0044 | Inf | 0.0044 | 1 | 1 | S-methylmethionine-homocysteine S-methyltransferase activity |
GO:0098625 | 0.0044 | Inf | 0.0044 | 1 | 1 | methylselenol reductase activity |
GO:0098626 | 0.0044 | Inf | 0.0044 | 1 | 1 | methylseleninic acid reductase activity |
GO:0102797 | 0.0044 | Inf | 0.0044 | 1 | 1 | geranial:oxygen oxidoreductase activity |
GO:0102798 | 0.0044 | Inf | 0.0044 | 1 | 1 | heptaldehyde:oxygen oxidoreductase activity |
GO:0009055 | 0.0061 | 8.7459 | 0.371 | 3 | 85 | electron transfer activity |
GO:0004601 | 0.007 | 17.4643 | 0.1266 | 2 | 29 | peroxidase activity |
GO:0003875 | 0.0087 | 232.0877 | 0.0087 | 1 | 2 | ADP-ribosylarginine hydrolase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0020037 | 2e-04 | 33.8256 | 0.1097 | 3 | 81 | heme binding |
GO:0017020 | 0.0014 | Inf | 0.0014 | 1 | 1 | myosin phosphatase regulator activity |
GO:0033791 | 0.0014 | Inf | 0.0014 | 1 | 1 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity |
GO:0004517 | 0.0027 | 780.5294 | 0.0027 | 1 | 2 | nitric-oxide synthase activity |
GO:0050660 | 0.003 | 27.9894 | 0.0826 | 2 | 61 | flavin adenine dinucleotide binding |
GO:0002950 | 0.0041 | 390.2353 | 0.0041 | 1 | 3 | ceramide phosphoethanolamine synthase activity |
GO:0016402 | 0.0041 | 390.2353 | 0.0041 | 1 | 3 | pristanoyl-CoA oxidase activity |
GO:0033188 | 0.0041 | 390.2353 | 0.0041 | 1 | 3 | sphingomyelin synthase activity |
GO:0034617 | 0.0041 | 390.2353 | 0.0041 | 1 | 3 | tetrahydrobiopterin binding |
GO:0047493 | 0.0041 | 390.2353 | 0.0041 | 1 | 3 | ceramide cholinephosphotransferase activity |
GO:0003958 | 0.0068 | 195.0882 | 0.0068 | 1 | 5 | NADPH-hemoprotein reductase activity |
GO:0004966 | 0.0068 | 195.0882 | 0.0068 | 1 | 5 | galanin receptor activity |
GO:0034618 | 0.0068 | 195.0882 | 0.0068 | 1 | 5 | arginine binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005147 | 0.0018 | Inf | 0.0018 | 1 | 1 | oncostatin-M receptor binding |
GO:0047747 | 0.0018 | Inf | 0.0018 | 1 | 1 | cholate-CoA ligase activity |
GO:0050429 | 0.0018 | Inf | 0.0018 | 1 | 1 | calcium-dependent phospholipase C activity |
GO:0005153 | 0.0036 | 576.6522 | 0.0036 | 1 | 2 | interleukin-8 receptor binding |
GO:0005094 | 0.0054 | 288.3043 | 0.0054 | 1 | 3 | Rho GDP-dissociation inhibitor activity |
GO:0015501 | 0.0054 | 288.3043 | 0.0054 | 1 | 3 | glutamate:sodium symporter activity |
GO:0017034 | 0.0072 | 192.1884 | 0.0072 | 1 | 4 | Rap guanyl-nucleotide exchange factor activity |
GO:0005096 | 0.0075 | 8.3543 | 0.4082 | 3 | 226 | GTPase activator activity |
GO:0098772 | 0.0086 | 3.6101 | 2.4654 | 7 | 1365 | molecular function regulator |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031732 | 0.0023 | Inf | 0.0023 | 1 | 1 | CCR7 chemokine receptor binding |
GO:0038182 | 0.0023 | Inf | 0.0023 | 1 | 1 | G-protein coupled bile acid receptor activity |
GO:0005085 | 0.0041 | 6.8661 | 0.6626 | 4 | 284 | guanyl-nucleotide exchange factor activity |
GO:0003873 | 0.0047 | 441.8667 | 0.0047 | 1 | 2 | 6-phosphofructo-2-kinase activity |
GO:0004063 | 0.0047 | 441.8667 | 0.0047 | 1 | 2 | aryldialkylphosphatase activity |
GO:0005412 | 0.0047 | 441.8667 | 0.0047 | 1 | 2 | glucose:sodium symporter activity |
GO:0047894 | 0.0047 | 441.8667 | 0.0047 | 1 | 2 | flavonol 3-sulfotransferase activity |
GO:0005543 | 0.0055 | 6.2912 | 0.7209 | 4 | 309 | phospholipid binding |
GO:0004331 | 0.007 | 220.9167 | 0.007 | 1 | 3 | fructose-2,6-bisphosphate 2-phosphatase activity |
GO:0008823 | 0.007 | 220.9167 | 0.007 | 1 | 3 | cupric reductase activity |
GO:0052851 | 0.007 | 220.9167 | 0.007 | 1 | 3 | ferric-chelate reductase (NADPH) activity |
GO:0102007 | 0.007 | 220.9167 | 0.007 | 1 | 3 | acyl-L-homoserine-lactone lactonohydrolase activity |
GO:0004984 | 0.007 | 17.5133 | 0.126 | 2 | 54 | olfactory receptor activity |
GO:0001591 | 0.0093 | 147.2667 | 0.0093 | 1 | 4 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
GO:0005176 | 0.0093 | 147.2667 | 0.0093 | 1 | 4 | ErbB-2 class receptor binding |
GO:0043125 | 0.0093 | 147.2667 | 0.0093 | 1 | 4 | ErbB-3 class receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001965 | 0.0016 | 39.8854 | 0.0598 | 2 | 15 | G-protein alpha-subunit binding |
GO:0004364 | 0.0018 | 37.0336 | 0.0638 | 2 | 16 | glutathione transferase activity |
GO:0031716 | 0.004 | Inf | 0.004 | 1 | 1 | calcitonin receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004842 | 8e-04 | 12.1404 | 0.4402 | 4 | 390 | ubiquitin-protein transferase activity |
GO:0018169 | 0.0011 | Inf | 0.0011 | 1 | 1 | ribosomal S6-glutamic acid ligase activity |
GO:0043739 | 0.0011 | Inf | 0.0011 | 1 | 1 | G/U mismatch-specific uracil-DNA glycosylase activity |
GO:0004750 | 0.0023 | 948 | 0.0023 | 1 | 2 | ribulose-phosphate 3-epimerase activity |
GO:0004996 | 0.0023 | 948 | 0.0023 | 1 | 2 | thyroid-stimulating hormone receptor activity |
GO:0000700 | 0.0034 | 473.9643 | 0.0034 | 1 | 3 | mismatch base pair DNA N-glycosylase activity |
GO:0005280 | 0.0034 | 473.9643 | 0.0034 | 1 | 3 | hydrogen:amino acid symporter activity |
GO:0051431 | 0.0034 | 473.9643 | 0.0034 | 1 | 3 | corticotropin-releasing hormone receptor 2 binding |
GO:0097506 | 0.0056 | 236.9464 | 0.0056 | 1 | 5 | deaminated base DNA N-glycosylase activity |
GO:0005314 | 0.0068 | 189.5429 | 0.0068 | 1 | 6 | high-affinity glutamate transmembrane transporter activity |
GO:0019788 | 0.0068 | 189.5429 | 0.0068 | 1 | 6 | NEDD8 transferase activity |
GO:0031404 | 0.0079 | 157.9405 | 0.0079 | 1 | 7 | chloride ion binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004953 | 4e-04 | 90.0476 | 0.0298 | 2 | 9 | icosanoid receptor activity |
GO:0001632 | 0.0033 | Inf | 0.0033 | 1 | 1 | leukotriene B4 receptor activity |
GO:0004946 | 0.0033 | Inf | 0.0033 | 1 | 1 | bombesin receptor activity |
GO:0005147 | 0.0033 | Inf | 0.0033 | 1 | 1 | oncostatin-M receptor binding |
GO:0016501 | 0.0033 | Inf | 0.0033 | 1 | 1 | prostacyclin receptor activity |
GO:0031370 | 0.0033 | Inf | 0.0033 | 1 | 1 | eukaryotic initiation factor 4G binding |
GO:0036403 | 0.0033 | Inf | 0.0033 | 1 | 1 | arachidonate 8(S)-lipoxygenase activity |
GO:0045029 | 0.0033 | Inf | 0.0033 | 1 | 1 | UDP-activated nucleotide receptor activity |
GO:0071553 | 0.0033 | Inf | 0.0033 | 1 | 1 | G-protein coupled pyrimidinergic nucleotide receptor activity |
GO:1903924 | 0.0033 | Inf | 0.0033 | 1 | 1 | estradiol binding |
GO:0004365 | 0.0066 | 307.9767 | 0.0066 | 1 | 2 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity |
GO:0016165 | 0.0066 | 307.9767 | 0.0066 | 1 | 2 | linoleate 13S-lipoxygenase activity |
GO:0017018 | 0.0066 | 307.9767 | 0.0066 | 1 | 2 | myosin phosphatase activity |
GO:0070401 | 0.0066 | 307.9767 | 0.0066 | 1 | 2 | NADP+ binding |
GO:0008374 | 0.007 | 17.4709 | 0.1258 | 2 | 38 | O-acyltransferase activity |
GO:0004321 | 0.0099 | 153.9767 | 0.0099 | 1 | 3 | fatty-acyl-CoA synthase activity |
GO:0047192 | 0.0099 | 153.9767 | 0.0099 | 1 | 3 | 1-alkylglycerophosphocholine O-acetyltransferase activity |
GO:0050473 | 0.0099 | 153.9767 | 0.0099 | 1 | 3 | arachidonate 15-lipoxygenase activity |
GO:1990599 | 0.0099 | 153.9767 | 0.0099 | 1 | 3 | 3' overhang single-stranded DNA endodeoxyribonuclease activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0033560 | 0.0036 | Inf | 0.0036 | 1 | 1 | folate reductase activity |
GO:0000406 | 0.0072 | 281.6809 | 0.0072 | 1 | 2 | double-strand/single-strand DNA junction binding |
GO:0004119 | 0.0072 | 281.6809 | 0.0072 | 1 | 2 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity |
GO:0004146 | 0.0072 | 281.6809 | 0.0072 | 1 | 2 | dihydrofolate reductase activity |
GO:0005223 | 0.0072 | 281.6809 | 0.0072 | 1 | 2 | intracellular cGMP activated cation channel activity |
GO:0032142 | 0.0072 | 281.6809 | 0.0072 | 1 | 2 | single guanine insertion binding |
GO:0032181 | 0.0072 | 281.6809 | 0.0072 | 1 | 2 | dinucleotide repeat insertion binding |
GO:0036461 | 0.0072 | 281.6809 | 0.0072 | 1 | 2 | BLOC-2 complex binding |
GO:0051870 | 0.0072 | 281.6809 | 0.0072 | 1 | 2 | methotrexate binding |
GO:0070735 | 0.0072 | 281.6809 | 0.0072 | 1 | 2 | protein-glycine ligase activity |
GO:0043168 | 0.009 | 2.2872 | 7.9831 | 15 | 2210 | anion binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0030676 | 6e-04 | 68.9688 | 0.0358 | 2 | 14 | Rac guanyl-nucleotide exchange factor activity |
GO:0008009 | 0.0011 | 48.6654 | 0.0486 | 2 | 19 | chemokine activity |
GO:0046906 | 0.0014 | 14.9932 | 0.2252 | 3 | 88 | tetrapyrrole binding |
GO:0005115 | 0.0026 | Inf | 0.0026 | 1 | 1 | receptor tyrosine kinase-like orphan receptor binding |
GO:0032500 | 0.0026 | Inf | 0.0026 | 1 | 1 | muramyl dipeptide binding |
GO:0048248 | 0.0026 | Inf | 0.0026 | 1 | 1 | CXCR3 chemokine receptor binding |
GO:1902379 | 0.0026 | Inf | 0.0026 | 1 | 1 | chemoattractant activity involved in axon guidance |
GO:0004980 | 0.0051 | 401.6061 | 0.0051 | 1 | 2 | melanocyte-stimulating hormone receptor activity |
GO:0005110 | 0.0051 | 401.6061 | 0.0051 | 1 | 2 | frizzled-2 binding |
GO:0008502 | 0.0051 | 401.6061 | 0.0051 | 1 | 2 | melatonin receptor activity |
GO:0005539 | 0.0054 | 9.2656 | 0.3582 | 3 | 140 | glycosaminoglycan binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005509 | 2e-04 | 5.7782 | 1.6568 | 8 | 512 | calcium ion binding |
GO:0009400 | 0.0032 | Inf | 0.0032 | 1 | 1 | signal transducer, downstream of receptor, with serine/threonine phosphatase activity |
GO:0052593 | 0.0032 | Inf | 0.0032 | 1 | 1 | tryptamine:oxygen oxidoreductase (deaminating) activity |
GO:0052594 | 0.0032 | Inf | 0.0032 | 1 | 1 | aminoacetone:oxygen oxidoreductase(deaminating) activity |
GO:0052595 | 0.0032 | Inf | 0.0032 | 1 | 1 | aliphatic-amine oxidase activity |
GO:0052596 | 0.0032 | Inf | 0.0032 | 1 | 1 | phenethylamine:oxygen oxidoreductase (deaminating) activity |
GO:0019894 | 0.0063 | 18.4111 | 0.1197 | 2 | 37 | kinesin binding |
GO:0004063 | 0.0065 | 315.3333 | 0.0065 | 1 | 2 | aryldialkylphosphatase activity |
GO:0004332 | 0.0065 | 315.3333 | 0.0065 | 1 | 2 | fructose-bisphosphate aldolase activity |
GO:0008131 | 0.0065 | 315.3333 | 0.0065 | 1 | 2 | primary amine oxidase activity |
GO:0005507 | 0.007 | 17.4133 | 0.1262 | 2 | 39 | copper ion binding |
GO:0043565 | 0.0079 | 3.1352 | 2.9383 | 8 | 908 | sequence-specific DNA binding |
GO:0102007 | 0.0097 | 157.6548 | 0.0097 | 1 | 3 | acyl-L-homoserine-lactone lactonohydrolase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031700 | 0.002 | Inf | 0.002 | 1 | 1 | adrenomedullin receptor binding |
GO:0042922 | 0.002 | Inf | 0.002 | 1 | 1 | neuromedin U receptor binding |
GO:0016603 | 0.0041 | 510 | 0.0041 | 1 | 2 | glutaminyl-peptide cyclotransferase activity |
GO:0018479 | 0.0041 | 510 | 0.0041 | 1 | 2 | benzaldehyde dehydrogenase (NAD+) activity |
GO:0008823 | 0.0061 | 254.9808 | 0.0061 | 1 | 3 | cupric reductase activity |
GO:0019958 | 0.0061 | 254.9808 | 0.0061 | 1 | 3 | C-X-C chemokine binding |
GO:0052851 | 0.0061 | 254.9808 | 0.0061 | 1 | 3 | ferric-chelate reductase (NADPH) activity |
GO:0004028 | 0.0081 | 169.9744 | 0.0081 | 1 | 4 | 3-chloroallyl aldehyde dehydrogenase activity |
GO:0005176 | 0.0081 | 169.9744 | 0.0081 | 1 | 4 | ErbB-2 class receptor binding |
GO:0043125 | 0.0081 | 169.9744 | 0.0081 | 1 | 4 | ErbB-3 class receptor binding |
GO:0047756 | 0.0081 | 169.9744 | 0.0081 | 1 | 4 | chondroitin 4-sulfotransferase activity |
GO:0019905 | 0.0081 | 16.2412 | 0.1361 | 2 | 67 | syntaxin binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005509 | 4e-04 | 6.0928 | 1.3871 | 7 | 512 | calcium ion binding |
GO:0004421 | 0.0027 | Inf | 0.0027 | 1 | 1 | hydroxymethylglutaryl-CoA synthase activity |
GO:0050661 | 0.004 | 23.5633 | 0.0948 | 2 | 35 | NADP binding |
GO:0003826 | 0.0054 | 378.6 | 0.0054 | 1 | 2 | alpha-ketoacid dehydrogenase activity |
GO:0003863 | 0.0054 | 378.6 | 0.0054 | 1 | 2 | 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity |
GO:0004096 | 0.0054 | 378.6 | 0.0054 | 1 | 2 | catalase activity |
GO:0004558 | 0.0054 | 378.6 | 0.0054 | 1 | 2 | alpha-1,4-glucosidase activity |
GO:0005135 | 0.0054 | 378.6 | 0.0054 | 1 | 2 | interleukin-3 receptor binding |
GO:0032450 | 0.0054 | 378.6 | 0.0054 | 1 | 2 | maltose alpha-glucosidase activity |
GO:0001588 | 0.0081 | 189.2857 | 0.0081 | 1 | 3 | dopamine neurotransmitter receptor activity, coupled via Gs |
GO:0003960 | 0.0081 | 189.2857 | 0.0081 | 1 | 3 | NADPH:quinone reductase activity |
GO:0004321 | 0.0081 | 189.2857 | 0.0081 | 1 | 3 | fatty-acyl-CoA synthase activity |
GO:0015143 | 0.0081 | 189.2857 | 0.0081 | 1 | 3 | urate transmembrane transporter activity |
GO:0071987 | 0.0081 | 189.2857 | 0.0081 | 1 | 3 | WD40-repeat domain binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050429 | 0.0032 | Inf | 0.0032 | 1 | 1 | calcium-dependent phospholipase C activity |
GO:0070002 | 0.0032 | Inf | 0.0032 | 1 | 1 | glutamic-type peptidase activity |
GO:0004911 | 0.0065 | 315.3333 | 0.0065 | 1 | 2 | interleukin-2 receptor activity |
GO:0005412 | 0.0065 | 315.3333 | 0.0065 | 1 | 2 | glucose:sodium symporter activity |
GO:0019976 | 0.0065 | 315.3333 | 0.0065 | 1 | 2 | interleukin-2 binding |
GO:0047844 | 0.0065 | 315.3333 | 0.0065 | 1 | 2 | deoxycytidine deaminase activity |
GO:0008083 | 0.0065 | 8.563 | 0.3818 | 3 | 118 | growth factor activity |
GO:0005160 | 0.007 | 17.4133 | 0.1262 | 2 | 39 | transforming growth factor beta receptor binding |
GO:0005125 | 0.0071 | 8.2727 | 0.3948 | 3 | 122 | cytokine activity |
GO:0004464 | 0.0097 | 157.6548 | 0.0097 | 1 | 3 | leukotriene-C4 synthase activity |
GO:0005127 | 0.0097 | 157.6548 | 0.0097 | 1 | 3 | ciliary neurotrophic factor receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0000048 | 0.0029 | Inf | 0.0029 | 1 | 1 | peptidyltransferase activity |
GO:0002951 | 0.0029 | Inf | 0.0029 | 1 | 1 | leukotriene-C(4) hydrolase |
GO:0004102 | 0.0029 | Inf | 0.0029 | 1 | 1 | choline O-acetyltransferase activity |
GO:0016501 | 0.0029 | Inf | 0.0029 | 1 | 1 | prostacyclin receptor activity |
GO:0030977 | 0.0029 | Inf | 0.0029 | 1 | 1 | taurine binding |
GO:0005412 | 0.0059 | 348.6316 | 0.0059 | 1 | 2 | glucose:sodium symporter activity |
GO:0005427 | 0.0059 | 348.6316 | 0.0059 | 1 | 2 | proton-dependent oligopeptide secondary active transmembrane transporter activity |
GO:0008502 | 0.0059 | 348.6316 | 0.0059 | 1 | 2 | melatonin receptor activity |
GO:0016934 | 0.0088 | 174.3026 | 0.0088 | 1 | 3 | extracellularly glycine-gated chloride channel activity |
GO:0043199 | 0.0088 | 174.3026 | 0.0088 | 1 | 3 | sulfate binding |
GO:0102953 | 0.0088 | 174.3026 | 0.0088 | 1 | 3 | hypoglycin A gamma-glutamyl transpeptidase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003957 | 0.0017 | Inf | 0.0017 | 1 | 1 | NAD(P)+ transhydrogenase (B-specific) activity |
GO:0008750 | 0.0017 | Inf | 0.0017 | 1 | 1 | NAD(P)+ transhydrogenase (AB-specific) activity |
GO:0016652 | 0.0017 | Inf | 0.0017 | 1 | 1 | oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor |
GO:0030246 | 0.0031 | 11.6762 | 0.298 | 3 | 180 | carbohydrate binding |
GO:0030883 | 0.0033 | 631.6667 | 0.0033 | 1 | 2 | endogenous lipid antigen binding |
GO:0030884 | 0.0033 | 631.6667 | 0.0033 | 1 | 2 | exogenous lipid antigen binding |
GO:0004321 | 0.005 | 315.8095 | 0.005 | 1 | 3 | fatty-acyl-CoA synthase activity |
GO:0008048 | 0.005 | 315.8095 | 0.005 | 1 | 3 | calcium sensitive guanylate cyclase activator activity |
GO:0008745 | 0.005 | 315.8095 | 0.005 | 1 | 3 | N-acetylmuramoyl-L-alanine amidase activity |
GO:1905576 | 0.005 | 315.8095 | 0.005 | 1 | 3 | ganglioside GT1b binding |
GO:0003996 | 0.0066 | 210.5238 | 0.0066 | 1 | 4 | acyl-CoA ligase activity |
GO:0016019 | 0.0066 | 210.5238 | 0.0066 | 1 | 4 | peptidoglycan receptor activity |
GO:0032190 | 0.0066 | 210.5238 | 0.0066 | 1 | 4 | acrosin binding |
GO:0047760 | 0.0066 | 210.5238 | 0.0066 | 1 | 4 | butyrate-CoA ligase activity |
GO:0071723 | 0.0066 | 210.5238 | 0.0066 | 1 | 4 | lipopeptide binding |
GO:0010853 | 0.0083 | 157.881 | 0.0083 | 1 | 5 | cyclase activator activity |
GO:0042834 | 0.0083 | 157.881 | 0.0083 | 1 | 5 | peptidoglycan binding |
GO:0050733 | 0.0083 | 157.881 | 0.0083 | 1 | 5 | RS domain binding |
GO:0030249 | 0.0099 | 126.2952 | 0.0099 | 1 | 6 | guanylate cyclase regulator activity |
GO:0030881 | 0.0099 | 126.2952 | 0.0099 | 1 | 6 | beta-2-microglobulin binding |
GO:0043208 | 0.0099 | 126.2952 | 0.0099 | 1 | 6 | glycosphingolipid binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004603 | 0.0041 | Inf | 0.0041 | 1 | 1 | phenylethanolamine N-methyltransferase activity |
GO:0003873 | 0.0083 | 245.037 | 0.0083 | 1 | 2 | 6-phosphofructo-2-kinase activity |
GO:0016603 | 0.0083 | 245.037 | 0.0083 | 1 | 2 | glutaminyl-peptide cyclotransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005201 | 1e-04 | 20.1083 | 0.2295 | 4 | 50 | extracellular matrix structural constituent |
GO:0043546 | 2e-04 | 149.4237 | 0.023 | 2 | 5 | molybdopterin cofactor binding |
GO:0048037 | 0.0037 | 5.2788 | 1.0329 | 5 | 225 | cofactor binding |
GO:0000334 | 0.0046 | Inf | 0.0046 | 1 | 1 | 3-hydroxyanthranilate 3,4-dioxygenase activity |
GO:0001567 | 0.0046 | Inf | 0.0046 | 1 | 1 | cholesterol 25-hydroxylase activity |
GO:0004031 | 0.0046 | Inf | 0.0046 | 1 | 1 | aldehyde oxidase activity |
GO:0004042 | 0.0046 | Inf | 0.0046 | 1 | 1 | acetyl-CoA:L-glutamate N-acetyltransferase activity |
GO:0004603 | 0.0046 | Inf | 0.0046 | 1 | 1 | phenylethanolamine N-methyltransferase activity |
GO:0008482 | 0.0046 | Inf | 0.0046 | 1 | 1 | sulfite oxidase activity |
GO:0061627 | 0.0046 | Inf | 0.0046 | 1 | 1 | S-methylmethionine-homocysteine S-methyltransferase activity |
GO:0098625 | 0.0046 | Inf | 0.0046 | 1 | 1 | methylselenol reductase activity |
GO:0098626 | 0.0046 | Inf | 0.0046 | 1 | 1 | methylseleninic acid reductase activity |
GO:0102797 | 0.0046 | Inf | 0.0046 | 1 | 1 | geranial:oxygen oxidoreductase activity |
GO:0102798 | 0.0046 | Inf | 0.0046 | 1 | 1 | heptaldehyde:oxygen oxidoreductase activity |
GO:0103045 | 0.0046 | Inf | 0.0046 | 1 | 1 | methione N-acyltransferase activity |
GO:0009055 | 0.007 | 8.2916 | 0.3902 | 3 | 85 | electron transfer activity |
GO:0004601 | 0.0078 | 16.5725 | 0.1331 | 2 | 29 | peroxidase activity |
GO:0003875 | 0.0092 | 220.4333 | 0.0092 | 1 | 2 | ADP-ribosylarginine hydrolase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0016501 | 0.0017 | Inf | 0.0017 | 1 | 1 | prostacyclin receptor activity |
GO:0017020 | 0.0017 | Inf | 0.0017 | 1 | 1 | myosin phosphatase regulator activity |
GO:0033791 | 0.0017 | Inf | 0.0017 | 1 | 1 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity |
GO:0004174 | 0.0033 | 631.6667 | 0.0033 | 1 | 2 | electron-transferring-flavoprotein dehydrogenase activity |
GO:0050660 | 0.0045 | 22.3847 | 0.101 | 2 | 61 | flavin adenine dinucleotide binding |
GO:0016402 | 0.005 | 315.8095 | 0.005 | 1 | 3 | pristanoyl-CoA oxidase activity |
GO:0020037 | 0.0078 | 16.6924 | 0.1341 | 2 | 81 | heme binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005147 | 0.0018 | Inf | 0.0018 | 1 | 1 | oncostatin-M receptor binding |
GO:0047747 | 0.0018 | Inf | 0.0018 | 1 | 1 | cholate-CoA ligase activity |
GO:0050429 | 0.0018 | Inf | 0.0018 | 1 | 1 | calcium-dependent phospholipase C activity |
GO:0005153 | 0.0036 | 576.6522 | 0.0036 | 1 | 2 | interleukin-8 receptor binding |
GO:0005094 | 0.0054 | 288.3043 | 0.0054 | 1 | 3 | Rho GDP-dissociation inhibitor activity |
GO:0015501 | 0.0054 | 288.3043 | 0.0054 | 1 | 3 | glutamate:sodium symporter activity |
GO:0017034 | 0.0072 | 192.1884 | 0.0072 | 1 | 4 | Rap guanyl-nucleotide exchange factor activity |
GO:0005096 | 0.0075 | 8.3543 | 0.4082 | 3 | 226 | GTPase activator activity |
GO:0098772 | 0.0086 | 3.6101 | 2.4654 | 7 | 1365 | molecular function regulator |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0047305 | 8e-04 | Inf | 8e-04 | 1 | 1 | (R)-3-amino-2-methylpropionate-pyruvate transaminase activity |
GO:0008453 | 0.0025 | 663.75 | 0.0025 | 1 | 3 | alanine-glyoxylate transaminase activity |
GO:0097153 | 0.0083 | 147.4222 | 0.0083 | 1 | 10 | cysteine-type endopeptidase activity involved in apoptotic process |
GO:0008093 | 0.0091 | 132.67 | 0.0091 | 1 | 11 | cytoskeletal adaptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004042 | 0.0034 | Inf | 0.0034 | 1 | 1 | acetyl-CoA:L-glutamate N-acetyltransferase activity |
GO:0005147 | 0.0034 | Inf | 0.0034 | 1 | 1 | oncostatin-M receptor binding |
GO:0047747 | 0.0034 | Inf | 0.0034 | 1 | 1 | cholate-CoA ligase activity |
GO:0050429 | 0.0034 | Inf | 0.0034 | 1 | 1 | calcium-dependent phospholipase C activity |
GO:0098625 | 0.0034 | Inf | 0.0034 | 1 | 1 | methylselenol reductase activity |
GO:0098626 | 0.0034 | Inf | 0.0034 | 1 | 1 | methylseleninic acid reductase activity |
GO:0103045 | 0.0034 | Inf | 0.0034 | 1 | 1 | methione N-acyltransferase activity |
GO:0030414 | 0.0039 | 10.3234 | 0.3183 | 3 | 94 | peptidase inhibitor activity |
GO:0098772 | 0.0049 | 2.8408 | 4.6226 | 11 | 1365 | molecular function regulator |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0017020 | 0.0017 | Inf | 0.0017 | 1 | 1 | myosin phosphatase regulator activity |
GO:0004517 | 0.0035 | 602.9091 | 0.0035 | 1 | 2 | nitric-oxide synthase activity |
GO:0070891 | 0.0035 | 602.9091 | 0.0035 | 1 | 2 | lipoteichoic acid binding |
GO:0034617 | 0.0052 | 301.4318 | 0.0052 | 1 | 3 | tetrahydrobiopterin binding |
GO:0071723 | 0.0069 | 200.9394 | 0.0069 | 1 | 4 | lipopeptide binding |
GO:1903231 | 0.0081 | 16.3117 | 0.1367 | 2 | 79 | mRNA binding involved in posttranscriptional gene silencing |
GO:0020037 | 0.0085 | 15.8963 | 0.1402 | 2 | 81 | heme binding |
GO:0003958 | 0.0086 | 150.6932 | 0.0087 | 1 | 5 | NADPH-hemoprotein reductase activity |
GO:0034618 | 0.0086 | 150.6932 | 0.0087 | 1 | 5 | arginine binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0016501 | 0.002 | Inf | 0.002 | 1 | 1 | prostacyclin receptor activity |
GO:0017020 | 0.002 | Inf | 0.002 | 1 | 1 | myosin phosphatase regulator activity |
GO:0033791 | 0.002 | Inf | 0.002 | 1 | 1 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity |
GO:0038182 | 0.002 | Inf | 0.002 | 1 | 1 | G-protein coupled bile acid receptor activity |
GO:0004174 | 0.0041 | 510 | 0.0041 | 1 | 2 | electron-transferring-flavoprotein dehydrogenase activity |
GO:0015333 | 0.0061 | 254.9808 | 0.0061 | 1 | 3 | peptide:proton symporter activity |
GO:0016402 | 0.0061 | 254.9808 | 0.0061 | 1 | 3 | pristanoyl-CoA oxidase activity |
GO:0050660 | 0.0068 | 17.901 | 0.1239 | 2 | 61 | flavin adenine dinucleotide binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0047305 | 0.0013 | Inf | 0.0013 | 1 | 1 | (R)-3-amino-2-methylpropionate-pyruvate transaminase activity |
GO:0004750 | 0.0026 | 829.375 | 0.0026 | 1 | 2 | ribulose-phosphate 3-epimerase activity |
GO:0008453 | 0.0038 | 414.6562 | 0.0038 | 1 | 3 | alanine-glyoxylate transaminase activity |
GO:0050544 | 0.0051 | 276.4167 | 0.0051 | 1 | 4 | arachidonic acid binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001594 | 0.0011 | Inf | 0.0011 | 1 | 1 | trace-amine receptor activity |
GO:0005477 | 0.0011 | Inf | 0.0011 | 1 | 1 | pyruvate secondary active transmembrane transporter activity |
GO:0036105 | 0.0011 | Inf | 0.0011 | 1 | 1 | peroxisome membrane class-1 targeting sequence binding |
GO:0003873 | 0.0023 | 948 | 0.0023 | 1 | 2 | 6-phosphofructo-2-kinase activity |
GO:0004331 | 0.0034 | 473.9643 | 0.0034 | 1 | 3 | fructose-2,6-bisphosphate 2-phosphatase activity |
GO:0000268 | 0.0045 | 315.9524 | 0.0045 | 1 | 4 | peroxisome targeting sequence binding |
GO:0015129 | 0.0045 | 315.9524 | 0.0045 | 1 | 4 | lactate transmembrane transporter activity |
GO:0004931 | 0.0068 | 189.5429 | 0.0068 | 1 | 6 | extracellularly ATP-gated cation channel activity |
GO:0019203 | 0.0068 | 189.5429 | 0.0068 | 1 | 6 | carbohydrate phosphatase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004364 | 0.001 | 49.7519 | 0.0482 | 2 | 16 | glutathione transferase activity |
GO:0001635 | 0.003 | Inf | 0.003 | 1 | 1 | calcitonin gene-related peptide receptor activity |
GO:0003837 | 0.003 | Inf | 0.003 | 1 | 1 | beta-ureidopropionase activity |
GO:0004946 | 0.003 | Inf | 0.003 | 1 | 1 | bombesin receptor activity |
GO:0031732 | 0.003 | Inf | 0.003 | 1 | 1 | CCR7 chemokine receptor binding |
GO:0001784 | 0.0041 | 23.1895 | 0.0963 | 2 | 32 | phosphotyrosine residue binding |
GO:0008374 | 0.0058 | 19.3158 | 0.1144 | 2 | 38 | O-acyltransferase activity |
GO:0004365 | 0.006 | 339.6667 | 0.006 | 1 | 2 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity |
GO:0005080 | 0.0061 | 18.7923 | 0.1174 | 2 | 39 | protein kinase C binding |
GO:0030971 | 0.0084 | 15.7943 | 0.1385 | 2 | 46 | receptor tyrosine kinase binding |
GO:0004321 | 0.009 | 169.8205 | 0.009 | 1 | 3 | fatty-acyl-CoA synthase activity |
GO:0008823 | 0.009 | 169.8205 | 0.009 | 1 | 3 | cupric reductase activity |
GO:0047192 | 0.009 | 169.8205 | 0.009 | 1 | 3 | 1-alkylglycerophosphocholine O-acetyltransferase activity |
GO:0052851 | 0.009 | 169.8205 | 0.009 | 1 | 3 | ferric-chelate reductase (NADPH) activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0033791 | 0.0013 | Inf | 0.0013 | 1 | 1 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity |
GO:0016402 | 0.0038 | 414.6562 | 0.0038 | 1 | 3 | pristanoyl-CoA oxidase activity |
GO:0032190 | 0.0051 | 276.4167 | 0.0051 | 1 | 4 | acrosin binding |
GO:0099104 | 0.0051 | 276.4167 | 0.0051 | 1 | 4 | potassium channel activator activity |
GO:0042608 | 0.0077 | 165.825 | 0.0077 | 1 | 6 | T cell receptor binding |
GO:0008201 | 0.0081 | 16.7187 | 0.1369 | 2 | 107 | heparin binding |
GO:0004252 | 0.0096 | 15.2533 | 0.1497 | 2 | 117 | serine-type endopeptidase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008389 | 0.0014 | Inf | 0.0014 | 1 | 1 | coumarin 7-hydroxylase activity |
GO:0052593 | 0.0014 | Inf | 0.0014 | 1 | 1 | tryptamine:oxygen oxidoreductase (deaminating) activity |
GO:0052594 | 0.0014 | Inf | 0.0014 | 1 | 1 | aminoacetone:oxygen oxidoreductase(deaminating) activity |
GO:0052595 | 0.0014 | Inf | 0.0014 | 1 | 1 | aliphatic-amine oxidase activity |
GO:0052596 | 0.0014 | Inf | 0.0014 | 1 | 1 | phenethylamine:oxygen oxidoreductase (deaminating) activity |
GO:0004047 | 0.0029 | 737.1111 | 0.0029 | 1 | 2 | aminomethyltransferase activity |
GO:0008131 | 0.0029 | 737.1111 | 0.0029 | 1 | 2 | primary amine oxidase activity |
GO:0071987 | 0.0043 | 368.5278 | 0.0043 | 1 | 3 | WD40-repeat domain binding |
GO:0008392 | 0.0086 | 147.3778 | 0.0086 | 1 | 6 | arachidonic acid epoxygenase activity |
GO:0055056 | 0.01 | 122.8056 | 0.01 | 1 | 7 | D-glucose transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001228 | 0.0022 | 6.1806 | 0.9298 | 5 | 353 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
GO:0030251 | 0.0026 | Inf | 0.0026 | 1 | 1 | guanylate cyclase inhibitor activity |
GO:0031732 | 0.0026 | Inf | 0.0026 | 1 | 1 | CCR7 chemokine receptor binding |
GO:0030550 | 0.0079 | 194.8676 | 0.0079 | 1 | 3 | acetylcholine receptor inhibitor activity |
GO:0000979 | 0.0079 | 16.3315 | 0.1343 | 2 | 51 | RNA polymerase II core promoter sequence-specific DNA binding |
GO:0043565 | 0.0085 | 3.4273 | 2.3916 | 7 | 908 | sequence-specific DNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0047305 | 0.0021 | Inf | 0.0021 | 1 | 1 | (R)-3-amino-2-methylpropionate-pyruvate transaminase activity |
GO:0008453 | 0.0063 | 245.5185 | 0.0063 | 1 | 3 | alanine-glyoxylate transaminase activity |
GO:0015143 | 0.0063 | 245.5185 | 0.0063 | 1 | 3 | urate transmembrane transporter activity |
GO:0019958 | 0.0063 | 245.5185 | 0.0063 | 1 | 3 | C-X-C chemokine binding |
GO:0001733 | 0.0084 | 163.6667 | 0.0084 | 1 | 4 | galactosylceramide sulfotransferase activity |
GO:0015057 | 0.0084 | 163.6667 | 0.0084 | 1 | 4 | thrombin-activated receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005338 | 1e-04 | 169.9231 | 0.0169 | 2 | 8 | nucleotide-sugar transmembrane transporter activity |
GO:0005459 | 0.0021 | Inf | 0.0021 | 1 | 1 | UDP-galactose transmembrane transporter activity |
GO:0050051 | 0.0021 | Inf | 0.0021 | 1 | 1 | leukotriene-B4 20-monooxygenase activity |
GO:0052871 | 0.0021 | Inf | 0.0021 | 1 | 1 | alpha-tocopherol omega-hydroxylase activity |
GO:0097258 | 0.0021 | Inf | 0.0021 | 1 | 1 | 20-hydroxy-leukotriene B4 omega oxidase activity |
GO:0097259 | 0.0021 | Inf | 0.0021 | 1 | 1 | 20-aldehyde-leukotriene B4 20-monooxygenase activity |
GO:0004980 | 0.0042 | 491.0741 | 0.0042 | 1 | 2 | melanocyte-stimulating hormone receptor activity |
GO:0005412 | 0.0042 | 491.0741 | 0.0042 | 1 | 2 | glucose:sodium symporter activity |
GO:0005427 | 0.0042 | 491.0741 | 0.0042 | 1 | 2 | proton-dependent oligopeptide secondary active transmembrane transporter activity |
GO:0008020 | 0.0084 | 163.6667 | 0.0084 | 1 | 4 | G-protein coupled photoreceptor activity |
GO:0035673 | 0.0084 | 163.6667 | 0.0084 | 1 | 4 | oligopeptide transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005539 | 0.0063 | 8.7027 | 0.3793 | 3 | 140 | glycosaminoglycan binding |
GO:0005201 | 0.0081 | 16.1814 | 0.1355 | 2 | 50 | extracellular matrix structural constituent |
GO:0031013 | 0.0081 | 189.2857 | 0.0081 | 1 | 3 | troponin I binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003944 | 0.002 | Inf | 0.002 | 1 | 1 | N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity |
GO:0051424 | 0.002 | Inf | 0.002 | 1 | 1 | corticotropin-releasing hormone binding |
GO:0005135 | 0.0039 | 530.44 | 0.0039 | 1 | 2 | interleukin-3 receptor binding |
GO:0050544 | 0.0078 | 176.7867 | 0.0078 | 1 | 4 | arachidonic acid binding |
GO:0070290 | 0.0078 | 176.7867 | 0.0078 | 1 | 4 | N-acylphosphatidylethanolamine-specific phospholipase D activity |
GO:0004630 | 0.0097 | 132.58 | 0.0098 | 1 | 5 | phospholipase D activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005115 | 0.0019 | Inf | 0.0019 | 1 | 1 | receptor tyrosine kinase-like orphan receptor binding |
GO:0039552 | 0.0019 | Inf | 0.0019 | 1 | 1 | RIG-I binding |
GO:0070002 | 0.0019 | Inf | 0.0019 | 1 | 1 | glutamic-type peptidase activity |
GO:1902379 | 0.0019 | Inf | 0.0019 | 1 | 1 | chemoattractant activity involved in axon guidance |
GO:0005105 | 0.0038 | 552.5833 | 0.0038 | 1 | 2 | type 1 fibroblast growth factor receptor binding |
GO:0005110 | 0.0038 | 552.5833 | 0.0038 | 1 | 2 | frizzled-2 binding |
GO:0008017 | 0.0054 | 9.4329 | 0.3612 | 3 | 192 | microtubule binding |
GO:0005111 | 0.0056 | 276.2708 | 0.0056 | 1 | 3 | type 2 fibroblast growth factor receptor binding |
GO:0015386 | 0.0094 | 138.1146 | 0.0094 | 1 | 5 | potassium:proton antiporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004364 | 4e-04 | 82.2919 | 0.0301 | 2 | 16 | glutathione transferase activity |
GO:0004769 | 0.0019 | Inf | 0.0019 | 1 | 1 | steroid delta-isomerase activity |
GO:0015603 | 0.0019 | Inf | 0.0019 | 1 | 1 | iron chelate transmembrane transporter activity |
GO:0042931 | 0.0019 | Inf | 0.0019 | 1 | 1 | enterobactin transmembrane transporter activity |
GO:0102294 | 0.0019 | Inf | 0.0019 | 1 | 1 | cholesterol dehydrogenase activity |
GO:0044736 | 0.0038 | 552.5833 | 0.0038 | 1 | 2 | acid-sensing ion channel activity |
GO:0004872 | 0.0046 | 4.5374 | 1.6349 | 6 | 869 | receptor activity |
GO:0003854 | 0.0056 | 276.2708 | 0.0056 | 1 | 3 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity |
GO:0099094 | 0.0062 | 18.8197 | 0.1185 | 2 | 63 | ligand-gated cation channel activity |
GO:0032190 | 0.0075 | 184.1667 | 0.0075 | 1 | 4 | acrosin binding |
GO:0001602 | 0.0094 | 138.1146 | 0.0094 | 1 | 5 | pancreatic polypeptide receptor activity |
GO:0004969 | 0.0094 | 138.1146 | 0.0094 | 1 | 5 | histamine receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001632 | 0.0035 | Inf | 0.0035 | 1 | 1 | leukotriene B4 receptor activity |
GO:0004825 | 0.0069 | 294.2444 | 0.0069 | 1 | 2 | methionine-tRNA ligase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008201 | 5e-04 | 22.3371 | 0.161 | 3 | 107 | heparin binding |
GO:0004507 | 0.0015 | Inf | 0.0015 | 1 | 1 | steroid 11-beta-monooxygenase activity |
GO:0047783 | 0.0015 | Inf | 0.0015 | 1 | 1 | corticosterone 18-monooxygenase activity |
GO:0070405 | 0.0023 | 31.9372 | 0.0722 | 2 | 48 | ammonium ion binding |
GO:0005135 | 0.003 | 698.2632 | 0.003 | 1 | 2 | interleukin-3 receptor binding |
GO:0030594 | 0.0035 | 25.7524 | 0.0888 | 2 | 59 | neurotransmitter receptor activity |
GO:0008048 | 0.0045 | 349.1053 | 0.0045 | 1 | 3 | calcium sensitive guanylate cyclase activator activity |
GO:0008745 | 0.0045 | 349.1053 | 0.0045 | 1 | 3 | N-acetylmuramoyl-L-alanine amidase activity |
GO:0001591 | 0.006 | 232.7193 | 0.006 | 1 | 4 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
GO:0016019 | 0.006 | 232.7193 | 0.006 | 1 | 4 | peptidoglycan receptor activity |
GO:0050501 | 0.006 | 232.7193 | 0.006 | 1 | 4 | hyaluronan synthase activity |
GO:0050544 | 0.006 | 232.7193 | 0.006 | 1 | 4 | arachidonic acid binding |
GO:0010853 | 0.0075 | 174.5263 | 0.0075 | 1 | 5 | cyclase activator activity |
GO:0042834 | 0.0075 | 174.5263 | 0.0075 | 1 | 5 | peptidoglycan binding |
GO:0048018 | 0.0083 | 8.1857 | 0.4259 | 3 | 283 | receptor ligand activity |
GO:0030414 | 0.0087 | 15.913 | 0.1415 | 2 | 94 | peptidase inhibitor activity |
GO:0030249 | 0.009 | 139.6105 | 0.009 | 1 | 6 | guanylate cyclase regulator activity |
GO:0070679 | 0.009 | 139.6105 | 0.009 | 1 | 6 | inositol 1,4,5 trisphosphate binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0097153 | 0.0068 | 184.3056 | 0.0068 | 1 | 10 | cysteine-type endopeptidase activity involved in apoptotic process |
GO:0048020 | 0.0088 | 138.1979 | 0.0088 | 1 | 13 | CCR chemokine receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005147 | 0.0016 | Inf | 0.0016 | 1 | 1 | oncostatin-M receptor binding |
GO:0047747 | 0.0016 | Inf | 0.0016 | 1 | 1 | cholate-CoA ligase activity |
GO:0050429 | 0.0016 | Inf | 0.0016 | 1 | 1 | calcium-dependent phospholipase C activity |
GO:0005094 | 0.0047 | 331.625 | 0.0047 | 1 | 3 | Rho GDP-dissociation inhibitor activity |
GO:0015501 | 0.0047 | 331.625 | 0.0047 | 1 | 3 | glutamate:sodium symporter activity |
GO:0005096 | 0.0051 | 9.7489 | 0.3572 | 3 | 226 | GTPase activator activity |
GO:0017034 | 0.0063 | 221.0667 | 0.0063 | 1 | 4 | Rap guanyl-nucleotide exchange factor activity |
GO:0005314 | 0.0094 | 132.62 | 0.0095 | 1 | 6 | high-affinity glutamate transmembrane transporter activity |
GO:0070679 | 0.0094 | 132.62 | 0.0095 | 1 | 6 | inositol 1,4,5 trisphosphate binding |
GO:0060589 | 0.0098 | 7.6466 | 0.452 | 3 | 286 | nucleoside-triphosphatase regulator activity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048646 | 0 | 2.8712 | 13.5076 | 34 | 965 | anatomical structure formation involved in morphogenesis |
GO:0003002 | 0 | 4.1941 | 4.4932 | 17 | 321 | regionalization |
GO:0060485 | 0 | 4.794 | 3.2334 | 14 | 231 | mesenchyme development |
GO:0072359 | 0 | 2.6029 | 12.8637 | 30 | 919 | circulatory system development |
GO:0009792 | 0 | 3.0105 | 7.6566 | 21 | 547 | embryo development ending in birth or egg hatching |
GO:0001944 | 0 | 2.839 | 8.4965 | 22 | 607 | vasculature development |
GO:0048856 | 1e-04 | 1.742 | 71.4152 | 99 | 5149 | anatomical structure development |
GO:2001199 | 1e-04 | 71.4333 | 0.084 | 3 | 6 | negative regulation of dendritic cell differentiation |
GO:0035909 | 1e-04 | 12.413 | 0.4759 | 5 | 34 | aorta morphogenesis |
GO:0051240 | 1e-04 | 2.1086 | 19.0174 | 36 | 1389 | positive regulation of multicellular organismal process |
GO:0008284 | 1e-04 | 2.4382 | 11.212 | 25 | 801 | positive regulation of cell proliferation |
GO:0048562 | 1e-04 | 3.6292 | 3.8773 | 13 | 277 | embryonic organ morphogenesis |
GO:0048514 | 3e-04 | 2.7516 | 7.0687 | 18 | 505 | blood vessel morphogenesis |
GO:0045165 | 3e-04 | 4.1705 | 2.5918 | 10 | 189 | cell fate commitment |
GO:0001655 | 4e-04 | 3.298 | 4.2412 | 13 | 303 | urogenital system development |
GO:0060037 | 4e-04 | 13.655 | 0.3499 | 4 | 25 | pharyngeal system development |
GO:0035050 | 5e-04 | 6.5604 | 1.0078 | 6 | 72 | embryonic heart tube development |
GO:0055014 | 6e-04 | 142.2085 | 0.042 | 2 | 3 | atrial cardiac muscle cell development |
GO:0060741 | 6e-04 | 142.2085 | 0.042 | 2 | 3 | prostate gland stromal morphogenesis |
GO:0021879 | 6e-04 | 8.1731 | 0.6859 | 5 | 49 | forebrain neuron differentiation |
GO:0060415 | 6e-04 | 6.2739 | 1.0498 | 6 | 75 | muscle tissue morphogenesis |
GO:0090596 | 6e-04 | 3.4673 | 3.4014 | 11 | 243 | sensory organ morphogenesis |
GO:0043066 | 7e-04 | 2.2532 | 11.03 | 23 | 788 | negative regulation of apoptotic process |
GO:2000026 | 9e-04 | 2.1692 | 12.0325 | 24 | 912 | regulation of multicellular organismal development |
GO:0060562 | 0.001 | 3.0723 | 4.1713 | 12 | 298 | epithelial tube morphogenesis |
GO:0010660 | 0.0011 | 7.048 | 0.7839 | 5 | 56 | regulation of muscle cell apoptotic process |
GO:0048665 | 0.0011 | 9.8829 | 0.4619 | 4 | 33 | neuron fate specification |
GO:0021764 | 0.0011 | 71.0995 | 0.056 | 2 | 4 | amygdala development |
GO:0072107 | 0.0011 | 71.0995 | 0.056 | 2 | 4 | positive regulation of ureteric bud formation |
GO:0090191 | 0.0011 | 71.0995 | 0.056 | 2 | 4 | negative regulation of branching involved in ureteric bud morphogenesis |
GO:1905205 | 0.0011 | 71.0995 | 0.056 | 2 | 4 | positive regulation of connective tissue replacement |
GO:0001947 | 0.0012 | 6.912 | 0.7979 | 5 | 57 | heart looping |
GO:0007498 | 0.0014 | 4.5592 | 1.6517 | 7 | 118 | mesoderm development |
GO:0060548 | 0.0014 | 2.0936 | 12.3458 | 24 | 882 | negative regulation of cell death |
GO:0010665 | 0.0014 | 9.244 | 0.4899 | 4 | 35 | regulation of cardiac muscle cell apoptotic process |
GO:0048738 | 0.0014 | 3.613 | 2.6595 | 9 | 190 | cardiac muscle tissue development |
GO:0045944 | 0.0015 | 1.9964 | 14.6134 | 27 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
GO:0030858 | 0.0015 | 6.5337 | 0.8399 | 5 | 60 | positive regulation of epithelial cell differentiation |
GO:0071542 | 0.0015 | 8.9545 | 0.5039 | 4 | 36 | dopaminergic neuron differentiation |
GO:0048706 | 0.0016 | 4.4383 | 1.6937 | 7 | 121 | embryonic skeletal system development |
GO:1903707 | 0.0016 | 4.4383 | 1.6937 | 7 | 121 | negative regulation of hemopoiesis |
GO:0001759 | 0.0019 | 14.2752 | 0.252 | 3 | 18 | organ induction |
GO:0051122 | 0.0019 | 47.3965 | 0.07 | 2 | 5 | hepoxilin biosynthetic process |
GO:0060455 | 0.0019 | 47.3965 | 0.07 | 2 | 5 | negative regulation of gastric acid secretion |
GO:0071502 | 0.0019 | 47.3965 | 0.07 | 2 | 5 | cellular response to temperature stimulus |
GO:2000609 | 0.0019 | 47.3965 | 0.07 | 2 | 5 | regulation of thyroid hormone generation |
GO:2001188 | 0.0019 | 47.3965 | 0.07 | 2 | 5 | regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
GO:0030803 | 0.0021 | 8.1854 | 0.5459 | 4 | 39 | negative regulation of cyclic nucleotide biosynthetic process |
GO:0003215 | 0.0022 | 13.3821 | 0.266 | 3 | 19 | cardiac right ventricle morphogenesis |
GO:0023019 | 0.0022 | 13.3821 | 0.266 | 3 | 19 | signal transduction involved in regulation of gene expression |
GO:0042403 | 0.0022 | 13.3821 | 0.266 | 3 | 19 | thyroid hormone metabolic process |
GO:0001709 | 0.0023 | 7.9575 | 0.5599 | 4 | 40 | cell fate determination |
GO:0010658 | 0.0023 | 7.9575 | 0.5599 | 4 | 40 | striated muscle cell apoptotic process |
GO:0048863 | 0.0025 | 3.0826 | 3.4434 | 10 | 246 | stem cell differentiation |
GO:0030815 | 0.0025 | 7.7419 | 0.5739 | 4 | 41 | negative regulation of cAMP metabolic process |
GO:1900372 | 0.0028 | 7.5376 | 0.5879 | 4 | 42 | negative regulation of purine nucleotide biosynthetic process |
GO:0008630 | 0.0028 | 4.5976 | 1.3998 | 6 | 100 | intrinsic apoptotic signaling pathway in response to DNA damage |
GO:0021902 | 0.0028 | 35.545 | 0.084 | 2 | 6 | commitment of neuronal cell to specific neuron type in forebrain |
GO:0034128 | 0.0028 | 35.545 | 0.084 | 2 | 6 | negative regulation of MyD88-independent toll-like receptor signaling pathway |
GO:0048699 | 0.0029 | 1.8139 | 18.4627 | 31 | 1319 | generation of neurons |
GO:0008543 | 0.0029 | 4.5489 | 1.4137 | 6 | 101 | fibroblast growth factor receptor signaling pathway |
GO:0007369 | 0.0037 | 3.3851 | 2.5056 | 8 | 179 | gastrulation |
GO:0003151 | 0.0038 | 5.2031 | 1.0358 | 5 | 74 | outflow tract morphogenesis |
GO:0060042 | 0.0038 | 6.818 | 0.6439 | 4 | 46 | retina morphogenesis in camera-type eye |
GO:0001826 | 0.0039 | 28.4341 | 0.098 | 2 | 7 | inner cell mass cell differentiation |
GO:0002118 | 0.0039 | 28.4341 | 0.098 | 2 | 7 | aggressive behavior |
GO:0002645 | 0.0039 | 28.4341 | 0.098 | 2 | 7 | positive regulation of tolerance induction |
GO:0055010 | 0.0042 | 6.659 | 0.6579 | 4 | 47 | ventricular cardiac muscle tissue morphogenesis |
GO:0007517 | 0.0042 | 2.5672 | 4.9411 | 12 | 353 | muscle organ development |
GO:0048771 | 0.0042 | 3.6875 | 2.0156 | 7 | 144 | tissue remodeling |
GO:0060537 | 0.0043 | 2.5595 | 4.9551 | 12 | 354 | muscle tissue development |
GO:0010628 | 0.0044 | 1.6831 | 23.8377 | 37 | 1703 | positive regulation of gene expression |
GO:0030878 | 0.0044 | 10.1925 | 0.3359 | 3 | 24 | thyroid gland development |
GO:0060487 | 0.0044 | 10.1925 | 0.3359 | 3 | 24 | lung epithelial cell differentiation |
GO:0060914 | 0.0044 | 10.1925 | 0.3359 | 3 | 24 | heart formation |
GO:0061217 | 0.0044 | 10.1925 | 0.3359 | 3 | 24 | regulation of mesonephros development |
GO:0048869 | 0.0044 | 1.5257 | 47.428 | 64 | 3588 | cellular developmental process |
GO:0030509 | 0.0045 | 3.634 | 2.0436 | 7 | 146 | BMP signaling pathway |
GO:0007368 | 0.0049 | 4.0738 | 1.5677 | 6 | 112 | determination of left/right symmetry |
GO:0030817 | 0.0051 | 4.0355 | 1.5817 | 6 | 113 | regulation of cAMP biosynthetic process |
GO:0001955 | 0.0052 | 23.6935 | 0.112 | 2 | 8 | blood vessel maturation |
GO:0010940 | 0.0052 | 23.6935 | 0.112 | 2 | 8 | positive regulation of necrotic cell death |
GO:0042756 | 0.0052 | 23.6935 | 0.112 | 2 | 8 | drinking behavior |
GO:0051584 | 0.0052 | 23.6935 | 0.112 | 2 | 8 | regulation of dopamine uptake involved in synaptic transmission |
GO:0060836 | 0.0052 | 23.6935 | 0.112 | 2 | 8 | lymphatic endothelial cell differentiation |
GO:0060840 | 0.0053 | 4.7849 | 1.1198 | 5 | 80 | artery development |
GO:0045765 | 0.0053 | 2.9376 | 3.2334 | 9 | 231 | regulation of angiogenesis |
GO:0045597 | 0.0055 | 1.9807 | 10.7314 | 20 | 782 | positive regulation of cell differentiation |
GO:0007194 | 0.0055 | 9.305 | 0.3639 | 3 | 26 | negative regulation of adenylate cyclase activity |
GO:0045471 | 0.0056 | 3.9609 | 1.6097 | 6 | 115 | response to ethanol |
GO:0045995 | 0.0056 | 3.9609 | 1.6097 | 6 | 115 | regulation of embryonic development |
GO:0009605 | 0.0056 | 1.6249 | 26.7212 | 40 | 1909 | response to external stimulus |
GO:0016477 | 0.006 | 1.765 | 16.979 | 28 | 1213 | cell migration |
GO:0040011 | 0.0062 | 1.674 | 21.8781 | 34 | 1563 | locomotion |
GO:0022414 | 0.0062 | 1.7433 | 17.8188 | 29 | 1273 | reproductive process |
GO:0001656 | 0.0065 | 4.5414 | 1.1758 | 5 | 84 | metanephros development |
GO:0060284 | 0.0065 | 1.9476 | 10.8901 | 20 | 778 | regulation of cell development |
GO:0003206 | 0.0066 | 3.8197 | 1.6657 | 6 | 119 | cardiac chamber morphogenesis |
GO:0072172 | 0.0066 | 20.3074 | 0.126 | 2 | 9 | mesonephric tubule formation |
GO:0071772 | 0.0066 | 3.365 | 2.1976 | 7 | 157 | response to BMP |
GO:0051674 | 0.0069 | 1.7122 | 18.7707 | 30 | 1341 | localization of cell |
GO:0060993 | 0.0071 | 4.4287 | 1.2038 | 5 | 86 | kidney morphogenesis |
GO:0051094 | 0.0072 | 2.6313 | 4.0097 | 10 | 308 | positive regulation of developmental process |
GO:0010033 | 0.0072 | 1.5113 | 39.291 | 54 | 2807 | response to organic substance |
GO:0009799 | 0.0074 | 3.7201 | 1.7077 | 6 | 122 | specification of symmetry |
GO:0090200 | 0.0076 | 8.2297 | 0.4059 | 3 | 29 | positive regulation of release of cytochrome c from mitochondria |
GO:0048666 | 0.0076 | 1.8319 | 13.3396 | 23 | 953 | neuron development |
GO:0072080 | 0.0079 | 4.3214 | 1.2318 | 5 | 88 | nephron tubule development |
GO:0021700 | 0.0081 | 2.7371 | 3.4574 | 9 | 247 | developmental maturation |
GO:0003211 | 0.0081 | 17.7678 | 0.14 | 2 | 10 | cardiac ventricle formation |
GO:0061042 | 0.0081 | 17.7678 | 0.14 | 2 | 10 | vascular wound healing |
GO:0097499 | 0.0081 | 17.7678 | 0.14 | 2 | 10 | protein localization to non-motile cilium |
GO:0052548 | 0.0082 | 2.4442 | 4.7312 | 11 | 338 | regulation of endopeptidase activity |
GO:0034142 | 0.0083 | 7.9243 | 0.4199 | 3 | 30 | toll-like receptor 4 signaling pathway |
GO:0090130 | 0.0083 | 2.7255 | 3.4714 | 9 | 248 | tissue migration |
GO:0050794 | 0.0086 | 1.4348 | 130.9046 | 148 | 9352 | regulation of cellular process |
GO:0030324 | 0.0086 | 3.1929 | 2.3096 | 7 | 165 | lung development |
GO:0051937 | 0.0088 | 5.2986 | 0.8119 | 4 | 58 | catecholamine transport |
GO:0051960 | 0.0089 | 1.9178 | 10.4701 | 19 | 748 | regulation of nervous system development |
GO:0042462 | 0.0091 | 7.6408 | 0.4339 | 3 | 31 | eye photoreceptor cell development |
GO:0051954 | 0.0091 | 7.6408 | 0.4339 | 3 | 31 | positive regulation of amine transport |
GO:0050769 | 0.0093 | 2.2976 | 5.487 | 12 | 392 | positive regulation of neurogenesis |
GO:0045664 | 0.0096 | 2.077 | 7.6006 | 15 | 543 | regulation of neuron differentiation |
GO:0042472 | 0.0099 | 4.0745 | 1.3018 | 5 | 93 | inner ear morphogenesis |
GO:0072164 | 0.0099 | 4.0745 | 1.3018 | 5 | 93 | mesonephric tubule development |
GO:2000117 | 0.0099 | 4.0745 | 1.3018 | 5 | 93 | negative regulation of cysteine-type endopeptidase activity |
GO:0010454 | 0.0099 | 15.7925 | 0.154 | 2 | 11 | negative regulation of cell fate commitment |
GO:0021903 | 0.0099 | 15.7925 | 0.154 | 2 | 11 | rostrocaudal neural tube patterning |
GO:0060675 | 0.0099 | 5.1087 | 0.8399 | 4 | 60 | ureteric bud morphogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0009790 | 0 | 3.3834 | 10.9312 | 32 | 818 | embryo development |
GO:0010648 | 0 | 2.7083 | 16.6326 | 39 | 1211 | negative regulation of cell communication |
GO:0023057 | 0 | 2.6983 | 16.6876 | 39 | 1215 | negative regulation of signaling |
GO:0007423 | 0 | 3.7186 | 6.9497 | 23 | 506 | sensory organ development |
GO:0048585 | 0 | 2.5716 | 18.9401 | 42 | 1379 | negative regulation of response to stimulus |
GO:0045597 | 0 | 2.9301 | 11.5646 | 30 | 842 | positive regulation of cell differentiation |
GO:0043009 | 0 | 3.4452 | 7.4579 | 23 | 543 | chordate embryonic development |
GO:0045944 | 0 | 2.6927 | 14.339 | 34 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
GO:0048729 | 0 | 3.2563 | 8.227 | 24 | 599 | tissue morphogenesis |
GO:0048562 | 0 | 5.8486 | 2.2894 | 12 | 173 | embryonic organ morphogenesis |
GO:1902679 | 0 | 2.5941 | 15.3141 | 35 | 1115 | negative regulation of RNA biosynthetic process |
GO:1903508 | 0 | 2.413 | 18.4319 | 39 | 1342 | positive regulation of nucleic acid-templated transcription |
GO:0001501 | 0 | 3.4551 | 6.4003 | 20 | 466 | skeletal system development |
GO:0001706 | 0 | 11.0309 | 0.7417 | 7 | 54 | endoderm formation |
GO:0001947 | 0 | 10.3669 | 0.7829 | 7 | 57 | heart looping |
GO:0021872 | 0 | 9.9669 | 0.8103 | 7 | 59 | forebrain generation of neurons |
GO:0097154 | 0 | 36.5854 | 0.1648 | 4 | 12 | GABAergic neuron differentiation |
GO:0009890 | 0 | 2.2459 | 20.7668 | 41 | 1512 | negative regulation of biosynthetic process |
GO:0051254 | 0 | 2.2801 | 19.3796 | 39 | 1411 | positive regulation of RNA metabolic process |
GO:0031328 | 0 | 2.1677 | 23.1841 | 44 | 1688 | positive regulation of cellular biosynthetic process |
GO:0010628 | 0 | 2.1457 | 23.3901 | 44 | 1703 | positive regulation of gene expression |
GO:0046533 | 0 | 109.267 | 0.0687 | 3 | 5 | negative regulation of photoreceptor cell differentiation |
GO:0080090 | 0 | 1.7747 | 76.186 | 105 | 5547 | regulation of primary metabolic process |
GO:0021756 | 0 | 29.2644 | 0.1923 | 4 | 14 | striatum development |
GO:0007267 | 0 | 2.1952 | 20.0388 | 39 | 1459 | cell-cell signaling |
GO:0009952 | 0 | 4.838 | 2.4912 | 11 | 183 | anterior/posterior pattern specification |
GO:0021544 | 0 | 74.2327 | 0.0809 | 3 | 6 | subpallium development |
GO:0035050 | 1e-04 | 7.9666 | 0.9889 | 7 | 72 | embryonic heart tube development |
GO:0045934 | 1e-04 | 2.2073 | 18.2533 | 36 | 1329 | negative regulation of nucleobase-containing compound metabolic process |
GO:0003407 | 1e-04 | 9.7067 | 0.7076 | 6 | 52 | neural retina development |
GO:0034654 | 1e-04 | 1.7621 | 54.76 | 80 | 3987 | nucleobase-containing compound biosynthetic process |
GO:0048665 | 1e-04 | 13.1127 | 0.4532 | 5 | 33 | neuron fate specification |
GO:0022008 | 1e-04 | 2.1431 | 19.3109 | 37 | 1406 | neurogenesis |
GO:0061303 | 1e-04 | 54.6262 | 0.0961 | 3 | 7 | cornea development in camera-type eye |
GO:2000678 | 1e-04 | 20.8976 | 0.2472 | 4 | 18 | negative regulation of transcription regulatory region DNA binding |
GO:0001764 | 1e-04 | 5.4015 | 1.8267 | 9 | 133 | neuron migration |
GO:0048468 | 1e-04 | 1.9983 | 25.5052 | 45 | 1857 | cell development |
GO:0000122 | 1e-04 | 2.5374 | 10.3559 | 24 | 754 | negative regulation of transcription from RNA polymerase II promoter |
GO:0007517 | 1e-04 | 3.3559 | 4.8483 | 15 | 353 | muscle organ development |
GO:0051173 | 1e-04 | 1.8217 | 37.4132 | 59 | 2724 | positive regulation of nitrogen compound metabolic process |
GO:0014032 | 2e-04 | 8.34 | 0.8103 | 6 | 59 | neural crest cell development |
GO:0048645 | 2e-04 | 8.34 | 0.8103 | 6 | 59 | animal organ formation |
GO:0007368 | 2e-04 | 5.7038 | 1.5383 | 8 | 112 | determination of left/right symmetry |
GO:0010557 | 2e-04 | 2.0342 | 21.426 | 39 | 1560 | positive regulation of macromolecule biosynthetic process |
GO:0021953 | 2e-04 | 4.9904 | 1.9654 | 9 | 145 | central nervous system neuron differentiation |
GO:2000112 | 2e-04 | 1.7253 | 52.329 | 76 | 3810 | regulation of cellular macromolecule biosynthetic process |
GO:0060675 | 2e-04 | 8.185 | 0.8241 | 6 | 60 | ureteric bud morphogenesis |
GO:0048839 | 2e-04 | 4.4389 | 2.4448 | 10 | 178 | inner ear development |
GO:0016331 | 2e-04 | 4.9209 | 1.9915 | 9 | 145 | morphogenesis of embryonic epithelium |
GO:0060993 | 2e-04 | 6.5486 | 1.1812 | 7 | 86 | kidney morphogenesis |
GO:0021882 | 2e-04 | Inf | 0.0275 | 2 | 2 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment |
GO:0021893 | 2e-04 | Inf | 0.0275 | 2 | 2 | cerebral cortex GABAergic interneuron fate commitment |
GO:1902868 | 2e-04 | Inf | 0.0275 | 2 | 2 | positive regulation of retina development in camera-type eye |
GO:1902871 | 2e-04 | Inf | 0.0275 | 2 | 2 | positive regulation of amacrine cell differentiation |
GO:2001111 | 2e-04 | Inf | 0.0275 | 2 | 2 | positive regulation of lens epithelial cell proliferation |
GO:0001763 | 2e-04 | 4.2593 | 2.5409 | 10 | 185 | morphogenesis of a branching structure |
GO:0048704 | 3e-04 | 6.0839 | 1.2636 | 7 | 92 | embryonic skeletal system morphogenesis |
GO:0009799 | 3e-04 | 5.2 | 1.6756 | 8 | 122 | specification of symmetry |
GO:0001708 | 3e-04 | 9.7221 | 0.5855 | 5 | 44 | cell fate specification |
GO:0072164 | 3e-04 | 6.0128 | 1.2773 | 7 | 93 | mesonephric tubule development |
GO:0032502 | 3e-04 | 1.7141 | 56.8929 | 79 | 4581 | developmental process |
GO:0071310 | 3e-04 | 1.822 | 31.0265 | 50 | 2259 | cellular response to organic substance |
GO:0072359 | 4e-04 | 2.2457 | 12.6221 | 26 | 919 | circulatory system development |
GO:0060537 | 4e-04 | 3.0973 | 4.8621 | 14 | 354 | muscle tissue development |
GO:0060042 | 4e-04 | 8.9473 | 0.6318 | 5 | 46 | retina morphogenesis in camera-type eye |
GO:0008285 | 4e-04 | 2.4977 | 8.6528 | 20 | 630 | negative regulation of cell proliferation |
GO:0021766 | 5e-04 | 6.6914 | 0.9889 | 6 | 72 | hippocampus development |
GO:0061333 | 5e-04 | 6.5911 | 1.0026 | 6 | 73 | renal tubule morphogenesis |
GO:0060766 | 5e-04 | 24.2702 | 0.1648 | 3 | 12 | negative regulation of androgen receptor signaling pathway |
GO:0031323 | 6e-04 | 1.5891 | 77.7518 | 101 | 5661 | regulation of cellular metabolic process |
GO:0048762 | 7e-04 | 7.8458 | 0.7096 | 5 | 53 | mesenchymal cell differentiation |
GO:0007399 | 7e-04 | 2.4697 | 8.3742 | 19 | 679 | nervous system development |
GO:2000243 | 7e-04 | 7.8019 | 0.7142 | 5 | 52 | positive regulation of reproductive process |
GO:0048592 | 7e-04 | 4.4514 | 1.9366 | 8 | 141 | eye morphogenesis |
GO:0042475 | 9e-04 | 5.8849 | 1.1125 | 6 | 81 | odontogenesis of dentin-containing tooth |
GO:0061053 | 9e-04 | 5.8071 | 1.1262 | 6 | 82 | somite development |
GO:0045746 | 9e-04 | 10.439 | 0.4395 | 4 | 32 | negative regulation of Notch signaling pathway |
GO:2000026 | 9e-04 | 1.9579 | 17.9713 | 32 | 1385 | regulation of multicellular organismal development |
GO:0048857 | 9e-04 | 7.3324 | 0.7554 | 5 | 55 | neural nucleus development |
GO:0010605 | 0.001 | 1.7144 | 33.3614 | 51 | 2429 | negative regulation of macromolecule metabolic process |
GO:0070848 | 0.001 | 2.3725 | 8.5979 | 19 | 626 | response to growth factor |
GO:0001656 | 0.001 | 5.6574 | 1.1537 | 6 | 84 | metanephros development |
GO:0003308 | 0.0011 | 72.4928 | 0.0549 | 2 | 4 | negative regulation of Wnt signaling pathway involved in heart development |
GO:0042662 | 0.0011 | 72.4928 | 0.0549 | 2 | 4 | negative regulation of mesodermal cell fate specification |
GO:0042663 | 0.0011 | 72.4928 | 0.0549 | 2 | 4 | regulation of endodermal cell fate specification |
GO:0048866 | 0.0011 | 72.4928 | 0.0549 | 2 | 4 | stem cell fate specification |
GO:0060729 | 0.0011 | 72.4928 | 0.0549 | 2 | 4 | intestinal epithelial structure maintenance |
GO:0097476 | 0.0011 | 72.4928 | 0.0549 | 2 | 4 | spinal cord motor neuron migration |
GO:1902412 | 0.0011 | 72.4928 | 0.0549 | 2 | 4 | regulation of mitotic cytokinesis |
GO:1902746 | 0.0011 | 72.4928 | 0.0549 | 2 | 4 | regulation of lens fiber cell differentiation |
GO:1905903 | 0.0011 | 72.4928 | 0.0549 | 2 | 4 | negative regulation of mesoderm formation |
GO:0009887 | 0.0012 | 3.0342 | 4.2367 | 12 | 344 | animal organ morphogenesis |
GO:0051937 | 0.0012 | 6.9159 | 0.7966 | 5 | 58 | catecholamine transport |
GO:0001711 | 0.0013 | 16.798 | 0.2198 | 3 | 16 | endodermal cell fate commitment |
GO:0072175 | 0.0013 | 4.6116 | 1.6332 | 7 | 120 | epithelial tube formation |
GO:0051962 | 0.0013 | 2.6151 | 6.1256 | 15 | 446 | positive regulation of nervous system development |
GO:0072080 | 0.0013 | 5.38 | 1.2086 | 6 | 88 | nephron tubule development |
GO:0071542 | 0.0014 | 9.1317 | 0.4944 | 4 | 36 | dopaminergic neuron differentiation |
GO:0007420 | 0.0015 | 2.4224 | 7.5086 | 17 | 557 | brain development |
GO:0042053 | 0.0015 | 15.5971 | 0.2335 | 3 | 17 | regulation of dopamine metabolic process |
GO:0048486 | 0.0015 | 15.5971 | 0.2335 | 3 | 17 | parasympathetic nervous system development |
GO:0090190 | 0.0015 | 15.5971 | 0.2335 | 3 | 17 | positive regulation of branching involved in ureteric bud morphogenesis |
GO:0048608 | 0.0016 | 3.5713 | 2.6896 | 9 | 201 | reproductive structure development |
GO:0050789 | 0.0016 | 1.6031 | 136.797 | 157 | 9960 | regulation of biological process |
GO:0045744 | 0.0016 | 8.8544 | 0.5082 | 4 | 37 | negative regulation of G-protein coupled receptor protein signaling pathway |
GO:0009953 | 0.0017 | 5.1284 | 1.2636 | 6 | 92 | dorsal/ventral pattern formation |
GO:1901576 | 0.0017 | 1.5219 | 80.7871 | 102 | 5882 | organic substance biosynthetic process |
GO:0001759 | 0.0018 | 14.5563 | 0.2472 | 3 | 18 | organ induction |
GO:0072077 | 0.0018 | 14.5563 | 0.2472 | 3 | 18 | renal vesicle morphogenesis |
GO:0060023 | 0.0018 | 48.3253 | 0.0687 | 2 | 5 | soft palate development |
GO:0061009 | 0.0018 | 48.3253 | 0.0687 | 2 | 5 | common bile duct development |
GO:0002088 | 0.0018 | 6.2101 | 0.879 | 5 | 64 | lens development in camera-type eye |
GO:0048565 | 0.0019 | 4.2993 | 1.7443 | 7 | 127 | digestive tract development |
GO:0044344 | 0.0019 | 4.2635 | 1.758 | 7 | 128 | cellular response to fibroblast growth factor stimulus |
GO:0001837 | 0.002 | 4.2283 | 1.7718 | 7 | 129 | epithelial to mesenchymal transition |
GO:0001502 | 0.0021 | 13.6456 | 0.261 | 3 | 19 | cartilage condensation |
GO:0003215 | 0.0021 | 13.6456 | 0.261 | 3 | 19 | cardiac right ventricle morphogenesis |
GO:0021895 | 0.0021 | 13.6456 | 0.261 | 3 | 19 | cerebral cortex neuron differentiation |
GO:0023019 | 0.0021 | 13.6456 | 0.261 | 3 | 19 | signal transduction involved in regulation of gene expression |
GO:0048557 | 0.0021 | 13.6456 | 0.261 | 3 | 19 | embryonic digestive tract morphogenesis |
GO:0072079 | 0.0021 | 13.6456 | 0.261 | 3 | 19 | nephron tubule formation |
GO:0014014 | 0.0021 | 8.1149 | 0.5494 | 4 | 40 | negative regulation of gliogenesis |
GO:0072006 | 0.0024 | 4.093 | 1.8267 | 7 | 133 | nephron development |
GO:1902532 | 0.0025 | 2.4344 | 6.5514 | 15 | 477 | negative regulation of intracellular signal transduction |
GO:0000003 | 0.0025 | 1.8544 | 17.4979 | 30 | 1274 | reproduction |
GO:0072073 | 0.0025 | 4.0605 | 1.8404 | 7 | 134 | kidney epithelium development |
GO:0033603 | 0.0027 | 36.2415 | 0.0824 | 2 | 6 | positive regulation of dopamine secretion |
GO:0035502 | 0.0027 | 36.2415 | 0.0824 | 2 | 6 | metanephric part of ureteric bud development |
GO:0060022 | 0.0027 | 36.2415 | 0.0824 | 2 | 6 | hard palate development |
GO:0061074 | 0.0027 | 36.2415 | 0.0824 | 2 | 6 | regulation of neural retina development |
GO:2000138 | 0.0027 | 36.2415 | 0.0824 | 2 | 6 | positive regulation of cell proliferation involved in heart morphogenesis |
GO:0021517 | 0.0028 | 7.4892 | 0.5906 | 4 | 43 | ventral spinal cord development |
GO:0050433 | 0.0028 | 7.4892 | 0.5906 | 4 | 43 | regulation of catecholamine secretion |
GO:0021516 | 0.0028 | 12.1278 | 0.2884 | 3 | 21 | dorsal spinal cord development |
GO:0048485 | 0.0028 | 12.1278 | 0.2884 | 3 | 21 | sympathetic nervous system development |
GO:0033993 | 0.0029 | 2.0356 | 11.5646 | 22 | 842 | response to lipid |
GO:0042310 | 0.0029 | 5.5489 | 0.9752 | 5 | 71 | vasoconstriction |
GO:0043010 | 0.0031 | 3.2091 | 2.9747 | 9 | 222 | camera-type eye development |
GO:0048646 | 0.0032 | 2.0155 | 11.6966 | 22 | 890 | anatomical structure formation involved in morphogenesis |
GO:0051241 | 0.0033 | 1.9783 | 12.4592 | 23 | 931 | negative regulation of multicellular organismal process |
GO:0048754 | 0.0033 | 3.8465 | 1.9366 | 7 | 141 | branching morphogenesis of an epithelial tube |
GO:0007275 | 0.0034 | 1.7055 | 28.0856 | 42 | 2483 | multicellular organism development |
GO:0051101 | 0.0034 | 4.4063 | 1.4559 | 6 | 106 | regulation of DNA binding |
GO:0003151 | 0.0035 | 5.3066 | 1.0164 | 5 | 74 | outflow tract morphogenesis |
GO:0060562 | 0.0036 | 6.9364 | 0.6318 | 4 | 48 | epithelial tube morphogenesis |
GO:0042481 | 0.0037 | 10.9136 | 0.3159 | 3 | 23 | regulation of odontogenesis |
GO:0090103 | 0.0037 | 10.9136 | 0.3159 | 3 | 23 | cochlea morphogenesis |
GO:0061448 | 0.0037 | 3.1109 | 3.0628 | 9 | 223 | connective tissue development |
GO:0001826 | 0.0038 | 28.9913 | 0.0961 | 2 | 7 | inner cell mass cell differentiation |
GO:0002645 | 0.0038 | 28.9913 | 0.0961 | 2 | 7 | positive regulation of tolerance induction |
GO:0002692 | 0.0038 | 28.9913 | 0.0961 | 2 | 7 | negative regulation of cellular extravasation |
GO:0003357 | 0.0038 | 28.9913 | 0.0961 | 2 | 7 | noradrenergic neuron differentiation |
GO:2000096 | 0.0038 | 28.9913 | 0.0961 | 2 | 7 | positive regulation of Wnt signaling pathway, planar cell polarity pathway |
GO:0042221 | 0.0038 | 1.5177 | 50.6396 | 68 | 3687 | response to chemical |
GO:0045165 | 0.0039 | 3.7319 | 1.9919 | 7 | 153 | cell fate commitment |
GO:0000188 | 0.0042 | 10.3932 | 0.3296 | 3 | 24 | inactivation of MAPK activity |
GO:0061037 | 0.0042 | 10.3932 | 0.3296 | 3 | 24 | negative regulation of cartilage development |
GO:0061217 | 0.0042 | 10.3932 | 0.3296 | 3 | 24 | regulation of mesonephros development |
GO:0042220 | 0.0042 | 6.6359 | 0.6593 | 4 | 48 | response to cocaine |
GO:0007626 | 0.0042 | 3.316 | 2.5546 | 8 | 186 | locomotory behavior |
GO:0007519 | 0.0044 | 3.6539 | 2.0327 | 7 | 148 | skeletal muscle tissue development |
GO:0045992 | 0.0047 | 9.9201 | 0.3434 | 3 | 25 | negative regulation of embryonic development |
GO:0072273 | 0.0047 | 9.9201 | 0.3434 | 3 | 25 | metanephric nephron morphogenesis |
GO:0060541 | 0.0048 | 3.2423 | 2.6096 | 8 | 190 | respiratory system development |
GO:0030916 | 0.005 | 24.1578 | 0.1099 | 2 | 8 | otic vesicle formation |
GO:0033085 | 0.005 | 24.1578 | 0.1099 | 2 | 8 | negative regulation of T cell differentiation in thymus |
GO:0051584 | 0.005 | 24.1578 | 0.1099 | 2 | 8 | regulation of dopamine uptake involved in synaptic transmission |
GO:0060052 | 0.005 | 24.1578 | 0.1099 | 2 | 8 | neurofilament cytoskeleton organization |
GO:0097084 | 0.005 | 24.1578 | 0.1099 | 2 | 8 | vascular smooth muscle cell development |
GO:1902669 | 0.005 | 24.1578 | 0.1099 | 2 | 8 | positive regulation of axon guidance |
GO:1905770 | 0.005 | 24.1578 | 0.1099 | 2 | 8 | regulation of mesodermal cell differentiation |
GO:2000698 | 0.005 | 24.1578 | 0.1099 | 2 | 8 | positive regulation of epithelial cell differentiation involved in kidney development |
GO:0009719 | 0.005 | 1.7435 | 19.1461 | 31 | 1394 | response to endogenous stimulus |
GO:0009798 | 0.0051 | 4.8155 | 1.1125 | 5 | 81 | axis specification |
GO:0021515 | 0.0052 | 6.2111 | 0.7005 | 4 | 51 | cell differentiation in spinal cord |
GO:0060425 | 0.0052 | 6.2111 | 0.7005 | 4 | 51 | lung morphogenesis |
GO:0061005 | 0.0052 | 6.2111 | 0.7005 | 4 | 51 | cell differentiation involved in kidney development |
GO:0003007 | 0.0052 | 3.5271 | 2.1016 | 7 | 156 | heart morphogenesis |
GO:0021884 | 0.0053 | 9.4882 | 0.3571 | 3 | 26 | forebrain neuron development |
GO:0048870 | 0.0053 | 1.751 | 18.4182 | 30 | 1341 | cell motility |
GO:0032231 | 0.0054 | 4.7527 | 1.1262 | 5 | 82 | regulation of actin filament bundle assembly |
GO:0009966 | 0.0055 | 1.5385 | 38.8004 | 54 | 2825 | regulation of signal transduction |
GO:0008406 | 0.0057 | 3.1375 | 2.692 | 8 | 196 | gonad development |
GO:0007498 | 0.0058 | 3.931 | 1.6207 | 6 | 118 | mesoderm development |
GO:0060706 | 0.0059 | 9.0922 | 0.3708 | 3 | 27 | cell differentiation involved in embryonic placenta development |
GO:0061311 | 0.0059 | 9.0922 | 0.3708 | 3 | 27 | cell surface receptor signaling pathway involved in heart development |
GO:0030901 | 0.006 | 4.6317 | 1.1537 | 5 | 84 | midbrain development |
GO:0071773 | 0.006 | 3.4325 | 2.1563 | 7 | 157 | cellular response to BMP stimulus |
GO:0045596 | 0.0062 | 2.193 | 7.2309 | 15 | 537 | negative regulation of cell differentiation |
GO:0007050 | 0.0062 | 2.866 | 3.31 | 9 | 241 | cell cycle arrest |
GO:0016202 | 0.0062 | 3.8616 | 1.6482 | 6 | 120 | regulation of striated muscle tissue development |
GO:0071901 | 0.0062 | 3.8616 | 1.6482 | 6 | 120 | negative regulation of protein serine/threonine kinase activity |
GO:0070472 | 0.0063 | 20.7053 | 0.1236 | 2 | 9 | regulation of uterine smooth muscle contraction |
GO:0070561 | 0.0063 | 20.7053 | 0.1236 | 2 | 9 | vitamin D receptor signaling pathway |
GO:1901203 | 0.0063 | 20.7053 | 0.1236 | 2 | 9 | positive regulation of extracellular matrix assembly |
GO:2000543 | 0.0063 | 20.7053 | 0.1236 | 2 | 9 | positive regulation of gastrulation |
GO:0048522 | 0.0064 | 1.5137 | 46.6085 | 62 | 3743 | positive regulation of cellular process |
GO:0097746 | 0.0068 | 3.7945 | 1.6756 | 6 | 122 | regulation of blood vessel diameter |
GO:0048863 | 0.007 | 2.8046 | 3.3787 | 9 | 246 | stem cell differentiation |
GO:0035270 | 0.007 | 3.7618 | 1.6894 | 6 | 123 | endocrine system development |
GO:0007548 | 0.0072 | 2.7926 | 3.3925 | 9 | 247 | sex differentiation |
GO:0030217 | 0.0073 | 3.0078 | 2.8019 | 8 | 204 | T cell differentiation |
GO:0003002 | 0.0075 | 5.5582 | 0.7743 | 4 | 60 | regionalization |
GO:0010470 | 0.0077 | 8.1558 | 0.4083 | 3 | 30 | regulation of gastrulation |
GO:0030856 | 0.0078 | 3.6721 | 1.7281 | 6 | 127 | regulation of epithelial cell differentiation |
GO:0000050 | 0.0079 | 18.1159 | 0.1373 | 2 | 10 | urea cycle |
GO:0003211 | 0.0079 | 18.1159 | 0.1373 | 2 | 10 | cardiac ventricle formation |
GO:0021877 | 0.0079 | 18.1159 | 0.1373 | 2 | 10 | forebrain neuron fate commitment |
GO:0030432 | 0.0079 | 18.1159 | 0.1373 | 2 | 10 | peristalsis |
GO:0033623 | 0.0079 | 18.1159 | 0.1373 | 2 | 10 | regulation of integrin activation |
GO:0048715 | 0.0079 | 18.1159 | 0.1373 | 2 | 10 | negative regulation of oligodendrocyte differentiation |
GO:0060174 | 0.0079 | 18.1159 | 0.1373 | 2 | 10 | limb bud formation |
GO:0060767 | 0.0079 | 18.1159 | 0.1373 | 2 | 10 | epithelial cell proliferation involved in prostate gland development |
GO:0001892 | 0.0079 | 5.4749 | 0.7866 | 4 | 58 | embryonic placenta development |
GO:0045664 | 0.0081 | 2.1204 | 7.4579 | 15 | 543 | regulation of neuron differentiation |
GO:0051240 | 0.0085 | 1.8711 | 11.9586 | 21 | 943 | positive regulation of multicellular organismal process |
GO:2000027 | 0.0086 | 2.9136 | 2.8879 | 8 | 213 | regulation of organ morphogenesis |
GO:0051954 | 0.0086 | 7.7913 | 0.4258 | 3 | 31 | positive regulation of amine transport |
GO:0001933 | 0.0087 | 2.3198 | 5.4389 | 12 | 396 | negative regulation of protein phosphorylation |
GO:0051148 | 0.0087 | 5.3048 | 0.8103 | 4 | 59 | negative regulation of muscle cell differentiation |
GO:0033673 | 0.0088 | 2.7004 | 3.5023 | 9 | 255 | negative regulation of kinase activity |
GO:0030534 | 0.0088 | 3.5768 | 1.7718 | 6 | 129 | adult behavior |
GO:0061572 | 0.0088 | 3.5768 | 1.7718 | 6 | 129 | actin filament bundle organization |
GO:0045936 | 0.0091 | 2.0917 | 7.5541 | 15 | 550 | negative regulation of phosphate metabolic process |
GO:0035150 | 0.0091 | 3.5478 | 1.7855 | 6 | 130 | regulation of tube size |
GO:0001655 | 0.0092 | 2.5237 | 4.1616 | 10 | 303 | urogenital system development |
GO:0050672 | 0.0093 | 5.2098 | 0.8241 | 4 | 60 | negative regulation of lymphocyte proliferation |
GO:0045892 | 0.0093 | 2.5248 | 4.17 | 10 | 326 | negative regulation of transcription, DNA-templated |
GO:0000165 | 0.0094 | 1.8744 | 11.2899 | 20 | 822 | MAPK cascade |
GO:0002087 | 0.0095 | 16.102 | 0.1511 | 2 | 11 | regulation of respiratory gaseous exchange by neurological system process |
GO:0003128 | 0.0095 | 16.102 | 0.1511 | 2 | 11 | heart field specification |
GO:0003413 | 0.0095 | 16.102 | 0.1511 | 2 | 11 | chondrocyte differentiation involved in endochondral bone morphogenesis |
GO:0010454 | 0.0095 | 16.102 | 0.1511 | 2 | 11 | negative regulation of cell fate commitment |
GO:0021903 | 0.0095 | 16.102 | 0.1511 | 2 | 11 | rostrocaudal neural tube patterning |
GO:0048484 | 0.0095 | 16.102 | 0.1511 | 2 | 11 | enteric nervous system development |
GO:0090009 | 0.0095 | 16.102 | 0.1511 | 2 | 11 | primitive streak formation |
GO:2000047 | 0.0095 | 16.102 | 0.1511 | 2 | 11 | regulation of cell-cell adhesion mediated by cadherin |
GO:0030804 | 0.0095 | 4.1086 | 1.2911 | 5 | 94 | positive regulation of cyclic nucleotide biosynthetic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 28.9556 | 0.3484 | 8 | 57 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009913 | 0 | 8.2842 | 1.5401 | 11 | 252 | epidermal cell differentiation |
GO:0009593 | 0 | 13.0858 | 0.7089 | 8 | 116 | detection of chemical stimulus |
GO:0050906 | 0 | 11.6698 | 0.7884 | 8 | 129 | detection of stimulus involved in sensory perception |
GO:0007606 | 0 | 11.3852 | 0.8067 | 8 | 132 | sensory perception of chemical stimulus |
GO:0070268 | 0 | 14.0683 | 0.5745 | 7 | 94 | cornification |
GO:0043588 | 0 | 6.6062 | 1.9068 | 11 | 312 | skin development |
GO:0007186 | 0 | 3.6107 | 5.1276 | 16 | 839 | G-protein coupled receptor signaling pathway |
GO:0031424 | 1e-04 | 18.7592 | 0.2445 | 4 | 43 | keratinization |
GO:0003095 | 1e-04 | 332.3736 | 0.0183 | 2 | 3 | pressure natriuresis |
GO:0061760 | 1e-04 | 332.3736 | 0.0183 | 2 | 3 | antifungal innate immune response |
GO:0036101 | 2e-04 | 166.1758 | 0.0244 | 2 | 4 | leukotriene B4 catabolic process |
GO:0019373 | 3e-04 | 27.9741 | 0.1283 | 3 | 21 | epoxygenase P450 pathway |
GO:0030825 | 3e-04 | 27.9741 | 0.1283 | 3 | 21 | positive regulation of cGMP metabolic process |
GO:0030826 | 3e-04 | 26.5 | 0.1345 | 3 | 22 | regulation of cGMP biosynthetic process |
GO:1901523 | 4e-04 | 110.7766 | 0.0306 | 2 | 5 | icosanoid catabolic process |
GO:0050877 | 7e-04 | 2.9797 | 5.2743 | 14 | 863 | nervous system process |
GO:0032501 | 9e-04 | 2.0452 | 33.5667 | 48 | 6173 | multicellular organismal process |
GO:0031103 | 0.0017 | 13.9704 | 0.2384 | 3 | 39 | axon regeneration |
GO:0031284 | 0.002 | 36.9109 | 0.0672 | 2 | 11 | positive regulation of guanylate cyclase activity |
GO:0001676 | 0.0023 | 7.768 | 0.5562 | 4 | 91 | long-chain fatty acid metabolic process |
GO:0033559 | 0.0026 | 7.5076 | 0.5745 | 4 | 94 | unsaturated fatty acid metabolic process |
GO:0060429 | 0.0027 | 2.4858 | 6.7289 | 15 | 1101 | epithelium development |
GO:0032645 | 0.0032 | 27.6777 | 0.0856 | 2 | 14 | regulation of granulocyte macrophage colony-stimulating factor production |
GO:1900017 | 0.0032 | 27.6777 | 0.0856 | 2 | 14 | positive regulation of cytokine production involved in inflammatory response |
GO:0031099 | 0.0036 | 5.2476 | 1.0206 | 5 | 167 | regeneration |
GO:0006544 | 0.0037 | 25.5469 | 0.0917 | 2 | 15 | glycine metabolic process |
GO:0051101 | 0.004 | 6.6191 | 0.6478 | 4 | 106 | regulation of DNA binding |
GO:0070098 | 0.0051 | 9.3025 | 0.3484 | 3 | 57 | chemokine-mediated signaling pathway |
GO:2000678 | 0.0053 | 20.7527 | 0.11 | 2 | 18 | negative regulation of transcription regulatory region DNA binding |
GO:0043496 | 0.0059 | 19.5307 | 0.1161 | 2 | 19 | regulation of protein homodimerization activity |
GO:0002152 | 0.0061 | Inf | 0.0061 | 1 | 1 | bile acid conjugation |
GO:0019408 | 0.0061 | Inf | 0.0061 | 1 | 1 | dolichol biosynthetic process |
GO:0048264 | 0.0061 | Inf | 0.0061 | 1 | 1 | determination of ventral identity |
GO:0072616 | 0.0061 | Inf | 0.0061 | 1 | 1 | interleukin-18 secretion |
GO:1902867 | 0.0061 | Inf | 0.0061 | 1 | 1 | negative regulation of retina development in camera-type eye |
GO:1902870 | 0.0061 | Inf | 0.0061 | 1 | 1 | negative regulation of amacrine cell differentiation |
GO:1903965 | 0.0061 | Inf | 0.0061 | 1 | 1 | monounsaturated fatty acid catabolic process |
GO:0050829 | 0.0067 | 8.3689 | 0.385 | 3 | 63 | defense response to Gram-negative bacterium |
GO:0031290 | 0.0072 | 17.4725 | 0.1283 | 2 | 21 | retinal ganglion cell axon guidance |
GO:0001837 | 0.0081 | 5.3929 | 0.7884 | 4 | 129 | epithelial to mesenchymal transition |
GO:0006501 | 0.0083 | 7.7226 | 0.4156 | 3 | 68 | C-terminal protein lipidation |
GO:0030593 | 0.0083 | 7.7226 | 0.4156 | 3 | 68 | neutrophil chemotaxis |
GO:0003071 | 0.0086 | 15.8064 | 0.1406 | 2 | 23 | renal system process involved in regulation of systemic arterial blood pressure |
GO:0035902 | 0.0086 | 15.8064 | 0.1406 | 2 | 23 | response to immobilization stress |
GO:0010469 | 0.0098 | 2.8776 | 2.9763 | 8 | 487 | regulation of receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0022404 | 0 | 10.5371 | 0.989 | 9 | 86 | molting cycle process |
GO:0006355 | 0 | 2.2006 | 38.8135 | 67 | 3375 | regulation of transcription, DNA-templated |
GO:0007389 | 0 | 4.3301 | 4.6691 | 18 | 406 | pattern specification process |
GO:0043009 | 0 | 3.7931 | 6.2447 | 21 | 543 | chordate embryonic development |
GO:2001141 | 0 | 2.1786 | 39.1125 | 67 | 3401 | regulation of RNA biosynthetic process |
GO:0048731 | 0 | 2.1136 | 47.1982 | 76 | 4171 | system development |
GO:0009952 | 0 | 6.0109 | 2.2311 | 12 | 194 | anterior/posterior pattern specification |
GO:0042633 | 0 | 8.6216 | 1.1845 | 9 | 103 | hair cycle |
GO:0010628 | 0 | 2.4632 | 19.585 | 41 | 1703 | positive regulation of gene expression |
GO:0019219 | 0 | 2.025 | 45.2192 | 72 | 3932 | regulation of nucleobase-containing compound metabolic process |
GO:0060322 | 0 | 3.1583 | 7.7857 | 22 | 677 | head development |
GO:0048646 | 0 | 2.7431 | 11.0978 | 27 | 965 | anatomical structure formation involved in morphogenesis |
GO:0043588 | 0 | 4.3023 | 3.5881 | 14 | 312 | skin development |
GO:1903508 | 0 | 2.4381 | 15.4334 | 33 | 1342 | positive regulation of nucleic acid-templated transcription |
GO:0045944 | 0 | 2.6295 | 12.0063 | 28 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
GO:0009888 | 0 | 2.476 | 14.849 | 32 | 1371 | tissue development |
GO:0051254 | 0 | 2.393 | 16.2269 | 34 | 1411 | positive regulation of RNA metabolic process |
GO:0048704 | 0 | 8.6411 | 0.9102 | 7 | 80 | embryonic skeletal system morphogenesis |
GO:2001012 | 1e-04 | 65.5727 | 0.0805 | 3 | 7 | mesenchymal cell differentiation involved in renal system development |
GO:0030900 | 1e-04 | 3.8059 | 4.0251 | 14 | 350 | forebrain development |
GO:0008544 | 1e-04 | 3.7829 | 4.0481 | 14 | 352 | epidermis development |
GO:0060231 | 1e-04 | 23.4339 | 0.2185 | 4 | 19 | mesenchymal to epithelial transition |
GO:0009887 | 1e-04 | 2.6475 | 10.0913 | 24 | 895 | animal organ morphogenesis |
GO:0009889 | 1e-04 | 2.0591 | 28.2309 | 48 | 2632 | regulation of biosynthetic process |
GO:0021544 | 1e-04 | 21.9678 | 0.23 | 4 | 20 | subpallium development |
GO:0031328 | 1e-04 | 2.1746 | 19.4125 | 37 | 1688 | positive regulation of cellular biosynthetic process |
GO:0034654 | 1e-04 | 1.8482 | 45.8517 | 69 | 3987 | nucleobase-containing compound biosynthetic process |
GO:0001964 | 1e-04 | 18.4955 | 0.2645 | 4 | 23 | startle response |
GO:0048663 | 1e-04 | 8.578 | 0.782 | 6 | 68 | neuron fate commitment |
GO:0048736 | 2e-04 | 5.0112 | 1.9551 | 9 | 170 | appendage development |
GO:0051216 | 2e-04 | 4.9799 | 1.9666 | 9 | 171 | cartilage development |
GO:0007416 | 2e-04 | 5.6259 | 1.5525 | 8 | 135 | synapse assembly |
GO:0031069 | 2e-04 | 16.7318 | 0.2875 | 4 | 25 | hair follicle morphogenesis |
GO:0010557 | 2e-04 | 2.1358 | 17.9405 | 34 | 1560 | positive regulation of macromolecule biosynthetic process |
GO:0048598 | 2e-04 | 3.6927 | 3.5266 | 12 | 322 | embryonic morphogenesis |
GO:0048468 | 3e-04 | 2.0272 | 20.6717 | 37 | 1825 | cell development |
GO:0021515 | 3e-04 | 9.5882 | 0.5865 | 5 | 51 | cell differentiation in spinal cord |
GO:0014707 | 4e-04 | 173.8844 | 0.0345 | 2 | 3 | branchiomeric skeletal muscle development |
GO:0021558 | 4e-04 | 173.8844 | 0.0345 | 2 | 3 | trochlear nerve development |
GO:0060435 | 4e-04 | 173.8844 | 0.0345 | 2 | 3 | bronchiole development |
GO:0001942 | 5e-04 | 8.3484 | 0.6641 | 5 | 59 | hair follicle development |
GO:0035113 | 6e-04 | 5.2251 | 1.449 | 7 | 126 | embryonic appendage morphogenesis |
GO:0009953 | 7e-04 | 6.1742 | 1.058 | 6 | 92 | dorsal/ventral pattern formation |
GO:0021557 | 8e-04 | 86.9364 | 0.046 | 2 | 4 | oculomotor nerve development |
GO:0002009 | 8e-04 | 3.9665 | 2.4393 | 9 | 225 | morphogenesis of an epithelium |
GO:1904888 | 8e-04 | 7.4691 | 0.736 | 5 | 64 | cranial skeletal system development |
GO:0048568 | 9e-04 | 2.9834 | 4.6806 | 13 | 407 | embryonic organ development |
GO:0048486 | 9e-04 | 18.7226 | 0.1955 | 3 | 17 | parasympathetic nervous system development |
GO:0072074 | 0.0011 | 17.4733 | 0.207 | 3 | 18 | kidney mesenchyme development |
GO:0051253 | 0.0011 | 2.0863 | 13.6509 | 26 | 1187 | negative regulation of RNA metabolic process |
GO:1901576 | 0.0011 | 1.6145 | 67.6447 | 88 | 5882 | organic substance biosynthetic process |
GO:0021879 | 0.0012 | 16.7411 | 0.2139 | 3 | 19 | forebrain neuron differentiation |
GO:0051952 | 0.0013 | 6.7769 | 0.805 | 5 | 70 | regulation of amine transport |
GO:0035482 | 0.0013 | 57.9538 | 0.0575 | 2 | 5 | gastric motility |
GO:0072162 | 0.0013 | 57.9538 | 0.0575 | 2 | 5 | metanephric mesenchymal cell differentiation |
GO:0045843 | 0.0013 | 9.2361 | 0.483 | 4 | 42 | negative regulation of striated muscle tissue development |
GO:0042127 | 0.0014 | 1.9528 | 16.9169 | 30 | 1471 | regulation of cell proliferation |
GO:0016331 | 0.0014 | 4.5 | 1.6675 | 7 | 145 | morphogenesis of embryonic epithelium |
GO:0035108 | 0.0014 | 4.5 | 1.6675 | 7 | 145 | limb morphogenesis |
GO:0021517 | 0.0015 | 8.9987 | 0.4945 | 4 | 43 | ventral spinal cord development |
GO:0007186 | 0.0016 | 2.2408 | 9.6487 | 20 | 839 | G-protein coupled receptor signaling pathway |
GO:0001708 | 0.0016 | 6.3639 | 0.853 | 5 | 75 | cell fate specification |
GO:0010629 | 0.0017 | 1.8696 | 19.5045 | 33 | 1696 | negative regulation of gene expression |
GO:0035239 | 0.0017 | 3.0565 | 3.8411 | 11 | 334 | tube morphogenesis |
GO:0007617 | 0.0017 | 14.5581 | 0.2415 | 3 | 21 | mating behavior |
GO:0035176 | 0.0017 | 8.5586 | 0.5175 | 4 | 45 | social behavior |
GO:0007156 | 0.0019 | 4.2807 | 1.748 | 7 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0009996 | 0.0019 | 43.4624 | 0.069 | 2 | 6 | negative regulation of cell fate specification |
GO:0045617 | 0.0019 | 43.4624 | 0.069 | 2 | 6 | negative regulation of keratinocyte differentiation |
GO:0046958 | 0.0019 | 43.4624 | 0.069 | 2 | 6 | nonassociative learning |
GO:0060022 | 0.0019 | 43.4624 | 0.069 | 2 | 6 | hard palate development |
GO:0060255 | 0.0021 | 1.5692 | 64.1026 | 83 | 5574 | regulation of macromolecule metabolic process |
GO:1903507 | 0.0021 | 2.0344 | 12.8113 | 24 | 1114 | negative regulation of nucleic acid-templated transcription |
GO:0030878 | 0.0025 | 12.4759 | 0.276 | 3 | 24 | thyroid gland development |
GO:2000542 | 0.0027 | 34.7676 | 0.0805 | 2 | 7 | negative regulation of gastrulation |
GO:0051966 | 0.0028 | 7.463 | 0.5865 | 4 | 51 | regulation of synaptic transmission, glutamatergic |
GO:0060425 | 0.0028 | 7.463 | 0.5865 | 4 | 51 | lung morphogenesis |
GO:0090304 | 0.0028 | 1.5612 | 55.2129 | 73 | 4801 | nucleic acid metabolic process |
GO:0030901 | 0.0028 | 5.5707 | 0.966 | 5 | 84 | midbrain development |
GO:0001843 | 0.003 | 5.5007 | 0.9775 | 5 | 85 | neural tube closure |
GO:0003016 | 0.0032 | 11.3895 | 0.299 | 3 | 26 | respiratory system process |
GO:0021884 | 0.0032 | 11.3895 | 0.299 | 3 | 26 | forebrain neuron development |
GO:0048522 | 0.0033 | 1.5544 | 52.7289 | 70 | 4585 | positive regulation of cellular process |
GO:0007405 | 0.0034 | 7.0138 | 0.621 | 4 | 54 | neuroblast proliferation |
GO:0060638 | 0.0035 | 28.9711 | 0.092 | 2 | 8 | mesenchymal-epithelial cell signaling |
GO:0021602 | 0.0036 | 10.9142 | 0.3105 | 3 | 27 | cranial nerve morphogenesis |
GO:0045923 | 0.0036 | 10.9142 | 0.3105 | 3 | 27 | positive regulation of fatty acid metabolic process |
GO:0072175 | 0.0036 | 4.3418 | 1.472 | 6 | 128 | epithelial tube formation |
GO:0030278 | 0.0036 | 3.78 | 1.9666 | 7 | 171 | regulation of ossification |
GO:0007267 | 0.0038 | 1.8473 | 16.5049 | 28 | 1451 | cell-cell signaling |
GO:0061138 | 0.0039 | 3.7339 | 1.9896 | 7 | 173 | morphogenesis of a branching epithelium |
GO:0035116 | 0.004 | 10.477 | 0.322 | 3 | 28 | embryonic hindlimb morphogenesis |
GO:0070098 | 0.0042 | 6.6155 | 0.6555 | 4 | 57 | chemokine-mediated signaling pathway |
GO:0007043 | 0.0042 | 5.0558 | 1.058 | 5 | 92 | cell-cell junction assembly |
GO:0032501 | 0.0043 | 1.5694 | 57.8512 | 74 | 5780 | multicellular organismal process |
GO:2000026 | 0.0043 | 1.7609 | 19.8725 | 32 | 1728 | regulation of multicellular organismal development |
GO:0051928 | 0.0044 | 4.998 | 1.0695 | 5 | 93 | positive regulation of calcium ion transport |
GO:0001764 | 0.0044 | 4.1695 | 1.5295 | 6 | 133 | neuron migration |
GO:0021772 | 0.0044 | 10.0733 | 0.3335 | 3 | 29 | olfactory bulb development |
GO:0042755 | 0.0044 | 10.0733 | 0.3335 | 3 | 29 | eating behavior |
GO:0021892 | 0.0045 | 24.8307 | 0.1035 | 2 | 9 | cerebral cortex GABAergic interneuron differentiation |
GO:0072239 | 0.0045 | 24.8307 | 0.1035 | 2 | 9 | metanephric glomerulus vasculature development |
GO:2000543 | 0.0045 | 24.8307 | 0.1035 | 2 | 9 | positive regulation of gastrulation |
GO:0034645 | 0.0046 | 1.6149 | 36.4712 | 51 | 3395 | cellular macromolecule biosynthetic process |
GO:0030855 | 0.0048 | 2.3395 | 6.3695 | 14 | 575 | epithelial cell differentiation |
GO:0032502 | 0.005 | 1.979 | 13.235 | 23 | 1510 | developmental process |
GO:0046888 | 0.0053 | 6.1496 | 0.7015 | 4 | 61 | negative regulation of hormone secretion |
GO:0009954 | 0.0053 | 9.3526 | 0.3565 | 3 | 31 | proximal/distal pattern formation |
GO:0048713 | 0.0053 | 9.3526 | 0.3565 | 3 | 31 | regulation of oligodendrocyte differentiation |
GO:0022008 | 0.0055 | 1.8075 | 16.1694 | 27 | 1406 | neurogenesis |
GO:0050966 | 0.0056 | 21.7254 | 0.115 | 2 | 10 | detection of mechanical stimulus involved in sensory perception of pain |
GO:0007626 | 0.0058 | 3.4597 | 2.1391 | 7 | 186 | locomotory behavior |
GO:0098751 | 0.0058 | 9.0295 | 0.368 | 3 | 32 | bone cell development |
GO:0001841 | 0.0059 | 4.6276 | 1.15 | 5 | 100 | neural tube formation |
GO:0042733 | 0.0059 | 5.9403 | 0.7245 | 4 | 63 | embryonic digit morphogenesis |
GO:0051173 | 0.006 | 1.5974 | 31.3268 | 45 | 2724 | positive regulation of nitrogen compound metabolic process |
GO:0000122 | 0.0062 | 2.0884 | 8.6712 | 17 | 754 | negative regulation of transcription from RNA polymerase II promoter |
GO:0001662 | 0.0063 | 8.7279 | 0.3795 | 3 | 33 | behavioral fear response |
GO:0038111 | 0.0063 | 8.7279 | 0.3795 | 3 | 33 | interleukin-7-mediated signaling pathway |
GO:0048333 | 0.0063 | 8.7279 | 0.3795 | 3 | 33 | mesodermal cell differentiation |
GO:0098760 | 0.0063 | 8.7279 | 0.3795 | 3 | 33 | response to interleukin-7 |
GO:2000113 | 0.0067 | 1.7975 | 15.6059 | 26 | 1357 | negative regulation of cellular macromolecule biosynthetic process |
GO:0034765 | 0.0067 | 2.5199 | 4.6116 | 11 | 401 | regulation of ion transmembrane transport |
GO:0021521 | 0.0068 | 19.3102 | 0.1265 | 2 | 11 | ventral spinal cord interneuron specification |
GO:0030509 | 0.0068 | 3.779 | 1.679 | 6 | 146 | BMP signaling pathway |
GO:0033555 | 0.007 | 5.6518 | 0.759 | 4 | 66 | multicellular organismal response to stress |
GO:0030857 | 0.0075 | 8.1813 | 0.4025 | 3 | 35 | negative regulation of epithelial cell differentiation |
GO:0060795 | 0.0075 | 8.1813 | 0.4025 | 3 | 35 | cell fate commitment involved in formation of primary germ layer |
GO:0009890 | 0.0077 | 1.7402 | 17.3884 | 28 | 1512 | negative regulation of biosynthetic process |
GO:0032099 | 0.008 | 17.378 | 0.138 | 2 | 12 | negative regulation of appetite |
GO:0060272 | 0.008 | 17.378 | 0.138 | 2 | 12 | embryonic skeletal joint morphogenesis |
GO:2000726 | 0.008 | 17.378 | 0.138 | 2 | 12 | negative regulation of cardiac muscle cell differentiation |
GO:0071542 | 0.0081 | 7.9329 | 0.414 | 3 | 36 | dopaminergic neuron differentiation |
GO:0019226 | 0.0082 | 5.3898 | 0.7935 | 4 | 69 | transmission of nerve impulse |
GO:0009612 | 0.0082 | 3.2227 | 2.2886 | 7 | 199 | response to mechanical stimulus |
GO:0048869 | 0.0088 | 1.716 | 19.406 | 30 | 1946 | cellular developmental process |
GO:0021675 | 0.009 | 5.2282 | 0.8165 | 4 | 71 | nerve development |
GO:0055024 | 0.009 | 5.2282 | 0.8165 | 4 | 71 | regulation of cardiac muscle tissue development |
GO:0021953 | 0.0091 | 4.1523 | 1.2737 | 5 | 115 | central nervous system neuron differentiation |
GO:0044057 | 0.0093 | 2.3027 | 5.4971 | 12 | 478 | regulation of system process |
GO:0060428 | 0.0094 | 7.4786 | 0.437 | 3 | 38 | lung epithelium development |
GO:0021978 | 0.0094 | 15.7972 | 0.1495 | 2 | 13 | telencephalon regionalization |
GO:0060044 | 0.0094 | 15.7972 | 0.1495 | 2 | 13 | negative regulation of cardiac muscle cell proliferation |
GO:0006334 | 0.0095 | 4.1053 | 1.288 | 5 | 112 | nucleosome assembly |
GO:0071772 | 0.0096 | 3.5012 | 1.8055 | 6 | 157 | response to BMP |
GO:0030001 | 0.0099 | 1.9807 | 9.1082 | 17 | 792 | metal ion transport |
GO:0048332 | 0.0099 | 5.076 | 0.8395 | 4 | 73 | mesoderm morphogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007389 | 0 | 5.0656 | 2.6749 | 12 | 391 | pattern specification process |
GO:0048562 | 0 | 5.7912 | 1.9296 | 10 | 277 | embryonic organ morphogenesis |
GO:0050706 | 1e-04 | 21.1246 | 0.2229 | 4 | 32 | regulation of interleukin-1 beta secretion |
GO:0007610 | 1e-04 | 3.8836 | 3.7477 | 13 | 538 | behavior |
GO:0048663 | 1e-04 | 11.8246 | 0.4737 | 5 | 68 | neuron fate commitment |
GO:0009790 | 2e-04 | 3.009 | 6.4017 | 17 | 919 | embryo development |
GO:0050701 | 2e-04 | 15.5552 | 0.2926 | 4 | 42 | interleukin-1 secretion |
GO:0003215 | 3e-04 | 27.4788 | 0.1324 | 3 | 19 | cardiac right ventricle morphogenesis |
GO:0009952 | 4e-04 | 5.643 | 1.3514 | 7 | 194 | anterior/posterior pattern specification |
GO:0055123 | 4e-04 | 6.7061 | 0.9752 | 6 | 140 | digestive system development |
GO:0021510 | 6e-04 | 8.171 | 0.6687 | 5 | 96 | spinal cord development |
GO:0001947 | 7e-04 | 11.1417 | 0.3971 | 4 | 57 | heart looping |
GO:0021902 | 7e-04 | 72.6298 | 0.0418 | 2 | 6 | commitment of neuronal cell to specific neuron type in forebrain |
GO:0032611 | 9e-04 | 10.3571 | 0.4249 | 4 | 61 | interleukin-1 beta production |
GO:0032652 | 9e-04 | 10.3571 | 0.4249 | 4 | 61 | regulation of interleukin-1 production |
GO:0051674 | 9e-04 | 2.4277 | 9.3413 | 20 | 1341 | localization of cell |
GO:0001826 | 0.001 | 58.1 | 0.0488 | 2 | 7 | inner cell mass cell differentiation |
GO:0060017 | 0.001 | 58.1 | 0.0488 | 2 | 7 | parathyroid gland development |
GO:0040011 | 0.001 | 2.3063 | 10.8877 | 22 | 1563 | locomotion |
GO:0001708 | 0.0011 | 9.5467 | 0.4583 | 4 | 67 | cell fate specification |
GO:0043009 | 0.0014 | 3.1731 | 3.7825 | 11 | 543 | chordate embryonic development |
GO:0001707 | 0.0015 | 8.8054 | 0.4946 | 4 | 71 | mesoderm formation |
GO:0007369 | 0.0016 | 5.1808 | 1.2469 | 6 | 179 | gastrulation |
GO:0002690 | 0.0016 | 8.6753 | 0.5015 | 4 | 72 | positive regulation of leukocyte chemotaxis |
GO:0048617 | 0.0017 | 41.4945 | 0.0627 | 2 | 9 | embryonic foregut morphogenesis |
GO:0044057 | 0.0018 | 3.2592 | 3.3297 | 10 | 478 | regulation of system process |
GO:0007186 | 0.002 | 2.6351 | 5.8444 | 14 | 839 | G-protein coupled receptor signaling pathway |
GO:1904627 | 0.0021 | 36.3053 | 0.0697 | 2 | 10 | response to phorbol 13-acetate 12-myristate |
GO:0045944 | 0.0023 | 2.4355 | 7.2724 | 16 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
GO:0001764 | 0.0024 | 5.7948 | 0.9265 | 5 | 133 | neuron migration |
GO:0042475 | 0.0025 | 7.6567 | 0.5642 | 4 | 81 | odontogenesis of dentin-containing tooth |
GO:0021521 | 0.0025 | 32.2692 | 0.0766 | 2 | 11 | ventral spinal cord interneuron specification |
GO:0001709 | 0.0027 | 11.8662 | 0.2786 | 3 | 40 | cell fate determination |
GO:0048514 | 0.0027 | 3.0758 | 3.5178 | 10 | 505 | blood vessel morphogenesis |
GO:0030217 | 0.003 | 4.5191 | 1.421 | 6 | 204 | T cell differentiation |
GO:0003207 | 0.003 | 29.0404 | 0.0836 | 2 | 12 | cardiac chamber formation |
GO:0060536 | 0.003 | 29.0404 | 0.0836 | 2 | 12 | cartilage morphogenesis |
GO:0002685 | 0.0033 | 5.3323 | 1.0031 | 5 | 144 | regulation of leukocyte migration |
GO:0001944 | 0.0033 | 2.8199 | 4.2283 | 11 | 607 | vasculature development |
GO:0032501 | 0.0034 | 1.8028 | 36.6733 | 50 | 5904 | multicellular organismal process |
GO:0051270 | 0.0035 | 2.5614 | 5.5379 | 13 | 795 | regulation of cellular component movement |
GO:2000026 | 0.0036 | 2.0579 | 12.0371 | 22 | 1728 | regulation of multicellular organismal development |
GO:0021520 | 0.0036 | 26.3986 | 0.0906 | 2 | 13 | spinal cord motor neuron cell fate specification |
GO:0030502 | 0.0036 | 26.3986 | 0.0906 | 2 | 13 | negative regulation of bone mineralization |
GO:0050707 | 0.0036 | 5.2186 | 1.024 | 5 | 147 | regulation of cytokine secretion |
GO:0048872 | 0.0037 | 4.3413 | 1.4768 | 6 | 212 | homeostasis of number of cells |
GO:0006874 | 0.0038 | 3.403 | 2.5217 | 8 | 362 | cellular calcium ion homeostasis |
GO:0009953 | 0.0039 | 6.6947 | 0.6409 | 4 | 92 | dorsal/ventral pattern formation |
GO:0050863 | 0.0039 | 3.7452 | 1.9992 | 7 | 287 | regulation of T cell activation |
GO:0007501 | 0.0041 | 24.1971 | 0.0975 | 2 | 14 | mesodermal cell fate specification |
GO:0060850 | 0.0047 | 22.5512 | 0.1035 | 2 | 15 | regulation of transcription involved in cell fate commitment |
GO:0048546 | 0.0047 | 9.6324 | 0.3381 | 3 | 49 | digestive tract morphogenesis |
GO:0050920 | 0.0047 | 4.9046 | 1.0867 | 5 | 156 | regulation of chemotaxis |
GO:0050729 | 0.0047 | 6.3327 | 0.6757 | 4 | 97 | positive regulation of inflammatory response |
GO:0060581 | 0.0048 | 22.3343 | 0.1045 | 2 | 15 | cell fate commitment involved in pattern specification |
GO:0021879 | 0.0048 | 9.5388 | 0.3413 | 3 | 49 | forebrain neuron differentiation |
GO:0060413 | 0.0054 | 20.7376 | 0.1115 | 2 | 16 | atrial septum morphogenesis |
GO:0045765 | 0.0055 | 3.9696 | 1.6091 | 6 | 231 | regulation of angiogenesis |
GO:0009605 | 0.0056 | 1.9431 | 13.2979 | 23 | 1909 | response to external stimulus |
GO:0021514 | 0.0061 | 19.3538 | 0.1184 | 2 | 17 | ventral spinal cord interneuron differentiation |
GO:0001706 | 0.0063 | 8.6008 | 0.3762 | 3 | 54 | endoderm formation |
GO:0050877 | 0.0069 | 2.3453 | 6.0116 | 13 | 863 | nervous system process |
GO:0009891 | 0.0069 | 1.9581 | 11.9395 | 21 | 1714 | positive regulation of biosynthetic process |
GO:0003142 | 0.007 | Inf | 0.007 | 1 | 1 | cardiogenic plate morphogenesis |
GO:0003144 | 0.007 | Inf | 0.007 | 1 | 1 | embryonic heart tube formation |
GO:0003322 | 0.007 | Inf | 0.007 | 1 | 1 | pancreatic A cell development |
GO:0021905 | 0.007 | Inf | 0.007 | 1 | 1 | forebrain-midbrain boundary formation |
GO:0021918 | 0.007 | Inf | 0.007 | 1 | 1 | regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment |
GO:0034972 | 0.007 | Inf | 0.007 | 1 | 1 | histone H3-R26 methylation |
GO:0036306 | 0.007 | Inf | 0.007 | 1 | 1 | embryonic heart tube elongation |
GO:0038115 | 0.007 | Inf | 0.007 | 1 | 1 | chemokine (C-C motif) ligand 19 signaling pathway |
GO:0038116 | 0.007 | Inf | 0.007 | 1 | 1 | chemokine (C-C motif) ligand 21 signaling pathway |
GO:0048621 | 0.007 | Inf | 0.007 | 1 | 1 | post-embryonic digestive tract morphogenesis |
GO:0051296 | 0.007 | Inf | 0.007 | 1 | 1 | establishment of meiotic spindle orientation |
GO:0060807 | 0.007 | Inf | 0.007 | 1 | 1 | regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification |
GO:0060817 | 0.007 | Inf | 0.007 | 1 | 1 | inactivation of paternal X chromosome |
GO:0097022 | 0.007 | Inf | 0.007 | 1 | 1 | lymphocyte migration into lymph node |
GO:1904325 | 0.007 | Inf | 0.007 | 1 | 1 | positive regulation of inhibitory G-protein coupled receptor phosphorylation |
GO:2000522 | 0.007 | Inf | 0.007 | 1 | 1 | positive regulation of immunological synapse formation |
GO:2000525 | 0.007 | Inf | 0.007 | 1 | 1 | positive regulation of T cell costimulation |
GO:2000526 | 0.007 | Inf | 0.007 | 1 | 1 | positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation |
GO:2000872 | 0.007 | Inf | 0.007 | 1 | 1 | positive regulation of progesterone secretion |
GO:0072507 | 0.0071 | 3.0413 | 2.8073 | 8 | 403 | divalent inorganic cation homeostasis |
GO:0023019 | 0.0076 | 17.0747 | 0.1324 | 2 | 19 | signal transduction involved in regulation of gene expression |
GO:0030828 | 0.0076 | 17.0747 | 0.1324 | 2 | 19 | positive regulation of cGMP biosynthetic process |
GO:0060575 | 0.0076 | 17.0747 | 0.1324 | 2 | 19 | intestinal epithelial cell differentiation |
GO:0007368 | 0.0078 | 5.4477 | 0.7802 | 4 | 112 | determination of left/right symmetry |
GO:0032845 | 0.0079 | 4.2997 | 1.233 | 5 | 177 | negative regulation of homeostatic process |
GO:0032760 | 0.0081 | 7.8303 | 0.411 | 3 | 59 | positive regulation of tumor necrosis factor production |
GO:0048645 | 0.0081 | 7.8303 | 0.411 | 3 | 59 | animal organ formation |
GO:2000147 | 0.0081 | 2.9717 | 2.8699 | 8 | 412 | positive regulation of cell motility |
GO:0007159 | 0.0083 | 3.2372 | 2.2987 | 7 | 330 | leukocyte cell-cell adhesion |
GO:0009913 | 0.0084 | 3.6256 | 1.7554 | 6 | 252 | epidermal cell differentiation |
GO:0051254 | 0.0084 | 2.0143 | 9.8289 | 18 | 1411 | positive regulation of RNA metabolic process |
GO:0001824 | 0.0084 | 7.6924 | 0.418 | 3 | 60 | blastocyst development |
GO:0007498 | 0.0093 | 5.1589 | 0.822 | 4 | 118 | mesoderm development |
GO:0045596 | 0.0094 | 2.5458 | 4.2074 | 10 | 604 | negative regulation of cell differentiation |
GO:2000021 | 0.0097 | 4.0835 | 1.2957 | 5 | 186 | regulation of ion homeostasis |
GO:0048534 | 0.0099 | 2.3142 | 5.5866 | 12 | 802 | hematopoietic or lymphoid organ development |
GO:0002521 | 0.0099 | 2.8624 | 2.9744 | 8 | 427 | leukocyte differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007416 | 0 | 13.3985 | 1.1711 | 13 | 135 | synapse assembly |
GO:0048704 | 0 | 16.8395 | 0.7981 | 11 | 92 | embryonic skeletal system morphogenesis |
GO:0009952 | 0 | 9.8244 | 1.6829 | 14 | 194 | anterior/posterior pattern specification |
GO:0007156 | 0 | 10.675 | 1.3185 | 12 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0032502 | 0 | 2.7332 | 47.2984 | 79 | 5531 | developmental process |
GO:0016339 | 0 | 32.6039 | 0.2429 | 6 | 28 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
GO:0007389 | 0 | 5.1972 | 3.5219 | 16 | 406 | pattern specification process |
GO:0048568 | 0 | 5.1835 | 3.5305 | 16 | 407 | embryonic organ development |
GO:0048731 | 0 | 2.5066 | 21.7089 | 41 | 2982 | system development |
GO:0009887 | 0 | 3.0652 | 8.2061 | 22 | 946 | animal organ morphogenesis |
GO:0032501 | 0 | 2.1951 | 43.6331 | 65 | 5769 | multicellular organismal process |
GO:0048598 | 0 | 3.652 | 4.9011 | 16 | 565 | embryonic morphogenesis |
GO:0001501 | 1e-04 | 3.841 | 4.0423 | 14 | 466 | skeletal system development |
GO:0021570 | 1e-04 | Inf | 0.0173 | 2 | 2 | rhombomere 4 development |
GO:0045944 | 1e-04 | 2.7521 | 9.0562 | 22 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
GO:0001764 | 2e-04 | 6.6484 | 1.1537 | 7 | 133 | neuron migration |
GO:0021520 | 2e-04 | 35.0581 | 0.1128 | 3 | 13 | spinal cord motor neuron cell fate specification |
GO:0060429 | 2e-04 | 2.5961 | 9.5506 | 22 | 1101 | epithelium development |
GO:0043009 | 3e-04 | 3.2646 | 4.7103 | 14 | 543 | chordate embryonic development |
GO:0010628 | 3e-04 | 2.2556 | 14.7727 | 29 | 1703 | positive regulation of gene expression |
GO:0048486 | 4e-04 | 25.0349 | 0.1475 | 3 | 17 | parasympathetic nervous system development |
GO:0051412 | 4e-04 | 25.0349 | 0.1475 | 3 | 17 | response to corticosterone |
GO:0019219 | 4e-04 | 1.8771 | 34.1082 | 52 | 3932 | regulation of nucleobase-containing compound metabolic process |
GO:0007268 | 4e-04 | 3.1061 | 4.9358 | 14 | 569 | chemical synaptic transmission |
GO:0099537 | 4e-04 | 3.0945 | 4.9531 | 14 | 571 | trans-synaptic signaling |
GO:0021615 | 4e-04 | 116.0231 | 0.0347 | 2 | 4 | glossopharyngeal nerve morphogenesis |
GO:0032811 | 4e-04 | 116.0231 | 0.0347 | 2 | 4 | negative regulation of epinephrine secretion |
GO:0050877 | 5e-04 | 2.6609 | 7.4861 | 18 | 863 | nervous system process |
GO:0034654 | 6e-04 | 1.8418 | 34.5853 | 52 | 3987 | nucleobase-containing compound biosynthetic process |
GO:0007267 | 7e-04 | 2.2242 | 12.6561 | 25 | 1459 | cell-cell signaling |
GO:0009889 | 8e-04 | 1.8029 | 35.9472 | 53 | 4144 | regulation of biosynthetic process |
GO:0006355 | 0.0011 | 1.8259 | 29.2765 | 45 | 3375 | regulation of transcription, DNA-templated |
GO:0048241 | 0.0011 | 58.0038 | 0.052 | 2 | 6 | epinephrine transport |
GO:0030878 | 0.0011 | 16.6822 | 0.2082 | 3 | 24 | thyroid gland development |
GO:1903508 | 0.0012 | 2.2022 | 11.6412 | 23 | 1342 | positive regulation of nucleic acid-templated transcription |
GO:0031328 | 0.0012 | 2.0782 | 14.6426 | 27 | 1688 | positive regulation of cellular biosynthetic process |
GO:2001141 | 0.0013 | 1.8077 | 29.502 | 45 | 3401 | regulation of RNA biosynthetic process |
GO:0007420 | 0.0013 | 2.7358 | 5.5604 | 14 | 641 | brain development |
GO:0010700 | 0.0015 | 46.4 | 0.0607 | 2 | 7 | negative regulation of norepinephrine secretion |
GO:0021612 | 0.0015 | 46.4 | 0.0607 | 2 | 7 | facial nerve structural organization |
GO:0032661 | 0.0015 | 46.4 | 0.0607 | 2 | 7 | regulation of interleukin-18 production |
GO:0060017 | 0.0015 | 46.4 | 0.0607 | 2 | 7 | parathyroid gland development |
GO:0033141 | 0.002 | 38.6641 | 0.0694 | 2 | 8 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
GO:0051254 | 0.0023 | 2.0823 | 12.2397 | 23 | 1411 | positive regulation of RNA metabolic process |
GO:0030154 | 0.0025 | 1.7421 | 30.5039 | 45 | 3614 | cell differentiation |
GO:0021561 | 0.0026 | 33.1385 | 0.0781 | 2 | 9 | facial nerve development |
GO:0043330 | 0.0026 | 12.0738 | 0.2776 | 3 | 32 | response to exogenous dsRNA |
GO:0051952 | 0.0032 | 7.1113 | 0.6072 | 4 | 70 | regulation of amine transport |
GO:0050830 | 0.0041 | 6.6083 | 0.6506 | 4 | 75 | defense response to Gram-positive bacterium |
GO:0021545 | 0.0041 | 10.1528 | 0.3248 | 3 | 38 | cranial nerve development |
GO:0097300 | 0.0046 | 9.7216 | 0.3383 | 3 | 39 | programmed necrotic cell death |
GO:0007252 | 0.0047 | 23.1923 | 0.1041 | 2 | 12 | I-kappaB phosphorylation |
GO:0042063 | 0.0049 | 3.5696 | 2.0819 | 7 | 240 | gliogenesis |
GO:0001709 | 0.005 | 9.4582 | 0.347 | 3 | 40 | cell fate determination |
GO:0032757 | 0.005 | 9.4582 | 0.347 | 3 | 40 | positive regulation of interleukin-8 production |
GO:0009893 | 0.0055 | 1.6879 | 26.3792 | 39 | 3041 | positive regulation of metabolic process |
GO:0061548 | 0.0055 | 21.0825 | 0.1128 | 2 | 13 | ganglion development |
GO:0098609 | 0.0056 | 2.3131 | 6.5059 | 14 | 750 | cell-cell adhesion |
GO:0043588 | 0.0059 | 3.1369 | 2.7064 | 8 | 312 | skin development |
GO:0098542 | 0.0059 | 2.902 | 3.2963 | 9 | 380 | defense response to other organism |
GO:0021517 | 0.0061 | 8.7471 | 0.373 | 3 | 43 | ventral spinal cord development |
GO:0034356 | 0.0063 | 19.3244 | 0.1214 | 2 | 14 | NAD biosynthesis via nicotinamide riboside salvage pathway |
GO:0042711 | 0.0063 | 19.3244 | 0.1214 | 2 | 14 | maternal behavior |
GO:0009913 | 0.0064 | 3.392 | 2.186 | 7 | 252 | epidermal cell differentiation |
GO:0031424 | 0.0068 | 4.4599 | 1.1884 | 5 | 137 | keratinization |
GO:0032655 | 0.0069 | 8.3295 | 0.3904 | 3 | 45 | regulation of interleukin-12 production |
GO:0035176 | 0.0069 | 8.3295 | 0.3904 | 3 | 45 | social behavior |
GO:0007417 | 0.0071 | 3.7619 | 1.692 | 6 | 209 | central nervous system development |
GO:0048532 | 0.0073 | 17.8367 | 0.1301 | 2 | 15 | anatomical structure arrangement |
GO:0010557 | 0.0077 | 1.86 | 13.5322 | 23 | 1560 | positive regulation of macromolecule biosynthetic process |
GO:0002067 | 0.0078 | 7.9498 | 0.4077 | 3 | 47 | glandular epithelial cell differentiation |
GO:0032722 | 0.0078 | 7.9498 | 0.4077 | 3 | 47 | positive regulation of chemokine production |
GO:0002323 | 0.0083 | 16.5615 | 0.1388 | 2 | 16 | natural killer cell activation involved in immune response |
GO:0007625 | 0.0083 | 16.5615 | 0.1388 | 2 | 16 | grooming behavior |
GO:0003311 | 0.0087 | Inf | 0.0087 | 1 | 1 | pancreatic D cell differentiation |
GO:0003322 | 0.0087 | Inf | 0.0087 | 1 | 1 | pancreatic A cell development |
GO:0016077 | 0.0087 | Inf | 0.0087 | 1 | 1 | snoRNA catabolic process |
GO:0021723 | 0.0087 | Inf | 0.0087 | 1 | 1 | medullary reticular formation development |
GO:0021754 | 0.0087 | Inf | 0.0087 | 1 | 1 | facial nucleus development |
GO:0021905 | 0.0087 | Inf | 0.0087 | 1 | 1 | forebrain-midbrain boundary formation |
GO:0021918 | 0.0087 | Inf | 0.0087 | 1 | 1 | regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment |
GO:0032197 | 0.0087 | Inf | 0.0087 | 1 | 1 | transposition, RNA-mediated |
GO:0032685 | 0.0087 | Inf | 0.0087 | 1 | 1 | negative regulation of granulocyte macrophage colony-stimulating factor production |
GO:0034346 | 0.0087 | Inf | 0.0087 | 1 | 1 | positive regulation of type III interferon production |
GO:0035863 | 0.0087 | Inf | 0.0087 | 1 | 1 | dITP catabolic process |
GO:0048894 | 0.0087 | Inf | 0.0087 | 1 | 1 | efferent axon development in a lateral line nerve |
GO:0061452 | 0.0087 | Inf | 0.0087 | 1 | 1 | retrotrapezoid nucleus neuron differentiation |
GO:0071444 | 0.0087 | Inf | 0.0087 | 1 | 1 | cellular response to pheromone |
GO:0071881 | 0.0087 | Inf | 0.0087 | 1 | 1 | adenylate cyclase-inhibiting adrenergic receptor signaling pathway |
GO:0071882 | 0.0087 | Inf | 0.0087 | 1 | 1 | phospholipase C-activating adrenergic receptor signaling pathway |
GO:0072274 | 0.0087 | Inf | 0.0087 | 1 | 1 | metanephric glomerular basement membrane development |
GO:0090104 | 0.0087 | Inf | 0.0087 | 1 | 1 | pancreatic epsilon cell differentiation |
GO:0110023 | 0.0087 | Inf | 0.0087 | 1 | 1 | negative regulation of cardiac muscle myoblast proliferation |
GO:1901639 | 0.0087 | Inf | 0.0087 | 1 | 1 | XDP catabolic process |
GO:1902867 | 0.0087 | Inf | 0.0087 | 1 | 1 | negative regulation of retina development in camera-type eye |
GO:1902870 | 0.0087 | Inf | 0.0087 | 1 | 1 | negative regulation of amacrine cell differentiation |
GO:1903769 | 0.0087 | Inf | 0.0087 | 1 | 1 | negative regulation of cell proliferation in bone marrow |
GO:0051928 | 0.0087 | 5.2654 | 0.8067 | 4 | 93 | positive regulation of calcium ion transport |
GO:0061178 | 0.0088 | 7.6031 | 0.4251 | 3 | 49 | regulation of insulin secretion involved in cellular response to glucose stimulus |
GO:2000738 | 0.0093 | 15.4564 | 0.1475 | 2 | 17 | positive regulation of stem cell differentiation |
GO:0019933 | 0.0097 | 5.0927 | 0.8328 | 4 | 96 | cAMP-mediated signaling |
GO:0021761 | 0.0097 | 5.0927 | 0.8328 | 4 | 96 | limbic system development |
GO:0021515 | 0.0098 | 7.2854 | 0.4424 | 3 | 51 | cell differentiation in spinal cord |
GO:0010469 | 0.0099 | 2.5102 | 4.2245 | 10 | 487 | regulation of receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 45.6727 | 0.3746 | 12 | 57 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 23.9637 | 0.7623 | 14 | 116 | detection of chemical stimulus |
GO:0050906 | 0 | 21.2364 | 0.8477 | 14 | 129 | detection of stimulus involved in sensory perception |
GO:0007606 | 0 | 20.6924 | 0.8675 | 14 | 132 | sensory perception of chemical stimulus |
GO:0007186 | 0 | 3.8223 | 5.5136 | 18 | 839 | G-protein coupled receptor signaling pathway |
GO:0050877 | 0 | 3.7075 | 5.6713 | 18 | 863 | nervous system process |
GO:0007565 | 0 | 7.7844 | 1.15 | 8 | 175 | female pregnancy |
GO:0061760 | 1e-04 | 308.4898 | 0.0197 | 2 | 3 | antifungal innate immune response |
GO:0045087 | 3e-04 | 3.3035 | 4.7667 | 14 | 740 | innate immune response |
GO:0050829 | 8e-04 | 10.6342 | 0.414 | 4 | 63 | defense response to Gram-negative bacterium |
GO:0035865 | 0.0012 | 51.398 | 0.0526 | 2 | 8 | cellular response to potassium ion |
GO:0019730 | 0.0012 | 9.3595 | 0.4666 | 4 | 71 | antimicrobial humoral response |
GO:0050830 | 0.0014 | 9.0508 | 0.4815 | 4 | 74 | defense response to Gram-positive bacterium |
GO:0032342 | 0.0015 | 44.0525 | 0.0591 | 2 | 9 | aldosterone biosynthetic process |
GO:0034651 | 0.0015 | 44.0525 | 0.0591 | 2 | 9 | cortisol biosynthetic process |
GO:0008212 | 0.0019 | 38.5434 | 0.0657 | 2 | 10 | mineralocorticoid metabolic process |
GO:0009620 | 0.0021 | 12.9562 | 0.2563 | 3 | 39 | response to fungus |
GO:0031640 | 0.0026 | 11.9572 | 0.276 | 3 | 42 | killing of cells of other organism |
GO:0098542 | 0.0035 | 3.4467 | 2.4972 | 8 | 380 | defense response to other organism |
GO:0001977 | 0.0055 | 20.5469 | 0.1117 | 2 | 17 | renal system process involved in regulation of blood volume |
GO:0001580 | 0.0061 | 19.2615 | 0.1183 | 2 | 18 | detection of chemical stimulus involved in sensory perception of bitter taste |
GO:0070098 | 0.0062 | 8.6271 | 0.3746 | 3 | 57 | chemokine-mediated signaling pathway |
GO:0060118 | 0.0066 | Inf | 0.0066 | 1 | 1 | vestibular receptor cell development |
GO:0070292 | 0.0066 | Inf | 0.0066 | 1 | 1 | N-acylphosphatidylethanolamine metabolic process |
GO:0070946 | 0.0066 | Inf | 0.0066 | 1 | 1 | neutrophil mediated killing of gram-positive bacterium |
GO:0071663 | 0.0066 | Inf | 0.0066 | 1 | 1 | positive regulation of granzyme B production |
GO:1901318 | 0.0066 | Inf | 0.0066 | 1 | 1 | negative regulation of flagellated sperm motility |
GO:0008211 | 0.0083 | 16.217 | 0.138 | 2 | 21 | glucocorticoid metabolic process |
GO:0050776 | 0.0088 | 2.3593 | 5.507 | 12 | 838 | regulation of immune response |
GO:0002376 | 0.0089 | 1.8095 | 16.3238 | 26 | 2484 | immune system process |
GO:0001895 | 0.009 | 7.51 | 0.4272 | 3 | 65 | retina homeostasis |
GO:0016338 | 0.0091 | 15.4051 | 0.1446 | 2 | 22 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules |
GO:0051346 | 0.0092 | 3.1757 | 2.3461 | 7 | 357 | negative regulation of hydrolase activity |
GO:0009617 | 0.0094 | 2.8938 | 2.9506 | 8 | 449 | response to bacterium |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0009952 | 0 | 7.0595 | 2.439 | 15 | 180 | anterior/posterior pattern specification |
GO:0009790 | 0 | 3.2279 | 12.1813 | 34 | 894 | embryo development |
GO:0048646 | 0 | 3.2847 | 11.2304 | 32 | 839 | anatomical structure formation involved in morphogenesis |
GO:0048704 | 0 | 9.1006 | 1.2696 | 10 | 92 | embryonic skeletal system morphogenesis |
GO:0072359 | 0 | 2.7536 | 12.6825 | 31 | 919 | circulatory system development |
GO:0045944 | 0 | 2.581 | 14.4076 | 33 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
GO:0010454 | 0 | 41.6089 | 0.1518 | 4 | 11 | negative regulation of cell fate commitment |
GO:0030878 | 0 | 19.2401 | 0.3312 | 5 | 24 | thyroid gland development |
GO:0010628 | 0 | 2.1326 | 23.502 | 44 | 1703 | positive regulation of gene expression |
GO:0051094 | 0 | 2.3719 | 15.5669 | 33 | 1143 | positive regulation of developmental process |
GO:0021515 | 1e-04 | 9.7791 | 0.7038 | 6 | 51 | cell differentiation in spinal cord |
GO:0009653 | 1e-04 | 3.5042 | 4.7215 | 15 | 407 | anatomical structure morphogenesis |
GO:0060485 | 1e-04 | 4.0924 | 3.1879 | 12 | 231 | mesenchyme development |
GO:0021953 | 1e-04 | 4.8224 | 2.2633 | 10 | 164 | central nervous system neuron differentiation |
GO:0023019 | 1e-04 | 19.4071 | 0.2622 | 4 | 19 | signal transduction involved in regulation of gene expression |
GO:0022603 | 1e-04 | 2.4118 | 11.835 | 26 | 872 | regulation of anatomical structure morphogenesis |
GO:0048562 | 2e-04 | 4.4361 | 2.4463 | 10 | 185 | embryonic organ morphogenesis |
GO:2000824 | 2e-04 | Inf | 0.0276 | 2 | 2 | negative regulation of androgen receptor activity |
GO:0016338 | 2e-04 | 16.1694 | 0.3036 | 4 | 22 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules |
GO:0051254 | 2e-04 | 2.0512 | 19.4723 | 36 | 1411 | positive regulation of RNA metabolic process |
GO:0006355 | 2e-04 | 1.732 | 46.5762 | 69 | 3375 | regulation of transcription, DNA-templated |
GO:0014706 | 3e-04 | 3.2472 | 4.6507 | 14 | 337 | striated muscle tissue development |
GO:0060562 | 3e-04 | 3.4088 | 4.1125 | 13 | 298 | epithelial tube morphogenesis |
GO:2001141 | 3e-04 | 1.7147 | 46.935 | 69 | 3401 | regulation of RNA biosynthetic process |
GO:0048514 | 3e-04 | 2.9413 | 5.8742 | 16 | 434 | blood vessel morphogenesis |
GO:0021517 | 3e-04 | 9.6078 | 0.5934 | 5 | 43 | ventral spinal cord development |
GO:0060914 | 3e-04 | 14.5505 | 0.3312 | 4 | 24 | heart formation |
GO:0048513 | 3e-04 | 1.8259 | 32.7321 | 52 | 2519 | animal organ development |
GO:1903508 | 4e-04 | 2.0232 | 18.5201 | 34 | 1342 | positive regulation of nucleic acid-templated transcription |
GO:0048484 | 4e-04 | 27.1721 | 0.1518 | 3 | 11 | enteric nervous system development |
GO:0060573 | 4e-04 | 27.1721 | 0.1518 | 3 | 11 | cell fate specification involved in pattern specification |
GO:2000736 | 4e-04 | 4.8723 | 1.7802 | 8 | 129 | regulation of stem cell differentiation |
GO:0050789 | 5e-04 | 1.7002 | 137.4515 | 160 | 9960 | regulation of biological process |
GO:0035050 | 5e-04 | 6.6582 | 0.9936 | 6 | 72 | embryonic heart tube development |
GO:0042659 | 5e-04 | 24.1514 | 0.1656 | 3 | 12 | regulation of cell fate specification |
GO:0003151 | 5e-04 | 6.4615 | 1.0212 | 6 | 74 | outflow tract morphogenesis |
GO:0019219 | 5e-04 | 1.6402 | 54.263 | 76 | 3932 | regulation of nucleobase-containing compound metabolic process |
GO:0003285 | 6e-04 | 144.2885 | 0.0414 | 2 | 3 | septum secundum development |
GO:0021912 | 6e-04 | 144.2885 | 0.0414 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
GO:0035054 | 6e-04 | 144.2885 | 0.0414 | 2 | 3 | embryonic heart tube anterior/posterior pattern specification |
GO:0060913 | 6e-04 | 144.2885 | 0.0414 | 2 | 3 | cardiac cell fate determination |
GO:0061010 | 6e-04 | 144.2885 | 0.0414 | 2 | 3 | gall bladder development |
GO:0048663 | 8e-04 | 7.7078 | 0.7217 | 5 | 53 | neuron fate commitment |
GO:0001708 | 8e-04 | 7.6592 | 0.7252 | 5 | 54 | cell fate specification |
GO:2000026 | 0.001 | 1.9308 | 18.7972 | 33 | 1439 | regulation of multicellular organismal development |
GO:0060579 | 0.001 | 18.1099 | 0.207 | 3 | 15 | ventral spinal cord interneuron fate commitment |
GO:0001947 | 0.0011 | 7.0145 | 0.7866 | 5 | 57 | heart looping |
GO:0003308 | 0.0011 | 72.1394 | 0.0552 | 2 | 4 | negative regulation of Wnt signaling pathway involved in heart development |
GO:0021764 | 0.0011 | 72.1394 | 0.0552 | 2 | 4 | amygdala development |
GO:0021913 | 0.0011 | 72.1394 | 0.0552 | 2 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
GO:0042662 | 0.0011 | 72.1394 | 0.0552 | 2 | 4 | negative regulation of mesodermal cell fate specification |
GO:0060920 | 0.0011 | 72.1394 | 0.0552 | 2 | 4 | cardiac pacemaker cell differentiation |
GO:0061055 | 0.0011 | 72.1394 | 0.0552 | 2 | 4 | myotome development |
GO:0072107 | 0.0011 | 72.1394 | 0.0552 | 2 | 4 | positive regulation of ureteric bud formation |
GO:0090191 | 0.0011 | 72.1394 | 0.0552 | 2 | 4 | negative regulation of branching involved in ureteric bud morphogenesis |
GO:1905903 | 0.0011 | 72.1394 | 0.0552 | 2 | 4 | negative regulation of mesoderm formation |
GO:0055003 | 0.0013 | 16.7157 | 0.2208 | 3 | 16 | cardiac myofibril assembly |
GO:0060541 | 0.0013 | 3.6677 | 2.6221 | 9 | 190 | respiratory system development |
GO:0003002 | 0.0014 | 5.3305 | 1.2163 | 6 | 97 | regionalization |
GO:0030858 | 0.0014 | 6.6306 | 0.828 | 5 | 60 | positive regulation of epithelial cell differentiation |
GO:1903507 | 0.0015 | 1.9721 | 15.3736 | 28 | 1114 | negative regulation of nucleic acid-templated transcription |
GO:0048486 | 0.0015 | 15.5207 | 0.2346 | 3 | 17 | parasympathetic nervous system development |
GO:0009890 | 0.0016 | 1.8321 | 20.8661 | 35 | 1512 | negative regulation of biosynthetic process |
GO:0000122 | 0.0018 | 2.1637 | 10.4055 | 21 | 754 | negative regulation of transcription from RNA polymerase II promoter |
GO:0032501 | 0.0018 | 1.58 | 62.7829 | 82 | 4896 | multicellular organismal process |
GO:0001759 | 0.0018 | 14.485 | 0.2484 | 3 | 18 | organ induction |
GO:0051891 | 0.0018 | 48.0897 | 0.069 | 2 | 5 | positive regulation of cardioblast differentiation |
GO:0061009 | 0.0018 | 48.0897 | 0.069 | 2 | 5 | common bile duct development |
GO:0071502 | 0.0018 | 48.0897 | 0.069 | 2 | 5 | cellular response to temperature stimulus |
GO:0051253 | 0.0019 | 1.9161 | 16.381 | 29 | 1187 | negative regulation of RNA metabolic process |
GO:2000113 | 0.0019 | 1.8564 | 18.7271 | 32 | 1357 | negative regulation of cellular macromolecule biosynthetic process |
GO:0001667 | 0.0019 | 2.8452 | 4.4851 | 12 | 325 | ameboidal-type cell migration |
GO:0010470 | 0.002 | 8.3062 | 0.5382 | 4 | 39 | regulation of gastrulation |
GO:0048729 | 0.0021 | 2.4045 | 7.0942 | 16 | 524 | tissue morphogenesis |
GO:0003215 | 0.0021 | 13.5788 | 0.2622 | 3 | 19 | cardiac right ventricle morphogenesis |
GO:0034654 | 0.0022 | 1.5427 | 55.022 | 74 | 3987 | nucleobase-containing compound biosynthetic process |
GO:0031497 | 0.0023 | 4.1388 | 1.8078 | 7 | 131 | chromatin assembly |
GO:0045766 | 0.0023 | 4.1388 | 1.8078 | 7 | 131 | positive regulation of angiogenesis |
GO:0001944 | 0.0024 | 2.7614 | 4.6194 | 12 | 349 | vasculature development |
GO:0060284 | 0.0026 | 2.0916 | 10.7367 | 21 | 778 | regulation of cell development |
GO:0010557 | 0.0026 | 1.7681 | 21.5286 | 35 | 1560 | positive regulation of macromolecule biosynthetic process |
GO:0021902 | 0.0027 | 36.0649 | 0.0828 | 2 | 6 | commitment of neuronal cell to specific neuron type in forebrain |
GO:0030240 | 0.0027 | 36.0649 | 0.0828 | 2 | 6 | skeletal muscle thin filament assembly |
GO:0033603 | 0.0027 | 36.0649 | 0.0828 | 2 | 6 | positive regulation of dopamine secretion |
GO:0034128 | 0.0027 | 36.0649 | 0.0828 | 2 | 6 | negative regulation of MyD88-independent toll-like receptor signaling pathway |
GO:2001199 | 0.0027 | 36.0649 | 0.0828 | 2 | 6 | negative regulation of dendritic cell differentiation |
GO:1905207 | 0.0029 | 7.4523 | 0.5934 | 4 | 43 | regulation of cardiocyte differentiation |
GO:0007263 | 0.0029 | 12.0684 | 0.2898 | 3 | 21 | nitric oxide mediated signal transduction |
GO:0001570 | 0.003 | 5.5214 | 0.9798 | 5 | 71 | vasculogenesis |
GO:0034728 | 0.0032 | 3.8858 | 1.9182 | 7 | 139 | nucleosome organization |
GO:0030154 | 0.0034 | 1.6118 | 36.4541 | 52 | 2954 | cell differentiation |
GO:0042127 | 0.0035 | 1.7593 | 20.3003 | 33 | 1471 | regulation of cell proliferation |
GO:0032989 | 0.0036 | 1.9353 | 13.2759 | 24 | 962 | cellular component morphogenesis |
GO:0045664 | 0.0036 | 2.2661 | 7.4936 | 16 | 543 | regulation of neuron differentiation |
GO:0007517 | 0.0037 | 2.6066 | 4.8715 | 12 | 353 | muscle organ development |
GO:0060415 | 0.0038 | 5.2045 | 1.035 | 5 | 75 | muscle tissue morphogenesis |
GO:0001826 | 0.0038 | 28.85 | 0.0966 | 2 | 7 | inner cell mass cell differentiation |
GO:0007492 | 0.0042 | 5.0593 | 1.0626 | 5 | 77 | endoderm development |
GO:0006335 | 0.0042 | 10.3423 | 0.3312 | 3 | 24 | DNA replication-dependent nucleosome assembly |
GO:0021511 | 0.0042 | 10.3423 | 0.3312 | 3 | 24 | spinal cord patterning |
GO:0060487 | 0.0042 | 10.3423 | 0.3312 | 3 | 24 | lung epithelial cell differentiation |
GO:0061217 | 0.0042 | 10.3423 | 0.3312 | 3 | 24 | regulation of mesonephros development |
GO:0030097 | 0.0044 | 2.0266 | 10.5021 | 20 | 761 | hemopoiesis |
GO:0007368 | 0.0046 | 4.1346 | 1.5456 | 6 | 112 | determination of left/right symmetry |
GO:0045992 | 0.0048 | 9.8715 | 0.345 | 3 | 25 | negative regulation of embryonic development |
GO:1905770 | 0.005 | 24.0401 | 0.1104 | 2 | 8 | regulation of mesodermal cell differentiation |
GO:0031328 | 0.0053 | 1.6726 | 23.295 | 36 | 1688 | positive regulation of cellular biosynthetic process |
GO:0000183 | 0.0053 | 9.4417 | 0.3588 | 3 | 26 | chromatin silencing at rDNA |
GO:0003231 | 0.0054 | 3.9832 | 1.6008 | 6 | 116 | cardiac ventricle development |
GO:0035295 | 0.0056 | 2.2885 | 6.4664 | 14 | 480 | tube development |
GO:0007498 | 0.0059 | 3.9115 | 1.6284 | 6 | 118 | mesoderm development |
GO:0048523 | 0.0061 | 1.4636 | 58.0167 | 75 | 4204 | negative regulation of cellular process |
GO:0016525 | 0.0061 | 4.6088 | 1.1592 | 5 | 84 | negative regulation of angiogenesis |
GO:0071773 | 0.0062 | 3.4154 | 2.1667 | 7 | 157 | cellular response to BMP stimulus |
GO:0001714 | 0.0064 | 20.6044 | 0.1242 | 2 | 9 | endodermal cell fate specification |
GO:0003139 | 0.0064 | 20.6044 | 0.1242 | 2 | 9 | secondary heart field specification |
GO:0048617 | 0.0064 | 20.6044 | 0.1242 | 2 | 9 | embryonic foregut morphogenesis |
GO:0070863 | 0.0064 | 20.6044 | 0.1242 | 2 | 9 | positive regulation of protein exit from endoplasmic reticulum |
GO:0072172 | 0.0064 | 20.6044 | 0.1242 | 2 | 9 | mesonephric tubule formation |
GO:1903430 | 0.0064 | 20.6044 | 0.1242 | 2 | 9 | negative regulation of cell maturation |
GO:2000288 | 0.0064 | 20.6044 | 0.1242 | 2 | 9 | positive regulation of myoblast proliferation |
GO:0048706 | 0.0065 | 8.7265 | 0.3835 | 3 | 29 | embryonic skeletal system development |
GO:0002520 | 0.0065 | 1.9149 | 11.6475 | 21 | 844 | immune system development |
GO:0043403 | 0.0066 | 8.6852 | 0.3864 | 3 | 28 | skeletal muscle tissue regeneration |
GO:0060441 | 0.0066 | 8.6852 | 0.3864 | 3 | 28 | epithelial tube branching involved in lung morphogenesis |
GO:0001704 | 0.0066 | 3.8087 | 1.6698 | 6 | 121 | formation of primary germ layer |
GO:0060993 | 0.0067 | 4.4944 | 1.1868 | 5 | 86 | kidney morphogenesis |
GO:0009799 | 0.0069 | 3.7756 | 1.6836 | 6 | 122 | specification of symmetry |
GO:0030855 | 0.007 | 2.1601 | 7.3352 | 15 | 547 | epithelial cell differentiation |
GO:0071276 | 0.0073 | 8.3506 | 0.4002 | 3 | 29 | cellular response to cadmium ion |
GO:0072080 | 0.0074 | 4.3855 | 1.2144 | 5 | 88 | nephron tubule development |
GO:1901342 | 0.0075 | 3.2821 | 2.2499 | 7 | 166 | regulation of vasculature development |
GO:0021520 | 0.0078 | 18.2015 | 0.1367 | 2 | 10 | spinal cord motor neuron cell fate specification |
GO:0003211 | 0.0079 | 18.0276 | 0.138 | 2 | 10 | cardiac ventricle formation |
GO:0030238 | 0.0079 | 18.0276 | 0.138 | 2 | 10 | male sex determination |
GO:0051967 | 0.0079 | 18.0276 | 0.138 | 2 | 10 | negative regulation of synaptic transmission, glutamatergic |
GO:0061042 | 0.0079 | 18.0276 | 0.138 | 2 | 10 | vascular wound healing |
GO:0034142 | 0.008 | 8.0408 | 0.414 | 3 | 30 | toll-like receptor 4 signaling pathway |
GO:0051240 | 0.0082 | 1.6907 | 19.0126 | 30 | 1396 | positive regulation of multicellular organismal process |
GO:0003209 | 0.0088 | 7.7531 | 0.4278 | 3 | 31 | cardiac atrium morphogenesis |
GO:0021872 | 0.0089 | 5.2787 | 0.8142 | 4 | 59 | forebrain generation of neurons |
GO:0035282 | 0.0089 | 4.1828 | 1.2696 | 5 | 92 | segmentation |
GO:1901343 | 0.0089 | 4.1828 | 1.2696 | 5 | 92 | negative regulation of vasculature development |
GO:0060429 | 0.0091 | 2.3113 | 5.4736 | 12 | 428 | epithelium development |
GO:0097305 | 0.0091 | 3.1599 | 2.3323 | 7 | 169 | response to alcohol |
GO:0042472 | 0.0093 | 4.135 | 1.2834 | 5 | 93 | inner ear morphogenesis |
GO:0001655 | 0.0095 | 2.5109 | 4.1815 | 10 | 303 | urogenital system development |
GO:0043009 | 0.0095 | 2.2923 | 5.507 | 12 | 422 | chordate embryonic development |
GO:0003161 | 0.0096 | 16.0235 | 0.1518 | 2 | 11 | cardiac conduction system development |
GO:0007512 | 0.0096 | 16.0235 | 0.1518 | 2 | 11 | adult heart development |
GO:0021903 | 0.0096 | 16.0235 | 0.1518 | 2 | 11 | rostrocaudal neural tube patterning |
GO:0090009 | 0.0096 | 16.0235 | 0.1518 | 2 | 11 | primitive streak formation |
GO:2000774 | 0.0096 | 16.0235 | 0.1518 | 2 | 11 | positive regulation of cellular senescence |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048646 | 0 | 2.8076 | 13.7613 | 34 | 965 | anatomical structure formation involved in morphogenesis |
GO:2000026 | 0 | 2.3141 | 24.6419 | 49 | 1728 | regulation of multicellular organismal development |
GO:0003002 | 0 | 3.8352 | 4.5776 | 16 | 321 | regionalization |
GO:0051240 | 0 | 2.276 | 19.3831 | 39 | 1389 | positive regulation of multicellular organismal process |
GO:0072359 | 0 | 2.5465 | 13.1053 | 30 | 919 | circulatory system development |
GO:0001944 | 0 | 2.9266 | 8.656 | 23 | 607 | vasculature development |
GO:0060485 | 0 | 4.3211 | 3.2941 | 13 | 231 | mesenchyme development |
GO:2001199 | 1e-04 | 70.0794 | 0.0856 | 3 | 6 | negative regulation of dendritic cell differentiation |
GO:0035909 | 1e-04 | 12.1755 | 0.4849 | 5 | 34 | aorta morphogenesis |
GO:0048514 | 1e-04 | 2.8658 | 7.2015 | 19 | 505 | blood vessel morphogenesis |
GO:0021872 | 2e-04 | 8.0195 | 0.8414 | 6 | 59 | forebrain generation of neurons |
GO:0008284 | 2e-04 | 2.3867 | 11.4226 | 25 | 801 | positive regulation of cell proliferation |
GO:0030858 | 2e-04 | 7.8705 | 0.8556 | 6 | 60 | positive regulation of epithelial cell differentiation |
GO:0051241 | 3e-04 | 2.1886 | 13.9609 | 28 | 979 | negative regulation of multicellular organismal process |
GO:0043066 | 4e-04 | 2.3171 | 11.2372 | 24 | 788 | negative regulation of apoptotic process |
GO:0060741 | 6e-04 | 139.5256 | 0.0428 | 2 | 3 | prostate gland stromal morphogenesis |
GO:0060041 | 7e-04 | 4.4474 | 1.9394 | 8 | 136 | retina development in camera-type eye |
GO:0051094 | 8e-04 | 3.1789 | 4.0526 | 12 | 308 | positive regulation of developmental process |
GO:0060548 | 8e-04 | 2.1488 | 12.5776 | 25 | 882 | negative regulation of cell death |
GO:0048468 | 8e-04 | 1.7964 | 26.4815 | 43 | 1857 | cell development |
GO:0048665 | 0.0012 | 9.6947 | 0.4706 | 4 | 33 | neuron fate specification |
GO:0021764 | 0.0012 | 69.7581 | 0.057 | 2 | 4 | amygdala development |
GO:0072107 | 0.0012 | 69.7581 | 0.057 | 2 | 4 | positive regulation of ureteric bud formation |
GO:0090191 | 0.0012 | 69.7581 | 0.057 | 2 | 4 | negative regulation of branching involved in ureteric bud morphogenesis |
GO:1905205 | 0.0012 | 69.7581 | 0.057 | 2 | 4 | positive regulation of connective tissue replacement |
GO:0045165 | 0.0012 | 3.4163 | 3.1253 | 10 | 222 | cell fate commitment |
GO:0001655 | 0.0014 | 2.9588 | 4.3209 | 12 | 303 | urogenital system development |
GO:0060850 | 0.0014 | 16.1614 | 0.2282 | 3 | 16 | regulation of transcription involved in cell fate commitment |
GO:0007498 | 0.0015 | 4.4712 | 1.6827 | 7 | 118 | mesoderm development |
GO:0045765 | 0.0018 | 3.2306 | 3.2941 | 10 | 231 | regulation of angiogenesis |
GO:0051122 | 0.002 | 46.5023 | 0.0713 | 2 | 5 | hepoxilin biosynthetic process |
GO:0060455 | 0.002 | 46.5023 | 0.0713 | 2 | 5 | negative regulation of gastric acid secretion |
GO:0071502 | 0.002 | 46.5023 | 0.0713 | 2 | 5 | cellular response to temperature stimulus |
GO:2000609 | 0.002 | 46.5023 | 0.0713 | 2 | 5 | regulation of thyroid hormone generation |
GO:2001188 | 0.002 | 46.5023 | 0.0713 | 2 | 5 | regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
GO:0001759 | 0.002 | 14.0047 | 0.2567 | 3 | 18 | organ induction |
GO:0009792 | 0.0022 | 2.3207 | 7.8004 | 17 | 547 | embryo development ending in birth or egg hatching |
GO:0030803 | 0.0022 | 8.0295 | 0.5562 | 4 | 39 | negative regulation of cyclic nucleotide biosynthetic process |
GO:0023019 | 0.0023 | 13.1285 | 0.2709 | 3 | 19 | signal transduction involved in regulation of gene expression |
GO:0042403 | 0.0023 | 13.1285 | 0.2709 | 3 | 19 | thyroid hormone metabolic process |
GO:0048729 | 0.0024 | 2.2448 | 8.542 | 18 | 599 | tissue morphogenesis |
GO:0007423 | 0.0025 | 2.3572 | 7.2157 | 16 | 506 | sensory organ development |
GO:0030815 | 0.0027 | 7.5945 | 0.5847 | 4 | 41 | negative regulation of cAMP metabolic process |
GO:0051093 | 0.0028 | 2.0402 | 11.5224 | 22 | 808 | negative regulation of developmental process |
GO:0034128 | 0.0029 | 34.8744 | 0.0856 | 2 | 6 | negative regulation of MyD88-independent toll-like receptor signaling pathway |
GO:1900372 | 0.0029 | 7.3941 | 0.5989 | 4 | 42 | negative regulation of purine nucleotide biosynthetic process |
GO:0045597 | 0.003 | 2.0602 | 10.8862 | 21 | 782 | positive regulation of cell differentiation |
GO:0035050 | 0.0036 | 5.2566 | 1.0267 | 5 | 72 | embryonic heart tube development |
GO:0060562 | 0.0037 | 2.7374 | 4.2496 | 11 | 298 | epithelial tube morphogenesis |
GO:0001826 | 0.0041 | 27.8977 | 0.0998 | 2 | 7 | inner cell mass cell differentiation |
GO:0002118 | 0.0041 | 27.8977 | 0.0998 | 2 | 7 | aggressive behavior |
GO:0002645 | 0.0041 | 27.8977 | 0.0998 | 2 | 7 | positive regulation of tolerance induction |
GO:0044332 | 0.0041 | 27.8977 | 0.0998 | 2 | 7 | Wnt signaling pathway involved in dorsal/ventral axis specification |
GO:0045686 | 0.0041 | 10.5 | 0.328 | 3 | 23 | negative regulation of glial cell differentiation |
GO:0048592 | 0.0041 | 3.698 | 2.0107 | 7 | 141 | eye morphogenesis |
GO:0009605 | 0.0046 | 1.6377 | 27.223 | 41 | 1909 | response to external stimulus |
GO:0048771 | 0.0046 | 3.6163 | 2.0535 | 7 | 144 | tissue remodeling |
GO:0060914 | 0.0046 | 9.9993 | 0.3422 | 3 | 24 | heart formation |
GO:0061217 | 0.0046 | 9.9993 | 0.3422 | 3 | 24 | regulation of mesonephros development |
GO:0003158 | 0.0049 | 4.0729 | 1.5686 | 6 | 110 | endothelium development |
GO:0030509 | 0.005 | 3.5638 | 2.082 | 7 | 146 | BMP signaling pathway |
GO:0060037 | 0.0052 | 9.5442 | 0.3565 | 3 | 25 | pharyngeal system development |
GO:0001955 | 0.0054 | 23.2465 | 0.1141 | 2 | 8 | blood vessel maturation |
GO:0042756 | 0.0054 | 23.2465 | 0.1141 | 2 | 8 | drinking behavior |
GO:0051584 | 0.0054 | 23.2465 | 0.1141 | 2 | 8 | regulation of dopamine uptake involved in synaptic transmission |
GO:0060836 | 0.0054 | 23.2465 | 0.1141 | 2 | 8 | lymphatic endothelial cell differentiation |
GO:0006334 | 0.0054 | 3.9955 | 1.5972 | 6 | 112 | nucleosome assembly |
GO:0030817 | 0.0056 | 3.9579 | 1.6114 | 6 | 113 | regulation of cAMP biosynthetic process |
GO:0060840 | 0.0057 | 4.6934 | 1.1408 | 5 | 80 | artery development |
GO:0007194 | 0.0058 | 9.1286 | 0.3708 | 3 | 26 | negative regulation of adenylate cyclase activity |
GO:0060541 | 0.006 | 3.1165 | 2.7095 | 8 | 190 | respiratory system development |
GO:0045471 | 0.0061 | 3.8848 | 1.6399 | 6 | 115 | response to ethanol |
GO:0060706 | 0.0065 | 8.7477 | 0.385 | 3 | 27 | cell differentiation involved in embryonic placenta development |
GO:1902230 | 0.0065 | 8.7477 | 0.385 | 3 | 27 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
GO:0048562 | 0.0065 | 2.6657 | 3.9501 | 10 | 277 | embryonic organ morphogenesis |
GO:0010033 | 0.0068 | 1.511 | 40.0288 | 55 | 2807 | response to organic substance |
GO:0042363 | 0.0068 | 19.9243 | 0.1283 | 2 | 9 | fat-soluble vitamin catabolic process |
GO:0072172 | 0.0068 | 19.9243 | 0.1283 | 2 | 9 | mesonephric tubule formation |
GO:0001656 | 0.007 | 4.4546 | 1.1979 | 5 | 84 | metanephros development |
GO:0001667 | 0.0071 | 2.4975 | 4.6346 | 11 | 325 | ameboidal-type cell migration |
GO:0071772 | 0.0073 | 3.3 | 2.2389 | 7 | 157 | response to BMP |
GO:0060993 | 0.0077 | 4.344 | 1.2264 | 5 | 86 | kidney morphogenesis |
GO:0046530 | 0.0078 | 5.5046 | 0.7843 | 4 | 55 | photoreceptor cell differentiation |
GO:0090132 | 0.008 | 2.7423 | 3.451 | 9 | 242 | epithelium migration |
GO:0010660 | 0.0083 | 5.3983 | 0.7986 | 4 | 56 | regulation of muscle cell apoptotic process |
GO:0048583 | 0.0084 | 1.4519 | 51.2803 | 67 | 3596 | regulation of response to stimulus |
GO:0021877 | 0.0084 | 17.4326 | 0.1426 | 2 | 10 | forebrain neuron fate commitment |
GO:0061042 | 0.0084 | 17.4326 | 0.1426 | 2 | 10 | vascular wound healing |
GO:0097499 | 0.0084 | 17.4326 | 0.1426 | 2 | 10 | protein localization to non-motile cilium |
GO:0072080 | 0.0085 | 4.2387 | 1.2549 | 5 | 88 | nephron tubule development |
GO:0034142 | 0.0087 | 7.7741 | 0.4278 | 3 | 30 | toll-like receptor 4 signaling pathway |
GO:0072604 | 0.0087 | 7.7741 | 0.4278 | 3 | 30 | interleukin-6 secretion |
GO:0001947 | 0.0088 | 5.2961 | 0.8128 | 4 | 57 | heart looping |
GO:0021953 | 0.0092 | 3.1514 | 2.3387 | 7 | 164 | central nervous system neuron differentiation |
GO:0051937 | 0.0094 | 5.1977 | 0.8271 | 4 | 58 | catecholamine transport |
GO:0042462 | 0.0096 | 7.496 | 0.4421 | 3 | 31 | eye photoreceptor cell development |
GO:0043537 | 0.0096 | 7.496 | 0.4421 | 3 | 31 | negative regulation of blood vessel endothelial cell migration |
GO:0051954 | 0.0096 | 7.496 | 0.4421 | 3 | 31 | positive regulation of amine transport |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 44.052 | 0.427 | 13 | 57 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007606 | 0 | 19.4069 | 0.9889 | 15 | 132 | sensory perception of chemical stimulus |
GO:0009593 | 0 | 20.5896 | 0.869 | 14 | 116 | detection of chemical stimulus |
GO:0050906 | 0 | 18.2463 | 0.9664 | 14 | 129 | detection of stimulus involved in sensory perception |
GO:0016579 | 0 | 7.7365 | 1.9512 | 13 | 265 | protein deubiquitination |
GO:0007565 | 0 | 7.7127 | 1.311 | 9 | 175 | female pregnancy |
GO:0007186 | 0 | 3.4837 | 6.2855 | 19 | 839 | G-protein coupled receptor signaling pathway |
GO:0050877 | 0 | 3.3789 | 6.4653 | 19 | 863 | nervous system process |
GO:0045087 | 0 | 3.4706 | 5.5663 | 17 | 743 | innate immune response |
GO:0043632 | 1e-04 | 3.6905 | 4.2403 | 14 | 566 | modification-dependent macromolecule catabolic process |
GO:0019730 | 2e-04 | 10.4511 | 0.5319 | 5 | 71 | antimicrobial humoral response |
GO:0006511 | 7e-04 | 3.2794 | 4.0129 | 12 | 545 | ubiquitin-dependent protein catabolic process |
GO:0071947 | 8e-04 | 67.4062 | 0.0449 | 2 | 6 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process |
GO:0090279 | 0.0012 | 16.3005 | 0.2098 | 3 | 28 | regulation of calcium ion import |
GO:0035865 | 0.0015 | 44.9315 | 0.0599 | 2 | 8 | cellular response to potassium ion |
GO:0032342 | 0.0019 | 38.5102 | 0.0674 | 2 | 9 | aldosterone biosynthetic process |
GO:0034651 | 0.0019 | 38.5102 | 0.0674 | 2 | 9 | cortisol biosynthetic process |
GO:0051603 | 0.0022 | 2.8261 | 4.6167 | 12 | 627 | proteolysis involved in cellular protein catabolic process |
GO:0008212 | 0.0024 | 33.6942 | 0.0749 | 2 | 10 | mineralocorticoid metabolic process |
GO:0042742 | 0.0025 | 4.7118 | 1.3635 | 6 | 182 | defense response to bacterium |
GO:0043207 | 0.0025 | 2.6643 | 5.3116 | 13 | 709 | response to external biotic stimulus |
GO:0030163 | 0.0029 | 2.5196 | 6.0607 | 14 | 809 | protein catabolic process |
GO:0009913 | 0.0029 | 3.9674 | 1.8879 | 7 | 252 | epidermal cell differentiation |
GO:0048247 | 0.0031 | 11.3116 | 0.2922 | 3 | 39 | lymphocyte chemotaxis |
GO:0031424 | 0.0037 | 10.4951 | 0.3128 | 3 | 43 | keratinization |
GO:0050776 | 0.0039 | 2.426 | 6.278 | 14 | 838 | regulation of immune response |
GO:0002548 | 0.0043 | 9.9288 | 0.3296 | 3 | 44 | monocyte chemotaxis |
GO:0002376 | 0.0044 | 1.8409 | 18.6092 | 30 | 2484 | immune system process |
GO:0070268 | 0.0054 | 6.0659 | 0.7042 | 4 | 94 | cornification |
GO:0032604 | 0.0055 | 20.728 | 0.1124 | 2 | 15 | granulocyte macrophage colony-stimulating factor production |
GO:0001977 | 0.007 | 17.9619 | 0.1274 | 2 | 17 | renal system process involved in regulation of blood volume |
GO:0007635 | 0.007 | 17.9619 | 0.1274 | 2 | 17 | chemosensory behavior |
GO:0006037 | 0.0075 | Inf | 0.0075 | 1 | 1 | cell wall chitin metabolic process |
GO:0038156 | 0.0075 | Inf | 0.0075 | 1 | 1 | interleukin-3-mediated signaling pathway |
GO:0046296 | 0.0075 | Inf | 0.0075 | 1 | 1 | glycolate catabolic process |
GO:1901318 | 0.0075 | Inf | 0.0075 | 1 | 1 | negative regulation of flagellated sperm motility |
GO:0002221 | 0.0078 | 4.3113 | 1.2286 | 5 | 164 | pattern recognition receptor signaling pathway |
GO:0070098 | 0.0089 | 7.532 | 0.427 | 3 | 57 | chemokine-mediated signaling pathway |
GO:0043588 | 0.0091 | 3.1741 | 2.3374 | 7 | 312 | skin development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0014717 | 4e-04 | 162.4757 | 0.0369 | 2 | 3 | regulation of satellite cell activation involved in skeletal muscle regeneration |
GO:0048706 | 7e-04 | 5.0883 | 1.487 | 7 | 121 | embryonic skeletal system development |
GO:1905205 | 9e-04 | 81.2324 | 0.0492 | 2 | 4 | positive regulation of connective tissue replacement |
GO:2000026 | 0.001 | 1.8794 | 21.2352 | 36 | 1728 | regulation of multicellular organismal development |
GO:0001944 | 0.0013 | 2.4475 | 7.4594 | 17 | 607 | vasculature development |
GO:0048514 | 0.0015 | 2.5878 | 6.2059 | 15 | 505 | blood vessel morphogenesis |
GO:0008630 | 0.0015 | 5.2672 | 1.2289 | 6 | 100 | intrinsic apoptotic signaling pathway in response to DNA damage |
GO:0060455 | 0.0015 | 54.1514 | 0.0614 | 2 | 5 | negative regulation of gastric acid secretion |
GO:0060216 | 0.0015 | 15.2996 | 0.2335 | 3 | 19 | definitive hemopoiesis |
GO:0048646 | 0.0017 | 2.0974 | 11.8588 | 23 | 965 | anatomical structure formation involved in morphogenesis |
GO:0042100 | 0.0018 | 6.2288 | 0.8725 | 5 | 71 | B cell proliferation |
GO:0048771 | 0.002 | 4.2275 | 1.7696 | 7 | 144 | tissue remodeling |
GO:0072359 | 0.0021 | 2.1008 | 11.2935 | 22 | 919 | circulatory system development |
GO:0014719 | 0.0022 | 40.6108 | 0.0737 | 2 | 6 | skeletal muscle satellite cell activation |
GO:0030817 | 0.0027 | 4.6232 | 1.3886 | 6 | 113 | regulation of cAMP biosynthetic process |
GO:0010469 | 0.0028 | 2.4905 | 5.9847 | 14 | 487 | regulation of receptor activity |
GO:0048583 | 0.0031 | 1.5743 | 44.1908 | 61 | 3596 | regulation of response to stimulus |
GO:0009792 | 0.0031 | 2.3766 | 6.722 | 15 | 547 | embryo development ending in birth or egg hatching |
GO:0050671 | 0.0032 | 4.4554 | 1.4378 | 6 | 117 | positive regulation of lymphocyte proliferation |
GO:0030216 | 0.0038 | 3.3825 | 2.5069 | 8 | 204 | keratinocyte differentiation |
GO:0070665 | 0.004 | 4.262 | 1.4992 | 6 | 122 | positive regulation of leukocyte proliferation |
GO:0001955 | 0.004 | 27.0703 | 0.0983 | 2 | 8 | blood vessel maturation |
GO:0033141 | 0.004 | 27.0703 | 0.0983 | 2 | 8 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
GO:0035912 | 0.004 | 27.0703 | 0.0983 | 2 | 8 | dorsal aorta morphogenesis |
GO:0030855 | 0.0046 | 2.2119 | 7.6928 | 16 | 626 | epithelial cell differentiation |
GO:0060837 | 0.0051 | 23.2015 | 0.1106 | 2 | 9 | blood vessel endothelial cell differentiation |
GO:0045321 | 0.0053 | 1.9003 | 12.9771 | 23 | 1056 | leukocyte activation |
GO:0009605 | 0.0055 | 1.6747 | 23.4595 | 36 | 1909 | response to external stimulus |
GO:0045766 | 0.0056 | 3.9527 | 1.6098 | 6 | 131 | positive regulation of angiogenesis |
GO:0072604 | 0.0058 | 9.0598 | 0.3687 | 3 | 30 | interleukin-6 secretion |
GO:0070268 | 0.006 | 4.612 | 1.1552 | 5 | 94 | cornification |
GO:0021877 | 0.0063 | 20.3 | 0.1229 | 2 | 10 | forebrain neuron fate commitment |
GO:0009888 | 0.0064 | 1.6915 | 21.1738 | 33 | 1723 | tissue development |
GO:0043537 | 0.0064 | 8.7356 | 0.381 | 3 | 31 | negative regulation of blood vessel endothelial cell migration |
GO:0003002 | 0.0064 | 2.6739 | 3.9447 | 10 | 321 | regionalization |
GO:0032943 | 0.0067 | 3.0508 | 2.765 | 8 | 225 | mononuclear cell proliferation |
GO:0043330 | 0.007 | 8.4338 | 0.3932 | 3 | 32 | response to exogenous dsRNA |
GO:0045746 | 0.007 | 8.4338 | 0.3932 | 3 | 32 | negative regulation of Notch signaling pathway |
GO:0045765 | 0.0071 | 4.4288 | 1.1998 | 5 | 100 | regulation of angiogenesis |
GO:0030183 | 0.0072 | 4.4124 | 1.2043 | 5 | 98 | B cell differentiation |
GO:0090084 | 0.0077 | 18.0432 | 0.1352 | 2 | 11 | negative regulation of inclusion body assembly |
GO:2000774 | 0.0077 | 18.0432 | 0.1352 | 2 | 11 | positive regulation of cellular senescence |
GO:0046058 | 0.0079 | 3.6575 | 1.7327 | 6 | 141 | cAMP metabolic process |
GO:0032501 | 0.0081 | 1.4511 | 73.6336 | 90 | 6166 | multicellular organismal process |
GO:0006954 | 0.0081 | 2.1232 | 7.4716 | 15 | 608 | inflammatory response |
GO:0030808 | 0.0082 | 3.6303 | 1.745 | 6 | 142 | regulation of nucleotide biosynthetic process |
GO:0006955 | 0.0083 | 1.6685 | 20.7314 | 32 | 1687 | immune response |
GO:0010633 | 0.0083 | 5.3638 | 0.7988 | 4 | 65 | negative regulation of epithelial cell migration |
GO:0001959 | 0.0085 | 3.6036 | 1.7573 | 6 | 143 | regulation of cytokine-mediated signaling pathway |
GO:0052652 | 0.0085 | 3.6036 | 1.7573 | 6 | 143 | cyclic purine nucleotide metabolic process |
GO:0048566 | 0.009 | 7.6416 | 0.4301 | 3 | 35 | embryonic digestive tract development |
GO:0048518 | 0.0091 | 1.4426 | 63.1157 | 79 | 5136 | positive regulation of biological process |
GO:0045835 | 0.0091 | 16.2378 | 0.1475 | 2 | 12 | negative regulation of meiotic nuclear division |
GO:0090197 | 0.0091 | 16.2378 | 0.1475 | 2 | 12 | positive regulation of chemokine secretion |
GO:0002687 | 0.0092 | 4.1434 | 1.278 | 5 | 104 | positive regulation of leukocyte migration |
GO:0006950 | 0.0093 | 1.4933 | 41.7945 | 56 | 3401 | response to stress |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0033690 | 0 | 62.846 | 0.0697 | 3 | 10 | positive regulation of osteoblast proliferation |
GO:2000502 | 0 | Inf | 0.0139 | 2 | 2 | negative regulation of natural killer cell chemotaxis |
GO:0043588 | 1e-04 | 5.108 | 2.1734 | 10 | 312 | skin development |
GO:0032502 | 1e-04 | 2.2174 | 29.5714 | 47 | 4581 | developmental process |
GO:0042335 | 1e-04 | 290.5769 | 0.0209 | 2 | 3 | cuticle development |
GO:0060429 | 2e-04 | 3.0255 | 6.4112 | 17 | 967 | epithelium development |
GO:0072073 | 3e-04 | 7.0233 | 0.9334 | 6 | 134 | kidney epithelium development |
GO:0031424 | 4e-04 | 6.8611 | 0.9543 | 6 | 137 | keratinization |
GO:0072164 | 5e-04 | 8.4513 | 0.6478 | 5 | 93 | mesonephric tubule development |
GO:0008544 | 5e-04 | 8.1828 | 0.6682 | 5 | 100 | epidermis development |
GO:0061217 | 6e-04 | 20.9293 | 0.1672 | 3 | 24 | regulation of mesonephros development |
GO:0072273 | 7e-04 | 19.9766 | 0.1741 | 3 | 25 | metanephric nephron morphogenesis |
GO:0003407 | 7e-04 | 10.9346 | 0.404 | 4 | 58 | neural retina development |
GO:2000489 | 7e-04 | 72.6298 | 0.0418 | 2 | 6 | regulation of hepatic stellate cell activation |
GO:0048729 | 9e-04 | 3.1587 | 4.1726 | 12 | 599 | tissue morphogenesis |
GO:2000402 | 0.001 | 58.1 | 0.0488 | 2 | 7 | negative regulation of lymphocyte migration |
GO:0042127 | 0.0011 | 2.3276 | 10.2468 | 21 | 1471 | regulation of cell proliferation |
GO:0046427 | 0.0014 | 8.9394 | 0.4876 | 4 | 70 | positive regulation of JAK-STAT cascade |
GO:0001501 | 0.0015 | 3.3477 | 3.2461 | 10 | 466 | skeletal system development |
GO:2000026 | 0.0016 | 2.1788 | 12.0371 | 23 | 1728 | regulation of multicellular organismal development |
GO:0072537 | 0.0017 | 41.4945 | 0.0627 | 2 | 9 | fibroblast activation |
GO:0048762 | 0.0017 | 5.0915 | 1.2678 | 6 | 182 | mesenchymal cell differentiation |
GO:0045429 | 0.0018 | 13.7248 | 0.2438 | 3 | 35 | positive regulation of nitric oxide biosynthetic process |
GO:0044057 | 0.0018 | 3.2592 | 3.3297 | 10 | 478 | regulation of system process |
GO:0090288 | 0.002 | 6.0324 | 0.8916 | 5 | 128 | negative regulation of cellular response to growth factor stimulus |
GO:0050665 | 0.0021 | 36.3053 | 0.0697 | 2 | 10 | hydrogen peroxide biosynthetic process |
GO:0060394 | 0.0021 | 36.3053 | 0.0697 | 2 | 10 | negative regulation of pathway-restricted SMAD protein phosphorylation |
GO:1904892 | 0.0021 | 5.935 | 0.9056 | 5 | 130 | regulation of STAT cascade |
GO:0032924 | 0.0023 | 12.5459 | 0.2647 | 3 | 38 | activin receptor signaling pathway |
GO:0045777 | 0.0023 | 12.5459 | 0.2647 | 3 | 38 | positive regulation of blood pressure |
GO:0090184 | 0.0023 | 12.5459 | 0.2647 | 3 | 38 | positive regulation of kidney development |
GO:0072006 | 0.0024 | 5.7948 | 0.9265 | 5 | 133 | nephron development |
GO:0006068 | 0.0025 | 32.2692 | 0.0766 | 2 | 11 | ethanol catabolic process |
GO:2000379 | 0.0026 | 7.5581 | 0.5712 | 4 | 82 | positive regulation of reactive oxygen species metabolic process |
GO:0098869 | 0.0027 | 7.4619 | 0.5782 | 4 | 83 | cellular oxidant detoxification |
GO:0055078 | 0.0027 | 11.8662 | 0.2786 | 3 | 40 | sodium ion homeostasis |
GO:0072001 | 0.0027 | 4.0074 | 1.8738 | 7 | 269 | renal system development |
GO:0001656 | 0.0028 | 7.3681 | 0.5851 | 4 | 84 | metanephros development |
GO:0001942 | 0.0028 | 7.3681 | 0.5851 | 4 | 84 | hair follicle development |
GO:0030154 | 0.0029 | 1.926 | 19.2053 | 31 | 2966 | cell differentiation |
GO:0060707 | 0.003 | 29.0404 | 0.0836 | 2 | 12 | trophoblast giant cell differentiation |
GO:0022404 | 0.003 | 7.1875 | 0.5991 | 4 | 86 | molting cycle process |
GO:0060993 | 0.003 | 7.1875 | 0.5991 | 4 | 86 | kidney morphogenesis |
GO:0040007 | 0.0031 | 2.5062 | 6.123 | 14 | 879 | growth |
GO:0072080 | 0.0033 | 7.0154 | 0.613 | 4 | 88 | nephron tubule development |
GO:0090092 | 0.0033 | 4.4284 | 1.4489 | 6 | 208 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0030509 | 0.0035 | 5.256 | 1.017 | 5 | 146 | BMP signaling pathway |
GO:0098754 | 0.0037 | 6.7721 | 0.6339 | 4 | 91 | detoxification |
GO:0060042 | 0.004 | 10.2064 | 0.3204 | 3 | 46 | retina morphogenesis in camera-type eye |
GO:0002689 | 0.0041 | 24.1971 | 0.0975 | 2 | 14 | negative regulation of leukocyte chemotaxis |
GO:0034616 | 0.0041 | 24.1971 | 0.0975 | 2 | 14 | response to laminar fluid shear stress |
GO:1901623 | 0.0041 | 24.1971 | 0.0975 | 2 | 14 | regulation of lymphocyte chemotaxis |
GO:0097237 | 0.0045 | 6.402 | 0.6687 | 4 | 96 | cellular response to toxic substance |
GO:0043009 | 0.0046 | 2.849 | 3.7825 | 10 | 543 | chordate embryonic development |
GO:0009790 | 0.0046 | 2.3887 | 6.4017 | 14 | 919 | embryo development |
GO:0050920 | 0.0047 | 4.9046 | 1.0867 | 5 | 156 | regulation of chemotaxis |
GO:0032516 | 0.0048 | 22.3343 | 0.1045 | 2 | 15 | positive regulation of phosphoprotein phosphatase activity |
GO:0071772 | 0.0048 | 4.872 | 1.0936 | 5 | 157 | response to BMP |
GO:0030336 | 0.005 | 4.0612 | 1.5743 | 6 | 226 | negative regulation of cell migration |
GO:0060688 | 0.0051 | 9.3353 | 0.3483 | 3 | 50 | regulation of morphogenesis of a branching structure |
GO:0035904 | 0.0054 | 9.1402 | 0.3553 | 3 | 51 | aorta development |
GO:0006590 | 0.0054 | 20.7376 | 0.1115 | 2 | 16 | thyroid hormone generation |
GO:0019218 | 0.0058 | 5.9465 | 0.7175 | 4 | 103 | regulation of steroid metabolic process |
GO:0042633 | 0.0058 | 5.9465 | 0.7175 | 4 | 103 | hair cycle |
GO:0048513 | 0.0061 | 1.8492 | 17.5512 | 28 | 2725 | animal organ development |
GO:0003198 | 0.0061 | 19.3538 | 0.1184 | 2 | 17 | epithelial to mesenchymal transition involved in endocardial cushion formation |
GO:0090190 | 0.0061 | 19.3538 | 0.1184 | 2 | 17 | positive regulation of branching involved in ureteric bud morphogenesis |
GO:0031099 | 0.0062 | 4.5682 | 1.1633 | 5 | 167 | regeneration |
GO:0048608 | 0.0065 | 3.0894 | 2.7655 | 8 | 397 | reproductive structure development |
GO:0019229 | 0.0066 | 8.4348 | 0.3831 | 3 | 55 | regulation of vasoconstriction |
GO:0048146 | 0.0066 | 8.4348 | 0.3831 | 3 | 55 | positive regulation of fibroblast proliferation |
GO:0000003 | 0.0068 | 2.1052 | 8.8745 | 17 | 1274 | reproduction |
GO:0045954 | 0.0068 | 18.143 | 0.1254 | 2 | 18 | positive regulation of natural killer cell mediated cytotoxicity |
GO:0072074 | 0.0068 | 18.143 | 0.1254 | 2 | 18 | kidney mesenchyme development |
GO:0072077 | 0.0068 | 18.143 | 0.1254 | 2 | 18 | renal vesicle morphogenesis |
GO:0030278 | 0.0069 | 4.4569 | 1.1912 | 5 | 171 | regulation of ossification |
GO:0007199 | 0.007 | Inf | 0.007 | 1 | 1 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger |
GO:0010734 | 0.007 | Inf | 0.007 | 1 | 1 | negative regulation of protein glutathionylation |
GO:0010805 | 0.007 | Inf | 0.007 | 1 | 1 | regulation of lysine import |
GO:0010963 | 0.007 | Inf | 0.007 | 1 | 1 | regulation of L-arginine import |
GO:0014905 | 0.007 | Inf | 0.007 | 1 | 1 | myoblast fusion involved in skeletal muscle regeneration |
GO:0048855 | 0.007 | Inf | 0.007 | 1 | 1 | adenohypophysis morphogenesis |
GO:0051134 | 0.007 | Inf | 0.007 | 1 | 1 | negative regulation of NK T cell activation |
GO:0060101 | 0.007 | Inf | 0.007 | 1 | 1 | negative regulation of phagocytosis, engulfment |
GO:0060739 | 0.007 | Inf | 0.007 | 1 | 1 | mesenchymal-epithelial cell signaling involved in prostate gland development |
GO:0060806 | 0.007 | Inf | 0.007 | 1 | 1 | negative regulation of cell differentiation involved in embryonic placenta development |
GO:0060857 | 0.007 | Inf | 0.007 | 1 | 1 | establishment of glial blood-brain barrier |
GO:0060981 | 0.007 | Inf | 0.007 | 1 | 1 | cell migration involved in coronary angiogenesis |
GO:0097275 | 0.007 | Inf | 0.007 | 1 | 1 | cellular ammonia homeostasis |
GO:0097276 | 0.007 | Inf | 0.007 | 1 | 1 | cellular creatinine homeostasis |
GO:0097277 | 0.007 | Inf | 0.007 | 1 | 1 | cellular urea homeostasis |
GO:0140076 | 0.007 | Inf | 0.007 | 1 | 1 | negative regulation of lipoprotein transport |
GO:1902567 | 0.007 | Inf | 0.007 | 1 | 1 | negative regulation of eosinophil activation |
GO:1902569 | 0.007 | Inf | 0.007 | 1 | 1 | negative regulation of activation of Janus kinase activity |
GO:1902867 | 0.007 | Inf | 0.007 | 1 | 1 | negative regulation of retina development in camera-type eye |
GO:1902870 | 0.007 | Inf | 0.007 | 1 | 1 | negative regulation of amacrine cell differentiation |
GO:1905010 | 0.007 | Inf | 0.007 | 1 | 1 | positive regulation of L-lysine import across plasma membrane |
GO:1905589 | 0.007 | Inf | 0.007 | 1 | 1 | positive regulation of L-arginine import across plasma membrane |
GO:0048646 | 0.007 | 2.2658 | 6.7221 | 14 | 965 | anatomical structure formation involved in morphogenesis |
GO:0090596 | 0.0071 | 3.7656 | 1.6927 | 6 | 243 | sensory organ morphogenesis |
GO:0001503 | 0.0071 | 4.4214 | 1.2016 | 5 | 179 | ossification |
GO:0006575 | 0.0072 | 4.4033 | 1.2051 | 5 | 173 | cellular modified amino acid metabolic process |
GO:0061138 | 0.0072 | 4.4033 | 1.2051 | 5 | 173 | morphogenesis of a branching epithelium |
GO:0051241 | 0.0072 | 2.2577 | 6.7488 | 14 | 978 | negative regulation of multicellular organismal process |
GO:0001568 | 0.0074 | 2.6429 | 4.0611 | 10 | 583 | blood vessel development |
GO:0035809 | 0.0076 | 17.0747 | 0.1324 | 2 | 19 | regulation of urine volume |
GO:0035813 | 0.0076 | 17.0747 | 0.1324 | 2 | 19 | regulation of renal sodium excretion |
GO:0042744 | 0.0076 | 17.0747 | 0.1324 | 2 | 19 | hydrogen peroxide catabolic process |
GO:0060193 | 0.0077 | 7.9732 | 0.404 | 3 | 58 | positive regulation of lipase activity |
GO:0006936 | 0.0079 | 3.2682 | 2.2778 | 7 | 327 | muscle contraction |
GO:0051271 | 0.0082 | 3.6407 | 1.7484 | 6 | 251 | negative regulation of cellular component movement |
GO:0009913 | 0.0084 | 3.6256 | 1.7554 | 6 | 252 | epidermal cell differentiation |
GO:0035929 | 0.0084 | 16.125 | 0.1393 | 2 | 20 | steroid hormone secretion |
GO:0060675 | 0.0084 | 7.6924 | 0.418 | 3 | 60 | ureteric bud morphogenesis |
GO:0045596 | 0.0087 | 2.5771 | 4.1611 | 10 | 603 | negative regulation of cell differentiation |
GO:0009611 | 0.0088 | 2.5728 | 4.1656 | 10 | 598 | response to wounding |
GO:0050896 | 0.0092 | 1.6242 | 52.4462 | 65 | 7529 | response to stimulus |
GO:0046209 | 0.0092 | 7.4306 | 0.4319 | 3 | 62 | nitric oxide metabolic process |
GO:0048844 | 0.0092 | 7.4306 | 0.4319 | 3 | 62 | artery morphogenesis |
GO:1901687 | 0.0093 | 15.2753 | 0.1463 | 2 | 21 | glutathione derivative biosynthetic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 25.7429 | 0.3334 | 7 | 57 | detection of chemical stimulus involved in sensory perception of smell |
GO:0002430 | 0 | 101.6538 | 0.0643 | 4 | 11 | complement receptor mediated signaling pathway |
GO:0009593 | 0 | 11.7625 | 0.6785 | 7 | 116 | detection of chemical stimulus |
GO:0050900 | 0 | 5.8183 | 2.1582 | 11 | 369 | leukocyte migration |
GO:0050906 | 0 | 10.5 | 0.7545 | 7 | 129 | detection of stimulus involved in sensory perception |
GO:0007606 | 0 | 10.246 | 0.772 | 7 | 132 | sensory perception of chemical stimulus |
GO:0031424 | 2e-04 | 8.2757 | 0.8013 | 6 | 137 | keratinization |
GO:0007200 | 2e-04 | 9.9458 | 0.5556 | 5 | 95 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0043588 | 5e-04 | 4.8161 | 1.8248 | 8 | 312 | skin development |
GO:0009913 | 7e-04 | 5.1857 | 1.4739 | 7 | 252 | epidermal cell differentiation |
GO:0060326 | 0.002 | 4.9442 | 1.3101 | 6 | 224 | cell chemotaxis |
GO:0007186 | 0.0027 | 2.9407 | 4.1328 | 11 | 744 | G-protein coupled receptor signaling pathway |
GO:0042330 | 0.0033 | 3.2246 | 3.0355 | 9 | 519 | taxis |
GO:0050918 | 0.0043 | 9.9221 | 0.3275 | 3 | 56 | positive chemotaxis |
GO:0060429 | 0.0046 | 2.4112 | 6.4394 | 14 | 1101 | epithelium development |
GO:0017198 | 0.0058 | Inf | 0.0058 | 1 | 1 | N-terminal peptidyl-serine acetylation |
GO:0018002 | 0.0058 | Inf | 0.0058 | 1 | 1 | N-terminal peptidyl-glutamic acid acetylation |
GO:0034156 | 0.0058 | Inf | 0.0058 | 1 | 1 | negative regulation of toll-like receptor 7 signaling pathway |
GO:0035759 | 0.0058 | Inf | 0.0058 | 1 | 1 | mesangial cell-matrix adhesion |
GO:1900035 | 0.0058 | Inf | 0.0058 | 1 | 1 | negative regulation of cellular response to heat |
GO:1901625 | 0.0058 | Inf | 0.0058 | 1 | 1 | cellular response to ergosterol |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0021515 | 1e-04 | 22.7288 | 0.2226 | 4 | 20 | cell differentiation in spinal cord |
GO:0048663 | 1e-04 | 8.7347 | 0.7686 | 6 | 68 | neuron fate commitment |
GO:0021517 | 3e-04 | 30.1365 | 0.1335 | 3 | 12 | ventral spinal cord development |
GO:0001708 | 3e-04 | 7.2145 | 0.9156 | 6 | 81 | cell fate specification |
GO:0021953 | 7e-04 | 5.1067 | 1.4801 | 7 | 133 | central nervous system neuron differentiation |
GO:0010662 | 8e-04 | 10.8312 | 0.4182 | 4 | 37 | regulation of striated muscle cell apoptotic process |
GO:0043415 | 0.0012 | 58.9882 | 0.0565 | 2 | 5 | positive regulation of skeletal muscle tissue regeneration |
GO:0021516 | 0.0016 | 14.8195 | 0.2374 | 3 | 21 | dorsal spinal cord development |
GO:0046469 | 0.0018 | 44.2382 | 0.0678 | 2 | 6 | platelet activating factor metabolic process |
GO:2001199 | 0.0018 | 44.2382 | 0.0678 | 2 | 6 | negative regulation of dendritic cell differentiation |
GO:0071157 | 0.0019 | 14.0386 | 0.2487 | 3 | 22 | negative regulation of cell cycle arrest |
GO:0007186 | 0.0023 | 2.2155 | 9.2463 | 19 | 827 | G-protein coupled receptor signaling pathway |
GO:0033601 | 0.0026 | 35.3882 | 0.0791 | 2 | 7 | positive regulation of mammary gland epithelial cell proliferation |
GO:0010657 | 0.0047 | 6.3729 | 0.6782 | 4 | 60 | muscle cell apoptotic process |
GO:0021522 | 0.0051 | 9.5205 | 0.3504 | 3 | 31 | spinal cord motor neuron differentiation |
GO:0097421 | 0.0055 | 9.1916 | 0.3617 | 3 | 32 | liver regeneration |
GO:0038111 | 0.006 | 8.8846 | 0.373 | 3 | 33 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0.006 | 8.8846 | 0.373 | 3 | 33 | response to interleukin-7 |
GO:0021521 | 0.0065 | 19.6549 | 0.1243 | 2 | 11 | ventral spinal cord interneuron specification |
GO:0015980 | 0.0068 | 3.0479 | 2.7693 | 8 | 245 | energy derivation by oxidation of organic compounds |
GO:0051290 | 0.0071 | 8.3282 | 0.3956 | 3 | 35 | protein heterotetramerization |
GO:0071392 | 0.0071 | 8.3282 | 0.3956 | 3 | 35 | cellular response to estradiol stimulus |
GO:0003376 | 0.0078 | 17.6882 | 0.1356 | 2 | 12 | sphingosine-1-phosphate signaling pathway |
GO:0010666 | 0.0078 | 17.6882 | 0.1356 | 2 | 12 | positive regulation of cardiac muscle cell apoptotic process |
GO:0060707 | 0.0078 | 17.6882 | 0.1356 | 2 | 12 | trophoblast giant cell differentiation |
GO:0090026 | 0.0078 | 17.6882 | 0.1356 | 2 | 12 | positive regulation of monocyte chemotaxis |
GO:0006334 | 0.0088 | 4.1799 | 1.266 | 5 | 112 | nucleosome assembly |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0009913 | 0 | 8.8906 | 1.7223 | 13 | 252 | epidermal cell differentiation |
GO:0043588 | 0 | 7.7334 | 2.1324 | 14 | 312 | skin development |
GO:0070268 | 0 | 14.561 | 0.6424 | 8 | 94 | cornification |
GO:0031424 | 0 | 21.6729 | 0.273 | 5 | 43 | keratinization |
GO:0060429 | 0 | 3.2875 | 7.5247 | 21 | 1101 | epithelium development |
GO:0010469 | 0 | 4.412 | 3.3284 | 13 | 487 | regulation of receptor activity |
GO:0061760 | 1e-04 | 296.3137 | 0.0205 | 2 | 3 | antifungal innate immune response |
GO:0006346 | 3e-04 | 26.3762 | 0.1367 | 3 | 20 | methylation-dependent chromatin silencing |
GO:0098868 | 4e-04 | 23.5967 | 0.1504 | 3 | 22 | bone growth |
GO:0071385 | 5e-04 | 12.2971 | 0.3622 | 4 | 53 | cellular response to glucocorticoid stimulus |
GO:0030823 | 9e-04 | 17.9263 | 0.1914 | 3 | 28 | regulation of cGMP metabolic process |
GO:0050829 | 9e-04 | 10.2061 | 0.4306 | 4 | 63 | defense response to Gram-negative bacterium |
GO:0006952 | 0.0017 | 2.3338 | 9.1582 | 19 | 1340 | defense response |
GO:0050830 | 0.0017 | 8.4744 | 0.5126 | 4 | 75 | defense response to Gram-positive bacterium |
GO:0071347 | 0.0017 | 8.4744 | 0.5126 | 4 | 75 | cellular response to interleukin-1 |
GO:0009605 | 0.002 | 2.1053 | 13.047 | 24 | 1909 | response to external stimulus |
GO:0048247 | 0.0024 | 12.4398 | 0.2665 | 3 | 39 | lymphocyte chemotaxis |
GO:0031960 | 0.0033 | 5.3628 | 0.9978 | 5 | 146 | response to corticosteroid |
GO:0002548 | 0.0034 | 10.9191 | 0.3007 | 3 | 44 | monocyte chemotaxis |
GO:0032645 | 0.0034 | 27.1863 | 0.088 | 2 | 13 | regulation of granulocyte macrophage colony-stimulating factor production |
GO:0003417 | 0.0034 | 26.9198 | 0.0888 | 2 | 13 | growth plate cartilage development |
GO:0030072 | 0.0046 | 4.1446 | 1.5446 | 6 | 226 | peptide hormone secretion |
GO:0050796 | 0.0051 | 4.8112 | 1.1072 | 5 | 162 | regulation of insulin secretion |
GO:0060413 | 0.0052 | 21.1471 | 0.1094 | 2 | 16 | atrial septum morphogenesis |
GO:0070372 | 0.0061 | 3.893 | 1.6403 | 6 | 240 | regulation of ERK1 and ERK2 cascade |
GO:0061458 | 0.0061 | 3.1295 | 2.7338 | 8 | 400 | reproductive system development |
GO:0002791 | 0.0066 | 3.089 | 2.768 | 8 | 405 | regulation of peptide secretion |
GO:0002041 | 0.0068 | Inf | 0.0068 | 1 | 1 | intussusceptive angiogenesis |
GO:0003421 | 0.0068 | Inf | 0.0068 | 1 | 1 | growth plate cartilage axis specification |
GO:0006742 | 0.0068 | Inf | 0.0068 | 1 | 1 | NADP catabolic process |
GO:0007495 | 0.0068 | Inf | 0.0068 | 1 | 1 | visceral mesoderm-endoderm interaction involved in midgut development |
GO:0021509 | 0.0068 | Inf | 0.0068 | 1 | 1 | roof plate formation |
GO:0032646 | 0.0068 | Inf | 0.0068 | 1 | 1 | regulation of hepatocyte growth factor production |
GO:0032685 | 0.0068 | Inf | 0.0068 | 1 | 1 | negative regulation of granulocyte macrophage colony-stimulating factor production |
GO:0032812 | 0.0068 | Inf | 0.0068 | 1 | 1 | positive regulation of epinephrine secretion |
GO:0048178 | 0.0068 | Inf | 0.0068 | 1 | 1 | negative regulation of hepatocyte growth factor biosynthetic process |
GO:1903403 | 0.0068 | Inf | 0.0068 | 1 | 1 | negative regulation of renal phosphate excretion |
GO:2001051 | 0.0068 | Inf | 0.0068 | 1 | 1 | positive regulation of tendon cell differentiation |
GO:0070098 | 0.0069 | 8.2833 | 0.3896 | 3 | 57 | chemokine-mediated signaling pathway |
GO:0046887 | 0.007 | 5.6135 | 0.7581 | 4 | 112 | positive regulation of hormone secretion |
GO:0002227 | 0.0073 | 17.4118 | 0.1299 | 2 | 19 | innate immune response in mucosa |
GO:0030828 | 0.0073 | 17.4118 | 0.1299 | 2 | 19 | positive regulation of cGMP biosynthetic process |
GO:0071346 | 0.008 | 5.4061 | 0.786 | 4 | 115 | cellular response to interferon-gamma |
GO:0060716 | 0.0081 | 16.4434 | 0.1367 | 2 | 20 | labyrinthine layer blood vessel development |
GO:0003181 | 0.0089 | 15.5769 | 0.1435 | 2 | 21 | atrioventricular valve morphogenesis |
GO:0019373 | 0.0089 | 15.5769 | 0.1435 | 2 | 21 | epoxygenase P450 pathway |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048704 | 0 | 17.1196 | 0.9492 | 13 | 92 | embryonic skeletal system morphogenesis |
GO:0007389 | 0 | 5.5497 | 4.1889 | 20 | 406 | pattern specification process |
GO:0048568 | 0 | 5.535 | 4.1992 | 20 | 407 | embryonic organ development |
GO:0009952 | 0 | 8.0932 | 2.0016 | 14 | 194 | anterior/posterior pattern specification |
GO:0043009 | 0 | 4.3005 | 5.6024 | 21 | 543 | chordate embryonic development |
GO:0009887 | 0 | 3.254 | 8.4507 | 24 | 852 | animal organ morphogenesis |
GO:0030878 | 0 | 26.0405 | 0.2476 | 5 | 24 | thyroid gland development |
GO:0021615 | 0 | 293.3571 | 0.0413 | 3 | 4 | glossopharyngeal nerve morphogenesis |
GO:0048598 | 0 | 3.7482 | 4.4217 | 15 | 439 | embryonic morphogenesis |
GO:0001501 | 0 | 4.4901 | 2.941 | 12 | 295 | skeletal system development |
GO:0045944 | 1e-04 | 2.6097 | 10.7714 | 25 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
GO:0021675 | 1e-04 | 9.1666 | 0.7325 | 6 | 71 | nerve development |
GO:0021570 | 1e-04 | Inf | 0.0206 | 2 | 2 | rhombomere 4 development |
GO:0035116 | 2e-04 | 16.3791 | 0.2889 | 4 | 28 | embryonic hindlimb morphogenesis |
GO:0008544 | 3e-04 | 3.583 | 3.6317 | 12 | 352 | epidermis development |
GO:0014707 | 3e-04 | 194.3097 | 0.031 | 2 | 3 | branchiomeric skeletal muscle development |
GO:0060435 | 3e-04 | 194.3097 | 0.031 | 2 | 3 | bronchiole development |
GO:0048869 | 4e-04 | 1.8048 | 39.4744 | 59 | 3826 | cellular developmental process |
GO:0032100 | 6e-04 | 97.1484 | 0.0413 | 2 | 4 | positive regulation of appetite |
GO:1905205 | 6e-04 | 97.1484 | 0.0413 | 2 | 4 | positive regulation of connective tissue replacement |
GO:0032691 | 7e-04 | 20.936 | 0.1754 | 3 | 17 | negative regulation of interleukin-1 beta production |
GO:0009888 | 7e-04 | 2.1727 | 13.3734 | 26 | 1371 | tissue development |
GO:0032095 | 8e-04 | 19.539 | 0.1857 | 3 | 18 | regulation of response to food |
GO:0045409 | 0.001 | 64.7613 | 0.0516 | 2 | 5 | negative regulation of interleukin-6 biosynthetic process |
GO:0030855 | 0.0012 | 2.6568 | 6.102 | 15 | 602 | epithelial cell differentiation |
GO:1903508 | 0.0013 | 2.0728 | 13.846 | 26 | 1342 | positive regulation of nucleic acid-templated transcription |
GO:0030216 | 0.0013 | 4.0718 | 2.1048 | 8 | 204 | keratinocyte differentiation |
GO:0032109 | 0.0015 | 48.5677 | 0.0619 | 2 | 6 | positive regulation of response to nutrient levels |
GO:0021602 | 0.0016 | 14.9394 | 0.2328 | 3 | 23 | cranial nerve morphogenesis |
GO:0032104 | 0.0019 | 13.9508 | 0.2476 | 3 | 24 | regulation of response to extracellular stimulus |
GO:0060487 | 0.0019 | 13.9508 | 0.2476 | 3 | 24 | lung epithelial cell differentiation |
GO:0060425 | 0.0019 | 8.351 | 0.5262 | 4 | 51 | lung morphogenesis |
GO:0060173 | 0.0019 | 4.265 | 1.754 | 7 | 170 | limb development |
GO:0051216 | 0.002 | 4.2387 | 1.7643 | 7 | 171 | cartilage development |
GO:0002645 | 0.0021 | 38.8516 | 0.0722 | 2 | 7 | positive regulation of tolerance induction |
GO:0010700 | 0.0021 | 38.8516 | 0.0722 | 2 | 7 | negative regulation of norepinephrine secretion |
GO:0021612 | 0.0021 | 38.8516 | 0.0722 | 2 | 7 | facial nerve structural organization |
GO:2000253 | 0.0021 | 38.8516 | 0.0722 | 2 | 7 | positive regulation of feeding behavior |
GO:0021884 | 0.0024 | 12.736 | 0.2683 | 3 | 26 | forebrain neuron development |
GO:0051254 | 0.0026 | 1.9597 | 14.5579 | 26 | 1411 | positive regulation of RNA metabolic process |
GO:0042129 | 0.0026 | 4.6722 | 1.3722 | 6 | 133 | regulation of T cell proliferation |
GO:0008343 | 0.0028 | 32.3742 | 0.0825 | 2 | 8 | adult feeding behavior |
GO:0010940 | 0.0028 | 32.3742 | 0.0825 | 2 | 8 | positive regulation of necrotic cell death |
GO:0021872 | 0.0032 | 7.1325 | 0.6087 | 4 | 59 | forebrain generation of neurons |
GO:0048645 | 0.0032 | 7.1325 | 0.6087 | 4 | 59 | animal organ formation |
GO:0042755 | 0.0032 | 11.2642 | 0.2992 | 3 | 29 | eating behavior |
GO:0031326 | 0.0033 | 1.6078 | 42.095 | 58 | 4080 | regulation of cellular biosynthetic process |
GO:0032652 | 0.0036 | 6.8813 | 0.6294 | 4 | 61 | regulation of interleukin-1 production |
GO:0021561 | 0.0036 | 27.7475 | 0.0929 | 2 | 9 | facial nerve development |
GO:0072239 | 0.0036 | 27.7475 | 0.0929 | 2 | 9 | metanephric glomerulus vasculature development |
GO:0009653 | 0.0038 | 2.0934 | 10.5239 | 20 | 1204 | anatomical structure morphogenesis |
GO:0010628 | 0.0045 | 1.8117 | 17.5705 | 29 | 1703 | positive regulation of gene expression |
GO:0042447 | 0.0045 | 24.2774 | 0.1032 | 2 | 10 | hormone catabolic process |
GO:0061042 | 0.0045 | 24.2774 | 0.1032 | 2 | 10 | vascular wound healing |
GO:0051239 | 0.0056 | 1.6537 | 27.0316 | 40 | 2620 | regulation of multicellular organismal process |
GO:0048731 | 0.0058 | 1.6196 | 34.3524 | 48 | 3691 | system development |
GO:0048536 | 0.006 | 8.8707 | 0.3714 | 3 | 36 | spleen development |
GO:1903531 | 0.0063 | 3.846 | 1.6508 | 6 | 160 | negative regulation of secretion by cell |
GO:0032099 | 0.0065 | 19.4194 | 0.1238 | 2 | 12 | negative regulation of appetite |
GO:0043568 | 0.0065 | 19.4194 | 0.1238 | 2 | 12 | positive regulation of insulin-like growth factor receptor signaling pathway |
GO:0045019 | 0.0065 | 19.4194 | 0.1238 | 2 | 12 | negative regulation of nitric oxide biosynthetic process |
GO:0060576 | 0.0065 | 19.4194 | 0.1238 | 2 | 12 | intestinal epithelial cell development |
GO:0048522 | 0.0075 | 1.5204 | 47.3053 | 62 | 4585 | positive regulation of cellular process |
GO:0050830 | 0.0075 | 5.5193 | 0.7738 | 4 | 75 | defense response to Gram-positive bacterium |
GO:0048608 | 0.0082 | 2.5792 | 4.096 | 10 | 397 | reproductive structure development |
GO:0048483 | 0.0086 | 7.701 | 0.423 | 3 | 41 | autonomic nervous system development |
GO:0006355 | 0.0088 | 1.553 | 34.8213 | 48 | 3375 | regulation of transcription, DNA-templated |
GO:0032108 | 0.0089 | 16.1806 | 0.1444 | 2 | 14 | negative regulation of response to nutrient levels |
GO:1904467 | 0.0089 | 16.1806 | 0.1444 | 2 | 14 | regulation of tumor necrosis factor secretion |
GO:2001212 | 0.0089 | 16.1806 | 0.1444 | 2 | 14 | regulation of vasculogenesis |
GO:0045843 | 0.0092 | 7.503 | 0.4333 | 3 | 42 | negative regulation of striated muscle tissue development |
GO:0010557 | 0.0095 | 1.75 | 16.0952 | 26 | 1560 | positive regulation of macromolecule biosynthetic process |
GO:0032720 | 0.0098 | 7.3149 | 0.4436 | 3 | 43 | negative regulation of tumor necrosis factor production |
GO:0035113 | 0.0099 | 4.0613 | 1.3 | 5 | 126 | embryonic appendage morphogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007275 | 0 | 2.2165 | 41.2983 | 68 | 4069 | multicellular organism development |
GO:0007423 | 0 | 3.6295 | 5.5199 | 18 | 506 | sensory organ development |
GO:0035108 | 0 | 6.2868 | 1.5818 | 9 | 145 | limb morphogenesis |
GO:0007601 | 0 | 5.4808 | 2.0072 | 10 | 184 | visual perception |
GO:0048568 | 0 | 3.7148 | 4.4399 | 15 | 407 | embryonic organ development |
GO:0008284 | 1e-04 | 2.799 | 8.738 | 22 | 801 | positive regulation of cell proliferation |
GO:0035113 | 1e-04 | 6.4076 | 1.3745 | 8 | 126 | embryonic appendage morphogenesis |
GO:0035195 | 1e-04 | 5.5819 | 1.7672 | 9 | 162 | gene silencing by miRNA |
GO:0043010 | 1e-04 | 4.156 | 3.1527 | 12 | 289 | camera-type eye development |
GO:0016441 | 1e-04 | 5.3352 | 1.8436 | 9 | 169 | posttranscriptional gene silencing |
GO:0048736 | 1e-04 | 5.3017 | 1.8545 | 9 | 170 | appendage development |
GO:0008544 | 1e-04 | 3.6874 | 3.8399 | 13 | 352 | epidermis development |
GO:0034249 | 2e-04 | 4.0852 | 2.9236 | 11 | 268 | negative regulation of cellular amide metabolic process |
GO:0048598 | 2e-04 | 3.3188 | 4.5962 | 14 | 439 | embryonic morphogenesis |
GO:0035116 | 2e-04 | 15.4599 | 0.3054 | 4 | 28 | embryonic hindlimb morphogenesis |
GO:0031047 | 3e-04 | 4.6574 | 2.0945 | 9 | 192 | gene silencing by RNA |
GO:0001942 | 3e-04 | 7.1986 | 0.9163 | 6 | 84 | hair follicle development |
GO:0022404 | 4e-04 | 7.0177 | 0.9382 | 6 | 86 | molting cycle process |
GO:0003099 | 4e-04 | 183.5366 | 0.0327 | 2 | 3 | positive regulation of the force of heart contraction by chemical signal |
GO:0048869 | 4e-04 | 1.7822 | 40.4119 | 60 | 3786 | cellular developmental process |
GO:0051241 | 4e-04 | 2.3714 | 10.6798 | 23 | 979 | negative regulation of multicellular organismal process |
GO:0051171 | 5e-04 | 1.7005 | 58.9296 | 80 | 5402 | regulation of nitrogen compound metabolic process |
GO:0007517 | 5e-04 | 3.3614 | 3.8508 | 12 | 353 | muscle organ development |
GO:0009887 | 5e-04 | 2.4301 | 9.4797 | 21 | 887 | animal organ morphogenesis |
GO:0048704 | 5e-04 | 6.5254 | 1.0036 | 6 | 92 | embryonic skeletal system morphogenesis |
GO:0032502 | 6e-04 | 2.2549 | 14.2536 | 27 | 1646 | developmental process |
GO:0034653 | 7e-04 | 91.7622 | 0.0436 | 2 | 4 | retinoic acid catabolic process |
GO:1905205 | 7e-04 | 91.7622 | 0.0436 | 2 | 4 | positive regulation of connective tissue replacement |
GO:0007600 | 8e-04 | 2.7815 | 5.8253 | 15 | 534 | sensory perception |
GO:0003002 | 8e-04 | 3.9682 | 2.4376 | 9 | 229 | regionalization |
GO:0006417 | 8e-04 | 2.9966 | 4.669 | 13 | 428 | regulation of translation |
GO:0001709 | 9e-04 | 10.2984 | 0.4364 | 4 | 40 | cell fate determination |
GO:0042633 | 9e-04 | 5.7812 | 1.1236 | 6 | 103 | hair cycle |
GO:0009792 | 0.001 | 2.7111 | 5.9671 | 15 | 547 | embryo development ending in birth or egg hatching |
GO:0045944 | 0.001 | 2.2102 | 11.3888 | 23 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
GO:0051122 | 0.0012 | 61.1707 | 0.0545 | 2 | 5 | hepoxilin biosynthetic process |
GO:0003008 | 0.0012 | 1.9781 | 16.7996 | 30 | 1540 | system process |
GO:0080090 | 0.0012 | 1.6308 | 60.5114 | 80 | 5547 | regulation of primary metabolic process |
GO:0061436 | 0.0013 | 16.2764 | 0.2182 | 3 | 20 | establishment of skin barrier |
GO:0097696 | 0.0013 | 4.5897 | 1.6363 | 7 | 150 | STAT cascade |
GO:0010628 | 0.0015 | 1.9122 | 18.5778 | 32 | 1703 | positive regulation of gene expression |
GO:0006935 | 0.0017 | 2.653 | 5.6617 | 14 | 519 | chemotaxis |
GO:0021545 | 0.0017 | 8.6179 | 0.5127 | 4 | 47 | cranial nerve development |
GO:0016115 | 0.0017 | 45.875 | 0.0655 | 2 | 6 | terpenoid catabolic process |
GO:1901894 | 0.0017 | 45.875 | 0.0655 | 2 | 6 | regulation of calcium-transporting ATPase activity |
GO:0060537 | 0.0018 | 3.0431 | 3.8617 | 11 | 354 | muscle tissue development |
GO:0001568 | 0.0018 | 2.5329 | 6.3599 | 15 | 583 | blood vessel development |
GO:0007498 | 0.0019 | 5.0019 | 1.2872 | 6 | 118 | mesoderm development |
GO:1901342 | 0.0021 | 3.4077 | 2.8145 | 9 | 258 | regulation of vasculature development |
GO:0035270 | 0.0023 | 4.7865 | 1.3418 | 6 | 123 | endocrine system development |
GO:0043542 | 0.0023 | 4.1234 | 1.8109 | 7 | 166 | endothelial cell migration |
GO:0048518 | 0.0023 | 1.5872 | 56.0279 | 74 | 5136 | positive regulation of biological process |
GO:0048513 | 0.0023 | 1.9747 | 15.3576 | 27 | 1646 | animal organ development |
GO:0009605 | 0.0025 | 1.81 | 20.825 | 34 | 1909 | response to external stimulus |
GO:0016101 | 0.0027 | 5.6005 | 0.96 | 5 | 88 | diterpenoid metabolic process |
GO:0070207 | 0.0028 | 12.0256 | 0.2836 | 3 | 26 | protein homotrimerization |
GO:0007411 | 0.0028 | 3.5611 | 2.389 | 8 | 219 | axon guidance |
GO:0072358 | 0.003 | 2.3967 | 6.698 | 15 | 614 | cardiovascular system development |
GO:0046425 | 0.003 | 4.5142 | 1.4182 | 6 | 130 | regulation of JAK-STAT cascade |
GO:0001667 | 0.003 | 2.9988 | 3.5454 | 10 | 325 | ameboidal-type cell migration |
GO:0042572 | 0.0031 | 11.5238 | 0.2945 | 3 | 27 | retinol metabolic process |
GO:0045766 | 0.0031 | 4.4778 | 1.4291 | 6 | 131 | positive regulation of angiogenesis |
GO:0051093 | 0.0032 | 2.1955 | 8.8144 | 18 | 808 | negative regulation of developmental process |
GO:0010940 | 0.0032 | 30.5793 | 0.0873 | 2 | 8 | positive regulation of necrotic cell death |
GO:0033141 | 0.0032 | 30.5793 | 0.0873 | 2 | 8 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
GO:0001501 | 0.0033 | 2.9656 | 3.588 | 10 | 345 | skeletal system development |
GO:0009953 | 0.0033 | 5.3416 | 1.0036 | 5 | 92 | dorsal/ventral pattern formation |
GO:0048706 | 0.0035 | 10.9792 | 0.3068 | 3 | 29 | embryonic skeletal system development |
GO:0045446 | 0.0035 | 5.2806 | 1.0145 | 5 | 93 | endothelial cell differentiation |
GO:0070268 | 0.0037 | 5.2209 | 1.0254 | 5 | 94 | cornification |
GO:0001525 | 0.0037 | 3.1176 | 3.0651 | 9 | 289 | angiogenesis |
GO:0048523 | 0.0039 | 1.5701 | 45.8608 | 62 | 4204 | negative regulation of cellular process |
GO:0048645 | 0.0039 | 6.7322 | 0.6436 | 4 | 59 | animal organ formation |
GO:0010459 | 0.004 | 26.2091 | 0.0982 | 2 | 9 | negative regulation of heart rate |
GO:0048387 | 0.004 | 26.2091 | 0.0982 | 2 | 9 | negative regulation of retinoic acid receptor signaling pathway |
GO:2000543 | 0.004 | 26.2091 | 0.0982 | 2 | 9 | positive regulation of gastrulation |
GO:0055002 | 0.0042 | 4.2062 | 1.5163 | 6 | 139 | striated muscle cell development |
GO:0002064 | 0.0042 | 3.6786 | 2.0181 | 7 | 185 | epithelial cell development |
GO:0010556 | 0.0045 | 1.5701 | 42.4791 | 58 | 3894 | regulation of macromolecule biosynthetic process |
GO:0003209 | 0.0046 | 9.8749 | 0.3382 | 3 | 31 | cardiac atrium morphogenesis |
GO:0043537 | 0.0046 | 9.8749 | 0.3382 | 3 | 31 | negative regulation of blood vessel endothelial cell migration |
GO:1903524 | 0.0049 | 6.2741 | 0.6873 | 4 | 63 | positive regulation of blood circulation |
GO:0006690 | 0.005 | 4.8379 | 1.1018 | 5 | 101 | icosanoid metabolic process |
GO:0090132 | 0.0051 | 3.2061 | 2.6399 | 8 | 242 | epithelium migration |
GO:0061045 | 0.0055 | 6.0676 | 0.7091 | 4 | 65 | negative regulation of wound healing |
GO:0007519 | 0.0057 | 3.9372 | 1.6145 | 6 | 148 | skeletal muscle tissue development |
GO:0040011 | 0.0058 | 1.7866 | 17.0505 | 28 | 1563 | locomotion |
GO:0045652 | 0.0058 | 5.9693 | 0.72 | 4 | 66 | regulation of megakaryocyte differentiation |
GO:0051101 | 0.0061 | 4.5969 | 1.1563 | 5 | 106 | regulation of DNA binding |
GO:0009111 | 0.0061 | 20.3821 | 0.12 | 2 | 11 | vitamin catabolic process |
GO:0009886 | 0.0061 | 20.3821 | 0.12 | 2 | 11 | post-embryonic animal morphogenesis |
GO:2000774 | 0.0061 | 20.3821 | 0.12 | 2 | 11 | positive regulation of cellular senescence |
GO:2000113 | 0.0065 | 1.8262 | 14.8033 | 25 | 1357 | negative regulation of cellular macromolecule biosynthetic process |
GO:0032269 | 0.0066 | 1.9253 | 11.7161 | 21 | 1074 | negative regulation of cellular protein metabolic process |
GO:0042692 | 0.0069 | 2.646 | 3.9926 | 10 | 366 | muscle cell differentiation |
GO:0048536 | 0.007 | 8.3759 | 0.3927 | 3 | 36 | spleen development |
GO:0071542 | 0.007 | 8.3759 | 0.3927 | 3 | 36 | dopaminergic neuron differentiation |
GO:0030216 | 0.0071 | 3.3195 | 2.2254 | 7 | 204 | keratinocyte differentiation |
GO:0060322 | 0.0072 | 2.1592 | 7.3853 | 15 | 677 | head development |
GO:0003093 | 0.0073 | 18.3427 | 0.1309 | 2 | 12 | regulation of glomerular filtration |
GO:0042471 | 0.0074 | 4.3786 | 1.2109 | 5 | 111 | ear morphogenesis |
GO:0021536 | 0.0075 | 5.522 | 0.7745 | 4 | 71 | diencephalon development |
GO:0045595 | 0.0075 | 1.7472 | 17.3887 | 28 | 1594 | regulation of cell differentiation |
GO:0035295 | 0.0077 | 2.2789 | 6.0435 | 13 | 554 | tube development |
GO:0050789 | 0.008 | 1.7033 | 44.0242 | 56 | 4824 | regulation of biological process |
GO:0031326 | 0.008 | 1.5125 | 44.5081 | 59 | 4080 | regulation of cellular biosynthetic process |
GO:0021520 | 0.0085 | 16.6741 | 0.1418 | 2 | 13 | spinal cord motor neuron cell fate specification |
GO:0021984 | 0.0085 | 16.6741 | 0.1418 | 2 | 13 | adenohypophysis development |
GO:0090196 | 0.0085 | 16.6741 | 0.1418 | 2 | 13 | regulation of chemokine secretion |
GO:0061564 | 0.0089 | 2.4189 | 4.7999 | 11 | 440 | axon development |
GO:0060415 | 0.0091 | 5.2095 | 0.8182 | 4 | 75 | muscle tissue morphogenesis |
GO:0021953 | 0.0092 | 3.5347 | 1.7891 | 6 | 164 | central nervous system neuron differentiation |
GO:0043043 | 0.0093 | 2.0929 | 7.6035 | 15 | 697 | peptide biosynthetic process |
GO:0006720 | 0.0095 | 4.1054 | 1.2872 | 5 | 118 | isoprenoid metabolic process |
GO:0003300 | 0.0095 | 5.1368 | 0.8291 | 4 | 76 | cardiac muscle hypertrophy |
GO:0016049 | 0.0097 | 2.3902 | 4.8544 | 11 | 445 | cell growth |
GO:0030855 | 0.0099 | 2.5048 | 4.2131 | 10 | 405 | epithelial cell differentiation |
GO:2000291 | 0.0099 | 15.2835 | 0.1527 | 2 | 14 | regulation of myoblast proliferation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0043266 | 1e-04 | 9.9159 | 0.6763 | 6 | 83 | regulation of potassium ion transport |
GO:0010960 | 1e-04 | 53.4333 | 0.0815 | 3 | 10 | magnesium ion homeostasis |
GO:0050906 | 1e-04 | 7.3418 | 1.0512 | 7 | 129 | detection of stimulus involved in sensory perception |
GO:0003008 | 1e-04 | 2.4983 | 12.5491 | 27 | 1540 | system process |
GO:0002724 | 3e-04 | 28.7603 | 0.1304 | 3 | 16 | regulation of T cell cytokine production |
GO:0009593 | 4e-04 | 6.9259 | 0.9453 | 6 | 116 | detection of chemical stimulus |
GO:0007389 | 5e-04 | 3.6222 | 3.3084 | 11 | 406 | pattern specification process |
GO:1903232 | 6e-04 | 82.459 | 0.0407 | 2 | 5 | melanosome assembly |
GO:0015672 | 7e-04 | 3.2618 | 4.0092 | 12 | 492 | monovalent inorganic cation transport |
GO:0048598 | 7e-04 | 3.0851 | 4.6041 | 13 | 565 | embryonic morphogenesis |
GO:0007606 | 7e-04 | 6.04 | 1.0756 | 6 | 132 | sensory perception of chemical stimulus |
GO:0001964 | 8e-04 | 18.6855 | 0.1874 | 3 | 23 | startle response |
GO:0048704 | 9e-04 | 7.2472 | 0.7497 | 5 | 92 | embryonic skeletal system morphogenesis |
GO:0071804 | 9e-04 | 4.8746 | 1.5483 | 7 | 190 | cellular potassium ion transport |
GO:0050911 | 0.0012 | 9.4591 | 0.4645 | 4 | 57 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007628 | 0.0013 | 15.5671 | 0.22 | 3 | 27 | adult walking behavior |
GO:0086028 | 0.0013 | 49.4689 | 0.057 | 2 | 7 | bundle of His cell to Purkinje myocyte signaling |
GO:0001501 | 0.0015 | 3.1317 | 3.7973 | 11 | 466 | skeletal system development |
GO:0060306 | 0.0015 | 14.9435 | 0.2282 | 3 | 28 | regulation of membrane repolarization |
GO:0021772 | 0.0017 | 14.3678 | 0.2363 | 3 | 29 | olfactory bulb development |
GO:0045188 | 0.0018 | 41.2213 | 0.0652 | 2 | 8 | regulation of circadian sleep/wake cycle, non-REM sleep |
GO:0060638 | 0.0018 | 41.2213 | 0.0652 | 2 | 8 | mesenchymal-epithelial cell signaling |
GO:0009887 | 0.002 | 2.4558 | 7.1406 | 16 | 895 | animal organ morphogenesis |
GO:0099622 | 0.002 | 13.3397 | 0.2526 | 3 | 31 | cardiac muscle cell membrane repolarization |
GO:0034762 | 0.0021 | 3.1732 | 3.3899 | 10 | 416 | regulation of transmembrane transport |
GO:1901381 | 0.0022 | 12.8789 | 0.2608 | 3 | 32 | positive regulation of potassium ion transmembrane transport |
GO:0086018 | 0.0023 | 35.3302 | 0.0733 | 2 | 9 | SA node cell to atrial cardiac muscle cell signaling |
GO:0032502 | 0.0024 | 1.6961 | 45.1931 | 61 | 5546 | developmental process |
GO:0001662 | 0.0024 | 12.4488 | 0.2689 | 3 | 33 | behavioral fear response |
GO:0048665 | 0.0024 | 12.4488 | 0.2689 | 3 | 33 | neuron fate specification |
GO:0019226 | 0.0024 | 7.7067 | 0.5623 | 4 | 69 | transmission of nerve impulse |
GO:0003231 | 0.0026 | 5.6711 | 0.9453 | 5 | 116 | cardiac ventricle development |
GO:0034767 | 0.0026 | 5.6711 | 0.9453 | 5 | 116 | positive regulation of ion transmembrane transport |
GO:0035646 | 0.0028 | 30.9119 | 0.0815 | 2 | 10 | endosome to melanosome transport |
GO:0048757 | 0.0028 | 30.9119 | 0.0815 | 2 | 10 | pigment granule maturation |
GO:0086091 | 0.0029 | 11.6692 | 0.2852 | 3 | 35 | regulation of heart rate by cardiac conduction |
GO:0003206 | 0.0029 | 5.5208 | 0.9697 | 5 | 119 | cardiac chamber morphogenesis |
GO:0035137 | 0.0031 | 11.3148 | 0.2934 | 3 | 36 | hindlimb morphogenesis |
GO:0003151 | 0.0031 | 7.1538 | 0.603 | 4 | 74 | outflow tract morphogenesis |
GO:0035270 | 0.0033 | 5.3322 | 1.0023 | 5 | 123 | endocrine system development |
GO:0043476 | 0.0035 | 27.4754 | 0.0896 | 2 | 11 | pigment accumulation |
GO:0015837 | 0.0036 | 6.8584 | 0.6275 | 4 | 77 | amine transport |
GO:0060428 | 0.0036 | 10.6668 | 0.3097 | 3 | 38 | lung epithelium development |
GO:0001508 | 0.0037 | 5.199 | 1.0267 | 5 | 126 | action potential |
GO:0007626 | 0.0042 | 4.2127 | 1.5157 | 6 | 186 | locomotory behavior |
GO:1904062 | 0.0046 | 3.6259 | 2.0535 | 7 | 252 | regulation of cation transmembrane transport |
GO:0021978 | 0.0048 | 22.4769 | 0.1059 | 2 | 13 | telencephalon regionalization |
GO:0071435 | 0.0048 | 22.4769 | 0.1059 | 2 | 13 | potassium ion export |
GO:1903818 | 0.0048 | 22.4769 | 0.1059 | 2 | 13 | positive regulation of voltage-gated potassium channel activity |
GO:0008284 | 0.0056 | 2.3135 | 6.5272 | 14 | 801 | positive regulation of cell proliferation |
GO:0048568 | 0.0061 | 2.8896 | 3.3166 | 9 | 407 | embryonic organ development |
GO:0035743 | 0.0065 | 19.0164 | 0.1222 | 2 | 15 | CD4-positive, alpha-beta T cell cytokine production |
GO:0051546 | 0.0065 | 19.0164 | 0.1222 | 2 | 15 | keratinocyte migration |
GO:0055075 | 0.0065 | 19.0164 | 0.1222 | 2 | 15 | potassium ion homeostasis |
GO:0035107 | 0.0067 | 4.4877 | 1.1816 | 5 | 145 | appendage morphogenesis |
GO:0009953 | 0.0068 | 5.6837 | 0.7497 | 4 | 92 | dorsal/ventral pattern formation |
GO:0043269 | 0.007 | 2.5216 | 4.6611 | 11 | 572 | regulation of ion transport |
GO:0007600 | 0.0071 | 3.0388 | 2.8 | 8 | 360 | sensory perception |
GO:0060413 | 0.0073 | 17.6569 | 0.1304 | 2 | 16 | atrial septum morphogenesis |
GO:1901016 | 0.0074 | 8.1101 | 0.3993 | 3 | 49 | regulation of potassium ion transmembrane transporter activity |
GO:0001503 | 0.0079 | 2.9746 | 2.8521 | 8 | 350 | ossification |
GO:0030900 | 0.0079 | 2.9746 | 2.8521 | 8 | 350 | forebrain development |
GO:0003294 | 0.0081 | Inf | 0.0081 | 1 | 1 | atrial ventricular junction remodeling |
GO:0016077 | 0.0081 | Inf | 0.0081 | 1 | 1 | snoRNA catabolic process |
GO:0032980 | 0.0081 | Inf | 0.0081 | 1 | 1 | keratinocyte activation |
GO:0035863 | 0.0081 | Inf | 0.0081 | 1 | 1 | dITP catabolic process |
GO:0051867 | 0.0081 | Inf | 0.0081 | 1 | 1 | general adaptation syndrome, behavioral process |
GO:0072168 | 0.0081 | Inf | 0.0081 | 1 | 1 | specification of anterior mesonephric tubule identity |
GO:0072169 | 0.0081 | Inf | 0.0081 | 1 | 1 | specification of posterior mesonephric tubule identity |
GO:0072184 | 0.0081 | Inf | 0.0081 | 1 | 1 | renal vesicle progenitor cell differentiation |
GO:0072259 | 0.0081 | Inf | 0.0081 | 1 | 1 | metanephric interstitial fibroblast development |
GO:0086044 | 0.0081 | Inf | 0.0081 | 1 | 1 | atrial cardiac muscle cell to AV node cell communication by electrical coupling |
GO:0086050 | 0.0081 | Inf | 0.0081 | 1 | 1 | membrane repolarization during bundle of His cell action potential |
GO:0086052 | 0.0081 | Inf | 0.0081 | 1 | 1 | membrane repolarization during SA node cell action potential |
GO:0086054 | 0.0081 | Inf | 0.0081 | 1 | 1 | bundle of His cell to Purkinje myocyte communication by electrical coupling |
GO:0086055 | 0.0081 | Inf | 0.0081 | 1 | 1 | Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling |
GO:0097275 | 0.0081 | Inf | 0.0081 | 1 | 1 | cellular ammonia homeostasis |
GO:0097276 | 0.0081 | Inf | 0.0081 | 1 | 1 | cellular creatinine homeostasis |
GO:0097277 | 0.0081 | Inf | 0.0081 | 1 | 1 | cellular urea homeostasis |
GO:0098906 | 0.0081 | Inf | 0.0081 | 1 | 1 | regulation of Purkinje myocyte action potential |
GO:1901639 | 0.0081 | Inf | 0.0081 | 1 | 1 | XDP catabolic process |
GO:1904325 | 0.0081 | Inf | 0.0081 | 1 | 1 | positive regulation of inhibitory G-protein coupled receptor phosphorylation |
GO:1990029 | 0.0081 | Inf | 0.0081 | 1 | 1 | vasomotion |
GO:0008544 | 0.0082 | 2.9569 | 2.8684 | 8 | 352 | epidermis development |
GO:0002029 | 0.0083 | 16.4787 | 0.1385 | 2 | 17 | desensitization of G-protein coupled receptor protein signaling pathway |
GO:0023058 | 0.0083 | 16.4787 | 0.1385 | 2 | 17 | adaptation of signaling pathway |
GO:0086014 | 0.0083 | 16.4787 | 0.1385 | 2 | 17 | atrial cardiac muscle cell action potential |
GO:0021515 | 0.0083 | 7.7712 | 0.4156 | 3 | 51 | cell differentiation in spinal cord |
GO:0060425 | 0.0083 | 7.7712 | 0.4156 | 3 | 51 | lung morphogenesis |
GO:0007423 | 0.0084 | 2.5815 | 4.1233 | 10 | 506 | sensory organ development |
GO:0001580 | 0.0093 | 15.4477 | 0.1467 | 2 | 18 | detection of chemical stimulus involved in sensory perception of bitter taste |
GO:0060307 | 0.0093 | 15.4477 | 0.1467 | 2 | 18 | regulation of ventricular cardiac muscle cell membrane repolarization |
GO:1901380 | 0.0093 | 15.4477 | 0.1467 | 2 | 18 | negative regulation of potassium ion transmembrane transport |
GO:0032675 | 0.0097 | 5.1003 | 0.8312 | 4 | 102 | regulation of interleukin-6 production |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007606 | 0 | 11.3597 | 0.7026 | 7 | 132 | sensory perception of chemical stimulus |
GO:0050911 | 0 | 19.084 | 0.3034 | 5 | 57 | detection of chemical stimulus involved in sensory perception of smell |
GO:0003091 | 0 | 26.1576 | 0.181 | 4 | 34 | renal water homeostasis |
GO:0009593 | 0 | 10.928 | 0.6175 | 6 | 116 | detection of chemical stimulus |
GO:0003008 | 0 | 3.1376 | 8.1974 | 21 | 1540 | system process |
GO:0050906 | 1e-04 | 9.7646 | 0.6867 | 6 | 129 | detection of stimulus involved in sensory perception |
GO:0061760 | 1e-04 | 383.1646 | 0.016 | 2 | 3 | antifungal innate immune response |
GO:0050829 | 3e-04 | 13.2749 | 0.3353 | 4 | 63 | defense response to Gram-negative bacterium |
GO:0030104 | 4e-04 | 13.0528 | 0.3407 | 4 | 64 | water homeostasis |
GO:0018149 | 5e-04 | 22.3521 | 0.1544 | 3 | 29 | peptide cross-linking |
GO:0009620 | 0.0012 | 16.1325 | 0.2076 | 3 | 39 | response to fungus |
GO:0043588 | 0.0014 | 4.5998 | 1.6608 | 7 | 312 | skin development |
GO:0003334 | 0.0018 | 38.2937 | 0.0639 | 2 | 12 | keratinocyte development |
GO:0007600 | 0.0019 | 4.3259 | 1.7709 | 7 | 360 | sensory perception |
GO:0009913 | 0.0022 | 4.8423 | 1.3414 | 6 | 252 | epidermal cell differentiation |
GO:0055075 | 0.0028 | 29.4508 | 0.0798 | 2 | 15 | potassium ion homeostasis |
GO:0060397 | 0.0028 | 29.4508 | 0.0798 | 2 | 15 | JAK-STAT cascade involved in growth hormone signaling pathway |
GO:0006833 | 0.0036 | 25.5207 | 0.0905 | 2 | 17 | water transport |
GO:0007635 | 0.0036 | 25.5207 | 0.0905 | 2 | 17 | chemosensory behavior |
GO:0070723 | 0.005 | 21.263 | 0.1065 | 2 | 20 | response to cholesterol |
GO:0031644 | 0.0052 | 9.2021 | 0.3513 | 3 | 66 | regulation of neurological system process |
GO:0002264 | 0.0053 | Inf | 0.0053 | 1 | 1 | endothelial cell activation involved in immune response |
GO:0009645 | 0.0053 | Inf | 0.0053 | 1 | 1 | response to low light intensity stimulus |
GO:0032980 | 0.0053 | Inf | 0.0053 | 1 | 1 | keratinocyte activation |
GO:0046690 | 0.0053 | Inf | 0.0053 | 1 | 1 | response to tellurium ion |
GO:0052182 | 0.0053 | Inf | 0.0053 | 1 | 1 | modification by host of symbiont morphology or physiology via secreted substance |
GO:0097275 | 0.0053 | Inf | 0.0053 | 1 | 1 | cellular ammonia homeostasis |
GO:0097276 | 0.0053 | Inf | 0.0053 | 1 | 1 | cellular creatinine homeostasis |
GO:0097277 | 0.0053 | Inf | 0.0053 | 1 | 1 | cellular urea homeostasis |
GO:1905322 | 0.0053 | Inf | 0.0053 | 1 | 1 | positive regulation of mesenchymal stem cell migration |
GO:0031424 | 0.0061 | 5.86 | 0.7293 | 4 | 137 | keratinization |
GO:0071378 | 0.0066 | 18.2218 | 0.1224 | 2 | 23 | cellular response to growth hormone stimulus |
GO:0006955 | 0.0068 | 2.1419 | 8.9799 | 17 | 1687 | immune response |
GO:0048871 | 0.007 | 3.7886 | 1.698 | 6 | 319 | multicellular organismal homeostasis |
GO:0050716 | 0.0072 | 17.3924 | 0.1278 | 2 | 24 | positive regulation of interleukin-1 secretion |
GO:0050830 | 0.0075 | 8.047 | 0.3992 | 3 | 75 | defense response to Gram-positive bacterium |
GO:0001654 | 0.0086 | 3.623 | 1.7726 | 6 | 333 | eye development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007156 | 0 | 19.2693 | 1.9378 | 27 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0098609 | 0 | 4.405 | 9.5617 | 35 | 750 | cell-cell adhesion |
GO:0022610 | 0 | 2.9839 | 16.3058 | 41 | 1279 | biological adhesion |
GO:0032501 | 0 | 2.1822 | 71.7521 | 106 | 5904 | multicellular organismal process |
GO:0032502 | 0 | 2.231 | 51.1223 | 82 | 4380 | developmental process |
GO:0048731 | 0 | 2.6081 | 22.3362 | 46 | 2076 | system development |
GO:0007399 | 0 | 2.3667 | 26.9257 | 53 | 2112 | nervous system development |
GO:0007267 | 0 | 2.3317 | 18.6006 | 38 | 1459 | cell-cell signaling |
GO:2001199 | 0 | 78.6387 | 0.0765 | 3 | 6 | negative regulation of dendritic cell differentiation |
GO:0009952 | 2e-04 | 4.383 | 2.4733 | 10 | 194 | anterior/posterior pattern specification |
GO:0009792 | 2e-04 | 2.8022 | 6.9736 | 18 | 547 | embryo development ending in birth or egg hatching |
GO:0061737 | 5e-04 | 156.4792 | 0.0382 | 2 | 3 | leukotriene signaling pathway |
GO:0007389 | 7e-04 | 2.903 | 5.1761 | 14 | 406 | pattern specification process |
GO:0051094 | 8e-04 | 2.0679 | 14.8015 | 28 | 1161 | positive regulation of developmental process |
GO:0008078 | 0.001 | 78.2344 | 0.051 | 2 | 4 | mesodermal cell migration |
GO:0048704 | 0.0011 | 5.5432 | 1.1729 | 6 | 92 | embryonic skeletal system morphogenesis |
GO:0051122 | 0.0016 | 52.1528 | 0.0637 | 2 | 5 | hepoxilin biosynthetic process |
GO:0060216 | 0.0017 | 14.732 | 0.2422 | 3 | 19 | definitive hemopoiesis |
GO:0006334 | 0.0031 | 4.4913 | 1.4279 | 6 | 112 | nucleosome assembly |
GO:0070206 | 0.0032 | 7.167 | 0.6119 | 4 | 48 | protein trimerization |
GO:0006333 | 0.0036 | 3.7881 | 1.9633 | 7 | 154 | chromatin assembly or disassembly |
GO:0001955 | 0.0043 | 26.0712 | 0.102 | 2 | 8 | blood vessel maturation |
GO:0030916 | 0.0043 | 26.0712 | 0.102 | 2 | 8 | otic vesicle formation |
GO:0009887 | 0.0046 | 1.9517 | 12.0605 | 22 | 946 | animal organ morphogenesis |
GO:0016339 | 0.0053 | 9.4228 | 0.357 | 3 | 28 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
GO:0035116 | 0.0053 | 9.4228 | 0.357 | 3 | 28 | embryonic hindlimb morphogenesis |
GO:0007218 | 0.0053 | 4.7619 | 1.1219 | 5 | 88 | neuropeptide signaling pathway |
GO:0048706 | 0.0054 | 9.3 | 0.3605 | 3 | 29 | embryonic skeletal system development |
GO:2000849 | 0.0055 | 22.3452 | 0.1147 | 2 | 9 | regulation of glucocorticoid secretion |
GO:0010660 | 0.0056 | 6.0611 | 0.7139 | 4 | 56 | regulation of muscle cell apoptotic process |
GO:0048598 | 0.0059 | 2.2051 | 7.2031 | 15 | 565 | embryonic morphogenesis |
GO:0006323 | 0.006 | 3.4339 | 2.1546 | 7 | 169 | DNA packaging |
GO:0048568 | 0.0061 | 2.4417 | 5.1888 | 12 | 407 | embryonic organ development |
GO:0045595 | 0.0063 | 1.7023 | 20.3217 | 32 | 1594 | regulation of cell differentiation |
GO:0009266 | 0.0064 | 3.0785 | 2.741 | 8 | 215 | response to temperature stimulus |
GO:2000026 | 0.0066 | 1.672 | 22.0301 | 34 | 1728 | regulation of multicellular organismal development |
GO:0045766 | 0.0067 | 3.8037 | 1.6701 | 6 | 131 | positive regulation of angiogenesis |
GO:0045446 | 0.0067 | 4.4898 | 1.1856 | 5 | 93 | endothelial cell differentiation |
GO:0043588 | 0.0068 | 2.6492 | 3.9777 | 10 | 312 | skin development |
GO:0043537 | 0.0071 | 8.4116 | 0.3952 | 3 | 31 | negative regulation of blood vessel endothelial cell migration |
GO:0030858 | 0.0072 | 5.6267 | 0.7649 | 4 | 60 | positive regulation of epithelial cell differentiation |
GO:0010454 | 0.0082 | 17.3773 | 0.1402 | 2 | 11 | negative regulation of cell fate commitment |
GO:0016322 | 0.0082 | 17.3773 | 0.1402 | 2 | 11 | neuron remodeling |
GO:0060033 | 0.0082 | 17.3773 | 0.1402 | 2 | 11 | anatomical structure regression |
GO:0090084 | 0.0082 | 17.3773 | 0.1402 | 2 | 11 | negative regulation of inclusion body assembly |
GO:2000774 | 0.0082 | 17.3773 | 0.1402 | 2 | 11 | positive regulation of cellular senescence |
GO:0045165 | 0.0083 | 2.9373 | 2.8662 | 8 | 227 | cell fate commitment |
GO:0010633 | 0.0095 | 5.1638 | 0.8287 | 4 | 65 | negative regulation of epithelial cell migration |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 57.2416 | 0.4083 | 15 | 57 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 25.8202 | 0.8309 | 16 | 116 | detection of chemical stimulus |
GO:0050906 | 0 | 22.83 | 0.924 | 16 | 129 | detection of stimulus involved in sensory perception |
GO:0007606 | 0 | 22.2351 | 0.9455 | 16 | 132 | sensory perception of chemical stimulus |
GO:0007186 | 0 | 4.9517 | 6.0098 | 24 | 839 | G-protein coupled receptor signaling pathway |
GO:0050877 | 0 | 3.3388 | 6.1817 | 18 | 863 | nervous system process |
GO:0045087 | 1e-04 | 3.4929 | 5.2044 | 16 | 740 | innate immune response |
GO:0003095 | 2e-04 | 282.3738 | 0.0215 | 2 | 3 | pressure natriuresis |
GO:0061760 | 2e-04 | 282.3738 | 0.0215 | 2 | 3 | antifungal innate immune response |
GO:0007565 | 3e-04 | 6.1029 | 1.2535 | 7 | 175 | female pregnancy |
GO:0036101 | 3e-04 | 141.1776 | 0.0287 | 2 | 4 | leukotriene B4 catabolic process |
GO:1901523 | 5e-04 | 94.1121 | 0.0358 | 2 | 5 | icosanoid catabolic process |
GO:0016579 | 6e-04 | 4.6683 | 1.8641 | 8 | 265 | protein deubiquitination |
GO:0003071 | 6e-04 | 21.3509 | 0.1647 | 3 | 23 | renal system process involved in regulation of systemic arterial blood pressure |
GO:0070098 | 7e-04 | 10.8212 | 0.4083 | 4 | 57 | chemokine-mediated signaling pathway |
GO:0071947 | 7e-04 | 70.5794 | 0.043 | 2 | 6 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process |
GO:0050829 | 0.0011 | 9.7169 | 0.4513 | 4 | 63 | defense response to Gram-negative bacterium |
GO:0035865 | 0.0014 | 47.0467 | 0.0573 | 2 | 8 | cellular response to potassium ion |
GO:0098542 | 0.0016 | 3.575 | 2.722 | 9 | 380 | defense response to other organism |
GO:0032342 | 0.0018 | 40.3231 | 0.0645 | 2 | 9 | aldosterone biosynthetic process |
GO:0034651 | 0.0018 | 40.3231 | 0.0645 | 2 | 9 | cortisol biosynthetic process |
GO:0003091 | 0.0018 | 13.7648 | 0.2435 | 3 | 34 | renal water homeostasis |
GO:0050830 | 0.002 | 8.0681 | 0.5372 | 4 | 75 | defense response to Gram-positive bacterium |
GO:0002376 | 0.0021 | 1.9582 | 17.793 | 30 | 2484 | immune system process |
GO:0008212 | 0.0022 | 35.2804 | 0.0716 | 2 | 10 | mineralocorticoid metabolic process |
GO:0050776 | 0.0026 | 2.5546 | 6.0026 | 14 | 838 | regulation of immune response |
GO:0009620 | 0.0027 | 11.8491 | 0.2794 | 3 | 39 | response to fungus |
GO:0048247 | 0.0027 | 11.8491 | 0.2794 | 3 | 39 | lymphocyte chemotaxis |
GO:0055078 | 0.0029 | 11.528 | 0.2865 | 3 | 40 | sodium ion homeostasis |
GO:0002548 | 0.0038 | 10.4006 | 0.3152 | 3 | 44 | monocyte chemotaxis |
GO:0009617 | 0.0049 | 3.0003 | 3.2162 | 9 | 449 | response to bacterium |
GO:0019941 | 0.0066 | 2.6889 | 3.9898 | 10 | 557 | modification-dependent protein catabolic process |
GO:0052182 | 0.0072 | Inf | 0.0072 | 1 | 1 | modification by host of symbiont morphology or physiology via secreted substance |
GO:1901318 | 0.0072 | Inf | 0.0072 | 1 | 1 | negative regulation of flagellated sperm motility |
GO:0006508 | 0.009 | 1.9309 | 11.4251 | 20 | 1595 | proteolysis |
GO:0044257 | 0.0092 | 2.434 | 4.8494 | 11 | 677 | cellular protein catabolic process |
GO:0008211 | 0.0098 | 14.8441 | 0.1504 | 2 | 21 | glucocorticoid metabolic process |
GO:0019373 | 0.0098 | 14.8441 | 0.1504 | 2 | 21 | epoxygenase P450 pathway |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 57.1774 | 0.3739 | 14 | 57 | olfactory receptor activity |
GO:0036459 | 0 | 19.3762 | 0.7018 | 11 | 107 | thiol-dependent ubiquitinyl hydrolase activity |
GO:0008234 | 0 | 12.4573 | 1.1544 | 12 | 176 | cysteine-type peptidase activity |
GO:0038023 | 0 | 4.2886 | 5.936 | 21 | 905 | signaling receptor activity |
GO:0004930 | 0 | 5.8953 | 2.7614 | 14 | 421 | G-protein coupled receptor activity |
GO:0060089 | 0 | 3.7121 | 7.5495 | 23 | 1151 | molecular transducer activity |
GO:0099600 | 0 | 4.0666 | 5.5424 | 19 | 845 | transmembrane receptor activity |
GO:0008233 | 0 | 4.1553 | 3.8371 | 14 | 585 | peptidase activity |
GO:0020037 | 0.0012 | 6.8792 | 0.7871 | 5 | 120 | heme binding |
GO:0008201 | 0.0028 | 5.5612 | 0.9642 | 5 | 147 | heparin binding |
GO:0030246 | 0.005 | 4.0676 | 1.5742 | 6 | 240 | carbohydrate binding |
GO:0008392 | 0.0054 | 20.5864 | 0.1115 | 2 | 17 | arachidonic acid epoxygenase activity |
GO:0031704 | 0.0066 | Inf | 0.0066 | 1 | 1 | apelin receptor binding |
GO:0042164 | 0.0066 | Inf | 0.0066 | 1 | 1 | interleukin-12 alpha subunit binding |
GO:0102116 | 0.0066 | Inf | 0.0066 | 1 | 1 | laurate hydroxylase activity |
GO:0103002 | 0.0066 | Inf | 0.0066 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031727 | 1e-04 | Inf | 0.0178 | 2 | 2 | CCR2 chemokine receptor binding |
GO:0008009 | 1e-04 | 17.5804 | 0.2676 | 4 | 30 | chemokine activity |
GO:0005132 | 8e-04 | 75.1592 | 0.0446 | 2 | 5 | type I interferon receptor binding |
GO:0055131 | 0.0012 | 56.3657 | 0.0535 | 2 | 6 | C3HC4-type RING finger domain binding |
GO:0048018 | 0.002 | 3.1972 | 3.3541 | 10 | 376 | receptor ligand activity |
GO:0042379 | 0.002 | 38.6564 | 0.0694 | 2 | 8 | chemokine receptor binding |
GO:0045236 | 0.0041 | 25.0431 | 0.0981 | 2 | 11 | CXCR chemokine receptor binding |
GO:0004888 | 0.0052 | 2.2592 | 7.1452 | 15 | 801 | transmembrane signaling receptor activity |
GO:0004631 | 0.0089 | Inf | 0.0089 | 1 | 1 | phosphomevalonate kinase activity |
GO:0005147 | 0.0089 | Inf | 0.0089 | 1 | 1 | oncostatin-M receptor binding |
GO:0008518 | 0.0089 | Inf | 0.0089 | 1 | 1 | reduced folate carrier activity |
GO:0031249 | 0.0089 | Inf | 0.0089 | 1 | 1 | denatured protein binding |
GO:0033735 | 0.0089 | Inf | 0.0089 | 1 | 1 | aspartate dehydrogenase activity |
GO:0034353 | 0.0089 | Inf | 0.0089 | 1 | 1 | RNA pyrophosphohydrolase activity |
GO:0035755 | 0.0089 | Inf | 0.0089 | 1 | 1 | cardiolipin hydrolase activity |
GO:0003735 | 0.0097 | 4.0812 | 1.2935 | 5 | 145 | structural constituent of ribosome |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003700 | 3e-04 | 2.8756 | 7.2199 | 18 | 1171 | DNA binding transcription factor activity |
GO:0030545 | 8e-04 | 3.9973 | 2.4662 | 9 | 400 | receptor regulator activity |
GO:0043565 | 0.001 | 2.7639 | 6.0977 | 15 | 989 | sequence-specific DNA binding |
GO:0036122 | 0.0013 | 47.0342 | 0.0555 | 2 | 9 | BMP binding |
GO:0001228 | 0.003 | 3.5491 | 2.4354 | 8 | 395 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
GO:0005179 | 0.0035 | 6.9039 | 0.6222 | 4 | 102 | hormone activity |
GO:0001604 | 0.0062 | Inf | 0.0062 | 1 | 1 | urotensin II receptor activity |
GO:0004063 | 0.0062 | Inf | 0.0062 | 1 | 1 | aryldialkylphosphatase activity |
GO:0004946 | 0.0062 | Inf | 0.0062 | 1 | 1 | bombesin receptor activity |
GO:0005130 | 0.0062 | Inf | 0.0062 | 1 | 1 | granulocyte colony-stimulating factor receptor binding |
GO:0005140 | 0.0062 | Inf | 0.0062 | 1 | 1 | interleukin-9 receptor binding |
GO:0005276 | 0.0062 | Inf | 0.0062 | 1 | 1 | vesicular hydrogen:amino acid antiporter activity |
GO:0015495 | 0.0062 | Inf | 0.0062 | 1 | 1 | gamma-aminobutyric acid:proton symporter activity |
GO:0017174 | 0.0062 | Inf | 0.0062 | 1 | 1 | glycine N-methyltransferase activity |
GO:0030354 | 0.0062 | Inf | 0.0062 | 1 | 1 | melanin-concentrating hormone activity |
GO:0031773 | 0.0062 | Inf | 0.0062 | 1 | 1 | kisspeptin receptor binding |
GO:0016799 | 0.008 | 16.4478 | 0.1356 | 2 | 22 | hydrolase activity, hydrolyzing N-glycosyl compounds |
GO:0005102 | 0.0084 | 2.1161 | 8.3543 | 16 | 1355 | receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 30.452 | 0.3327 | 8 | 57 | olfactory receptor activity |
GO:0004930 | 0 | 5.0725 | 2.4576 | 11 | 421 | G-protein coupled receptor activity |
GO:0031727 | 0 | Inf | 0.0117 | 2 | 2 | CCR2 chemokine receptor binding |
GO:0018685 | 2e-04 | 174.1954 | 0.0234 | 2 | 4 | alkane 1-monooxygenase activity |
GO:0050051 | 2e-04 | 174.1954 | 0.0234 | 2 | 4 | leukotriene-B4 20-monooxygenase activity |
GO:0008048 | 3e-04 | 116.1226 | 0.0292 | 2 | 5 | calcium sensitive guanylate cyclase activator activity |
GO:0020037 | 7e-04 | 7.7857 | 0.7005 | 5 | 120 | heme binding |
GO:0010853 | 7e-04 | 69.6644 | 0.0409 | 2 | 7 | cyclase activator activity |
GO:0030249 | 9e-04 | 58.0498 | 0.0467 | 2 | 8 | guanylate cyclase regulator activity |
GO:0102991 | 9e-04 | 58.0498 | 0.0467 | 2 | 8 | myristoyl-CoA hydrolase activity |
GO:0048018 | 0.0016 | 3.9691 | 2.1949 | 8 | 376 | receptor ligand activity |
GO:0004497 | 0.0017 | 8.5448 | 0.508 | 4 | 88 | monooxygenase activity |
GO:0019825 | 0.0017 | 13.8791 | 0.2393 | 3 | 41 | oxygen binding |
GO:0005506 | 0.0018 | 6.2058 | 0.8698 | 5 | 149 | iron ion binding |
GO:0016290 | 0.0018 | 38.6922 | 0.0642 | 2 | 11 | palmitoyl-CoA hydrolase activity |
GO:0001664 | 0.0021 | 4.9081 | 1.3193 | 6 | 226 | G-protein coupled receptor binding |
GO:0099600 | 0.0036 | 2.6798 | 4.9328 | 12 | 845 | transmembrane receptor activity |
GO:0008392 | 0.0038 | 25.1545 | 0.0924 | 2 | 16 | arachidonic acid epoxygenase activity |
GO:0016289 | 0.0054 | 20.4733 | 0.1109 | 2 | 19 | CoA hydrolase activity |
GO:0004508 | 0.0058 | Inf | 0.0058 | 1 | 1 | steroid 17-alpha-monooxygenase activity |
GO:0005130 | 0.0058 | Inf | 0.0058 | 1 | 1 | granulocyte colony-stimulating factor receptor binding |
GO:0008404 | 0.0058 | Inf | 0.0058 | 1 | 1 | arachidonic acid 14,15-epoxygenase activity |
GO:0008405 | 0.0058 | Inf | 0.0058 | 1 | 1 | arachidonic acid 11,12-epoxygenase activity |
GO:0018169 | 0.0058 | Inf | 0.0058 | 1 | 1 | ribosomal S6-glutamic acid ligase activity |
GO:0030273 | 0.0058 | Inf | 0.0058 | 1 | 1 | melanin-concentrating hormone receptor activity |
GO:0033560 | 0.0058 | Inf | 0.0058 | 1 | 1 | folate reductase activity |
GO:0047442 | 0.0058 | Inf | 0.0058 | 1 | 1 | 17-alpha-hydroxyprogesterone aldolase activity |
GO:0047963 | 0.0058 | Inf | 0.0058 | 1 | 1 | glycine N-choloyltransferase activity |
GO:0052817 | 0.0058 | Inf | 0.0058 | 1 | 1 | very long chain acyl-CoA hydrolase activity |
GO:0071614 | 0.0058 | Inf | 0.0058 | 1 | 1 | linoleic acid epoxygenase activity |
GO:0102116 | 0.0058 | Inf | 0.0058 | 1 | 1 | laurate hydroxylase activity |
GO:0103002 | 0.0058 | Inf | 0.0058 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
GO:0038023 | 0.0062 | 2.4893 | 5.283 | 12 | 905 | signaling receptor activity |
GO:0070330 | 0.0066 | 18.3158 | 0.1226 | 2 | 21 | aromatase activity |
GO:0060089 | 0.0066 | 2.3017 | 6.7191 | 14 | 1151 | molecular transducer activity |
GO:0048020 | 0.0069 | 17.8082 | 0.1256 | 2 | 22 | CCR chemokine receptor binding |
GO:0005126 | 0.0081 | 4.2877 | 1.2411 | 5 | 215 | cytokine receptor binding |
GO:0001530 | 0.0086 | 15.815 | 0.1401 | 2 | 24 | lipopolysaccharide binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 16.1314 | 0.3552 | 5 | 57 | olfactory receptor activity |
GO:0031727 | 0 | Inf | 0.0125 | 2 | 2 | CCR2 chemokine receptor binding |
GO:0004497 | 2e-04 | 9.9649 | 0.5546 | 5 | 89 | monooxygenase activity |
GO:0004930 | 3e-04 | 4.2193 | 2.6233 | 10 | 421 | G-protein coupled receptor activity |
GO:0008201 | 3e-04 | 7.1767 | 0.916 | 6 | 147 | heparin binding |
GO:0001530 | 4e-04 | 23.4938 | 0.1495 | 3 | 24 | lipopolysaccharide binding |
GO:0008009 | 8e-04 | 18.2657 | 0.1869 | 3 | 30 | chemokine activity |
GO:0035240 | 0.001 | 54.2832 | 0.0498 | 2 | 8 | dopamine binding |
GO:0033691 | 0.0013 | 46.5253 | 0.0561 | 2 | 9 | sialic acid binding |
GO:0019825 | 0.0021 | 12.9688 | 0.2555 | 3 | 41 | oxygen binding |
GO:0005126 | 0.0023 | 4.7965 | 1.3459 | 6 | 216 | cytokine receptor binding |
GO:0016705 | 0.0023 | 5.8306 | 0.9222 | 5 | 148 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
GO:0048018 | 0.0024 | 3.6939 | 2.3429 | 8 | 376 | receptor ligand activity |
GO:0001664 | 0.0029 | 4.5754 | 1.4082 | 6 | 226 | G-protein coupled receptor binding |
GO:0008392 | 0.0049 | 21.7004 | 0.1059 | 2 | 17 | arachidonic acid epoxygenase activity |
GO:0099600 | 0.0061 | 2.4851 | 5.2653 | 12 | 845 | transmembrane receptor activity |
GO:0004506 | 0.0062 | Inf | 0.0062 | 1 | 1 | squalene monooxygenase activity |
GO:0004511 | 0.0062 | Inf | 0.0062 | 1 | 1 | tyrosine 3-monooxygenase activity |
GO:0004556 | 0.0062 | Inf | 0.0062 | 1 | 1 | alpha-amylase activity |
GO:0005276 | 0.0062 | Inf | 0.0062 | 1 | 1 | vesicular hydrogen:amino acid antiporter activity |
GO:0008891 | 0.0062 | Inf | 0.0062 | 1 | 1 | glycolate oxidase activity |
GO:0015495 | 0.0062 | Inf | 0.0062 | 1 | 1 | gamma-aminobutyric acid:proton symporter activity |
GO:0047016 | 0.0062 | Inf | 0.0062 | 1 | 1 | cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity |
GO:0047969 | 0.0062 | Inf | 0.0062 | 1 | 1 | glyoxylate oxidase activity |
GO:0102116 | 0.0062 | Inf | 0.0062 | 1 | 1 | laurate hydroxylase activity |
GO:0103002 | 0.0062 | Inf | 0.0062 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
GO:0103025 | 0.0062 | Inf | 0.0062 | 1 | 1 | alpha-amylase activity (releasing maltohexaose) |
GO:0048020 | 0.0079 | 16.6275 | 0.1342 | 2 | 22 | CCR chemokine receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 39.8363 | 0.4225 | 12 | 57 | olfactory receptor activity |
GO:0004930 | 0 | 6.4561 | 3.1204 | 17 | 421 | G-protein coupled receptor activity |
GO:0038023 | 0 | 3.2502 | 6.7077 | 19 | 905 | signaling receptor activity |
GO:0099600 | 0 | 3.2776 | 6.263 | 18 | 845 | transmembrane receptor activity |
GO:0060089 | 3e-04 | 2.6624 | 8.531 | 20 | 1151 | molecular transducer activity |
GO:0004867 | 0.0021 | 8.0117 | 0.5411 | 4 | 73 | serine-type endopeptidase inhibitor activity |
GO:0002113 | 0.0074 | Inf | 0.0074 | 1 | 1 | interleukin-33 binding |
GO:0008613 | 0.0074 | Inf | 0.0074 | 1 | 1 | diuretic hormone activity |
GO:0034899 | 0.0074 | Inf | 0.0074 | 1 | 1 | trimethylamine monooxygenase activity |
GO:0022840 | 0.0086 | 16.0212 | 0.1408 | 2 | 19 | leak channel activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008502 | 0 | Inf | 0.0139 | 2 | 2 | melatonin receptor activity |
GO:0000977 | 1e-04 | 3.8686 | 4.0812 | 14 | 587 | RNA polymerase II regulatory region sequence-specific DNA binding |
GO:1990837 | 4e-04 | 3.1965 | 4.8808 | 14 | 702 | sequence-specific double-stranded DNA binding |
GO:0044212 | 5e-04 | 2.9743 | 5.6316 | 15 | 810 | transcription regulatory region DNA binding |
GO:0001067 | 5e-04 | 2.9625 | 5.6525 | 15 | 813 | regulatory region nucleic acid binding |
GO:0001077 | 5e-04 | 4.7651 | 1.8285 | 8 | 263 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
GO:0000981 | 5e-04 | 3.0746 | 5.0615 | 14 | 728 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
GO:0140110 | 6e-04 | 2.4101 | 10.4707 | 22 | 1506 | transcription regulator activity |
GO:0099600 | 7e-04 | 2.8419 | 5.875 | 15 | 845 | transmembrane receptor activity |
GO:0038023 | 0.0015 | 2.6392 | 6.2921 | 15 | 905 | signaling receptor activity |
GO:0070410 | 0.0017 | 41.5742 | 0.0626 | 2 | 9 | co-SMAD binding |
GO:0004930 | 0.0023 | 3.4036 | 2.8586 | 9 | 419 | G-protein coupled receptor activity |
GO:0043565 | 0.0023 | 4.1682 | 1.8155 | 7 | 287 | sequence-specific DNA binding |
GO:0030955 | 0.0047 | 22.3772 | 0.1043 | 2 | 15 | potassium ion binding |
GO:0097159 | 0.0053 | 1.682 | 38.6845 | 52 | 5564 | organic cyclic compound binding |
GO:0004252 | 0.006 | 4.6058 | 1.1541 | 5 | 166 | serine-type endopeptidase activity |
GO:0071837 | 0.0068 | 18.1779 | 0.1251 | 2 | 18 | HMG box domain binding |
GO:1901363 | 0.0069 | 1.652 | 38.1978 | 51 | 5494 | heterocyclic compound binding |
GO:0001604 | 0.007 | Inf | 0.007 | 1 | 1 | urotensin II receptor activity |
GO:0035757 | 0.007 | Inf | 0.007 | 1 | 1 | chemokine (C-C motif) ligand 19 binding |
GO:0035758 | 0.007 | Inf | 0.007 | 1 | 1 | chemokine (C-C motif) ligand 21 binding |
GO:0038117 | 0.007 | Inf | 0.007 | 1 | 1 | C-C motif chemokine 19 receptor activity |
GO:0038121 | 0.007 | Inf | 0.007 | 1 | 1 | C-C motif chemokine 21 receptor activity |
GO:0097621 | 0.007 | Inf | 0.007 | 1 | 1 | monoamine oxidase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 55.2183 | 0.3178 | 12 | 57 | olfactory receptor activity |
GO:0004930 | 0 | 7.7876 | 2.3472 | 15 | 421 | G-protein coupled receptor activity |
GO:0060089 | 0 | 4.3402 | 6.4171 | 22 | 1151 | molecular transducer activity |
GO:0038023 | 0 | 4.6382 | 5.0456 | 19 | 905 | signaling receptor activity |
GO:0099600 | 0 | 4.3276 | 4.7111 | 17 | 845 | transmembrane receptor activity |
GO:0004321 | 0 | 138.6311 | 0.039 | 3 | 7 | fatty-acyl-CoA synthase activity |
GO:0003996 | 0 | 110.8976 | 0.0446 | 3 | 8 | acyl-CoA ligase activity |
GO:0047760 | 0 | 110.8976 | 0.0446 | 3 | 8 | butyrate-CoA ligase activity |
GO:0004507 | 0 | Inf | 0.0112 | 2 | 2 | steroid 11-beta-monooxygenase activity |
GO:0031727 | 0 | Inf | 0.0112 | 2 | 2 | CCR2 chemokine receptor binding |
GO:0047783 | 0 | Inf | 0.0112 | 2 | 2 | corticosterone 18-monooxygenase activity |
GO:0004497 | 1e-04 | 11.218 | 0.4962 | 5 | 89 | monooxygenase activity |
GO:0015645 | 2e-04 | 32.5911 | 0.1115 | 3 | 20 | fatty acid ligase activity |
GO:0008233 | 4e-04 | 3.7776 | 3.2615 | 11 | 585 | peptidase activity |
GO:0004867 | 7e-04 | 10.8012 | 0.407 | 4 | 73 | serine-type endopeptidase inhibitor activity |
GO:0030414 | 0.0011 | 7.0089 | 0.775 | 5 | 139 | peptidase inhibitor activity |
GO:0061135 | 0.0011 | 7.0089 | 0.775 | 5 | 139 | endopeptidase regulator activity |
GO:0016705 | 0.0014 | 6.5638 | 0.8251 | 5 | 148 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
GO:0004252 | 0.0023 | 5.823 | 0.9255 | 5 | 166 | serine-type endopeptidase activity |
GO:0036459 | 0.003 | 7.2195 | 0.5965 | 4 | 107 | thiol-dependent ubiquitinyl hydrolase activity |
GO:0008234 | 0.003 | 5.4788 | 0.9812 | 5 | 176 | cysteine-type peptidase activity |
GO:0061783 | 0.0035 | 26.0706 | 0.0892 | 2 | 16 | peptidoglycan muralytic activity |
GO:0020037 | 0.0045 | 6.4049 | 0.669 | 4 | 120 | heme binding |
GO:0019865 | 0.0049 | 21.4656 | 0.1059 | 2 | 19 | immunoglobulin binding |
GO:0017171 | 0.005 | 4.8472 | 1.1039 | 5 | 198 | serine hydrolase activity |
GO:0004506 | 0.0056 | Inf | 0.0056 | 1 | 1 | squalene monooxygenase activity |
GO:0102116 | 0.0056 | Inf | 0.0056 | 1 | 1 | laurate hydroxylase activity |
GO:0103002 | 0.0056 | Inf | 0.0056 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
GO:0048020 | 0.0063 | 18.6926 | 0.1198 | 2 | 22 | CCR chemokine receptor binding |
GO:0001530 | 0.0078 | 16.5816 | 0.1338 | 2 | 24 | lipopolysaccharide binding |
GO:0005506 | 0.0096 | 5.114 | 0.8307 | 4 | 149 | iron ion binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0043565 | 1e-04 | 2.3177 | 13.2982 | 28 | 989 | sequence-specific DNA binding |
GO:0016165 | 2e-04 | Inf | 0.0269 | 2 | 2 | linoleate 13S-lipoxygenase activity |
GO:0005179 | 0.0027 | 4.6451 | 1.385 | 6 | 103 | hormone activity |
GO:0046982 | 0.0031 | 2.4553 | 6.0508 | 14 | 450 | protein heterodimerization activity |
GO:0004952 | 0.0048 | 24.688 | 0.1076 | 2 | 8 | dopamine neurotransmitter receptor activity |
GO:0102991 | 0.0048 | 24.688 | 0.1076 | 2 | 8 | myristoyl-CoA hydrolase activity |
GO:0005501 | 0.0082 | 7.963 | 0.4168 | 3 | 31 | retinoid binding |
GO:0016290 | 0.0091 | 16.4554 | 0.1479 | 2 | 11 | palmitoyl-CoA hydrolase activity |
GO:0000981 | 0.0095 | 1.9429 | 9.7888 | 18 | 728 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031727 | 1e-04 | Inf | 0.0178 | 2 | 2 | CCR2 chemokine receptor binding |
GO:0008009 | 1e-04 | 17.5804 | 0.2676 | 4 | 30 | chemokine activity |
GO:0005132 | 8e-04 | 75.1592 | 0.0446 | 2 | 5 | type I interferon receptor binding |
GO:0055131 | 0.0012 | 56.3657 | 0.0535 | 2 | 6 | C3HC4-type RING finger domain binding |
GO:0048018 | 0.002 | 3.1972 | 3.3541 | 10 | 376 | receptor ligand activity |
GO:0042379 | 0.002 | 38.6564 | 0.0694 | 2 | 8 | chemokine receptor binding |
GO:0045236 | 0.0041 | 25.0431 | 0.0981 | 2 | 11 | CXCR chemokine receptor binding |
GO:0004888 | 0.0052 | 2.2592 | 7.1452 | 15 | 801 | transmembrane signaling receptor activity |
GO:0004631 | 0.0089 | Inf | 0.0089 | 1 | 1 | phosphomevalonate kinase activity |
GO:0005147 | 0.0089 | Inf | 0.0089 | 1 | 1 | oncostatin-M receptor binding |
GO:0008518 | 0.0089 | Inf | 0.0089 | 1 | 1 | reduced folate carrier activity |
GO:0031249 | 0.0089 | Inf | 0.0089 | 1 | 1 | denatured protein binding |
GO:0033735 | 0.0089 | Inf | 0.0089 | 1 | 1 | aspartate dehydrogenase activity |
GO:0034353 | 0.0089 | Inf | 0.0089 | 1 | 1 | RNA pyrophosphohydrolase activity |
GO:0035755 | 0.0089 | Inf | 0.0089 | 1 | 1 | cardiolipin hydrolase activity |
GO:0003735 | 0.0097 | 4.0812 | 1.2935 | 5 | 145 | structural constituent of ribosome |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 46.9431 | 0.4038 | 13 | 57 | olfactory receptor activity |
GO:0036459 | 0 | 26.378 | 0.758 | 15 | 107 | thiol-dependent ubiquitinyl hydrolase activity |
GO:0008234 | 0 | 16.2804 | 1.2468 | 16 | 176 | cysteine-type peptidase activity |
GO:0004872 | 0 | 4.3389 | 7.8418 | 27 | 1107 | receptor activity |
GO:0008233 | 0 | 5.1397 | 4.144 | 18 | 585 | peptidase activity |
GO:0004930 | 0 | 5.8525 | 2.9823 | 15 | 421 | G-protein coupled receptor activity |
GO:0004871 | 0 | 3.3735 | 8.5431 | 24 | 1206 | signal transducer activity |
GO:0004507 | 0 | Inf | 0.0142 | 2 | 2 | steroid 11-beta-monooxygenase activity |
GO:0047783 | 0 | Inf | 0.0142 | 2 | 2 | corticosterone 18-monooxygenase activity |
GO:0004497 | 4e-04 | 8.6997 | 0.6305 | 5 | 89 | monooxygenase activity |
GO:0048020 | 6e-04 | 20.5673 | 0.17 | 3 | 24 | CCR chemokine receptor binding |
GO:0016705 | 6e-04 | 6.2121 | 1.0484 | 6 | 148 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
GO:0004321 | 0.001 | 57.1057 | 0.0496 | 2 | 7 | fatty-acyl-CoA synthase activity |
GO:0008009 | 0.0012 | 15.9905 | 0.2125 | 3 | 30 | chemokine activity |
GO:0003996 | 0.0014 | 47.5849 | 0.0567 | 2 | 8 | acyl-CoA ligase activity |
GO:0047760 | 0.0014 | 47.5849 | 0.0567 | 2 | 8 | butyrate-CoA ligase activity |
GO:0030246 | 0.0016 | 4.4336 | 1.7001 | 7 | 240 | carbohydrate binding |
GO:0020037 | 0.0016 | 6.3415 | 0.8501 | 5 | 120 | heme binding |
GO:0004867 | 0.0018 | 8.3997 | 0.5171 | 4 | 73 | serine-type endopeptidase inhibitor activity |
GO:0005549 | 0.0026 | 31.717 | 0.0779 | 2 | 11 | odorant binding |
GO:0003823 | 0.004 | 10.2694 | 0.3188 | 3 | 45 | antigen binding |
GO:0005506 | 0.0041 | 5.0546 | 1.0555 | 5 | 149 | iron ion binding |
GO:0008329 | 0.0056 | 20.3827 | 0.1133 | 2 | 16 | signaling pattern recognition receptor activity |
GO:0061783 | 0.0056 | 20.3827 | 0.1133 | 2 | 16 | peptidoglycan muralytic activity |
GO:0004912 | 0.0071 | Inf | 0.0071 | 1 | 1 | interleukin-3 receptor activity |
GO:0008891 | 0.0071 | Inf | 0.0071 | 1 | 1 | glycolate oxidase activity |
GO:0035375 | 0.0071 | Inf | 0.0071 | 1 | 1 | zymogen binding |
GO:0042164 | 0.0071 | Inf | 0.0071 | 1 | 1 | interleukin-12 alpha subunit binding |
GO:0047969 | 0.0071 | Inf | 0.0071 | 1 | 1 | glyoxylate oxidase activity |
GO:0102116 | 0.0071 | Inf | 0.0071 | 1 | 1 | laurate hydroxylase activity |
GO:0103002 | 0.0071 | Inf | 0.0071 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
GO:0015645 | 0.0087 | 15.8491 | 0.1417 | 2 | 20 | fatty acid ligase activity |
GO:0004888 | 0.0099 | 3.1334 | 2.3838 | 7 | 380 | transmembrane signaling receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0030545 | 2e-04 | 3.2671 | 4.6438 | 14 | 400 | receptor regulator activity |
GO:1903231 | 5e-04 | 12.4203 | 0.3715 | 4 | 32 | mRNA binding involved in posttranscriptional gene silencing |
GO:0005179 | 0.0013 | 5.4158 | 1.1958 | 6 | 103 | hormone activity |
GO:0005132 | 0.0013 | 57.3943 | 0.058 | 2 | 5 | type I interferon receptor binding |
GO:0051379 | 0.0027 | 34.432 | 0.0813 | 2 | 7 | epinephrine binding |
GO:0004952 | 0.0036 | 28.6914 | 0.0929 | 2 | 8 | dopamine neurotransmitter receptor activity |
GO:0102991 | 0.0036 | 28.6914 | 0.0929 | 2 | 8 | myristoyl-CoA hydrolase activity |
GO:0005125 | 0.0036 | 3.789 | 1.962 | 7 | 169 | cytokine activity |
GO:0008190 | 0.0046 | 24.591 | 0.1045 | 2 | 9 | eukaryotic initiation factor 4E binding |
GO:0016290 | 0.0069 | 19.1238 | 0.1277 | 2 | 11 | palmitoyl-CoA hydrolase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0030617 | 0 | Inf | 0.0132 | 2 | 2 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity |
GO:0032394 | 0 | Inf | 0.0132 | 2 | 2 | MHC class Ib receptor activity |
GO:0070697 | 3e-04 | 152.9596 | 0.0265 | 2 | 4 | activin receptor binding |
GO:0016174 | 4e-04 | 101.9663 | 0.0331 | 2 | 5 | NAD(P)H oxidase activity |
GO:0020037 | 0.0012 | 6.8071 | 0.795 | 5 | 120 | heme binding |
GO:0034713 | 0.0015 | 43.6883 | 0.0596 | 2 | 9 | type I transforming growth factor beta receptor binding |
GO:0004601 | 0.0018 | 13.7456 | 0.2427 | 3 | 37 | peroxidase activity |
GO:0070411 | 0.0023 | 33.9753 | 0.0729 | 2 | 11 | I-SMAD binding |
GO:0033612 | 0.0043 | 23.5152 | 0.0994 | 2 | 15 | receptor serine/threonine kinase binding |
GO:0042288 | 0.0062 | 19.1023 | 0.1192 | 2 | 18 | MHC class I protein binding |
GO:0001604 | 0.0066 | Inf | 0.0066 | 1 | 1 | urotensin II receptor activity |
GO:0004790 | 0.0066 | Inf | 0.0066 | 1 | 1 | thioether S-methyltransferase activity |
GO:0008112 | 0.0066 | Inf | 0.0066 | 1 | 1 | nicotinamide N-methyltransferase activity |
GO:0030354 | 0.0066 | Inf | 0.0066 | 1 | 1 | melanin-concentrating hormone activity |
GO:0030748 | 0.0066 | Inf | 0.0066 | 1 | 1 | amine N-methyltransferase activity |
GO:0030760 | 0.0066 | Inf | 0.0066 | 1 | 1 | pyridine N-methyltransferase activity |
GO:0031703 | 0.0066 | Inf | 0.0066 | 1 | 1 | type 2 angiotensin receptor binding |
GO:0047888 | 0.0066 | Inf | 0.0066 | 1 | 1 | fatty acid peroxidase activity |
GO:0102707 | 0.0066 | Inf | 0.0066 | 1 | 1 | S-adenosyl-L-methionine:beta-alanine N-methyltransferase activity |
GO:0004930 | 0.0068 | 3.0684 | 2.789 | 8 | 421 | G-protein coupled receptor activity |
GO:0060089 | 0.0086 | 2.1509 | 7.625 | 15 | 1151 | molecular transducer activity |
GO:0099600 | 0.0099 | 2.3166 | 5.5979 | 12 | 845 | transmembrane receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 29.3942 | 0.2954 | 7 | 57 | olfactory receptor activity |
GO:0004930 | 0 | 7.811 | 2.1815 | 14 | 421 | G-protein coupled receptor activity |
GO:0004875 | 0 | 134.7644 | 0.0518 | 4 | 10 | complement receptor activity |
GO:0099600 | 0 | 5.1167 | 4.3785 | 18 | 845 | transmembrane receptor activity |
GO:0004982 | 0 | 598.6579 | 0.0207 | 3 | 4 | N-formyl peptide receptor activity |
GO:0060089 | 0 | 4.2069 | 5.9641 | 20 | 1151 | molecular transducer activity |
GO:0005549 | 0 | 74.7977 | 0.057 | 3 | 11 | odorant binding |
GO:0038023 | 0 | 4.2234 | 3.9158 | 14 | 790 | signaling receptor activity |
GO:0005124 | 1e-04 | 393.9221 | 0.0155 | 2 | 3 | scavenger receptor binding |
GO:0001653 | 0.003 | 7.2341 | 0.5959 | 4 | 115 | peptide receptor activity |
GO:0004838 | 0.0052 | Inf | 0.0052 | 1 | 1 | L-tyrosine:2-oxoglutarate aminotransferase activity |
GO:0015327 | 0.0052 | Inf | 0.0052 | 1 | 1 | cystine:glutamate antiporter activity |
GO:1901680 | 0.0052 | Inf | 0.0052 | 1 | 1 | sulfur-containing amino acid secondary active transmembrane transporter activity |
GO:1990190 | 0.0052 | Inf | 0.0052 | 1 | 1 | peptide-glutamate-N-acetyltransferase activity |
GO:0042056 | 0.0092 | 15.1259 | 0.1451 | 2 | 28 | chemoattractant activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0061629 | 0 | Inf | 0.0119 | 2 | 2 | RNA polymerase II sequence-specific DNA binding transcription factor binding |
GO:0008048 | 3e-04 | 113.4981 | 0.0298 | 2 | 5 | calcium sensitive guanylate cyclase activator activity |
GO:0004984 | 4e-04 | 13.1008 | 0.3402 | 4 | 57 | olfactory receptor activity |
GO:0030545 | 6e-04 | 4.1443 | 2.3875 | 9 | 400 | receptor regulator activity |
GO:0010853 | 7e-04 | 68.0899 | 0.0418 | 2 | 7 | cyclase activator activity |
GO:0030249 | 0.001 | 56.7378 | 0.0478 | 2 | 8 | guanylate cyclase regulator activity |
GO:0099600 | 0.0015 | 2.8692 | 5.0436 | 13 | 845 | transmembrane receptor activity |
GO:0038023 | 0.0027 | 2.665 | 5.4017 | 13 | 905 | signaling receptor activity |
GO:0031432 | 0.0031 | 28.3577 | 0.0836 | 2 | 14 | titin binding |
GO:0005125 | 0.0034 | 5.3144 | 1.0087 | 5 | 169 | cytokine activity |
GO:0005509 | 0.0046 | 2.8653 | 3.7961 | 10 | 636 | calcium ion binding |
GO:0004462 | 0.006 | Inf | 0.006 | 1 | 1 | lactoylglutathione lyase activity |
GO:0005147 | 0.006 | Inf | 0.006 | 1 | 1 | oncostatin-M receptor binding |
GO:0019767 | 0.006 | Inf | 0.006 | 1 | 1 | IgE receptor activity |
GO:0030354 | 0.006 | Inf | 0.006 | 1 | 1 | melanin-concentrating hormone activity |
GO:0031854 | 0.006 | Inf | 0.006 | 1 | 1 | orexigenic neuropeptide QRFP receptor binding |
GO:0033560 | 0.006 | Inf | 0.006 | 1 | 1 | folate reductase activity |
GO:0042497 | 0.006 | Inf | 0.006 | 1 | 1 | triacyl lipopeptide binding |
GO:0047963 | 0.006 | Inf | 0.006 | 1 | 1 | glycine N-choloyltransferase activity |
GO:0050528 | 0.006 | Inf | 0.006 | 1 | 1 | acyloxyacyl hydrolase activity |
GO:0052817 | 0.006 | Inf | 0.006 | 1 | 1 | very long chain acyl-CoA hydrolase activity |
GO:0080048 | 0.006 | Inf | 0.006 | 1 | 1 | GDP-D-glucose phosphorylase activity |
GO:0060089 | 0.0081 | 2.2416 | 6.8701 | 14 | 1151 | molecular transducer activity |
GO:0005126 | 0.0089 | 4.1863 | 1.2693 | 5 | 215 | cytokine receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0000981 | 0.0014 | 2.3803 | 8.1653 | 18 | 728 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
GO:0038036 | 0.0033 | 29.7219 | 0.0897 | 2 | 8 | sphingosine-1-phosphate receptor activity |
GO:0005542 | 0.0043 | 25.4742 | 0.1009 | 2 | 9 | folic acid binding |
GO:0005372 | 0.0053 | 22.2885 | 0.1122 | 2 | 10 | water transmembrane transporter activity |
GO:0043565 | 0.0076 | 1.9281 | 11.0927 | 20 | 989 | sequence-specific DNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031727 | 0 | Inf | 0.0134 | 2 | 2 | CCR2 chemokine receptor binding |
GO:0005179 | 1e-04 | 9.6952 | 0.6891 | 6 | 103 | hormone activity |
GO:0005126 | 1e-04 | 7.1376 | 1.0833 | 7 | 168 | cytokine receptor binding |
GO:0005198 | 2e-04 | 3.5102 | 4.1346 | 13 | 618 | structural molecule activity |
GO:0008327 | 3e-04 | 28.6515 | 0.1271 | 3 | 19 | methyl-CpG binding |
GO:0048020 | 3e-04 | 26.2604 | 0.1364 | 3 | 21 | CCR chemokine receptor binding |
GO:0001664 | 8e-04 | 5.0216 | 1.512 | 7 | 226 | G-protein coupled receptor binding |
GO:0032395 | 9e-04 | 60.556 | 0.0468 | 2 | 7 | MHC class II receptor activity |
GO:0008009 | 0.001 | 16.9663 | 0.2007 | 3 | 30 | chemokine activity |
GO:0048018 | 0.0017 | 4.3705 | 1.7307 | 7 | 273 | receptor ligand activity |
GO:0005160 | 0.0038 | 10.3994 | 0.3144 | 3 | 47 | transforming growth factor beta receptor binding |
GO:0008391 | 0.0056 | 20.172 | 0.1137 | 2 | 17 | arachidonic acid monooxygenase activity |
GO:0005130 | 0.0067 | Inf | 0.0067 | 1 | 1 | granulocyte colony-stimulating factor receptor binding |
GO:0008397 | 0.0067 | Inf | 0.0067 | 1 | 1 | sterol 12-alpha-hydroxylase activity |
GO:0008404 | 0.0067 | Inf | 0.0067 | 1 | 1 | arachidonic acid 14,15-epoxygenase activity |
GO:0008405 | 0.0067 | Inf | 0.0067 | 1 | 1 | arachidonic acid 11,12-epoxygenase activity |
GO:0008579 | 0.0067 | Inf | 0.0067 | 1 | 1 | JUN kinase phosphatase activity |
GO:0030251 | 0.0067 | Inf | 0.0067 | 1 | 1 | guanylate cyclase inhibitor activity |
GO:0030273 | 0.0067 | Inf | 0.0067 | 1 | 1 | melanin-concentrating hormone receptor activity |
GO:0031731 | 0.0067 | Inf | 0.0067 | 1 | 1 | CCR6 chemokine receptor binding |
GO:0033735 | 0.0067 | Inf | 0.0067 | 1 | 1 | aspartate dehydrogenase activity |
GO:0033778 | 0.0067 | Inf | 0.0067 | 1 | 1 | 7alpha-hydroxycholest-4-en-3-one 12alpha-hydroxylase activity |
GO:0046789 | 0.0067 | Inf | 0.0067 | 1 | 1 | host cell surface receptor binding |
GO:0047395 | 0.0067 | Inf | 0.0067 | 1 | 1 | glycerophosphoinositol glycerophosphodiesterase activity |
GO:0071614 | 0.0067 | Inf | 0.0067 | 1 | 1 | linoleic acid epoxygenase activity |
GO:1990439 | 0.0067 | Inf | 0.0067 | 1 | 1 | MAP kinase serine/threonine phosphatase activity |
GO:0070330 | 0.0086 | 15.9211 | 0.1405 | 2 | 21 | aromatase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031727 | 0 | Inf | 0.0135 | 2 | 2 | CCR2 chemokine receptor binding |
GO:0008201 | 5e-04 | 6.5813 | 0.9931 | 6 | 147 | heparin binding |
GO:0043565 | 9e-04 | 2.6783 | 6.6816 | 16 | 989 | sequence-specific DNA binding |
GO:0000981 | 0.0012 | 2.9147 | 4.9183 | 13 | 728 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
GO:0001846 | 0.0029 | 29.9663 | 0.0811 | 2 | 12 | opsonin binding |
GO:0010181 | 0.0039 | 24.9686 | 0.0946 | 2 | 14 | FMN binding |
GO:0031432 | 0.0039 | 24.9686 | 0.0946 | 2 | 14 | titin binding |
GO:0001604 | 0.0068 | Inf | 0.0068 | 1 | 1 | urotensin II receptor activity |
GO:0001850 | 0.0068 | Inf | 0.0068 | 1 | 1 | complement component C3a binding |
GO:0004531 | 0.0068 | Inf | 0.0068 | 1 | 1 | deoxyribonuclease II activity |
GO:0004607 | 0.0068 | Inf | 0.0068 | 1 | 1 | phosphatidylcholine-sterol O-acyltransferase activity |
GO:0031686 | 0.0068 | Inf | 0.0068 | 1 | 1 | A1 adenosine receptor binding |
GO:0045032 | 0.0068 | Inf | 0.0068 | 1 | 1 | ADP-activated adenosine receptor activity |
GO:0050113 | 0.0068 | Inf | 0.0068 | 1 | 1 | inositol oxygenase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0043565 | 0 | 4.3221 | 10.0548 | 35 | 989 | sequence-specific DNA binding |
GO:0003700 | 0 | 3.5829 | 11.9051 | 35 | 1171 | DNA binding transcription factor activity |
GO:0001228 | 0 | 8.935 | 1.2774 | 10 | 132 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
GO:0001012 | 1e-04 | 3.1326 | 5.978 | 17 | 588 | RNA polymerase II regulatory region DNA binding |
GO:0003690 | 1e-04 | 2.8013 | 7.9096 | 20 | 778 | double-stranded DNA binding |
GO:0001077 | 4e-04 | 4.0447 | 2.6738 | 10 | 263 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
GO:0000976 | 4e-04 | 2.7457 | 6.7608 | 17 | 665 | transcription regulatory region sequence-specific DNA binding |
GO:0000975 | 6e-04 | 2.5189 | 8.2553 | 19 | 812 | regulatory region DNA binding |
GO:0000978 | 9e-04 | 3.3443 | 3.538 | 11 | 348 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
GO:0001159 | 0.0012 | 3.1893 | 3.7006 | 11 | 364 | core promoter proximal region DNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1903231 | 0 | 27.5626 | 0.3358 | 7 | 32 | mRNA binding involved in posttranscriptional gene silencing |
GO:0043565 | 0 | 3.3995 | 10.3791 | 30 | 989 | sequence-specific DNA binding |
GO:0001077 | 1e-04 | 4.3457 | 2.7601 | 11 | 263 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
GO:0016165 | 1e-04 | Inf | 0.021 | 2 | 2 | linoleate 13S-lipoxygenase activity |
GO:0000981 | 2e-04 | 2.7325 | 7.64 | 19 | 728 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
GO:0008191 | 3e-04 | 28.8076 | 0.1364 | 3 | 13 | metalloendopeptidase inhibitor activity |
GO:0019840 | 4e-04 | 13.313 | 0.3463 | 4 | 33 | isoprenoid binding |
GO:0140110 | 4e-04 | 2.1279 | 15.8048 | 30 | 1506 | transcription regulator activity |
GO:0031490 | 5e-04 | 6.6402 | 0.9865 | 6 | 94 | chromatin DNA binding |
GO:0008401 | 6e-04 | 95.4684 | 0.042 | 2 | 4 | retinoic acid 4-hydroxylase activity |
GO:0030545 | 0.0011 | 3.0715 | 4.1978 | 12 | 400 | receptor regulator activity |
GO:0005132 | 0.0011 | 63.6414 | 0.0525 | 2 | 5 | type I interferon receptor binding |
GO:0001012 | 0.0013 | 2.6201 | 6.1708 | 15 | 588 | RNA polymerase II regulatory region DNA binding |
GO:0001159 | 0.0016 | 3.0812 | 3.82 | 11 | 364 | core promoter proximal region DNA binding |
GO:0005125 | 0.002 | 4.2148 | 1.7736 | 7 | 169 | cytokine activity |
GO:0000978 | 0.0037 | 2.9089 | 3.6521 | 10 | 348 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
GO:0000976 | 0.0043 | 2.2975 | 6.9789 | 15 | 665 | transcription regulatory region sequence-specific DNA binding |
GO:0005506 | 0.0049 | 4.0713 | 1.5637 | 6 | 149 | iron ion binding |
GO:0003676 | 0.0049 | 1.5835 | 39.1027 | 54 | 3726 | nucleic acid binding |
GO:0000975 | 0.0051 | 2.137 | 8.5216 | 17 | 812 | regulatory region DNA binding |
GO:0016918 | 0.0092 | 15.9008 | 0.1469 | 2 | 14 | retinal binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031727 | 1e-04 | Inf | 0.0195 | 2 | 2 | CCR2 chemokine receptor binding |
GO:0001530 | 0.0016 | 14.7515 | 0.2346 | 3 | 24 | lipopolysaccharide binding |
GO:0003680 | 0.0026 | 34.22 | 0.0782 | 2 | 8 | AT DNA binding |
GO:0043565 | 0.0036 | 2.1286 | 9.6656 | 19 | 989 | sequence-specific DNA binding |
GO:0048018 | 0.0039 | 2.8956 | 3.6747 | 10 | 376 | receptor ligand activity |
GO:0000981 | 0.0051 | 2.2583 | 7.1148 | 15 | 728 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
GO:0042379 | 0.0069 | 8.3636 | 0.3909 | 3 | 40 | chemokine receptor binding |
GO:0005130 | 0.0098 | Inf | 0.0098 | 1 | 1 | granulocyte colony-stimulating factor receptor binding |
GO:0031732 | 0.0098 | Inf | 0.0098 | 1 | 1 | CCR7 chemokine receptor binding |
GO:0032003 | 0.0098 | Inf | 0.0098 | 1 | 1 | interleukin-28 receptor binding |
GO:0033798 | 0.0098 | Inf | 0.0098 | 1 | 1 | thyroxine 5-deiodinase activity |
GO:0036105 | 0.0098 | Inf | 0.0098 | 1 | 1 | peroxisome membrane class-1 targeting sequence binding |
GO:0036219 | 0.0098 | Inf | 0.0098 | 1 | 1 | GTP diphosphatase activity |
GO:0044713 | 0.0098 | Inf | 0.0098 | 1 | 1 | 2-hydroxy-adenosine triphosphate pyrophosphatase activity |
GO:0044714 | 0.0098 | Inf | 0.0098 | 1 | 1 | 2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity |
GO:0047693 | 0.0098 | Inf | 0.0098 | 1 | 1 | ATP diphosphatase activity |
GO:0050113 | 0.0098 | Inf | 0.0098 | 1 | 1 | inositol oxygenase activity |
GO:0070009 | 0.0098 | Inf | 0.0098 | 1 | 1 | serine-type aminopeptidase activity |
GO:0070320 | 0.0098 | Inf | 0.0098 | 1 | 1 | inward rectifier potassium channel inhibitor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 18.628 | 0.3103 | 5 | 57 | olfactory receptor activity |
GO:0031727 | 0 | Inf | 0.0109 | 2 | 2 | CCR2 chemokine receptor binding |
GO:0015250 | 0.001 | 53.4603 | 0.049 | 2 | 9 | water channel activity |
GO:0042379 | 0.0013 | 15.3304 | 0.2178 | 3 | 40 | chemokine receptor binding |
GO:0000121 | 0.0054 | Inf | 0.0054 | 1 | 1 | glycerol-1-phosphatase activity |
GO:0008458 | 0.0054 | Inf | 0.0054 | 1 | 1 | carnitine O-octanoyltransferase activity |
GO:0015361 | 0.0054 | Inf | 0.0054 | 1 | 1 | low-affinity sodium:dicarboxylate symporter activity |
GO:0016415 | 0.0054 | Inf | 0.0054 | 1 | 1 | octanoyltransferase activity |
GO:0043136 | 0.0054 | Inf | 0.0054 | 1 | 1 | glycerol-3-phosphatase activity |
GO:0005343 | 0.0069 | 17.8036 | 0.1252 | 2 | 23 | organic acid:sodium symporter activity |
GO:0001530 | 0.0075 | 16.9933 | 0.1307 | 2 | 24 | lipopolysaccharide binding |
GO:0004930 | 0.008 | 3.2813 | 2.2919 | 7 | 421 | G-protein coupled receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005509 | 0 | 5.5028 | 7.8426 | 35 | 636 | calcium ion binding |
GO:0001632 | 2e-04 | Inf | 0.0247 | 2 | 2 | leukotriene B4 receptor activity |
GO:0016165 | 2e-04 | Inf | 0.0247 | 2 | 2 | linoleate 13S-lipoxygenase activity |
GO:0005179 | 0.0017 | 5.0847 | 1.2701 | 6 | 103 | hormone activity |
GO:0043565 | 0.0025 | 2.0335 | 12.1955 | 23 | 989 | sequence-specific DNA binding |
GO:0004966 | 0.003 | 32.372 | 0.0863 | 2 | 7 | galanin receptor activity |
GO:0003705 | 0.0059 | 4.6479 | 1.1468 | 5 | 93 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding |
GO:1903231 | 0.007 | 8.4039 | 0.3946 | 3 | 32 | mRNA binding involved in posttranscriptional gene silencing |
GO:0004861 | 0.0092 | 16.1806 | 0.148 | 2 | 12 | cyclin-dependent protein serine/threonine kinase inhibitor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 58.6064 | 0.4 | 15 | 57 | olfactory receptor activity |
GO:0004930 | 0 | 8.449 | 2.9547 | 20 | 421 | G-protein coupled receptor activity |
GO:0060089 | 0 | 4.872 | 8.078 | 30 | 1151 | molecular transducer activity |
GO:0099600 | 0 | 5.3238 | 5.9304 | 25 | 845 | transmembrane receptor activity |
GO:0038023 | 0 | 5.1581 | 6.129 | 25 | 889 | signaling receptor activity |
GO:0036459 | 0 | 15.9868 | 0.751 | 10 | 107 | thiol-dependent ubiquitinyl hydrolase activity |
GO:0008234 | 0 | 10.3986 | 1.2352 | 11 | 176 | cysteine-type peptidase activity |
GO:0008233 | 0 | 4.1673 | 4.1057 | 15 | 585 | peptidase activity |
GO:0004507 | 0 | Inf | 0.014 | 2 | 2 | steroid 11-beta-monooxygenase activity |
GO:0031727 | 0 | Inf | 0.014 | 2 | 2 | CCR2 chemokine receptor binding |
GO:0047783 | 0 | Inf | 0.014 | 2 | 2 | corticosterone 18-monooxygenase activity |
GO:0003823 | 3e-04 | 14.3007 | 0.3158 | 4 | 45 | antigen binding |
GO:0018685 | 3e-04 | 144.1619 | 0.0281 | 2 | 4 | alkane 1-monooxygenase activity |
GO:0050051 | 3e-04 | 144.1619 | 0.0281 | 2 | 4 | leukotriene-B4 20-monooxygenase activity |
GO:0004497 | 4e-04 | 8.7856 | 0.6246 | 5 | 89 | monooxygenase activity |
GO:0048020 | 4e-04 | 23.4056 | 0.1515 | 3 | 22 | CCR chemokine receptor binding |
GO:0004321 | 0.001 | 57.6533 | 0.0491 | 2 | 7 | fatty-acyl-CoA synthase activity |
GO:0008009 | 0.0012 | 16.1453 | 0.2105 | 3 | 30 | chemokine activity |
GO:0003996 | 0.0013 | 48.0413 | 0.0561 | 2 | 8 | acyl-CoA ligase activity |
GO:0047760 | 0.0013 | 48.0413 | 0.0561 | 2 | 8 | butyrate-CoA ligase activity |
GO:0020037 | 0.0016 | 6.4041 | 0.8422 | 5 | 120 | heme binding |
GO:0004867 | 0.0017 | 8.4818 | 0.5123 | 4 | 73 | serine-type endopeptidase inhibitor activity |
GO:0016705 | 0.0039 | 5.1405 | 1.0387 | 5 | 148 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
GO:0005506 | 0.004 | 5.1045 | 1.0457 | 5 | 149 | iron ion binding |
GO:0008329 | 0.0055 | 20.5782 | 0.1123 | 2 | 16 | signaling pattern recognition receptor activity |
GO:0008392 | 0.0062 | 19.2051 | 0.1193 | 2 | 17 | arachidonic acid epoxygenase activity |
GO:0035375 | 0.007 | Inf | 0.007 | 1 | 1 | zymogen binding |
GO:0102116 | 0.007 | Inf | 0.007 | 1 | 1 | laurate hydroxylase activity |
GO:0103002 | 0.007 | Inf | 0.007 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
GO:0015645 | 0.0085 | 16.0011 | 0.1404 | 2 | 20 | fatty acid ligase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 50.6564 | 0.415 | 14 | 57 | olfactory receptor activity |
GO:0036459 | 0 | 27.8431 | 0.779 | 16 | 107 | thiol-dependent ubiquitinyl hydrolase activity |
GO:0008234 | 0 | 17.0341 | 1.2814 | 17 | 176 | cysteine-type peptidase activity |
GO:0004872 | 0 | 4.8344 | 8.0596 | 30 | 1107 | receptor activity |
GO:0008233 | 0 | 5.6676 | 4.2591 | 20 | 585 | peptidase activity |
GO:0004930 | 0 | 6.1255 | 3.0651 | 16 | 421 | G-protein coupled receptor activity |
GO:0004871 | 0 | 3.6174 | 8.7804 | 26 | 1206 | signal transducer activity |
GO:0004497 | 0 | 10.3628 | 0.648 | 6 | 89 | monooxygenase activity |
GO:0004507 | 1e-04 | Inf | 0.0146 | 2 | 2 | steroid 11-beta-monooxygenase activity |
GO:0047783 | 1e-04 | Inf | 0.0146 | 2 | 2 | corticosterone 18-monooxygenase activity |
GO:0016705 | 1e-04 | 7.1575 | 1.0775 | 7 | 148 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
GO:0020037 | 2e-04 | 7.5293 | 0.8737 | 6 | 120 | heme binding |
GO:0003823 | 3e-04 | 13.7625 | 0.3276 | 4 | 45 | antigen binding |
GO:0048020 | 7e-04 | 19.9921 | 0.1747 | 3 | 24 | CCR chemokine receptor binding |
GO:0005506 | 8e-04 | 5.9908 | 1.0848 | 6 | 149 | iron ion binding |
GO:0004321 | 0.0011 | 55.5229 | 0.051 | 2 | 7 | fatty-acyl-CoA synthase activity |
GO:0008009 | 0.0013 | 15.5432 | 0.2184 | 3 | 30 | chemokine activity |
GO:0003996 | 0.0014 | 46.2661 | 0.0582 | 2 | 8 | acyl-CoA ligase activity |
GO:0047760 | 0.0014 | 46.2661 | 0.0582 | 2 | 8 | butyrate-CoA ligase activity |
GO:0004867 | 0.002 | 8.1625 | 0.5315 | 4 | 73 | serine-type endopeptidase inhibitor activity |
GO:0005549 | 0.0028 | 30.8379 | 0.0801 | 2 | 11 | odorant binding |
GO:0004888 | 0.003 | 3.5491 | 2.4351 | 8 | 380 | transmembrane signaling receptor activity |
GO:0008329 | 0.0059 | 19.8178 | 0.1165 | 2 | 16 | signaling pattern recognition receptor activity |
GO:0061783 | 0.0059 | 19.8178 | 0.1165 | 2 | 16 | peptidoglycan muralytic activity |
GO:0008392 | 0.0067 | 18.4954 | 0.1238 | 2 | 17 | arachidonic acid epoxygenase activity |
GO:0004912 | 0.0073 | Inf | 0.0073 | 1 | 1 | interleukin-3 receptor activity |
GO:0035375 | 0.0073 | Inf | 0.0073 | 1 | 1 | zymogen binding |
GO:0042164 | 0.0073 | Inf | 0.0073 | 1 | 1 | interleukin-12 alpha subunit binding |
GO:0102116 | 0.0073 | Inf | 0.0073 | 1 | 1 | laurate hydroxylase activity |
GO:0103002 | 0.0073 | Inf | 0.0073 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
GO:0030246 | 0.0082 | 3.6388 | 1.7473 | 6 | 240 | carbohydrate binding |
GO:0015645 | 0.0092 | 15.4098 | 0.1456 | 2 | 20 | fatty acid ligase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031727 | 1e-04 | Inf | 0.0194 | 2 | 2 | CCR2 chemokine receptor binding |
GO:0051380 | 6e-04 | 103.3973 | 0.0388 | 2 | 4 | norepinephrine binding |
GO:0005132 | 9e-04 | 68.9269 | 0.0485 | 2 | 5 | type I interferon receptor binding |
GO:0055131 | 0.0014 | 51.6918 | 0.0582 | 2 | 6 | C3HC4-type RING finger domain binding |
GO:0001664 | 0.0018 | 4.336 | 1.7277 | 7 | 185 | G-protein coupled receptor binding |
GO:0051379 | 0.0019 | 41.3507 | 0.068 | 2 | 7 | epinephrine binding |
GO:0042379 | 0.0024 | 35.1119 | 0.0762 | 2 | 8 | chemokine receptor binding |
GO:0008009 | 0.003 | 11.5487 | 0.2912 | 3 | 30 | chemokine activity |
GO:0004935 | 0.0032 | 29.5323 | 0.0874 | 2 | 9 | adrenergic receptor activity |
GO:0048018 | 0.0037 | 2.9168 | 3.65 | 10 | 376 | receptor ligand activity |
GO:0045236 | 0.0049 | 22.9665 | 0.1068 | 2 | 11 | CXCR chemokine receptor binding |
GO:0004527 | 0.0058 | 5.9635 | 0.7184 | 4 | 74 | exonuclease activity |
GO:0004516 | 0.0097 | Inf | 0.0097 | 1 | 1 | nicotinate phosphoribosyltransferase activity |
GO:0004631 | 0.0097 | Inf | 0.0097 | 1 | 1 | phosphomevalonate kinase activity |
GO:0004940 | 0.0097 | Inf | 0.0097 | 1 | 1 | beta1-adrenergic receptor activity |
GO:0005147 | 0.0097 | Inf | 0.0097 | 1 | 1 | oncostatin-M receptor binding |
GO:0008311 | 0.0097 | Inf | 0.0097 | 1 | 1 | double-stranded DNA 3'-5' exodeoxyribonuclease activity |
GO:0008518 | 0.0097 | Inf | 0.0097 | 1 | 1 | reduced folate carrier activity |
GO:0015052 | 0.0097 | Inf | 0.0097 | 1 | 1 | beta3-adrenergic receptor activity |
GO:0016277 | 0.0097 | Inf | 0.0097 | 1 | 1 | [myelin basic protein]-arginine N-methyltransferase activity |
GO:0031249 | 0.0097 | Inf | 0.0097 | 1 | 1 | denatured protein binding |
GO:0031700 | 0.0097 | Inf | 0.0097 | 1 | 1 | adrenomedullin receptor binding |
GO:0031773 | 0.0097 | Inf | 0.0097 | 1 | 1 | kisspeptin receptor binding |
GO:0033735 | 0.0097 | Inf | 0.0097 | 1 | 1 | aspartate dehydrogenase activity |
GO:0034353 | 0.0097 | Inf | 0.0097 | 1 | 1 | RNA pyrophosphohydrolase activity |
GO:0035755 | 0.0097 | Inf | 0.0097 | 1 | 1 | cardiolipin hydrolase activity |
GO:0047915 | 0.0097 | Inf | 0.0097 | 1 | 1 | ganglioside galactosyltransferase activity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0030948 | 1e-04 | 63.2516 | 0.0836 | 3 | 7 | negative regulation of vascular endothelial growth factor receptor signaling pathway |
GO:0048514 | 8e-04 | 2.887 | 5.2531 | 14 | 440 | blood vessel morphogenesis |
GO:0035021 | 8e-04 | 83.8077 | 0.0478 | 2 | 4 | negative regulation of Rac protein signal transduction |
GO:1900747 | 8e-04 | 83.8077 | 0.0478 | 2 | 4 | negative regulation of vascular endothelial growth factor signaling pathway |
GO:0051240 | 0.001 | 2.0798 | 14.3984 | 27 | 1206 | positive regulation of multicellular organismal process |
GO:0048646 | 0.0011 | 2.2704 | 10.1242 | 21 | 848 | anatomical structure formation involved in morphogenesis |
GO:0044030 | 0.0016 | 14.8679 | 0.2388 | 3 | 20 | regulation of DNA methylation |
GO:0048870 | 0.0025 | 1.9872 | 13.7895 | 25 | 1155 | cell motility |
GO:0016525 | 0.0027 | 5.6649 | 0.9551 | 5 | 80 | negative regulation of angiogenesis |
GO:0010533 | 0.0029 | 33.5154 | 0.0836 | 2 | 7 | regulation of activation of Janus kinase activity |
GO:0043697 | 0.0029 | 33.5154 | 0.0836 | 2 | 7 | cell dedifferentiation |
GO:0023052 | 0.0029 | 1.5815 | 56.7339 | 74 | 4752 | signaling |
GO:0060285 | 0.0032 | 11.4845 | 0.2985 | 3 | 25 | cilium-dependent cell motility |
GO:0022603 | 0.0032 | 2.1519 | 9.5512 | 19 | 800 | regulation of anatomical structure morphogenesis |
GO:1901343 | 0.0036 | 5.2429 | 1.0267 | 5 | 86 | negative regulation of vasculature development |
GO:0055002 | 0.0037 | 4.3347 | 1.4804 | 6 | 124 | striated muscle cell development |
GO:1900239 | 0.0038 | 27.9274 | 0.0955 | 2 | 8 | regulation of phenotypic switching |
GO:0010719 | 0.004 | 10.5258 | 0.3224 | 3 | 27 | negative regulation of epithelial to mesenchymal transition |
GO:0048147 | 0.004 | 10.5258 | 0.3224 | 3 | 27 | negative regulation of fibroblast proliferation |
GO:1901890 | 0.0044 | 10.104 | 0.3343 | 3 | 28 | positive regulation of cell junction assembly |
GO:0051094 | 0.0045 | 1.9727 | 12.0942 | 22 | 1013 | positive regulation of developmental process |
GO:0060099 | 0.0048 | 23.9359 | 0.1075 | 2 | 9 | regulation of phagocytosis, engulfment |
GO:0072677 | 0.0048 | 23.9359 | 0.1075 | 2 | 9 | eosinophil migration |
GO:1903726 | 0.0048 | 23.9359 | 0.1075 | 2 | 9 | negative regulation of phospholipid metabolic process |
GO:0072358 | 0.0049 | 2.3429 | 6.3873 | 14 | 535 | cardiovascular system development |
GO:0032964 | 0.0054 | 9.3541 | 0.3582 | 3 | 30 | collagen biosynthetic process |
GO:1901342 | 0.0055 | 3.9774 | 1.6059 | 6 | 138 | regulation of vasculature development |
GO:0050896 | 0.0057 | 1.5239 | 76.7077 | 93 | 6425 | response to stimulus |
GO:0048266 | 0.006 | 20.9423 | 0.1194 | 2 | 10 | behavioral response to pain |
GO:0007166 | 0.0067 | 1.6486 | 25.609 | 38 | 2145 | cell surface receptor signaling pathway |
GO:0010657 | 0.0067 | 5.7306 | 0.7522 | 4 | 63 | muscle cell apoptotic process |
GO:0051101 | 0.0069 | 4.4654 | 1.1939 | 5 | 100 | regulation of DNA binding |
GO:0034433 | 0.0073 | 18.614 | 0.1313 | 2 | 11 | steroid esterification |
GO:0034435 | 0.0073 | 18.614 | 0.1313 | 2 | 11 | cholesterol esterification |
GO:1902547 | 0.0073 | 18.614 | 0.1313 | 2 | 11 | regulation of cellular response to vascular endothelial growth factor stimulus |
GO:0007266 | 0.0074 | 3.7281 | 1.7073 | 6 | 143 | Rho protein signal transduction |
GO:0007154 | 0.0082 | 1.4935 | 56.9368 | 72 | 4769 | cell communication |
GO:1904892 | 0.0088 | 4.1982 | 1.2655 | 5 | 106 | regulation of STAT cascade |
GO:0070372 | 0.0089 | 3.178 | 2.3281 | 7 | 195 | regulation of ERK1 and ERK2 cascade |
GO:0008360 | 0.0091 | 4.1567 | 1.2775 | 5 | 107 | regulation of cell shape |
GO:0046456 | 0.0096 | 7.4243 | 0.4417 | 3 | 37 | icosanoid biosynthetic process |
GO:0048856 | 0.0097 | 1.4837 | 53.4865 | 68 | 4480 | anatomical structure development |
GO:0009968 | 0.0099 | 1.8828 | 11.4126 | 20 | 980 | negative regulation of signal transduction |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042126 | 0 | 157.0403 | 0.0759 | 3 | 4 | nitrate metabolic process |
GO:0006805 | 1e-04 | 7.1341 | 1.119 | 7 | 59 | xenobiotic metabolic process |
GO:0009410 | 3e-04 | 6.179 | 1.2707 | 7 | 67 | response to xenobiotic stimulus |
GO:1905205 | 4e-04 | 31.3984 | 0.1517 | 3 | 8 | positive regulation of connective tissue replacement |
GO:0061029 | 5e-04 | 26.1633 | 0.1707 | 3 | 9 | eyelid development in camera-type eye |
GO:1903244 | 5e-04 | 26.1633 | 0.1707 | 3 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
GO:0072358 | 6e-04 | 2.3353 | 10.147 | 22 | 535 | cardiovascular system development |
GO:1903671 | 8e-04 | 11.0496 | 0.4362 | 4 | 23 | negative regulation of sprouting angiogenesis |
GO:2000181 | 9e-04 | 5.0046 | 1.5363 | 7 | 81 | negative regulation of blood vessel morphogenesis |
GO:0030198 | 9e-04 | 2.9631 | 4.7036 | 13 | 248 | extracellular matrix organization |
GO:0014744 | 0.001 | 19.6195 | 0.2086 | 3 | 11 | positive regulation of muscle adaptation |
GO:0033128 | 0.0011 | 104.2731 | 0.0569 | 2 | 3 | negative regulation of histone phosphorylation |
GO:0051410 | 0.0011 | 104.2731 | 0.0569 | 2 | 3 | detoxification of nitrogen compound |
GO:0061044 | 0.0011 | 104.2731 | 0.0569 | 2 | 3 | negative regulation of vascular wound healing |
GO:0070634 | 0.0011 | 104.2731 | 0.0569 | 2 | 3 | transepithelial ammonium transport |
GO:2001199 | 0.0011 | 104.2731 | 0.0569 | 2 | 3 | negative regulation of dendritic cell differentiation |
GO:0048646 | 0.0012 | 1.9726 | 15.8496 | 29 | 842 | anatomical structure formation involved in morphogenesis |
GO:0046500 | 0.0013 | 17.4382 | 0.2276 | 3 | 12 | S-adenosylmethionine metabolic process |
GO:0006954 | 0.0013 | 2.3128 | 8.7814 | 19 | 463 | inflammatory response |
GO:0045765 | 0.0014 | 4.5531 | 1.6735 | 7 | 90 | regulation of angiogenesis |
GO:0070286 | 0.0016 | 9.1252 | 0.5121 | 4 | 27 | axonemal dynein complex assembly |
GO:0007605 | 0.0016 | 3.9247 | 2.2001 | 8 | 116 | sensory perception of sound |
GO:0006590 | 0.0017 | 15.6931 | 0.2466 | 3 | 13 | thyroid hormone generation |
GO:0072593 | 0.0018 | 3.0373 | 3.8691 | 11 | 204 | reactive oxygen species metabolic process |
GO:0018958 | 0.0021 | 4.9435 | 1.3276 | 6 | 70 | phenol-containing compound metabolic process |
GO:0051122 | 0.0021 | 52.1325 | 0.0759 | 2 | 4 | hepoxilin biosynthetic process |
GO:0060455 | 0.0021 | 52.1325 | 0.0759 | 2 | 4 | negative regulation of gastric acid secretion |
GO:0043537 | 0.0023 | 8.0704 | 0.569 | 4 | 30 | negative regulation of blood vessel endothelial cell migration |
GO:0010612 | 0.0026 | 13.0756 | 0.2845 | 3 | 15 | regulation of cardiac muscle adaptation |
GO:0019372 | 0.0026 | 13.0756 | 0.2845 | 3 | 15 | lipoxygenase pathway |
GO:0008217 | 0.0027 | 3.5893 | 2.3898 | 8 | 126 | regulation of blood pressure |
GO:0001568 | 0.0031 | 2.1371 | 9.4502 | 19 | 502 | blood vessel development |
GO:0006555 | 0.0031 | 12.0689 | 0.3035 | 3 | 16 | methionine metabolic process |
GO:0010757 | 0.0035 | 34.7523 | 0.0948 | 2 | 5 | negative regulation of plasminogen activation |
GO:0034112 | 0.0035 | 34.7523 | 0.0948 | 2 | 5 | positive regulation of homotypic cell-cell adhesion |
GO:0060023 | 0.0035 | 34.7523 | 0.0948 | 2 | 5 | soft palate development |
GO:0006575 | 0.0037 | 3.414 | 2.5036 | 8 | 132 | cellular modified amino acid metabolic process |
GO:0045606 | 0.0038 | 11.2059 | 0.3224 | 3 | 17 | positive regulation of epidermal cell differentiation |
GO:0007610 | 0.0039 | 2.132 | 8.9521 | 18 | 472 | behavior |
GO:0046394 | 0.0039 | 2.5889 | 4.9123 | 12 | 259 | carboxylic acid biosynthetic process |
GO:0033555 | 0.0048 | 4.9586 | 1.1 | 5 | 58 | multicellular organismal response to stress |
GO:0034103 | 0.0048 | 4.9586 | 1.1 | 5 | 58 | regulation of tissue remodeling |
GO:0048568 | 0.0048 | 2.2544 | 7.0365 | 15 | 371 | embryonic organ development |
GO:0006082 | 0.005 | 1.7686 | 17.4869 | 29 | 922 | organic acid metabolic process |
GO:0006681 | 0.0051 | 26.0622 | 0.1138 | 2 | 6 | galactosylceramide metabolic process |
GO:0015917 | 0.0051 | 26.0622 | 0.1138 | 2 | 6 | aminophospholipid transport |
GO:0019062 | 0.0051 | 26.0622 | 0.1138 | 2 | 6 | virion attachment to host cell |
GO:0021603 | 0.0051 | 26.0622 | 0.1138 | 2 | 6 | cranial nerve formation |
GO:0060017 | 0.0051 | 26.0622 | 0.1138 | 2 | 6 | parathyroid gland development |
GO:0060836 | 0.0051 | 26.0622 | 0.1138 | 2 | 6 | lymphatic endothelial cell differentiation |
GO:0055067 | 0.0052 | 3.5527 | 2.1053 | 7 | 111 | monovalent inorganic cation homeostasis |
GO:0090103 | 0.0052 | 9.8037 | 0.3604 | 3 | 19 | cochlea morphogenesis |
GO:0051241 | 0.0053 | 1.7949 | 16.0076 | 27 | 844 | negative regulation of multicellular organismal process |
GO:0045766 | 0.0054 | 3.5186 | 2.1242 | 7 | 112 | positive regulation of angiogenesis |
GO:0048706 | 0.0054 | 3.5186 | 2.1242 | 7 | 112 | embryonic skeletal system development |
GO:0030194 | 0.0061 | 9.2263 | 0.3793 | 3 | 20 | positive regulation of blood coagulation |
GO:0048701 | 0.0062 | 5.991 | 0.7397 | 4 | 39 | embryonic cranial skeleton morphogenesis |
GO:0001975 | 0.007 | 8.713 | 0.3983 | 3 | 21 | response to amphetamine |
GO:0060037 | 0.007 | 8.713 | 0.3983 | 3 | 21 | pharyngeal system development |
GO:0060055 | 0.007 | 8.713 | 0.3983 | 3 | 21 | angiogenesis involved in wound healing |
GO:0001955 | 0.0071 | 20.8482 | 0.1328 | 2 | 7 | blood vessel maturation |
GO:0061085 | 0.0071 | 20.8482 | 0.1328 | 2 | 7 | regulation of histone H3-K27 methylation |
GO:0009605 | 0.0071 | 1.566 | 29.5305 | 43 | 1557 | response to external stimulus |
GO:0042554 | 0.008 | 8.2538 | 0.4173 | 3 | 22 | superoxide anion generation |
GO:2000026 | 0.0082 | 1.5583 | 28.9236 | 42 | 1525 | regulation of multicellular organismal development |
GO:0048839 | 0.0088 | 2.9148 | 2.9018 | 8 | 153 | inner ear development |
GO:0001841 | 0.0089 | 3.5886 | 1.7828 | 6 | 94 | neural tube formation |
GO:0042473 | 0.0093 | 17.3722 | 0.1517 | 2 | 8 | outer ear morphogenesis |
GO:0044406 | 0.0093 | 17.3722 | 0.1517 | 2 | 8 | adhesion of symbiont to host |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0051241 | 0 | 2.7389 | 9.8851 | 24 | 844 | negative regulation of multicellular organismal process |
GO:0007389 | 1e-04 | 3.6111 | 4.2633 | 14 | 364 | pattern specification process |
GO:0042475 | 1e-04 | 8.8864 | 0.7613 | 6 | 65 | odontogenesis of dentin-containing tooth |
GO:0009952 | 2e-04 | 4.7374 | 2.0731 | 9 | 177 | anterior/posterior pattern specification |
GO:0009954 | 3e-04 | 14.4095 | 0.3279 | 4 | 28 | proximal/distal pattern formation |
GO:0000003 | 3e-04 | 2.2995 | 12.6492 | 26 | 1080 | reproduction |
GO:0030801 | 3e-04 | 7.1744 | 0.9253 | 6 | 79 | positive regulation of cyclic nucleotide metabolic process |
GO:0009887 | 6e-04 | 2.4183 | 9.5689 | 21 | 817 | animal organ morphogenesis |
GO:0035855 | 8e-04 | 19.837 | 0.1874 | 3 | 16 | megakaryocyte development |
GO:0060638 | 8e-04 | 85.4706 | 0.0468 | 2 | 4 | mesenchymal-epithelial cell signaling |
GO:0007399 | 9e-04 | 1.9104 | 22.0308 | 37 | 1881 | nervous system development |
GO:0009792 | 9e-04 | 2.7527 | 5.9147 | 15 | 505 | embryo development ending in birth or egg hatching |
GO:1900020 | 0.0013 | 56.976 | 0.0586 | 2 | 5 | positive regulation of protein kinase C activity |
GO:1900544 | 0.0014 | 5.3339 | 1.2181 | 6 | 104 | positive regulation of purine nucleotide metabolic process |
GO:0051093 | 0.0016 | 2.3591 | 8.2923 | 18 | 708 | negative regulation of developmental process |
GO:0007275 | 0.0017 | 1.7176 | 38.6535 | 55 | 3588 | multicellular organism development |
GO:0030326 | 0.0018 | 5.073 | 1.2766 | 6 | 109 | embryonic limb morphogenesis |
GO:0060173 | 0.0018 | 4.3091 | 1.7451 | 7 | 149 | limb development |
GO:0001501 | 0.0019 | 3.2269 | 3.3272 | 10 | 297 | skeletal system development |
GO:0061074 | 0.002 | 42.7288 | 0.0703 | 2 | 6 | regulation of neural retina development |
GO:0060561 | 0.0023 | 12.8872 | 0.2694 | 3 | 23 | apoptotic process involved in morphogenesis |
GO:0045597 | 0.0025 | 2.252 | 8.6554 | 18 | 739 | positive regulation of cell differentiation |
GO:0044703 | 0.0026 | 2.2454 | 8.6788 | 18 | 741 | multi-organism reproductive process |
GO:0002830 | 0.0028 | 34.1804 | 0.082 | 2 | 7 | positive regulation of type 2 immune response |
GO:2000049 | 0.0028 | 34.1804 | 0.082 | 2 | 7 | positive regulation of cell-cell adhesion mediated by cadherin |
GO:0032649 | 0.0032 | 7.1915 | 0.609 | 4 | 52 | regulation of interferon-gamma production |
GO:0048704 | 0.0032 | 5.4162 | 0.9955 | 5 | 85 | embryonic skeletal system morphogenesis |
GO:0009953 | 0.0034 | 5.349 | 1.0073 | 5 | 86 | dorsal/ventral pattern formation |
GO:0048706 | 0.0035 | 11.0332 | 0.308 | 3 | 27 | embryonic skeletal system development |
GO:0035107 | 0.0036 | 4.3487 | 1.4757 | 6 | 126 | appendage morphogenesis |
GO:0046629 | 0.0036 | 28.4815 | 0.0937 | 2 | 8 | gamma-delta T cell activation |
GO:0060534 | 0.0036 | 28.4815 | 0.0937 | 2 | 8 | trachea cartilage development |
GO:0002696 | 0.0037 | 3.4008 | 2.5064 | 8 | 214 | positive regulation of leukocyte activation |
GO:0048598 | 0.0038 | 2.7488 | 4.2763 | 11 | 376 | embryonic morphogenesis |
GO:0007165 | 0.0041 | 1.5691 | 50.8312 | 67 | 4340 | signal transduction |
GO:0002682 | 0.0044 | 1.9766 | 12.087 | 22 | 1032 | regulation of immune system process |
GO:0061035 | 0.0044 | 6.5106 | 0.6676 | 4 | 57 | regulation of cartilage development |
GO:0045137 | 0.0045 | 3.6349 | 2.0496 | 7 | 175 | development of primary sexual characteristics |
GO:0007494 | 0.0046 | 24.4108 | 0.1054 | 2 | 9 | midgut development |
GO:0046950 | 0.0046 | 24.4108 | 0.1054 | 2 | 9 | cellular ketone body metabolic process |
GO:0070234 | 0.0046 | 24.4108 | 0.1054 | 2 | 9 | positive regulation of T cell apoptotic process |
GO:0016331 | 0.0047 | 4.1067 | 1.5577 | 6 | 133 | morphogenesis of embryonic epithelium |
GO:0048589 | 0.0048 | 2.4292 | 5.7156 | 13 | 488 | developmental growth |
GO:0035148 | 0.0049 | 4.0743 | 1.5694 | 6 | 134 | tube formation |
GO:0030819 | 0.0053 | 6.1604 | 0.7027 | 4 | 60 | positive regulation of cAMP biosynthetic process |
GO:0007423 | 0.0055 | 2.4864 | 5.1417 | 12 | 439 | sensory organ development |
GO:0006955 | 0.0055 | 1.8388 | 15.4368 | 26 | 1318 | immune response |
GO:0045746 | 0.0056 | 9.1995 | 0.3631 | 3 | 31 | negative regulation of Notch signaling pathway |
GO:1902224 | 0.0058 | 21.3578 | 0.1171 | 2 | 10 | ketone body metabolic process |
GO:0031076 | 0.0061 | 8.8816 | 0.3748 | 3 | 32 | embryonic camera-type eye development |
GO:0048869 | 0.0065 | 1.5644 | 38.8144 | 53 | 3314 | cellular developmental process |
GO:0045747 | 0.0066 | 8.5849 | 0.3865 | 3 | 33 | positive regulation of Notch signaling pathway |
GO:0007266 | 0.0067 | 3.804 | 1.6749 | 6 | 143 | Rho protein signal transduction |
GO:0048534 | 0.0069 | 2.1219 | 8.0697 | 16 | 689 | hematopoietic or lymphoid organ development |
GO:0048609 | 0.007 | 2.1751 | 7.367 | 15 | 629 | multicellular organismal reproductive process |
GO:0010759 | 0.007 | 18.9833 | 0.1288 | 2 | 11 | positive regulation of macrophage chemotaxis |
GO:0071621 | 0.007 | 5.6532 | 0.7613 | 4 | 65 | granulocyte chemotaxis |
GO:0050870 | 0.0072 | 3.7487 | 1.6983 | 6 | 145 | positive regulation of T cell activation |
GO:0030814 | 0.0072 | 4.4153 | 1.2064 | 5 | 103 | regulation of cAMP metabolic process |
GO:0021983 | 0.0072 | 8.3073 | 0.3982 | 3 | 34 | pituitary gland development |
GO:0045785 | 0.0075 | 2.7873 | 3.42 | 9 | 292 | positive regulation of cell adhesion |
GO:2000241 | 0.0075 | 4.3704 | 1.2181 | 5 | 104 | regulation of reproductive process |
GO:0050900 | 0.0076 | 2.7772 | 3.4317 | 9 | 293 | leukocyte migration |
GO:0042981 | 0.0079 | 1.8219 | 14.2772 | 24 | 1219 | regulation of apoptotic process |
GO:0042035 | 0.0082 | 5.387 | 0.7964 | 4 | 68 | regulation of cytokine biosynthetic process |
GO:0002374 | 0.0083 | 17.0837 | 0.1405 | 2 | 12 | cytokine secretion involved in immune response |
GO:0032695 | 0.0083 | 17.0837 | 0.1405 | 2 | 12 | negative regulation of interleukin-12 production |
GO:0061138 | 0.0084 | 3.6172 | 1.7568 | 6 | 150 | morphogenesis of a branching epithelium |
GO:0032720 | 0.0085 | 7.8026 | 0.4216 | 3 | 36 | negative regulation of tumor necrosis factor production |
GO:0061448 | 0.0087 | 3.1915 | 2.319 | 7 | 198 | connective tissue development |
GO:0045638 | 0.0091 | 5.223 | 0.8199 | 4 | 70 | negative regulation of myeloid cell differentiation |
GO:0008584 | 0.0094 | 4.1187 | 1.2883 | 5 | 110 | male gonad development |
GO:0032502 | 0.0097 | 1.8815 | 13.1869 | 22 | 1343 | developmental process |
GO:0072148 | 0.0098 | 15.5294 | 0.1523 | 2 | 13 | epithelial cell fate commitment |
GO:0030850 | 0.0098 | 7.3556 | 0.4451 | 3 | 38 | prostate gland development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050832 | 1e-04 | 20.9622 | 0.2441 | 4 | 19 | defense response to fungus |
GO:0044657 | 2e-04 | Inf | 0.0257 | 2 | 2 | pore formation in membrane of other organism during symbiotic interaction |
GO:0051610 | 2e-04 | Inf | 0.0257 | 2 | 2 | serotonin uptake |
GO:0052043 | 2e-04 | Inf | 0.0257 | 2 | 2 | modification by symbiont of host cellular component |
GO:0052185 | 2e-04 | Inf | 0.0257 | 2 | 2 | modification of structure of other organism involved in symbiotic interaction |
GO:0052332 | 2e-04 | Inf | 0.0257 | 2 | 2 | modification by organism of membrane in other organism involved in symbiotic interaction |
GO:0007399 | 2e-04 | 2.0028 | 24.1628 | 42 | 1881 | nervous system development |
GO:0061844 | 5e-04 | 12.5677 | 0.3725 | 4 | 29 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0032227 | 5e-04 | 155.5119 | 0.0385 | 2 | 3 | negative regulation of synaptic transmission, dopaminergic |
GO:0051673 | 5e-04 | 155.5119 | 0.0385 | 2 | 3 | membrane disruption in other organism |
GO:0007268 | 6e-04 | 2.7596 | 6.2944 | 16 | 490 | chemical synaptic transmission |
GO:0099537 | 6e-04 | 2.7536 | 6.3072 | 16 | 491 | trans-synaptic signaling |
GO:0051897 | 7e-04 | 5.2003 | 1.4644 | 7 | 114 | positive regulation of protein kinase B signaling |
GO:0042221 | 7e-04 | 1.7274 | 40.2456 | 59 | 3133 | response to chemical |
GO:0015872 | 8e-04 | 10.8309 | 0.4239 | 4 | 33 | dopamine transport |
GO:0048625 | 0.001 | 77.75 | 0.0514 | 2 | 4 | myoblast fate commitment |
GO:2000354 | 0.001 | 77.75 | 0.0514 | 2 | 4 | regulation of ovarian follicle development |
GO:0002227 | 0.001 | 18.0345 | 0.2055 | 3 | 16 | innate immune response in mucosa |
GO:0042445 | 0.0014 | 4.5557 | 1.6571 | 7 | 129 | hormone metabolic process |
GO:0007267 | 0.0014 | 1.977 | 16.1856 | 29 | 1260 | cell-cell signaling |
GO:0010469 | 0.0014 | 2.8251 | 4.9456 | 13 | 385 | regulation of receptor activity |
GO:0009605 | 0.0015 | 1.8913 | 19.4136 | 33 | 1536 | response to external stimulus |
GO:0001547 | 0.0016 | 51.8294 | 0.0642 | 2 | 5 | antral ovarian follicle growth |
GO:0003105 | 0.0016 | 51.8294 | 0.0642 | 2 | 5 | negative regulation of glomerular filtration |
GO:0097211 | 0.0016 | 51.8294 | 0.0642 | 2 | 5 | cellular response to gonadotropin-releasing hormone |
GO:0001964 | 0.0023 | 13.02 | 0.2698 | 3 | 21 | startle response |
GO:0021826 | 0.0024 | 38.869 | 0.0771 | 2 | 6 | substrate-independent telencephalic tangential migration |
GO:0021830 | 0.0024 | 38.869 | 0.0771 | 2 | 6 | interneuron migration from the subpallium to the cortex |
GO:0043416 | 0.0024 | 38.869 | 0.0771 | 2 | 6 | regulation of skeletal muscle tissue regeneration |
GO:0045938 | 0.0024 | 38.869 | 0.0771 | 2 | 6 | positive regulation of circadian sleep/wake cycle, sleep |
GO:0002251 | 0.0027 | 12.3338 | 0.2826 | 3 | 22 | organ or tissue specific immune response |
GO:0019731 | 0.0027 | 12.3338 | 0.2826 | 3 | 22 | antibacterial humoral response |
GO:0060143 | 0.0027 | 12.3338 | 0.2826 | 3 | 22 | positive regulation of syncytium formation by plasma membrane fusion |
GO:0007186 | 0.003 | 2.2045 | 8.7865 | 18 | 684 | G-protein coupled receptor signaling pathway |
GO:0021885 | 0.003 | 7.2967 | 0.6037 | 4 | 47 | forebrain cell migration |
GO:0014059 | 0.0031 | 11.7162 | 0.2955 | 3 | 23 | regulation of dopamine secretion |
GO:0033993 | 0.0035 | 2.1735 | 8.9021 | 18 | 693 | response to lipid |
GO:0007265 | 0.0037 | 2.9174 | 3.6482 | 10 | 284 | Ras protein signal transduction |
GO:2000344 | 0.0044 | 25.9087 | 0.1028 | 2 | 8 | positive regulation of acrosome reaction |
GO:0003016 | 0.0049 | 9.7605 | 0.3468 | 3 | 27 | respiratory system process |
GO:0050793 | 0.0056 | 1.6638 | 25.2418 | 38 | 1965 | regulation of developmental process |
GO:0048149 | 0.0056 | 22.2058 | 0.1156 | 2 | 9 | behavioral response to ethanol |
GO:0051852 | 0.0056 | 22.2058 | 0.1156 | 2 | 9 | disruption by host of symbiont cells |
GO:2000392 | 0.0056 | 22.2058 | 0.1156 | 2 | 9 | regulation of lamellipodium morphogenesis |
GO:0042127 | 0.0056 | 1.8085 | 16.2113 | 27 | 1262 | regulation of cell proliferation |
GO:1903727 | 0.006 | 9.0083 | 0.3725 | 3 | 29 | positive regulation of phospholipid metabolic process |
GO:0009719 | 0.0062 | 1.8133 | 15.5305 | 26 | 1209 | response to endogenous stimulus |
GO:0032501 | 0.0062 | 1.4894 | 69.4695 | 86 | 5408 | multicellular organismal process |
GO:0014031 | 0.0065 | 5.8054 | 0.7451 | 4 | 58 | mesenchymal cell development |
GO:0015844 | 0.0065 | 5.8054 | 0.7451 | 4 | 58 | monoamine transport |
GO:0031640 | 0.0066 | 8.674 | 0.3854 | 3 | 30 | killing of cells of other organism |
GO:0048870 | 0.0067 | 1.8209 | 14.8368 | 25 | 1155 | cell motility |
GO:0006067 | 0.0069 | 19.4286 | 0.1285 | 2 | 10 | ethanol metabolic process |
GO:0010960 | 0.0069 | 19.4286 | 0.1285 | 2 | 10 | magnesium ion homeostasis |
GO:0070486 | 0.0069 | 19.4286 | 0.1285 | 2 | 10 | leukocyte aggregation |
GO:0030595 | 0.0071 | 3.7567 | 1.6956 | 6 | 132 | leukocyte chemotaxis |
GO:0048469 | 0.0076 | 3.6974 | 1.7213 | 6 | 134 | cell maturation |
GO:0001977 | 0.0084 | 17.2685 | 0.1413 | 2 | 11 | renal system process involved in regulation of blood volume |
GO:0002087 | 0.0084 | 17.2685 | 0.1413 | 2 | 11 | regulation of respiratory gaseous exchange by neurological system process |
GO:0010310 | 0.0084 | 17.2685 | 0.1413 | 2 | 11 | regulation of hydrogen peroxide metabolic process |
GO:0021978 | 0.0084 | 17.2685 | 0.1413 | 2 | 11 | telencephalon regionalization |
GO:0032753 | 0.0084 | 17.2685 | 0.1413 | 2 | 11 | positive regulation of interleukin-4 production |
GO:0048663 | 0.0092 | 5.2225 | 0.8221 | 4 | 64 | neuron fate commitment |
GO:0008037 | 0.0093 | 4.1368 | 1.2846 | 5 | 100 | cell recognition |
GO:0051716 | 0.0094 | 1.4552 | 69.4439 | 85 | 5406 | cellular response to stimulus |
GO:0009755 | 0.0099 | 3.1089 | 2.3765 | 7 | 185 | hormone-mediated signaling pathway |
GO:0010818 | 0.0099 | 15.5405 | 0.1541 | 2 | 12 | T cell chemotaxis |
GO:0051583 | 0.0099 | 15.5405 | 0.1541 | 2 | 12 | dopamine uptake involved in synaptic transmission |
GO:0090493 | 0.0099 | 15.5405 | 0.1541 | 2 | 12 | catecholamine uptake |
GO:1903818 | 0.0099 | 15.5405 | 0.1541 | 2 | 12 | positive regulation of voltage-gated potassium channel activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0072272 | 4e-04 | Inf | 0.039 | 2 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
GO:1903507 | 7e-04 | 1.917 | 19.8267 | 35 | 1017 | negative regulation of nucleic acid-templated transcription |
GO:0007186 | 9e-04 | 2.098 | 13.3347 | 26 | 684 | G-protein coupled receptor signaling pathway |
GO:0021903 | 0.0011 | 19.0706 | 0.2144 | 3 | 11 | rostrocaudal neural tube patterning |
GO:0003002 | 0.0012 | 2.8559 | 4.8682 | 13 | 255 | regionalization |
GO:0009887 | 0.0013 | 1.9587 | 15.9276 | 29 | 817 | animal organ morphogenesis |
GO:0007631 | 0.0013 | 4.6116 | 1.6571 | 7 | 85 | feeding behavior |
GO:0048731 | 0.0016 | 1.4948 | 71.0796 | 93 | 3646 | system development |
GO:0009954 | 0.002 | 8.4987 | 0.5459 | 4 | 28 | proximal/distal pattern formation |
GO:0006334 | 0.0021 | 3.7775 | 2.2809 | 8 | 117 | nucleosome assembly |
GO:0000122 | 0.0021 | 1.9895 | 13.4322 | 25 | 689 | negative regulation of transcription from RNA polymerase II promoter |
GO:0021915 | 0.0021 | 3.4125 | 2.8268 | 9 | 145 | neural tube development |
GO:0006323 | 0.0022 | 3.1501 | 3.3922 | 10 | 174 | DNA packaging |
GO:0051253 | 0.0022 | 1.779 | 21.1913 | 35 | 1087 | negative regulation of RNA metabolic process |
GO:0072086 | 0.0022 | 50.6797 | 0.078 | 2 | 4 | specification of loop of Henle identity |
GO:1902412 | 0.0022 | 50.6797 | 0.078 | 2 | 4 | regulation of mitotic cytokinesis |
GO:0007379 | 0.0023 | 13.8663 | 0.2729 | 3 | 14 | segment specification |
GO:0009611 | 0.0023 | 2.1459 | 9.9231 | 20 | 509 | response to wounding |
GO:0006925 | 0.0028 | 12.7098 | 0.2924 | 3 | 15 | inflammatory cell apoptotic process |
GO:0008217 | 0.0033 | 3.4869 | 2.4564 | 8 | 126 | regulation of blood pressure |
GO:0048665 | 0.0033 | 7.2823 | 0.6238 | 4 | 32 | neuron fate specification |
GO:0006333 | 0.0034 | 3.1763 | 3.0218 | 9 | 155 | chromatin assembly or disassembly |
GO:0003215 | 0.0034 | 11.7312 | 0.3119 | 3 | 16 | cardiac right ventricle morphogenesis |
GO:0032502 | 0.0034 | 1.4232 | 93.5771 | 115 | 4800 | developmental process |
GO:0061053 | 0.0036 | 4.3898 | 1.4816 | 6 | 76 | somite development |
GO:0001709 | 0.0046 | 6.5761 | 0.6823 | 4 | 35 | cell fate determination |
GO:0003013 | 0.0053 | 2.168 | 7.7981 | 16 | 400 | circulatory system process |
GO:0018242 | 0.0054 | 25.3359 | 0.117 | 2 | 6 | protein O-linked glycosylation via serine |
GO:0018243 | 0.0054 | 25.3359 | 0.117 | 2 | 6 | protein O-linked glycosylation via threonine |
GO:0021796 | 0.0054 | 25.3359 | 0.117 | 2 | 6 | cerebral cortex regionalization |
GO:0051482 | 0.0056 | 9.5294 | 0.3704 | 3 | 19 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway |
GO:0007596 | 0.0059 | 2.4531 | 5.1662 | 12 | 265 | blood coagulation |
GO:0009948 | 0.0068 | 5.8227 | 0.7603 | 4 | 39 | anterior/posterior axis specification |
GO:0001838 | 0.0069 | 3.3542 | 2.2225 | 7 | 114 | embryonic epithelial tube formation |
GO:0032963 | 0.007 | 3.7904 | 1.6961 | 6 | 87 | collagen metabolic process |
GO:0021517 | 0.0074 | 5.6605 | 0.7798 | 4 | 40 | ventral spinal cord development |
GO:0032501 | 0.0077 | 1.3686 | 105.4303 | 125 | 5408 | multicellular organismal process |
GO:0031016 | 0.0081 | 4.3267 | 1.2477 | 5 | 64 | pancreas development |
GO:0050878 | 0.0082 | 2.1149 | 7.4667 | 15 | 383 | regulation of body fluid levels |
GO:0046530 | 0.0096 | 5.2239 | 0.8383 | 4 | 43 | photoreceptor cell differentiation |
GO:0090303 | 0.0096 | 5.2239 | 0.8383 | 4 | 43 | positive regulation of wound healing |
GO:0042593 | 0.0097 | 2.6593 | 3.5676 | 9 | 183 | glucose homeostasis |
GO:0003310 | 0.0098 | 16.888 | 0.156 | 2 | 8 | pancreatic A cell differentiation |
GO:0061004 | 0.0098 | 16.888 | 0.156 | 2 | 8 | pattern specification involved in kidney development |
GO:1990403 | 0.0098 | 16.888 | 0.156 | 2 | 8 | embryonic brain development |
GO:2000109 | 0.0098 | 16.888 | 0.156 | 2 | 8 | regulation of macrophage apoptotic process |
GO:0043524 | 0.0099 | 3.1189 | 2.3784 | 7 | 122 | negative regulation of neuron apoptotic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032621 | 6e-04 | 82.5346 | 0.0408 | 2 | 5 | interleukin-18 production |
GO:0032760 | 8e-04 | 10.7029 | 0.4162 | 4 | 51 | positive regulation of tumor necrosis factor production |
GO:0007339 | 0.0015 | 14.9726 | 0.2285 | 3 | 28 | binding of sperm to zona pellucida |
GO:0070268 | 0.0018 | 8.457 | 0.5175 | 4 | 64 | cornification |
GO:0035562 | 0.0018 | 41.2579 | 0.0653 | 2 | 8 | negative regulation of chromatin binding |
GO:0032725 | 0.0023 | 35.3612 | 0.0734 | 2 | 9 | positive regulation of granulocyte macrophage colony-stimulating factor production |
GO:0046164 | 0.0026 | 12.0691 | 0.2775 | 3 | 34 | alcohol catabolic process |
GO:0008406 | 0.0028 | 4.6207 | 1.3955 | 6 | 171 | gonad development |
GO:0046185 | 0.0028 | 30.9387 | 0.0816 | 2 | 10 | aldehyde catabolic process |
GO:0048266 | 0.0028 | 30.9387 | 0.0816 | 2 | 10 | behavioral response to pain |
GO:0055002 | 0.0034 | 5.3059 | 1.0119 | 5 | 124 | striated muscle cell development |
GO:0055001 | 0.0038 | 25.7366 | 0.0943 | 2 | 12 | muscle cell development |
GO:0060009 | 0.0049 | 22.4957 | 0.1061 | 2 | 13 | Sertoli cell development |
GO:0070200 | 0.0056 | 20.6195 | 0.1143 | 2 | 14 | establishment of protein localization to telomere |
GO:1903555 | 0.0058 | 5.9716 | 0.7182 | 4 | 88 | regulation of tumor necrosis factor superfamily cytokine production |
GO:0009988 | 0.0062 | 8.693 | 0.3754 | 3 | 46 | cell-cell recognition |
GO:0061025 | 0.0071 | 3.7635 | 1.6974 | 6 | 208 | membrane fusion |
GO:0032026 | 0.0073 | 17.6712 | 0.1306 | 2 | 16 | response to magnesium ion |
GO:0007548 | 0.0076 | 3.7076 | 1.7219 | 6 | 211 | sex differentiation |
GO:0003336 | 0.0082 | Inf | 0.0082 | 1 | 1 | corneocyte desquamation |
GO:0019265 | 0.0082 | Inf | 0.0082 | 1 | 1 | glycine biosynthetic process, by transamination of glyoxylate |
GO:0019481 | 0.0082 | Inf | 0.0082 | 1 | 1 | L-alanine catabolic process, by transamination |
GO:0045356 | 0.0082 | Inf | 0.0082 | 1 | 1 | positive regulation of interferon-alpha biosynthetic process |
GO:0045381 | 0.0082 | Inf | 0.0082 | 1 | 1 | regulation of interleukin-18 biosynthetic process |
GO:0045751 | 0.0082 | Inf | 0.0082 | 1 | 1 | negative regulation of Toll signaling pathway |
GO:0046296 | 0.0082 | Inf | 0.0082 | 1 | 1 | glycolate catabolic process |
GO:0046901 | 0.0082 | Inf | 0.0082 | 1 | 1 | tetrahydrofolylpolyglutamate biosynthetic process |
GO:0061368 | 0.0082 | Inf | 0.0082 | 1 | 1 | behavioral response to formalin induced pain |
GO:0071799 | 0.0082 | Inf | 0.0082 | 1 | 1 | cellular response to prostaglandin D stimulus |
GO:1905716 | 0.0082 | Inf | 0.0082 | 1 | 1 | negative regulation of cornification |
GO:2000612 | 0.0082 | Inf | 0.0082 | 1 | 1 | regulation of thyroid-stimulating hormone secretion |
GO:0042346 | 0.0083 | 16.4918 | 0.1387 | 2 | 17 | positive regulation of NF-kappaB import into nucleus |
GO:0019730 | 0.0083 | 7.7845 | 0.4162 | 3 | 51 | antimicrobial humoral response |
GO:0050911 | 0.0097 | 7.3249 | 0.4407 | 3 | 54 | detection of chemical stimulus involved in sensory perception of smell |
GO:0030216 | 0.01 | 4.0623 | 1.3057 | 5 | 160 | keratinocyte differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1905205 | 0 | 122.1723 | 0.1106 | 5 | 8 | positive regulation of connective tissue replacement |
GO:0021633 | 2e-04 | Inf | 0.0277 | 2 | 2 | optic nerve structural organization |
GO:1903244 | 2e-04 | 36.2361 | 0.1245 | 3 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
GO:0006703 | 3e-04 | 31.0571 | 0.1383 | 3 | 10 | estrogen biosynthetic process |
GO:0010744 | 3e-04 | 31.0571 | 0.1383 | 3 | 10 | positive regulation of macrophage derived foam cell differentiation |
GO:0021554 | 3e-04 | 31.0571 | 0.1383 | 3 | 10 | optic nerve development |
GO:0014744 | 4e-04 | 27.1729 | 0.1521 | 3 | 11 | positive regulation of muscle adaptation |
GO:0045918 | 6e-04 | 144.1989 | 0.0415 | 2 | 3 | negative regulation of cytolysis |
GO:0061844 | 6e-04 | 11.6434 | 0.401 | 4 | 29 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0010612 | 0.001 | 18.1097 | 0.2074 | 3 | 15 | regulation of cardiac muscle adaptation |
GO:0030321 | 0.0011 | 72.0939 | 0.0553 | 2 | 4 | transepithelial chloride transport |
GO:0034103 | 0.0012 | 6.8889 | 0.802 | 5 | 58 | regulation of tissue remodeling |
GO:0042832 | 0.0013 | 16.7154 | 0.2212 | 3 | 16 | defense response to protozoan |
GO:0048731 | 0.0017 | 1.6031 | 50.417 | 69 | 3646 | system development |
GO:0009744 | 0.0019 | 48.0589 | 0.0691 | 2 | 5 | response to sucrose |
GO:0051351 | 0.0019 | 48.0589 | 0.0691 | 2 | 5 | positive regulation of ligase activity |
GO:0045765 | 0.002 | 3.446 | 2.7933 | 9 | 202 | regulation of angiogenesis |
GO:0043950 | 0.0028 | 36.0414 | 0.083 | 2 | 6 | positive regulation of cAMP-mediated signaling |
GO:0034694 | 0.0029 | 12.0676 | 0.2904 | 3 | 21 | response to prostaglandin |
GO:0051898 | 0.0031 | 7.2687 | 0.6084 | 4 | 44 | negative regulation of protein kinase B signaling |
GO:0051094 | 0.0033 | 1.9319 | 14.0078 | 25 | 1013 | positive regulation of developmental process |
GO:1903671 | 0.0038 | 10.8592 | 0.318 | 3 | 23 | negative regulation of sprouting angiogenesis |
GO:0042756 | 0.0038 | 28.8309 | 0.0968 | 2 | 7 | drinking behavior |
GO:0007155 | 0.0046 | 1.8783 | 14.3673 | 25 | 1039 | cell adhesion |
GO:0003299 | 0.0048 | 9.8705 | 0.3457 | 3 | 25 | muscle hypertrophy in response to stress |
GO:0090077 | 0.0048 | 9.8705 | 0.3457 | 3 | 25 | foam cell differentiation |
GO:0055114 | 0.005 | 2.0096 | 10.6614 | 20 | 771 | oxidation-reduction process |
GO:1990403 | 0.005 | 24.0239 | 0.1106 | 2 | 8 | embryonic brain development |
GO:0035082 | 0.0057 | 6.0535 | 0.7191 | 4 | 52 | axoneme assembly |
GO:0044242 | 0.0062 | 3.4207 | 2.171 | 7 | 157 | cellular lipid catabolic process |
GO:0051852 | 0.0064 | 20.5904 | 0.1245 | 2 | 9 | disruption by host of symbiont cells |
GO:0048704 | 0.0064 | 4.5544 | 1.1754 | 5 | 85 | embryonic skeletal system morphogenesis |
GO:0009620 | 0.0066 | 8.684 | 0.3872 | 3 | 28 | response to fungus |
GO:0001906 | 0.0068 | 4.4978 | 1.1892 | 5 | 86 | cell killing |
GO:0051149 | 0.0078 | 4.3362 | 1.2307 | 5 | 89 | positive regulation of muscle cell differentiation |
GO:0014742 | 0.0088 | 7.7518 | 0.4287 | 3 | 31 | positive regulation of muscle hypertrophy |
GO:0048870 | 0.009 | 1.7488 | 15.9714 | 26 | 1155 | cell motility |
GO:0051093 | 0.0093 | 1.9543 | 9.7902 | 18 | 708 | negative regulation of developmental process |
GO:0003012 | 0.0093 | 2.4054 | 4.826 | 11 | 349 | muscle system process |
GO:0045618 | 0.0096 | 16.0123 | 0.1521 | 2 | 11 | positive regulation of keratinocyte differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007186 | 0 | 2.6266 | 10.9572 | 26 | 684 | G-protein coupled receptor signaling pathway |
GO:0060290 | 1e-04 | 46.7153 | 0.1121 | 3 | 7 | transdifferentiation |
GO:0071314 | 8e-04 | 124.0095 | 0.0481 | 2 | 3 | cellular response to cocaine |
GO:1900449 | 0.0013 | 9.6124 | 0.4806 | 4 | 30 | regulation of glutamate receptor signaling pathway |
GO:0045683 | 0.0013 | 16.9783 | 0.2243 | 3 | 14 | negative regulation of epidermis development |
GO:0008628 | 0.0015 | 62 | 0.0641 | 2 | 4 | hormone-mediated apoptotic signaling pathway |
GO:0023052 | 0.0019 | 1.5161 | 76.1239 | 97 | 4752 | signaling |
GO:0021854 | 0.0023 | 13.337 | 0.2723 | 3 | 17 | hypothalamus development |
GO:0016115 | 0.0025 | 41.3302 | 0.0801 | 2 | 5 | terpenoid catabolic process |
GO:0045617 | 0.0025 | 41.3302 | 0.0801 | 2 | 5 | negative regulation of keratinocyte differentiation |
GO:0051459 | 0.0025 | 41.3302 | 0.0801 | 2 | 5 | regulation of corticotropin secretion |
GO:0010810 | 0.0025 | 3.6346 | 2.3548 | 8 | 147 | regulation of cell-substrate adhesion |
GO:0032501 | 0.0027 | 1.4843 | 86.6326 | 107 | 5408 | multicellular organismal process |
GO:0048705 | 0.003 | 3.2359 | 2.9636 | 9 | 185 | skeletal system morphogenesis |
GO:0007154 | 0.0033 | 1.4786 | 76.3963 | 96 | 4769 | cell communication |
GO:0008015 | 0.0048 | 2.3333 | 6.3597 | 14 | 397 | blood circulation |
GO:0043951 | 0.0051 | 24.7943 | 0.1121 | 2 | 7 | negative regulation of cAMP-mediated signaling |
GO:0098655 | 0.0059 | 2.0066 | 10.0601 | 19 | 628 | cation transmembrane transport |
GO:0051928 | 0.0063 | 4.6014 | 1.1694 | 5 | 73 | positive regulation of calcium ion transport |
GO:0050877 | 0.0063 | 1.9238 | 11.614 | 21 | 725 | nervous system process |
GO:0071773 | 0.0065 | 3.3863 | 2.1947 | 7 | 137 | cellular response to BMP stimulus |
GO:0001574 | 0.0067 | 20.6603 | 0.1282 | 2 | 8 | ganglioside biosynthetic process |
GO:0050907 | 0.007 | 4.4693 | 1.2015 | 5 | 75 | detection of chemical stimulus involved in sensory perception |
GO:0042634 | 0.008 | 8.1125 | 0.4165 | 3 | 26 | regulation of hair cycle |
GO:0050856 | 0.008 | 8.1125 | 0.4165 | 3 | 26 | regulation of T cell receptor signaling pathway |
GO:0072677 | 0.0085 | 17.7075 | 0.1442 | 2 | 9 | eosinophil migration |
GO:0070838 | 0.0087 | 2.3221 | 5.4466 | 12 | 340 | divalent metal ion transport |
GO:0045766 | 0.0092 | 3.549 | 1.7942 | 6 | 112 | positive regulation of angiogenesis |
GO:0006811 | 0.0093 | 1.6729 | 19.1912 | 30 | 1198 | ion transport |
GO:0007339 | 0.0099 | 7.4624 | 0.4485 | 3 | 28 | binding of sperm to zona pellucida |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0060602 | 0 | 31.4702 | 0.1757 | 4 | 15 | branch elongation of an epithelium |
GO:0007586 | 1e-04 | 6.7896 | 1.3118 | 8 | 112 | digestion |
GO:0038060 | 1e-04 | Inf | 0.0234 | 2 | 2 | nitric oxide-cGMP-mediated signaling pathway |
GO:0097530 | 3e-04 | 7.3776 | 0.9018 | 6 | 77 | granulocyte migration |
GO:1903818 | 3e-04 | 28.6623 | 0.1405 | 3 | 12 | positive regulation of voltage-gated potassium channel activity |
GO:0035814 | 4e-04 | 170.9542 | 0.0351 | 2 | 3 | negative regulation of renal sodium excretion |
GO:0070384 | 4e-04 | 170.9542 | 0.0351 | 2 | 3 | Harderian gland development |
GO:0007588 | 4e-04 | 8.8639 | 0.6325 | 5 | 54 | excretion |
GO:0006182 | 4e-04 | 12.8055 | 0.3631 | 4 | 31 | cGMP biosynthetic process |
GO:0071732 | 5e-04 | 23.4474 | 0.164 | 3 | 14 | cellular response to nitric oxide |
GO:0019935 | 8e-04 | 6.0134 | 1.0892 | 6 | 93 | cyclic-nucleotide-mediated signaling |
GO:0048593 | 8e-04 | 6.0134 | 1.0892 | 6 | 93 | camera-type eye morphogenesis |
GO:0071804 | 8e-04 | 4.4222 | 1.9559 | 8 | 167 | cellular potassium ion transport |
GO:0032414 | 8e-04 | 7.6152 | 0.7262 | 5 | 62 | positive regulation of ion transmembrane transporter activity |
GO:0030903 | 8e-04 | 19.837 | 0.1874 | 3 | 16 | notochord development |
GO:0097205 | 8e-04 | 19.837 | 0.1874 | 3 | 16 | renal filtration |
GO:0038028 | 8e-04 | 85.4706 | 0.0468 | 2 | 4 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase |
GO:0060638 | 8e-04 | 85.4706 | 0.0468 | 2 | 4 | mesenchymal-epithelial cell signaling |
GO:0002696 | 9e-04 | 3.8712 | 2.5064 | 9 | 214 | positive regulation of leukocyte activation |
GO:0060560 | 0.001 | 4.2334 | 2.0379 | 8 | 174 | developmental growth involved in morphogenesis |
GO:0050921 | 0.0011 | 5.6229 | 1.1595 | 6 | 99 | positive regulation of chemotaxis |
GO:0043270 | 0.0012 | 4.108 | 2.0965 | 8 | 179 | positive regulation of ion transport |
GO:0022898 | 0.0013 | 4.0838 | 2.1082 | 8 | 180 | regulation of transmembrane transporter activity |
GO:0022409 | 0.0013 | 4.0599 | 2.1199 | 8 | 181 | positive regulation of cell-cell adhesion |
GO:0098528 | 0.0013 | 56.976 | 0.0586 | 2 | 5 | skeletal muscle fiber differentiation |
GO:1900544 | 0.0014 | 5.3339 | 1.2181 | 6 | 104 | positive regulation of purine nucleotide metabolic process |
GO:0060688 | 0.0014 | 9.091 | 0.4919 | 4 | 42 | regulation of morphogenesis of a branching structure |
GO:0090066 | 0.0016 | 2.9148 | 4.4272 | 12 | 378 | regulation of anatomical structure size |
GO:0060512 | 0.0018 | 14.3213 | 0.246 | 3 | 21 | prostate gland morphogenesis |
GO:0046877 | 0.002 | 42.7288 | 0.0703 | 2 | 6 | regulation of saliva secretion |
GO:0060513 | 0.002 | 42.7288 | 0.0703 | 2 | 6 | prostatic bud formation |
GO:0043266 | 0.0022 | 5.9388 | 0.9136 | 5 | 78 | regulation of potassium ion transport |
GO:0002685 | 0.0023 | 4.7916 | 1.3469 | 6 | 115 | regulation of leukocyte migration |
GO:0009190 | 0.0023 | 4.7916 | 1.3469 | 6 | 115 | cyclic nucleotide biosynthetic process |
GO:0030801 | 0.0023 | 5.8581 | 0.9253 | 5 | 79 | positive regulation of cyclic nucleotide metabolic process |
GO:0002703 | 0.0026 | 4.6622 | 1.382 | 6 | 118 | regulation of leukocyte mediated immunity |
GO:0048146 | 0.0027 | 7.5053 | 0.5856 | 4 | 50 | positive regulation of fibroblast proliferation |
GO:0050795 | 0.0027 | 7.5053 | 0.5856 | 4 | 50 | regulation of behavior |
GO:0010820 | 0.0028 | 34.1804 | 0.082 | 2 | 7 | positive regulation of T cell chemotaxis |
GO:0032808 | 0.0028 | 34.1804 | 0.082 | 2 | 7 | lacrimal gland development |
GO:0060174 | 0.0028 | 34.1804 | 0.082 | 2 | 7 | limb bud formation |
GO:0070102 | 0.0028 | 34.1804 | 0.082 | 2 | 7 | interleukin-6-mediated signaling pathway |
GO:0030593 | 0.0029 | 7.3451 | 0.5973 | 4 | 51 | neutrophil chemotaxis |
GO:1903530 | 0.003 | 2.4876 | 6.0435 | 14 | 516 | regulation of secretion by cell |
GO:1901701 | 0.003 | 2.1674 | 9.4986 | 19 | 811 | cellular response to oxygen-containing compound |
GO:0006954 | 0.0031 | 2.5693 | 5.4228 | 13 | 463 | inflammatory response |
GO:0016049 | 0.0032 | 2.6737 | 4.802 | 12 | 410 | cell growth |
GO:0032732 | 0.0034 | 11.2037 | 0.3045 | 3 | 26 | positive regulation of interleukin-1 production |
GO:0090596 | 0.0035 | 3.4347 | 2.483 | 8 | 212 | sensory organ morphogenesis |
GO:0007193 | 0.0036 | 6.9028 | 0.6325 | 4 | 54 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway |
GO:0016045 | 0.0036 | 28.4815 | 0.0937 | 2 | 8 | detection of bacterium |
GO:0030916 | 0.0036 | 28.4815 | 0.0937 | 2 | 8 | otic vesicle formation |
GO:0051967 | 0.0036 | 28.4815 | 0.0937 | 2 | 8 | negative regulation of synaptic transmission, glutamatergic |
GO:0007159 | 0.0039 | 3.1001 | 3.092 | 9 | 264 | leukocyte cell-cell adhesion |
GO:0007187 | 0.0042 | 4.2071 | 1.5226 | 6 | 130 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0050865 | 0.0046 | 2.6759 | 4.3804 | 11 | 374 | regulation of cell activation |
GO:0030595 | 0.0046 | 4.1397 | 1.546 | 6 | 132 | leukocyte chemotaxis |
GO:1901381 | 0.0046 | 9.9087 | 0.3397 | 3 | 29 | positive regulation of potassium ion transmembrane transport |
GO:0000463 | 0.0046 | 24.4108 | 0.1054 | 2 | 9 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) |
GO:0046628 | 0.0046 | 24.4108 | 0.1054 | 2 | 9 | positive regulation of insulin receptor signaling pathway |
GO:0034599 | 0.0049 | 3.2409 | 2.6235 | 8 | 224 | cellular response to oxidative stress |
GO:0032941 | 0.0051 | 9.5409 | 0.3514 | 3 | 30 | secretion by tissue |
GO:0045861 | 0.0051 | 3.2106 | 2.647 | 8 | 226 | negative regulation of proteolysis |
GO:0046068 | 0.0055 | 21.8859 | 0.1144 | 2 | 10 | cGMP metabolic process |
GO:0006955 | 0.0055 | 1.8388 | 15.4368 | 26 | 1318 | immune response |
GO:0055078 | 0.0056 | 9.1995 | 0.3631 | 3 | 31 | sodium ion homeostasis |
GO:0002674 | 0.0058 | 21.3578 | 0.1171 | 2 | 10 | negative regulation of acute inflammatory response |
GO:0003093 | 0.0058 | 21.3578 | 0.1171 | 2 | 10 | regulation of glomerular filtration |
GO:0009642 | 0.0058 | 21.3578 | 0.1171 | 2 | 10 | response to light intensity |
GO:0021889 | 0.0058 | 21.3578 | 0.1171 | 2 | 10 | olfactory bulb interneuron differentiation |
GO:0030238 | 0.0058 | 21.3578 | 0.1171 | 2 | 10 | male sex determination |
GO:0042268 | 0.0058 | 21.3578 | 0.1171 | 2 | 10 | regulation of cytolysis |
GO:1902894 | 0.0058 | 21.3578 | 0.1171 | 2 | 10 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter |
GO:0034764 | 0.0064 | 4.5558 | 1.1712 | 5 | 100 | positive regulation of transmembrane transport |
GO:0002237 | 0.0065 | 3.0812 | 2.7524 | 8 | 235 | response to molecule of bacterial origin |
GO:0045747 | 0.0066 | 8.5849 | 0.3865 | 3 | 33 | positive regulation of Notch signaling pathway |
GO:0090184 | 0.0066 | 8.5849 | 0.3865 | 3 | 33 | positive regulation of kidney development |
GO:0030335 | 0.0069 | 2.6561 | 3.9939 | 10 | 341 | positive regulation of cell migration |
GO:0032101 | 0.0069 | 2.3177 | 5.9733 | 13 | 510 | regulation of response to external stimulus |
GO:0002087 | 0.007 | 18.9833 | 0.1288 | 2 | 11 | regulation of respiratory gaseous exchange by neurological system process |
GO:0008595 | 0.007 | 18.9833 | 0.1288 | 2 | 11 | anterior/posterior axis specification, embryo |
GO:0032753 | 0.007 | 18.9833 | 0.1288 | 2 | 11 | positive regulation of interleukin-4 production |
GO:0045725 | 0.007 | 18.9833 | 0.1288 | 2 | 11 | positive regulation of glycogen biosynthetic process |
GO:0098581 | 0.007 | 18.9833 | 0.1288 | 2 | 11 | detection of external biotic stimulus |
GO:0043491 | 0.007 | 3.333 | 2.2253 | 7 | 190 | protein kinase B signaling |
GO:0005977 | 0.007 | 5.6532 | 0.7613 | 4 | 65 | glycogen metabolic process |
GO:0044042 | 0.007 | 5.6532 | 0.7613 | 4 | 65 | glucan metabolic process |
GO:0008015 | 0.007 | 2.5119 | 4.6498 | 11 | 397 | blood circulation |
GO:0050870 | 0.0072 | 3.7487 | 1.6983 | 6 | 145 | positive regulation of T cell activation |
GO:0001754 | 0.0072 | 8.3073 | 0.3982 | 3 | 34 | eye photoreceptor cell differentiation |
GO:0007589 | 0.0082 | 5.387 | 0.7964 | 4 | 68 | body fluid secretion |
GO:0002374 | 0.0083 | 17.0837 | 0.1405 | 2 | 12 | cytokine secretion involved in immune response |
GO:0002643 | 0.0083 | 17.0837 | 0.1405 | 2 | 12 | regulation of tolerance induction |
GO:0006833 | 0.0083 | 17.0837 | 0.1405 | 2 | 12 | water transport |
GO:0030277 | 0.0083 | 17.0837 | 0.1405 | 2 | 12 | maintenance of gastrointestinal epithelium |
GO:1900029 | 0.0083 | 17.0837 | 0.1405 | 2 | 12 | positive regulation of ruffle assembly |
GO:1901623 | 0.0083 | 17.0837 | 0.1405 | 2 | 12 | regulation of lymphocyte chemotaxis |
GO:0002683 | 0.0085 | 2.7281 | 3.4903 | 9 | 298 | negative regulation of immune system process |
GO:0051353 | 0.0085 | 7.8026 | 0.4216 | 3 | 36 | positive regulation of oxidoreductase activity |
GO:0097756 | 0.0087 | 5.3037 | 0.8081 | 4 | 69 | negative regulation of blood vessel diameter |
GO:0010951 | 0.009 | 3.5671 | 1.7803 | 6 | 152 | negative regulation of endopeptidase activity |
GO:0001942 | 0.0091 | 5.223 | 0.8199 | 4 | 70 | hair follicle development |
GO:0016266 | 0.0091 | 7.5726 | 0.4334 | 3 | 37 | O-glycan processing |
GO:0045776 | 0.0091 | 7.5726 | 0.4334 | 3 | 37 | negative regulation of blood pressure |
GO:0030001 | 0.0095 | 2.0927 | 7.6364 | 15 | 652 | metal ion transport |
GO:0009798 | 0.0096 | 5.1446 | 0.8316 | 4 | 71 | axis specification |
GO:0007350 | 0.0098 | 15.5294 | 0.1523 | 2 | 13 | blastoderm segmentation |
GO:0030540 | 0.0098 | 15.5294 | 0.1523 | 2 | 13 | female genitalia development |
GO:0060788 | 0.0098 | 15.5294 | 0.1523 | 2 | 13 | ectodermal placode formation |
GO:0045088 | 0.0098 | 2.6621 | 3.5722 | 9 | 305 | regulation of innate immune response |
GO:0045123 | 0.0098 | 7.3556 | 0.4451 | 3 | 38 | cellular extravasation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042733 | 1e-04 | 7.5913 | 1.0562 | 7 | 58 | embryonic digit morphogenesis |
GO:0048736 | 1e-04 | 4.4551 | 2.7134 | 11 | 149 | appendage development |
GO:0035108 | 1e-04 | 4.8056 | 2.2945 | 10 | 126 | limb morphogenesis |
GO:0035113 | 2e-04 | 5.0016 | 1.985 | 9 | 109 | embryonic appendage morphogenesis |
GO:1903244 | 5e-04 | 27.2836 | 0.1639 | 3 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
GO:0014744 | 9e-04 | 20.4596 | 0.2003 | 3 | 11 | positive regulation of muscle adaptation |
GO:0070495 | 0.001 | 108.7197 | 0.0546 | 2 | 3 | negative regulation of thrombin-activated receptor signaling pathway |
GO:0048468 | 0.001 | 1.7526 | 28.2706 | 45 | 1578 | cell development |
GO:0003203 | 0.001 | 10.4256 | 0.4553 | 4 | 25 | endocardial cushion morphogenesis |
GO:0009952 | 0.0015 | 3.3248 | 3.2233 | 10 | 177 | anterior/posterior pattern specification |
GO:0003188 | 0.0019 | 14.8762 | 0.2549 | 3 | 14 | heart valve formation |
GO:0003253 | 0.0019 | 54.3556 | 0.0728 | 2 | 4 | cardiac neural crest cell migration involved in outflow tract morphogenesis |
GO:0006928 | 0.0022 | 1.6833 | 28.5179 | 44 | 1566 | movement of cell or subcellular component |
GO:0009792 | 0.0023 | 2.2025 | 9.1964 | 19 | 505 | embryo development ending in birth or egg hatching |
GO:0014742 | 0.0023 | 8.105 | 0.5645 | 4 | 31 | positive regulation of muscle hypertrophy |
GO:0030857 | 0.0023 | 8.105 | 0.5645 | 4 | 31 | negative regulation of epithelial cell differentiation |
GO:0010612 | 0.0023 | 13.6355 | 0.2732 | 3 | 15 | regulation of cardiac muscle adaptation |
GO:0043069 | 0.0023 | 2.0027 | 12.8203 | 24 | 704 | negative regulation of programmed cell death |
GO:0006302 | 0.0025 | 3.0815 | 3.46 | 10 | 190 | double-strand break repair |
GO:0007389 | 0.0028 | 2.4046 | 6.6287 | 15 | 364 | pattern specification process |
GO:0035482 | 0.0032 | 36.2343 | 0.0911 | 2 | 5 | gastric motility |
GO:0045617 | 0.0032 | 36.2343 | 0.0911 | 2 | 5 | negative regulation of keratinocyte differentiation |
GO:0051459 | 0.0032 | 36.2343 | 0.0911 | 2 | 5 | regulation of corticotropin secretion |
GO:0007130 | 0.0034 | 11.6858 | 0.3096 | 3 | 17 | synaptonemal complex assembly |
GO:0048070 | 0.0034 | 11.6858 | 0.3096 | 3 | 17 | regulation of developmental pigmentation |
GO:0060644 | 0.0034 | 11.6858 | 0.3096 | 3 | 17 | mammary gland epithelial cell differentiation |
GO:0001501 | 0.0034 | 2.2799 | 7.4482 | 16 | 409 | skeletal system development |
GO:0071772 | 0.0036 | 3.4239 | 2.4949 | 8 | 137 | response to BMP |
GO:0032502 | 0.0037 | 1.5517 | 46.3451 | 63 | 2740 | developmental process |
GO:0048864 | 0.0037 | 5.2726 | 1.038 | 5 | 57 | stem cell development |
GO:0048731 | 0.0037 | 1.4924 | 56.7895 | 75 | 3237 | system development |
GO:0051291 | 0.0038 | 3.7807 | 1.985 | 7 | 109 | protein heterooligomerization |
GO:0030182 | 0.004 | 1.7524 | 19.5947 | 32 | 1076 | neuron differentiation |
GO:0014031 | 0.004 | 5.1727 | 1.0562 | 5 | 58 | mesenchymal cell development |
GO:0060485 | 0.0041 | 2.871 | 3.6968 | 10 | 203 | mesenchyme development |
GO:0022008 | 0.0042 | 1.6916 | 22.909 | 36 | 1258 | neurogenesis |
GO:0090278 | 0.0044 | 6.6283 | 0.6738 | 4 | 37 | negative regulation of peptide hormone secretion |
GO:0040011 | 0.0045 | 1.6624 | 24.639 | 38 | 1353 | locomotion |
GO:0061621 | 0.0047 | 10.2235 | 0.346 | 3 | 19 | canonical glycolysis |
GO:0043583 | 0.005 | 2.9794 | 3.2051 | 9 | 176 | ear development |
GO:0014033 | 0.005 | 4.8944 | 1.1109 | 5 | 61 | neural crest cell differentiation |
GO:0021915 | 0.0051 | 3.222 | 2.6405 | 8 | 145 | neural tube development |
GO:0031111 | 0.0054 | 9.6214 | 0.3642 | 3 | 20 | negative regulation of microtubule polymerization or depolymerization |
GO:0061615 | 0.0054 | 9.6214 | 0.3642 | 3 | 20 | glycolytic process through fructose-6-phosphate |
GO:0001764 | 0.0061 | 3.4404 | 2.1671 | 7 | 119 | neuron migration |
GO:0048842 | 0.0065 | 21.7372 | 0.1275 | 2 | 7 | positive regulation of axon extension involved in axon guidance |
GO:2000026 | 0.0067 | 1.5899 | 27.7713 | 41 | 1525 | regulation of multicellular organismal development |
GO:0043524 | 0.0069 | 3.3499 | 2.2217 | 7 | 122 | negative regulation of neuron apoptotic process |
GO:0060964 | 0.0074 | 3.7442 | 1.7118 | 6 | 94 | regulation of gene silencing by miRNA |
GO:0042476 | 0.0077 | 3.7018 | 1.73 | 6 | 95 | odontogenesis |
GO:0009653 | 0.0078 | 1.5051 | 37.514 | 52 | 2060 | anatomical structure morphogenesis |
GO:0007156 | 0.0079 | 3.264 | 2.2763 | 7 | 125 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0007155 | 0.0079 | 1.6887 | 18.9209 | 30 | 1039 | cell adhesion |
GO:0003148 | 0.0081 | 8.1763 | 0.4188 | 3 | 23 | outflow tract septum morphogenesis |
GO:0006007 | 0.0081 | 8.1763 | 0.4188 | 3 | 23 | glucose catabolic process |
GO:0035116 | 0.0081 | 8.1763 | 0.4188 | 3 | 23 | embryonic hindlimb morphogenesis |
GO:0030509 | 0.0082 | 3.2363 | 2.2945 | 7 | 126 | BMP signaling pathway |
GO:0000281 | 0.0082 | 5.4654 | 0.8013 | 4 | 44 | mitotic cytokinesis |
GO:0045840 | 0.0082 | 5.4654 | 0.8013 | 4 | 44 | positive regulation of mitotic nuclear division |
GO:0051898 | 0.0082 | 5.4654 | 0.8013 | 4 | 44 | negative regulation of protein kinase B signaling |
GO:0006950 | 0.0083 | 1.438 | 52.8656 | 69 | 2903 | response to stress |
GO:0010940 | 0.0086 | 18.113 | 0.1457 | 2 | 8 | positive regulation of necrotic cell death |
GO:0030916 | 0.0086 | 18.113 | 0.1457 | 2 | 8 | otic vesicle formation |
GO:0060346 | 0.0086 | 18.113 | 0.1457 | 2 | 8 | bone trabecula formation |
GO:0060363 | 0.0086 | 18.113 | 0.1457 | 2 | 8 | cranial suture morphogenesis |
GO:0061308 | 0.0086 | 18.113 | 0.1457 | 2 | 8 | cardiac neural crest cell development involved in heart development |
GO:1905205 | 0.0086 | 18.113 | 0.1457 | 2 | 8 | positive regulation of connective tissue replacement |
GO:1905941 | 0.0086 | 18.113 | 0.1457 | 2 | 8 | positive regulation of gonad development |
GO:0045923 | 0.0091 | 7.7863 | 0.4371 | 3 | 24 | positive regulation of fatty acid metabolic process |
GO:0048477 | 0.0094 | 4.1497 | 1.293 | 5 | 71 | oogenesis |
GO:0051241 | 0.0094 | 1.7475 | 15.1577 | 25 | 839 | negative regulation of multicellular organismal process |
GO:0032103 | 0.0095 | 2.6711 | 3.5511 | 9 | 195 | positive regulation of response to external stimulus |
GO:0046661 | 0.0097 | 3.1301 | 2.3674 | 7 | 130 | male sex differentiation |
GO:0030879 | 0.0099 | 3.5036 | 1.8211 | 6 | 100 | mammary gland development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048704 | 0 | 11.4009 | 1.0405 | 10 | 85 | embryonic skeletal system morphogenesis |
GO:0007389 | 0 | 4.5975 | 4.4558 | 18 | 364 | pattern specification process |
GO:0021675 | 0 | 12.5233 | 0.759 | 8 | 62 | nerve development |
GO:0021602 | 0 | 38.2962 | 0.1935 | 5 | 16 | cranial nerve morphogenesis |
GO:0048532 | 0 | 41.3418 | 0.1469 | 4 | 12 | anatomical structure arrangement |
GO:0048486 | 0 | 36.7454 | 0.1591 | 4 | 13 | parasympathetic nervous system development |
GO:0009887 | 0 | 2.8294 | 10.0011 | 25 | 817 | animal organ morphogenesis |
GO:0021561 | 0 | 82.195 | 0.0734 | 3 | 6 | facial nerve development |
GO:0001708 | 0 | 8.2696 | 0.9548 | 7 | 78 | cell fate specification |
GO:0048568 | 1e-04 | 3.6448 | 4.5415 | 15 | 371 | embryonic organ development |
GO:0030855 | 1e-04 | 3.1171 | 6.3899 | 18 | 522 | epithelial cell differentiation |
GO:0043009 | 1e-04 | 3.0492 | 6.1328 | 17 | 501 | chordate embryonic development |
GO:0021633 | 1e-04 | Inf | 0.0245 | 2 | 2 | optic nerve structural organization |
GO:0030878 | 2e-04 | 17.3924 | 0.2815 | 4 | 23 | thyroid gland development |
GO:0021554 | 2e-04 | 35.2156 | 0.1224 | 3 | 10 | optic nerve development |
GO:0051241 | 2e-04 | 2.4691 | 10.3316 | 23 | 844 | negative regulation of multicellular organismal process |
GO:0048598 | 3e-04 | 2.97 | 5.8956 | 16 | 490 | embryonic morphogenesis |
GO:0009952 | 3e-04 | 4.5182 | 2.1667 | 9 | 177 | anterior/posterior pattern specification |
GO:0061551 | 4e-04 | 163.3875 | 0.0367 | 2 | 3 | trigeminal ganglion development |
GO:0072513 | 4e-04 | 163.3875 | 0.0367 | 2 | 3 | positive regulation of secondary heart field cardioblast proliferation |
GO:0001501 | 5e-04 | 3.0359 | 5.0066 | 14 | 409 | skeletal system development |
GO:0003199 | 9e-04 | 81.6875 | 0.049 | 2 | 4 | endocardial cushion to mesenchymal transition involved in heart valve formation |
GO:0021612 | 9e-04 | 81.6875 | 0.049 | 2 | 4 | facial nerve structural organization |
GO:0021648 | 9e-04 | 81.6875 | 0.049 | 2 | 4 | vestibulocochlear nerve morphogenesis |
GO:0098706 | 9e-04 | 81.6875 | 0.049 | 2 | 4 | ferric iron import across plasma membrane |
GO:0007507 | 0.0011 | 2.7811 | 5.4351 | 14 | 444 | heart development |
GO:0042749 | 0.0013 | 16.4239 | 0.2203 | 3 | 18 | regulation of circadian sleep/wake cycle |
GO:0048512 | 0.0014 | 9.1674 | 0.4896 | 4 | 40 | circadian behavior |
GO:0015677 | 0.0015 | 54.4542 | 0.0612 | 2 | 5 | copper ion import |
GO:0021546 | 0.0015 | 54.4542 | 0.0612 | 2 | 5 | rhombomere development |
GO:0090103 | 0.0015 | 15.3962 | 0.2326 | 3 | 19 | cochlea morphogenesis |
GO:0035176 | 0.0017 | 8.6835 | 0.5141 | 4 | 42 | social behavior |
GO:0001525 | 0.0017 | 2.8909 | 4.4558 | 12 | 364 | angiogenesis |
GO:0050802 | 0.002 | 13.6834 | 0.2571 | 3 | 21 | circadian sleep/wake cycle, sleep |
GO:0019233 | 0.0025 | 5.7502 | 0.9426 | 5 | 77 | sensory perception of pain |
GO:0051093 | 0.0026 | 2.2431 | 8.6668 | 18 | 708 | negative regulation of developmental process |
GO:0010092 | 0.0027 | 12.3132 | 0.2815 | 3 | 23 | specification of animal organ identity |
GO:0009888 | 0.0028 | 1.8625 | 17.7885 | 30 | 1470 | tissue development |
GO:0043587 | 0.003 | 32.6675 | 0.0857 | 2 | 7 | tongue morphogenesis |
GO:0045188 | 0.003 | 32.6675 | 0.0857 | 2 | 7 | regulation of circadian sleep/wake cycle, non-REM sleep |
GO:0060837 | 0.003 | 32.6675 | 0.0857 | 2 | 7 | blood vessel endothelial cell differentiation |
GO:2000252 | 0.003 | 32.6675 | 0.0857 | 2 | 7 | negative regulation of feeding behavior |
GO:1901214 | 0.003 | 3.2272 | 2.9746 | 9 | 243 | regulation of neuron death |
GO:0050877 | 0.0033 | 2.1862 | 8.8749 | 18 | 725 | nervous system process |
GO:0048762 | 0.0034 | 3.8387 | 1.9464 | 7 | 159 | mesenchymal cell differentiation |
GO:0035115 | 0.0038 | 10.7047 | 0.3183 | 3 | 26 | embryonic forelimb morphogenesis |
GO:0043524 | 0.0039 | 4.2958 | 1.4934 | 6 | 122 | negative regulation of neuron apoptotic process |
GO:0060982 | 0.004 | 27.2208 | 0.0979 | 2 | 8 | coronary artery morphogenesis |
GO:0003014 | 0.0041 | 5.1077 | 1.0527 | 5 | 86 | renal system process |
GO:0009953 | 0.0041 | 5.1077 | 1.0527 | 5 | 86 | dorsal/ventral pattern formation |
GO:0045907 | 0.0042 | 10.2579 | 0.3305 | 3 | 27 | positive regulation of vasoconstriction |
GO:0050768 | 0.0043 | 3.3098 | 2.5707 | 8 | 210 | negative regulation of neurogenesis |
GO:0097286 | 0.0051 | 23.3304 | 0.1102 | 2 | 9 | iron ion import |
GO:2001054 | 0.0051 | 23.3304 | 0.1102 | 2 | 9 | negative regulation of mesenchymal cell apoptotic process |
GO:0001944 | 0.0056 | 2.3018 | 6.4878 | 14 | 530 | vasculature development |
GO:0001822 | 0.0057 | 3.1512 | 2.6931 | 8 | 220 | kidney development |
GO:0031640 | 0.0057 | 9.116 | 0.3672 | 3 | 30 | killing of cells of other organism |
GO:0035148 | 0.0061 | 3.8894 | 1.6403 | 6 | 134 | tube formation |
GO:0003264 | 0.0063 | 20.4125 | 0.1224 | 2 | 10 | regulation of cardioblast proliferation |
GO:0006703 | 0.0063 | 20.4125 | 0.1224 | 2 | 10 | estrogen biosynthetic process |
GO:0045987 | 0.0063 | 8.7898 | 0.3795 | 3 | 31 | positive regulation of smooth muscle contraction |
GO:0035295 | 0.0068 | 2.3233 | 5.9533 | 13 | 492 | tube development |
GO:0003179 | 0.0069 | 8.486 | 0.3917 | 3 | 32 | heart valve morphogenesis |
GO:0048589 | 0.007 | 2.3138 | 5.9737 | 13 | 488 | developmental growth |
GO:0048870 | 0.0071 | 1.8362 | 14.1386 | 24 | 1155 | cell motility |
GO:0060322 | 0.0072 | 2.1626 | 7.3937 | 15 | 604 | head development |
GO:0060795 | 0.0075 | 8.2025 | 0.404 | 3 | 33 | cell fate commitment involved in formation of primary germ layer |
GO:1901998 | 0.0075 | 8.2025 | 0.404 | 3 | 33 | toxin transport |
GO:0003161 | 0.0076 | 18.1431 | 0.1347 | 2 | 11 | cardiac conduction system development |
GO:0072189 | 0.0076 | 18.1431 | 0.1347 | 2 | 11 | ureter development |
GO:0003206 | 0.0086 | 4.2162 | 1.2608 | 5 | 103 | cardiac chamber morphogenesis |
GO:0001709 | 0.0088 | 7.6887 | 0.4284 | 3 | 35 | cell fate determination |
GO:0046579 | 0.0088 | 7.6887 | 0.4284 | 3 | 35 | positive regulation of Ras protein signal transduction |
GO:0061323 | 0.0091 | 16.3275 | 0.1469 | 2 | 12 | cell proliferation involved in heart morphogenesis |
GO:0061548 | 0.0091 | 16.3275 | 0.1469 | 2 | 12 | ganglion development |
GO:0072075 | 0.0091 | 16.3275 | 0.1469 | 2 | 12 | metanephric mesenchyme development |
GO:2001014 | 0.0091 | 16.3275 | 0.1469 | 2 | 12 | regulation of skeletal muscle cell differentiation |
GO:0022603 | 0.0091 | 1.9645 | 9.793 | 18 | 800 | regulation of anatomical structure morphogenesis |
GO:0003151 | 0.0096 | 5.1456 | 0.8324 | 4 | 68 | outflow tract morphogenesis |
GO:0031623 | 0.0096 | 5.1456 | 0.8324 | 4 | 68 | receptor internalization |
GO:0051341 | 0.0096 | 5.1456 | 0.8324 | 4 | 68 | regulation of oxidoreductase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0051445 | 9e-04 | 10.3603 | 0.4352 | 4 | 40 | regulation of meiotic cell cycle |
GO:0018149 | 9e-04 | 18.5461 | 0.1959 | 3 | 18 | peptide cross-linking |
GO:0043009 | 0.0011 | 2.787 | 5.4514 | 14 | 501 | chordate embryonic development |
GO:0007186 | 0.0012 | 2.4931 | 7.4426 | 17 | 684 | G-protein coupled receptor signaling pathway |
GO:0007188 | 0.0015 | 5.2262 | 1.2404 | 6 | 114 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GO:1900040 | 0.0017 | 46.0775 | 0.0653 | 2 | 6 | regulation of interleukin-2 secretion |
GO:0050808 | 0.002 | 3.772 | 2.2741 | 8 | 209 | synapse organization |
GO:0048704 | 0.0023 | 5.8498 | 0.9249 | 5 | 85 | embryonic skeletal system morphogenesis |
GO:0007156 | 0.0024 | 4.7391 | 1.3601 | 6 | 125 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0050911 | 0.0028 | 7.4514 | 0.5876 | 4 | 54 | detection of chemical stimulus involved in sensory perception of smell |
GO:0021859 | 0.0032 | 30.7136 | 0.087 | 2 | 8 | pyramidal neuron differentiation |
GO:0035095 | 0.0032 | 30.7136 | 0.087 | 2 | 8 | behavioral response to nicotine |
GO:1904861 | 0.0032 | 30.7136 | 0.087 | 2 | 8 | excitatory synapse assembly |
GO:0009642 | 0.005 | 23.0317 | 0.1088 | 2 | 10 | response to light intensity |
GO:0099068 | 0.005 | 23.0317 | 0.1088 | 2 | 10 | postsynapse assembly |
GO:0033197 | 0.0061 | 20.471 | 0.1197 | 2 | 11 | response to vitamin E |
GO:0045836 | 0.0061 | 20.471 | 0.1197 | 2 | 11 | positive regulation of meiotic nuclear division |
GO:0071397 | 0.0061 | 20.471 | 0.1197 | 2 | 11 | cellular response to cholesterol |
GO:0007268 | 0.0072 | 2.3986 | 5.3317 | 12 | 490 | chemical synaptic transmission |
GO:0099537 | 0.0073 | 2.3934 | 5.3426 | 12 | 491 | trans-synaptic signaling |
GO:0007625 | 0.0085 | 16.7465 | 0.1415 | 2 | 13 | grooming behavior |
GO:0043252 | 0.0085 | 16.7465 | 0.1415 | 2 | 13 | sodium-independent organic anion transport |
GO:2000242 | 0.0087 | 7.7151 | 0.4244 | 3 | 39 | negative regulation of reproductive process |
GO:0007600 | 0.0092 | 2.4176 | 4.8312 | 11 | 444 | sensory perception |
GO:0007269 | 0.0093 | 4.131 | 1.284 | 5 | 118 | neurotransmitter secretion |
GO:0001829 | 0.0098 | 15.3498 | 0.1523 | 2 | 14 | trophectodermal cell differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048704 | 0 | 7.3613 | 1.2268 | 8 | 85 | embryonic skeletal system morphogenesis |
GO:0021602 | 2e-04 | 17.4158 | 0.2887 | 4 | 20 | cranial nerve morphogenesis |
GO:0009952 | 2e-04 | 4.2598 | 2.5546 | 10 | 177 | anterior/posterior pattern specification |
GO:0032501 | 6e-04 | 1.6535 | 69.3697 | 91 | 5044 | multicellular organismal process |
GO:0061044 | 6e-04 | 138.0106 | 0.0433 | 2 | 3 | negative regulation of vascular wound healing |
GO:0009605 | 8e-04 | 1.8842 | 22.4714 | 38 | 1557 | response to external stimulus |
GO:0032502 | 8e-04 | 1.6105 | 69.2761 | 91 | 4800 | developmental process |
GO:0007389 | 8e-04 | 2.8685 | 5.2534 | 14 | 364 | pattern specification process |
GO:0006954 | 0.0011 | 2.5764 | 6.6823 | 16 | 463 | inflammatory response |
GO:0009887 | 0.0016 | 2.112 | 11.7914 | 23 | 817 | animal organ morphogenesis |
GO:0034220 | 0.002 | 2.0731 | 11.9934 | 23 | 831 | ion transmembrane transport |
GO:0006828 | 0.002 | 45.9965 | 0.0722 | 2 | 5 | manganese ion transport |
GO:0021546 | 0.002 | 45.9965 | 0.0722 | 2 | 5 | rhombomere development |
GO:0002684 | 0.0022 | 2.1701 | 9.9151 | 20 | 687 | positive regulation of immune system process |
GO:0048731 | 0.0022 | 1.567 | 52.621 | 71 | 3646 | system development |
GO:0016485 | 0.0029 | 3.5424 | 2.4102 | 8 | 167 | protein processing |
GO:0042060 | 0.0031 | 2.4682 | 6.0472 | 14 | 419 | wound healing |
GO:1903317 | 0.0032 | 5.4515 | 0.9958 | 5 | 69 | regulation of protein maturation |
GO:0060143 | 0.0037 | 10.9384 | 0.3175 | 3 | 22 | positive regulation of syncytium formation by plasma membrane fusion |
GO:0001955 | 0.0041 | 27.5937 | 0.101 | 2 | 7 | blood vessel maturation |
GO:0006949 | 0.0043 | 6.6213 | 0.6639 | 4 | 46 | syncytium formation |
GO:0072376 | 0.0043 | 6.6213 | 0.6639 | 4 | 46 | protein activation cascade |
GO:0002253 | 0.0045 | 2.447 | 5.6431 | 13 | 391 | activation of immune response |
GO:0006026 | 0.0046 | 6.4669 | 0.6783 | 4 | 47 | aminoglycan catabolic process |
GO:0007274 | 0.0048 | 9.8951 | 0.3464 | 3 | 24 | neuromuscular synaptic transmission |
GO:0006959 | 0.0052 | 4.035 | 1.5876 | 6 | 110 | humoral immune response |
GO:0050867 | 0.0053 | 2.9505 | 3.2329 | 9 | 224 | positive regulation of cell activation |
GO:0001820 | 0.0055 | 22.9929 | 0.1155 | 2 | 8 | serotonin secretion |
GO:0006957 | 0.0055 | 22.9929 | 0.1155 | 2 | 8 | complement activation, alternative pathway |
GO:0035095 | 0.0055 | 22.9929 | 0.1155 | 2 | 8 | behavioral response to nicotine |
GO:1905205 | 0.0055 | 22.9929 | 0.1155 | 2 | 8 | positive regulation of connective tissue replacement |
GO:0030449 | 0.006 | 9.0333 | 0.3752 | 3 | 26 | regulation of complement activation |
GO:0050776 | 0.0061 | 2.0432 | 9.3811 | 18 | 650 | regulation of immune response |
GO:0010951 | 0.0065 | 3.384 | 2.1937 | 7 | 152 | negative regulation of endopeptidase activity |
GO:0051251 | 0.0067 | 3.0551 | 2.771 | 8 | 192 | positive regulation of lymphocyte activation |
GO:0030207 | 0.007 | 19.7067 | 0.1299 | 2 | 9 | chondroitin sulfate catabolic process |
GO:0042110 | 0.0078 | 2.4693 | 4.705 | 11 | 326 | T cell activation |
GO:0048247 | 0.0082 | 7.9892 | 0.4185 | 3 | 29 | lymphocyte chemotaxis |
GO:0006853 | 0.0086 | 17.2421 | 0.1443 | 2 | 10 | carnitine shuttle |
GO:0030208 | 0.0086 | 17.2421 | 0.1443 | 2 | 10 | dermatan sulfate biosynthetic process |
GO:1903034 | 0.0099 | 3.4927 | 1.8185 | 6 | 126 | regulation of response to wounding |
GO:0045785 | 0.0099 | 2.5001 | 4.2143 | 10 | 292 | positive regulation of cell adhesion |
GO:0030198 | 0.01 | 2.6492 | 3.5793 | 9 | 248 | extracellular matrix organization |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001501 | 1e-04 | 3.3292 | 4.9448 | 15 | 409 | skeletal system development |
GO:0060536 | 1e-04 | 41.6178 | 0.1088 | 3 | 9 | cartilage morphogenesis |
GO:0048598 | 1e-04 | 3.0402 | 6.1538 | 17 | 509 | embryonic morphogenesis |
GO:2000363 | 1e-04 | Inf | 0.0242 | 2 | 2 | positive regulation of prostaglandin-E synthase activity |
GO:0030878 | 2e-04 | 17.6181 | 0.2781 | 4 | 23 | thyroid gland development |
GO:0003219 | 4e-04 | 165.481 | 0.0363 | 2 | 3 | cardiac right ventricle formation |
GO:0048704 | 6e-04 | 6.4088 | 1.0277 | 6 | 85 | embryonic skeletal system morphogenesis |
GO:0048568 | 6e-04 | 3.1412 | 4.4854 | 13 | 371 | embryonic organ development |
GO:0002227 | 9e-04 | 19.1979 | 0.1934 | 3 | 16 | innate immune response in mucosa |
GO:0080154 | 0.001 | 17.8253 | 0.2055 | 3 | 17 | regulation of fertilization |
GO:0016054 | 0.0011 | 3.7602 | 2.5752 | 9 | 213 | organic acid catabolic process |
GO:1902565 | 0.0014 | 55.1519 | 0.0605 | 2 | 5 | positive regulation of neutrophil activation |
GO:0007389 | 0.0016 | 2.9304 | 4.4008 | 12 | 364 | pattern specification process |
GO:0042482 | 0.0021 | 41.3608 | 0.0725 | 2 | 6 | positive regulation of odontogenesis |
GO:0002251 | 0.0023 | 13.1294 | 0.266 | 3 | 22 | organ or tissue specific immune response |
GO:0061140 | 0.0029 | 33.0861 | 0.0846 | 2 | 7 | lung secretory cell differentiation |
GO:0010611 | 0.0033 | 7.1069 | 0.6166 | 4 | 51 | regulation of cardiac muscle hypertrophy |
GO:0048856 | 0.0035 | 1.5678 | 54.1635 | 71 | 4480 | anatomical structure development |
GO:0001574 | 0.0039 | 27.5696 | 0.0967 | 2 | 8 | ganglioside biosynthetic process |
GO:0010911 | 0.0039 | 27.5696 | 0.0967 | 2 | 8 | regulation of isomerase activity |
GO:0016045 | 0.0039 | 27.5696 | 0.0967 | 2 | 8 | detection of bacterium |
GO:0051712 | 0.0039 | 27.5696 | 0.0967 | 2 | 8 | positive regulation of killing of cells of other organism |
GO:2000344 | 0.0039 | 27.5696 | 0.0967 | 2 | 8 | positive regulation of acrosome reaction |
GO:0032963 | 0.004 | 5.1109 | 1.0518 | 5 | 87 | collagen metabolic process |
GO:0044243 | 0.0041 | 6.679 | 0.6529 | 4 | 54 | multicellular organismal catabolic process |
GO:0042742 | 0.0044 | 4.1708 | 1.5354 | 6 | 127 | defense response to bacterium |
GO:0007610 | 0.0048 | 2.4305 | 5.7065 | 13 | 472 | behavior |
GO:0003207 | 0.0049 | 23.6293 | 0.1088 | 2 | 9 | cardiac chamber formation |
GO:1903244 | 0.0049 | 23.6293 | 0.1088 | 2 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
GO:0045595 | 0.0051 | 1.8107 | 16.914 | 28 | 1399 | regulation of cell differentiation |
GO:0009063 | 0.0056 | 4.7064 | 1.1365 | 5 | 94 | cellular amino acid catabolic process |
GO:0009952 | 0.0057 | 3.4728 | 2.1399 | 7 | 177 | anterior/posterior pattern specification |
GO:0003208 | 0.0059 | 5.9606 | 0.7254 | 4 | 60 | cardiac ventricle morphogenesis |
GO:0014742 | 0.0061 | 8.9031 | 0.3748 | 3 | 31 | positive regulation of muscle hypertrophy |
GO:0035646 | 0.0061 | 20.6741 | 0.1209 | 2 | 10 | endosome to melanosome transport |
GO:0043476 | 0.0061 | 20.6741 | 0.1209 | 2 | 10 | pigment accumulation |
GO:0048757 | 0.0061 | 20.6741 | 0.1209 | 2 | 10 | pigment granule maturation |
GO:0060707 | 0.0061 | 20.6741 | 0.1209 | 2 | 10 | trophoblast giant cell differentiation |
GO:0001570 | 0.0063 | 5.8556 | 0.7375 | 4 | 61 | vasculogenesis |
GO:0003008 | 0.0063 | 1.8145 | 15.5841 | 26 | 1289 | system process |
GO:0006952 | 0.0073 | 1.882 | 12.6099 | 22 | 1043 | defense response |
GO:0014744 | 0.0074 | 18.3755 | 0.133 | 2 | 11 | positive regulation of muscle adaptation |
GO:0031645 | 0.0074 | 18.3755 | 0.133 | 2 | 11 | negative regulation of neurological system process |
GO:0031953 | 0.0074 | 18.3755 | 0.133 | 2 | 11 | negative regulation of protein autophosphorylation |
GO:0098581 | 0.0074 | 18.3755 | 0.133 | 2 | 11 | detection of external biotic stimulus |
GO:1900025 | 0.0074 | 18.3755 | 0.133 | 2 | 11 | negative regulation of substrate adhesion-dependent cell spreading |
GO:2000026 | 0.0088 | 1.7133 | 18.4374 | 29 | 1525 | regulation of multicellular organismal development |
GO:0002374 | 0.0089 | 16.5367 | 0.1451 | 2 | 12 | cytokine secretion involved in immune response |
GO:0030277 | 0.0089 | 16.5367 | 0.1451 | 2 | 12 | maintenance of gastrointestinal epithelium |
GO:0061042 | 0.0089 | 16.5367 | 0.1451 | 2 | 12 | vascular wound healing |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007156 | 0 | 9.215 | 1.8041 | 14 | 125 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0048704 | 0 | 8.4372 | 1.2268 | 9 | 85 | embryonic skeletal system morphogenesis |
GO:0051295 | 0 | 208.117 | 0.0577 | 3 | 4 | establishment of meiotic spindle localization |
GO:0048568 | 1e-04 | 3.2677 | 5.3545 | 16 | 371 | embryonic organ development |
GO:0051653 | 2e-04 | 11.2834 | 0.5196 | 5 | 36 | spindle localization |
GO:0042472 | 2e-04 | 6.6674 | 1.169 | 7 | 81 | inner ear morphogenesis |
GO:0070649 | 2e-04 | Inf | 0.0289 | 2 | 2 | formin-nucleated actin cable assembly |
GO:0030878 | 3e-04 | 14.6625 | 0.3319 | 4 | 23 | thyroid gland development |
GO:0003264 | 3e-04 | 29.7173 | 0.1443 | 3 | 10 | regulation of cardioblast proliferation |
GO:0021783 | 4e-04 | 26.0007 | 0.1588 | 3 | 11 | preganglionic parasympathetic fiber development |
GO:0061323 | 6e-04 | 23.1099 | 0.1732 | 3 | 12 | cell proliferation involved in heart morphogenesis |
GO:0031296 | 6e-04 | 138.0106 | 0.0433 | 2 | 3 | B cell costimulation |
GO:0060435 | 6e-04 | 138.0106 | 0.0433 | 2 | 3 | bronchiole development |
GO:0072513 | 6e-04 | 138.0106 | 0.0433 | 2 | 3 | positive regulation of secondary heart field cardioblast proliferation |
GO:0071675 | 8e-04 | 11.1384 | 0.4185 | 4 | 29 | regulation of mononuclear cell migration |
GO:0043433 | 0.001 | 4.8267 | 1.5731 | 7 | 109 | negative regulation of DNA binding transcription factor activity |
GO:0009887 | 0.0012 | 2.1623 | 11.5472 | 23 | 808 | animal organ morphogenesis |
GO:0040038 | 0.0012 | 69 | 0.0577 | 2 | 4 | polar body extrusion after meiotic divisions |
GO:0060638 | 0.0012 | 69 | 0.0577 | 2 | 4 | mesenchymal-epithelial cell signaling |
GO:0070350 | 0.0012 | 69 | 0.0577 | 2 | 4 | regulation of white fat cell proliferation |
GO:0060173 | 0.0014 | 4.0002 | 2.1504 | 8 | 149 | limb development |
GO:0032602 | 0.0015 | 6.5886 | 0.8371 | 5 | 58 | chemokine production |
GO:0098609 | 0.0015 | 2.2949 | 8.9193 | 19 | 618 | cell-cell adhesion |
GO:0048483 | 0.0016 | 8.9784 | 0.5051 | 4 | 35 | autonomic nervous system development |
GO:0021546 | 0.002 | 45.9965 | 0.0722 | 2 | 5 | rhombomere development |
GO:0036089 | 0.002 | 45.9965 | 0.0722 | 2 | 5 | cleavage furrow formation |
GO:0051891 | 0.002 | 45.9965 | 0.0722 | 2 | 5 | positive regulation of cardioblast differentiation |
GO:0030850 | 0.0021 | 8.1843 | 0.5484 | 4 | 38 | prostate gland development |
GO:0022610 | 0.0021 | 1.9489 | 15.0531 | 27 | 1043 | biological adhesion |
GO:0008589 | 0.0023 | 5.9158 | 0.9237 | 5 | 64 | regulation of smoothened signaling pathway |
GO:0048663 | 0.0023 | 5.9158 | 0.9237 | 5 | 64 | neuron fate commitment |
GO:0061448 | 0.0023 | 3.3632 | 2.8576 | 9 | 198 | connective tissue development |
GO:0035107 | 0.0023 | 4.1317 | 1.8185 | 7 | 126 | appendage morphogenesis |
GO:0021545 | 0.0023 | 7.9499 | 0.5629 | 4 | 39 | cranial nerve development |
GO:0060914 | 0.0024 | 12.9924 | 0.2742 | 3 | 19 | heart formation |
GO:0060485 | 0.0028 | 3.2752 | 2.9298 | 9 | 203 | mesenchyme development |
GO:0021610 | 0.003 | 34.4947 | 0.0866 | 2 | 6 | facial nerve morphogenesis |
GO:0042482 | 0.003 | 34.4947 | 0.0866 | 2 | 6 | positive regulation of odontogenesis |
GO:0070345 | 0.003 | 34.4947 | 0.0866 | 2 | 6 | negative regulation of fat cell proliferation |
GO:0003002 | 0.0032 | 2.8061 | 4.171 | 11 | 289 | regionalization |
GO:0003211 | 0.0041 | 27.5937 | 0.101 | 2 | 7 | cardiac ventricle formation |
GO:0030656 | 0.0041 | 27.5937 | 0.101 | 2 | 7 | regulation of vitamin metabolic process |
GO:0060290 | 0.0041 | 27.5937 | 0.101 | 2 | 7 | transdifferentiation |
GO:0061140 | 0.0041 | 27.5937 | 0.101 | 2 | 7 | lung secretory cell differentiation |
GO:0071476 | 0.0041 | 27.5937 | 0.101 | 2 | 7 | cellular hypotonic response |
GO:0061005 | 0.0043 | 6.6213 | 0.6639 | 4 | 46 | cell differentiation involved in kidney development |
GO:0048791 | 0.0048 | 9.8951 | 0.3464 | 3 | 24 | calcium ion-regulated exocytosis of neurotransmitter |
GO:0051294 | 0.0048 | 9.8951 | 0.3464 | 3 | 24 | establishment of spindle orientation |
GO:0030326 | 0.005 | 4.0745 | 1.5731 | 6 | 109 | embryonic limb morphogenesis |
GO:0047484 | 0.0055 | 22.9929 | 0.1155 | 2 | 8 | regulation of response to osmotic stress |
GO:0015672 | 0.0064 | 2.3325 | 5.9029 | 13 | 409 | monovalent inorganic cation transport |
GO:0007267 | 0.0065 | 1.7451 | 17.9429 | 29 | 1256 | cell-cell signaling |
GO:0022414 | 0.0066 | 1.7942 | 15.5727 | 26 | 1079 | reproductive process |
GO:0060536 | 0.007 | 19.7067 | 0.1299 | 2 | 9 | cartilage morphogenesis |
GO:0090026 | 0.007 | 19.7067 | 0.1299 | 2 | 9 | positive regulation of monocyte chemotaxis |
GO:0051046 | 0.0071 | 2.1047 | 8.0678 | 16 | 559 | regulation of secretion |
GO:0017158 | 0.0081 | 5.4491 | 0.7938 | 4 | 55 | regulation of calcium ion-dependent exocytosis |
GO:0030890 | 0.0082 | 7.9892 | 0.4185 | 3 | 29 | positive regulation of B cell proliferation |
GO:2000826 | 0.0082 | 7.9892 | 0.4185 | 3 | 29 | regulation of heart morphogenesis |
GO:0002544 | 0.0086 | 17.2421 | 0.1443 | 2 | 10 | chronic inflammatory response |
GO:0010755 | 0.0086 | 17.2421 | 0.1443 | 2 | 10 | regulation of plasminogen activation |
GO:0045073 | 0.0086 | 17.2421 | 0.1443 | 2 | 10 | regulation of chemokine biosynthetic process |
GO:0050755 | 0.0086 | 17.2421 | 0.1443 | 2 | 10 | chemokine metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045765 | 0 | 6.1303 | 1.6529 | 9 | 90 | regulation of angiogenesis |
GO:0001944 | 1e-04 | 2.6426 | 9.932 | 24 | 530 | vasculature development |
GO:2000026 | 1e-04 | 1.9201 | 28.5779 | 49 | 1525 | regulation of multicellular organismal development |
GO:0048646 | 1e-04 | 2.2095 | 15.8912 | 32 | 848 | anatomical structure formation involved in morphogenesis |
GO:2000181 | 1e-04 | 5.8963 | 1.5179 | 8 | 81 | negative regulation of blood vessel morphogenesis |
GO:0003211 | 2e-04 | 39.7408 | 0.1312 | 3 | 7 | cardiac ventricle formation |
GO:0045814 | 2e-04 | 4.7566 | 2.0801 | 9 | 111 | negative regulation of gene expression, epigenetic |
GO:0072359 | 3e-04 | 2.1623 | 15.1229 | 30 | 807 | circulatory system development |
GO:1905205 | 3e-04 | 31.7902 | 0.1499 | 3 | 8 | positive regulation of connective tissue replacement |
GO:0003342 | 3e-04 | Inf | 0.0375 | 2 | 2 | proepicardium development |
GO:1903244 | 5e-04 | 26.4898 | 0.1687 | 3 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
GO:0060055 | 6e-04 | 12.5063 | 0.3935 | 4 | 21 | angiogenesis involved in wound healing |
GO:0071941 | 7e-04 | 22.7038 | 0.1874 | 3 | 10 | nitrogen cycle metabolic process |
GO:0034103 | 7e-04 | 6.1669 | 1.0869 | 6 | 58 | regulation of tissue remodeling |
GO:0014744 | 0.001 | 19.8643 | 0.2061 | 3 | 11 | positive regulation of muscle adaptation |
GO:0061044 | 0.001 | 105.5691 | 0.0562 | 2 | 3 | negative regulation of vascular wound healing |
GO:2001199 | 0.001 | 105.5691 | 0.0562 | 2 | 3 | negative regulation of dendritic cell differentiation |
GO:0046500 | 0.0013 | 17.6558 | 0.2249 | 3 | 12 | S-adenosylmethionine metabolic process |
GO:0007389 | 0.0014 | 2.5046 | 6.8212 | 16 | 364 | pattern specification process |
GO:0051093 | 0.0017 | 2.0194 | 13.2676 | 25 | 708 | negative regulation of developmental process |
GO:0006335 | 0.002 | 8.499 | 0.5434 | 4 | 29 | DNA replication-dependent nucleosome assembly |
GO:0051122 | 0.002 | 52.7805 | 0.075 | 2 | 4 | hepoxilin biosynthetic process |
GO:0060920 | 0.002 | 52.7805 | 0.075 | 2 | 4 | cardiac pacemaker cell differentiation |
GO:0061055 | 0.002 | 52.7805 | 0.075 | 2 | 4 | myotome development |
GO:0097176 | 0.002 | 52.7805 | 0.075 | 2 | 4 | epoxide metabolic process |
GO:0009888 | 0.0023 | 1.6832 | 27.7721 | 43 | 1482 | tissue development |
GO:0048514 | 0.0025 | 2.4359 | 6.5506 | 15 | 359 | blood vessel morphogenesis |
GO:0001759 | 0.0025 | 13.2388 | 0.2811 | 3 | 15 | organ induction |
GO:0010612 | 0.0025 | 13.2388 | 0.2811 | 3 | 15 | regulation of cardiac muscle adaptation |
GO:0019372 | 0.0025 | 13.2388 | 0.2811 | 3 | 15 | lipoxygenase pathway |
GO:0014742 | 0.0025 | 7.8682 | 0.5809 | 4 | 31 | positive regulation of muscle hypertrophy |
GO:0000183 | 0.0029 | 7.5867 | 0.5997 | 4 | 32 | chromatin silencing at rDNA |
GO:0042445 | 0.003 | 3.5441 | 2.4174 | 8 | 129 | hormone metabolic process |
GO:2000379 | 0.003 | 4.5747 | 1.4242 | 6 | 76 | positive regulation of reactive oxygen species metabolic process |
GO:0006555 | 0.003 | 12.2195 | 0.2998 | 3 | 16 | methionine metabolic process |
GO:0048870 | 0.0031 | 1.7409 | 21.6442 | 35 | 1155 | cell motility |
GO:0038111 | 0.0032 | 7.3245 | 0.6184 | 4 | 33 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0.0032 | 7.3245 | 0.6184 | 4 | 33 | response to interleukin-7 |
GO:0030858 | 0.0033 | 5.4325 | 1.0119 | 5 | 54 | positive regulation of epithelial cell differentiation |
GO:0006526 | 0.0034 | 35.1843 | 0.0937 | 2 | 5 | arginine biosynthetic process |
GO:0010757 | 0.0034 | 35.1843 | 0.0937 | 2 | 5 | negative regulation of plasminogen activation |
GO:0006575 | 0.0034 | 3.4575 | 2.4736 | 8 | 132 | cellular modified amino acid metabolic process |
GO:0046394 | 0.0036 | 2.6225 | 4.8536 | 12 | 259 | carboxylic acid biosynthetic process |
GO:0031497 | 0.0039 | 3.3751 | 2.5298 | 8 | 135 | chromatin assembly |
GO:0040012 | 0.0046 | 1.9152 | 12.7617 | 23 | 681 | regulation of locomotion |
GO:0002291 | 0.005 | 26.3862 | 0.1124 | 2 | 6 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
GO:0003278 | 0.005 | 26.3862 | 0.1124 | 2 | 6 | apoptotic process involved in heart morphogenesis |
GO:0035360 | 0.005 | 26.3862 | 0.1124 | 2 | 6 | positive regulation of peroxisome proliferator activated receptor signaling pathway |
GO:0071472 | 0.005 | 26.3862 | 0.1124 | 2 | 6 | cellular response to salt stress |
GO:0060914 | 0.005 | 9.926 | 0.3561 | 3 | 19 | heart formation |
GO:0045766 | 0.0051 | 3.5632 | 2.0988 | 7 | 112 | positive regulation of angiogenesis |
GO:0048706 | 0.0051 | 3.5632 | 2.0988 | 7 | 112 | embryonic skeletal system development |
GO:0034728 | 0.0057 | 3.1495 | 2.6985 | 8 | 144 | nucleosome organization |
GO:0048731 | 0.0063 | 1.4786 | 49.7759 | 66 | 2837 | system development |
GO:0051290 | 0.0065 | 5.8971 | 0.7496 | 4 | 40 | protein heterotetramerization |
GO:0030334 | 0.0065 | 1.9428 | 10.8877 | 20 | 581 | regulation of cell migration |
GO:0060037 | 0.0067 | 8.8218 | 0.3935 | 3 | 21 | pharyngeal system development |
GO:0061085 | 0.0069 | 21.1073 | 0.1312 | 2 | 7 | regulation of histone H3-K27 methylation |
GO:0006691 | 0.0077 | 8.3568 | 0.4123 | 3 | 22 | leukotriene metabolic process |
GO:0042554 | 0.0077 | 8.3568 | 0.4123 | 3 | 22 | superoxide anion generation |
GO:0048538 | 0.0077 | 5.5858 | 0.7871 | 4 | 42 | thymus development |
GO:0048562 | 0.0083 | 2.4442 | 4.7411 | 11 | 253 | embryonic organ morphogenesis |
GO:0051216 | 0.0085 | 2.9315 | 2.8859 | 8 | 154 | cartilage development |
GO:0030878 | 0.0087 | 7.9384 | 0.431 | 3 | 23 | thyroid gland development |
GO:0061756 | 0.0087 | 7.9384 | 0.431 | 3 | 23 | leukocyte adhesion to vascular endothelial cell |
GO:1903671 | 0.0087 | 7.9384 | 0.431 | 3 | 23 | negative regulation of sprouting angiogenesis |
GO:0003266 | 0.0091 | 17.5881 | 0.1499 | 2 | 8 | regulation of secondary heart field cardioblast proliferation |
GO:0007512 | 0.0091 | 17.5881 | 0.1499 | 2 | 8 | adult heart development |
GO:0010940 | 0.0091 | 17.5881 | 0.1499 | 2 | 8 | positive regulation of necrotic cell death |
GO:0014841 | 0.0091 | 17.5881 | 0.1499 | 2 | 8 | skeletal muscle satellite cell proliferation |
GO:0045647 | 0.0091 | 17.5881 | 0.1499 | 2 | 8 | negative regulation of erythrocyte differentiation |
GO:0007156 | 0.0092 | 3.1675 | 2.3425 | 7 | 125 | homophilic cell adhesion via plasma membrane adhesion molecules |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042126 | 0 | 150.2432 | 0.0792 | 3 | 4 | nitrate metabolic process |
GO:0072358 | 1e-04 | 2.5776 | 10.5917 | 25 | 535 | cardiovascular system development |
GO:0006805 | 2e-04 | 6.8205 | 1.1681 | 7 | 59 | xenobiotic metabolic process |
GO:0048646 | 3e-04 | 2.1066 | 16.5497 | 32 | 842 | anatomical structure formation involved in morphogenesis |
GO:0009410 | 3e-04 | 5.9075 | 1.3264 | 7 | 67 | response to xenobiotic stimulus |
GO:0006954 | 4e-04 | 2.4702 | 9.1662 | 21 | 463 | inflammatory response |
GO:0001568 | 4e-04 | 2.4047 | 9.8677 | 22 | 502 | blood vessel development |
GO:1905205 | 4e-04 | 30.0394 | 0.1584 | 3 | 8 | positive regulation of connective tissue replacement |
GO:1900048 | 6e-04 | 12.5543 | 0.3959 | 4 | 20 | positive regulation of hemostasis |
GO:0061029 | 6e-04 | 25.0309 | 0.1782 | 3 | 9 | eyelid development in camera-type eye |
GO:1903244 | 6e-04 | 25.0309 | 0.1782 | 3 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
GO:0050820 | 7e-04 | 11.8149 | 0.4157 | 4 | 21 | positive regulation of coagulation |
GO:0042471 | 8e-04 | 4.4094 | 1.9797 | 8 | 100 | ear morphogenesis |
GO:0048701 | 0.001 | 7.4033 | 0.7721 | 5 | 39 | embryonic cranial skeleton morphogenesis |
GO:1903671 | 0.001 | 10.5696 | 0.4553 | 4 | 23 | negative regulation of sprouting angiogenesis |
GO:2000181 | 0.0011 | 4.7846 | 1.6036 | 7 | 81 | negative regulation of blood vessel morphogenesis |
GO:0014744 | 0.0011 | 18.7703 | 0.2178 | 3 | 11 | positive regulation of muscle adaptation |
GO:0033128 | 0.0012 | 99.7769 | 0.0594 | 2 | 3 | negative regulation of histone phosphorylation |
GO:0051410 | 0.0012 | 99.7769 | 0.0594 | 2 | 3 | detoxification of nitrogen compound |
GO:0061044 | 0.0012 | 99.7769 | 0.0594 | 2 | 3 | negative regulation of vascular wound healing |
GO:0070634 | 0.0012 | 99.7769 | 0.0594 | 2 | 3 | transepithelial ammonium transport |
GO:2001199 | 0.0012 | 99.7769 | 0.0594 | 2 | 3 | negative regulation of dendritic cell differentiation |
GO:0030198 | 0.0013 | 2.8297 | 4.9098 | 13 | 248 | extracellular matrix organization |
GO:0045766 | 0.0017 | 3.897 | 2.2173 | 8 | 112 | positive regulation of angiogenesis |
GO:0048706 | 0.0017 | 3.897 | 2.2173 | 8 | 112 | embryonic skeletal system development |
GO:0045765 | 0.0018 | 4.3654 | 1.7421 | 7 | 90 | regulation of angiogenesis |
GO:0050896 | 0.0018 | 1.4523 | 127.1989 | 151 | 6425 | response to stimulus |
GO:0070286 | 0.0018 | 8.7287 | 0.5345 | 4 | 27 | axonemal dynein complex assembly |
GO:0006590 | 0.0019 | 15.0139 | 0.2574 | 3 | 13 | thyroid hormone generation |
GO:0007605 | 0.0021 | 3.7515 | 2.2965 | 8 | 116 | sensory perception of sound |
GO:0010572 | 0.0023 | 49.8846 | 0.0792 | 2 | 4 | positive regulation of platelet activation |
GO:0051122 | 0.0023 | 49.8846 | 0.0792 | 2 | 4 | hepoxilin biosynthetic process |
GO:0060455 | 0.0023 | 49.8846 | 0.0792 | 2 | 4 | negative regulation of gastric acid secretion |
GO:0072593 | 0.0025 | 2.9017 | 4.0387 | 11 | 204 | reactive oxygen species metabolic process |
GO:0018958 | 0.0026 | 4.7271 | 1.3858 | 6 | 70 | phenol-containing compound metabolic process |
GO:0003158 | 0.0026 | 4.0656 | 1.861 | 7 | 94 | endothelium development |
GO:0043537 | 0.0027 | 7.7197 | 0.5939 | 4 | 30 | negative regulation of blood vessel endothelial cell migration |
GO:0010612 | 0.0029 | 12.5097 | 0.297 | 3 | 15 | regulation of cardiac muscle adaptation |
GO:0019372 | 0.0029 | 12.5097 | 0.297 | 3 | 15 | lipoxygenase pathway |
GO:0048568 | 0.003 | 2.3116 | 7.3449 | 16 | 371 | embryonic organ development |
GO:0048839 | 0.0034 | 3.169 | 3.029 | 9 | 153 | inner ear development |
GO:0006629 | 0.0035 | 1.7221 | 21.797 | 35 | 1101 | lipid metabolic process |
GO:0010757 | 0.0038 | 33.2538 | 0.099 | 2 | 5 | negative regulation of plasminogen activation |
GO:0034112 | 0.0038 | 33.2538 | 0.099 | 2 | 5 | positive regulation of homotypic cell-cell adhesion |
GO:0060023 | 0.0038 | 33.2538 | 0.099 | 2 | 5 | soft palate development |
GO:0050878 | 0.0041 | 2.2339 | 7.5824 | 16 | 383 | regulation of body fluid levels |
GO:0042445 | 0.0041 | 3.3451 | 2.5539 | 8 | 129 | hormone metabolic process |
GO:0045606 | 0.0042 | 10.7209 | 0.3366 | 3 | 17 | positive regulation of epidermal cell differentiation |
GO:0002700 | 0.0047 | 4.1414 | 1.564 | 6 | 79 | regulation of production of molecular mediator of immune response |
GO:0006575 | 0.0047 | 3.2634 | 2.6133 | 8 | 132 | cellular modified amino acid metabolic process |
GO:0051270 | 0.005 | 1.8722 | 13.6009 | 24 | 687 | regulation of cellular component movement |
GO:0046394 | 0.0055 | 2.4729 | 5.1276 | 12 | 259 | carboxylic acid biosynthetic process |
GO:0055114 | 0.0055 | 1.8081 | 15.2639 | 26 | 771 | oxidation-reduction process |
GO:0002291 | 0.0056 | 24.9385 | 0.1188 | 2 | 6 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
GO:0006681 | 0.0056 | 24.9385 | 0.1188 | 2 | 6 | galactosylceramide metabolic process |
GO:0015917 | 0.0056 | 24.9385 | 0.1188 | 2 | 6 | aminophospholipid transport |
GO:0019062 | 0.0056 | 24.9385 | 0.1188 | 2 | 6 | virion attachment to host cell |
GO:0021603 | 0.0056 | 24.9385 | 0.1188 | 2 | 6 | cranial nerve formation |
GO:0060017 | 0.0056 | 24.9385 | 0.1188 | 2 | 6 | parathyroid gland development |
GO:0060836 | 0.0056 | 24.9385 | 0.1188 | 2 | 6 | lymphatic endothelial cell differentiation |
GO:0030334 | 0.0058 | 1.9313 | 11.5023 | 21 | 581 | regulation of cell migration |
GO:0090103 | 0.0059 | 9.3793 | 0.3762 | 3 | 19 | cochlea morphogenesis |
GO:0050829 | 0.0059 | 6.0789 | 0.7325 | 4 | 37 | defense response to Gram-negative bacterium |
GO:0010594 | 0.0065 | 3.3965 | 2.1975 | 7 | 111 | regulation of endothelial cell migration |
GO:0055067 | 0.0065 | 3.3965 | 2.1975 | 7 | 111 | monovalent inorganic cation homeostasis |
GO:0050793 | 0.0068 | 1.5027 | 38.9021 | 54 | 1965 | regulation of developmental process |
GO:0030193 | 0.0071 | 4.4872 | 1.2076 | 5 | 61 | regulation of blood coagulation |
GO:0001955 | 0.0077 | 19.9492 | 0.1386 | 2 | 7 | blood vessel maturation |
GO:0001975 | 0.0078 | 8.3359 | 0.4157 | 3 | 21 | response to amphetamine |
GO:0060055 | 0.0078 | 8.3359 | 0.4157 | 3 | 21 | angiogenesis involved in wound healing |
GO:0009617 | 0.0083 | 2.1761 | 6.7707 | 14 | 342 | response to bacterium |
GO:0008589 | 0.0086 | 4.2581 | 1.267 | 5 | 64 | regulation of smoothened signaling pathway |
GO:0006691 | 0.0089 | 7.8966 | 0.4355 | 3 | 22 | leukotriene metabolic process |
GO:0042554 | 0.0089 | 7.8966 | 0.4355 | 3 | 22 | superoxide anion generation |
GO:0040017 | 0.009 | 2.0917 | 7.5428 | 15 | 381 | positive regulation of locomotion |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0044057 | 0.0013 | 3.0176 | 4.3059 | 12 | 419 | regulation of system process |
GO:0006936 | 0.002 | 3.4584 | 2.7952 | 9 | 272 | muscle contraction |
GO:0010533 | 0.0021 | 39.0836 | 0.0719 | 2 | 7 | regulation of activation of Janus kinase activity |
GO:0043697 | 0.0021 | 39.0836 | 0.0719 | 2 | 7 | cell dedifferentiation |
GO:1900239 | 0.0028 | 32.5672 | 0.0822 | 2 | 8 | regulation of phenotypic switching |
GO:0072677 | 0.0036 | 27.9126 | 0.0925 | 2 | 9 | eosinophil migration |
GO:0010657 | 0.004 | 6.697 | 0.6474 | 4 | 63 | muscle cell apoptotic process |
GO:1904892 | 0.0047 | 4.9116 | 1.0893 | 5 | 106 | regulation of STAT cascade |
GO:0034433 | 0.0054 | 21.7065 | 0.113 | 2 | 11 | steroid esterification |
GO:0034435 | 0.0054 | 21.7065 | 0.113 | 2 | 11 | cholesterol esterification |
GO:0050729 | 0.0064 | 5.8066 | 0.7399 | 4 | 72 | positive regulation of inflammatory response |
GO:2000846 | 0.0065 | 19.5343 | 0.1233 | 2 | 12 | regulation of corticosteroid hormone secretion |
GO:0090288 | 0.0066 | 4.5066 | 1.1818 | 5 | 115 | negative regulation of cellular response to growth factor stimulus |
GO:0001974 | 0.0069 | 8.4187 | 0.3905 | 3 | 38 | blood vessel remodeling |
GO:0042692 | 0.007 | 2.8207 | 3.3913 | 9 | 330 | muscle cell differentiation |
GO:0007200 | 0.007 | 5.6398 | 0.7605 | 4 | 74 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0002028 | 0.0074 | 5.56 | 0.7707 | 4 | 75 | regulation of sodium ion transport |
GO:0010665 | 0.0079 | 7.9624 | 0.4111 | 3 | 40 | regulation of cardiac muscle cell apoptotic process |
GO:0007186 | 0.0082 | 2.2747 | 6.1185 | 13 | 610 | G-protein coupled receptor signaling pathway |
GO:0048771 | 0.0083 | 5.3697 | 0.7962 | 4 | 79 | tissue remodeling |
GO:0048145 | 0.0085 | 5.3333 | 0.8016 | 4 | 78 | regulation of fibroblast proliferation |
GO:0019932 | 0.0086 | 3.206 | 2.3122 | 7 | 225 | second-messenger-mediated signaling |
GO:0007259 | 0.009 | 4.1629 | 1.2743 | 5 | 124 | JAK-STAT cascade |
GO:0055002 | 0.009 | 4.1629 | 1.2743 | 5 | 124 | striated muscle cell development |
GO:0060986 | 0.0091 | 7.5529 | 0.4316 | 3 | 42 | endocrine hormone secretion |
GO:2000677 | 0.0091 | 7.5529 | 0.4316 | 3 | 42 | regulation of transcription regulatory region DNA binding |
GO:0007166 | 0.0096 | 1.6666 | 22.0432 | 33 | 2145 | cell surface receptor signaling pathway |
GO:0043392 | 0.0097 | 7.3635 | 0.4419 | 3 | 43 | negative regulation of DNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048646 | 0 | 2.5314 | 14.6096 | 33 | 848 | anatomical structure formation involved in morphogenesis |
GO:0001944 | 1e-04 | 2.6274 | 9.131 | 22 | 530 | vasculature development |
GO:0072359 | 1e-04 | 2.2904 | 13.9033 | 29 | 807 | circulatory system development |
GO:1905205 | 3e-04 | 34.6693 | 0.1378 | 3 | 8 | positive regulation of connective tissue replacement |
GO:0040012 | 3e-04 | 2.3185 | 11.7325 | 25 | 681 | regulation of locomotion |
GO:0051270 | 3e-04 | 2.2964 | 11.8359 | 25 | 687 | regulation of cellular component movement |
GO:0002696 | 3e-04 | 3.5215 | 3.6869 | 12 | 214 | positive regulation of leukocyte activation |
GO:1903244 | 4e-04 | 28.8889 | 0.1551 | 3 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
GO:0006954 | 4e-04 | 2.5721 | 7.9767 | 19 | 463 | inflammatory response |
GO:0030334 | 5e-04 | 2.378 | 10.0097 | 22 | 581 | regulation of cell migration |
GO:0061756 | 6e-04 | 12.2058 | 0.3963 | 4 | 23 | leukocyte adhesion to vascular endothelial cell |
GO:0048856 | 7e-04 | 1.5652 | 76.4495 | 100 | 4475 | anatomical structure development |
GO:0051674 | 7e-04 | 1.9245 | 19.8987 | 35 | 1155 | localization of cell |
GO:0014744 | 8e-04 | 21.6633 | 0.1895 | 3 | 11 | positive regulation of muscle adaptation |
GO:0050870 | 9e-04 | 3.889 | 2.4981 | 9 | 145 | positive regulation of T cell activation |
GO:0022409 | 0.0012 | 3.443 | 3.1183 | 10 | 181 | positive regulation of cell-cell adhesion |
GO:0050671 | 0.0012 | 4.7034 | 1.6195 | 7 | 94 | positive regulation of lymphocyte proliferation |
GO:0030168 | 0.0012 | 4.1123 | 2.1019 | 8 | 122 | platelet activation |
GO:0032715 | 0.0013 | 9.6592 | 0.4824 | 4 | 28 | negative regulation of interleukin-6 production |
GO:2000026 | 0.0014 | 1.7545 | 26.2732 | 42 | 1525 | regulation of multicellular organismal development |
GO:0070665 | 0.0014 | 4.5456 | 1.6712 | 7 | 97 | positive regulation of leukocyte proliferation |
GO:0043537 | 0.0017 | 8.9148 | 0.5169 | 4 | 30 | negative regulation of blood vessel endothelial cell migration |
GO:0002699 | 0.0017 | 3.9048 | 2.2052 | 8 | 128 | positive regulation of immune effector process |
GO:0009972 | 0.0017 | 57.5398 | 0.0689 | 2 | 4 | cytidine deamination |
GO:0046087 | 0.0017 | 57.5398 | 0.0689 | 2 | 4 | cytidine metabolic process |
GO:0051122 | 0.0017 | 57.5398 | 0.0689 | 2 | 4 | hepoxilin biosynthetic process |
GO:0070383 | 0.0017 | 57.5398 | 0.0689 | 2 | 4 | DNA cytosine deamination |
GO:2000354 | 0.0017 | 57.5398 | 0.0689 | 2 | 4 | regulation of ovarian follicle development |
GO:0046394 | 0.0018 | 2.8698 | 4.4621 | 12 | 259 | carboxylic acid biosynthetic process |
GO:0010612 | 0.002 | 14.4378 | 0.2584 | 3 | 15 | regulation of cardiac muscle adaptation |
GO:0002708 | 0.0025 | 5.8099 | 0.9476 | 5 | 55 | positive regulation of lymphocyte mediated immunity |
GO:2000181 | 0.0027 | 4.6598 | 1.3955 | 6 | 81 | negative regulation of blood vessel morphogenesis |
GO:0060023 | 0.0029 | 38.3569 | 0.0861 | 2 | 5 | soft palate development |
GO:0010633 | 0.0029 | 5.5855 | 0.982 | 5 | 57 | negative regulation of epithelial cell migration |
GO:0090132 | 0.0029 | 3.0136 | 3.5318 | 10 | 205 | epithelium migration |
GO:2000146 | 0.0031 | 2.998 | 3.549 | 10 | 206 | negative regulation of cell motility |
GO:0010594 | 0.0031 | 3.9294 | 1.9123 | 7 | 111 | regulation of endothelial cell migration |
GO:0009611 | 0.0031 | 2.1848 | 8.7692 | 18 | 509 | response to wounding |
GO:0048514 | 0.0032 | 2.4555 | 6.0593 | 14 | 359 | blood vessel morphogenesis |
GO:0032101 | 0.0032 | 2.1801 | 8.7865 | 18 | 510 | regulation of response to external stimulus |
GO:0045766 | 0.0032 | 3.8917 | 1.9296 | 7 | 112 | positive regulation of angiogenesis |
GO:0032720 | 0.0033 | 7.24 | 0.6202 | 4 | 36 | negative regulation of tumor necrosis factor production |
GO:0001667 | 0.0033 | 2.6506 | 4.8067 | 12 | 279 | ameboidal-type cell migration |
GO:0016486 | 0.0034 | 11.5476 | 0.3101 | 3 | 18 | peptide hormone processing |
GO:0002687 | 0.0037 | 4.3669 | 1.4816 | 6 | 86 | positive regulation of leukocyte migration |
GO:0045765 | 0.0041 | 4.2581 | 1.5158 | 6 | 90 | regulation of angiogenesis |
GO:0002291 | 0.0042 | 28.7655 | 0.1034 | 2 | 6 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
GO:0045869 | 0.0042 | 28.7655 | 0.1034 | 2 | 6 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate |
GO:0046133 | 0.0042 | 28.7655 | 0.1034 | 2 | 6 | pyrimidine ribonucleoside catabolic process |
GO:2000242 | 0.0044 | 6.6179 | 0.6719 | 4 | 39 | negative regulation of reproductive process |
GO:0006629 | 0.0044 | 1.7554 | 18.9684 | 31 | 1101 | lipid metabolic process |
GO:0002440 | 0.0045 | 3.6465 | 2.0502 | 7 | 119 | production of molecular mediator of immune response |
GO:0002230 | 0.0046 | 10.1875 | 0.3446 | 3 | 20 | positive regulation of defense response to virus by host |
GO:0051094 | 0.0047 | 1.7804 | 17.4523 | 29 | 1013 | positive regulation of developmental process |
GO:0051249 | 0.0052 | 2.4976 | 5.0824 | 12 | 295 | regulation of lymphocyte activation |
GO:0042475 | 0.0052 | 4.8378 | 1.1198 | 5 | 65 | odontogenesis of dentin-containing tooth |
GO:0032496 | 0.0053 | 2.7551 | 3.8419 | 10 | 223 | response to lipopolysaccharide |
GO:0042104 | 0.0053 | 9.6207 | 0.3618 | 3 | 21 | positive regulation of activated T cell proliferation |
GO:0060055 | 0.0053 | 9.6207 | 0.3618 | 3 | 21 | angiogenesis involved in wound healing |
GO:0050865 | 0.0054 | 2.2981 | 6.4434 | 14 | 374 | regulation of cell activation |
GO:0002263 | 0.0056 | 2.1025 | 8.5625 | 17 | 497 | cell activation involved in immune response |
GO:0042098 | 0.0056 | 3.4893 | 2.1363 | 7 | 124 | T cell proliferation |
GO:0003158 | 0.0057 | 3.9674 | 1.6195 | 6 | 94 | endothelium development |
GO:0001955 | 0.0059 | 23.0106 | 0.1206 | 2 | 7 | blood vessel maturation |
GO:0006691 | 0.0061 | 9.1137 | 0.379 | 3 | 22 | leukotriene metabolic process |
GO:0002718 | 0.0063 | 5.9373 | 0.7408 | 4 | 43 | regulation of cytokine production involved in immune response |
GO:0009164 | 0.0069 | 8.6573 | 0.3963 | 3 | 23 | nucleoside catabolic process |
GO:1903671 | 0.0069 | 8.6573 | 0.3963 | 3 | 23 | negative regulation of sprouting angiogenesis |
GO:0002285 | 0.0073 | 3.7527 | 1.7056 | 6 | 99 | lymphocyte activation involved in immune response |
GO:2001238 | 0.0074 | 5.6468 | 0.7753 | 4 | 45 | positive regulation of extrinsic apoptotic signaling pathway |
GO:0008283 | 0.0076 | 1.5876 | 27.1691 | 40 | 1577 | cell proliferation |
GO:0000038 | 0.0078 | 8.2444 | 0.4135 | 3 | 24 | very long-chain fatty acid metabolic process |
GO:0019221 | 0.0079 | 2.0724 | 8.149 | 16 | 473 | cytokine-mediated signaling pathway |
GO:1903037 | 0.0085 | 2.5594 | 4.1176 | 10 | 239 | regulation of leukocyte cell-cell adhesion |
GO:0003299 | 0.0088 | 7.8691 | 0.4307 | 3 | 25 | muscle hypertrophy in response to stress |
GO:0006955 | 0.0093 | 1.798 | 13.6006 | 23 | 821 | immune response |
GO:0032501 | 0.0096 | 1.3807 | 93.1709 | 111 | 5408 | multicellular organismal process |
GO:0016264 | 0.0098 | 16.4336 | 0.1551 | 2 | 9 | gap junction assembly |
GO:0016553 | 0.0098 | 16.4336 | 0.1551 | 2 | 9 | base conversion or substitution editing |
GO:0061045 | 0.0099 | 5.1433 | 0.8442 | 4 | 49 | negative regulation of wound healing |
GO:0034754 | 0.01 | 4.0848 | 1.3094 | 5 | 76 | cellular hormone metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0030948 | 1e-04 | 63.2516 | 0.0836 | 3 | 7 | negative regulation of vascular endothelial growth factor receptor signaling pathway |
GO:0048514 | 8e-04 | 2.887 | 5.2531 | 14 | 440 | blood vessel morphogenesis |
GO:0035021 | 8e-04 | 83.8077 | 0.0478 | 2 | 4 | negative regulation of Rac protein signal transduction |
GO:1900747 | 8e-04 | 83.8077 | 0.0478 | 2 | 4 | negative regulation of vascular endothelial growth factor signaling pathway |
GO:0051240 | 0.001 | 2.0798 | 14.3984 | 27 | 1206 | positive regulation of multicellular organismal process |
GO:0048646 | 0.0011 | 2.2704 | 10.1242 | 21 | 848 | anatomical structure formation involved in morphogenesis |
GO:0044030 | 0.0016 | 14.8679 | 0.2388 | 3 | 20 | regulation of DNA methylation |
GO:0048870 | 0.0025 | 1.9872 | 13.7895 | 25 | 1155 | cell motility |
GO:0016525 | 0.0027 | 5.6649 | 0.9551 | 5 | 80 | negative regulation of angiogenesis |
GO:0010533 | 0.0029 | 33.5154 | 0.0836 | 2 | 7 | regulation of activation of Janus kinase activity |
GO:0043697 | 0.0029 | 33.5154 | 0.0836 | 2 | 7 | cell dedifferentiation |
GO:0023052 | 0.0029 | 1.5815 | 56.7339 | 74 | 4752 | signaling |
GO:0060285 | 0.0032 | 11.4845 | 0.2985 | 3 | 25 | cilium-dependent cell motility |
GO:0022603 | 0.0032 | 2.1519 | 9.5512 | 19 | 800 | regulation of anatomical structure morphogenesis |
GO:1901343 | 0.0036 | 5.2429 | 1.0267 | 5 | 86 | negative regulation of vasculature development |
GO:0055002 | 0.0037 | 4.3347 | 1.4804 | 6 | 124 | striated muscle cell development |
GO:1900239 | 0.0038 | 27.9274 | 0.0955 | 2 | 8 | regulation of phenotypic switching |
GO:0010719 | 0.004 | 10.5258 | 0.3224 | 3 | 27 | negative regulation of epithelial to mesenchymal transition |
GO:0048147 | 0.004 | 10.5258 | 0.3224 | 3 | 27 | negative regulation of fibroblast proliferation |
GO:1901890 | 0.0044 | 10.104 | 0.3343 | 3 | 28 | positive regulation of cell junction assembly |
GO:0051094 | 0.0045 | 1.9727 | 12.0942 | 22 | 1013 | positive regulation of developmental process |
GO:0060099 | 0.0048 | 23.9359 | 0.1075 | 2 | 9 | regulation of phagocytosis, engulfment |
GO:0072677 | 0.0048 | 23.9359 | 0.1075 | 2 | 9 | eosinophil migration |
GO:1903726 | 0.0048 | 23.9359 | 0.1075 | 2 | 9 | negative regulation of phospholipid metabolic process |
GO:0072358 | 0.0049 | 2.3429 | 6.3873 | 14 | 535 | cardiovascular system development |
GO:0032964 | 0.0054 | 9.3541 | 0.3582 | 3 | 30 | collagen biosynthetic process |
GO:1901342 | 0.0055 | 3.9774 | 1.6059 | 6 | 138 | regulation of vasculature development |
GO:0050896 | 0.0057 | 1.5239 | 76.7077 | 93 | 6425 | response to stimulus |
GO:0048266 | 0.006 | 20.9423 | 0.1194 | 2 | 10 | behavioral response to pain |
GO:0007166 | 0.0067 | 1.6486 | 25.609 | 38 | 2145 | cell surface receptor signaling pathway |
GO:0010657 | 0.0067 | 5.7306 | 0.7522 | 4 | 63 | muscle cell apoptotic process |
GO:0051101 | 0.0069 | 4.4654 | 1.1939 | 5 | 100 | regulation of DNA binding |
GO:0034433 | 0.0073 | 18.614 | 0.1313 | 2 | 11 | steroid esterification |
GO:0034435 | 0.0073 | 18.614 | 0.1313 | 2 | 11 | cholesterol esterification |
GO:1902547 | 0.0073 | 18.614 | 0.1313 | 2 | 11 | regulation of cellular response to vascular endothelial growth factor stimulus |
GO:0007266 | 0.0074 | 3.7281 | 1.7073 | 6 | 143 | Rho protein signal transduction |
GO:0007154 | 0.0082 | 1.4935 | 56.9368 | 72 | 4769 | cell communication |
GO:1904892 | 0.0088 | 4.1982 | 1.2655 | 5 | 106 | regulation of STAT cascade |
GO:0070372 | 0.0089 | 3.178 | 2.3281 | 7 | 195 | regulation of ERK1 and ERK2 cascade |
GO:0008360 | 0.0091 | 4.1567 | 1.2775 | 5 | 107 | regulation of cell shape |
GO:0046456 | 0.0096 | 7.4243 | 0.4417 | 3 | 37 | icosanoid biosynthetic process |
GO:0048856 | 0.0097 | 1.4837 | 53.4865 | 68 | 4480 | anatomical structure development |
GO:0009968 | 0.0099 | 1.8828 | 11.4126 | 20 | 980 | negative regulation of signal transduction |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006952 | 0 | 3.5719 | 6.4626 | 19 | 1043 | defense response |
GO:0050911 | 0 | 17.3642 | 0.3346 | 5 | 54 | detection of chemical stimulus involved in sensory perception of smell |
GO:0051606 | 1e-04 | 6.4441 | 1.3941 | 8 | 225 | detection of stimulus |
GO:0006955 | 2e-04 | 3.4864 | 4.7054 | 14 | 821 | immune response |
GO:0007600 | 4e-04 | 4.07 | 2.7511 | 10 | 444 | sensory perception |
GO:0002764 | 5e-04 | 4.3559 | 2.2988 | 9 | 371 | immune response-regulating signaling pathway |
GO:0002684 | 0.001 | 3.1688 | 4.2568 | 12 | 687 | positive regulation of immune system process |
GO:0050908 | 0.0013 | 46.9464 | 0.0558 | 2 | 9 | detection of light stimulus involved in visual perception |
GO:0043303 | 0.0015 | 14.6515 | 0.2293 | 3 | 37 | mast cell degranulation |
GO:0050829 | 0.0015 | 14.6515 | 0.2293 | 3 | 37 | defense response to Gram-negative bacterium |
GO:0002758 | 0.002 | 4.9614 | 1.3136 | 6 | 212 | innate immune response-activating signal transduction |
GO:0003008 | 0.0021 | 2.4427 | 7.9869 | 17 | 1289 | system process |
GO:0042742 | 0.0021 | 8.0819 | 0.5388 | 4 | 90 | defense response to bacterium |
GO:0007166 | 0.0021 | 2.1521 | 13.2908 | 24 | 2145 | cell surface receptor signaling pathway |
GO:0045576 | 0.0022 | 12.7683 | 0.2602 | 3 | 42 | mast cell activation |
GO:0051707 | 0.0023 | 3.1823 | 3.4699 | 10 | 560 | response to other organism |
GO:0002253 | 0.0029 | 3.6043 | 2.4227 | 8 | 391 | activation of immune response |
GO:0001580 | 0.0033 | 27.375 | 0.0867 | 2 | 14 | detection of chemical stimulus involved in sensory perception of bitter taste |
GO:0046597 | 0.0033 | 27.375 | 0.0867 | 2 | 14 | negative regulation of viral entry into host cell |
GO:0002223 | 0.0034 | 6.9744 | 0.6196 | 4 | 100 | stimulatory C-type lectin receptor signaling pathway |
GO:0002263 | 0.0036 | 3.1994 | 3.0795 | 9 | 497 | cell activation involved in immune response |
GO:0002275 | 0.0037 | 3.4554 | 2.5218 | 8 | 407 | myeloid cell activation involved in immune response |
GO:0034341 | 0.0037 | 6.831 | 0.632 | 4 | 102 | response to interferon-gamma |
GO:0009607 | 0.0037 | 2.973 | 3.6991 | 10 | 597 | response to biotic stimulus |
GO:0002444 | 0.0039 | 3.4113 | 2.5528 | 8 | 412 | myeloid leukocyte mediated immunity |
GO:0002429 | 0.0041 | 4.2655 | 1.5181 | 6 | 245 | immune response-activating cell surface receptor signaling pathway |
GO:0035455 | 0.0043 | 23.4607 | 0.0991 | 2 | 16 | response to interferon-alpha |
GO:0042346 | 0.0049 | 21.895 | 0.1053 | 2 | 17 | positive regulation of NF-kappaB import into nucleus |
GO:0046835 | 0.0049 | 21.895 | 0.1053 | 2 | 17 | carbohydrate phosphorylation |
GO:0045089 | 0.0052 | 4.0578 | 1.5924 | 6 | 257 | positive regulation of innate immune response |
GO:0002694 | 0.0054 | 3.5492 | 2.1315 | 7 | 344 | regulation of leukocyte activation |
GO:0023052 | 0.006 | 1.7918 | 29.4442 | 41 | 4752 | signaling |
GO:0031069 | 0.0061 | 19.3162 | 0.1177 | 2 | 19 | hair follicle morphogenesis |
GO:0043462 | 0.0061 | 8.7242 | 0.3718 | 3 | 60 | regulation of ATPase activity |
GO:0003365 | 0.0062 | Inf | 0.0062 | 1 | 1 | establishment of cell polarity involved in ameboidal cell migration |
GO:0035038 | 0.0062 | Inf | 0.0062 | 1 | 1 | female pronucleus assembly |
GO:0035039 | 0.0062 | Inf | 0.0062 | 1 | 1 | male pronucleus assembly |
GO:0035499 | 0.0062 | Inf | 0.0062 | 1 | 1 | carnosine biosynthetic process |
GO:0045356 | 0.0062 | Inf | 0.0062 | 1 | 1 | positive regulation of interferon-alpha biosynthetic process |
GO:0050677 | 0.0062 | Inf | 0.0062 | 1 | 1 | positive regulation of urothelial cell proliferation |
GO:0060436 | 0.0062 | Inf | 0.0062 | 1 | 1 | bronchiole morphogenesis |
GO:0060496 | 0.0062 | Inf | 0.0062 | 1 | 1 | mesenchymal-epithelial cell signaling involved in lung development |
GO:0060879 | 0.0062 | Inf | 0.0062 | 1 | 1 | semicircular canal fusion |
GO:0061033 | 0.0062 | Inf | 0.0062 | 1 | 1 | secretion by lung epithelial cell involved in lung growth |
GO:0061115 | 0.0062 | Inf | 0.0062 | 1 | 1 | lung proximal/distal axis specification |
GO:0070075 | 0.0062 | Inf | 0.0062 | 1 | 1 | tear secretion |
GO:0070488 | 0.0062 | Inf | 0.0062 | 1 | 1 | neutrophil aggregation |
GO:1900131 | 0.0062 | Inf | 0.0062 | 1 | 1 | negative regulation of lipid binding |
GO:1990134 | 0.0062 | Inf | 0.0062 | 1 | 1 | epithelial cell apoptotic process involved in palatal shelf morphogenesis |
GO:0050907 | 0.0066 | 18.3635 | 0.1227 | 2 | 21 | detection of chemical stimulus involved in sensory perception |
GO:0060333 | 0.0067 | 8.4272 | 0.3842 | 3 | 62 | interferon-gamma-mediated signaling pathway |
GO:0007141 | 0.0067 | 18.2417 | 0.1239 | 2 | 20 | male meiosis I |
GO:0051716 | 0.007 | 1.7675 | 33.4964 | 45 | 5406 | cellular response to stimulus |
GO:0052548 | 0.0071 | 3.781 | 1.7039 | 6 | 275 | regulation of endopeptidase activity |
GO:0042475 | 0.0076 | 8.0176 | 0.4028 | 3 | 65 | odontogenesis of dentin-containing tooth |
GO:0070268 | 0.0076 | 8.0176 | 0.4028 | 3 | 65 | cornification |
GO:0009913 | 0.0077 | 4.3601 | 1.2268 | 5 | 198 | epidermal cell differentiation |
GO:0001556 | 0.0081 | 16.415 | 0.1363 | 2 | 22 | oocyte maturation |
GO:0045321 | 0.0093 | 2.9348 | 2.9616 | 8 | 509 | leukocyte activation |
GO:0051346 | 0.0096 | 3.5389 | 1.8155 | 6 | 293 | negative regulation of hydrolase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1903796 | 3e-04 | Inf | 0.0358 | 2 | 2 | negative regulation of inorganic anion transmembrane transport |
GO:2000404 | 7e-04 | 11.7262 | 0.4119 | 4 | 23 | regulation of T cell migration |
GO:0016051 | 7e-04 | 3.6981 | 2.9191 | 10 | 163 | carbohydrate biosynthetic process |
GO:0010836 | 9e-04 | 110.6043 | 0.0537 | 2 | 3 | negative regulation of protein ADP-ribosylation |
GO:0072679 | 9e-04 | 110.6043 | 0.0537 | 2 | 3 | thymocyte migration |
GO:0048565 | 0.0011 | 4.2085 | 2.0595 | 8 | 115 | digestive tract development |
GO:0072111 | 0.0018 | 15.1352 | 0.2507 | 3 | 14 | cell proliferation involved in kidney development |
GO:0070221 | 0.0019 | 55.2979 | 0.0716 | 2 | 4 | sulfide oxidation, using sulfide:quinone oxidoreductase |
GO:0035264 | 0.0021 | 3.7488 | 2.2923 | 8 | 128 | multicellular organism growth |
GO:0048535 | 0.0022 | 13.8729 | 0.2686 | 3 | 15 | lymph node development |
GO:0072676 | 0.0023 | 5.9382 | 0.9312 | 5 | 52 | lymphocyte migration |
GO:0033692 | 0.0025 | 5.814 | 0.9491 | 5 | 53 | cellular polysaccharide biosynthetic process |
GO:0019233 | 0.0025 | 4.7287 | 1.3789 | 6 | 77 | sensory perception of pain |
GO:0007214 | 0.0027 | 12.8047 | 0.2865 | 3 | 16 | gamma-aminobutyric acid signaling pathway |
GO:0008210 | 0.0027 | 12.8047 | 0.2865 | 3 | 16 | estrogen metabolic process |
GO:0048469 | 0.0028 | 3.5686 | 2.3997 | 8 | 134 | cell maturation |
GO:0051351 | 0.0031 | 36.8624 | 0.0895 | 2 | 5 | positive regulation of ligase activity |
GO:2001023 | 0.0031 | 36.8624 | 0.0895 | 2 | 5 | regulation of response to drug |
GO:0001709 | 0.0034 | 7.1804 | 0.6268 | 4 | 35 | cell fate determination |
GO:0045685 | 0.0037 | 5.2635 | 1.0387 | 5 | 58 | regulation of glial cell differentiation |
GO:0050832 | 0.0044 | 10.4014 | 0.3403 | 3 | 19 | defense response to fungus |
GO:0061621 | 0.0044 | 10.4014 | 0.3403 | 3 | 19 | canonical glycolysis |
GO:0050882 | 0.0046 | 27.6447 | 0.1075 | 2 | 6 | voluntary musculoskeletal movement |
GO:0061615 | 0.0052 | 9.7888 | 0.3582 | 3 | 20 | glycolytic process through fructose-6-phosphate |
GO:0009581 | 0.0052 | 4.0413 | 1.5938 | 6 | 89 | detection of external stimulus |
GO:0005978 | 0.0055 | 6.1807 | 0.7163 | 4 | 40 | glycogen biosynthetic process |
GO:0006749 | 0.0055 | 6.1807 | 0.7163 | 4 | 40 | glutathione metabolic process |
GO:0055114 | 0.0059 | 1.8478 | 13.8074 | 24 | 771 | oxidation-reduction process |
GO:0009582 | 0.0061 | 3.8994 | 1.6476 | 6 | 92 | detection of abiotic stimulus |
GO:0002692 | 0.0063 | 22.114 | 0.1254 | 2 | 7 | negative regulation of cellular extravasation |
GO:0042756 | 0.0063 | 22.114 | 0.1254 | 2 | 7 | drinking behavior |
GO:0098711 | 0.0063 | 22.114 | 0.1254 | 2 | 7 | iron ion import across plasma membrane |
GO:2000510 | 0.0063 | 22.114 | 0.1254 | 2 | 7 | positive regulation of dendritic cell chemotaxis |
GO:0006007 | 0.0077 | 8.3186 | 0.4119 | 3 | 23 | glucose catabolic process |
GO:0043552 | 0.0077 | 8.3186 | 0.4119 | 3 | 23 | positive regulation of phosphatidylinositol 3-kinase activity |
GO:1990403 | 0.0083 | 18.427 | 0.1433 | 2 | 8 | embryonic brain development |
GO:0048870 | 0.0087 | 1.6505 | 20.6842 | 32 | 1155 | cell motility |
GO:0051896 | 0.0091 | 2.8944 | 2.9191 | 8 | 163 | regulation of protein kinase B signaling |
GO:0065004 | 0.0094 | 2.675 | 3.5459 | 9 | 198 | protein-DNA complex assembly |
GO:0008038 | 0.0098 | 7.5612 | 0.4477 | 3 | 25 | neuron recognition |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048704 | 0 | 9.2421 | 1.2653 | 10 | 85 | embryonic skeletal system morphogenesis |
GO:0032502 | 0 | 1.7913 | 71.4523 | 99 | 4800 | developmental process |
GO:0022610 | 2e-04 | 2.219 | 15.526 | 31 | 1043 | biological adhesion |
GO:1905205 | 2e-04 | 40.3052 | 0.1191 | 3 | 8 | positive regulation of connective tissue replacement |
GO:0071469 | 2e-04 | Inf | 0.0298 | 2 | 2 | cellular response to alkaline pH |
GO:2000404 | 3e-04 | 14.2002 | 0.3424 | 4 | 23 | regulation of T cell migration |
GO:0009887 | 5e-04 | 2.2472 | 12.1618 | 25 | 817 | animal organ morphogenesis |
GO:0043009 | 5e-04 | 2.6137 | 7.4578 | 18 | 501 | chordate embryonic development |
GO:0001568 | 6e-04 | 2.5695 | 7.5769 | 18 | 509 | blood vessel development |
GO:0021615 | 7e-04 | 133.7026 | 0.0447 | 2 | 3 | glossopharyngeal nerve morphogenesis |
GO:0036159 | 8e-04 | 20.1448 | 0.1935 | 3 | 13 | inner dynein arm assembly |
GO:0072358 | 0.0011 | 2.4352 | 7.964 | 18 | 535 | cardiovascular system development |
GO:0016525 | 0.0012 | 5.5029 | 1.1909 | 6 | 80 | negative regulation of angiogenesis |
GO:0031532 | 0.0012 | 5.5029 | 1.1909 | 6 | 80 | actin cytoskeleton reorganization |
GO:0048598 | 0.0016 | 2.4081 | 7.5769 | 17 | 509 | embryonic morphogenesis |
GO:0034103 | 0.0017 | 6.3797 | 0.8634 | 5 | 58 | regulation of tissue remodeling |
GO:1901343 | 0.0018 | 5.0878 | 1.2802 | 6 | 86 | negative regulation of vasculature development |
GO:0007275 | 0.002 | 1.5799 | 53.4844 | 72 | 3741 | multicellular organism development |
GO:0044259 | 0.0021 | 4.9028 | 1.3248 | 6 | 89 | multicellular organismal macromolecule metabolic process |
GO:0021546 | 0.0021 | 44.5607 | 0.0744 | 2 | 5 | rhombomere development |
GO:0045617 | 0.0021 | 44.5607 | 0.0744 | 2 | 5 | negative regulation of keratinocyte differentiation |
GO:2000507 | 0.0021 | 44.5607 | 0.0744 | 2 | 5 | positive regulation of energy homeostasis |
GO:0070098 | 0.0026 | 7.6992 | 0.5806 | 4 | 39 | chemokine-mediated signaling pathway |
GO:0036336 | 0.0026 | 12.5847 | 0.2828 | 3 | 19 | dendritic cell migration |
GO:0007156 | 0.0026 | 4.0336 | 1.8607 | 7 | 125 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0001525 | 0.0029 | 2.8407 | 4.1238 | 11 | 284 | angiogenesis |
GO:0007389 | 0.0032 | 2.5535 | 5.4185 | 13 | 364 | pattern specification process |
GO:0021902 | 0.0032 | 33.4179 | 0.0893 | 2 | 6 | commitment of neuronal cell to specific neuron type in forebrain |
GO:0060056 | 0.0032 | 33.4179 | 0.0893 | 2 | 6 | mammary gland involution |
GO:1904995 | 0.0032 | 33.4179 | 0.0893 | 2 | 6 | negative regulation of leukocyte adhesion to vascular endothelial cell |
GO:2000253 | 0.0032 | 33.4179 | 0.0893 | 2 | 6 | positive regulation of feeding behavior |
GO:0001501 | 0.0033 | 2.4485 | 6.0883 | 14 | 409 | skeletal system development |
GO:0050921 | 0.0036 | 4.3722 | 1.4737 | 6 | 99 | positive regulation of chemotaxis |
GO:0031589 | 0.0037 | 2.9132 | 3.647 | 10 | 245 | cell-substrate adhesion |
GO:0048568 | 0.0037 | 2.5022 | 5.5227 | 13 | 371 | embryonic organ development |
GO:0006954 | 0.0039 | 2.316 | 6.8922 | 15 | 463 | inflammatory response |
GO:0030198 | 0.004 | 2.8758 | 3.6917 | 10 | 248 | extracellular matrix organization |
GO:0002688 | 0.0043 | 5.0412 | 1.0718 | 5 | 72 | regulation of leukocyte chemotaxis |
GO:2000510 | 0.0044 | 26.7323 | 0.1042 | 2 | 7 | positive regulation of dendritic cell chemotaxis |
GO:0060561 | 0.0046 | 10.0647 | 0.3424 | 3 | 23 | apoptotic process involved in morphogenesis |
GO:0032652 | 0.0048 | 6.4125 | 0.6848 | 4 | 46 | regulation of interleukin-1 production |
GO:0009952 | 0.005 | 3.2229 | 2.6348 | 8 | 177 | anterior/posterior pattern specification |
GO:0050707 | 0.005 | 4.064 | 1.5779 | 6 | 106 | regulation of cytokine secretion |
GO:0098609 | 0.005 | 2.0844 | 9.1995 | 18 | 618 | cell-cell adhesion |
GO:0048246 | 0.0052 | 9.5847 | 0.3573 | 3 | 24 | macrophage chemotaxis |
GO:0060326 | 0.0054 | 3.1848 | 2.6646 | 8 | 179 | cell chemotaxis |
GO:0030574 | 0.0056 | 6.1201 | 0.7145 | 4 | 48 | collagen catabolic process |
GO:0001574 | 0.0058 | 22.2752 | 0.1191 | 2 | 8 | ganglioside biosynthetic process |
GO:0040012 | 0.0063 | 1.9954 | 10.1373 | 19 | 681 | regulation of locomotion |
GO:0042755 | 0.0066 | 8.7499 | 0.387 | 3 | 26 | eating behavior |
GO:0072604 | 0.0066 | 8.7499 | 0.387 | 3 | 26 | interleukin-6 secretion |
GO:0009888 | 0.0067 | 1.6694 | 22.0609 | 34 | 1482 | tissue development |
GO:0048870 | 0.0069 | 1.7509 | 17.1932 | 28 | 1155 | cell motility |
GO:0051270 | 0.0069 | 1.9765 | 10.2266 | 19 | 687 | regulation of cellular component movement |
GO:0031644 | 0.0074 | 5.6084 | 0.7741 | 4 | 52 | regulation of neurological system process |
GO:0032099 | 0.0074 | 19.0916 | 0.134 | 2 | 9 | negative regulation of appetite |
GO:1903244 | 0.0074 | 19.0916 | 0.134 | 2 | 9 | positive regulation of cardiac muscle hypertrophy in response to stress |
GO:0001952 | 0.0079 | 4.3266 | 1.2355 | 5 | 83 | regulation of cell-matrix adhesion |
GO:0048771 | 0.0082 | 5.4231 | 0.7975 | 4 | 55 | tissue remodeling |
GO:0032094 | 0.0089 | 7.7385 | 0.4317 | 3 | 29 | response to food |
GO:0048247 | 0.0089 | 7.7385 | 0.4317 | 3 | 29 | lymphocyte chemotaxis |
GO:0002687 | 0.0091 | 4.1654 | 1.2802 | 5 | 86 | positive regulation of leukocyte migration |
GO:0043537 | 0.0098 | 7.4513 | 0.4466 | 3 | 30 | negative regulation of blood vessel endothelial cell migration |
GO:0030155 | 0.01 | 2.0708 | 7.6514 | 15 | 514 | regulation of cell adhesion |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032501 | 0 | 2.0207 | 63.3399 | 90 | 5408 | multicellular organismal process |
GO:2001275 | 0 | 38.4695 | 0.1523 | 4 | 13 | positive regulation of glucose import in response to insulin stimulus |
GO:0007156 | 0 | 6.8887 | 1.464 | 9 | 125 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0051046 | 0 | 3.244 | 6.5472 | 19 | 559 | regulation of secretion |
GO:0098609 | 1e-04 | 2.9107 | 7.2382 | 19 | 618 | cell-cell adhesion |
GO:0016339 | 1e-04 | 18.2084 | 0.2694 | 4 | 23 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
GO:1902957 | 1e-04 | Inf | 0.0234 | 2 | 2 | negative regulation of mitochondrial electron transport, NADH to ubiquinone |
GO:2000502 | 1e-04 | Inf | 0.0234 | 2 | 2 | negative regulation of natural killer cell chemotaxis |
GO:0007154 | 3e-04 | 1.7646 | 55.8558 | 77 | 4769 | cell communication |
GO:0007186 | 4e-04 | 2.608 | 8.0112 | 19 | 684 | G-protein coupled receptor signaling pathway |
GO:1901856 | 4e-04 | 170.9542 | 0.0351 | 2 | 3 | negative regulation of cellular respiration |
GO:0023052 | 5e-04 | 1.7288 | 55.6566 | 76 | 4752 | signaling |
GO:1900076 | 5e-04 | 8.3506 | 0.6676 | 5 | 57 | regulation of cellular response to insulin stimulus |
GO:0008643 | 7e-04 | 5.151 | 1.4757 | 7 | 126 | carbohydrate transport |
GO:0032502 | 7e-04 | 1.7015 | 56.2188 | 76 | 4800 | developmental process |
GO:0007198 | 8e-04 | 85.4706 | 0.0468 | 2 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
GO:0023061 | 9e-04 | 3.1441 | 4.1227 | 12 | 352 | signal release |
GO:0010828 | 0.0011 | 9.8725 | 0.4568 | 4 | 39 | positive regulation of glucose transport |
GO:1903426 | 0.0012 | 6.8868 | 0.7964 | 5 | 68 | regulation of reactive oxygen species biosynthetic process |
GO:1901701 | 0.0013 | 2.3014 | 9.4986 | 20 | 811 | cellular response to oxygen-containing compound |
GO:0032890 | 0.0013 | 9.3374 | 0.4802 | 4 | 41 | regulation of organic acid transport |
GO:0008645 | 0.0014 | 5.3339 | 1.2181 | 6 | 104 | hexose transport |
GO:0031295 | 0.0019 | 8.4238 | 0.5271 | 4 | 45 | T cell costimulation |
GO:0031340 | 0.002 | 42.7288 | 0.0703 | 2 | 6 | positive regulation of vesicle fusion |
GO:0090324 | 0.002 | 42.7288 | 0.0703 | 2 | 6 | negative regulation of oxidative phosphorylation |
GO:1905446 | 0.002 | 42.7288 | 0.0703 | 2 | 6 | regulation of mitochondrial ATP synthesis coupled electron transport |
GO:2000402 | 0.002 | 42.7288 | 0.0703 | 2 | 6 | negative regulation of lymphocyte migration |
GO:0007188 | 0.0022 | 4.8363 | 1.3352 | 6 | 114 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GO:0030072 | 0.0023 | 3.6918 | 2.319 | 8 | 198 | peptide hormone secretion |
GO:0042269 | 0.0023 | 12.8872 | 0.2694 | 3 | 23 | regulation of natural killer cell mediated cytotoxicity |
GO:0032102 | 0.0025 | 3.6336 | 2.3542 | 8 | 201 | negative regulation of response to external stimulus |
GO:0009914 | 0.0027 | 3.2977 | 2.9164 | 9 | 249 | hormone transport |
GO:0007416 | 0.0029 | 4.5797 | 1.4055 | 6 | 120 | synapse assembly |
GO:0050866 | 0.0029 | 4.5797 | 1.4055 | 6 | 120 | negative regulation of cell activation |
GO:0046883 | 0.0029 | 3.5404 | 2.4127 | 8 | 206 | regulation of hormone secretion |
GO:0003298 | 0.003 | 11.7138 | 0.2928 | 3 | 25 | physiological muscle hypertrophy |
GO:0061049 | 0.003 | 11.7138 | 0.2928 | 3 | 25 | cell growth involved in cardiac muscle cell development |
GO:0050830 | 0.0032 | 7.1915 | 0.609 | 4 | 52 | defense response to Gram-positive bacterium |
GO:0007210 | 0.0036 | 28.4815 | 0.0937 | 2 | 8 | serotonin receptor signaling pathway |
GO:0032000 | 0.0036 | 28.4815 | 0.0937 | 2 | 8 | positive regulation of fatty acid beta-oxidation |
GO:0042535 | 0.0036 | 28.4815 | 0.0937 | 2 | 8 | positive regulation of tumor necrosis factor biosynthetic process |
GO:0046324 | 0.0039 | 6.7669 | 0.6442 | 4 | 55 | regulation of glucose import |
GO:0001662 | 0.0046 | 9.9087 | 0.3397 | 3 | 29 | behavioral fear response |
GO:0002689 | 0.0046 | 24.4108 | 0.1054 | 2 | 9 | negative regulation of leukocyte chemotaxis |
GO:0002862 | 0.0046 | 24.4108 | 0.1054 | 2 | 9 | negative regulation of inflammatory response to antigenic stimulus |
GO:0015780 | 0.0046 | 24.4108 | 0.1054 | 2 | 9 | nucleotide-sugar transport |
GO:0046209 | 0.0047 | 6.3895 | 0.6793 | 4 | 58 | nitric oxide metabolic process |
GO:0022610 | 0.005 | 1.9535 | 12.2159 | 22 | 1043 | biological adhesion |
GO:0043270 | 0.0051 | 3.5492 | 2.0965 | 7 | 179 | positive regulation of ion transport |
GO:0006968 | 0.0056 | 9.1995 | 0.3631 | 3 | 31 | cellular defense response |
GO:0006837 | 0.0058 | 21.3578 | 0.1171 | 2 | 10 | serotonin transport |
GO:0009642 | 0.0058 | 21.3578 | 0.1171 | 2 | 10 | response to light intensity |
GO:0019896 | 0.0058 | 21.3578 | 0.1171 | 2 | 10 | axonal transport of mitochondrion |
GO:0008284 | 0.0064 | 2.1386 | 8.0112 | 16 | 684 | positive regulation of cell proliferation |
GO:0051952 | 0.0067 | 5.7479 | 0.7496 | 4 | 64 | regulation of amine transport |
GO:0045725 | 0.007 | 18.9833 | 0.1288 | 2 | 11 | positive regulation of glycogen biosynthetic process |
GO:0009617 | 0.007 | 2.6479 | 4.0056 | 10 | 342 | response to bacterium |
GO:0019217 | 0.007 | 5.6532 | 0.7613 | 4 | 65 | regulation of fatty acid metabolic process |
GO:0045429 | 0.0072 | 8.3073 | 0.3982 | 3 | 34 | positive regulation of nitric oxide biosynthetic process |
GO:0033993 | 0.0073 | 2.1087 | 8.1166 | 16 | 693 | response to lipid |
GO:0048731 | 0.0074 | 1.5379 | 42.7029 | 57 | 3646 | system development |
GO:0001819 | 0.0075 | 2.7873 | 3.42 | 9 | 292 | positive regulation of cytokine production |
GO:0051249 | 0.0079 | 2.7574 | 3.4551 | 9 | 295 | regulation of lymphocyte activation |
GO:1901623 | 0.0083 | 17.0837 | 0.1405 | 2 | 12 | regulation of lymphocyte chemotaxis |
GO:0002697 | 0.0084 | 2.9363 | 2.8812 | 8 | 246 | regulation of immune effector process |
GO:0002683 | 0.0085 | 2.7281 | 3.4903 | 9 | 298 | negative regulation of immune system process |
GO:0010676 | 0.0091 | 7.5726 | 0.4334 | 3 | 37 | positive regulation of cellular carbohydrate metabolic process |
GO:0006836 | 0.0092 | 3.5425 | 1.792 | 6 | 153 | neurotransmitter transport |
GO:1903039 | 0.0095 | 3.5183 | 1.8037 | 6 | 154 | positive regulation of leukocyte cell-cell adhesion |
GO:0097006 | 0.0096 | 5.1446 | 0.8316 | 4 | 71 | regulation of plasma lipoprotein particle levels |
GO:0014048 | 0.0098 | 15.5294 | 0.1523 | 2 | 13 | regulation of glutamate secretion |
GO:0006865 | 0.0098 | 4.0796 | 1.3001 | 5 | 111 | amino acid transport |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008628 | 0.0013 | 67.1959 | 0.0592 | 2 | 4 | hormone-mediated apoptotic signaling pathway |
GO:0045606 | 0.0019 | 14.4604 | 0.2518 | 3 | 17 | positive regulation of epidermal cell differentiation |
GO:0072359 | 0.0019 | 2.078 | 11.9519 | 23 | 807 | circulatory system development |
GO:0045682 | 0.0025 | 5.7587 | 0.9479 | 5 | 64 | regulation of epidermis development |
GO:0046503 | 0.0026 | 7.7399 | 0.5776 | 4 | 39 | glycerolipid catabolic process |
GO:0035360 | 0.0031 | 33.5928 | 0.0889 | 2 | 6 | positive regulation of peroxisome proliferator activated receptor signaling pathway |
GO:0071472 | 0.0031 | 33.5928 | 0.0889 | 2 | 6 | cellular response to salt stress |
GO:0032502 | 0.0033 | 1.5013 | 71.0896 | 90 | 4800 | developmental process |
GO:0050729 | 0.0042 | 5.068 | 1.0663 | 5 | 72 | positive regulation of inflammatory response |
GO:0010459 | 0.0044 | 26.8722 | 0.1037 | 2 | 7 | negative regulation of heart rate |
GO:0061085 | 0.0044 | 26.8722 | 0.1037 | 2 | 7 | regulation of histone H3-K27 methylation |
GO:0006954 | 0.0047 | 2.4331 | 5.674 | 13 | 391 | inflammatory response |
GO:0017148 | 0.0049 | 2.6417 | 4.4135 | 11 | 298 | negative regulation of translation |
GO:0048246 | 0.0051 | 9.6351 | 0.3554 | 3 | 24 | macrophage chemotaxis |
GO:0016045 | 0.0058 | 22.3918 | 0.1185 | 2 | 8 | detection of bacterium |
GO:1905205 | 0.0058 | 22.3918 | 0.1185 | 2 | 8 | positive regulation of connective tissue replacement |
GO:0050704 | 0.0058 | 9.1964 | 0.3703 | 3 | 25 | regulation of interleukin-1 secretion |
GO:0048514 | 0.0059 | 2.2774 | 6.5165 | 14 | 440 | blood vessel morphogenesis |
GO:0009888 | 0.0062 | 1.6799 | 21.9489 | 34 | 1482 | tissue development |
GO:0045616 | 0.0072 | 8.4288 | 0.3999 | 3 | 27 | regulation of keratinocyte differentiation |
GO:0045600 | 0.0073 | 5.638 | 0.7701 | 4 | 52 | positive regulation of fat cell differentiation |
GO:0016264 | 0.0073 | 19.1915 | 0.1333 | 2 | 9 | gap junction assembly |
GO:2000392 | 0.0073 | 19.1915 | 0.1333 | 2 | 9 | regulation of lamellipodium morphogenesis |
GO:0048839 | 0.0077 | 3.2704 | 2.266 | 7 | 153 | inner ear development |
GO:0050702 | 0.008 | 8.091 | 0.4147 | 3 | 28 | interleukin-1 beta secretion |
GO:0007275 | 0.0081 | 1.4474 | 60.7964 | 77 | 4105 | multicellular organism development |
GO:0032612 | 0.0083 | 5.4117 | 0.7998 | 4 | 54 | interleukin-1 production |
GO:0010744 | 0.0091 | 16.7912 | 0.1481 | 2 | 10 | positive regulation of macrophage derived foam cell differentiation |
GO:0010755 | 0.0091 | 16.7912 | 0.1481 | 2 | 10 | regulation of plasminogen activation |
GO:0046541 | 0.0091 | 16.7912 | 0.1481 | 2 | 10 | saliva secretion |
GO:0051770 | 0.0091 | 16.7912 | 0.1481 | 2 | 10 | positive regulation of nitric-oxide synthase biosynthetic process |
GO:0048583 | 0.0098 | 1.4698 | 45.4677 | 60 | 3070 | regulation of response to stimulus |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046425 | 1e-04 | 6.8052 | 1.1374 | 7 | 106 | regulation of JAK-STAT cascade |
GO:0031644 | 2e-04 | 10.1297 | 0.558 | 5 | 52 | regulation of neurological system process |
GO:0098916 | 2e-04 | 3.1373 | 5.2577 | 15 | 490 | anterograde trans-synaptic signaling |
GO:0099536 | 3e-04 | 3.1304 | 5.2684 | 15 | 491 | synaptic signaling |
GO:0048704 | 3e-04 | 7.2671 | 0.912 | 6 | 85 | embryonic skeletal system morphogenesis |
GO:0045987 | 3e-04 | 14.0258 | 0.3326 | 4 | 31 | positive regulation of smooth muscle contraction |
GO:0097696 | 4e-04 | 5.7502 | 1.3305 | 7 | 124 | STAT cascade |
GO:0007600 | 0.001 | 2.9604 | 4.7641 | 13 | 444 | sensory perception |
GO:0033141 | 0.0011 | 62.3286 | 0.0536 | 2 | 5 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
GO:0003008 | 0.0012 | 2.0992 | 13.8309 | 26 | 1289 | system process |
GO:0007204 | 0.0014 | 4.0325 | 2.1353 | 8 | 199 | positive regulation of cytosolic calcium ion concentration |
GO:0014059 | 0.0018 | 14.1065 | 0.2468 | 3 | 23 | regulation of dopamine secretion |
GO:0051930 | 0.0018 | 14.1065 | 0.2468 | 3 | 23 | regulation of sensory perception of pain |
GO:0051281 | 0.0021 | 13.4337 | 0.2575 | 3 | 24 | positive regulation of release of sequestered calcium ion into cytosol |
GO:2000252 | 0.0023 | 37.3914 | 0.0751 | 2 | 7 | negative regulation of feeding behavior |
GO:0007187 | 0.0028 | 4.6139 | 1.3949 | 6 | 130 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0048534 | 0.0029 | 2.3433 | 7.3929 | 16 | 689 | hematopoietic or lymphoid organ development |
GO:1901137 | 0.0029 | 2.4127 | 6.7169 | 15 | 626 | carbohydrate derivative biosynthetic process |
GO:0032769 | 0.0031 | 31.1571 | 0.0858 | 2 | 8 | negative regulation of monooxygenase activity |
GO:0006342 | 0.0039 | 5.1571 | 1.0408 | 5 | 97 | chromatin silencing |
GO:0031115 | 0.0039 | 26.7041 | 0.0966 | 2 | 9 | negative regulation of microtubule polymerization |
GO:0051239 | 0.0046 | 1.7164 | 24.3248 | 37 | 2267 | regulation of multicellular organismal process |
GO:0007610 | 0.0048 | 2.5348 | 5.0645 | 12 | 472 | behavior |
GO:0015872 | 0.0052 | 9.3971 | 0.3541 | 3 | 33 | dopamine transport |
GO:0009100 | 0.0055 | 2.7499 | 3.8735 | 10 | 361 | glycoprotein metabolic process |
GO:0051048 | 0.0057 | 3.9392 | 1.6202 | 6 | 151 | negative regulation of secretion |
GO:0002323 | 0.0059 | 20.7667 | 0.118 | 2 | 11 | natural killer cell activation involved in immune response |
GO:0019934 | 0.0059 | 20.7667 | 0.118 | 2 | 11 | cGMP-mediated signaling |
GO:0031643 | 0.0059 | 20.7667 | 0.118 | 2 | 11 | positive regulation of myelination |
GO:0070493 | 0.0059 | 20.7667 | 0.118 | 2 | 11 | thrombin-activated receptor signaling pathway |
GO:0050804 | 0.0059 | 3.1306 | 2.7147 | 8 | 253 | modulation of chemical synaptic transmission |
GO:2000010 | 0.007 | 18.6886 | 0.1288 | 2 | 12 | positive regulation of protein localization to cell surface |
GO:0007218 | 0.0071 | 5.6349 | 0.7618 | 4 | 71 | neuropeptide signaling pathway |
GO:0051928 | 0.0078 | 5.4707 | 0.7833 | 4 | 73 | positive regulation of calcium ion transport |
GO:0001696 | 0.0083 | 16.9883 | 0.1395 | 2 | 13 | gastric acid secretion |
GO:0098586 | 0.0083 | 7.8273 | 0.4185 | 3 | 39 | cellular response to virus |
GO:0051607 | 0.009 | 3.5658 | 1.7812 | 6 | 166 | defense response to virus |
GO:0002724 | 0.0096 | 15.5714 | 0.1502 | 2 | 14 | regulation of T cell cytokine production |
GO:0035067 | 0.0096 | 15.5714 | 0.1502 | 2 | 14 | negative regulation of histone acetylation |
GO:0039535 | 0.0096 | 15.5714 | 0.1502 | 2 | 14 | regulation of RIG-I signaling pathway |
GO:0050432 | 0.0096 | 7.4142 | 0.4399 | 3 | 41 | catecholamine secretion |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048731 | 0 | 2.0897 | 39.3969 | 63 | 3646 | system development |
GO:0032502 | 1e-04 | 1.8983 | 51.8664 | 74 | 4800 | developmental process |
GO:0030101 | 1e-04 | 11.8216 | 0.4862 | 5 | 45 | natural killer cell activation |
GO:0007186 | 1e-04 | 2.8631 | 7.391 | 19 | 684 | G-protein coupled receptor signaling pathway |
GO:0032501 | 3e-04 | 1.9553 | 39.5418 | 58 | 4101 | multicellular organismal process |
GO:0055078 | 3e-04 | 13.9238 | 0.335 | 4 | 31 | sodium ion homeostasis |
GO:0001906 | 3e-04 | 7.1228 | 0.9293 | 6 | 86 | cell killing |
GO:0003014 | 3e-04 | 7.1228 | 0.9293 | 6 | 86 | renal system process |
GO:0055075 | 4e-04 | 25.4805 | 0.1513 | 3 | 14 | potassium ion homeostasis |
GO:0048534 | 4e-04 | 2.6654 | 7.445 | 18 | 689 | hematopoietic or lymphoid organ development |
GO:0045596 | 5e-04 | 2.9087 | 5.6405 | 15 | 522 | negative regulation of cell differentiation |
GO:0048640 | 6e-04 | 8.1416 | 0.6807 | 5 | 63 | negative regulation of developmental growth |
GO:0008628 | 7e-04 | 92.8298 | 0.0432 | 2 | 4 | hormone-mediated apoptotic signaling pathway |
GO:0097039 | 7e-04 | 92.8298 | 0.0432 | 2 | 4 | protein linear polyubiquitination |
GO:0002449 | 9e-04 | 4.9397 | 1.5344 | 7 | 142 | lymphocyte mediated immunity |
GO:0045981 | 9e-04 | 5.8065 | 1.1238 | 6 | 104 | positive regulation of nucleotide metabolic process |
GO:0061117 | 0.0011 | 17.5112 | 0.2053 | 3 | 19 | negative regulation of heart growth |
GO:0002521 | 0.0012 | 3.2325 | 3.6739 | 11 | 340 | leukocyte differentiation |
GO:0034765 | 0.0014 | 3.1634 | 3.7495 | 11 | 347 | regulation of ion transmembrane transport |
GO:0007204 | 0.0014 | 4.0023 | 2.1503 | 8 | 199 | positive regulation of cytosolic calcium ion concentration |
GO:0042592 | 0.0015 | 2.0576 | 14.0688 | 26 | 1302 | homeostatic process |
GO:0046620 | 0.0015 | 6.4612 | 0.8428 | 5 | 78 | regulation of organ growth |
GO:0002250 | 0.0016 | 6.4224 | 0.8472 | 5 | 81 | adaptive immune response |
GO:0014741 | 0.0016 | 14.7429 | 0.2377 | 3 | 22 | negative regulation of muscle hypertrophy |
GO:0001775 | 0.0017 | 2.2048 | 10.4705 | 21 | 969 | cell activation |
GO:0051340 | 0.0017 | 46.4078 | 0.0648 | 2 | 6 | regulation of ligase activity |
GO:0060297 | 0.0017 | 46.4078 | 0.0648 | 2 | 6 | regulation of sarcomere organization |
GO:0060373 | 0.0017 | 46.4078 | 0.0648 | 2 | 6 | regulation of ventricular cardiac muscle cell membrane depolarization |
GO:0061052 | 0.0017 | 46.4078 | 0.0648 | 2 | 6 | negative regulation of cell growth involved in cardiac muscle cell development |
GO:0007155 | 0.0017 | 2.1586 | 11.2269 | 22 | 1039 | cell adhesion |
GO:0050776 | 0.0018 | 2.4754 | 7.0236 | 16 | 650 | regulation of immune response |
GO:0019933 | 0.0019 | 6.1237 | 0.8861 | 5 | 82 | cAMP-mediated signaling |
GO:0010562 | 0.0021 | 2.2462 | 9.2387 | 19 | 855 | positive regulation of phosphorus metabolic process |
GO:0007585 | 0.0022 | 7.9865 | 0.5511 | 4 | 51 | respiratory gaseous exchange |
GO:0007159 | 0.0023 | 3.3809 | 2.8527 | 9 | 264 | leukocyte cell-cell adhesion |
GO:0023035 | 0.0023 | 37.1234 | 0.0756 | 2 | 7 | CD40 signaling pathway |
GO:0045188 | 0.0023 | 37.1234 | 0.0756 | 2 | 7 | regulation of circadian sleep/wake cycle, non-REM sleep |
GO:0009566 | 0.0024 | 4.7339 | 1.3615 | 6 | 126 | fertilization |
GO:0044703 | 0.0026 | 2.3046 | 8.0069 | 17 | 741 | multi-organism reproductive process |
GO:0071417 | 0.0027 | 2.7433 | 4.7004 | 12 | 435 | cellular response to organonitrogen compound |
GO:0000003 | 0.0028 | 2.0679 | 11.6699 | 22 | 1080 | reproduction |
GO:0055082 | 0.0028 | 2.5079 | 6.0187 | 14 | 557 | cellular chemical homeostasis |
GO:0050878 | 0.0029 | 2.8492 | 4.1385 | 11 | 383 | regulation of body fluid levels |
GO:0072507 | 0.003 | 3.0201 | 3.5442 | 10 | 328 | divalent inorganic cation homeostasis |
GO:0050863 | 0.003 | 3.5322 | 2.4204 | 8 | 224 | regulation of T cell activation |
GO:0030003 | 0.003 | 2.6972 | 4.776 | 12 | 442 | cellular cation homeostasis |
GO:0019932 | 0.0031 | 3.5157 | 2.4312 | 8 | 225 | second-messenger-mediated signaling |
GO:0050852 | 0.0031 | 4.5064 | 1.4263 | 6 | 132 | T cell receptor signaling pathway |
GO:0098655 | 0.0032 | 2.3854 | 6.7859 | 15 | 628 | cation transmembrane transport |
GO:0097553 | 0.0033 | 5.3537 | 1.0049 | 5 | 93 | calcium ion transmembrane import into cytosol |
GO:0002460 | 0.0034 | 4.4006 | 1.4587 | 6 | 135 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
GO:0002253 | 0.0034 | 2.7875 | 4.225 | 11 | 391 | activation of immune response |
GO:0071407 | 0.0036 | 2.64 | 4.8733 | 12 | 451 | cellular response to organic cyclic compound |
GO:0055026 | 0.0037 | 10.7679 | 0.3134 | 3 | 29 | negative regulation of cardiac muscle tissue development |
GO:0017187 | 0.004 | 26.5127 | 0.0972 | 2 | 9 | peptidyl-glutamic acid carboxylation |
GO:0033148 | 0.004 | 26.5127 | 0.0972 | 2 | 9 | positive regulation of intracellular estrogen receptor signaling pathway |
GO:0045759 | 0.004 | 26.5127 | 0.0972 | 2 | 9 | negative regulation of action potential |
GO:0002694 | 0.0042 | 2.8718 | 3.7171 | 10 | 344 | regulation of leukocyte activation |
GO:0050900 | 0.0045 | 3.0288 | 3.166 | 9 | 293 | leukocyte migration |
GO:0008037 | 0.0045 | 4.9565 | 1.0806 | 5 | 100 | cell recognition |
GO:0032879 | 0.0046 | 1.7374 | 22.6159 | 35 | 2093 | regulation of localization |
GO:0006874 | 0.0046 | 3.0179 | 3.1768 | 9 | 294 | cellular calcium ion homeostasis |
GO:0002762 | 0.0049 | 9.6517 | 0.3458 | 3 | 32 | negative regulation of myeloid leukocyte differentiation |
GO:2000725 | 0.0049 | 9.6517 | 0.3458 | 3 | 32 | regulation of cardiac muscle cell differentiation |
GO:0036166 | 0.0049 | 23.1968 | 0.1081 | 2 | 10 | phenotypic switching |
GO:0006813 | 0.005 | 3.5711 | 2.0855 | 7 | 193 | potassium ion transport |
GO:0030816 | 0.005 | 6.2499 | 0.6916 | 4 | 64 | positive regulation of cAMP metabolic process |
GO:0046165 | 0.0056 | 4.7069 | 1.1346 | 5 | 105 | alcohol biosynthetic process |
GO:0031113 | 0.0058 | 9.0276 | 0.3674 | 3 | 34 | regulation of microtubule polymerization |
GO:1900542 | 0.0062 | 3.4217 | 2.1719 | 7 | 201 | regulation of purine nucleotide metabolic process |
GO:0048870 | 0.0062 | 1.919 | 12.4804 | 22 | 1155 | cell motility |
GO:0001910 | 0.0063 | 8.7449 | 0.3782 | 3 | 35 | regulation of leukocyte mediated cytotoxicity |
GO:0035036 | 0.0063 | 8.7449 | 0.3782 | 3 | 35 | sperm-egg recognition |
GO:0008285 | 0.0063 | 2.3515 | 5.9106 | 13 | 547 | negative regulation of cell proliferation |
GO:0003008 | 0.0065 | 1.9163 | 12.5351 | 22 | 1203 | system process |
GO:0097756 | 0.0066 | 5.7669 | 0.7456 | 4 | 69 | negative regulation of blood vessel diameter |
GO:0022407 | 0.0067 | 2.8442 | 3.3605 | 9 | 311 | regulation of cell-cell adhesion |
GO:0042113 | 0.0067 | 3.804 | 1.6749 | 6 | 155 | B cell activation |
GO:0006959 | 0.0068 | 4.481 | 1.1886 | 5 | 110 | humoral immune response |
GO:0002643 | 0.0071 | 18.5546 | 0.1297 | 2 | 12 | regulation of tolerance induction |
GO:2000021 | 0.0076 | 3.7034 | 1.7181 | 6 | 159 | regulation of ion homeostasis |
GO:0007188 | 0.0079 | 4.3153 | 1.2318 | 5 | 114 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GO:0048609 | 0.0081 | 2.2016 | 6.7967 | 14 | 629 | multicellular organismal reproductive process |
GO:0035810 | 0.0084 | 16.8665 | 0.1405 | 2 | 13 | positive regulation of urine volume |
GO:0048012 | 0.0084 | 16.8665 | 0.1405 | 2 | 13 | hepatocyte growth factor receptor signaling pathway |
GO:1904754 | 0.0084 | 16.8665 | 0.1405 | 2 | 13 | positive regulation of vascular associated smooth muscle cell migration |
GO:0002027 | 0.0084 | 5.3529 | 0.7996 | 4 | 74 | regulation of heart rate |
GO:0009605 | 0.0085 | 1.7588 | 16.8242 | 27 | 1557 | response to external stimulus |
GO:0002703 | 0.0091 | 4.1612 | 1.275 | 5 | 118 | regulation of leukocyte mediated immunity |
GO:0007077 | 0.0091 | 7.5602 | 0.4322 | 3 | 40 | mitotic nuclear envelope disassembly |
GO:1901698 | 0.0091 | 2.0112 | 9.0766 | 17 | 840 | response to nitrogen compound |
GO:0071805 | 0.0095 | 3.5173 | 1.8045 | 6 | 167 | potassium ion transmembrane transport |
GO:0042327 | 0.0096 | 2.0441 | 8.3851 | 16 | 776 | positive regulation of phosphorylation |
GO:0010447 | 0.0097 | 15.4598 | 0.1513 | 2 | 14 | response to acidic pH |
GO:0050965 | 0.0097 | 15.4598 | 0.1513 | 2 | 14 | detection of temperature stimulus involved in sensory perception of pain |
GO:0060401 | 0.0097 | 4.0882 | 1.2967 | 5 | 120 | cytosolic calcium ion transport |
GO:0042267 | 0.0098 | 7.3607 | 0.443 | 3 | 41 | natural killer cell mediated cytotoxicity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048731 | 2e-04 | 1.6497 | 62.5391 | 87 | 3646 | system development |
GO:0007156 | 3e-04 | 4.5879 | 2.1441 | 9 | 125 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0060142 | 6e-04 | 12.2615 | 0.3945 | 4 | 23 | regulation of syncytium formation by plasma membrane fusion |
GO:0006928 | 6e-04 | 1.8143 | 26.8613 | 44 | 1566 | movement of cell or subcellular component |
GO:0090132 | 8e-04 | 3.3635 | 3.5163 | 11 | 205 | epithelium migration |
GO:0051122 | 0.0017 | 57.8 | 0.0686 | 2 | 4 | hepoxilin biosynthetic process |
GO:0097176 | 0.0017 | 57.8 | 0.0686 | 2 | 4 | epoxide metabolic process |
GO:0010632 | 0.0018 | 3.5149 | 2.7444 | 9 | 160 | regulation of epithelial cell migration |
GO:0019372 | 0.0019 | 14.5033 | 0.2573 | 3 | 15 | lipoxygenase pathway |
GO:0050793 | 0.0023 | 1.6362 | 33.7052 | 50 | 1965 | regulation of developmental process |
GO:0051674 | 0.0025 | 1.8018 | 19.8115 | 33 | 1155 | localization of cell |
GO:2000507 | 0.0028 | 38.5304 | 0.0858 | 2 | 5 | positive regulation of energy homeostasis |
GO:2000818 | 0.0028 | 38.5304 | 0.0858 | 2 | 5 | negative regulation of myoblast proliferation |
GO:0048240 | 0.0028 | 12.4295 | 0.2916 | 3 | 17 | sperm capacitation |
GO:0001667 | 0.0032 | 2.6632 | 4.7856 | 12 | 279 | ameboidal-type cell migration |
GO:0006805 | 0.0034 | 5.4025 | 1.012 | 5 | 59 | xenobiotic metabolic process |
GO:1901741 | 0.0034 | 11.6 | 0.3088 | 3 | 18 | positive regulation of myoblast fusion |
GO:0043535 | 0.0039 | 5.2087 | 1.0463 | 5 | 61 | regulation of blood vessel endothelial cell migration |
GO:1900117 | 0.0039 | 10.8742 | 0.3259 | 3 | 19 | regulation of execution phase of apoptosis |
GO:0006334 | 0.004 | 3.7305 | 2.0069 | 7 | 117 | nucleosome assembly |
GO:0048771 | 0.004 | 3.7305 | 2.0069 | 7 | 117 | tissue remodeling |
GO:0015917 | 0.0042 | 28.8956 | 0.1029 | 2 | 6 | aminophospholipid transport |
GO:0035360 | 0.0042 | 28.8956 | 0.1029 | 2 | 6 | positive regulation of peroxisome proliferator activated receptor signaling pathway |
GO:0043416 | 0.0042 | 28.8956 | 0.1029 | 2 | 6 | regulation of skeletal muscle tissue regeneration |
GO:1904995 | 0.0042 | 28.8956 | 0.1029 | 2 | 6 | negative regulation of leukocyte adhesion to vascular endothelial cell |
GO:0048646 | 0.0047 | 1.8892 | 13.5613 | 24 | 802 | anatomical structure formation involved in morphogenesis |
GO:0098609 | 0.0048 | 2.0049 | 10.6004 | 20 | 618 | cell-cell adhesion |
GO:0071157 | 0.0053 | 9.6644 | 0.3602 | 3 | 21 | negative regulation of cell cycle arrest |
GO:0006333 | 0.0053 | 3.1957 | 2.6587 | 8 | 155 | chromatin assembly or disassembly |
GO:2000145 | 0.0055 | 1.9806 | 10.7205 | 20 | 625 | regulation of cell motility |
GO:0009410 | 0.0058 | 4.7025 | 1.1492 | 5 | 67 | response to xenobiotic stimulus |
GO:0061085 | 0.0058 | 23.1147 | 0.1201 | 2 | 7 | regulation of histone H3-K27 methylation |
GO:2000510 | 0.0058 | 23.1147 | 0.1201 | 2 | 7 | positive regulation of dendritic cell chemotaxis |
GO:0042060 | 0.0058 | 2.2072 | 7.187 | 15 | 419 | wound healing |
GO:0030335 | 0.006 | 2.3482 | 5.8491 | 13 | 341 | positive regulation of cell migration |
GO:0071674 | 0.0062 | 5.9644 | 0.7376 | 4 | 43 | mononuclear cell migration |
GO:0010092 | 0.0068 | 8.6967 | 0.3945 | 3 | 23 | specification of animal organ identity |
GO:2000404 | 0.0068 | 8.6967 | 0.3945 | 3 | 23 | regulation of T cell migration |
GO:0032501 | 0.0073 | 1.4088 | 88.7413 | 107 | 5291 | multicellular organismal process |
GO:0047484 | 0.0077 | 19.2607 | 0.1372 | 2 | 8 | regulation of response to osmotic stress |
GO:0006949 | 0.0078 | 5.537 | 0.789 | 4 | 46 | syncytium formation |
GO:0002688 | 0.0078 | 4.3499 | 1.235 | 5 | 72 | regulation of leukocyte chemotaxis |
GO:0045765 | 0.0081 | 2.741 | 3.4649 | 9 | 202 | regulation of angiogenesis |
GO:0035023 | 0.0082 | 3.6513 | 1.7496 | 6 | 102 | regulation of Rho protein signal transduction |
GO:0045597 | 0.0083 | 1.8395 | 12.6759 | 22 | 739 | positive regulation of cell differentiation |
GO:0030049 | 0.0087 | 7.9048 | 0.4288 | 3 | 25 | muscle filament sliding |
GO:0040011 | 0.0088 | 1.6167 | 23.2077 | 35 | 1353 | locomotion |
GO:0048514 | 0.009 | 2.0947 | 7.5472 | 15 | 440 | blood vessel morphogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0051251 | 1e-04 | 4.9214 | 2.2342 | 10 | 192 | positive regulation of lymphocyte activation |
GO:0050867 | 3e-04 | 4.1751 | 2.6066 | 10 | 224 | positive regulation of cell activation |
GO:0008588 | 4e-04 | 172.0921 | 0.0349 | 2 | 3 | release of cytoplasmic sequestered NF-kappaB |
GO:0022610 | 4e-04 | 2.2963 | 12.1371 | 25 | 1043 | biological adhesion |
GO:1903039 | 4e-04 | 4.8542 | 1.7921 | 8 | 154 | positive regulation of leukocyte cell-cell adhesion |
GO:0045747 | 6e-04 | 12.0009 | 0.384 | 4 | 33 | positive regulation of Notch signaling pathway |
GO:0048731 | 7e-04 | 1.7372 | 42.4274 | 61 | 3646 | system development |
GO:0048523 | 9e-04 | 1.713 | 43.6958 | 62 | 3755 | negative regulation of cellular process |
GO:0007165 | 0.0012 | 1.6743 | 50.5032 | 69 | 4340 | signal transduction |
GO:0050863 | 0.0012 | 3.714 | 2.6066 | 9 | 224 | regulation of T cell activation |
GO:0051241 | 0.0014 | 2.2845 | 9.5754 | 20 | 833 | negative regulation of multicellular organismal process |
GO:0051125 | 0.0018 | 14.4172 | 0.2444 | 3 | 21 | regulation of actin nucleation |
GO:0031295 | 0.0018 | 8.4807 | 0.5237 | 4 | 45 | T cell costimulation |
GO:0048706 | 0.002 | 4.962 | 1.3033 | 6 | 112 | embryonic skeletal system development |
GO:1903243 | 0.002 | 43.0132 | 0.0698 | 2 | 6 | negative regulation of cardiac muscle hypertrophy in response to stress |
GO:0045785 | 0.0022 | 3.1516 | 3.3979 | 10 | 292 | positive regulation of cell adhesion |
GO:0002694 | 0.0023 | 2.9446 | 4.003 | 11 | 344 | regulation of leukocyte activation |
GO:0006955 | 0.0025 | 1.9414 | 15.3372 | 27 | 1318 | immune response |
GO:0002830 | 0.0027 | 34.4079 | 0.0815 | 2 | 7 | positive regulation of type 2 immune response |
GO:0009653 | 0.0031 | 1.9953 | 13.3079 | 24 | 1212 | anatomical structure morphogenesis |
GO:0022407 | 0.0035 | 2.9483 | 3.619 | 10 | 311 | regulation of cell-cell adhesion |
GO:0046629 | 0.0036 | 28.6711 | 0.0931 | 2 | 8 | gamma-delta T cell activation |
GO:0060534 | 0.0036 | 28.6711 | 0.0931 | 2 | 8 | trachea cartilage development |
GO:0032501 | 0.0039 | 1.6226 | 48.6237 | 64 | 4564 | multicellular organismal process |
GO:0035194 | 0.0041 | 3.3419 | 2.5484 | 8 | 219 | posttranscriptional gene silencing by RNA |
GO:0048167 | 0.0041 | 4.2358 | 1.5128 | 6 | 130 | regulation of synaptic plasticity |
GO:0008283 | 0.0043 | 1.8036 | 18.3511 | 30 | 1577 | cell proliferation |
GO:0046950 | 0.0046 | 24.5733 | 0.1047 | 2 | 9 | cellular ketone body metabolic process |
GO:0009952 | 0.0047 | 3.6162 | 2.0597 | 7 | 177 | anterior/posterior pattern specification |
GO:1901342 | 0.0047 | 3.2633 | 2.6066 | 8 | 224 | regulation of vasculature development |
GO:0048583 | 0.0052 | 1.6015 | 35.7246 | 50 | 3070 | regulation of response to stimulus |
GO:0045746 | 0.0055 | 9.2611 | 0.3607 | 3 | 31 | negative regulation of Notch signaling pathway |
GO:1902224 | 0.0057 | 21.5 | 0.1164 | 2 | 10 | ketone body metabolic process |
GO:2001241 | 0.0057 | 21.5 | 0.1164 | 2 | 10 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand |
GO:0042345 | 0.006 | 8.9411 | 0.3724 | 3 | 32 | regulation of NF-kappaB import into nucleus |
GO:0045744 | 0.006 | 8.9411 | 0.3724 | 3 | 32 | negative regulation of G-protein coupled receptor protein signaling pathway |
GO:0043123 | 0.0061 | 3.8874 | 1.6408 | 6 | 141 | positive regulation of I-kappaB kinase/NF-kappaB signaling |
GO:0002684 | 0.0063 | 2.1441 | 7.9944 | 16 | 687 | positive regulation of immune system process |
GO:0030155 | 0.0064 | 4.5469 | 1.1736 | 5 | 106 | regulation of cell adhesion |
GO:0034314 | 0.0065 | 8.6424 | 0.384 | 3 | 33 | Arp2/3 complex-mediated actin nucleation |
GO:0042993 | 0.0065 | 8.6424 | 0.384 | 3 | 33 | positive regulation of transcription factor import into nucleus |
GO:0022414 | 0.0069 | 1.8958 | 12.556 | 22 | 1079 | reproductive process |
GO:0042475 | 0.0069 | 5.6914 | 0.7564 | 4 | 65 | odontogenesis of dentin-containing tooth |
GO:0014745 | 0.0069 | 19.1096 | 0.128 | 2 | 11 | negative regulation of muscle adaptation |
GO:0032103 | 0.0078 | 3.2655 | 2.2692 | 7 | 195 | positive regulation of response to external stimulus |
GO:0031623 | 0.0081 | 5.4233 | 0.7913 | 4 | 68 | receptor internalization |
GO:0017148 | 0.0081 | 2.7471 | 3.4677 | 9 | 298 | negative regulation of translation |
GO:0051093 | 0.0083 | 2.0756 | 8.2388 | 16 | 708 | negative regulation of developmental process |
GO:0032502 | 0.0083 | 1.6919 | 24.7141 | 36 | 2473 | developmental process |
GO:0032720 | 0.0083 | 7.8549 | 0.4189 | 3 | 36 | negative regulation of tumor necrosis factor production |
GO:0021766 | 0.0089 | 5.2582 | 0.8146 | 4 | 70 | hippocampus development |
GO:0045638 | 0.0089 | 5.2582 | 0.8146 | 4 | 70 | negative regulation of myeloid cell differentiation |
GO:0072148 | 0.0096 | 15.6328 | 0.1513 | 2 | 13 | epithelial cell fate commitment |
GO:0042551 | 0.0097 | 7.4049 | 0.4422 | 3 | 38 | neuron maturation |
GO:0048646 | 0.0097 | 1.9534 | 9.8679 | 18 | 848 | anatomical structure formation involved in morphogenesis |
GO:0045766 | 0.0099 | 4.0686 | 1.3033 | 5 | 112 | positive regulation of angiogenesis |
GO:0030154 | 0.01 | 1.5335 | 36.9116 | 50 | 3172 | cell differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004930 | 0.0022 | 2.9687 | 3.9699 | 11 | 336 | G-protein coupled receptor activity |
GO:0004896 | 0.0035 | 6.9799 | 0.6262 | 4 | 53 | cytokine receptor activity |
GO:0030547 | 0.0085 | 16.9303 | 0.1418 | 2 | 12 | receptor inhibitor activity |
GO:0005452 | 0.0099 | 15.39 | 0.1536 | 2 | 13 | inorganic anion exchanger activity |
GO:0097493 | 0.0099 | 15.39 | 0.1536 | 2 | 13 | structural molecule activity conferring elasticity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0043546 | 0 | 216.4647 | 0.0922 | 4 | 5 | molybdopterin cofactor binding |
GO:0030151 | 0 | 161.6777 | 0.0738 | 3 | 4 | molybdenum ion binding |
GO:0016165 | 3e-04 | Inf | 0.0369 | 2 | 2 | linoleate 13S-lipoxygenase activity |
GO:0008940 | 0.001 | 107.3416 | 0.0553 | 2 | 3 | nitrate reductase activity |
GO:0005201 | 0.0013 | 6.8277 | 0.8232 | 5 | 45 | extracellular matrix structural constituent |
GO:0015247 | 0.0033 | 35.775 | 0.0922 | 2 | 5 | aminophospholipid transporter activity |
GO:0030020 | 0.0033 | 35.775 | 0.0922 | 2 | 5 | extracellular matrix structural constituent conferring tensile strength |
GO:0016701 | 0.0035 | 11.5369 | 0.3134 | 3 | 17 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen |
GO:0047617 | 0.0035 | 11.5369 | 0.3134 | 3 | 17 | acyl-CoA hydrolase activity |
GO:0005179 | 0.004 | 5.1648 | 1.0577 | 5 | 58 | hormone activity |
GO:0005184 | 0.0041 | 10.7669 | 0.3319 | 3 | 18 | neuropeptide hormone activity |
GO:0005164 | 0.0056 | 9.4988 | 0.3688 | 3 | 20 | tumor necrosis factor receptor binding |
GO:1901612 | 0.0067 | 21.4617 | 0.1291 | 2 | 7 | cardiolipin binding |
GO:0102991 | 0.0088 | 17.8834 | 0.1475 | 2 | 8 | myristoyl-CoA hydrolase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004930 | 0 | 6.6812 | 2.4708 | 14 | 335 | G-protein coupled receptor activity |
GO:0038023 | 0 | 4.231 | 5.3642 | 19 | 720 | signaling receptor activity |
GO:0099600 | 0 | 4.2868 | 4.9768 | 18 | 668 | transmembrane receptor activity |
GO:0004984 | 0 | 17.6626 | 0.4023 | 6 | 54 | olfactory receptor activity |
GO:0060089 | 0 | 3.5112 | 6.7575 | 20 | 907 | molecular transducer activity |
GO:0071723 | 3e-04 | 135.9485 | 0.0298 | 2 | 4 | lipopeptide binding |
GO:0001530 | 0.0069 | 18.1086 | 0.1267 | 2 | 17 | lipopolysaccharide binding |
GO:0001856 | 0.0075 | Inf | 0.0075 | 1 | 1 | complement component C5a binding |
GO:0003858 | 0.0075 | Inf | 0.0075 | 1 | 1 | 3-hydroxybutyrate dehydrogenase activity |
GO:0004878 | 0.0075 | Inf | 0.0075 | 1 | 1 | complement component C5a receptor activity |
GO:0005550 | 0.0075 | Inf | 0.0075 | 1 | 1 | pheromone binding |
GO:0016501 | 0.0075 | Inf | 0.0075 | 1 | 1 | prostacyclin receptor activity |
GO:0017020 | 0.0075 | Inf | 0.0075 | 1 | 1 | myosin phosphatase regulator activity |
GO:0033791 | 0.0075 | Inf | 0.0075 | 1 | 1 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity |
GO:0038182 | 0.0075 | Inf | 0.0075 | 1 | 1 | G-protein coupled bile acid receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005094 | 4e-04 | 172.8026 | 0.0348 | 2 | 3 | Rho GDP-dissociation inhibitor activity |
GO:0043565 | 8e-04 | 2.304 | 10.5232 | 22 | 908 | sequence-specific DNA binding |
GO:0048027 | 9e-04 | 18.6187 | 0.197 | 3 | 17 | mRNA 5'-UTR binding |
GO:0003779 | 0.0011 | 3.2685 | 3.6275 | 11 | 313 | actin binding |
GO:0000979 | 0.0028 | 7.4252 | 0.5911 | 4 | 51 | RNA polymerase II core promoter sequence-specific DNA binding |
GO:0005509 | 0.0066 | 2.3345 | 5.9338 | 13 | 512 | calcium ion binding |
GO:0042923 | 0.0096 | 15.6974 | 0.1507 | 2 | 13 | neuropeptide binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005094 | 3e-04 | 205.5781 | 0.0293 | 2 | 3 | Rho GDP-dissociation inhibitor activity |
GO:0030246 | 0.0019 | 4.2716 | 1.761 | 7 | 180 | carbohydrate binding |
GO:0001846 | 0.0049 | 22.8281 | 0.1076 | 2 | 11 | opsonin binding |
GO:0005070 | 0.006 | 8.8569 | 0.3718 | 3 | 38 | SH3/SH2 adaptor activity |
GO:0033293 | 0.0074 | 8.1558 | 0.4011 | 3 | 41 | monocarboxylic acid binding |
GO:1903231 | 0.0075 | 5.5378 | 0.7729 | 4 | 79 | mRNA binding involved in posttranscriptional gene silencing |
GO:0005159 | 0.008 | 17.1172 | 0.137 | 2 | 14 | insulin-like growth factor receptor binding |
GO:0008092 | 0.0093 | 2.1708 | 6.9168 | 14 | 707 | cytoskeletal protein binding |
GO:0001604 | 0.0098 | Inf | 0.0098 | 1 | 1 | urotensin II receptor activity |
GO:0003937 | 0.0098 | Inf | 0.0098 | 1 | 1 | IMP cyclohydrolase activity |
GO:0004137 | 0.0098 | Inf | 0.0098 | 1 | 1 | deoxycytidine kinase activity |
GO:0004643 | 0.0098 | Inf | 0.0098 | 1 | 1 | phosphoribosylaminoimidazolecarboxamide formyltransferase activity |
GO:0004982 | 0.0098 | Inf | 0.0098 | 1 | 1 | N-formyl peptide receptor activity |
GO:0005124 | 0.0098 | Inf | 0.0098 | 1 | 1 | scavenger receptor binding |
GO:0005147 | 0.0098 | Inf | 0.0098 | 1 | 1 | oncostatin-M receptor binding |
GO:0008579 | 0.0098 | Inf | 0.0098 | 1 | 1 | JUN kinase phosphatase activity |
GO:0035755 | 0.0098 | Inf | 0.0098 | 1 | 1 | cardiolipin hydrolase activity |
GO:0036487 | 0.0098 | Inf | 0.0098 | 1 | 1 | nitric-oxide synthase inhibitor activity |
GO:0039552 | 0.0098 | Inf | 0.0098 | 1 | 1 | RIG-I binding |
GO:0045485 | 0.0098 | Inf | 0.0098 | 1 | 1 | omega-6 fatty acid desaturase activity |
GO:0047305 | 0.0098 | Inf | 0.0098 | 1 | 1 | (R)-3-amino-2-methylpropionate-pyruvate transaminase activity |
GO:0047747 | 0.0098 | Inf | 0.0098 | 1 | 1 | cholate-CoA ligase activity |
GO:0050429 | 0.0098 | Inf | 0.0098 | 1 | 1 | calcium-dependent phospholipase C activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005509 | 2e-04 | 2.8908 | 6.4347 | 17 | 512 | calcium ion binding |
GO:0030545 | 5e-04 | 3.4014 | 3.8206 | 12 | 304 | receptor regulator activity |
GO:0005088 | 6e-04 | 4.5968 | 1.8862 | 8 | 153 | Ras guanyl-nucleotide exchange factor activity |
GO:0008083 | 7e-04 | 5.1278 | 1.483 | 7 | 118 | growth factor activity |
GO:0031267 | 0.002 | 2.6005 | 5.7812 | 14 | 460 | small GTPase binding |
GO:0001106 | 0.0033 | 11.4111 | 0.3016 | 3 | 24 | RNA polymerase II transcription corepressor activity |
GO:0031406 | 0.0069 | 3.7829 | 1.6841 | 6 | 134 | carboxylic acid binding |
GO:0098772 | 0.0076 | 1.877 | 12.666 | 22 | 1061 | molecular function regulator |
GO:0005089 | 0.0095 | 5.1688 | 0.8295 | 4 | 66 | Rho guanyl-nucleotide exchange factor activity |
GO:0016594 | 0.0095 | 15.8921 | 0.1508 | 2 | 12 | glycine binding |
GO:0030247 | 0.0095 | 15.8921 | 0.1508 | 2 | 12 | polysaccharide binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004930 | 1e-04 | 3.0764 | 6.3721 | 18 | 336 | G-protein coupled receptor activity |
GO:0099600 | 2e-04 | 2.3204 | 12.6683 | 27 | 668 | transmembrane receptor activity |
GO:0038023 | 6e-04 | 2.1373 | 13.6544 | 27 | 720 | signaling receptor activity |
GO:0003677 | 0.001 | 1.6404 | 40.6978 | 60 | 2146 | DNA binding |
GO:0060089 | 0.001 | 1.9471 | 17.2008 | 31 | 907 | molecular transducer activity |
GO:0097108 | 0.0011 | 104.28 | 0.0569 | 2 | 3 | hedgehog family protein binding |
GO:0000977 | 0.0014 | 2.2013 | 10.2029 | 21 | 538 | RNA polymerase II regulatory region sequence-specific DNA binding |
GO:0000981 | 0.002 | 2.0255 | 12.6683 | 24 | 668 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
GO:0046982 | 0.0022 | 2.3211 | 7.7944 | 17 | 411 | protein heterodimerization activity |
GO:1990837 | 0.0028 | 2.0012 | 12.2511 | 23 | 646 | sequence-specific double-stranded DNA binding |
GO:0004364 | 0.0031 | 12.0695 | 0.3034 | 3 | 16 | glutathione transferase activity |
GO:0004653 | 0.0031 | 12.0695 | 0.3034 | 3 | 16 | polypeptide N-acetylgalactosaminyltransferase activity |
GO:0001047 | 0.0052 | 3.2052 | 2.655 | 8 | 140 | core promoter binding |
GO:0005005 | 0.0071 | 20.8496 | 0.1328 | 2 | 7 | transmembrane-ephrin receptor activity |
GO:0031492 | 0.0074 | 5.6665 | 0.7775 | 4 | 41 | nucleosomal DNA binding |
GO:0003831 | 0.0093 | 17.3733 | 0.1517 | 2 | 8 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity |
GO:0015556 | 0.0093 | 17.3733 | 0.1517 | 2 | 8 | C4-dicarboxylate transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004303 | 2e-04 | 38.5559 | 0.1172 | 3 | 9 | estradiol 17-beta-dehydrogenase activity |
GO:0004095 | 0.001 | 76.6842 | 0.0521 | 2 | 4 | carnitine O-palmitoyltransferase activity |
GO:0005070 | 0.0015 | 9.1062 | 0.4947 | 4 | 38 | SH3/SH2 adaptor activity |
GO:0008374 | 0.0015 | 9.1062 | 0.4947 | 4 | 38 | O-acyltransferase activity |
GO:0016229 | 0.0015 | 15.4118 | 0.2343 | 3 | 18 | steroid dehydrogenase activity |
GO:0005509 | 0.0028 | 2.4103 | 6.6659 | 15 | 512 | calcium ion binding |
GO:0016616 | 0.005 | 4.8493 | 1.1066 | 5 | 85 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor |
GO:0004953 | 0.0057 | 21.9014 | 0.1172 | 2 | 9 | icosanoid receptor activity |
GO:0005229 | 0.0071 | 19.1623 | 0.1302 | 2 | 10 | intracellular calcium activated chloride channel activity |
GO:0015271 | 0.0071 | 19.1623 | 0.1302 | 2 | 10 | outward rectifier potassium channel activity |
GO:0003823 | 0.0082 | 7.9631 | 0.4166 | 3 | 32 | antigen binding |
GO:0017124 | 0.0098 | 4.0789 | 1.3019 | 5 | 100 | SH3 domain binding |
GO:0005539 | 0.01 | 3.4805 | 1.8227 | 6 | 140 | glycosaminoglycan binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0099600 | 0 | 2.8308 | 10.2553 | 26 | 668 | transmembrane receptor activity |
GO:0060089 | 0 | 2.4972 | 13.9244 | 31 | 907 | molecular transducer activity |
GO:0038023 | 0 | 2.6077 | 11.0536 | 26 | 720 | signaling receptor activity |
GO:0004930 | 1e-04 | 3.3947 | 5.1583 | 16 | 336 | G-protein coupled receptor activity |
GO:0004977 | 0.0014 | 64.7624 | 0.0614 | 2 | 4 | melanocortin receptor activity |
GO:0005179 | 0.0018 | 6.2649 | 0.8785 | 5 | 58 | hormone activity |
GO:0005184 | 0.0025 | 13.004 | 0.2763 | 3 | 18 | neuropeptide hormone activity |
GO:0015079 | 0.0039 | 3.7443 | 1.9958 | 7 | 130 | potassium ion transmembrane transporter activity |
GO:0005221 | 0.0047 | 25.899 | 0.1075 | 2 | 7 | intracellular cyclic nucleotide activated cation channel activity |
GO:0015267 | 0.0088 | 2.3216 | 5.45 | 12 | 355 | channel activity |
GO:0005154 | 0.0097 | 7.496 | 0.4452 | 3 | 29 | epidermal growth factor receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004556 | 0 | Inf | 0.0366 | 3 | 3 | alpha-amylase activity |
GO:0103025 | 0 | Inf | 0.0366 | 3 | 3 | alpha-amylase activity (releasing maltohexaose) |
GO:0015079 | 2e-04 | 5.5372 | 1.5849 | 8 | 130 | potassium ion transmembrane transporter activity |
GO:0099104 | 9e-04 | 82.025 | 0.0488 | 2 | 4 | potassium channel activator activity |
GO:0044325 | 0.0011 | 5.5709 | 1.1704 | 6 | 96 | ion channel binding |
GO:0042834 | 0.0014 | 54.6792 | 0.061 | 2 | 5 | peptidoglycan binding |
GO:0008201 | 0.002 | 4.96 | 1.3045 | 6 | 107 | heparin binding |
GO:0005249 | 0.0023 | 5.8558 | 0.9266 | 5 | 76 | voltage-gated potassium channel activity |
GO:0015250 | 0.003 | 32.8025 | 0.0853 | 2 | 7 | water channel activity |
GO:0005261 | 0.0033 | 3.1854 | 3.0113 | 9 | 247 | cation channel activity |
GO:0061134 | 0.0039 | 4.2765 | 1.4995 | 6 | 123 | peptidase regulator activity |
GO:0015267 | 0.0042 | 2.7068 | 4.328 | 11 | 355 | channel activity |
GO:0004866 | 0.0048 | 4.8861 | 1.0972 | 5 | 90 | endopeptidase inhibitor activity |
GO:0008081 | 0.0095 | 5.1669 | 0.829 | 4 | 68 | phosphoric diester hydrolase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005509 | 0.0011 | 2.3093 | 9.286 | 20 | 512 | calcium ion binding |
GO:0005249 | 0.0025 | 4.7333 | 1.3784 | 6 | 76 | voltage-gated potassium channel activity |
GO:0070888 | 0.0036 | 7.0864 | 0.6348 | 4 | 35 | E-box binding |
GO:0070700 | 0.0065 | 21.8276 | 0.127 | 2 | 7 | BMP receptor binding |
GO:0046982 | 0.0081 | 2.1204 | 7.4542 | 15 | 411 | protein heterodimerization activity |
GO:0038036 | 0.0085 | 18.1883 | 0.1451 | 2 | 8 | sphingosine-1-phosphate receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004930 | 2e-04 | 3.7701 | 3.4895 | 12 | 336 | G-protein coupled receptor activity |
GO:0099600 | 0.0015 | 2.5139 | 6.9374 | 16 | 668 | transmembrane receptor activity |
GO:0004984 | 0.0024 | 7.8209 | 0.5608 | 4 | 54 | olfactory receptor activity |
GO:0030594 | 0.0033 | 7.1072 | 0.6127 | 4 | 59 | neurotransmitter receptor activity |
GO:0016405 | 0.0046 | 24.1581 | 0.1039 | 2 | 10 | CoA-ligase activity |
GO:0060089 | 0.006 | 2.0688 | 9.4195 | 18 | 907 | molecular transducer activity |
GO:0015347 | 0.0066 | 19.3235 | 0.1246 | 2 | 12 | sodium-independent organic anion transmembrane transporter activity |
GO:0022848 | 0.0066 | 19.3235 | 0.1246 | 2 | 12 | acetylcholine-gated cation-selective channel activity |
GO:0005452 | 0.0077 | 17.5655 | 0.135 | 2 | 13 | inorganic anion exchanger activity |
GO:0020037 | 0.01 | 5.068 | 0.8412 | 4 | 81 | heme binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004867 | 4e-04 | 8.751 | 0.6474 | 5 | 46 | serine-type endopeptidase inhibitor activity |
GO:0001733 | 0.0012 | 70.8054 | 0.0563 | 2 | 4 | galactosylceramide sulfotransferase activity |
GO:0042043 | 0.0019 | 47.2 | 0.0704 | 2 | 5 | neurexin family protein binding |
GO:0030414 | 0.0021 | 4.9019 | 1.3228 | 6 | 94 | peptidase inhibitor activity |
GO:0061135 | 0.0023 | 4.7923 | 1.351 | 6 | 96 | endopeptidase regulator activity |
GO:0022838 | 0.0026 | 2.7388 | 4.6722 | 12 | 332 | substrate-specific channel activity |
GO:0070679 | 0.0028 | 35.3973 | 0.0844 | 2 | 6 | inositol 1,4,5 trisphosphate binding |
GO:0017171 | 0.0038 | 3.7632 | 1.9843 | 7 | 141 | serine hydrolase activity |
GO:0072509 | 0.0038 | 3.7632 | 1.9843 | 7 | 141 | divalent inorganic cation transmembrane transporter activity |
GO:0015279 | 0.0039 | 28.3157 | 0.0985 | 2 | 7 | store-operated calcium channel activity |
GO:0022803 | 0.0046 | 2.5429 | 5.0099 | 12 | 356 | passive transmembrane transporter activity |
GO:0004252 | 0.0062 | 3.8793 | 1.6465 | 6 | 117 | serine-type endopeptidase activity |
GO:0015368 | 0.0066 | 20.2224 | 0.1267 | 2 | 9 | calcium:cation antiporter activity |
GO:0005215 | 0.0072 | 1.8029 | 14.8891 | 25 | 1058 | transporter activity |
GO:0005261 | 0.0083 | 2.7327 | 3.476 | 9 | 247 | cation channel activity |
GO:0008329 | 0.01 | 15.7261 | 0.1548 | 2 | 11 | signaling pattern recognition receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0010181 | 5e-04 | 24.1325 | 0.1624 | 3 | 13 | FMN binding |
GO:0001602 | 0.0015 | 53.3293 | 0.0625 | 2 | 5 | pancreatic polypeptide receptor activity |
GO:0003958 | 0.0015 | 53.3293 | 0.0625 | 2 | 5 | NADPH-hemoprotein reductase activity |
GO:0042834 | 0.0015 | 53.3293 | 0.0625 | 2 | 5 | peptidoglycan binding |
GO:0046982 | 0.0055 | 2.4847 | 5.1344 | 12 | 411 | protein heterodimerization activity |
GO:0001161 | 0.0065 | 19.9909 | 0.1249 | 2 | 10 | intronic transcription regulatory region sequence-specific DNA binding |
GO:0004745 | 0.0065 | 19.9909 | 0.1249 | 2 | 10 | retinol dehydrogenase activity |
GO:0050660 | 0.0071 | 5.6595 | 0.762 | 4 | 61 | flavin adenine dinucleotide binding |
GO:0016491 | 0.0092 | 2.1586 | 6.8834 | 14 | 551 | oxidoreductase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005509 | 0 | 3.5513 | 7.3209 | 23 | 512 | calcium ion binding |
GO:0001077 | 0.0021 | 3.1785 | 3.3602 | 10 | 235 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
GO:0003680 | 0.0041 | 27.8574 | 0.1001 | 2 | 7 | AT DNA binding |
GO:0030553 | 0.0041 | 27.8574 | 0.1001 | 2 | 7 | cGMP binding |
GO:0000977 | 0.0045 | 2.2154 | 7.6927 | 16 | 538 | RNA polymerase II regulatory region sequence-specific DNA binding |
GO:0000981 | 0.0073 | 2.0042 | 9.5515 | 18 | 668 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
GO:1990837 | 0.0093 | 1.9933 | 9.0454 | 17 | 639 | sequence-specific double-stranded DNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008020 | 2e-04 | 165.05 | 0.0247 | 2 | 4 | G-protein coupled photoreceptor activity |
GO:0042834 | 4e-04 | 110.025 | 0.0309 | 2 | 5 | peptidoglycan binding |
GO:0010851 | 6e-04 | 82.5125 | 0.037 | 2 | 6 | cyclase regulator activity |
GO:0031404 | 8e-04 | 66.005 | 0.0432 | 2 | 7 | chloride ion binding |
GO:0016405 | 0.0016 | 41.2437 | 0.0617 | 2 | 10 | CoA-ligase activity |
GO:0015347 | 0.0024 | 32.99 | 0.0741 | 2 | 12 | sodium-independent organic anion transmembrane transporter activity |
GO:0005452 | 0.0028 | 29.9886 | 0.0802 | 2 | 13 | inorganic anion exchanger activity |
GO:0005267 | 0.0042 | 6.5882 | 0.6541 | 4 | 106 | potassium channel activity |
GO:0022843 | 0.0046 | 6.3985 | 0.6726 | 4 | 109 | voltage-gated cation channel activity |
GO:0005215 | 0.005 | 2.3984 | 6.5289 | 14 | 1058 | transporter activity |
GO:0030246 | 0.0051 | 4.8353 | 1.1108 | 5 | 180 | carbohydrate binding |
GO:0005251 | 0.0054 | 20.6094 | 0.1111 | 2 | 18 | delayed rectifier potassium channel activity |
GO:0003957 | 0.0062 | Inf | 0.0062 | 1 | 1 | NAD(P)+ transhydrogenase (B-specific) activity |
GO:0004463 | 0.0062 | Inf | 0.0062 | 1 | 1 | leukotriene-A4 hydrolase activity |
GO:0008750 | 0.0062 | Inf | 0.0062 | 1 | 1 | NAD(P)+ transhydrogenase (AB-specific) activity |
GO:0008891 | 0.0062 | Inf | 0.0062 | 1 | 1 | glycolate oxidase activity |
GO:0016652 | 0.0062 | Inf | 0.0062 | 1 | 1 | oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor |
GO:0030251 | 0.0062 | Inf | 0.0062 | 1 | 1 | guanylate cyclase inhibitor activity |
GO:0032500 | 0.0062 | Inf | 0.0062 | 1 | 1 | muramyl dipeptide binding |
GO:0043739 | 0.0062 | Inf | 0.0062 | 1 | 1 | G/U mismatch-specific uracil-DNA glycosylase activity |
GO:0047969 | 0.0062 | Inf | 0.0062 | 1 | 1 | glyoxylate oxidase activity |
GO:0050051 | 0.0062 | Inf | 0.0062 | 1 | 1 | leukotriene-B4 20-monooxygenase activity |
GO:0052871 | 0.0062 | Inf | 0.0062 | 1 | 1 | alpha-tocopherol omega-hydroxylase activity |
GO:0097258 | 0.0062 | Inf | 0.0062 | 1 | 1 | 20-hydroxy-leukotriene B4 omega oxidase activity |
GO:0097259 | 0.0062 | Inf | 0.0062 | 1 | 1 | 20-aldehyde-leukotriene B4 20-monooxygenase activity |
GO:0015077 | 0.0069 | 3.8113 | 1.6908 | 6 | 274 | monovalent inorganic cation transmembrane transporter activity |
GO:0015075 | 0.007 | 2.696 | 4.0543 | 10 | 657 | ion transmembrane transporter activity |
GO:0061134 | 0.007 | 5.6397 | 0.759 | 4 | 123 | peptidase regulator activity |
GO:0016878 | 0.0073 | 17.3513 | 0.1296 | 2 | 21 | acid-thiol ligase activity |
GO:0015301 | 0.008 | 16.4825 | 0.1358 | 2 | 22 | anion:anion antiporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0016165 | 3e-04 | Inf | 0.0358 | 2 | 2 | linoleate 13S-lipoxygenase activity |
GO:0016801 | 6e-04 | 23.7866 | 0.1791 | 3 | 10 | hydrolase activity, acting on ether bonds |
GO:0031492 | 8e-04 | 7.7575 | 0.7343 | 5 | 41 | nucleosomal DNA binding |
GO:0030020 | 0.0031 | 36.8559 | 0.0896 | 2 | 5 | extracellular matrix structural constituent conferring tensile strength |
GO:0043546 | 0.0031 | 36.8559 | 0.0896 | 2 | 5 | molybdopterin cofactor binding |
GO:0001077 | 0.0034 | 2.7747 | 4.2091 | 11 | 235 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
GO:0003680 | 0.0063 | 22.1102 | 0.1254 | 2 | 7 | AT DNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0043546 | 0 | 206.0079 | 0.0967 | 4 | 5 | molybdopterin cofactor binding |
GO:0030151 | 0 | 153.8976 | 0.0774 | 3 | 4 | molybdenum ion binding |
GO:0016165 | 4e-04 | Inf | 0.0387 | 2 | 2 | linoleate 13S-lipoxygenase activity |
GO:0005201 | 4e-04 | 7.0556 | 0.967 | 6 | 50 | extracellular matrix structural constituent |
GO:0005164 | 5e-04 | 12.8607 | 0.3868 | 4 | 20 | tumor necrosis factor receptor binding |
GO:0008940 | 0.0011 | 102.1961 | 0.058 | 2 | 3 | nitrate reductase activity |
GO:0015247 | 0.0036 | 34.0601 | 0.0967 | 2 | 5 | aminophospholipid transporter activity |
GO:0016701 | 0.004 | 10.9817 | 0.3288 | 3 | 17 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen |
GO:0047617 | 0.004 | 10.9817 | 0.3288 | 3 | 17 | acyl-CoA hydrolase activity |
GO:0005184 | 0.0047 | 10.2488 | 0.3481 | 3 | 18 | neuropeptide hormone activity |
GO:1901612 | 0.0073 | 20.4329 | 0.1354 | 2 | 7 | cardiolipin binding |
GO:0102991 | 0.0097 | 17.0261 | 0.1547 | 2 | 8 | myristoyl-CoA hydrolase activity |
GO:0030414 | 0.0097 | 3.5158 | 1.818 | 6 | 94 | peptidase inhibitor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0038023 | 7e-04 | 2.6418 | 7.0981 | 17 | 720 | signaling receptor activity |
GO:0099600 | 9e-04 | 2.6684 | 6.5855 | 16 | 668 | transmembrane receptor activity |
GO:0004966 | 9e-04 | 67.9793 | 0.0493 | 2 | 5 | galanin receptor activity |
GO:0008528 | 0.002 | 6.0313 | 0.8971 | 5 | 91 | G-protein coupled peptide receptor activity |
GO:0004930 | 0.0022 | 3.7187 | 2.3113 | 8 | 244 | G-protein coupled receptor activity |
GO:0004954 | 0.0026 | 33.9819 | 0.0789 | 2 | 8 | prostanoid receptor activity |
GO:0060089 | 0.0034 | 2.1982 | 8.9417 | 18 | 907 | molecular transducer activity |
GO:0030547 | 0.006 | 20.3829 | 0.1183 | 2 | 12 | receptor inhibitor activity |
GO:0004252 | 0.006 | 4.622 | 1.1534 | 5 | 117 | serine-type endopeptidase activity |
GO:0008307 | 0.0061 | 8.7871 | 0.3746 | 3 | 38 | structural constituent of muscle |
GO:0097493 | 0.007 | 18.5285 | 0.1282 | 2 | 13 | structural molecule activity conferring elasticity |
GO:1903231 | 0.0077 | 5.4938 | 0.7788 | 4 | 79 | mRNA binding involved in posttranscriptional gene silencing |
GO:0004950 | 0.0081 | 16.9832 | 0.138 | 2 | 14 | chemokine receptor activity |
GO:0003951 | 0.0093 | 15.6756 | 0.1479 | 2 | 15 | NAD+ kinase activity |
GO:0001785 | 0.0099 | Inf | 0.0099 | 1 | 1 | prostaglandin J receptor activity |
GO:0003858 | 0.0099 | Inf | 0.0099 | 1 | 1 | 3-hydroxybutyrate dehydrogenase activity |
GO:0004607 | 0.0099 | Inf | 0.0099 | 1 | 1 | phosphatidylcholine-sterol O-acyltransferase activity |
GO:0004667 | 0.0099 | Inf | 0.0099 | 1 | 1 | prostaglandin-D synthase activity |
GO:0004956 | 0.0099 | Inf | 0.0099 | 1 | 1 | prostaglandin D receptor activity |
GO:0008147 | 0.0099 | Inf | 0.0099 | 1 | 1 | structural constituent of bone |
GO:0008843 | 0.0099 | Inf | 0.0099 | 1 | 1 | endochitinase activity |
GO:0016501 | 0.0099 | Inf | 0.0099 | 1 | 1 | prostacyclin receptor activity |
GO:0017020 | 0.0099 | Inf | 0.0099 | 1 | 1 | myosin phosphatase regulator activity |
GO:0031703 | 0.0099 | Inf | 0.0099 | 1 | 1 | type 2 angiotensin receptor binding |
GO:0031764 | 0.0099 | Inf | 0.0099 | 1 | 1 | type 1 galanin receptor binding |
GO:0031765 | 0.0099 | Inf | 0.0099 | 1 | 1 | type 2 galanin receptor binding |
GO:0031766 | 0.0099 | Inf | 0.0099 | 1 | 1 | type 3 galanin receptor binding |
GO:0033791 | 0.0099 | Inf | 0.0099 | 1 | 1 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity |
GO:0038182 | 0.0099 | Inf | 0.0099 | 1 | 1 | G-protein coupled bile acid receptor activity |
GO:0097573 | 0.0099 | Inf | 0.0099 | 1 | 1 | glutathione oxidoreductase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005094 | 3e-04 | 205.5781 | 0.0293 | 2 | 3 | Rho GDP-dissociation inhibitor activity |
GO:0030246 | 0.0019 | 4.2716 | 1.761 | 7 | 180 | carbohydrate binding |
GO:0001846 | 0.0049 | 22.8281 | 0.1076 | 2 | 11 | opsonin binding |
GO:0005070 | 0.006 | 8.8569 | 0.3718 | 3 | 38 | SH3/SH2 adaptor activity |
GO:0033293 | 0.0074 | 8.1558 | 0.4011 | 3 | 41 | monocarboxylic acid binding |
GO:1903231 | 0.0075 | 5.5378 | 0.7729 | 4 | 79 | mRNA binding involved in posttranscriptional gene silencing |
GO:0005159 | 0.008 | 17.1172 | 0.137 | 2 | 14 | insulin-like growth factor receptor binding |
GO:0008092 | 0.0093 | 2.1708 | 6.9168 | 14 | 707 | cytoskeletal protein binding |
GO:0001604 | 0.0098 | Inf | 0.0098 | 1 | 1 | urotensin II receptor activity |
GO:0003937 | 0.0098 | Inf | 0.0098 | 1 | 1 | IMP cyclohydrolase activity |
GO:0004137 | 0.0098 | Inf | 0.0098 | 1 | 1 | deoxycytidine kinase activity |
GO:0004643 | 0.0098 | Inf | 0.0098 | 1 | 1 | phosphoribosylaminoimidazolecarboxamide formyltransferase activity |
GO:0004982 | 0.0098 | Inf | 0.0098 | 1 | 1 | N-formyl peptide receptor activity |
GO:0005124 | 0.0098 | Inf | 0.0098 | 1 | 1 | scavenger receptor binding |
GO:0005147 | 0.0098 | Inf | 0.0098 | 1 | 1 | oncostatin-M receptor binding |
GO:0008579 | 0.0098 | Inf | 0.0098 | 1 | 1 | JUN kinase phosphatase activity |
GO:0035755 | 0.0098 | Inf | 0.0098 | 1 | 1 | cardiolipin hydrolase activity |
GO:0036487 | 0.0098 | Inf | 0.0098 | 1 | 1 | nitric-oxide synthase inhibitor activity |
GO:0039552 | 0.0098 | Inf | 0.0098 | 1 | 1 | RIG-I binding |
GO:0045485 | 0.0098 | Inf | 0.0098 | 1 | 1 | omega-6 fatty acid desaturase activity |
GO:0047305 | 0.0098 | Inf | 0.0098 | 1 | 1 | (R)-3-amino-2-methylpropionate-pyruvate transaminase activity |
GO:0047747 | 0.0098 | Inf | 0.0098 | 1 | 1 | cholate-CoA ligase activity |
GO:0050429 | 0.0098 | Inf | 0.0098 | 1 | 1 | calcium-dependent phospholipase C activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 37.5567 | 0.2804 | 8 | 54 | olfactory receptor activity |
GO:0004930 | 1e-04 | 5.9138 | 1.7447 | 9 | 336 | G-protein coupled receptor activity |
GO:0030414 | 0.0014 | 8.9771 | 0.4881 | 4 | 94 | peptidase inhibitor activity |
GO:0005198 | 0.0017 | 3.6125 | 2.7833 | 9 | 536 | structural molecule activity |
GO:0099600 | 0.0022 | 3.2355 | 3.4687 | 10 | 668 | transmembrane receptor activity |
GO:0038023 | 0.0038 | 2.9862 | 3.7387 | 10 | 720 | signaling receptor activity |
GO:0004507 | 0.0052 | Inf | 0.0052 | 1 | 1 | steroid 11-beta-monooxygenase activity |
GO:0004982 | 0.0052 | Inf | 0.0052 | 1 | 1 | N-formyl peptide receptor activity |
GO:0005124 | 0.0052 | Inf | 0.0052 | 1 | 1 | scavenger receptor binding |
GO:0047305 | 0.0052 | Inf | 0.0052 | 1 | 1 | (R)-3-amino-2-methylpropionate-pyruvate transaminase activity |
GO:0047783 | 0.0052 | Inf | 0.0052 | 1 | 1 | corticosterone 18-monooxygenase activity |
GO:0005539 | 0.006 | 5.9199 | 0.727 | 4 | 140 | glycosaminoglycan binding |
GO:0060089 | 0.0067 | 2.6084 | 4.7097 | 11 | 907 | molecular transducer activity |
GO:0005249 | 0.0072 | 8.1856 | 0.3946 | 3 | 76 | voltage-gated potassium channel activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005201 | 2e-04 | 8.1824 | 0.8391 | 6 | 50 | extracellular matrix structural constituent |
GO:0016165 | 3e-04 | Inf | 0.0336 | 2 | 2 | linoleate 13S-lipoxygenase activity |
GO:0004126 | 8e-04 | 118.2262 | 0.0503 | 2 | 3 | cytidine deaminase activity |
GO:0016701 | 0.0027 | 12.712 | 0.2853 | 3 | 17 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen |
GO:0043546 | 0.0027 | 39.4027 | 0.0839 | 2 | 5 | molybdopterin cofactor binding |
GO:0005164 | 0.0043 | 10.4663 | 0.3356 | 3 | 20 | tumor necrosis factor receptor binding |
GO:0005031 | 0.005 | 9.8841 | 0.3524 | 3 | 21 | tumor necrosis factor-activated receptor activity |
GO:0033691 | 0.0056 | 23.638 | 0.1175 | 2 | 7 | sialic acid binding |
GO:0004871 | 0.0082 | 1.7351 | 16.5807 | 27 | 988 | signal transducer activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0038023 | 1e-04 | 3.109 | 6.177 | 17 | 720 | signaling receptor activity |
GO:0099600 | 2e-04 | 3.1356 | 5.7309 | 16 | 668 | transmembrane receptor activity |
GO:0060089 | 2e-04 | 2.7671 | 7.7813 | 19 | 907 | molecular transducer activity |
GO:0004966 | 7e-04 | 78.3988 | 0.0429 | 2 | 5 | galanin receptor activity |
GO:0004930 | 0.001 | 4.2949 | 2.0236 | 8 | 245 | G-protein coupled receptor activity |
GO:0008528 | 0.0011 | 6.981 | 0.7807 | 5 | 91 | G-protein coupled peptide receptor activity |
GO:0050660 | 0.0018 | 8.3681 | 0.5233 | 4 | 61 | flavin adenine dinucleotide binding |
GO:0004954 | 0.002 | 39.1905 | 0.0686 | 2 | 8 | prostanoid receptor activity |
GO:0004950 | 0.0062 | 19.5863 | 0.1201 | 2 | 14 | chemokine receptor activity |
GO:0003951 | 0.0071 | 18.0783 | 0.1287 | 2 | 15 | NAD+ kinase activity |
GO:0016491 | 0.0077 | 2.4986 | 4.7271 | 11 | 551 | oxidoreductase activity |
GO:0001785 | 0.0086 | Inf | 0.0086 | 1 | 1 | prostaglandin J receptor activity |
GO:0004607 | 0.0086 | Inf | 0.0086 | 1 | 1 | phosphatidylcholine-sterol O-acyltransferase activity |
GO:0004667 | 0.0086 | Inf | 0.0086 | 1 | 1 | prostaglandin-D synthase activity |
GO:0004956 | 0.0086 | Inf | 0.0086 | 1 | 1 | prostaglandin D receptor activity |
GO:0008147 | 0.0086 | Inf | 0.0086 | 1 | 1 | structural constituent of bone |
GO:0008445 | 0.0086 | Inf | 0.0086 | 1 | 1 | D-aspartate oxidase activity |
GO:0008843 | 0.0086 | Inf | 0.0086 | 1 | 1 | endochitinase activity |
GO:0016501 | 0.0086 | Inf | 0.0086 | 1 | 1 | prostacyclin receptor activity |
GO:0017020 | 0.0086 | Inf | 0.0086 | 1 | 1 | myosin phosphatase regulator activity |
GO:0031703 | 0.0086 | Inf | 0.0086 | 1 | 1 | type 2 angiotensin receptor binding |
GO:0031764 | 0.0086 | Inf | 0.0086 | 1 | 1 | type 1 galanin receptor binding |
GO:0031765 | 0.0086 | Inf | 0.0086 | 1 | 1 | type 2 galanin receptor binding |
GO:0031766 | 0.0086 | Inf | 0.0086 | 1 | 1 | type 3 galanin receptor binding |
GO:0033791 | 0.0086 | Inf | 0.0086 | 1 | 1 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity |
GO:0097573 | 0.0086 | Inf | 0.0086 | 1 | 1 | glutathione oxidoreductase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004930 | 0.0022 | 2.9687 | 3.9699 | 11 | 336 | G-protein coupled receptor activity |
GO:0004896 | 0.0035 | 6.9799 | 0.6262 | 4 | 53 | cytokine receptor activity |
GO:0030547 | 0.0085 | 16.9303 | 0.1418 | 2 | 12 | receptor inhibitor activity |
GO:0005452 | 0.0099 | 15.39 | 0.1536 | 2 | 13 | inorganic anion exchanger activity |
GO:0097493 | 0.0099 | 15.39 | 0.1536 | 2 | 13 | structural molecule activity conferring elasticity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0030883 | 1e-04 | Inf | 0.0148 | 2 | 2 | endogenous lipid antigen binding |
GO:0030884 | 1e-04 | Inf | 0.0148 | 2 | 2 | exogenous lipid antigen binding |
GO:0005159 | 1e-04 | 37.8344 | 0.1033 | 3 | 14 | insulin-like growth factor receptor binding |
GO:0004035 | 3e-04 | 137.375 | 0.0295 | 2 | 4 | alkaline phosphatase activity |
GO:0071723 | 3e-04 | 137.375 | 0.0295 | 2 | 4 | lipopeptide binding |
GO:0004984 | 7e-04 | 11.183 | 0.3983 | 4 | 54 | olfactory receptor activity |
GO:0030881 | 8e-04 | 68.6771 | 0.0443 | 2 | 6 | beta-2-microglobulin binding |
GO:0003823 | 0.0017 | 14.3314 | 0.236 | 3 | 32 | antigen binding |
GO:0033204 | 0.0074 | Inf | 0.0074 | 1 | 1 | ribonuclease P RNA binding |
GO:0047305 | 0.0074 | Inf | 0.0074 | 1 | 1 | (R)-3-amino-2-methylpropionate-pyruvate transaminase activity |
GO:0008483 | 0.0075 | 17.3342 | 0.1314 | 2 | 18 | transaminase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 16.7781 | 0.3454 | 5 | 54 | olfactory receptor activity |
GO:0099600 | 1e-04 | 3.7836 | 4.273 | 14 | 668 | transmembrane receptor activity |
GO:0038023 | 2e-04 | 3.4904 | 4.6057 | 14 | 720 | signaling receptor activity |
GO:0060089 | 2e-04 | 3.2042 | 5.8019 | 16 | 907 | molecular transducer activity |
GO:0032395 | 6e-04 | 79.512 | 0.0384 | 2 | 6 | MHC class II receptor activity |
GO:0004866 | 0.0026 | 7.532 | 0.5757 | 4 | 90 | endopeptidase inhibitor activity |
GO:0004930 | 0.0057 | 3.5117 | 2.1493 | 7 | 336 | G-protein coupled receptor activity |
GO:0001594 | 0.0064 | Inf | 0.0064 | 1 | 1 | trace-amine receptor activity |
GO:0001792 | 0.0064 | Inf | 0.0064 | 1 | 1 | polymeric immunoglobulin receptor activity |
GO:0005477 | 0.0064 | Inf | 0.0064 | 1 | 1 | pyruvate secondary active transmembrane transporter activity |
GO:0019150 | 0.0064 | Inf | 0.0064 | 1 | 1 | D-ribulokinase activity |
GO:0036105 | 0.0064 | Inf | 0.0064 | 1 | 1 | peroxisome membrane class-1 targeting sequence binding |
GO:0047730 | 0.0064 | Inf | 0.0064 | 1 | 1 | carnosine synthase activity |
GO:0102102 | 0.0064 | Inf | 0.0064 | 1 | 1 | homocarnosine synthase activity |
GO:0004252 | 0.0067 | 5.7205 | 0.7484 | 4 | 117 | serine-type endopeptidase activity |
GO:0061134 | 0.008 | 5.4296 | 0.7868 | 4 | 123 | peptidase regulator activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004890 | 8e-04 | 21.5584 | 0.1904 | 3 | 11 | GABA-A receptor activity |
GO:0004364 | 0.0024 | 13.2616 | 0.2769 | 3 | 16 | glutathione transferase activity |
GO:0016229 | 0.0034 | 11.4916 | 0.3116 | 3 | 18 | steroid dehydrogenase activity |
GO:0005005 | 0.0059 | 22.9 | 0.1212 | 2 | 7 | transmembrane-ephrin receptor activity |
GO:0016723 | 0.0078 | 19.0819 | 0.1385 | 2 | 8 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor |
GO:1990825 | 0.0078 | 19.0819 | 0.1385 | 2 | 8 | sequence-specific mRNA binding |
GO:0046914 | 0.0091 | 1.7757 | 14.3317 | 24 | 828 | transition metal ion binding |
GO:0000182 | 0.0099 | 16.3546 | 0.1558 | 2 | 9 | rDNA binding |
GO:0004303 | 0.0099 | 16.3546 | 0.1558 | 2 | 9 | estradiol 17-beta-dehydrogenase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0052689 | 8e-04 | 5.0944 | 1.4968 | 7 | 102 | carboxylic ester hydrolase activity |
GO:0016493 | 0.0021 | 45.2159 | 0.0734 | 2 | 5 | C-C chemokine receptor activity |
GO:0019957 | 0.0021 | 45.2159 | 0.0734 | 2 | 5 | C-C chemokine binding |
GO:0008528 | 0.0022 | 4.8583 | 1.3354 | 6 | 91 | G-protein coupled peptide receptor activity |
GO:0003680 | 0.0043 | 27.1254 | 0.1027 | 2 | 7 | AT DNA binding |
GO:0008381 | 0.0057 | 22.6028 | 0.1174 | 2 | 8 | mechanically-gated ion channel activity |
GO:0005201 | 0.0061 | 5.9399 | 0.7337 | 4 | 50 | extracellular matrix structural constituent |
GO:0046030 | 0.0072 | 19.3723 | 0.1321 | 2 | 9 | inositol trisphosphate phosphatase activity |
GO:0001077 | 0.0079 | 2.7549 | 3.4486 | 9 | 235 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
GO:0005509 | 0.0085 | 2.112 | 7.5135 | 15 | 512 | calcium ion binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005509 | 3e-04 | 3.267 | 4.7393 | 14 | 512 | calcium ion binding |
GO:0038023 | 3e-04 | 2.843 | 6.6647 | 17 | 720 | signaling receptor activity |
GO:0099600 | 4e-04 | 2.8698 | 6.1833 | 16 | 668 | transmembrane receptor activity |
GO:0004930 | 0.0011 | 3.4853 | 3.1102 | 10 | 336 | G-protein coupled receptor activity |
GO:0060089 | 0.0017 | 2.3672 | 8.3956 | 18 | 907 | molecular transducer activity |
GO:0015103 | 0.009 | 5.2345 | 0.8146 | 4 | 88 | inorganic anion transmembrane transporter activity |
GO:0001604 | 0.0093 | Inf | 0.0093 | 1 | 1 | urotensin II receptor activity |
GO:0004310 | 0.0093 | Inf | 0.0093 | 1 | 1 | farnesyl-diphosphate farnesyltransferase activity |
GO:0004963 | 0.0093 | Inf | 0.0093 | 1 | 1 | follicle-stimulating hormone receptor activity |
GO:0004964 | 0.0093 | Inf | 0.0093 | 1 | 1 | luteinizing hormone receptor activity |
GO:0019782 | 0.0093 | Inf | 0.0093 | 1 | 1 | ISG15 activating enzyme activity |
GO:0030899 | 0.0093 | Inf | 0.0093 | 1 | 1 | calcium-dependent ATPase activity |
GO:0035472 | 0.0093 | Inf | 0.0093 | 1 | 1 | choriogonadotropin hormone receptor activity |
GO:0036105 | 0.0093 | Inf | 0.0093 | 1 | 1 | peroxisome membrane class-1 targeting sequence binding |
GO:0038106 | 0.0093 | Inf | 0.0093 | 1 | 1 | choriogonadotropin hormone binding |
GO:0046556 | 0.0093 | Inf | 0.0093 | 1 | 1 | alpha-L-arabinofuranosidase activity |
GO:0047305 | 0.0093 | Inf | 0.0093 | 1 | 1 | (R)-3-amino-2-methylpropionate-pyruvate transaminase activity |
GO:0050429 | 0.0093 | Inf | 0.0093 | 1 | 1 | calcium-dependent phospholipase C activity |
GO:0051996 | 0.0093 | Inf | 0.0093 | 1 | 1 | squalene synthase activity |
GO:0090409 | 0.0093 | Inf | 0.0093 | 1 | 1 | malonyl-CoA synthetase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0099600 | 1e-04 | 2.9653 | 7.5406 | 20 | 668 | transmembrane receptor activity |
GO:0060089 | 1e-04 | 2.6436 | 10.2386 | 24 | 907 | molecular transducer activity |
GO:0032394 | 1e-04 | Inf | 0.0226 | 2 | 2 | MHC class Ib receptor activity |
GO:0005509 | 2e-04 | 3.0433 | 5.7797 | 16 | 512 | calcium ion binding |
GO:0004930 | 4e-04 | 3.4391 | 3.7929 | 12 | 336 | G-protein coupled receptor activity |
GO:0038023 | 0.001 | 2.5454 | 7.295 | 17 | 661 | signaling receptor activity |
GO:0051378 | 0.0018 | 44.3716 | 0.0677 | 2 | 6 | serotonin binding |
GO:0004993 | 0.0034 | 29.5766 | 0.0903 | 2 | 8 | G-protein coupled serotonin receptor activity |
GO:0005338 | 0.0034 | 29.5766 | 0.0903 | 2 | 8 | nucleotide-sugar transmembrane transporter activity |
GO:0030594 | 0.0044 | 6.5171 | 0.666 | 4 | 59 | neurotransmitter receptor activity |
GO:0005102 | 0.0085 | 1.8588 | 12.801 | 22 | 1134 | receptor binding |
GO:0023026 | 0.0091 | 16.1265 | 0.1467 | 2 | 13 | MHC class II protein complex binding |
GO:0042923 | 0.0091 | 16.1265 | 0.1467 | 2 | 13 | neuropeptide binding |
GO:0005507 | 0.0096 | 7.4274 | 0.4402 | 3 | 39 | copper ion binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042169 | 0.005 | 9.6929 | 0.3518 | 3 | 25 | SH2 domain binding |
GO:1903231 | 0.0051 | 4.8363 | 1.1118 | 5 | 79 | mRNA binding involved in posttranscriptional gene silencing |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005132 | 1e-04 | Inf | 0.0208 | 2 | 2 | type I interferon receptor binding |
GO:0071855 | 0.0011 | 17.1673 | 0.2077 | 3 | 20 | neuropeptide receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0015079 | 3e-04 | 5.0703 | 1.7219 | 8 | 130 | potassium ion transmembrane transporter activity |
GO:0070405 | 4e-04 | 8.8868 | 0.6358 | 5 | 48 | ammonium ion binding |
GO:0008569 | 7e-04 | 20.6532 | 0.1854 | 3 | 14 | ATP-dependent microtubule motor activity, minus-end-directed |
GO:0015057 | 0.001 | 75.3448 | 0.053 | 2 | 4 | thrombin-activated receptor activity |
GO:0022890 | 0.0015 | 2.6909 | 5.5894 | 14 | 422 | inorganic cation transmembrane transporter activity |
GO:0005251 | 0.0016 | 15.141 | 0.2384 | 3 | 18 | delayed rectifier potassium channel activity |
GO:1990239 | 0.0017 | 50.2261 | 0.0662 | 2 | 5 | steroid hormone binding |
GO:0045503 | 0.0022 | 13.3577 | 0.2649 | 3 | 20 | dynein light chain binding |
GO:0042623 | 0.0022 | 2.9476 | 3.9868 | 11 | 301 | ATPase activity, coupled |
GO:0022803 | 0.0028 | 2.7158 | 4.7152 | 12 | 356 | passive transmembrane transporter activity |
GO:0031681 | 0.0035 | 30.131 | 0.0927 | 2 | 7 | G-protein beta-subunit binding |
GO:0044183 | 0.0042 | 10.3179 | 0.3311 | 3 | 25 | protein binding involved in protein folding |
GO:0022838 | 0.0047 | 2.6565 | 4.3974 | 11 | 332 | substrate-specific channel activity |
GO:0019829 | 0.0049 | 6.3295 | 0.6887 | 4 | 52 | cation-transporting ATPase activity |
GO:0004930 | 0.0052 | 2.623 | 4.4503 | 11 | 336 | G-protein coupled receptor activity |
GO:0042626 | 0.0054 | 4.7632 | 1.1258 | 5 | 85 | ATPase activity, coupled to transmembrane movement of substances |
GO:0005391 | 0.0059 | 21.5189 | 0.1192 | 2 | 9 | sodium:potassium-exchanging ATPase activity |
GO:0015075 | 0.0064 | 2.0836 | 8.702 | 17 | 657 | ion transmembrane transporter activity |
GO:0022836 | 0.0064 | 2.8541 | 3.3377 | 9 | 252 | gated channel activity |
GO:0015485 | 0.0071 | 8.404 | 0.3974 | 3 | 30 | cholesterol binding |
GO:0030594 | 0.0077 | 5.5209 | 0.7815 | 4 | 59 | neurotransmitter receptor activity |
GO:0015399 | 0.0078 | 4.3275 | 1.2318 | 5 | 93 | primary active transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0060089 | 3e-04 | 2.5505 | 9.2147 | 21 | 907 | molecular transducer activity |
GO:0099600 | 4e-04 | 2.7667 | 6.7866 | 17 | 668 | transmembrane receptor activity |
GO:0004930 | 6e-04 | 3.5014 | 3.4136 | 11 | 336 | G-protein coupled receptor activity |
GO:0016494 | 0.001 | 65.9148 | 0.0508 | 2 | 5 | C-X-C chemokine receptor activity |
GO:0098634 | 0.0015 | 49.4323 | 0.061 | 2 | 6 | cell-matrix adhesion mediator activity |
GO:0046873 | 0.0026 | 3.0894 | 3.4746 | 10 | 342 | metal ion transmembrane transporter activity |
GO:0015026 | 0.0028 | 11.9345 | 0.2845 | 3 | 28 | coreceptor activity |
GO:0038023 | 0.0037 | 2.3579 | 6.8887 | 15 | 692 | signaling receptor activity |
GO:0099094 | 0.0038 | 6.7766 | 0.6401 | 4 | 63 | ligand-gated cation channel activity |
GO:0097153 | 0.0044 | 24.7086 | 0.1016 | 2 | 10 | cysteine-type endopeptidase activity involved in apoptotic process |
GO:0008324 | 0.0049 | 2.5374 | 5.0696 | 12 | 499 | cation transmembrane transporter activity |
GO:0032403 | 0.0051 | 2.3389 | 6.4411 | 14 | 634 | protein complex binding |
GO:0005216 | 0.0062 | 2.883 | 3.3222 | 9 | 327 | ion channel activity |
GO:0050998 | 0.0063 | 19.7639 | 0.1219 | 2 | 12 | nitric-oxide synthase binding |
GO:0015077 | 0.0069 | 3.0518 | 2.7837 | 8 | 274 | monovalent inorganic cation transmembrane transporter activity |
GO:0005249 | 0.0074 | 5.5475 | 0.7721 | 4 | 76 | voltage-gated potassium channel activity |
GO:0001637 | 0.0086 | 16.4674 | 0.1422 | 2 | 14 | G-protein coupled chemoattractant receptor activity |
GO:0019956 | 0.0086 | 16.4674 | 0.1422 | 2 | 14 | chemokine binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0016165 | 3e-04 | Inf | 0.0334 | 2 | 2 | linoleate 13S-lipoxygenase activity |
GO:0005089 | 8e-04 | 6.0213 | 1.1026 | 6 | 66 | Rho guanyl-nucleotide exchange factor activity |
GO:0005509 | 0.0024 | 2.2455 | 8.5539 | 18 | 512 | calcium ion binding |
GO:0015247 | 0.0027 | 39.5848 | 0.0835 | 2 | 5 | aminophospholipid transporter activity |
GO:0016493 | 0.0027 | 39.5848 | 0.0835 | 2 | 5 | C-C chemokine receptor activity |
GO:0043546 | 0.0027 | 39.5848 | 0.0835 | 2 | 5 | molybdopterin cofactor binding |
GO:0008307 | 0.0036 | 7.0329 | 0.6349 | 4 | 38 | structural constituent of muscle |
GO:0031490 | 0.0049 | 4.0966 | 1.5704 | 6 | 94 | chromatin DNA binding |
GO:0016803 | 0.0093 | 16.9597 | 0.1504 | 2 | 9 | ether hydrolase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 2e-04 | 15.4894 | 0.2926 | 4 | 54 | olfactory receptor activity |
GO:0004952 | 6e-04 | 75.4914 | 0.0379 | 2 | 7 | dopamine neurotransmitter receptor activity |
GO:0030414 | 0.0017 | 8.5791 | 0.5093 | 4 | 94 | peptidase inhibitor activity |
GO:0060089 | 0.0033 | 2.7533 | 4.9145 | 12 | 907 | molecular transducer activity |
GO:0042056 | 0.0042 | 23.5714 | 0.0975 | 2 | 18 | chemoattractant activity |
GO:0005504 | 0.0052 | 20.9492 | 0.1084 | 2 | 20 | fatty acid binding |
GO:0038023 | 0.0052 | 2.841 | 3.9013 | 10 | 720 | signaling receptor activity |
GO:0004507 | 0.0054 | Inf | 0.0054 | 1 | 1 | steroid 11-beta-monooxygenase activity |
GO:0004982 | 0.0054 | Inf | 0.0054 | 1 | 1 | N-formyl peptide receptor activity |
GO:0005124 | 0.0054 | Inf | 0.0054 | 1 | 1 | scavenger receptor binding |
GO:0031727 | 0.0054 | Inf | 0.0054 | 1 | 1 | CCR2 chemokine receptor binding |
GO:0033560 | 0.0054 | Inf | 0.0054 | 1 | 1 | folate reductase activity |
GO:0047305 | 0.0054 | Inf | 0.0054 | 1 | 1 | (R)-3-amino-2-methylpropionate-pyruvate transaminase activity |
GO:0047783 | 0.0054 | Inf | 0.0054 | 1 | 1 | corticosterone 18-monooxygenase activity |
GO:0008324 | 0.0054 | 3.2396 | 2.7038 | 8 | 499 | cation transmembrane transporter activity |
GO:0005539 | 0.007 | 5.6574 | 0.7586 | 4 | 140 | glycosaminoglycan binding |
GO:0042379 | 0.0087 | 15.7048 | 0.1409 | 2 | 26 | chemokine receptor binding |
GO:0022838 | 0.0091 | 3.5945 | 1.7989 | 6 | 332 | substrate-specific channel activity |
GO:0099600 | 0.0097 | 2.7221 | 3.6195 | 9 | 668 | transmembrane receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005094 | 4e-04 | 178.7483 | 0.0336 | 2 | 3 | Rho GDP-dissociation inhibitor activity |
GO:0004871 | 0.0015 | 2.1829 | 11.0786 | 22 | 988 | signal transducer activity |
GO:1903231 | 0.0019 | 6.1303 | 0.8858 | 5 | 79 | mRNA binding involved in posttranscriptional gene silencing |
GO:0017080 | 0.0045 | 9.9787 | 0.3364 | 3 | 30 | sodium channel regulator activity |
GO:0030169 | 0.0077 | 17.8626 | 0.1346 | 2 | 12 | low-density lipoprotein particle binding |
GO:0003779 | 0.0087 | 2.7142 | 3.5097 | 9 | 313 | actin binding |
GO:0042923 | 0.009 | 16.2375 | 0.1458 | 2 | 13 | neuropeptide binding |
GO:0098772 | 0.0094 | 1.7752 | 15.3059 | 25 | 1365 | molecular function regulator |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007275 | 0 | 2.7167 | 50.5353 | 100 | 2732 | multicellular organism development |
GO:0007156 | 0 | 6.6793 | 3.1465 | 18 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0022610 | 0 | 2.5847 | 26.476 | 59 | 1279 | biological adhesion |
GO:0007399 | 0 | 2.7976 | 18.979 | 46 | 983 | nervous system development |
GO:0098609 | 0 | 2.8203 | 15.5254 | 39 | 750 | cell-cell adhesion |
GO:0045944 | 0 | 2.3195 | 21.6114 | 45 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
GO:0009888 | 0 | 1.9352 | 32.8493 | 57 | 1611 | tissue development |
GO:0051254 | 0 | 1.9703 | 29.2085 | 52 | 1411 | positive regulation of RNA metabolic process |
GO:1903508 | 0 | 1.9876 | 27.7801 | 50 | 1342 | positive regulation of nucleic acid-templated transcription |
GO:2000026 | 0 | 1.8668 | 35.7705 | 60 | 1728 | regulation of multicellular organismal development |
GO:0048699 | 0 | 1.9773 | 27.304 | 49 | 1319 | generation of neurons |
GO:0070848 | 0 | 2.4297 | 12.9585 | 29 | 626 | response to growth factor |
GO:0048513 | 0 | 1.7814 | 46.0457 | 72 | 2387 | animal organ development |
GO:0009653 | 1e-04 | 1.9759 | 25.1763 | 45 | 1302 | anatomical structure morphogenesis |
GO:0060538 | 1e-04 | 4.0875 | 3.2086 | 12 | 155 | skeletal muscle organ development |
GO:0042476 | 1e-04 | 4.6652 | 2.3599 | 10 | 114 | odontogenesis |
GO:0007267 | 1e-04 | 1.8514 | 30.2021 | 51 | 1459 | cell-cell signaling |
GO:0042127 | 1e-04 | 2.1522 | 16.662 | 33 | 841 | regulation of cell proliferation |
GO:0003278 | 2e-04 | 47.7532 | 0.1242 | 3 | 6 | apoptotic process involved in heart morphogenesis |
GO:0001558 | 2e-04 | 2.7327 | 7.4729 | 19 | 361 | regulation of cell growth |
GO:0001568 | 2e-04 | 2.317 | 12.0684 | 26 | 583 | blood vessel development |
GO:0061061 | 2e-04 | 2.317 | 12.0684 | 26 | 583 | muscle structure development |
GO:0090288 | 3e-04 | 4.1078 | 2.6497 | 10 | 128 | negative regulation of cellular response to growth factor stimulus |
GO:0010557 | 4e-04 | 1.7561 | 32.2928 | 52 | 1560 | positive regulation of macromolecule biosynthetic process |
GO:0035914 | 4e-04 | 5.8166 | 1.3455 | 7 | 65 | skeletal muscle cell differentiation |
GO:0031328 | 4e-04 | 1.7189 | 34.9425 | 55 | 1688 | positive regulation of cellular biosynthetic process |
GO:0072358 | 5e-04 | 2.1901 | 12.7101 | 26 | 614 | cardiovascular system development |
GO:0009792 | 5e-04 | 2.2675 | 11.3232 | 24 | 547 | embryo development ending in birth or egg hatching |
GO:0072073 | 5e-04 | 3.9075 | 2.7739 | 10 | 134 | kidney epithelium development |
GO:0060216 | 5e-04 | 12.7648 | 0.3933 | 4 | 19 | definitive hemopoiesis |
GO:0010720 | 6e-04 | 2.3699 | 9.4601 | 21 | 457 | positive regulation of cell development |
GO:0055002 | 6e-04 | 3.7547 | 2.8774 | 10 | 139 | striated muscle cell development |
GO:0008285 | 7e-04 | 2.1297 | 13.0413 | 26 | 630 | negative regulation of cell proliferation |
GO:0070886 | 7e-04 | 23.8718 | 0.1863 | 3 | 9 | positive regulation of calcineurin-NFAT signaling cascade |
GO:0042060 | 7e-04 | 2.2756 | 10.3089 | 22 | 498 | wound healing |
GO:0045596 | 8e-04 | 2.1325 | 12.5031 | 25 | 604 | negative regulation of cell differentiation |
GO:0023052 | 9e-04 | 1.5143 | 78.0026 | 102 | 4065 | signaling |
GO:0001649 | 9e-04 | 3.1334 | 4.0987 | 12 | 198 | osteoblast differentiation |
GO:0048146 | 9e-04 | 5.8859 | 1.1385 | 6 | 55 | positive regulation of fibroblast proliferation |
GO:0033690 | 9e-04 | 20.4602 | 0.207 | 3 | 10 | positive regulation of osteoblast proliferation |
GO:0050665 | 9e-04 | 20.4602 | 0.207 | 3 | 10 | hydrogen peroxide biosynthetic process |
GO:0030198 | 0.001 | 2.587 | 6.5828 | 16 | 318 | extracellular matrix organization |
GO:0009719 | 0.001 | 1.7194 | 28.8565 | 46 | 1394 | response to endogenous stimulus |
GO:0051962 | 0.001 | 2.3038 | 9.2324 | 20 | 446 | positive regulation of nervous system development |
GO:0032924 | 0.0011 | 7.2674 | 0.7866 | 5 | 38 | activin receptor signaling pathway |
GO:0060348 | 0.0011 | 3.2318 | 3.6433 | 11 | 176 | bone development |
GO:0035295 | 0.0013 | 2.1318 | 11.4681 | 23 | 554 | tube development |
GO:0003350 | 0.0013 | 95.2141 | 0.0621 | 2 | 3 | pulmonary myocardium development |
GO:0042335 | 0.0013 | 95.2141 | 0.0621 | 2 | 3 | cuticle development |
GO:2000254 | 0.0013 | 95.2141 | 0.0621 | 2 | 3 | regulation of male germ cell proliferation |
GO:0007512 | 0.0013 | 17.9014 | 0.2277 | 3 | 11 | adult heart development |
GO:0032964 | 0.0013 | 6.8512 | 0.828 | 5 | 40 | collagen biosynthetic process |
GO:0007166 | 0.0014 | 1.5361 | 52.1446 | 73 | 2519 | cell surface receptor signaling pathway |
GO:0030878 | 0.0014 | 9.5704 | 0.4968 | 4 | 24 | thyroid gland development |
GO:0048762 | 0.0015 | 3.1171 | 3.7675 | 11 | 182 | mesenchymal cell differentiation |
GO:0014706 | 0.0016 | 2.4705 | 6.8714 | 16 | 334 | striated muscle tissue development |
GO:0007154 | 0.0016 | 1.4791 | 78.3864 | 101 | 4085 | cell communication |
GO:0071773 | 0.0016 | 3.291 | 3.25 | 10 | 157 | cellular response to BMP stimulus |
GO:0010922 | 0.0016 | 9.1141 | 0.5175 | 4 | 25 | positive regulation of phosphatase activity |
GO:0060415 | 0.0016 | 16.1075 | 0.2455 | 3 | 12 | muscle tissue morphogenesis |
GO:0060707 | 0.0017 | 15.9113 | 0.2484 | 3 | 12 | trophoblast giant cell differentiation |
GO:0090596 | 0.0017 | 2.746 | 5.0302 | 13 | 243 | sensory organ morphogenesis |
GO:0007588 | 0.0017 | 5.1477 | 1.2834 | 6 | 62 | excretion |
GO:0010718 | 0.0021 | 6.1468 | 0.9108 | 5 | 44 | positive regulation of epithelial to mesenchymal transition |
GO:0045666 | 0.0022 | 2.4672 | 6.4379 | 15 | 311 | positive regulation of neuron differentiation |
GO:0043588 | 0.0022 | 2.4588 | 6.4586 | 15 | 312 | skin development |
GO:0001954 | 0.0023 | 5.9927 | 0.9315 | 5 | 45 | positive regulation of cell-matrix adhesion |
GO:0001994 | 0.0025 | 47.6038 | 0.0828 | 2 | 4 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure |
GO:0048852 | 0.0025 | 47.6038 | 0.0828 | 2 | 4 | diencephalon morphogenesis |
GO:0060018 | 0.0025 | 47.6038 | 0.0828 | 2 | 4 | astrocyte fate commitment |
GO:0061325 | 0.0025 | 47.6038 | 0.0828 | 2 | 4 | cell proliferation involved in outflow tract morphogenesis |
GO:0010628 | 0.0026 | 1.5869 | 35.253 | 52 | 1703 | positive regulation of gene expression |
GO:0003231 | 0.0028 | 3.5696 | 2.4013 | 8 | 116 | cardiac ventricle development |
GO:0044259 | 0.0028 | 3.5696 | 2.4013 | 8 | 116 | multicellular organismal macromolecule metabolic process |
GO:0051216 | 0.003 | 3.0019 | 3.5398 | 10 | 171 | cartilage development |
GO:0030512 | 0.003 | 4.5736 | 1.4283 | 6 | 69 | negative regulation of transforming growth factor beta receptor signaling pathway |
GO:0048869 | 0.0032 | 1.6195 | 31.6481 | 47 | 1722 | cellular developmental process |
GO:1901890 | 0.0032 | 7.3589 | 0.621 | 4 | 30 | positive regulation of cell junction assembly |
GO:0030516 | 0.0032 | 4.5018 | 1.449 | 6 | 70 | regulation of axon extension |
GO:0001667 | 0.0033 | 2.3535 | 6.7277 | 15 | 325 | ameboidal-type cell migration |
GO:0003206 | 0.0033 | 3.4724 | 2.4634 | 8 | 119 | cardiac chamber morphogenesis |
GO:0031960 | 0.0034 | 3.1698 | 3.0223 | 9 | 146 | response to corticosteroid |
GO:0050768 | 0.0036 | 2.6189 | 4.8439 | 12 | 234 | negative regulation of neurogenesis |
GO:0048706 | 0.0037 | 3.4105 | 2.5048 | 8 | 121 | embryonic skeletal system development |
GO:0003002 | 0.0037 | 2.3979 | 6.1595 | 14 | 300 | regionalization |
GO:0048705 | 0.0038 | 2.729 | 4.2643 | 11 | 206 | skeletal system morphogenesis |
GO:0010810 | 0.0038 | 2.8929 | 3.664 | 10 | 177 | regulation of cell-substrate adhesion |
GO:0051241 | 0.0039 | 1.7264 | 20.2658 | 33 | 979 | negative regulation of multicellular organismal process |
GO:0090257 | 0.004 | 2.7149 | 4.285 | 11 | 207 | regulation of muscle system process |
GO:0021515 | 0.004 | 5.209 | 1.0557 | 5 | 51 | cell differentiation in spinal cord |
GO:0071260 | 0.004 | 4.2994 | 1.5111 | 6 | 73 | cellular response to mechanical stimulus |
GO:0006590 | 0.004 | 11.0126 | 0.3312 | 3 | 16 | thyroid hormone generation |
GO:0045165 | 0.0041 | 2.5718 | 4.9267 | 12 | 238 | cell fate commitment |
GO:0036093 | 0.0041 | 31.7338 | 0.1035 | 2 | 5 | germ cell proliferation |
GO:0051270 | 0.0043 | 1.7979 | 16.4569 | 28 | 795 | regulation of cellular component movement |
GO:0010001 | 0.0043 | 2.8413 | 3.7261 | 10 | 180 | glial cell differentiation |
GO:0001655 | 0.0044 | 2.3518 | 6.2723 | 14 | 303 | urogenital system development |
GO:0014902 | 0.0045 | 3.6586 | 2.0494 | 7 | 99 | myotube differentiation |
GO:0071560 | 0.0046 | 2.6599 | 4.3678 | 11 | 211 | cellular response to transforming growth factor beta stimulus |
GO:0071385 | 0.0047 | 4.9913 | 1.0971 | 5 | 53 | cellular response to glucocorticoid stimulus |
GO:0048856 | 0.0047 | 24.8897 | 0.1072 | 2 | 8 | anatomical structure development |
GO:0048666 | 0.0048 | 1.7165 | 19.7276 | 32 | 953 | neuron development |
GO:0003198 | 0.0048 | 10.2253 | 0.3519 | 3 | 17 | epithelial to mesenchymal transition involved in endocardial cushion formation |
GO:0106056 | 0.0048 | 10.2253 | 0.3519 | 3 | 17 | regulation of calcineurin-mediated signaling |
GO:0032526 | 0.005 | 3.5803 | 2.0908 | 7 | 101 | response to retinoic acid |
GO:0048562 | 0.0052 | 2.3868 | 5.734 | 13 | 277 | embryonic organ morphogenesis |
GO:0048468 | 0.0053 | 1.8361 | 14.4141 | 25 | 739 | cell development |
GO:0008016 | 0.0054 | 2.5941 | 4.4713 | 11 | 216 | regulation of heart contraction |
GO:0032989 | 0.0054 | 1.6988 | 19.9139 | 32 | 962 | cellular component morphogenesis |
GO:0030220 | 0.0057 | 9.5429 | 0.3726 | 3 | 18 | platelet formation |
GO:0007417 | 0.0057 | 1.7391 | 17.5955 | 29 | 850 | central nervous system development |
GO:0045637 | 0.0058 | 2.5687 | 4.5127 | 11 | 218 | regulation of myeloid cell differentiation |
GO:0046958 | 0.0061 | 23.7987 | 0.1242 | 2 | 6 | nonassociative learning |
GO:0072014 | 0.0061 | 23.7987 | 0.1242 | 2 | 6 | proximal tubule development |
GO:2000489 | 0.0061 | 23.7987 | 0.1242 | 2 | 6 | regulation of hepatic stellate cell activation |
GO:0001501 | 0.0062 | 3.8905 | 1.6534 | 6 | 84 | skeletal system development |
GO:0060412 | 0.0063 | 5.9767 | 0.7452 | 4 | 36 | ventricular septum morphogenesis |
GO:0001525 | 0.0067 | 2.0524 | 8.6942 | 17 | 420 | angiogenesis |
GO:0048593 | 0.0068 | 3.3641 | 2.215 | 7 | 107 | camera-type eye morphogenesis |
GO:0003407 | 0.0069 | 4.5189 | 1.2006 | 5 | 58 | neural retina development |
GO:0060193 | 0.0069 | 4.5189 | 1.2006 | 5 | 58 | positive regulation of lipase activity |
GO:0007162 | 0.0071 | 2.4954 | 4.6369 | 11 | 224 | negative regulation of cell adhesion |
GO:0030334 | 0.0074 | 1.7997 | 14.0143 | 24 | 677 | regulation of cell migration |
GO:0030219 | 0.0075 | 3.7385 | 1.7181 | 6 | 83 | megakaryocyte differentiation |
GO:0030510 | 0.0075 | 3.7385 | 1.7181 | 6 | 83 | regulation of BMP signaling pathway |
GO:0040012 | 0.0076 | 1.7325 | 16.3948 | 27 | 792 | regulation of locomotion |
GO:0045777 | 0.0076 | 5.6244 | 0.7866 | 4 | 38 | positive regulation of blood pressure |
GO:0002695 | 0.0077 | 2.9842 | 2.836 | 8 | 137 | negative regulation of leukocyte activation |
GO:0035929 | 0.0077 | 8.4191 | 0.414 | 3 | 20 | steroid hormone secretion |
GO:0051716 | 0.0084 | 1.3231 | 129.7095 | 151 | 6266 | cellular response to stimulus |
GO:0003253 | 0.0084 | 19.0377 | 0.1449 | 2 | 7 | cardiac neural crest cell migration involved in outflow tract morphogenesis |
GO:0045650 | 0.0084 | 19.0377 | 0.1449 | 2 | 7 | negative regulation of macrophage differentiation |
GO:0060215 | 0.0084 | 19.0377 | 0.1449 | 2 | 7 | primitive hemopoiesis |
GO:0040007 | 0.0084 | 2.1683 | 6.7744 | 14 | 337 | growth |
GO:0031214 | 0.0087 | 3.2028 | 2.3185 | 7 | 112 | biomineral tissue development |
GO:0097435 | 0.0087 | 1.8788 | 11.1576 | 20 | 539 | supramolecular fiber organization |
GO:0003181 | 0.0089 | 7.9509 | 0.4347 | 3 | 21 | atrioventricular valve morphogenesis |
GO:0021516 | 0.0089 | 7.9509 | 0.4347 | 3 | 21 | dorsal spinal cord development |
GO:0060972 | 0.0089 | 7.9509 | 0.4347 | 3 | 21 | left/right pattern formation |
GO:0001775 | 0.0089 | 1.5797 | 24.7371 | 37 | 1195 | cell activation |
GO:0030003 | 0.0091 | 1.8714 | 11.199 | 20 | 541 | cellular cation homeostasis |
GO:0048844 | 0.0091 | 4.2006 | 1.2834 | 5 | 62 | artery morphogenesis |
GO:0003170 | 0.0092 | 5.3112 | 0.828 | 4 | 40 | heart valve development |
GO:0072210 | 0.0092 | 5.3112 | 0.828 | 4 | 40 | metanephric nephron development |
GO:0043583 | 0.0092 | 2.5253 | 4.1608 | 10 | 201 | ear development |
GO:0048589 | 0.0092 | 1.8677 | 11.2197 | 20 | 542 | developmental growth |
GO:0055008 | 0.0097 | 4.1279 | 1.3041 | 5 | 63 | cardiac muscle tissue morphogenesis |
GO:0050868 | 0.0098 | 3.5094 | 1.8216 | 6 | 88 | negative regulation of T cell activation |
GO:0010559 | 0.01 | 5.1673 | 0.8487 | 4 | 41 | regulation of glycoprotein biosynthetic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045944 | 0 | 2.5086 | 30.942 | 68 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
GO:0048562 | 0 | 3.8592 | 8.2097 | 28 | 277 | embryonic organ morphogenesis |
GO:0048706 | 0 | 5.5223 | 3.5862 | 17 | 121 | embryonic skeletal system development |
GO:0010628 | 0 | 1.916 | 50.4734 | 86 | 1703 | positive regulation of gene expression |
GO:0051094 | 0 | 2.1003 | 34.4096 | 65 | 1161 | positive regulation of developmental process |
GO:1903508 | 0 | 2.0188 | 39.7741 | 72 | 1342 | positive regulation of nucleic acid-templated transcription |
GO:0051254 | 0 | 1.9715 | 41.8191 | 74 | 1411 | positive regulation of RNA metabolic process |
GO:0009792 | 0 | 2.5772 | 16.2119 | 38 | 547 | embryo development ending in birth or egg hatching |
GO:0072358 | 0 | 2.477 | 18.1977 | 41 | 614 | cardiovascular system development |
GO:0051240 | 0 | 1.9498 | 41.6151 | 73 | 1410 | positive regulation of multicellular organismal process |
GO:0031328 | 0 | 1.8209 | 50.0288 | 82 | 1688 | positive regulation of cellular biosynthetic process |
GO:0048536 | 0 | 9.5053 | 1.067 | 8 | 36 | spleen development |
GO:0090596 | 0 | 4.9642 | 2.9837 | 13 | 102 | sensory organ morphogenesis |
GO:2000026 | 0 | 1.8831 | 39.2369 | 67 | 1372 | regulation of multicellular organismal development |
GO:0003151 | 0 | 5.8345 | 2.1932 | 11 | 74 | outflow tract morphogenesis |
GO:0048468 | 0 | 2.0695 | 25.9209 | 49 | 904 | cell development |
GO:0010557 | 0 | 1.7839 | 46.2351 | 75 | 1560 | positive regulation of macromolecule biosynthetic process |
GO:0051241 | 0 | 2.2063 | 19.1874 | 39 | 665 | negative regulation of multicellular organismal process |
GO:0001568 | 0 | 2.3453 | 14.754 | 32 | 503 | blood vessel development |
GO:0008284 | 0 | 2.0402 | 23.3309 | 44 | 792 | positive regulation of cell proliferation |
GO:0060429 | 0 | 1.9112 | 30.0988 | 53 | 1029 | epithelium development |
GO:0030878 | 1e-04 | 11.0472 | 0.7113 | 6 | 24 | thyroid gland development |
GO:0030858 | 1e-04 | 5.875 | 1.7783 | 9 | 60 | positive regulation of epithelial cell differentiation |
GO:0022603 | 1e-04 | 1.9188 | 27.0001 | 48 | 911 | regulation of anatomical structure morphogenesis |
GO:0060485 | 1e-04 | 6.6051 | 1.4275 | 8 | 49 | mesenchyme development |
GO:0021879 | 1e-04 | 6.4857 | 1.4523 | 8 | 49 | forebrain neuron differentiation |
GO:0048646 | 1e-04 | 2.223 | 15.5062 | 32 | 545 | anatomical structure formation involved in morphogenesis |
GO:0006355 | 1e-04 | 1.5032 | 100.0279 | 134 | 3375 | regulation of transcription, DNA-templated |
GO:0019219 | 1e-04 | 1.4775 | 116.5362 | 152 | 3932 | regulation of nucleobase-containing compound metabolic process |
GO:0032502 | 1e-04 | 1.5446 | 96.0719 | 128 | 3688 | developmental process |
GO:0048729 | 1e-04 | 2.1186 | 17.7531 | 35 | 599 | tissue morphogenesis |
GO:2001141 | 1e-04 | 1.4878 | 100.7985 | 134 | 3401 | regulation of RNA biosynthetic process |
GO:0042474 | 1e-04 | 12.7225 | 0.5335 | 5 | 18 | middle ear morphogenesis |
GO:0048863 | 1e-04 | 2.8169 | 7.2909 | 19 | 246 | stem cell differentiation |
GO:0033993 | 2e-04 | 1.8923 | 24.9551 | 44 | 842 | response to lipid |
GO:0023019 | 2e-04 | 11.8129 | 0.5631 | 5 | 19 | signal transduction involved in regulation of gene expression |
GO:0060455 | 2e-04 | 49.433 | 0.1482 | 3 | 5 | negative regulation of gastric acid secretion |
GO:0051954 | 3e-04 | 7.9502 | 0.9188 | 6 | 31 | positive regulation of amine transport |
GO:0030154 | 3e-04 | 1.8464 | 27.1493 | 46 | 1060 | cell differentiation |
GO:0048701 | 3e-04 | 6.2761 | 1.3041 | 7 | 44 | embryonic cranial skeleton morphogenesis |
GO:0009889 | 4e-04 | 1.5152 | 74.7062 | 102 | 2632 | regulation of biosynthetic process |
GO:0048665 | 4e-04 | 7.3603 | 0.9781 | 6 | 33 | neuron fate specification |
GO:0035909 | 4e-04 | 7.097 | 1.0077 | 6 | 34 | aorta morphogenesis |
GO:0021902 | 5e-04 | 32.9531 | 0.1778 | 3 | 6 | commitment of neuronal cell to specific neuron type in forebrain |
GO:0042713 | 5e-04 | 32.9531 | 0.1778 | 3 | 6 | sperm ejaculation |
GO:2001199 | 5e-04 | 32.9531 | 0.1778 | 3 | 6 | negative regulation of dendritic cell differentiation |
GO:0007368 | 5e-04 | 3.63 | 3.3194 | 11 | 112 | determination of left/right symmetry |
GO:0045766 | 5e-04 | 3.3645 | 3.8826 | 12 | 131 | positive regulation of angiogenesis |
GO:0030198 | 5e-04 | 2.3792 | 9.4249 | 21 | 318 | extracellular matrix organization |
GO:0048644 | 6e-04 | 4.2144 | 2.371 | 9 | 80 | muscle organ morphogenesis |
GO:0007275 | 6e-04 | 1.5261 | 67.1827 | 92 | 2608 | multicellular organism development |
GO:0060411 | 6e-04 | 4.6601 | 1.9265 | 8 | 65 | cardiac septum morphogenesis |
GO:1901342 | 7e-04 | 2.5161 | 7.6466 | 18 | 258 | regulation of vasculature development |
GO:0001667 | 7e-04 | 2.3233 | 9.6323 | 21 | 325 | ameboidal-type cell migration |
GO:0060037 | 7e-04 | 8.2657 | 0.7409 | 5 | 25 | pharyngeal system development |
GO:0045596 | 7e-04 | 1.9467 | 17.471 | 32 | 593 | negative regulation of cell differentiation |
GO:0008630 | 8e-04 | 3.6977 | 2.9638 | 10 | 100 | intrinsic apoptotic signaling pathway in response to DNA damage |
GO:0007498 | 8e-04 | 3.425 | 3.4973 | 11 | 118 | mesoderm development |
GO:0071772 | 8e-04 | 3.0138 | 4.6532 | 13 | 157 | response to BMP |
GO:0034127 | 8e-04 | 24.7132 | 0.2075 | 3 | 7 | regulation of MyD88-independent toll-like receptor signaling pathway |
GO:0002930 | 9e-04 | Inf | 0.0593 | 2 | 2 | trabecular meshwork development |
GO:1901246 | 9e-04 | Inf | 0.0593 | 2 | 2 | regulation of lung ciliated cell differentiation |
GO:2000824 | 9e-04 | Inf | 0.0593 | 2 | 2 | negative regulation of androgen receptor activity |
GO:0043583 | 0.001 | 2.6968 | 5.9572 | 15 | 201 | ear development |
GO:0009799 | 0.001 | 3.3007 | 3.6158 | 11 | 122 | specification of symmetry |
GO:0050789 | 0.001 | 1.4401 | 174.6937 | 202 | 6364 | regulation of biological process |
GO:0001709 | 0.0011 | 5.8422 | 1.1855 | 6 | 40 | cell fate determination |
GO:0071363 | 0.0012 | 1.8883 | 17.9606 | 32 | 606 | cellular response to growth factor stimulus |
GO:0016101 | 0.0012 | 3.7855 | 2.6081 | 9 | 88 | diterpenoid metabolic process |
GO:0009605 | 0.0012 | 1.5012 | 56.5788 | 79 | 1909 | response to external stimulus |
GO:0034654 | 0.0013 | 1.3759 | 118.1663 | 147 | 3987 | nucleobase-containing compound biosynthetic process |
GO:0035050 | 0.0013 | 4.1484 | 2.1339 | 8 | 72 | embryonic heart tube development |
GO:0002520 | 0.0013 | 1.7389 | 25.0144 | 41 | 844 | immune system development |
GO:0010940 | 0.0013 | 19.7692 | 0.2371 | 3 | 8 | positive regulation of necrotic cell death |
GO:0048486 | 0.0013 | 10.1552 | 0.5038 | 4 | 17 | parasympathetic nervous system development |
GO:0051173 | 0.0014 | 1.4257 | 80.7337 | 106 | 2724 | positive regulation of nitrogen compound metabolic process |
GO:0007417 | 0.0015 | 1.7252 | 25.1922 | 41 | 850 | central nervous system development |
GO:0010092 | 0.0015 | 6.8862 | 0.8595 | 5 | 29 | specification of animal organ identity |
GO:0048513 | 0.0015 | 1.5333 | 48.6522 | 69 | 1827 | animal organ development |
GO:0019098 | 0.0017 | 6.6103 | 0.8891 | 5 | 30 | reproductive behavior |
GO:0042221 | 0.0018 | 1.7041 | 26.3856 | 42 | 943 | response to chemical |
GO:0006334 | 0.0018 | 3.26 | 3.3194 | 10 | 112 | nucleosome assembly |
GO:0030900 | 0.0018 | 2.143 | 10.3733 | 21 | 350 | forebrain development |
GO:0060180 | 0.0019 | 16.4732 | 0.2667 | 3 | 9 | female mating behavior |
GO:2000288 | 0.0019 | 16.4732 | 0.2667 | 3 | 9 | positive regulation of myoblast proliferation |
GO:0060322 | 0.0019 | 1.7908 | 20.0649 | 34 | 677 | head development |
GO:0035176 | 0.002 | 5.0914 | 1.3337 | 6 | 45 | social behavior |
GO:0071774 | 0.002 | 3.0008 | 3.9418 | 11 | 133 | response to fibroblast growth factor |
GO:0003205 | 0.002 | 2.8353 | 4.5346 | 12 | 153 | cardiac chamber development |
GO:0001525 | 0.0021 | 2.2681 | 8.4099 | 18 | 289 | angiogenesis |
GO:0003215 | 0.0021 | 8.8 | 0.5631 | 4 | 19 | cardiac right ventricle morphogenesis |
GO:0042403 | 0.0021 | 8.8 | 0.5631 | 4 | 19 | thyroid hormone metabolic process |
GO:0060216 | 0.0021 | 8.8 | 0.5631 | 4 | 19 | definitive hemopoiesis |
GO:0045595 | 0.0022 | 1.6568 | 28.1831 | 44 | 990 | regulation of cell differentiation |
GO:0007631 | 0.0022 | 3.4356 | 2.8452 | 9 | 96 | feeding behavior |
GO:0001818 | 0.0023 | 2.4558 | 6.4907 | 15 | 219 | negative regulation of cytokine production |
GO:0032649 | 0.0023 | 3.7376 | 2.3414 | 8 | 79 | regulation of interferon-gamma production |
GO:0007399 | 0.0025 | 1.5751 | 35.8227 | 53 | 1258 | nervous system development |
GO:0021544 | 0.0025 | 8.2494 | 0.5928 | 4 | 20 | subpallium development |
GO:0043032 | 0.0025 | 8.2494 | 0.5928 | 4 | 20 | positive regulation of macrophage activation |
GO:0055008 | 0.0025 | 4.1413 | 1.8672 | 7 | 63 | cardiac muscle tissue morphogenesis |
GO:0002125 | 0.0026 | 65.7684 | 0.0889 | 2 | 3 | maternal aggressive behavior |
GO:0003285 | 0.0026 | 65.7684 | 0.0889 | 2 | 3 | septum secundum development |
GO:0003350 | 0.0026 | 65.7684 | 0.0889 | 2 | 3 | pulmonary myocardium development |
GO:0014717 | 0.0026 | 65.7684 | 0.0889 | 2 | 3 | regulation of satellite cell activation involved in skeletal muscle regeneration |
GO:0021912 | 0.0026 | 65.7684 | 0.0889 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
GO:0035054 | 0.0026 | 65.7684 | 0.0889 | 2 | 3 | embryonic heart tube anterior/posterior pattern specification |
GO:0055014 | 0.0026 | 65.7684 | 0.0889 | 2 | 3 | atrial cardiac muscle cell development |
GO:0060741 | 0.0026 | 65.7684 | 0.0889 | 2 | 3 | prostate gland stromal morphogenesis |
GO:0061010 | 0.0026 | 65.7684 | 0.0889 | 2 | 3 | gall bladder development |
GO:0061031 | 0.0026 | 65.7684 | 0.0889 | 2 | 3 | endodermal digestive tract morphogenesis |
GO:1902869 | 0.0026 | 65.7684 | 0.0889 | 2 | 3 | regulation of amacrine cell differentiation |
GO:2000297 | 0.0026 | 65.7684 | 0.0889 | 2 | 3 | negative regulation of synapse maturation |
GO:0009887 | 0.0026 | 2.0019 | 12.1325 | 23 | 433 | animal organ morphogenesis |
GO:0007369 | 0.0026 | 2.6104 | 5.3052 | 13 | 179 | gastrulation |
GO:0001708 | 0.0027 | 4.7826 | 1.4067 | 6 | 48 | cell fate specification |
GO:0061072 | 0.0027 | 14.1189 | 0.2964 | 3 | 10 | iris morphogenesis |
GO:0042475 | 0.0027 | 3.6347 | 2.4007 | 8 | 81 | odontogenesis of dentin-containing tooth |
GO:0042220 | 0.0028 | 4.7268 | 1.4226 | 6 | 48 | response to cocaine |
GO:0048583 | 0.003 | 1.3501 | 106.5779 | 132 | 3596 | regulation of response to stimulus |
GO:0007263 | 0.0031 | 7.7637 | 0.6224 | 4 | 21 | nitric oxide mediated signal transduction |
GO:0043586 | 0.0031 | 7.7637 | 0.6224 | 4 | 21 | tongue development |
GO:0048762 | 0.0031 | 2.5636 | 5.3941 | 13 | 182 | mesenchymal cell differentiation |
GO:0008543 | 0.0031 | 3.2477 | 2.9934 | 9 | 101 | fibroblast growth factor receptor signaling pathway |
GO:1903707 | 0.0032 | 2.9938 | 3.5862 | 10 | 121 | negative regulation of hemopoiesis |
GO:0048663 | 0.0033 | 5.5716 | 1.0258 | 5 | 35 | neuron fate commitment |
GO:0007601 | 0.0034 | 2.5332 | 5.4534 | 13 | 184 | visual perception |
GO:0048705 | 0.0034 | 2.4318 | 6.1054 | 14 | 206 | skeletal system morphogenesis |
GO:0007618 | 0.0035 | 5.5067 | 1.0373 | 5 | 35 | mating |
GO:0035295 | 0.0036 | 2.0139 | 10.9855 | 21 | 379 | tube development |
GO:0010454 | 0.0036 | 12.3532 | 0.326 | 3 | 11 | negative regulation of cell fate commitment |
GO:0021903 | 0.0036 | 12.3532 | 0.326 | 3 | 11 | rostrocaudal neural tube patterning |
GO:0048484 | 0.0036 | 12.3532 | 0.326 | 3 | 11 | enteric nervous system development |
GO:0042743 | 0.004 | 5.3287 | 1.067 | 5 | 36 | hydrogen peroxide metabolic process |
GO:0071542 | 0.004 | 5.3287 | 1.067 | 5 | 36 | dopaminergic neuron differentiation |
GO:0072009 | 0.004 | 3.1116 | 3.112 | 9 | 105 | nephron epithelium development |
GO:0030509 | 0.0042 | 2.7094 | 4.3271 | 11 | 146 | BMP signaling pathway |
GO:0045686 | 0.0043 | 6.9455 | 0.6817 | 4 | 23 | negative regulation of glial cell differentiation |
GO:0090103 | 0.0043 | 6.9455 | 0.6817 | 4 | 23 | cochlea morphogenesis |
GO:0060541 | 0.0044 | 2.4464 | 5.6312 | 13 | 190 | respiratory system development |
GO:0042472 | 0.0044 | 3.7081 | 2.0594 | 7 | 70 | inner ear morphogenesis |
GO:0030818 | 0.0045 | 5.1619 | 1.0966 | 5 | 37 | negative regulation of cAMP biosynthetic process |
GO:0030814 | 0.0045 | 2.8391 | 3.764 | 10 | 127 | regulation of cAMP metabolic process |
GO:0048565 | 0.0045 | 2.8391 | 3.764 | 10 | 127 | digestive tract development |
GO:0060537 | 0.0045 | 2.0051 | 10.4918 | 20 | 354 | muscle tissue development |
GO:0061061 | 0.0046 | 1.7629 | 17.2789 | 29 | 583 | muscle structure development |
GO:0043306 | 0.0047 | 10.9799 | 0.3557 | 3 | 12 | positive regulation of mast cell degranulation |
GO:0055015 | 0.0047 | 10.9799 | 0.3557 | 3 | 12 | ventricular cardiac muscle cell development |
GO:0097154 | 0.0047 | 10.9799 | 0.3557 | 3 | 12 | GABAergic neuron differentiation |
GO:0030099 | 0.0047 | 1.999 | 10.5215 | 20 | 355 | myeloid cell differentiation |
GO:0001707 | 0.005 | 3.6217 | 2.1043 | 7 | 71 | mesoderm formation |
GO:0002886 | 0.005 | 5.0051 | 1.1262 | 5 | 38 | regulation of myeloid leukocyte mediated immunity |
GO:0001975 | 0.0051 | 6.5978 | 0.7113 | 4 | 24 | response to amphetamine |
GO:0042554 | 0.0051 | 6.5978 | 0.7113 | 4 | 24 | superoxide anion generation |
GO:0060487 | 0.0051 | 6.5978 | 0.7113 | 4 | 24 | lung epithelial cell differentiation |
GO:0061217 | 0.0051 | 6.5978 | 0.7113 | 4 | 24 | regulation of mesonephros development |
GO:0001992 | 0.0051 | 32.882 | 0.1186 | 2 | 4 | regulation of systemic arterial blood pressure by vasopressin |
GO:0002580 | 0.0051 | 32.882 | 0.1186 | 2 | 4 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II |
GO:0007621 | 0.0051 | 32.882 | 0.1186 | 2 | 4 | negative regulation of female receptivity |
GO:0010701 | 0.0051 | 32.882 | 0.1186 | 2 | 4 | positive regulation of norepinephrine secretion |
GO:0021764 | 0.0051 | 32.882 | 0.1186 | 2 | 4 | amygdala development |
GO:0021913 | 0.0051 | 32.882 | 0.1186 | 2 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
GO:0060406 | 0.0051 | 32.882 | 0.1186 | 2 | 4 | positive regulation of penile erection |
GO:0061055 | 0.0051 | 32.882 | 0.1186 | 2 | 4 | myotome development |
GO:0072107 | 0.0051 | 32.882 | 0.1186 | 2 | 4 | positive regulation of ureteric bud formation |
GO:0090191 | 0.0051 | 32.882 | 0.1186 | 2 | 4 | negative regulation of branching involved in ureteric bud morphogenesis |
GO:1905205 | 0.0051 | 32.882 | 0.1186 | 2 | 4 | positive regulation of connective tissue replacement |
GO:0009890 | 0.0052 | 1.4637 | 44.8125 | 62 | 1512 | negative regulation of biosynthetic process |
GO:0003002 | 0.0052 | 2.9681 | 3.2449 | 9 | 113 | regionalization |
GO:0010469 | 0.0056 | 1.817 | 14.4337 | 25 | 487 | regulation of receptor activity |
GO:0090132 | 0.0058 | 2.2035 | 7.1724 | 15 | 242 | epithelium migration |
GO:0039528 | 0.0059 | 6.2832 | 0.7409 | 4 | 25 | cytoplasmic pattern recognition receptor signaling pathway in response to virus |
GO:0061548 | 0.0059 | 9.8812 | 0.3853 | 3 | 13 | ganglion development |
GO:0090196 | 0.0059 | 9.8812 | 0.3853 | 3 | 13 | regulation of chemokine secretion |
GO:0030802 | 0.0062 | 2.6995 | 3.9418 | 10 | 133 | regulation of cyclic nucleotide biosynthetic process |
GO:0046849 | 0.0062 | 3.4588 | 2.1932 | 7 | 74 | bone remodeling |
GO:0043300 | 0.0063 | 4.7184 | 1.1855 | 5 | 40 | regulation of leukocyte degranulation |
GO:0045446 | 0.0063 | 3.1191 | 2.7563 | 8 | 93 | endothelial cell differentiation |
GO:0060255 | 0.0064 | 1.2805 | 165.2017 | 191 | 5574 | regulation of macromolecule metabolic process |
GO:0048666 | 0.0065 | 1.5618 | 28.2449 | 42 | 953 | neuron development |
GO:0001947 | 0.0066 | 3.8903 | 1.6894 | 6 | 57 | heart looping |
GO:0043066 | 0.0066 | 1.6166 | 23.3547 | 36 | 788 | negative regulation of apoptotic process |
GO:0050830 | 0.0067 | 3.4077 | 2.2228 | 7 | 75 | defense response to Gram-positive bacterium |
GO:0050866 | 0.0068 | 2.5209 | 4.6235 | 11 | 156 | negative regulation of cell activation |
GO:0009952 | 0.0069 | 2.4011 | 5.2805 | 12 | 180 | anterior/posterior pattern specification |
GO:0021700 | 0.007 | 2.1553 | 7.3206 | 15 | 247 | developmental maturation |
GO:0010951 | 0.007 | 2.3015 | 5.9572 | 13 | 201 | negative regulation of endopeptidase activity |
GO:0007611 | 0.0071 | 2.2206 | 6.6389 | 14 | 224 | learning or memory |
GO:0070887 | 0.0072 | 1.3412 | 81.3264 | 102 | 2744 | cellular response to chemical stimulus |
GO:0045995 | 0.0072 | 2.8161 | 3.4084 | 9 | 115 | regulation of embryonic development |
GO:0003407 | 0.0072 | 3.8152 | 1.719 | 6 | 58 | neural retina development |
GO:0051937 | 0.0072 | 3.8152 | 1.719 | 6 | 58 | catecholamine transport |
GO:0042711 | 0.0074 | 8.9823 | 0.4149 | 3 | 14 | maternal behavior |
GO:0030809 | 0.0077 | 4.4628 | 1.2448 | 5 | 42 | negative regulation of nucleotide biosynthetic process |
GO:0048522 | 0.0077 | 1.3137 | 106.0444 | 128 | 3784 | positive regulation of cellular process |
GO:0033006 | 0.0078 | 5.736 | 0.8002 | 4 | 27 | regulation of mast cell activation involved in immune response |
GO:0042572 | 0.0078 | 5.736 | 0.8002 | 4 | 27 | retinol metabolic process |
GO:0060706 | 0.0078 | 5.736 | 0.8002 | 4 | 27 | cell differentiation involved in embryonic placenta development |
GO:0042127 | 0.0078 | 1.676 | 18.7764 | 30 | 670 | regulation of cell proliferation |
GO:0060041 | 0.0079 | 3.2961 | 2.2897 | 7 | 78 | retina development in camera-type eye |
GO:0051122 | 0.0083 | 21.9198 | 0.1482 | 2 | 5 | hepoxilin biosynthetic process |
GO:0051891 | 0.0083 | 21.9198 | 0.1482 | 2 | 5 | positive regulation of cardioblast differentiation |
GO:0061009 | 0.0083 | 21.9198 | 0.1482 | 2 | 5 | common bile duct development |
GO:0071502 | 0.0083 | 21.9198 | 0.1482 | 2 | 5 | cellular response to temperature stimulus |
GO:1903232 | 0.0083 | 21.9198 | 0.1482 | 2 | 5 | melanosome assembly |
GO:2000609 | 0.0083 | 21.9198 | 0.1482 | 2 | 5 | regulation of thyroid hormone generation |
GO:2001188 | 0.0083 | 21.9198 | 0.1482 | 2 | 5 | regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
GO:0048870 | 0.0084 | 1.4558 | 39.7444 | 55 | 1341 | cell motility |
GO:0048699 | 0.0084 | 1.6652 | 18.8758 | 30 | 654 | generation of neurons |
GO:0006720 | 0.0085 | 2.738 | 3.4973 | 9 | 118 | isoprenoid metabolic process |
GO:0030800 | 0.0085 | 4.3451 | 1.2744 | 5 | 43 | negative regulation of cyclic nucleotide metabolic process |
GO:0050433 | 0.0085 | 4.3451 | 1.2744 | 5 | 43 | regulation of catecholamine secretion |
GO:0050767 | 0.0087 | 1.6452 | 19.7092 | 31 | 665 | regulation of neurogenesis |
GO:0043403 | 0.0089 | 5.4966 | 0.8299 | 4 | 28 | skeletal muscle tissue regeneration |
GO:0007224 | 0.0089 | 2.713 | 3.5269 | 9 | 119 | smoothened signaling pathway |
GO:0009950 | 0.009 | 8.2333 | 0.4446 | 3 | 15 | dorsal/ventral axis specification |
GO:0033005 | 0.009 | 8.2333 | 0.4446 | 3 | 15 | positive regulation of mast cell activation |
GO:2000484 | 0.009 | 8.2333 | 0.4446 | 3 | 15 | positive regulation of interleukin-8 secretion |
GO:0001655 | 0.0091 | 1.9832 | 8.9803 | 17 | 303 | urogenital system development |
GO:0007423 | 0.0092 | 2.4102 | 4.8156 | 11 | 169 | sensory organ development |
GO:0048592 | 0.0093 | 2.5333 | 4.1789 | 10 | 141 | eye morphogenesis |
GO:0048754 | 0.0093 | 2.5333 | 4.1789 | 10 | 141 | branching morphogenesis of an epithelial tube |
GO:1900371 | 0.0093 | 2.5333 | 4.1789 | 10 | 141 | regulation of purine nucleotide biosynthetic process |
GO:0002448 | 0.0094 | 4.2334 | 1.3041 | 5 | 44 | mast cell mediated immunity |
GO:0060840 | 0.0095 | 3.1732 | 2.371 | 7 | 80 | artery development |
GO:0050877 | 0.0095 | 1.5548 | 25.5775 | 38 | 863 | nervous system process |
GO:0007389 | 0.0096 | 5.3368 | 0.847 | 4 | 30 | pattern specification process |
GO:0007409 | 0.0098 | 1.8242 | 12.033 | 21 | 406 | axonogenesis |
GO:0000122 | 0.0099 | 1.5906 | 22.347 | 34 | 754 | negative regulation of transcription from RNA polymerase II promoter |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007156 | 1e-04 | 4.6802 | 2.5771 | 11 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0021562 | 3e-04 | 35.1859 | 0.1356 | 3 | 8 | vestibulocochlear nerve development |
GO:0045165 | 3e-04 | 3.4986 | 3.691 | 12 | 220 | cell fate commitment |
GO:0030198 | 4e-04 | 2.9858 | 5.3916 | 15 | 318 | extracellular matrix organization |
GO:0050911 | 4e-04 | 6.9599 | 0.9664 | 6 | 57 | detection of chemical stimulus involved in sensory perception of smell |
GO:0032501 | 5e-04 | 1.6064 | 73.2952 | 97 | 4673 | multicellular organismal process |
GO:0071626 | 8e-04 | 116.8594 | 0.0509 | 2 | 3 | mastication |
GO:0098583 | 8e-04 | 116.8594 | 0.0509 | 2 | 3 | learned vocalization behavior |
GO:1905747 | 8e-04 | 116.8594 | 0.0509 | 2 | 3 | negative regulation of saliva secretion |
GO:1905748 | 8e-04 | 116.8594 | 0.0509 | 2 | 3 | hard palate morphogenesis |
GO:0050482 | 0.001 | 10.2266 | 0.4578 | 4 | 27 | arachidonic acid secretion |
GO:0008284 | 0.0012 | 2.0511 | 13.5807 | 26 | 801 | positive regulation of cell proliferation |
GO:0050906 | 0.0016 | 3.9241 | 2.1872 | 8 | 129 | detection of stimulus involved in sensory perception |
GO:0050900 | 0.0016 | 2.5467 | 6.2563 | 15 | 369 | leukocyte migration |
GO:0034653 | 0.0017 | 58.4258 | 0.0678 | 2 | 4 | retinoic acid catabolic process |
GO:0019372 | 0.0019 | 14.6539 | 0.2543 | 3 | 15 | lipoxygenase pathway |
GO:0060429 | 0.0019 | 1.8398 | 18.6671 | 32 | 1101 | epithelium development |
GO:0048333 | 0.0022 | 8.1075 | 0.5595 | 4 | 33 | mesodermal cell differentiation |
GO:0048665 | 0.0022 | 8.1075 | 0.5595 | 4 | 33 | neuron fate specification |
GO:0042246 | 0.0025 | 5.777 | 0.9495 | 5 | 56 | tissue regeneration |
GO:0036148 | 0.0027 | 12.5588 | 0.2882 | 3 | 17 | phosphatidylglycerol acyl-chain remodeling |
GO:0000467 | 0.0028 | 38.9479 | 0.0848 | 2 | 5 | exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) |
GO:0007356 | 0.0028 | 38.9479 | 0.0848 | 2 | 5 | thorax and anterior abdomen determination |
GO:0021650 | 0.0028 | 38.9479 | 0.0848 | 2 | 5 | vestibulocochlear nerve formation |
GO:0043305 | 0.0028 | 38.9479 | 0.0848 | 2 | 5 | negative regulation of mast cell degranulation |
GO:0071038 | 0.0028 | 38.9479 | 0.0848 | 2 | 5 | nuclear polyadenylation-dependent tRNA catabolic process |
GO:0097070 | 0.0028 | 38.9479 | 0.0848 | 2 | 5 | ductus arteriosus closure |
GO:1901078 | 0.0028 | 38.9479 | 0.0848 | 2 | 5 | negative regulation of relaxation of muscle |
GO:0048856 | 0.0029 | 1.9347 | 14.6994 | 26 | 965 | anatomical structure development |
GO:0042693 | 0.0033 | 11.7208 | 0.3052 | 3 | 18 | muscle cell fate commitment |
GO:0009593 | 0.0036 | 3.7995 | 1.9667 | 7 | 116 | detection of chemical stimulus |
GO:0007218 | 0.0038 | 4.3197 | 1.492 | 6 | 88 | neuropeptide signaling pathway |
GO:0048557 | 0.0038 | 10.9875 | 0.3221 | 3 | 19 | embryonic digestive tract morphogenesis |
GO:0001957 | 0.0041 | 29.209 | 0.1017 | 2 | 6 | intramembranous ossification |
GO:0016115 | 0.0041 | 29.209 | 0.1017 | 2 | 6 | terpenoid catabolic process |
GO:0060426 | 0.0041 | 29.209 | 0.1017 | 2 | 6 | lung vasculature development |
GO:0060842 | 0.0041 | 29.209 | 0.1017 | 2 | 6 | arterial endothelial cell differentiation |
GO:0061074 | 0.0041 | 29.209 | 0.1017 | 2 | 6 | regulation of neural retina development |
GO:0071029 | 0.0041 | 29.209 | 0.1017 | 2 | 6 | nuclear ncRNA surveillance |
GO:0071035 | 0.0041 | 29.209 | 0.1017 | 2 | 6 | nuclear polyadenylation-dependent rRNA catabolic process |
GO:1902302 | 0.0041 | 29.209 | 0.1017 | 2 | 6 | regulation of potassium ion export |
GO:0048568 | 0.0041 | 2.2939 | 6.9006 | 15 | 407 | embryonic organ development |
GO:0001756 | 0.0043 | 5.0773 | 1.0681 | 5 | 63 | somitogenesis |
GO:0070268 | 0.0053 | 4.0235 | 1.5937 | 6 | 94 | cornification |
GO:0045927 | 0.0053 | 2.7522 | 3.8318 | 10 | 226 | positive regulation of growth |
GO:0048731 | 0.0054 | 1.4198 | 71.0064 | 90 | 4188 | system development |
GO:0071715 | 0.0055 | 6.1836 | 0.7121 | 4 | 42 | icosanoid transport |
GO:0032429 | 0.0057 | 23.3656 | 0.1187 | 2 | 7 | regulation of phospholipase A2 activity |
GO:0043634 | 0.0057 | 23.3656 | 0.1187 | 2 | 7 | polyadenylation-dependent ncRNA catabolic process |
GO:0097623 | 0.0057 | 23.3656 | 0.1187 | 2 | 7 | potassium ion export across plasma membrane |
GO:0098700 | 0.0057 | 23.3656 | 0.1187 | 2 | 7 | neurotransmitter loading into synaptic vesicle |
GO:0045944 | 0.006 | 1.7397 | 17.7007 | 29 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
GO:0045686 | 0.0066 | 8.7876 | 0.39 | 3 | 23 | negative regulation of glial cell differentiation |
GO:0048729 | 0.0067 | 1.9709 | 10.1559 | 19 | 599 | tissue morphogenesis |
GO:0055007 | 0.0068 | 3.8059 | 1.6785 | 6 | 99 | cardiac muscle cell differentiation |
GO:0006955 | 0.0069 | 1.5738 | 28.6026 | 42 | 1687 | immune response |
GO:0003008 | 0.007 | 1.5967 | 26.1103 | 39 | 1540 | system process |
GO:0010927 | 0.0071 | 3.7652 | 1.6955 | 6 | 100 | cellular component assembly involved in morphogenesis |
GO:0007606 | 0.0073 | 3.3096 | 2.238 | 7 | 132 | sensory perception of chemical stimulus |
GO:0072202 | 0.0075 | 8.3686 | 0.4069 | 3 | 24 | cell differentiation involved in metanephros development |
GO:0031017 | 0.0075 | 19.4701 | 0.1356 | 2 | 8 | exocrine pancreas development |
GO:0034475 | 0.0075 | 19.4701 | 0.1356 | 2 | 8 | U4 snRNA 3'-end processing |
GO:0035881 | 0.0075 | 19.4701 | 0.1356 | 2 | 8 | amacrine cell differentiation |
GO:0048743 | 0.0075 | 19.4701 | 0.1356 | 2 | 8 | positive regulation of skeletal muscle fiber development |
GO:0045661 | 0.0075 | 5.5932 | 0.7799 | 4 | 46 | regulation of myoblast differentiation |
GO:0060042 | 0.0075 | 5.5932 | 0.7799 | 4 | 46 | retina morphogenesis in camera-type eye |
GO:0044236 | 0.0082 | 3.2314 | 2.2889 | 7 | 135 | multicellular organism metabolic process |
GO:0036152 | 0.0084 | 7.9877 | 0.4239 | 3 | 25 | phosphatidylethanolamine acyl-chain remodeling |
GO:1902253 | 0.0084 | 7.9877 | 0.4239 | 3 | 25 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator |
GO:0009605 | 0.0084 | 1.5253 | 32.3666 | 46 | 1909 | response to external stimulus |
GO:0003002 | 0.0088 | 2.3127 | 5.4425 | 12 | 321 | regionalization |
GO:0040011 | 0.0089 | 1.5699 | 26.5002 | 39 | 1563 | locomotion |
GO:0072009 | 0.0089 | 3.5738 | 1.7802 | 6 | 105 | nephron epithelium development |
GO:0070207 | 0.0094 | 7.6399 | 0.4408 | 3 | 26 | protein homotrimerization |
GO:0050885 | 0.0094 | 5.2192 | 0.8308 | 4 | 49 | neuromuscular process controlling balance |
GO:0015816 | 0.0095 | 16.6875 | 0.1526 | 2 | 9 | glycine transport |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006355 | 0 | 1.8523 | 99.5843 | 153 | 3375 | regulation of transcription, DNA-templated |
GO:0009792 | 0 | 2.9975 | 16.14 | 43 | 547 | embryo development ending in birth or egg hatching |
GO:2001141 | 0 | 1.8333 | 100.3515 | 153 | 3401 | regulation of RNA biosynthetic process |
GO:0007389 | 0 | 4.3814 | 6.5168 | 25 | 229 | pattern specification process |
GO:1903507 | 0 | 2.2985 | 32.8702 | 67 | 1114 | negative regulation of nucleic acid-templated transcription |
GO:0023019 | 0 | 24.3364 | 0.5606 | 8 | 19 | signal transduction involved in regulation of gene expression |
GO:0051253 | 0 | 2.217 | 35.0242 | 69 | 1187 | negative regulation of RNA metabolic process |
GO:0007423 | 0 | 2.9129 | 14.9303 | 39 | 506 | sensory organ development |
GO:0048562 | 0 | 6.7812 | 2.6416 | 15 | 93 | embryonic organ morphogenesis |
GO:0019219 | 0 | 1.6967 | 116.0195 | 165 | 3932 | regulation of nucleobase-containing compound metabolic process |
GO:0000122 | 0 | 2.4436 | 22.2479 | 49 | 754 | negative regulation of transcription from RNA polymerase II promoter |
GO:0034654 | 0 | 1.6805 | 117.6423 | 166 | 3987 | nucleobase-containing compound biosynthetic process |
GO:0010454 | 0 | 39.9901 | 0.3246 | 6 | 11 | negative regulation of cell fate commitment |
GO:0009952 | 0 | 4.2247 | 5.3434 | 20 | 183 | anterior/posterior pattern specification |
GO:0010648 | 0 | 2.0503 | 35.7323 | 66 | 1211 | negative regulation of cell communication |
GO:0023057 | 0 | 2.0425 | 35.8504 | 66 | 1215 | negative regulation of signaling |
GO:0045944 | 0 | 2.0734 | 30.8048 | 58 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
GO:0048585 | 0 | 1.9329 | 40.6894 | 71 | 1379 | negative regulation of response to stimulus |
GO:0009890 | 0 | 1.8917 | 44.6138 | 76 | 1512 | negative regulation of biosynthetic process |
GO:0022008 | 0 | 2.0123 | 34.0266 | 62 | 1172 | neurogenesis |
GO:0048704 | 0 | 5.544 | 2.7146 | 13 | 92 | embryonic skeletal system morphogenesis |
GO:0048729 | 0 | 2.4953 | 15.3174 | 35 | 526 | tissue morphogenesis |
GO:2000113 | 0 | 1.9004 | 40.0403 | 69 | 1357 | negative regulation of cellular macromolecule biosynthetic process |
GO:0072175 | 0 | 4.4824 | 3.7768 | 15 | 128 | epithelial tube formation |
GO:0001947 | 0 | 7.1347 | 1.6819 | 10 | 57 | heart looping |
GO:1903508 | 0 | 1.8904 | 39.5977 | 68 | 1342 | positive regulation of nucleic acid-templated transcription |
GO:0051172 | 0 | 1.6927 | 66.0355 | 100 | 2238 | negative regulation of nitrogen compound metabolic process |
GO:0003151 | 0 | 5.862 | 2.1835 | 11 | 74 | outflow tract morphogenesis |
GO:0060255 | 0 | 1.5122 | 164.4691 | 208 | 5574 | regulation of macromolecule metabolic process |
GO:0060485 | 0 | 3.2163 | 6.816 | 20 | 231 | mesenchyme development |
GO:0070848 | 0 | 2.2297 | 18.4711 | 38 | 626 | response to growth factor |
GO:0048839 | 0 | 3.5703 | 5.2522 | 17 | 178 | inner ear development |
GO:0060322 | 0 | 2.1696 | 19.9759 | 40 | 677 | head development |
GO:0003357 | 0 | 44.2397 | 0.2065 | 4 | 7 | noradrenergic neuron differentiation |
GO:0061303 | 0 | 44.2397 | 0.2065 | 4 | 7 | cornea development in camera-type eye |
GO:0014033 | 0 | 5.879 | 1.9769 | 10 | 67 | neural crest cell differentiation |
GO:0016331 | 0 | 3.8917 | 4.2784 | 15 | 145 | morphogenesis of embryonic epithelium |
GO:0035107 | 0 | 3.8917 | 4.2784 | 15 | 145 | appendage morphogenesis |
GO:0009954 | 0 | 9.7293 | 0.9147 | 7 | 31 | proximal/distal pattern formation |
GO:0031324 | 0 | 1.6288 | 70.3729 | 103 | 2385 | negative regulation of cellular metabolic process |
GO:0010628 | 0 | 1.7281 | 50.2495 | 79 | 1703 | positive regulation of gene expression |
GO:0051254 | 0 | 1.7841 | 41.6336 | 68 | 1411 | positive regulation of RNA metabolic process |
GO:0030901 | 0 | 5.0555 | 2.4785 | 11 | 84 | midbrain development |
GO:0001764 | 0 | 3.9619 | 3.9244 | 14 | 133 | neuron migration |
GO:0048665 | 0 | 8.9796 | 0.9737 | 7 | 33 | neuron fate specification |
GO:0035050 | 0 | 5.403 | 2.1245 | 10 | 72 | embryonic heart tube development |
GO:0021915 | 1e-04 | 3.6375 | 4.544 | 15 | 154 | neural tube development |
GO:0071901 | 1e-04 | 4.0854 | 3.5408 | 13 | 120 | negative regulation of protein serine/threonine kinase activity |
GO:0031328 | 1e-04 | 1.6905 | 49.8069 | 77 | 1688 | positive regulation of cellular biosynthetic process |
GO:0009799 | 1e-04 | 4.0099 | 3.5998 | 13 | 122 | specification of symmetry |
GO:0090287 | 1e-04 | 2.9768 | 6.934 | 19 | 235 | regulation of cellular response to growth factor stimulus |
GO:0071542 | 1e-04 | 8.0491 | 1.0622 | 7 | 36 | dopaminergic neuron differentiation |
GO:0043433 | 1e-04 | 3.9017 | 3.6883 | 13 | 125 | negative regulation of DNA binding transcription factor activity |
GO:0030326 | 1e-04 | 3.8669 | 3.7178 | 13 | 126 | embryonic limb morphogenesis |
GO:0014031 | 1e-04 | 5.5735 | 1.8589 | 9 | 63 | mesenchymal cell development |
GO:0042662 | 1e-04 | 99.3296 | 0.118 | 3 | 4 | negative regulation of mesodermal cell fate specification |
GO:0070836 | 1e-04 | 99.3296 | 0.118 | 3 | 4 | caveola assembly |
GO:1902746 | 1e-04 | 99.3296 | 0.118 | 3 | 4 | regulation of lens fiber cell differentiation |
GO:1905903 | 1e-04 | 99.3296 | 0.118 | 3 | 4 | negative regulation of mesoderm formation |
GO:0048486 | 1e-04 | 13.8476 | 0.5016 | 5 | 17 | parasympathetic nervous system development |
GO:0007368 | 1e-04 | 4.0278 | 3.3047 | 12 | 112 | determination of left/right symmetry |
GO:0010629 | 1e-04 | 1.6537 | 50.043 | 76 | 1696 | negative regulation of gene expression |
GO:0010470 | 1e-04 | 7.293 | 1.1508 | 7 | 39 | regulation of gastrulation |
GO:0032502 | 1e-04 | 1.5004 | 110.9959 | 144 | 4066 | developmental process |
GO:0010557 | 1e-04 | 1.6751 | 46.0301 | 71 | 1560 | positive regulation of macromolecule biosynthetic process |
GO:2000678 | 1e-04 | 12.7815 | 0.5311 | 5 | 18 | negative regulation of transcription regulatory region DNA binding |
GO:0060173 | 2e-04 | 3.2584 | 5.0161 | 15 | 170 | limb development |
GO:1901576 | 2e-04 | 1.4221 | 173.5571 | 211 | 5882 | organic substance biosynthetic process |
GO:0001706 | 2e-04 | 5.8058 | 1.5933 | 8 | 54 | endoderm formation |
GO:0009953 | 2e-04 | 4.492 | 2.4924 | 10 | 85 | dorsal/ventral pattern formation |
GO:0044857 | 2e-04 | 49.6614 | 0.1475 | 3 | 5 | plasma membrane raft organization |
GO:0046533 | 2e-04 | 49.6614 | 0.1475 | 3 | 5 | negative regulation of photoreceptor cell differentiation |
GO:0048731 | 3e-04 | 1.5588 | 68.9197 | 96 | 2657 | system development |
GO:1901861 | 3e-04 | 3.6592 | 3.5998 | 12 | 122 | regulation of muscle tissue development |
GO:0048592 | 3e-04 | 3.4103 | 4.1604 | 13 | 141 | eye morphogenesis |
GO:0007267 | 3e-04 | 1.6546 | 43.0499 | 66 | 1459 | cell-cell signaling |
GO:0048485 | 3e-04 | 10.3829 | 0.6196 | 5 | 21 | sympathetic nervous system development |
GO:0030900 | 3e-04 | 2.3843 | 10.3273 | 23 | 350 | forebrain development |
GO:0045746 | 3e-04 | 7.6795 | 0.9442 | 6 | 32 | negative regulation of Notch signaling pathway |
GO:0003207 | 3e-04 | 16.5843 | 0.3541 | 4 | 12 | cardiac chamber formation |
GO:0097154 | 3e-04 | 16.5843 | 0.3541 | 4 | 12 | GABAergic neuron differentiation |
GO:0048634 | 3e-04 | 3.5613 | 3.6883 | 12 | 125 | regulation of muscle organ development |
GO:0007517 | 4e-04 | 2.7708 | 6.6019 | 17 | 228 | muscle organ development |
GO:0042127 | 4e-04 | 1.639 | 43.404 | 66 | 1471 | regulation of cell proliferation |
GO:0042471 | 4e-04 | 3.6837 | 3.2752 | 11 | 111 | ear morphogenesis |
GO:0045597 | 4e-04 | 1.864 | 22.9113 | 40 | 784 | positive regulation of cell differentiation |
GO:0045936 | 4e-04 | 2.0361 | 16.2286 | 31 | 550 | negative regulation of phosphate metabolic process |
GO:0021544 | 5e-04 | 33.3824 | 0.1756 | 3 | 6 | subpallium development |
GO:0045686 | 5e-04 | 9.228 | 0.6786 | 5 | 23 | negative regulation of glial cell differentiation |
GO:0060022 | 5e-04 | 33.1054 | 0.177 | 3 | 6 | hard palate development |
GO:0061074 | 5e-04 | 33.1054 | 0.177 | 3 | 6 | regulation of neural retina development |
GO:0048646 | 5e-04 | 1.7864 | 26.9189 | 45 | 931 | anatomical structure formation involved in morphogenesis |
GO:2000826 | 5e-04 | 6.8836 | 1.0327 | 6 | 35 | regulation of heart morphogenesis |
GO:0048864 | 5e-04 | 4.8528 | 1.8589 | 8 | 63 | stem cell development |
GO:1903524 | 5e-04 | 4.8528 | 1.8589 | 8 | 63 | positive regulation of blood circulation |
GO:0021510 | 5e-04 | 3.8889 | 2.8326 | 10 | 96 | spinal cord development |
GO:0071560 | 5e-04 | 2.7615 | 6.2259 | 16 | 211 | cellular response to transforming growth factor beta stimulus |
GO:0009888 | 6e-04 | 1.816 | 24.7711 | 42 | 898 | tissue development |
GO:0002088 | 6e-04 | 4.7658 | 1.8884 | 8 | 64 | lens development in camera-type eye |
GO:0060914 | 6e-04 | 8.7417 | 0.7082 | 5 | 24 | heart formation |
GO:0021756 | 6e-04 | 13.2656 | 0.4131 | 4 | 14 | striatum development |
GO:0090304 | 6e-04 | 1.3867 | 141.6606 | 174 | 4801 | nucleic acid metabolic process |
GO:0009798 | 6e-04 | 4.175 | 2.39 | 9 | 81 | axis specification |
GO:0061138 | 6e-04 | 2.9571 | 5.1046 | 14 | 173 | morphogenesis of a branching epithelium |
GO:0030182 | 7e-04 | 1.6911 | 32.8905 | 52 | 1144 | neuron differentiation |
GO:0061053 | 7e-04 | 4.1175 | 2.4195 | 9 | 82 | somite development |
GO:0045744 | 7e-04 | 6.4387 | 1.0917 | 6 | 37 | negative regulation of G-protein coupled receptor protein signaling pathway |
GO:0051100 | 7e-04 | 3.2429 | 4.0129 | 12 | 136 | negative regulation of binding |
GO:0045992 | 7e-04 | 8.3041 | 0.7377 | 5 | 25 | negative regulation of embryonic development |
GO:0048596 | 7e-04 | 8.3041 | 0.7377 | 5 | 25 | embryonic camera-type eye morphogenesis |
GO:0060562 | 7e-04 | 3.4437 | 3.4755 | 11 | 121 | epithelial tube morphogenesis |
GO:0071773 | 8e-04 | 3.028 | 4.6325 | 13 | 157 | cellular response to BMP stimulus |
GO:0060026 | 8e-04 | 12.0588 | 0.4426 | 4 | 15 | convergent extension |
GO:0051093 | 8e-04 | 1.815 | 22.8562 | 39 | 782 | negative regulation of developmental process |
GO:0021798 | 8e-04 | 24.8274 | 0.2065 | 3 | 7 | forebrain dorsal/ventral pattern formation |
GO:2000096 | 8e-04 | 24.8274 | 0.2065 | 3 | 7 | positive regulation of Wnt signaling pathway, planar cell polarity pathway |
GO:0061458 | 8e-04 | 2.1615 | 11.8026 | 24 | 400 | reproductive system development |
GO:0042221 | 9e-04 | 1.4027 | 108.7904 | 138 | 3687 | response to chemical |
GO:0021903 | 9e-04 | Inf | 0.0587 | 2 | 2 | rostrocaudal neural tube patterning |
GO:0014036 | 9e-04 | Inf | 0.059 | 2 | 2 | neural crest cell fate specification |
GO:0021882 | 9e-04 | Inf | 0.059 | 2 | 2 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment |
GO:0021893 | 9e-04 | Inf | 0.059 | 2 | 2 | cerebral cortex GABAergic interneuron fate commitment |
GO:0071228 | 9e-04 | Inf | 0.059 | 2 | 2 | cellular response to tumor cell |
GO:1902868 | 9e-04 | Inf | 0.059 | 2 | 2 | positive regulation of retina development in camera-type eye |
GO:1902871 | 9e-04 | Inf | 0.059 | 2 | 2 | positive regulation of amacrine cell differentiation |
GO:2001111 | 9e-04 | Inf | 0.059 | 2 | 2 | positive regulation of lens epithelial cell proliferation |
GO:0048732 | 9e-04 | 2.1498 | 11.8616 | 24 | 402 | gland development |
GO:0097746 | 0.001 | 3.3162 | 3.5998 | 11 | 122 | regulation of blood vessel diameter |
GO:0061311 | 0.001 | 7.5481 | 0.7967 | 5 | 27 | cell surface receptor signaling pathway involved in heart development |
GO:0035270 | 0.001 | 3.2864 | 3.6293 | 11 | 123 | endocrine system development |
GO:0071310 | 0.0011 | 1.5407 | 49.612 | 71 | 1731 | cellular response to organic substance |
GO:0055024 | 0.0011 | 4.2342 | 2.095 | 8 | 71 | regulation of cardiac muscle tissue development |
GO:0051101 | 0.0012 | 3.4814 | 3.1277 | 10 | 106 | regulation of DNA binding |
GO:2000026 | 0.0012 | 1.5945 | 39.6033 | 59 | 1397 | regulation of multicellular organismal development |
GO:0042659 | 0.0013 | 19.9473 | 0.2351 | 3 | 8 | regulation of cell fate specification |
GO:0003310 | 0.0013 | 19.8605 | 0.2361 | 3 | 8 | pancreatic A cell differentiation |
GO:1903251 | 0.0013 | 19.8605 | 0.2361 | 3 | 8 | multi-ciliated epithelial cell differentiation |
GO:1905770 | 0.0013 | 19.8605 | 0.2361 | 3 | 8 | regulation of mesodermal cell differentiation |
GO:0048332 | 0.0014 | 4.1034 | 2.154 | 8 | 73 | mesoderm morphogenesis |
GO:0003203 | 0.0014 | 6.9182 | 0.8557 | 5 | 29 | endocardial cushion morphogenesis |
GO:0031128 | 0.0014 | 6.9182 | 0.8557 | 5 | 29 | developmental induction |
GO:0007519 | 0.0015 | 2.9544 | 4.367 | 12 | 148 | skeletal muscle tissue development |
GO:0033673 | 0.0015 | 2.4024 | 7.5242 | 17 | 255 | negative regulation of kinase activity |
GO:1905207 | 0.0015 | 5.3923 | 1.2688 | 6 | 43 | regulation of cardiocyte differentiation |
GO:0009889 | 0.0016 | 1.4541 | 71.6334 | 95 | 2632 | regulation of biosynthetic process |
GO:0031016 | 0.0016 | 3.9804 | 2.213 | 8 | 75 | pancreas development |
GO:0048598 | 0.0016 | 2.6525 | 5.629 | 14 | 206 | embryonic morphogenesis |
GO:0035150 | 0.0016 | 3.0916 | 3.8358 | 11 | 130 | regulation of tube size |
GO:0051962 | 0.0017 | 2.0093 | 13.1599 | 25 | 446 | positive regulation of nervous system development |
GO:0051148 | 0.0017 | 4.4819 | 1.7409 | 7 | 59 | negative regulation of muscle cell differentiation |
GO:0051173 | 0.0017 | 1.4159 | 80.3756 | 105 | 2724 | positive regulation of nitrogen compound metabolic process |
GO:0051241 | 0.0018 | 1.6746 | 27.8541 | 44 | 953 | negative regulation of multicellular organismal process |
GO:0009719 | 0.0018 | 1.5533 | 41.132 | 60 | 1394 | response to endogenous stimulus |
GO:0030917 | 0.0019 | 16.5493 | 0.2656 | 3 | 9 | midbrain-hindbrain boundary development |
GO:0048865 | 0.0019 | 16.5493 | 0.2656 | 3 | 9 | stem cell fate commitment |
GO:0051240 | 0.002 | 1.6973 | 25.6235 | 41 | 906 | positive regulation of multicellular organismal process |
GO:0006725 | 0.002 | 1.3303 | 165.2067 | 195 | 5599 | cellular aromatic compound metabolic process |
GO:0001502 | 0.002 | 8.8407 | 0.5606 | 4 | 19 | cartilage condensation |
GO:0001710 | 0.002 | 8.8407 | 0.5606 | 4 | 19 | mesodermal cell fate commitment |
GO:0072079 | 0.002 | 8.8407 | 0.5606 | 4 | 19 | nephron tubule formation |
GO:2000050 | 0.002 | 8.8407 | 0.5606 | 4 | 19 | regulation of non-canonical Wnt signaling pathway |
GO:0071396 | 0.0021 | 1.8979 | 15.5794 | 28 | 528 | cellular response to lipid |
GO:0030514 | 0.0025 | 4.8649 | 1.3868 | 6 | 47 | negative regulation of BMP signaling pathway |
GO:0042476 | 0.0025 | 6.0071 | 0.9615 | 5 | 33 | odontogenesis |
GO:0048468 | 0.0025 | 1.4796 | 51.9868 | 72 | 1790 | cell development |
GO:0043576 | 0.0025 | 8.2876 | 0.5901 | 4 | 20 | regulation of respiratory gaseous exchange |
GO:0019065 | 0.0026 | 66.0716 | 0.0885 | 2 | 3 | receptor-mediated endocytosis of virus by host cell |
GO:0021558 | 0.0026 | 66.0716 | 0.0885 | 2 | 3 | trochlear nerve development |
GO:0021912 | 0.0026 | 66.0716 | 0.0885 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
GO:0033693 | 0.0026 | 66.0716 | 0.0885 | 2 | 3 | neurofilament bundle assembly |
GO:0035880 | 0.0026 | 66.0716 | 0.0885 | 2 | 3 | embryonic nail plate morphogenesis |
GO:0001765 | 0.0026 | 14.1842 | 0.2951 | 3 | 10 | membrane raft assembly |
GO:0021877 | 0.0026 | 14.1842 | 0.2951 | 3 | 10 | forebrain neuron fate commitment |
GO:0050966 | 0.0026 | 14.1842 | 0.2951 | 3 | 10 | detection of mechanical stimulus involved in sensory perception of pain |
GO:0003156 | 0.0026 | 5.9282 | 0.9737 | 5 | 33 | regulation of animal organ formation |
GO:0042475 | 0.0026 | 3.6517 | 2.39 | 8 | 81 | odontogenesis of dentin-containing tooth |
GO:0009966 | 0.0028 | 1.3871 | 83.3558 | 107 | 2825 | regulation of signal transduction |
GO:0055123 | 0.0029 | 2.85 | 4.1309 | 11 | 140 | digestive system development |
GO:0060411 | 0.003 | 4.0166 | 1.9179 | 7 | 65 | cardiac septum morphogenesis |
GO:0017015 | 0.003 | 3.2629 | 2.9802 | 9 | 101 | regulation of transforming growth factor beta receptor signaling pathway |
GO:0031116 | 0.003 | 7.7996 | 0.6196 | 4 | 21 | positive regulation of microtubule polymerization |
GO:0050951 | 0.003 | 7.7996 | 0.6196 | 4 | 21 | sensory perception of temperature stimulus |
GO:0003008 | 0.003 | 1.497 | 45.44 | 64 | 1540 | system process |
GO:0065007 | 0.0032 | 1.3518 | 310.6146 | 337 | 10527 | biological regulation |
GO:0002011 | 0.0034 | 4.5323 | 1.4753 | 6 | 50 | morphogenesis of an epithelial sheet |
GO:0010665 | 0.0034 | 5.5323 | 1.0327 | 5 | 35 | regulation of cardiac muscle cell apoptotic process |
GO:0030857 | 0.0034 | 5.5323 | 1.0327 | 5 | 35 | negative regulation of epithelial cell differentiation |
GO:0001708 | 0.0035 | 5.4898 | 1.0369 | 5 | 36 | cell fate specification |
GO:0046483 | 0.0035 | 1.3067 | 164.174 | 192 | 5564 | heterocycle metabolic process |
GO:0060573 | 0.0035 | 12.4103 | 0.3246 | 3 | 11 | cell fate specification involved in pattern specification |
GO:0090009 | 0.0035 | 12.4103 | 0.3246 | 3 | 11 | primitive streak formation |
GO:0001892 | 0.0036 | 3.4611 | 2.5081 | 8 | 85 | embryonic placenta development |
GO:0007417 | 0.0036 | 1.7629 | 18.5182 | 31 | 645 | central nervous system development |
GO:1901360 | 0.0038 | 1.302 | 171.1966 | 199 | 5802 | organic cyclic compound metabolic process |
GO:0043500 | 0.0038 | 3.4165 | 2.5376 | 8 | 86 | muscle adaptation |
GO:0060606 | 0.0038 | 3.4165 | 2.5376 | 8 | 86 | tube closure |
GO:0060993 | 0.0038 | 3.4165 | 2.5376 | 8 | 86 | kidney morphogenesis |
GO:0003407 | 0.004 | 4.3633 | 1.5247 | 6 | 52 | neural retina development |
GO:0032355 | 0.0041 | 2.8772 | 3.7178 | 10 | 126 | response to estradiol |
GO:0050794 | 0.0041 | 1.3382 | 211.7988 | 237 | 7754 | regulation of cellular process |
GO:0090103 | 0.0042 | 6.9776 | 0.6786 | 4 | 23 | cochlea morphogenesis |
GO:0090175 | 0.0044 | 3.0619 | 3.1572 | 9 | 107 | regulation of establishment of planar polarity |
GO:0001755 | 0.0044 | 5.1858 | 1.0917 | 5 | 37 | neural crest cell migration |
GO:0014029 | 0.0046 | 11.0306 | 0.3541 | 3 | 12 | neural crest formation |
GO:0033605 | 0.0046 | 11.0306 | 0.3541 | 3 | 12 | positive regulation of catecholamine secretion |
GO:0060766 | 0.0046 | 11.0306 | 0.3541 | 3 | 12 | negative regulation of androgen receptor signaling pathway |
GO:2000726 | 0.0046 | 11.0306 | 0.3541 | 3 | 12 | negative regulation of cardiac muscle cell differentiation |
GO:0043409 | 0.0047 | 2.6625 | 4.3965 | 11 | 149 | negative regulation of MAPK cascade |
GO:0042310 | 0.0049 | 3.6386 | 2.095 | 7 | 71 | vasoconstriction |
GO:0072088 | 0.0049 | 3.6386 | 2.095 | 7 | 71 | nephron epithelium morphogenesis |
GO:0034641 | 0.0049 | 1.289 | 178.9568 | 206 | 6065 | cellular nitrogen compound metabolic process |
GO:0000188 | 0.005 | 6.6283 | 0.7082 | 4 | 24 | inactivation of MAPK activity |
GO:0050927 | 0.005 | 6.6283 | 0.7082 | 4 | 24 | positive regulation of positive chemotaxis |
GO:0001705 | 0.005 | 33.0336 | 0.118 | 2 | 4 | ectoderm formation |
GO:0003199 | 0.005 | 33.0336 | 0.118 | 2 | 4 | endocardial cushion to mesenchymal transition involved in heart valve formation |
GO:0003219 | 0.005 | 33.0336 | 0.118 | 2 | 4 | cardiac right ventricle formation |
GO:0003308 | 0.005 | 33.0336 | 0.118 | 2 | 4 | negative regulation of Wnt signaling pathway involved in heart development |
GO:0008078 | 0.005 | 33.0336 | 0.118 | 2 | 4 | mesodermal cell migration |
GO:0021557 | 0.005 | 33.0336 | 0.118 | 2 | 4 | oculomotor nerve development |
GO:0021913 | 0.005 | 33.0336 | 0.118 | 2 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
GO:0042663 | 0.005 | 33.0336 | 0.118 | 2 | 4 | regulation of endodermal cell fate specification |
GO:0060406 | 0.005 | 33.0336 | 0.118 | 2 | 4 | positive regulation of penile erection |
GO:0060729 | 0.005 | 33.0336 | 0.118 | 2 | 4 | intestinal epithelial structure maintenance |
GO:0090244 | 0.005 | 33.0336 | 0.118 | 2 | 4 | Wnt signaling pathway involved in somitogenesis |
GO:0097476 | 0.005 | 33.0336 | 0.118 | 2 | 4 | spinal cord motor neuron migration |
GO:1902412 | 0.005 | 33.0336 | 0.118 | 2 | 4 | regulation of mitotic cytokinesis |
GO:0001501 | 0.0051 | 2.0234 | 9.8728 | 19 | 345 | skeletal system development |
GO:0003018 | 0.0052 | 2.6241 | 4.4555 | 11 | 151 | vascular process in circulatory system |
GO:0021766 | 0.0053 | 3.5824 | 2.1245 | 7 | 72 | hippocampus development |
GO:0021879 | 0.0054 | 4.911 | 1.1438 | 5 | 39 | forebrain neuron differentiation |
GO:0007050 | 0.0054 | 2.2239 | 7.1111 | 15 | 241 | cell cycle arrest |
GO:0001658 | 0.0055 | 4.0685 | 1.6229 | 6 | 55 | branching involved in ureteric bud morphogenesis |
GO:0031110 | 0.0055 | 4.0685 | 1.6229 | 6 | 55 | regulation of microtubule polymerization or depolymerization |
GO:0048857 | 0.0055 | 4.0685 | 1.6229 | 6 | 55 | neural nucleus development |
GO:0008406 | 0.0055 | 2.3764 | 5.7833 | 13 | 196 | gonad development |
GO:0050680 | 0.0056 | 2.941 | 3.2752 | 9 | 111 | negative regulation of epithelial cell proliferation |
GO:0061333 | 0.0057 | 3.5278 | 2.154 | 7 | 73 | renal tubule morphogenesis |
GO:0014020 | 0.0058 | 3.1711 | 2.7146 | 8 | 92 | primary neural tube formation |
GO:0042074 | 0.0059 | 9.9269 | 0.3836 | 3 | 13 | cell migration involved in gastrulation |
GO:0048935 | 0.0059 | 9.9269 | 0.3836 | 3 | 13 | peripheral nervous system neuron development |
GO:0061029 | 0.0059 | 9.9269 | 0.3836 | 3 | 13 | eyelid development in camera-type eye |
GO:0010660 | 0.006 | 3.9868 | 1.6524 | 6 | 56 | regulation of muscle cell apoptotic process |
GO:0001709 | 0.0061 | 4.7403 | 1.1803 | 5 | 40 | cell fate determination |
GO:0010658 | 0.0061 | 4.7403 | 1.1803 | 5 | 40 | striated muscle cell apoptotic process |
GO:0061448 | 0.0065 | 2.2419 | 6.5799 | 14 | 223 | connective tissue development |
GO:0030855 | 0.0065 | 1.7319 | 16.9437 | 28 | 583 | epithelial cell differentiation |
GO:0008344 | 0.0066 | 3.4236 | 2.213 | 7 | 75 | adult locomotory behavior |
GO:0021522 | 0.0066 | 6.0509 | 0.764 | 4 | 26 | spinal cord motor neuron differentiation |
GO:1904030 | 0.0067 | 6.0249 | 0.7672 | 4 | 26 | negative regulation of cyclin-dependent protein kinase activity |
GO:0003300 | 0.0071 | 3.3738 | 2.2425 | 7 | 76 | cardiac muscle hypertrophy |
GO:0045669 | 0.0071 | 3.833 | 1.7114 | 6 | 58 | positive regulation of osteoblast differentiation |
GO:0051937 | 0.0071 | 3.833 | 1.7114 | 6 | 58 | catecholamine transport |
GO:0007507 | 0.0073 | 1.8803 | 11.702 | 21 | 406 | heart development |
GO:0003214 | 0.0073 | 9.0238 | 0.4131 | 3 | 14 | cardiac left ventricle morphogenesis |
GO:1900116 | 0.0073 | 9.0238 | 0.4131 | 3 | 14 | extracellular negative regulation of signal transduction |
GO:2001212 | 0.0073 | 9.0238 | 0.4131 | 3 | 14 | regulation of vasculogenesis |
GO:0003231 | 0.0074 | 2.8027 | 3.4228 | 9 | 116 | cardiac ventricle development |
GO:0007164 | 0.0074 | 2.8027 | 3.4228 | 9 | 116 | establishment of tissue polarity |
GO:0015837 | 0.0076 | 3.3253 | 2.272 | 7 | 77 | amine transport |
GO:0045843 | 0.0076 | 4.4835 | 1.2393 | 5 | 42 | negative regulation of striated muscle tissue development |
GO:0048870 | 0.0077 | 1.4635 | 39.5682 | 55 | 1341 | cell motility |
GO:0016055 | 0.0079 | 1.8085 | 13.3104 | 23 | 453 | Wnt signaling pathway |
GO:0090101 | 0.0079 | 3.7307 | 1.7521 | 6 | 60 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:2000027 | 0.0081 | 3.2763 | 2.3 | 7 | 80 | regulation of organ morphogenesis |
GO:0003150 | 0.0082 | 22.0209 | 0.1475 | 2 | 5 | muscular septum morphogenesis |
GO:0021523 | 0.0082 | 22.0209 | 0.1475 | 2 | 5 | somatic motor neuron differentiation |
GO:0060023 | 0.0082 | 22.0209 | 0.1475 | 2 | 5 | soft palate development |
GO:0061009 | 0.0082 | 22.0209 | 0.1475 | 2 | 5 | common bile duct development |
GO:0061043 | 0.0082 | 22.0209 | 0.1475 | 2 | 5 | regulation of vascular wound healing |
GO:0061743 | 0.0082 | 22.0209 | 0.1475 | 2 | 5 | motor learning |
GO:1904956 | 0.0082 | 22.0209 | 0.1475 | 2 | 5 | regulation of midbrain dopaminergic neuron differentiation |
GO:2000823 | 0.0082 | 22.0209 | 0.1475 | 2 | 5 | regulation of androgen receptor activity |
GO:0050982 | 0.0084 | 4.3652 | 1.2688 | 5 | 43 | detection of mechanical stimulus |
GO:0090090 | 0.0087 | 2.4311 | 4.78 | 11 | 162 | negative regulation of canonical Wnt signaling pathway |
GO:0014896 | 0.0087 | 3.2325 | 2.331 | 7 | 79 | muscle hypertrophy |
GO:0003215 | 0.0088 | 8.3074 | 0.4407 | 3 | 15 | cardiac right ventricle morphogenesis |
GO:0071229 | 0.0089 | 2.3166 | 5.4587 | 12 | 185 | cellular response to acid chemical |
GO:0050965 | 0.0089 | 8.2713 | 0.4426 | 3 | 15 | detection of temperature stimulus involved in sensory perception of pain |
GO:0060579 | 0.0089 | 8.2713 | 0.4426 | 3 | 15 | ventral spinal cord interneuron fate commitment |
GO:0090177 | 0.0089 | 8.2713 | 0.4426 | 3 | 15 | establishment of planar polarity involved in neural tube closure |
GO:2000380 | 0.0089 | 8.2713 | 0.4426 | 3 | 15 | regulation of mesoderm development |
GO:0072171 | 0.009 | 3.6231 | 1.7999 | 6 | 61 | mesonephric tubule morphogenesis |
GO:0048706 | 0.0091 | 5.4311 | 0.836 | 4 | 29 | embryonic skeletal system development |
GO:0097659 | 0.0097 | 1.4478 | 41.1023 | 56 | 1558 | nucleic acid-templated transcription |
GO:0048708 | 0.0097 | 3.5582 | 1.8294 | 6 | 62 | astrocyte differentiation |
GO:1901701 | 0.0098 | 1.5267 | 28.1197 | 41 | 953 | cellular response to oxygen-containing compound |
GO:0050768 | 0.0098 | 2.1282 | 6.9045 | 14 | 234 | negative regulation of neurogenesis |
GO:0007187 | 0.0099 | 2.3832 | 4.8686 | 11 | 165 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0048709 | 0.0099 | 3.1447 | 2.39 | 7 | 81 | oligodendrocyte differentiation |
GO:0010092 | 0.0099 | 5.3009 | 0.8557 | 4 | 29 | specification of animal organ identity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0009913 | 0 | 7.5184 | 3.4777 | 22 | 252 | epidermal cell differentiation |
GO:0070268 | 0 | 13.3277 | 1.2972 | 14 | 94 | cornification |
GO:0043588 | 0 | 5.9386 | 4.3057 | 22 | 312 | skin development |
GO:0050911 | 0 | 15.9149 | 0.7866 | 10 | 57 | detection of chemical stimulus involved in sensory perception of smell |
GO:0031424 | 0 | 15.32 | 0.5573 | 7 | 43 | keratinization |
GO:0050906 | 0 | 6.9747 | 1.7802 | 11 | 129 | detection of stimulus involved in sensory perception |
GO:0009593 | 0 | 7.0288 | 1.6008 | 10 | 116 | detection of chemical stimulus |
GO:0007606 | 0 | 6.1004 | 1.8216 | 10 | 132 | sensory perception of chemical stimulus |
GO:0007186 | 1e-04 | 2.467 | 11.5785 | 26 | 839 | G-protein coupled receptor signaling pathway |
GO:0060429 | 3e-04 | 2.1687 | 15.1942 | 30 | 1101 | epithelium development |
GO:0007320 | 5e-04 | 24.1514 | 0.1656 | 3 | 12 | insemination |
GO:0003095 | 6e-04 | 144.2885 | 0.0414 | 2 | 3 | pressure natriuresis |
GO:0042109 | 6e-04 | 144.2885 | 0.0414 | 2 | 3 | lymphotoxin A biosynthetic process |
GO:0061760 | 6e-04 | 144.2885 | 0.0414 | 2 | 3 | antifungal innate immune response |
GO:0032645 | 8e-04 | 19.7576 | 0.1932 | 3 | 14 | regulation of granulocyte macrophage colony-stimulating factor production |
GO:0036101 | 0.0011 | 72.1394 | 0.0552 | 2 | 4 | leukotriene B4 catabolic process |
GO:0007618 | 0.0013 | 9.3805 | 0.483 | 4 | 35 | mating |
GO:0050829 | 0.0018 | 6.2864 | 0.8694 | 5 | 63 | defense response to Gram-negative bacterium |
GO:1901523 | 0.0018 | 48.0897 | 0.069 | 2 | 5 | icosanoid catabolic process |
GO:0033559 | 0.0019 | 4.9863 | 1.2972 | 6 | 94 | unsaturated fatty acid metabolic process |
GO:0009620 | 0.002 | 8.3062 | 0.5382 | 4 | 39 | response to fungus |
GO:0006501 | 0.0025 | 5.7855 | 0.9384 | 5 | 68 | C-terminal protein lipidation |
GO:0015939 | 0.0027 | 36.0649 | 0.0828 | 2 | 6 | pantothenate metabolic process |
GO:0045087 | 0.0029 | 2.1108 | 10.117 | 20 | 740 | innate immune response |
GO:0019373 | 0.0029 | 12.0684 | 0.2898 | 3 | 21 | epoxygenase P450 pathway |
GO:0030825 | 0.0029 | 12.0684 | 0.2898 | 3 | 21 | positive regulation of cGMP metabolic process |
GO:0030826 | 0.0033 | 11.4325 | 0.3036 | 3 | 22 | regulation of cGMP biosynthetic process |
GO:0050830 | 0.0038 | 5.2045 | 1.035 | 5 | 75 | defense response to Gram-positive bacterium |
GO:0050877 | 0.0041 | 1.9711 | 11.9097 | 22 | 863 | nervous system process |
GO:0007586 | 0.0042 | 3.6884 | 2.0149 | 7 | 146 | digestion |
GO:0032501 | 0.0051 | 1.4852 | 73.4508 | 91 | 6027 | multicellular organismal process |
GO:0071346 | 0.0052 | 4.02 | 1.587 | 6 | 115 | cellular response to interferon-gamma |
GO:0032621 | 0.0064 | 20.6044 | 0.1242 | 2 | 9 | interleukin-18 production |
GO:0048262 | 0.0064 | 20.6044 | 0.1242 | 2 | 9 | determination of dorsal/ventral asymmetry |
GO:0070098 | 0.0079 | 5.4787 | 0.7866 | 4 | 57 | chemokine-mediated signaling pathway |
GO:0006691 | 0.008 | 8.0408 | 0.414 | 3 | 30 | leukotriene metabolic process |
GO:0001676 | 0.0085 | 4.2317 | 1.2558 | 5 | 91 | long-chain fatty acid metabolic process |
GO:0031284 | 0.0096 | 16.0235 | 0.1518 | 2 | 11 | positive regulation of guanylate cyclase activity |
GO:0031295 | 0.01 | 5.0928 | 0.8418 | 4 | 61 | T cell costimulation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048663 | 2e-04 | 5.7555 | 1.5685 | 8 | 68 | neuron fate commitment |
GO:0021527 | 2e-04 | 17.1251 | 0.3229 | 4 | 14 | spinal cord association neuron differentiation |
GO:2000502 | 5e-04 | Inf | 0.0461 | 2 | 2 | negative regulation of natural killer cell chemotaxis |
GO:0042756 | 6e-04 | 25.6224 | 0.1845 | 3 | 8 | drinking behavior |
GO:0010469 | 0.001 | 2.1765 | 11.2333 | 23 | 487 | regulation of receptor activity |
GO:0007186 | 0.001 | 1.8734 | 19.3526 | 34 | 839 | G-protein coupled receptor signaling pathway |
GO:0006334 | 0.0011 | 3.7718 | 2.5834 | 9 | 112 | nucleosome assembly |
GO:0016338 | 0.0015 | 9.5088 | 0.5075 | 4 | 22 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules |
GO:0021530 | 0.0016 | 85.1862 | 0.0692 | 2 | 3 | spinal cord oligodendrocyte cell fate specification |
GO:0060415 | 0.0017 | 4.4283 | 1.73 | 7 | 75 | muscle tissue morphogenesis |
GO:0021517 | 0.003 | 5.6389 | 0.9919 | 5 | 43 | ventral spinal cord development |
GO:0030321 | 0.0031 | 42.5903 | 0.0923 | 2 | 4 | transepithelial chloride transport |
GO:1900037 | 0.0037 | 11.6418 | 0.3229 | 3 | 14 | regulation of cellular response to hypoxia |
GO:2000291 | 0.0037 | 11.6418 | 0.3229 | 3 | 14 | regulation of myoblast proliferation |
GO:0010744 | 0.0045 | 10.671 | 0.346 | 3 | 15 | positive regulation of macrophage derived foam cell differentiation |
GO:0035914 | 0.0047 | 5.0203 | 1.0989 | 5 | 48 | skeletal muscle cell differentiation |
GO:0042220 | 0.0048 | 4.9815 | 1.1072 | 5 | 48 | response to cocaine |
GO:0070265 | 0.0048 | 4.9815 | 1.1072 | 5 | 48 | necrotic cell death |
GO:0021779 | 0.0051 | 28.3916 | 0.1153 | 2 | 5 | oligodendrocyte cell fate commitment |
GO:0021780 | 0.0051 | 28.3916 | 0.1153 | 2 | 5 | glial cell fate specification |
GO:0060455 | 0.0051 | 28.3916 | 0.1153 | 2 | 5 | negative regulation of gastric acid secretion |
GO:0009953 | 0.0054 | 3.5385 | 2.1221 | 7 | 92 | dorsal/ventral pattern formation |
GO:1902914 | 0.0055 | 9.8495 | 0.3691 | 3 | 16 | regulation of protein polyubiquitination |
GO:2001014 | 0.0065 | 9.1453 | 0.3921 | 3 | 17 | regulation of skeletal muscle cell differentiation |
GO:0090077 | 0.0067 | 5.8976 | 0.7612 | 4 | 33 | foam cell differentiation |
GO:0033993 | 0.0069 | 1.6789 | 19.4218 | 31 | 842 | response to lipid |
GO:0006578 | 0.0075 | 21.2923 | 0.1384 | 2 | 6 | amino-acid betaine biosynthetic process |
GO:0022605 | 0.0075 | 21.2923 | 0.1384 | 2 | 6 | oogenesis stage |
GO:2000766 | 0.0075 | 21.2923 | 0.1384 | 2 | 6 | negative regulation of cytoplasmic translation |
GO:2001199 | 0.0075 | 21.2923 | 0.1384 | 2 | 6 | negative regulation of dendritic cell differentiation |
GO:0051965 | 0.0086 | 4.2821 | 1.2686 | 5 | 55 | positive regulation of synapse assembly |
GO:0003009 | 0.0092 | 5.3437 | 0.8304 | 4 | 36 | skeletal muscle contraction |
GO:0030814 | 0.0092 | 2.8904 | 2.9294 | 8 | 127 | regulation of cAMP metabolic process |
GO:0030801 | 0.0093 | 3.1639 | 2.3528 | 7 | 102 | positive regulation of cyclic nucleotide metabolic process |
GO:0006333 | 0.0095 | 2.6717 | 3.5522 | 9 | 154 | chromatin assembly or disassembly |
GO:0021515 | 0.0097 | 5.2383 | 0.8445 | 4 | 37 | cell differentiation in spinal cord |
GO:0050911 | 0.01 | 4.1168 | 1.3148 | 5 | 57 | detection of chemical stimulus involved in sensory perception of smell |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007156 | 0 | 8.6555 | 3.596 | 25 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0007267 | 0 | 2.2802 | 34.1972 | 68 | 1453 | cell-cell signaling |
GO:0098609 | 0 | 2.5647 | 17.7433 | 41 | 750 | cell-cell adhesion |
GO:0007389 | 0 | 3.5428 | 7.5152 | 24 | 325 | pattern specification process |
GO:0009952 | 0 | 4.3903 | 4.5896 | 18 | 194 | anterior/posterior pattern specification |
GO:0007399 | 0 | 1.9104 | 47.7033 | 80 | 2041 | nervous system development |
GO:0032502 | 0 | 1.6963 | 103.1786 | 142 | 4581 | developmental process |
GO:0035108 | 0 | 4.5485 | 3.4304 | 14 | 145 | limb morphogenesis |
GO:0035113 | 0 | 4.8882 | 2.9809 | 13 | 126 | embryonic appendage morphogenesis |
GO:0003253 | 0 | 55.633 | 0.1656 | 4 | 7 | cardiac neural crest cell migration involved in outflow tract morphogenesis |
GO:0048736 | 0 | 4.124 | 4.0218 | 15 | 170 | appendage development |
GO:0009798 | 0 | 5.9501 | 1.9163 | 10 | 81 | axis specification |
GO:0048568 | 0 | 2.6994 | 9.6287 | 24 | 407 | embryonic organ development |
GO:0003008 | 1e-04 | 1.8077 | 36.4329 | 60 | 1540 | system process |
GO:0022610 | 1e-04 | 1.8754 | 30.2583 | 52 | 1279 | biological adhesion |
GO:0061308 | 1e-04 | 23.8363 | 0.2602 | 4 | 11 | cardiac neural crest cell development involved in heart development |
GO:0014033 | 2e-04 | 5.7003 | 1.5851 | 8 | 67 | neural crest cell differentiation |
GO:0032501 | 2e-04 | 1.5735 | 90.5648 | 119 | 4446 | multicellular organismal process |
GO:0030855 | 2e-04 | 2.1753 | 14.8098 | 30 | 626 | epithelial cell differentiation |
GO:0072109 | 3e-04 | 16.682 | 0.3312 | 4 | 14 | glomerular mesangium development |
GO:1903508 | 3e-04 | 1.7756 | 31.7487 | 52 | 1342 | positive regulation of nucleic acid-templated transcription |
GO:0045944 | 3e-04 | 1.8776 | 24.6987 | 43 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
GO:0001657 | 3e-04 | 4.5641 | 2.1765 | 9 | 92 | ureteric bud development |
GO:0009953 | 3e-04 | 4.5641 | 2.1765 | 9 | 92 | dorsal/ventral pattern formation |
GO:0048704 | 3e-04 | 4.5641 | 2.1765 | 9 | 92 | embryonic skeletal system morphogenesis |
GO:0072163 | 4e-04 | 4.5095 | 2.2002 | 9 | 93 | mesonephric epithelium development |
GO:0030216 | 4e-04 | 3.1235 | 4.8262 | 14 | 204 | keratinocyte differentiation |
GO:0007186 | 4e-04 | 1.9447 | 19.8489 | 36 | 839 | G-protein coupled receptor signaling pathway |
GO:0035116 | 5e-04 | 9.0839 | 0.6624 | 5 | 28 | embryonic hindlimb morphogenesis |
GO:0048729 | 5e-04 | 2.1101 | 14.171 | 28 | 599 | tissue morphogenesis |
GO:0060809 | 6e-04 | Inf | 0.0473 | 2 | 2 | mesodermal to mesenchymal transition involved in gastrulation |
GO:0061032 | 6e-04 | Inf | 0.0473 | 2 | 2 | visceral serous pericardium development |
GO:0072254 | 6e-04 | Inf | 0.0473 | 2 | 2 | metanephric glomerular mesangial cell differentiation |
GO:0097402 | 6e-04 | Inf | 0.0473 | 2 | 2 | neuroblast migration |
GO:1905772 | 6e-04 | Inf | 0.0473 | 2 | 2 | positive regulation of mesodermal cell differentiation |
GO:2000054 | 6e-04 | Inf | 0.0473 | 2 | 2 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification |
GO:2000079 | 6e-04 | Inf | 0.0473 | 2 | 2 | regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation |
GO:2000738 | 6e-04 | 12.8297 | 0.4022 | 4 | 17 | positive regulation of stem cell differentiation |
GO:0014031 | 7e-04 | 5.2411 | 1.4904 | 7 | 63 | mesenchymal cell development |
GO:0048864 | 7e-04 | 5.2411 | 1.4904 | 7 | 63 | stem cell development |
GO:0007530 | 7e-04 | 11.9125 | 0.4258 | 4 | 18 | sex determination |
GO:0048646 | 7e-04 | 1.8278 | 22.8297 | 39 | 965 | anatomical structure formation involved in morphogenesis |
GO:0031328 | 8e-04 | 1.6252 | 39.9343 | 60 | 1688 | positive regulation of cellular biosynthetic process |
GO:0051254 | 9e-04 | 1.6769 | 33.3811 | 52 | 1411 | positive regulation of RNA metabolic process |
GO:1902742 | 9e-04 | 7.736 | 0.757 | 5 | 32 | apoptotic process involved in development |
GO:0061138 | 9e-04 | 3.1476 | 4.0928 | 12 | 173 | morphogenesis of a branching epithelium |
GO:0090288 | 9e-04 | 3.5688 | 3.0282 | 10 | 128 | negative regulation of cellular response to growth factor stimulus |
GO:0046661 | 9e-04 | 3.3133 | 3.5723 | 11 | 151 | male sex differentiation |
GO:0060993 | 0.001 | 4.3062 | 2.0346 | 8 | 86 | kidney morphogenesis |
GO:0003156 | 0.001 | 7.4593 | 0.7807 | 5 | 33 | regulation of animal organ formation |
GO:0060923 | 0.001 | 20.7997 | 0.2129 | 3 | 9 | cardiac muscle cell fate commitment |
GO:0072239 | 0.001 | 20.7997 | 0.2129 | 3 | 9 | metanephric glomerulus vasculature development |
GO:0035051 | 0.001 | 3.8511 | 2.5369 | 9 | 108 | cardiocyte differentiation |
GO:0035239 | 0.001 | 2.4219 | 7.9017 | 18 | 334 | tube morphogenesis |
GO:0048663 | 0.0011 | 4.8099 | 1.6087 | 7 | 68 | neuron fate commitment |
GO:0060688 | 0.0011 | 5.7061 | 1.1829 | 6 | 50 | regulation of morphogenesis of a branching structure |
GO:0072080 | 0.0011 | 4.198 | 2.0819 | 8 | 88 | nephron tubule development |
GO:0060485 | 0.0012 | 2.7298 | 5.4649 | 14 | 231 | mesenchyme development |
GO:0009792 | 0.0013 | 2.0494 | 12.9408 | 25 | 547 | embryo development ending in birth or egg hatching |
GO:0032275 | 0.0014 | 17.8271 | 0.2366 | 3 | 10 | luteinizing hormone secretion |
GO:0001707 | 0.0014 | 4.5835 | 1.6797 | 7 | 71 | mesoderm formation |
GO:0072088 | 0.0014 | 4.5835 | 1.6797 | 7 | 71 | nephron epithelium morphogenesis |
GO:0072125 | 0.0016 | 82.9944 | 0.071 | 2 | 3 | negative regulation of glomerular mesangial cell proliferation |
GO:1904862 | 0.0016 | 82.9944 | 0.071 | 2 | 3 | inhibitory synapse assembly |
GO:0010557 | 0.0017 | 1.5998 | 36.9061 | 55 | 1560 | positive regulation of macromolecule biosynthetic process |
GO:0061333 | 0.0017 | 4.444 | 1.727 | 7 | 73 | renal tubule morphogenesis |
GO:0070268 | 0.0017 | 3.9035 | 2.2238 | 8 | 94 | cornification |
GO:0048731 | 0.0017 | 1.6057 | 39.0307 | 57 | 1922 | system development |
GO:0001658 | 0.0018 | 5.1221 | 1.3012 | 6 | 55 | branching involved in ureteric bud morphogenesis |
GO:0008544 | 0.0019 | 2.2885 | 8.3275 | 18 | 352 | epidermis development |
GO:0048484 | 0.0019 | 15.5977 | 0.2602 | 3 | 11 | enteric nervous system development |
GO:0042481 | 0.0019 | 8.7747 | 0.5441 | 4 | 23 | regulation of odontogenesis |
GO:0021510 | 0.002 | 3.8143 | 2.2711 | 8 | 96 | spinal cord development |
GO:0007423 | 0.0022 | 2.0311 | 11.9708 | 23 | 506 | sensory organ development |
GO:0050911 | 0.0022 | 4.9206 | 1.3485 | 6 | 57 | detection of chemical stimulus involved in sensory perception of smell |
GO:0061217 | 0.0023 | 8.3354 | 0.5678 | 4 | 24 | regulation of mesonephros development |
GO:0072210 | 0.0024 | 5.9646 | 0.9463 | 5 | 40 | metanephric nephron development |
GO:1901722 | 0.0025 | 13.8637 | 0.2839 | 3 | 12 | regulation of cell proliferation involved in kidney development |
GO:0048596 | 0.0026 | 7.9379 | 0.5914 | 4 | 25 | embryonic camera-type eye morphogenesis |
GO:0051705 | 0.0026 | 4.7343 | 1.3958 | 6 | 59 | multi-organism behavior |
GO:0010628 | 0.0027 | 1.5425 | 40.2892 | 58 | 1703 | positive regulation of gene expression |
GO:0055013 | 0.0029 | 4.6463 | 1.4195 | 6 | 60 | cardiac muscle cell development |
GO:0042475 | 0.003 | 3.9615 | 1.9163 | 7 | 81 | odontogenesis of dentin-containing tooth |
GO:0061440 | 0.0031 | 7.5766 | 0.6151 | 4 | 26 | kidney vasculature development |
GO:0072171 | 0.0031 | 4.5615 | 1.4431 | 6 | 61 | mesonephric tubule morphogenesis |
GO:0048935 | 0.0031 | 12.4765 | 0.3076 | 3 | 13 | peripheral nervous system neuron development |
GO:0072216 | 0.0031 | 12.4765 | 0.3076 | 3 | 13 | positive regulation of metanephros development |
GO:0034653 | 0.0032 | 41.4944 | 0.0946 | 2 | 4 | retinoic acid catabolic process |
GO:0051464 | 0.0032 | 41.4944 | 0.0946 | 2 | 4 | positive regulation of cortisol secretion |
GO:0060686 | 0.0032 | 41.4944 | 0.0946 | 2 | 4 | negative regulation of prostatic bud formation |
GO:0061325 | 0.0032 | 41.4944 | 0.0946 | 2 | 4 | cell proliferation involved in outflow tract morphogenesis |
GO:0090245 | 0.0032 | 41.4944 | 0.0946 | 2 | 4 | axis elongation involved in somitogenesis |
GO:0008584 | 0.0034 | 3.1756 | 3.0282 | 9 | 128 | male gonad development |
GO:1901342 | 0.0034 | 2.4233 | 6.1037 | 14 | 258 | regulation of vasculature development |
GO:0060986 | 0.0037 | 5.3514 | 1.0409 | 5 | 44 | endocrine hormone secretion |
GO:0003281 | 0.0037 | 4.4008 | 1.4904 | 6 | 63 | ventricular septum development |
GO:0042733 | 0.0037 | 4.4008 | 1.4904 | 6 | 63 | embryonic digit morphogenesis |
GO:0090101 | 0.0039 | 3.388 | 2.5314 | 8 | 107 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0021527 | 0.0039 | 11.3415 | 0.3312 | 3 | 14 | spinal cord association neuron differentiation |
GO:2000846 | 0.0039 | 11.3415 | 0.3312 | 3 | 14 | regulation of corticosteroid hormone secretion |
GO:0007274 | 0.004 | 6.9443 | 0.6624 | 4 | 28 | neuromuscular synaptic transmission |
GO:0007600 | 0.0043 | 1.9161 | 12.6332 | 23 | 534 | sensory perception |
GO:0048706 | 0.0043 | 6.8007 | 0.673 | 4 | 29 | embryonic skeletal system development |
GO:0060411 | 0.0043 | 4.2511 | 1.5378 | 6 | 65 | cardiac septum morphogenesis |
GO:0061045 | 0.0043 | 4.2511 | 1.5378 | 6 | 65 | negative regulation of wound healing |
GO:0035094 | 0.0045 | 5.0897 | 1.0883 | 5 | 46 | response to nicotine |
GO:0046660 | 0.0046 | 3.2877 | 2.6024 | 8 | 110 | female sex differentiation |
GO:0060537 | 0.0047 | 2.1355 | 8.3748 | 17 | 354 | muscle tissue development |
GO:0001667 | 0.0047 | 2.1898 | 7.6888 | 16 | 325 | ameboidal-type cell migration |
GO:0008595 | 0.0048 | 10.3957 | 0.3549 | 3 | 15 | anterior/posterior axis specification, embryo |
GO:0071300 | 0.005 | 4.1111 | 1.5851 | 6 | 67 | cellular response to retinoic acid |
GO:1901890 | 0.0052 | 6.4092 | 0.7097 | 4 | 30 | positive regulation of cell junction assembly |
GO:0060157 | 0.0053 | 27.6611 | 0.1183 | 2 | 5 | urinary bladder development |
GO:0060591 | 0.0053 | 27.6611 | 0.1183 | 2 | 5 | chondroblast differentiation |
GO:0070172 | 0.0053 | 27.6611 | 0.1183 | 2 | 5 | positive regulation of tooth mineralization |
GO:0072298 | 0.0053 | 27.6611 | 0.1183 | 2 | 5 | regulation of metanephric glomerulus development |
GO:2000195 | 0.0053 | 27.6611 | 0.1183 | 2 | 5 | negative regulation of female gonad development |
GO:0060429 | 0.0058 | 1.9576 | 10.7429 | 20 | 475 | epithelium development |
GO:0043092 | 0.0058 | 9.5953 | 0.3785 | 3 | 16 | L-amino acid import |
GO:0090185 | 0.0058 | 9.5953 | 0.3785 | 3 | 16 | negative regulation of kidney development |
GO:0003209 | 0.0059 | 6.1715 | 0.7334 | 4 | 31 | cardiac atrium morphogenesis |
GO:0009954 | 0.0059 | 6.1715 | 0.7334 | 4 | 31 | proximal/distal pattern formation |
GO:0009887 | 0.0059 | 1.6849 | 20.0066 | 32 | 860 | animal organ morphogenesis |
GO:0072006 | 0.0061 | 3.4467 | 2.1753 | 7 | 93 | nephron development |
GO:0001568 | 0.0062 | 1.827 | 13.7925 | 24 | 583 | blood vessel development |
GO:0009593 | 0.0063 | 3.1037 | 2.7443 | 8 | 116 | detection of chemical stimulus |
GO:0048608 | 0.0066 | 2.0106 | 9.3921 | 18 | 397 | reproductive structure development |
GO:0045165 | 0.0066 | 2.6669 | 3.9613 | 10 | 170 | cell fate commitment |
GO:0021536 | 0.0066 | 3.8571 | 1.6797 | 6 | 71 | diencephalon development |
GO:0021675 | 0.0066 | 3.8571 | 1.6797 | 6 | 71 | nerve development |
GO:0060079 | 0.0069 | 3.3665 | 2.2238 | 7 | 94 | excitatory postsynaptic potential |
GO:0009790 | 0.0069 | 2.3948 | 5.2754 | 12 | 233 | embryo development |
GO:0051412 | 0.007 | 8.9094 | 0.4022 | 3 | 17 | response to corticosterone |
GO:1904948 | 0.007 | 8.9094 | 0.4022 | 3 | 17 | midbrain dopaminergic neuron differentiation |
GO:2001026 | 0.007 | 8.9094 | 0.4022 | 3 | 17 | regulation of endothelial cell chemotaxis |
GO:0043388 | 0.0075 | 4.4381 | 1.2302 | 5 | 52 | positive regulation of DNA binding |
GO:0001838 | 0.0077 | 2.9921 | 2.8389 | 8 | 120 | embryonic epithelial tube formation |
GO:0003278 | 0.0079 | 20.7444 | 0.1419 | 2 | 6 | apoptotic process involved in heart morphogenesis |
GO:0003402 | 0.0079 | 20.7444 | 0.1419 | 2 | 6 | planar cell polarity pathway involved in axis elongation |
GO:0016115 | 0.0079 | 20.7444 | 0.1419 | 2 | 6 | terpenoid catabolic process |
GO:0038001 | 0.0079 | 20.7444 | 0.1419 | 2 | 6 | paracrine signaling |
GO:0038031 | 0.0079 | 20.7444 | 0.1419 | 2 | 6 | non-canonical Wnt signaling pathway via JNK cascade |
GO:0044340 | 0.0079 | 20.7444 | 0.1419 | 2 | 6 | canonical Wnt signaling pathway involved in regulation of cell proliferation |
GO:0051964 | 0.0079 | 20.7444 | 0.1419 | 2 | 6 | negative regulation of synapse assembly |
GO:2000382 | 0.0079 | 20.7444 | 0.1419 | 2 | 6 | positive regulation of mesoderm development |
GO:2001023 | 0.0079 | 20.7444 | 0.1419 | 2 | 6 | regulation of response to drug |
GO:0007271 | 0.0082 | 5.5532 | 0.8044 | 4 | 34 | synaptic transmission, cholinergic |
GO:0007350 | 0.0082 | 8.3148 | 0.4258 | 3 | 18 | blastoderm segmentation |
GO:0007519 | 0.0087 | 2.715 | 3.5013 | 9 | 148 | skeletal muscle tissue development |
GO:0035270 | 0.0089 | 2.9134 | 2.9099 | 8 | 123 | endocrine system development |
GO:0007618 | 0.009 | 5.3737 | 0.828 | 4 | 35 | mating |
GO:2000826 | 0.009 | 5.3737 | 0.828 | 4 | 35 | regulation of heart morphogenesis |
GO:0010002 | 0.0096 | 7.7946 | 0.4495 | 3 | 19 | cardioblast differentiation |
GO:0016048 | 0.0096 | 7.7946 | 0.4495 | 3 | 19 | detection of temperature stimulus |
GO:0060575 | 0.0096 | 7.7946 | 0.4495 | 3 | 19 | intestinal epithelial cell differentiation |
GO:0072001 | 0.0099 | 2.1923 | 6.213 | 13 | 264 | renal system development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048704 | 0 | 8.7419 | 1.2591 | 9 | 48 | embryonic skeletal system morphogenesis |
GO:0043009 | 0 | 2.6991 | 12.5749 | 31 | 480 | chordate embryonic development |
GO:0009887 | 0 | 2.5701 | 13.1658 | 31 | 515 | animal organ morphogenesis |
GO:0022404 | 0 | 5.5146 | 2.2776 | 11 | 86 | molting cycle process |
GO:0007416 | 0 | 4.5707 | 3.1836 | 13 | 121 | synapse assembly |
GO:0007420 | 0 | 2.3038 | 16.9759 | 36 | 641 | brain development |
GO:0014707 | 0 | Inf | 0.0795 | 3 | 3 | branchiomeric skeletal muscle development |
GO:0043269 | 0 | 2.3621 | 15.1486 | 33 | 572 | regulation of ion transport |
GO:0032502 | 0 | 1.6198 | 92.8912 | 127 | 3821 | developmental process |
GO:0007267 | 0 | 1.9941 | 27.4219 | 50 | 1064 | cell-cell signaling |
GO:0007399 | 0 | 1.7294 | 50.7293 | 79 | 1977 | nervous system development |
GO:0048568 | 0 | 2.6125 | 10.7788 | 26 | 407 | embryonic organ development |
GO:0021879 | 0 | 7.2976 | 1.2977 | 8 | 49 | forebrain neuron differentiation |
GO:0009889 | 1e-04 | 1.5199 | 109.7478 | 145 | 4144 | regulation of biosynthetic process |
GO:0010628 | 1e-04 | 1.7274 | 45.1015 | 71 | 1703 | positive regulation of gene expression |
GO:0006355 | 1e-04 | 1.543 | 89.3819 | 122 | 3375 | regulation of transcription, DNA-templated |
GO:0008284 | 1e-04 | 2.0349 | 21.2133 | 40 | 801 | positive regulation of cell proliferation |
GO:0042633 | 1e-04 | 4.4904 | 2.7278 | 11 | 103 | hair cycle |
GO:0048598 | 1e-04 | 2.7463 | 8.2575 | 21 | 322 | embryonic morphogenesis |
GO:2001141 | 1e-04 | 1.5273 | 90.0705 | 122 | 3401 | regulation of RNA biosynthetic process |
GO:0007268 | 1e-04 | 2.2113 | 15.0691 | 31 | 569 | chemical synaptic transmission |
GO:0099537 | 1e-04 | 2.2028 | 15.1221 | 31 | 571 | trans-synaptic signaling |
GO:0021544 | 1e-04 | 12.3945 | 0.5297 | 5 | 20 | subpallium development |
GO:0002009 | 1e-04 | 2.5768 | 9.1835 | 22 | 354 | morphogenesis of an epithelium |
GO:0001708 | 2e-04 | 5.1289 | 1.9772 | 9 | 75 | cell fate specification |
GO:0007275 | 2e-04 | 1.6089 | 64.8588 | 92 | 2683 | multicellular organism development |
GO:0030154 | 2e-04 | 1.7025 | 44.2556 | 68 | 1789 | cell differentiation |
GO:0009952 | 2e-04 | 3.834 | 3.4319 | 12 | 131 | anterior/posterior pattern specification |
GO:0048736 | 2e-04 | 3.3816 | 4.5022 | 14 | 170 | appendage development |
GO:0097154 | 2e-04 | 18.5539 | 0.3178 | 4 | 12 | GABAergic neuron differentiation |
GO:0048646 | 2e-04 | 1.9118 | 23.6303 | 42 | 902 | anatomical structure formation involved in morphogenesis |
GO:0019219 | 2e-04 | 1.4784 | 104.1333 | 136 | 3932 | regulation of nucleobase-containing compound metabolic process |
GO:0045944 | 2e-04 | 1.8296 | 27.6488 | 47 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
GO:0051924 | 3e-04 | 3.0739 | 5.2702 | 15 | 199 | regulation of calcium ion transport |
GO:0048699 | 3e-04 | 1.7315 | 34.9318 | 56 | 1319 | generation of neurons |
GO:0030857 | 3e-04 | 7.7052 | 0.9269 | 6 | 35 | negative regulation of epithelial cell differentiation |
GO:0048663 | 3e-04 | 5.1789 | 1.7395 | 8 | 66 | neuron fate commitment |
GO:0060022 | 3e-04 | 37.0275 | 0.1589 | 3 | 6 | hard palate development |
GO:1903508 | 4e-04 | 1.6977 | 35.5409 | 56 | 1342 | positive regulation of nucleic acid-templated transcription |
GO:0031069 | 4e-04 | 9.2927 | 0.6621 | 5 | 25 | hair follicle morphogenesis |
GO:0031328 | 4e-04 | 1.6229 | 44.7042 | 67 | 1688 | positive regulation of cellular biosynthetic process |
GO:0016331 | 5e-04 | 3.3877 | 3.8401 | 12 | 145 | morphogenesis of embryonic epithelium |
GO:0035108 | 5e-04 | 3.3877 | 3.8401 | 12 | 145 | limb morphogenesis |
GO:0051254 | 5e-04 | 1.6726 | 37.3683 | 58 | 1411 | positive regulation of RNA metabolic process |
GO:0055024 | 6e-04 | 4.7421 | 1.8803 | 8 | 71 | regulation of cardiac muscle tissue development |
GO:0034654 | 6e-04 | 1.4335 | 105.5899 | 135 | 3987 | nucleobase-containing compound biosynthetic process |
GO:0051051 | 6e-04 | 2.2191 | 11.5203 | 24 | 435 | negative regulation of transport |
GO:0003357 | 6e-04 | 27.7688 | 0.1854 | 3 | 7 | noradrenergic neuron differentiation |
GO:2001012 | 6e-04 | 27.7688 | 0.1854 | 3 | 7 | mesenchymal cell differentiation involved in renal system development |
GO:0043588 | 7e-04 | 2.4522 | 8.2629 | 19 | 312 | skin development |
GO:0021882 | 7e-04 | Inf | 0.053 | 2 | 2 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment |
GO:0021893 | 7e-04 | Inf | 0.053 | 2 | 2 | cerebral cortex GABAergic interneuron fate commitment |
GO:1902868 | 7e-04 | Inf | 0.053 | 2 | 2 | positive regulation of retina development in camera-type eye |
GO:1902871 | 7e-04 | Inf | 0.053 | 2 | 2 | positive regulation of amacrine cell differentiation |
GO:0007156 | 7e-04 | 3.2168 | 4.0255 | 12 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0072359 | 7e-04 | 1.7977 | 24.3384 | 41 | 919 | circulatory system development |
GO:0034762 | 7e-04 | 2.221 | 11.0172 | 23 | 416 | regulation of transmembrane transport |
GO:0016339 | 8e-04 | 8.079 | 0.7415 | 5 | 28 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
GO:0035116 | 8e-04 | 8.079 | 0.7415 | 5 | 28 | embryonic hindlimb morphogenesis |
GO:0006812 | 8e-04 | 1.755 | 26.7749 | 44 | 1011 | cation transport |
GO:0045607 | 9e-04 | 22.2135 | 0.2119 | 3 | 8 | regulation of auditory receptor cell differentiation |
GO:0045631 | 9e-04 | 22.2135 | 0.2119 | 3 | 8 | regulation of mechanoreceptor differentiation |
GO:0097084 | 9e-04 | 22.2135 | 0.2119 | 3 | 8 | vascular smooth muscle cell development |
GO:0044057 | 0.001 | 2.0967 | 12.6591 | 25 | 478 | regulation of system process |
GO:2000678 | 0.0011 | 10.5979 | 0.4767 | 4 | 18 | negative regulation of transcription regulatory region DNA binding |
GO:0009954 | 0.0012 | 7.1453 | 0.821 | 5 | 31 | proximal/distal pattern formation |
GO:0001841 | 0.0013 | 3.6957 | 2.6484 | 9 | 100 | neural tube formation |
GO:0048468 | 0.0014 | 1.5324 | 49.1799 | 70 | 1857 | cell development |
GO:0021895 | 0.0014 | 9.8907 | 0.5032 | 4 | 19 | cerebral cortex neuron differentiation |
GO:0060231 | 0.0014 | 9.8907 | 0.5032 | 4 | 19 | mesenchymal to epithelial transition |
GO:0042178 | 0.0014 | 18.51 | 0.2384 | 3 | 9 | xenobiotic catabolic process |
GO:0070838 | 0.0015 | 2.1412 | 10.8847 | 22 | 411 | divalent metal ion transport |
GO:0035239 | 0.0015 | 2.2775 | 8.8455 | 19 | 334 | tube morphogenesis |
GO:0051047 | 0.0015 | 2.223 | 9.5341 | 20 | 360 | positive regulation of secretion |
GO:0043266 | 0.0016 | 3.9802 | 2.1981 | 8 | 83 | regulation of potassium ion transport |
GO:0021515 | 0.0018 | 6.4474 | 0.8947 | 5 | 34 | cell differentiation in spinal cord |
GO:0001501 | 0.0019 | 2.3507 | 7.6662 | 17 | 295 | skeletal system development |
GO:0035113 | 0.0019 | 3.2241 | 3.3369 | 10 | 126 | embryonic appendage morphogenesis |
GO:0050966 | 0.0019 | 15.8646 | 0.2648 | 3 | 10 | detection of mechanical stimulus involved in sensory perception of pain |
GO:0023061 | 0.002 | 2.1225 | 10.461 | 21 | 395 | signal release |
GO:0051216 | 0.002 | 2.8287 | 4.5287 | 12 | 171 | cartilage development |
GO:0007617 | 0.002 | 8.7259 | 0.5562 | 4 | 21 | mating behavior |
GO:0021558 | 0.0021 | 73.8803 | 0.0795 | 2 | 3 | trochlear nerve development |
GO:0038162 | 0.0021 | 73.8803 | 0.0795 | 2 | 3 | erythropoietin-mediated signaling pathway |
GO:0060435 | 0.0021 | 73.8803 | 0.0795 | 2 | 3 | bronchiole development |
GO:1905333 | 0.0021 | 73.8803 | 0.0795 | 2 | 3 | regulation of gastric motility |
GO:0072175 | 0.0021 | 3.169 | 3.3899 | 10 | 128 | epithelial tube formation |
GO:0003002 | 0.0023 | 3.3928 | 2.8582 | 9 | 112 | regionalization |
GO:0021513 | 0.0024 | 8.2406 | 0.5826 | 4 | 22 | spinal cord dorsal/ventral patterning |
GO:0051952 | 0.0025 | 4.1389 | 1.8538 | 7 | 70 | regulation of amine transport |
GO:0021521 | 0.0026 | 13.8806 | 0.2913 | 3 | 11 | ventral spinal cord interneuron specification |
GO:0007186 | 0.0026 | 1.7878 | 18.915 | 32 | 727 | G-protein coupled receptor signaling pathway |
GO:0001964 | 0.0029 | 7.8064 | 0.6091 | 4 | 23 | startle response |
GO:2000026 | 0.0029 | 1.5121 | 43.7823 | 62 | 1672 | regulation of multicellular organismal development |
GO:0051384 | 0.003 | 3.0144 | 3.5488 | 10 | 134 | response to glucocorticoid |
GO:1904062 | 0.003 | 2.3778 | 6.6739 | 15 | 252 | regulation of cation transmembrane transport |
GO:0046887 | 0.0031 | 3.2309 | 2.9926 | 9 | 113 | positive regulation of hormone secretion |
GO:0071773 | 0.0031 | 2.8192 | 4.1579 | 11 | 157 | cellular response to BMP stimulus |
GO:0033993 | 0.0032 | 1.7048 | 22.2991 | 36 | 842 | response to lipid |
GO:1904427 | 0.0032 | 4.5541 | 1.4566 | 6 | 55 | positive regulation of calcium ion transmembrane transport |
GO:0000122 | 0.0033 | 1.7433 | 19.9686 | 33 | 754 | negative regulation of transcription from RNA polymerase II promoter |
GO:0030878 | 0.0034 | 7.4155 | 0.6356 | 4 | 24 | thyroid gland development |
GO:0060487 | 0.0034 | 7.4155 | 0.6356 | 4 | 24 | lung epithelial cell differentiation |
GO:0072182 | 0.0034 | 12.3375 | 0.3178 | 3 | 12 | regulation of nephron tubule epithelial cell differentiation |
GO:2000726 | 0.0034 | 12.3375 | 0.3178 | 3 | 12 | negative regulation of cardiac muscle cell differentiation |
GO:0010470 | 0.0035 | 5.4611 | 1.0329 | 5 | 39 | regulation of gastrulation |
GO:0060043 | 0.0035 | 5.4611 | 1.0329 | 5 | 39 | regulation of cardiac muscle cell proliferation |
GO:0060420 | 0.0035 | 4.4627 | 1.4831 | 6 | 56 | regulation of heart growth |
GO:0060255 | 0.0036 | 1.3246 | 147.6192 | 174 | 5574 | regulation of macromolecule metabolic process |
GO:0034767 | 0.0037 | 3.1397 | 3.0721 | 9 | 116 | positive regulation of ion transmembrane transport |
GO:0060548 | 0.0038 | 1.6712 | 23.3585 | 37 | 882 | negative regulation of cell death |
GO:0003013 | 0.0039 | 1.932 | 12.5267 | 23 | 473 | circulatory system process |
GO:0007626 | 0.004 | 2.5822 | 4.9259 | 12 | 186 | locomotory behavior |
GO:0007621 | 0.0041 | 36.9377 | 0.1059 | 2 | 4 | negative regulation of female receptivity |
GO:0018916 | 0.0041 | 36.9377 | 0.1059 | 2 | 4 | nitrobenzene metabolic process |
GO:0021557 | 0.0041 | 36.9377 | 0.1059 | 2 | 4 | oculomotor nerve development |
GO:0021615 | 0.0041 | 36.9377 | 0.1059 | 2 | 4 | glossopharyngeal nerve morphogenesis |
GO:0035910 | 0.0041 | 36.9377 | 0.1059 | 2 | 4 | ascending aorta morphogenesis |
GO:0042663 | 0.0041 | 36.9377 | 0.1059 | 2 | 4 | regulation of endodermal cell fate specification |
GO:0046952 | 0.0041 | 36.9377 | 0.1059 | 2 | 4 | ketone body catabolic process |
GO:0060480 | 0.0041 | 36.9377 | 0.1059 | 2 | 4 | lung goblet cell differentiation |
GO:0072137 | 0.0041 | 36.9377 | 0.1059 | 2 | 4 | condensed mesenchymal cell proliferation |
GO:1904340 | 0.0041 | 36.9377 | 0.1059 | 2 | 4 | positive regulation of dopaminergic neuron differentiation |
GO:1905024 | 0.0041 | 36.9377 | 0.1059 | 2 | 4 | regulation of membrane repolarization during ventricular cardiac muscle cell action potential |
GO:0060456 | 0.0043 | 11.103 | 0.3443 | 3 | 13 | positive regulation of digestive system process |
GO:0001942 | 0.0043 | 4.2571 | 1.5457 | 6 | 59 | hair follicle development |
GO:0021517 | 0.0045 | 6.7851 | 0.6842 | 4 | 26 | ventral spinal cord development |
GO:0003016 | 0.0046 | 6.7405 | 0.6886 | 4 | 26 | respiratory system process |
GO:0045745 | 0.0046 | 6.7405 | 0.6886 | 4 | 26 | positive regulation of G-protein coupled receptor protein signaling pathway |
GO:0035295 | 0.0048 | 2.4193 | 5.6763 | 13 | 220 | tube development |
GO:0071805 | 0.0048 | 2.5235 | 5.0319 | 12 | 190 | potassium ion transmembrane transport |
GO:0045843 | 0.0048 | 5.0173 | 1.1123 | 5 | 42 | negative regulation of striated muscle tissue development |
GO:0010557 | 0.0049 | 1.49 | 41.3143 | 58 | 1560 | positive regulation of macromolecule biosynthetic process |
GO:1903507 | 0.005 | 1.5743 | 29.5027 | 44 | 1114 | negative regulation of nucleic acid-templated transcription |
GO:0060429 | 0.0051 | 1.8125 | 15.0929 | 26 | 602 | epithelium development |
GO:0045923 | 0.0052 | 6.447 | 0.7151 | 4 | 27 | positive regulation of fatty acid metabolic process |
GO:0090280 | 0.0054 | 10.093 | 0.3708 | 3 | 14 | positive regulation of calcium ion import |
GO:0099054 | 0.0054 | 10.093 | 0.3708 | 3 | 14 | presynapse assembly |
GO:2001212 | 0.0054 | 10.093 | 0.3708 | 3 | 14 | regulation of vasculogenesis |
GO:0090596 | 0.0054 | 2.2922 | 6.4355 | 14 | 243 | sensory organ morphogenesis |
GO:0010469 | 0.0055 | 1.8719 | 12.8975 | 23 | 487 | regulation of receptor activity |
GO:0051094 | 0.0057 | 1.5545 | 30.5461 | 45 | 1159 | positive regulation of developmental process |
GO:0051253 | 0.0058 | 1.5441 | 31.436 | 46 | 1187 | negative regulation of RNA metabolic process |
GO:0048701 | 0.0059 | 4.7594 | 1.1653 | 5 | 44 | embryonic cranial skeleton morphogenesis |
GO:0010453 | 0.006 | 6.1779 | 0.7415 | 4 | 28 | regulation of cell fate commitment |
GO:1903530 | 0.0061 | 1.7623 | 16.0755 | 27 | 607 | regulation of secretion by cell |
GO:0043066 | 0.0063 | 1.6608 | 20.869 | 33 | 788 | negative regulation of apoptotic process |
GO:0001756 | 0.0063 | 3.9128 | 1.6685 | 6 | 63 | somitogenesis |
GO:0030510 | 0.0064 | 3.4279 | 2.1981 | 7 | 83 | regulation of BMP signaling pathway |
GO:0045683 | 0.0066 | 9.2513 | 0.3973 | 3 | 15 | negative regulation of epidermis development |
GO:0060581 | 0.0066 | 9.2513 | 0.3973 | 3 | 15 | cell fate commitment involved in pattern specification |
GO:0003150 | 0.0066 | 24.6234 | 0.1324 | 2 | 5 | muscular septum morphogenesis |
GO:0010040 | 0.0066 | 24.6234 | 0.1324 | 2 | 5 | response to iron(II) ion |
GO:0021523 | 0.0066 | 24.6234 | 0.1324 | 2 | 5 | somatic motor neuron differentiation |
GO:0046533 | 0.0066 | 24.6234 | 0.1324 | 2 | 5 | negative regulation of photoreceptor cell differentiation |
GO:0051970 | 0.0066 | 24.6234 | 0.1324 | 2 | 5 | negative regulation of transmission of nerve impulse |
GO:0060023 | 0.0066 | 24.6234 | 0.1324 | 2 | 5 | soft palate development |
GO:0060336 | 0.0066 | 24.6234 | 0.1324 | 2 | 5 | negative regulation of interferon-gamma-mediated signaling pathway |
GO:0072162 | 0.0066 | 24.6234 | 0.1324 | 2 | 5 | metanephric mesenchymal cell differentiation |
GO:0090325 | 0.0066 | 24.6234 | 0.1324 | 2 | 5 | regulation of locomotion involved in locomotory behavior |
GO:0061061 | 0.0068 | 1.7652 | 15.4399 | 26 | 583 | muscle structure development |
GO:0042755 | 0.0068 | 5.9304 | 0.768 | 4 | 29 | eating behavior |
GO:0009893 | 0.0069 | 1.3507 | 80.5364 | 101 | 3041 | positive regulation of metabolic process |
GO:0001843 | 0.0073 | 3.3395 | 2.2511 | 7 | 85 | neural tube closure |
GO:0032411 | 0.0073 | 3.3395 | 2.2511 | 7 | 85 | positive regulation of transporter activity |
GO:0060411 | 0.0074 | 3.7796 | 1.7214 | 6 | 65 | cardiac septum morphogenesis |
GO:0044706 | 0.0074 | 2.3749 | 5.3232 | 12 | 201 | multi-multicellular organism process |
GO:0009913 | 0.0074 | 2.2041 | 6.6739 | 14 | 252 | epidermal cell differentiation |
GO:0043114 | 0.0077 | 5.7019 | 0.7945 | 4 | 30 | regulation of vascular permeability |
GO:0060563 | 0.0078 | 4.4185 | 1.2447 | 5 | 47 | neuroepithelial cell differentiation |
GO:0003007 | 0.0084 | 2.2422 | 6.0912 | 13 | 230 | heart morphogenesis |
GO:0036092 | 0.0085 | 4.3155 | 1.2712 | 5 | 48 | phosphatidylinositol-3-phosphate biosynthetic process |
GO:0048713 | 0.0087 | 5.4904 | 0.821 | 4 | 31 | regulation of oligodendrocyte differentiation |
GO:0007218 | 0.0088 | 3.2152 | 2.3306 | 7 | 88 | neuropeptide signaling pathway |
GO:0032879 | 0.009 | 1.368 | 63.9048 | 82 | 2413 | regulation of localization |
GO:0042742 | 0.0093 | 2.4029 | 4.82 | 11 | 182 | defense response to bacterium |
GO:0021514 | 0.0095 | 7.9286 | 0.4502 | 3 | 17 | ventral spinal cord interneuron differentiation |
GO:0048486 | 0.0095 | 7.9286 | 0.4502 | 3 | 17 | parasympathetic nervous system development |
GO:2000406 | 0.0095 | 7.9286 | 0.4502 | 3 | 17 | positive regulation of T cell migration |
GO:0045823 | 0.0097 | 5.2939 | 0.8475 | 4 | 32 | positive regulation of heart contraction |
GO:0009996 | 0.0098 | 18.4663 | 0.1589 | 2 | 6 | negative regulation of cell fate specification |
GO:0038031 | 0.0098 | 18.4663 | 0.1589 | 2 | 6 | non-canonical Wnt signaling pathway via JNK cascade |
GO:0043987 | 0.0098 | 18.4663 | 0.1589 | 2 | 6 | histone H3-S10 phosphorylation |
GO:0045617 | 0.0098 | 18.4663 | 0.1589 | 2 | 6 | negative regulation of keratinocyte differentiation |
GO:0046958 | 0.0098 | 18.4663 | 0.1589 | 2 | 6 | nonassociative learning |
GO:0060482 | 0.0098 | 18.4663 | 0.1589 | 2 | 6 | lobar bronchus development |
GO:0060842 | 0.0098 | 18.4663 | 0.1589 | 2 | 6 | arterial endothelial cell differentiation |
GO:0061074 | 0.0098 | 18.4663 | 0.1589 | 2 | 6 | regulation of neural retina development |
GO:0097647 | 0.0098 | 18.4663 | 0.1589 | 2 | 6 | amylin receptor signaling pathway |
GO:1901894 | 0.0098 | 18.4663 | 0.1589 | 2 | 6 | regulation of calcium-transporting ATPase activity |
GO:0006334 | 0.0098 | 2.8647 | 2.9662 | 8 | 112 | nucleosome assembly |
GO:0021953 | 0.0098 | 3.1375 | 2.3812 | 7 | 92 | central nervous system neuron differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048704 | 0 | 9.0197 | 1.717 | 13 | 92 | embryonic skeletal system morphogenesis |
GO:0030878 | 0 | 22.1729 | 0.4479 | 7 | 24 | thyroid gland development |
GO:0009887 | 0 | 2.6153 | 17.6555 | 41 | 946 | animal organ morphogenesis |
GO:0007275 | 0 | 1.8303 | 87.7923 | 127 | 4704 | multicellular organism development |
GO:0009952 | 0 | 5.8184 | 2.7218 | 14 | 148 | anterior/posterior pattern specification |
GO:0001525 | 0 | 3.3886 | 7.8386 | 24 | 420 | angiogenesis |
GO:0072358 | 0 | 2.7893 | 11.4593 | 29 | 614 | cardiovascular system development |
GO:0048568 | 0 | 3.5229 | 5.9157 | 19 | 322 | embryonic organ development |
GO:0048598 | 0 | 2.8338 | 10.0595 | 26 | 544 | embryonic morphogenesis |
GO:0031424 | 0 | 5.2264 | 2.5569 | 12 | 137 | keratinization |
GO:0045944 | 0 | 2.2743 | 19.4845 | 40 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
GO:0001568 | 0 | 2.7506 | 10.3389 | 26 | 559 | blood vessel development |
GO:0009888 | 0 | 2.2209 | 18.4172 | 37 | 1033 | tissue development |
GO:0060037 | 1e-04 | 13.3629 | 0.4666 | 5 | 25 | pharyngeal system development |
GO:0051216 | 1e-04 | 4.0993 | 3.1914 | 12 | 171 | cartilage development |
GO:1903524 | 2e-04 | 6.7134 | 1.1758 | 7 | 63 | positive regulation of blood circulation |
GO:0001656 | 2e-04 | 5.6663 | 1.5677 | 8 | 84 | metanephros development |
GO:0050900 | 2e-04 | 2.8113 | 6.8868 | 18 | 369 | leukocyte migration |
GO:0002791 | 2e-04 | 2.7021 | 7.5587 | 19 | 405 | regulation of peptide secretion |
GO:0021545 | 2e-04 | 7.8393 | 0.8772 | 6 | 47 | cranial nerve development |
GO:0009913 | 3e-04 | 3.2015 | 4.7032 | 14 | 252 | epidermal cell differentiation |
GO:0048869 | 3e-04 | 1.5935 | 64.9141 | 90 | 3588 | cellular developmental process |
GO:0003231 | 3e-04 | 4.5347 | 2.1649 | 9 | 116 | cardiac ventricle development |
GO:0071657 | 3e-04 | Inf | 0.0373 | 2 | 2 | positive regulation of granulocyte colony-stimulating factor production |
GO:0003279 | 4e-04 | 4.8897 | 1.7917 | 8 | 96 | cardiac septum development |
GO:0070555 | 5e-04 | 4.8344 | 1.8103 | 8 | 97 | response to interleukin-1 |
GO:0032501 | 5e-04 | 2.1096 | 16.7277 | 31 | 1135 | multicellular organismal process |
GO:0003266 | 5e-04 | 26.5605 | 0.168 | 3 | 9 | regulation of secondary heart field cardioblast proliferation |
GO:0010656 | 5e-04 | 8.6149 | 0.6719 | 5 | 36 | negative regulation of muscle cell apoptotic process |
GO:0051241 | 6e-04 | 1.9744 | 18.0213 | 33 | 972 | negative regulation of multicellular organismal process |
GO:0010662 | 6e-04 | 8.3451 | 0.6905 | 5 | 37 | regulation of striated muscle cell apoptotic process |
GO:0022603 | 6e-04 | 2.0126 | 16.5794 | 31 | 897 | regulation of anatomical structure morphogenesis |
GO:0002718 | 6e-04 | 6.4243 | 1.0451 | 6 | 56 | regulation of cytokine production involved in immune response |
GO:0048870 | 6e-04 | 1.8216 | 25.0275 | 42 | 1341 | cell motility |
GO:1903508 | 6e-04 | 1.82 | 25.0462 | 42 | 1342 | positive regulation of nucleic acid-templated transcription |
GO:0003002 | 6e-04 | 6.329 | 1.0551 | 6 | 60 | regionalization |
GO:0003263 | 7e-04 | 22.7646 | 0.1866 | 3 | 10 | cardioblast proliferation |
GO:0006935 | 8e-04 | 2.3145 | 9.6863 | 21 | 519 | chemotaxis |
GO:0042481 | 8e-04 | 11.2135 | 0.4293 | 4 | 23 | regulation of odontogenesis |
GO:0050714 | 8e-04 | 3.1696 | 4.0499 | 12 | 217 | positive regulation of protein secretion |
GO:0043588 | 8e-04 | 2.7479 | 5.823 | 15 | 312 | skin development |
GO:1903555 | 8e-04 | 4.3878 | 1.9783 | 8 | 106 | regulation of tumor necrosis factor superfamily cytokine production |
GO:0010469 | 8e-04 | 2.3467 | 9.089 | 20 | 487 | regulation of receptor activity |
GO:0048729 | 9e-04 | 2.1965 | 11.1793 | 23 | 599 | tissue morphogenesis |
GO:0009111 | 9e-04 | 19.9177 | 0.2053 | 3 | 11 | vitamin catabolic process |
GO:0051173 | 0.001 | 1.5727 | 50.8389 | 72 | 2724 | positive regulation of nitrogen compound metabolic process |
GO:0032264 | 0.001 | 105.9007 | 0.056 | 2 | 3 | IMP salvage |
GO:2000297 | 0.001 | 105.9007 | 0.056 | 2 | 3 | negative regulation of synapse maturation |
GO:0007507 | 0.0011 | 2.3009 | 9.257 | 20 | 496 | heart development |
GO:0003148 | 0.0011 | 10.1442 | 0.4666 | 4 | 25 | outflow tract septum morphogenesis |
GO:0051094 | 0.0012 | 1.8332 | 21.1319 | 36 | 1143 | positive regulation of developmental process |
GO:0051047 | 0.0012 | 2.5319 | 6.7188 | 16 | 360 | positive regulation of secretion |
GO:0003207 | 0.0012 | 17.7034 | 0.224 | 3 | 12 | cardiac chamber formation |
GO:0090197 | 0.0012 | 17.7034 | 0.224 | 3 | 12 | positive regulation of chemokine secretion |
GO:0030855 | 0.0013 | 2.5227 | 6.7477 | 16 | 374 | epithelial cell differentiation |
GO:0070374 | 0.0014 | 3.3486 | 3.1914 | 10 | 171 | positive regulation of ERK1 and ERK2 cascade |
GO:0035176 | 0.0015 | 6.6725 | 0.8399 | 5 | 45 | social behavior |
GO:0009948 | 0.0016 | 6.5093 | 0.8585 | 5 | 46 | anterior/posterior axis specification |
GO:0051254 | 0.0016 | 1.7196 | 26.334 | 42 | 1411 | positive regulation of RNA metabolic process |
GO:0006959 | 0.0017 | 3.2665 | 3.2661 | 10 | 175 | humoral immune response |
GO:0070741 | 0.0017 | 8.8744 | 0.5226 | 4 | 28 | response to interleukin-6 |
GO:0043207 | 0.0017 | 2.0108 | 13.2323 | 25 | 709 | response to external biotic stimulus |
GO:0050710 | 0.0018 | 6.3539 | 0.8772 | 5 | 47 | negative regulation of cytokine secretion |
GO:2001212 | 0.002 | 14.4827 | 0.2613 | 3 | 14 | regulation of vasculogenesis |
GO:0021615 | 0.002 | 52.9468 | 0.0747 | 2 | 4 | glossopharyngeal nerve morphogenesis |
GO:0034653 | 0.002 | 52.9468 | 0.0747 | 2 | 4 | retinoic acid catabolic process |
GO:0072040 | 0.002 | 52.9468 | 0.0747 | 2 | 4 | negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis |
GO:0097029 | 0.002 | 52.9468 | 0.0747 | 2 | 4 | mature conventional dendritic cell differentiation |
GO:1900738 | 0.002 | 52.9468 | 0.0747 | 2 | 4 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:1901256 | 0.002 | 52.9468 | 0.0747 | 2 | 4 | regulation of macrophage colony-stimulating factor production |
GO:1904637 | 0.002 | 52.9468 | 0.0747 | 2 | 4 | cellular response to ionomycin |
GO:2001181 | 0.002 | 52.9468 | 0.0747 | 2 | 4 | positive regulation of interleukin-10 secretion |
GO:0008284 | 0.0022 | 1.9219 | 14.9493 | 27 | 801 | positive regulation of cell proliferation |
GO:0048534 | 0.0022 | 1.9192 | 14.968 | 27 | 802 | hematopoietic or lymphoid organ development |
GO:1903530 | 0.0023 | 2.0595 | 11.3286 | 22 | 607 | regulation of secretion by cell |
GO:0072028 | 0.0024 | 4.7888 | 1.3624 | 6 | 73 | nephron morphogenesis |
GO:0003156 | 0.0024 | 13.4047 | 0.2773 | 3 | 15 | regulation of animal organ formation |
GO:0071599 | 0.0025 | 13.2749 | 0.28 | 3 | 15 | otic vesicle development |
GO:2000484 | 0.0025 | 13.2749 | 0.28 | 3 | 15 | positive regulation of interleukin-8 secretion |
GO:0030326 | 0.0025 | 3.6392 | 2.3516 | 8 | 126 | embryonic limb morphogenesis |
GO:0032355 | 0.0025 | 3.6392 | 2.3516 | 8 | 126 | response to estradiol |
GO:0051954 | 0.0025 | 7.8868 | 0.5786 | 4 | 31 | positive regulation of amine transport |
GO:0002440 | 0.0025 | 3.3146 | 2.8928 | 9 | 155 | production of molecular mediator of immune response |
GO:0002286 | 0.0026 | 4.718 | 1.3811 | 6 | 74 | T cell activation involved in immune response |
GO:0065008 | 0.0027 | 1.4741 | 60.8798 | 81 | 3262 | regulation of biological quality |
GO:0032729 | 0.0028 | 5.676 | 0.9705 | 5 | 52 | positive regulation of interferon-gamma production |
GO:0007599 | 0.0029 | 2.4703 | 5.9909 | 14 | 321 | hemostasis |
GO:0050896 | 0.0029 | 1.4043 | 140.5163 | 164 | 7529 | response to stimulus |
GO:0032675 | 0.003 | 3.947 | 1.9037 | 7 | 102 | regulation of interleukin-6 production |
GO:0007267 | 0.003 | 1.6554 | 27.2298 | 42 | 1459 | cell-cell signaling |
GO:0001662 | 0.0032 | 7.3419 | 0.6159 | 4 | 33 | behavioral fear response |
GO:0048665 | 0.0032 | 7.3419 | 0.6159 | 4 | 33 | neuron fate specification |
GO:0031328 | 0.0033 | 1.6063 | 31.5037 | 47 | 1688 | positive regulation of cellular biosynthetic process |
GO:0019236 | 0.0033 | 35.2955 | 0.0933 | 2 | 5 | response to pheromone |
GO:0046642 | 0.0033 | 35.2955 | 0.0933 | 2 | 5 | negative regulation of alpha-beta T cell proliferation |
GO:0070945 | 0.0033 | 35.2955 | 0.0933 | 2 | 5 | neutrophil mediated killing of gram-negative bacterium |
GO:0043009 | 0.0034 | 2.1109 | 9.513 | 19 | 518 | chordate embryonic development |
GO:0003013 | 0.0035 | 2.1532 | 8.8278 | 18 | 473 | circulatory system process |
GO:0072009 | 0.0035 | 3.8254 | 1.9597 | 7 | 105 | nephron epithelium development |
GO:0035909 | 0.0035 | 7.0967 | 0.6346 | 4 | 34 | aorta morphogenesis |
GO:0019229 | 0.0036 | 5.3344 | 1.0265 | 5 | 55 | regulation of vasoconstriction |
GO:0032677 | 0.0036 | 5.3344 | 1.0265 | 5 | 55 | regulation of interleukin-8 production |
GO:0071294 | 0.0036 | 11.377 | 0.3173 | 3 | 17 | cellular response to zinc ion |
GO:2000136 | 0.0036 | 11.377 | 0.3173 | 3 | 17 | regulation of cell proliferation involved in heart morphogenesis |
GO:2000738 | 0.0036 | 11.377 | 0.3173 | 3 | 17 | positive regulation of stem cell differentiation |
GO:0003206 | 0.0037 | 3.7872 | 1.9774 | 7 | 107 | cardiac chamber morphogenesis |
GO:0010628 | 0.0039 | 1.59 | 31.7837 | 47 | 1703 | positive regulation of gene expression |
GO:0036293 | 0.0039 | 2.3831 | 6.1962 | 14 | 332 | response to decreased oxygen levels |
GO:0060562 | 0.004 | 2.4655 | 5.5617 | 13 | 298 | epithelial tube morphogenesis |
GO:0060485 | 0.0042 | 2.6947 | 4.3112 | 11 | 231 | mesenchyme development |
GO:0001759 | 0.0043 | 10.6178 | 0.3359 | 3 | 18 | organ induction |
GO:0032682 | 0.0043 | 10.6178 | 0.3359 | 3 | 18 | negative regulation of chemokine production |
GO:0042693 | 0.0043 | 10.6178 | 0.3359 | 3 | 18 | muscle cell fate commitment |
GO:0072643 | 0.0043 | 10.6178 | 0.3359 | 3 | 18 | interferon-gamma secretion |
GO:1905331 | 0.0043 | 10.6178 | 0.3359 | 3 | 18 | negative regulation of morphogenesis of an epithelium |
GO:0030193 | 0.0043 | 4.2191 | 1.5304 | 6 | 82 | regulation of blood coagulation |
GO:0009615 | 0.0046 | 2.5294 | 5.0018 | 12 | 268 | response to virus |
GO:0060173 | 0.0047 | 3.0028 | 3.1728 | 9 | 170 | limb development |
GO:0019915 | 0.0048 | 4.9379 | 1.1011 | 5 | 59 | lipid storage |
GO:0032653 | 0.0048 | 6.4502 | 0.6905 | 4 | 37 | regulation of interleukin-10 production |
GO:0060561 | 0.0049 | 10.0222 | 0.3522 | 3 | 19 | apoptotic process involved in morphogenesis |
GO:0003278 | 0.005 | 26.4699 | 0.112 | 2 | 6 | apoptotic process involved in heart morphogenesis |
GO:0016115 | 0.005 | 26.4699 | 0.112 | 2 | 6 | terpenoid catabolic process |
GO:0021546 | 0.005 | 26.4699 | 0.112 | 2 | 6 | rhombomere development |
GO:0097647 | 0.005 | 26.4699 | 0.112 | 2 | 6 | amylin receptor signaling pathway |
GO:1904746 | 0.005 | 26.4699 | 0.112 | 2 | 6 | negative regulation of apoptotic process involved in development |
GO:0003215 | 0.005 | 9.9535 | 0.3546 | 3 | 19 | cardiac right ventricle morphogenesis |
GO:0010002 | 0.005 | 9.9535 | 0.3546 | 3 | 19 | cardioblast differentiation |
GO:0072079 | 0.005 | 9.9535 | 0.3546 | 3 | 19 | nephron tubule formation |
GO:1900745 | 0.005 | 9.9535 | 0.3546 | 3 | 19 | positive regulation of p38MAPK cascade |
GO:0012501 | 0.005 | 1.5453 | 34.7885 | 50 | 1864 | programmed cell death |
GO:0001892 | 0.0051 | 4.0581 | 1.5864 | 6 | 85 | embryonic placenta development |
GO:0050702 | 0.0053 | 6.2601 | 0.7092 | 4 | 38 | interleukin-1 beta secretion |
GO:0045995 | 0.0058 | 3.4689 | 2.1463 | 7 | 115 | regulation of embryonic development |
GO:2000778 | 0.0058 | 9.3674 | 0.3733 | 3 | 20 | positive regulation of interleukin-6 secretion |
GO:0051240 | 0.0059 | 1.6342 | 24.1307 | 37 | 1333 | positive regulation of multicellular organismal process |
GO:0035107 | 0.0059 | 3.1304 | 2.7062 | 8 | 145 | appendage morphogenesis |
GO:0010557 | 0.0059 | 1.5779 | 29.1148 | 43 | 1560 | positive regulation of macromolecule biosynthetic process |
GO:0007218 | 0.0061 | 3.9088 | 1.6424 | 6 | 88 | neuropeptide signaling pathway |
GO:0006937 | 0.0061 | 3.1075 | 2.7248 | 8 | 146 | regulation of muscle contraction |
GO:1901215 | 0.0063 | 2.8591 | 3.3221 | 9 | 178 | negative regulation of neuron death |
GO:0021983 | 0.0064 | 5.9115 | 0.7465 | 4 | 40 | pituitary gland development |
GO:0043586 | 0.0067 | 8.8464 | 0.3919 | 3 | 21 | tongue development |
GO:0048520 | 0.0067 | 8.8464 | 0.3919 | 3 | 21 | positive regulation of behavior |
GO:0060713 | 0.0067 | 8.8464 | 0.3919 | 3 | 21 | labyrinthine layer morphogenesis |
GO:0003203 | 0.0067 | 21.3749 | 0.1295 | 2 | 7 | endocardial cushion morphogenesis |
GO:0021700 | 0.0068 | 2.5093 | 4.6098 | 11 | 247 | developmental maturation |
GO:0003253 | 0.0069 | 21.1745 | 0.1306 | 2 | 7 | cardiac neural crest cell migration involved in outflow tract morphogenesis |
GO:0070943 | 0.0069 | 21.1745 | 0.1306 | 2 | 7 | neutrophil mediated killing of symbiont cell |
GO:0071863 | 0.0069 | 21.1745 | 0.1306 | 2 | 7 | regulation of cell proliferation in bone marrow |
GO:1902455 | 0.0069 | 21.1745 | 0.1306 | 2 | 7 | negative regulation of stem cell population maintenance |
GO:1904672 | 0.0069 | 21.1745 | 0.1306 | 2 | 7 | regulation of somatic stem cell population maintenance |
GO:0042345 | 0.007 | 5.7514 | 0.7652 | 4 | 41 | regulation of NF-kappaB import into nucleus |
GO:0051048 | 0.007 | 2.8086 | 3.3781 | 9 | 181 | negative regulation of secretion |
GO:0061138 | 0.0071 | 3.0269 | 2.7924 | 8 | 151 | morphogenesis of a branching epithelium |
GO:0042742 | 0.0072 | 2.7922 | 3.3967 | 9 | 182 | defense response to bacterium |
GO:0032088 | 0.0073 | 4.4424 | 1.2131 | 5 | 65 | negative regulation of NF-kappaB transcription factor activity |
GO:0050817 | 0.0073 | 2.2854 | 5.9723 | 13 | 320 | coagulation |
GO:0045937 | 0.0075 | 1.689 | 18.7753 | 30 | 1006 | positive regulation of phosphate metabolic process |
GO:0001657 | 0.0075 | 3.726 | 1.717 | 6 | 92 | ureteric bud development |
GO:0009953 | 0.0075 | 3.726 | 1.717 | 6 | 92 | dorsal/ventral pattern formation |
GO:0001501 | 0.0076 | 2.3633 | 5.333 | 12 | 295 | skeletal system development |
GO:0009855 | 0.0076 | 3.285 | 2.2583 | 7 | 121 | determination of bilateral symmetry |
GO:0003272 | 0.0076 | 8.3802 | 0.4106 | 3 | 22 | endocardial cushion formation |
GO:0060445 | 0.0076 | 8.3802 | 0.4106 | 3 | 22 | branching involved in salivary gland morphogenesis |
GO:0072163 | 0.0079 | 3.683 | 1.7357 | 6 | 93 | mesonephric epithelium development |
GO:0045165 | 0.0079 | 2.5844 | 4.0674 | 10 | 220 | cell fate commitment |
GO:0032502 | 0.0081 | 1.6249 | 24.9425 | 37 | 1576 | developmental process |
GO:0002443 | 0.0081 | 1.8363 | 12.5978 | 22 | 675 | leukocyte mediated immunity |
GO:0007411 | 0.0082 | 2.5712 | 4.0873 | 10 | 219 | axon guidance |
GO:0032720 | 0.0083 | 5.4557 | 0.8025 | 4 | 43 | negative regulation of tumor necrosis factor production |
GO:0010667 | 0.0086 | 7.9607 | 0.4293 | 3 | 23 | negative regulation of cardiac muscle cell apoptotic process |
GO:0002741 | 0.009 | 17.6442 | 0.1493 | 2 | 8 | positive regulation of cytokine secretion involved in immune response |
GO:0033141 | 0.009 | 17.6442 | 0.1493 | 2 | 8 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
GO:0045188 | 0.009 | 17.6442 | 0.1493 | 2 | 8 | regulation of circadian sleep/wake cycle, non-REM sleep |
GO:0001934 | 0.0097 | 1.7167 | 15.9385 | 26 | 854 | positive regulation of protein phosphorylation |
GO:0009967 | 0.0097 | 1.5644 | 25.7554 | 38 | 1380 | positive regulation of signal transduction |
GO:0072012 | 0.0097 | 7.5811 | 0.4479 | 3 | 24 | glomerulus vasculature development |
GO:0030178 | 0.0098 | 2.6525 | 3.5647 | 9 | 191 | negative regulation of Wnt signaling pathway |
GO:0032612 | 0.0099 | 4.0993 | 1.3064 | 5 | 70 | interleukin-1 production |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007389 | 0 | 4.1434 | 5.9765 | 22 | 406 | pattern specification process |
GO:0021877 | 0 | 205.3151 | 0.0584 | 3 | 4 | forebrain neuron fate commitment |
GO:0009790 | 0 | 2.5513 | 13.528 | 31 | 919 | embryo development |
GO:0045165 | 1e-04 | 4.0439 | 3.5035 | 13 | 238 | cell fate commitment |
GO:0045638 | 2e-04 | 6.685 | 1.1629 | 7 | 79 | negative regulation of myeloid cell differentiation |
GO:0021882 | 2e-04 | Inf | 0.0294 | 2 | 2 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment |
GO:0021893 | 2e-04 | Inf | 0.0294 | 2 | 2 | cerebral cortex GABAergic interneuron fate commitment |
GO:1902868 | 2e-04 | Inf | 0.0294 | 2 | 2 | positive regulation of retina development in camera-type eye |
GO:1902871 | 2e-04 | Inf | 0.0294 | 2 | 2 | positive regulation of amacrine cell differentiation |
GO:0008544 | 2e-04 | 3.1213 | 5.1816 | 15 | 352 | epidermis development |
GO:0043009 | 3e-04 | 2.6586 | 7.7179 | 19 | 531 | chordate embryonic development |
GO:0090023 | 3e-04 | 14.3292 | 0.3386 | 4 | 23 | positive regulation of neutrophil chemotaxis |
GO:0002690 | 3e-04 | 7.1499 | 0.9342 | 6 | 64 | positive regulation of leukocyte chemotaxis |
GO:0048562 | 3e-04 | 4.0671 | 2.6542 | 10 | 185 | embryonic organ morphogenesis |
GO:0048704 | 4e-04 | 5.6577 | 1.3543 | 7 | 92 | embryonic skeletal system morphogenesis |
GO:0031644 | 4e-04 | 6.85 | 0.9715 | 6 | 66 | regulation of neurological system process |
GO:0050920 | 5e-04 | 4.2276 | 2.2964 | 9 | 156 | regulation of chemotaxis |
GO:0021761 | 5e-04 | 5.402 | 1.4132 | 7 | 96 | limbic system development |
GO:0009952 | 6e-04 | 3.7609 | 2.8558 | 10 | 194 | anterior/posterior pattern specification |
GO:0014029 | 6e-04 | 22.6003 | 0.1766 | 3 | 12 | neural crest formation |
GO:0097154 | 6e-04 | 22.6003 | 0.1766 | 3 | 12 | GABAergic neuron differentiation |
GO:0002501 | 6e-04 | 135.0631 | 0.0442 | 2 | 3 | peptide antigen assembly with MHC protein complex |
GO:0099566 | 6e-04 | 135.0631 | 0.0442 | 2 | 3 | regulation of postsynaptic cytosolic calcium ion concentration |
GO:1902732 | 6e-04 | 135.0631 | 0.0442 | 2 | 3 | positive regulation of chondrocyte proliferation |
GO:0030216 | 9e-04 | 3.5646 | 3.003 | 10 | 204 | keratinocyte differentiation |
GO:1902622 | 9e-04 | 10.4664 | 0.4416 | 4 | 30 | regulation of neutrophil migration |
GO:0007610 | 0.001 | 2.432 | 7.9196 | 18 | 538 | behavior |
GO:0048513 | 0.0011 | 1.7169 | 32.7402 | 50 | 2370 | animal organ development |
GO:0055123 | 0.0011 | 4.1698 | 2.0609 | 8 | 140 | digestive system development |
GO:0050706 | 0.0012 | 9.7175 | 0.4711 | 4 | 32 | regulation of interleukin-1 beta secretion |
GO:0048870 | 0.0012 | 1.8738 | 19.74 | 34 | 1341 | cell motility |
GO:0042475 | 0.0012 | 5.4745 | 1.1924 | 6 | 81 | odontogenesis of dentin-containing tooth |
GO:0048866 | 0.0013 | 67.527 | 0.0589 | 2 | 4 | stem cell fate specification |
GO:0048665 | 0.0013 | 9.3818 | 0.4858 | 4 | 33 | neuron fate specification |
GO:0007186 | 0.0014 | 2.0876 | 12.3504 | 24 | 839 | G-protein coupled receptor signaling pathway |
GO:0048646 | 0.0015 | 2.0219 | 13.8516 | 26 | 953 | anatomical structure formation involved in morphogenesis |
GO:0070098 | 0.0015 | 6.56 | 0.8391 | 5 | 57 | chemokine-mediated signaling pathway |
GO:0009953 | 0.0015 | 5.2423 | 1.2406 | 6 | 85 | dorsal/ventral pattern formation |
GO:0021872 | 0.0017 | 6.3162 | 0.8685 | 5 | 59 | forebrain generation of neurons |
GO:0060326 | 0.0018 | 3.2271 | 3.2974 | 10 | 224 | cell chemotaxis |
GO:1903557 | 0.002 | 6.0898 | 0.8979 | 5 | 61 | positive regulation of tumor necrosis factor superfamily cytokine production |
GO:0046533 | 0.0021 | 45.015 | 0.0736 | 2 | 5 | negative regulation of photoreceptor cell differentiation |
GO:0042474 | 0.0022 | 13.5548 | 0.265 | 3 | 18 | middle ear morphogenesis |
GO:0045765 | 0.0023 | 3.1234 | 3.4004 | 10 | 231 | regulation of angiogenesis |
GO:0060485 | 0.0023 | 3.1234 | 3.4004 | 10 | 231 | mesenchyme development |
GO:0030855 | 0.0023 | 2.1966 | 9.215 | 19 | 626 | epithelial cell differentiation |
GO:1902105 | 0.0023 | 3.1092 | 3.4151 | 10 | 232 | regulation of leukocyte differentiation |
GO:2000026 | 0.0024 | 1.7135 | 25.4368 | 40 | 1728 | regulation of multicellular organismal development |
GO:0021543 | 0.0025 | 3.6404 | 2.3405 | 8 | 159 | pallium development |
GO:0003215 | 0.0026 | 12.7067 | 0.2797 | 3 | 19 | cardiac right ventricle morphogenesis |
GO:0021895 | 0.0026 | 12.7067 | 0.2797 | 3 | 19 | cerebral cortex neuron differentiation |
GO:0023019 | 0.0026 | 12.7067 | 0.2797 | 3 | 19 | signal transduction involved in regulation of gene expression |
GO:0008284 | 0.0026 | 2.0492 | 11.4679 | 22 | 789 | positive regulation of cell proliferation |
GO:0070268 | 0.0026 | 4.6617 | 1.3837 | 6 | 94 | cornification |
GO:0071622 | 0.0028 | 7.554 | 0.5888 | 4 | 40 | regulation of granulocyte chemotaxis |
GO:0006874 | 0.0028 | 2.5852 | 5.3288 | 13 | 362 | cellular calcium ion homeostasis |
GO:0044706 | 0.003 | 3.227 | 2.9588 | 9 | 201 | multi-multicellular organism process |
GO:0051482 | 0.003 | 11.9585 | 0.2944 | 3 | 20 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway |
GO:0045944 | 0.003 | 1.8835 | 15.3681 | 27 | 1044 | positive regulation of transcription from RNA polymerase II promoter |
GO:0021902 | 0.0031 | 33.759 | 0.0883 | 2 | 6 | commitment of neuronal cell to specific neuron type in forebrain |
GO:0061074 | 0.0031 | 33.759 | 0.0883 | 2 | 6 | regulation of neural retina development |
GO:0050701 | 0.0033 | 7.1555 | 0.6183 | 4 | 42 | interleukin-1 secretion |
GO:0048514 | 0.0034 | 2.2816 | 7.4338 | 16 | 505 | blood vessel morphogenesis |
GO:0097530 | 0.0034 | 4.4096 | 1.4573 | 6 | 99 | granulocyte migration |
GO:0003008 | 0.0035 | 1.7174 | 22.6694 | 36 | 1540 | system process |
GO:0048863 | 0.0036 | 2.9219 | 3.6212 | 10 | 246 | stem cell differentiation |
GO:0021517 | 0.0036 | 6.9716 | 0.633 | 4 | 43 | ventral spinal cord development |
GO:0030826 | 0.0039 | 10.6983 | 0.3238 | 3 | 22 | regulation of cGMP biosynthetic process |
GO:0045589 | 0.0039 | 10.6983 | 0.3238 | 3 | 22 | regulation of regulatory T cell differentiation |
GO:0051093 | 0.004 | 1.9686 | 11.8941 | 22 | 808 | negative regulation of developmental process |
GO:0051272 | 0.0041 | 2.3772 | 6.2267 | 14 | 423 | positive regulation of cellular component movement |
GO:0002573 | 0.0041 | 3.3284 | 2.5466 | 8 | 173 | myeloid leukocyte differentiation |
GO:0035050 | 0.0042 | 5.0862 | 1.0599 | 5 | 72 | embryonic heart tube development |
GO:0032501 | 0.0043 | 1.5678 | 47.1172 | 63 | 3751 | multicellular organismal process |
GO:0001826 | 0.0043 | 27.0054 | 0.103 | 2 | 7 | inner cell mass cell differentiation |
GO:0021798 | 0.0043 | 27.0054 | 0.103 | 2 | 7 | forebrain dorsal/ventral pattern formation |
GO:0060017 | 0.0043 | 27.0054 | 0.103 | 2 | 7 | parathyroid gland development |
GO:0006952 | 0.0043 | 1.7438 | 19.7253 | 32 | 1340 | defense response |
GO:0017148 | 0.0045 | 2.8246 | 3.739 | 10 | 254 | negative regulation of translation |
GO:0032461 | 0.0045 | 10.1627 | 0.3386 | 3 | 23 | positive regulation of protein oligomerization |
GO:0044030 | 0.0045 | 10.1627 | 0.3386 | 3 | 23 | regulation of DNA methylation |
GO:0007215 | 0.0047 | 4.9381 | 1.0893 | 5 | 74 | glutamate receptor signaling pathway |
GO:0060562 | 0.0047 | 2.6462 | 4.3867 | 11 | 298 | epithelial tube morphogenesis |
GO:0030878 | 0.0051 | 9.6781 | 0.3533 | 3 | 24 | thyroid gland development |
GO:0007492 | 0.0055 | 4.7314 | 1.1335 | 5 | 77 | endoderm development |
GO:0030335 | 0.0057 | 2.3629 | 5.7998 | 13 | 394 | positive regulation of cell migration |
GO:0060638 | 0.0057 | 22.503 | 0.1178 | 2 | 8 | mesenchymal-epithelial cell signaling |
GO:2000510 | 0.0057 | 22.503 | 0.1178 | 2 | 8 | positive regulation of dendritic cell chemotaxis |
GO:0010469 | 0.0058 | 2.208 | 7.1688 | 15 | 487 | regulation of receptor activity |
GO:0007566 | 0.0058 | 6.0396 | 0.7213 | 4 | 49 | embryo implantation |
GO:0040017 | 0.0059 | 2.2687 | 6.5064 | 14 | 442 | positive regulation of locomotion |
GO:0048546 | 0.0062 | 5.9079 | 0.736 | 4 | 50 | digestive tract morphogenesis |
GO:0060688 | 0.0062 | 5.9079 | 0.736 | 4 | 50 | regulation of morphogenesis of a branching structure |
GO:0002685 | 0.0063 | 3.8575 | 1.6514 | 6 | 114 | regulation of leukocyte migration |
GO:0021515 | 0.0067 | 5.7818 | 0.7507 | 4 | 51 | cell differentiation in spinal cord |
GO:0072507 | 0.0068 | 2.307 | 5.9323 | 13 | 403 | divalent inorganic cation homeostasis |
GO:0000003 | 0.0069 | 1.7091 | 18.7538 | 30 | 1274 | reproduction |
GO:0002385 | 0.0071 | 8.4666 | 0.3975 | 3 | 27 | mucosal immune response |
GO:0042104 | 0.0071 | 8.4666 | 0.3975 | 3 | 27 | positive regulation of activated T cell proliferation |
GO:0060706 | 0.0071 | 8.4666 | 0.3975 | 3 | 27 | cell differentiation involved in embryonic placenta development |
GO:0002664 | 0.0073 | 19.287 | 0.1325 | 2 | 9 | regulation of T cell tolerance induction |
GO:0006069 | 0.0073 | 19.287 | 0.1325 | 2 | 9 | ethanol oxidation |
GO:0007196 | 0.0073 | 19.287 | 0.1325 | 2 | 9 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway |
GO:0042747 | 0.0073 | 19.287 | 0.1325 | 2 | 9 | circadian sleep/wake cycle, REM sleep |
GO:0048617 | 0.0073 | 19.287 | 0.1325 | 2 | 9 | embryonic foregut morphogenesis |
GO:0007423 | 0.0081 | 2.1198 | 7.4485 | 15 | 506 | sensory organ development |
GO:0051707 | 0.0084 | 1.9271 | 10.4073 | 19 | 707 | response to other organism |
GO:0040029 | 0.0085 | 2.43 | 4.7547 | 11 | 323 | regulation of gene expression, epigenetic |
GO:0001944 | 0.0085 | 2.0048 | 8.9353 | 17 | 607 | vasculature development |
GO:0036230 | 0.0088 | 2.1595 | 6.8155 | 14 | 463 | granulocyte activation |
GO:0033690 | 0.009 | 16.875 | 0.1472 | 2 | 10 | positive regulation of osteoblast proliferation |
GO:0048715 | 0.009 | 16.875 | 0.1472 | 2 | 10 | negative regulation of oligodendrocyte differentiation |
GO:0061140 | 0.009 | 16.875 | 0.1472 | 2 | 10 | lung secretory cell differentiation |
GO:1904627 | 0.009 | 16.875 | 0.1472 | 2 | 10 | response to phorbol 13-acetate 12-myristate |
GO:0050918 | 0.0092 | 5.2241 | 0.8243 | 4 | 56 | positive chemotaxis |
GO:0001501 | 0.0093 | 2.1447 | 6.8597 | 14 | 466 | skeletal system development |
GO:0051930 | 0.0095 | 7.5244 | 0.4416 | 3 | 30 | regulation of sensory perception of pain |
GO:0051241 | 0.0097 | 1.7639 | 14.4113 | 24 | 979 | negative regulation of multicellular organismal process |
GO:0032496 | 0.0097 | 2.5009 | 4.1953 | 10 | 285 |